<SEC-DOCUMENT>0001641172-25-011816.txt : 20250520
<SEC-HEADER>0001641172-25-011816.hdr.sgml : 20250520
<ACCEPTANCE-DATETIME>20250520173008
ACCESSION NUMBER:		0001641172-25-011816
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20241228
FILED AS OF DATE:		20250520
DATE AS OF CHANGE:		20250520

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KOPIN CORP
		CENTRAL INDEX KEY:			0000771266
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				042833935
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1228

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19882
		FILM NUMBER:		25970162

	BUSINESS ADDRESS:	
		STREET 1:		125 NORTH DRIVE
		CITY:			WESTBOROUGH
		STATE:			MA
		ZIP:			01581
		BUSINESS PHONE:		508-870-5959

	MAIL ADDRESS:	
		STREET 1:		125 NORTH DRIVE
		CITY:			WESTBOROUGH
		STATE:			MA
		ZIP:			01581
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>formdef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:KOPN="http://kopin.com/20241228">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_ECD%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_KOPN_kopin.com_20241228 -->
<!-- Field: Set; Name: xdx; ID: xdx_047_20231231_20241228 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0000771266 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-12-31to2024-12-28" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-12-31to2024-12-28" id="Fact000004" name="dei:EntityCentralIndexKey">0000771266</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-12-31to2024-12-28" id="xdx2ixbrl0011" name="dei:DocumentType">DEF 14A</ix:nonNumeric>
  <ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-12-312024-12-28_custom_JohnCCFanMember" id="xdx2ixbrl0016" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-12-312024-12-28_custom_JohnCCFanMember" id="xdx2ixbrl0017" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-01-012023-12-30_custom_JohnCCFanMember" id="xdx2ixbrl0024" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-01-012023-12-30_custom_JohnCCFanMember" id="xdx2ixbrl0025" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-12-312024-12-28_custom_MMurrayMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" id="xdx2ixbrl0066" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-12-312024-12-28_custom_MMurrayMember_custom_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" id="xdx2ixbrl0069" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-30_custom_MMurrayMember_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" id="xdx2ixbrl0075" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-30_custom_MMurrayMember_custom_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" id="xdx2ixbrl0076" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-06-272022-12-31_custom_MMurrayMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" id="xdx2ixbrl0079" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-06-272022-12-31_custom_MMurrayMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" id="xdx2ixbrl0080" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-06-272022-12-31_custom_MMurrayMember_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" id="xdx2ixbrl0081" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-06-272022-12-31_custom_MMurrayMember_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" id="xdx2ixbrl0082" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-06-272022-12-31_custom_MMurrayMember_custom_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" id="xdx2ixbrl0083" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-12-262022-12-31_custom_DrFanMember_custom_ReportedValueOfEquityAwardsMember" id="xdx2ixbrl0086" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-12-262022-12-31_custom_DrFanMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember" id="xdx2ixbrl0091" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-12-262022-12-31_custom_DrFanMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" id="xdx2ixbrl0093" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-12-262022-12-31_custom_DrFanMember_custom_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" id="xdx2ixbrl0096" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_ReportedValueOfEquityAwardsMember" id="xdx2ixbrl0109" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" id="xdx2ixbrl0116" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" id="xdx2ixbrl0119" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" id="xdx2ixbrl0126" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember" id="xdx2ixbrl0128" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" id="xdx2ixbrl0130" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" id="xdx2ixbrl0133" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="kopn-20241228.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-12-31to2024-12-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-312024-12-28_custom_JohnCCFanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:JohnCCFanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-312024-12-28_custom_MMurrayMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-30_custom_JohnCCFanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:JohnCCFanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-30_custom_MMurrayMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-262022-12-31_custom_JohnCCFanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:JohnCCFanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-26</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-262022-12-31_custom_MMurrayMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-26</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-262022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-26</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-262022-06-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-26</xbrli:startDate>
        <xbrli:endDate>2022-06-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-272022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-27</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-312024-12-28_custom_MMurrayMember_custom_ReportedValueOfEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-30_custom_MMurrayMember_custom_ReportedValueOfEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-272022-12-31_custom_MMurrayMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-27</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-272022-12-31_custom_MMurrayMember_custom_ReportedValueOfEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-27</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-312024-12-28_custom_MMurrayMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-312024-12-28_custom_MMurrayMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-312024-12-28_custom_MMurrayMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-312024-12-28_custom_MMurrayMember_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-312024-12-28_custom_MMurrayMember_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-312024-12-28_custom_MMurrayMember_custom_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-30_custom_MMurrayMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-30_custom_MMurrayMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-30_custom_MMurrayMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-30_custom_MMurrayMember_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-30_custom_MMurrayMember_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-30_custom_MMurrayMember_custom_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-272022-12-31_custom_MMurrayMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-27</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-272022-12-31_custom_MMurrayMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-27</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-272022-12-31_custom_MMurrayMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-27</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-272022-12-31_custom_MMurrayMember_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-27</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-272022-12-31_custom_MMurrayMember_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-27</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-272022-12-31_custom_MMurrayMember_custom_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-27</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-262022-12-31_custom_DrFanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:DrFanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-26</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-262022-12-31_custom_DrFanMember_custom_ReportedValueOfEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:DrFanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-26</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-262022-12-31_custom_DrFanMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:DrFanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-26</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-262022-12-31_custom_DrFanMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:DrFanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-26</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-262022-12-31_custom_DrFanMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:DrFanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-26</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-262022-12-31_custom_DrFanMember_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:DrFanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-26</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-262022-12-31_custom_DrFanMember_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:DrFanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-26</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-262022-12-31_custom_DrFanMember_custom_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:DrFanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-26</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-312024-12-28_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_ReportedValueOfEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-30_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_ReportedValueOfEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-262022-12-31_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-26</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_ReportedValueOfEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-26</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-26</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-26</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-26</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-26</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-26</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000771266</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-26</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="xdx2ixbrl0016" toRefs="Footnote000046"/>
  <ix:relationship fromRefs="xdx2ixbrl0017" toRefs="Footnote000046"/>
  <ix:relationship fromRefs="Fact000018" toRefs="Footnote000046"/>
  <ix:relationship fromRefs="Fact000019" toRefs="Footnote000046 Footnote000047"/>
  <ix:relationship fromRefs="Fact000020" toRefs="Footnote000046"/>
  <ix:relationship fromRefs="Fact000021" toRefs="Footnote000046 Footnote000047"/>
  <ix:relationship fromRefs="xdx2ixbrl0024" toRefs="Footnote000046"/>
  <ix:relationship fromRefs="xdx2ixbrl0025" toRefs="Footnote000046"/>
  <ix:relationship fromRefs="Fact000026" toRefs="Footnote000046"/>
  <ix:relationship fromRefs="Fact000027" toRefs="Footnote000046 Footnote000047"/>
  <ix:relationship fromRefs="Fact000028" toRefs="Footnote000046"/>
  <ix:relationship fromRefs="Fact000029" toRefs="Footnote000046 Footnote000047"/>
  <ix:relationship fromRefs="Fact000032" toRefs="Footnote000046"/>
  <ix:relationship fromRefs="Fact000033" toRefs="Footnote000046"/>
  <ix:relationship fromRefs="Fact000034" toRefs="Footnote000046"/>
  <ix:relationship fromRefs="Fact000035" toRefs="Footnote000046 Footnote000047"/>
  <ix:relationship fromRefs="Fact000036" toRefs="Footnote000046"/>
  <ix:relationship fromRefs="Fact000037" toRefs="Footnote000046 Footnote000047"/>
  <ix:relationship fromRefs="Fact000051" toRefs="Footnote000062"/>
  <ix:relationship fromRefs="Fact000055" toRefs="Footnote000062"/>
  <ix:relationship fromRefs="Fact000059" toRefs="Footnote000062"/>
  <ix:relationship fromRefs="Fact000052" toRefs="Footnote000063"/>
  <ix:relationship fromRefs="Fact000056" toRefs="Footnote000063"/>
  <ix:relationship fromRefs="Fact000060" toRefs="Footnote000063"/>
  <ix:relationship fromRefs="xdx2ixbrl0086" toRefs="Footnote000089"/>
  <ix:relationship fromRefs="Fact000087" toRefs="Footnote000090"/>
  <ix:relationship fromRefs="Fact000100" toRefs="Footnote000112"/>
  <ix:relationship fromRefs="Fact000104" toRefs="Footnote000112"/>
  <ix:relationship fromRefs="Fact000108" toRefs="Footnote000112"/>
  <ix:relationship fromRefs="Fact000102" toRefs="Footnote000113"/>
  <ix:relationship fromRefs="Fact000103" toRefs="Footnote000113"/>
  <ix:relationship fromRefs="Fact000106" toRefs="Footnote000113"/>
  <ix:relationship fromRefs="Fact000107" toRefs="Footnote000113"/>
  <ix:relationship fromRefs="Fact000110" toRefs="Footnote000113"/>
  <ix:relationship fromRefs="Fact000111" toRefs="Footnote000113"/>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; margin-top: 0pt; font-size: 1pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_906_edei--DocumentType_dxL_c20231231__20241228_zjR03mLFkOD" title="::XDX::DEF%2014A"><span style="-sec-ix-hidden: xdx2ixbrl0011">SCHEDULE
14A</span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Rule
14a-101)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INFORMATION
REQUIRED IN PROXY STATEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SCHEDULE
14A INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proxy
Statement Pursuant to Section 14(a) of the</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Exchange Act of 1934 (Amendment No.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
by the Registrant &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
by a Party other than the Registrant &#8201;&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary
    Proxy Statement </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidential,
    for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Proxy Statement </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Additional Materials </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    Material Pursuant to Section &#167;240.14a-12 </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_909_edei--EntityRegistrantName_c20231231__20241228_zWIypdcEziwe"><ix:nonNumeric contextRef="From2023-12-31to2024-12-28" id="Fact000012" name="dei:EntityRegistrantName">Kopin
Corporation</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of Registrant as Specified in Its Charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of Person(s) Filing Proxy Statement, if other than the Registrant)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
of Filing Fee (Check the appropriate box):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    fee required</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    paid previously with preliminary materials.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>KOPIN
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">125
North Drive, Westborough, Massachusetts 01581</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
19, 2025</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
Our Stockholders:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
are cordially invited to attend the 2025 Annual Meeting of Stockholders of KOPIN CORPORATION, to be held at the offices of Morgan, Lewis
&amp; Bockius LLP, One Federal Street, Boston, Massachusetts 02110 at 9:00 a.m. Eastern Time on Thursday, June 26, 2025 (the &#8220;Meeting&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notice of Meeting and the Proxy Statement that follow describe the business to be considered and acted upon by the stockholders at the
Meeting. Our Annual Report on Form 10-K for the fiscal year ended December 28, 2024, as amended, is also enclosed for your information.
The enclosed proxy statement is being mailed to stockholders of record on or about May 19, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors encourages your participation in Kopin Corporation&#8217;s electoral process and, to that end, solicits your proxy
with respect to the matters described in the Notice of Meeting and the Proxy Statement. You may submit your proxy by completing, dating
and signing the enclosed Proxy Card and returning it promptly in the enclosed envelope. You may also vote by telephone or by the Internet,
as described in the Proxy Statement. You are urged to vote by mail, telephone or Internet even if you plan to attend the Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
                                            Murray</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Chairman</i></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>KOPIN
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">125
North Drive, Westborough, Massachusetts 01581</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTICE
OF ANNUAL MEETING OF STOCKHOLDERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>To
Be Held On Thursday, June 26, 2025</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
is hereby given that the 2025 Annual Meeting (the &#8220;Meeting&#8221;) of Stockholders of Kopin Corporation (the &#8220;Company&#8221;)
will be held at the offices of Morgan, Lewis &amp; Bockius LLP, One Federal Street, Boston, Massachusetts 02110, on Thursday, June 26,
2025, at 9:00 a.m. Eastern Time, to consider and act upon the following matters:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    elect the five (5) directors named in the accompanying proxy statement to serve on the Board of Directors of the Company each for
    a term expiring at the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve an amendment to the Company&#8217;s 2020 Equity Incentive Plan to increase the number of shares authorized for issuance under
    the 2020 Equity Incentive Plan from 14,000,000 to 19,000,000. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve an amendment to the Company&#8217;s Certificate of Incorporation to increase the number of authorized common shares from
    200,000,000 to 275,000,000. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    ratify the appointment of BDO USA, P.C. (BDO) as the independent registered public accounting firm of the Company for the
    current fiscal year ending December 27, 2025. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve, on an advisory basis, the compensation of the Company&#8217;s named executive officers during the fiscal year ended December
    28, 2024. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
of record at the close of business on Thursday, May 1, 2025, the record date for the Meeting, are entitled to notice of and to vote at
the Meeting and any adjournments thereof. The enclosed proxy statement is being mailed to those stockholders on or about May 19,
2025. All stockholders are cordially invited to attend the Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Order of the Board of Directors</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MICHAEL
    MURRAY</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Chairman</i></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Westborough,
Massachusetts</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
19, 2025</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHETHER
OR NOT YOU EXPECT TO BE PRESENT AT THE MEETING, PLEASE COMPLETE, DATE, SIGN AND MAIL THE ENCLOSED PROXY CARD, WHICH IS SOLICITED BY THE
BOARD OF DIRECTORS OF THE COMPANY, AND PROMPTLY RETURN IT IN THE PREADDRESSED ENVELOPE PROVIDED FOR THAT PURPOSE. THE ENCLOSED ENVELOPE
REQUIRES NO POSTAGE IF MAILED IN THE UNITED STATES. ALTERNATIVELY, YOU MAY VOTE BY TELEPHONE OR THE INTERNET AS DESCRIBED IN THE PROXY
STATEMENT. IF YOU ATTEND THE MEETING, YOU MAY WITHDRAW ANY PROXY PREVIOUSLY GIVEN BY YOU AND YOU MAY VOTE YOUR SHARES IN PERSON AT THE
MEETING.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SPECIAL
NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
proxy statement may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), which are subject to the safe harbor
created by such sections. Words such as &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221;
&#8220;believes,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;seeks,&#8221; &#8220;estimates,&#8221; and variations of such
words and similar expressions, and the negatives thereof, are intended to identify such forward-looking statements. These statements
involve known and unknown risks, uncertainties and other factors that could cause our actual results to differ materially from the forward-looking
statements expressed or implied in the proxy statement. Such risks, uncertainties and other factors include those risks described in
&#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;
in the Company&#8217;s most recent Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;)
and other subsequent documents we file with the SEC. The Company expressly disclaims any obligation to update or alter any statements
whether as a result of new information, future events or otherwise, except as required by law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Websites
and Other Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Website
addresses referenced in this proxy statement inactive textual references only, and the content on the referenced websites specifically
does not constitute a part of this proxy statement and is not incorporated by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>125
North Drive</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Westborough,
Massachusetts 01581</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROXY
STATEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Important
Notice Regarding Internet Availability of Proxy Materials for the Stockholders Meeting to be Held at the Offices of Morgan, Lewis &amp;
Bockius LLP, One Federal Street, Boston, Massachusetts 02110 on Thursday, June 26, 2025, at 9:00 a.m. Eastern Time. The Proxy
Statement and our 2024 Annual Report to Stockholders are also available on our website at www.kopin.com/proxy.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement and the accompanying proxy card are being furnished in connection with the solicitation by the Board of Directors (the
&#8220;Board&#8221;) of Kopin Corporation (the &#8220;Company&#8221;) for use at the 2025 Annual Meeting of Stockholders (the &#8220;Meeting&#8221;)
to be held at the offices of Morgan, Lewis &amp; Bockius LLP, One Federal Street, Boston, Massachusetts 02110 on Thursday, June 26, 2025,
at 9:00 a.m Eastern Time., and at any adjournments, continuations or postponements thereof. This proxy statement, the accompanying proxy
card and our Annual Report for the fiscal year ended December 28, 2024, are being first mailed to stockholders on or about May 19,
2025. Stockholders will be asked to consider and act upon the following matters at the Meeting:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    elect the five (5) directors to serve on the Board of Directors of the Company each for a term expiring at the 2026 Annual Meeting
    of Stockholders and until their successors are duly elected and qualified. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve an amendment to the Company&#8217;s 2020 Equity Incentive Plan to increase the number of shares authorized for issuance under
    the 2020 Equity Incentive Plan from 14,000,000 to 19,000,000. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    proposal to approve an amendment to the Company&#8217;s Certificate of Incorporation to increase the number of authorized
    common shares from 200,000,000 to 275,000,000. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    ratify the appointment of BDO. as the independent registered public accounting firm of the Company for the current fiscal
    year ending December 27, 2025. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve, on an advisory basis, the compensation of the Company&#8217;s named executive officers during the fiscal year ended December
    28, 2024. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
solicitation expenses, including costs of preparing, assembling and mailing proxy materials, will be borne by the Company. It is expected
that solicitations will be made primarily by mail, but our directors, officers and other employees also may solicit proxies by telephone
and in person, without additional compensation. Arrangements will be made with brokerage houses and other custodians, nominees and fiduciaries
for proxy materials to be sent to their principals, and we will reimburse such persons for their reasonable expenses in so doing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
close of business on Thursday, May 1, 2025, has been established as the record date for determining the stockholders entitled to notice
of and to vote at the Meeting and at any adjournments thereof. As of the record date, there were 162,797,894 shares of our common
stock issued and outstanding and entitled to vote. Holders of shares of our common stock are entitled to one vote for each share owned
as of the record date on all matters to come before the Meeting and any adjournments thereof. The presence in person or by proxy of holders
of a majority of the issued and outstanding shares of our common stock entitled to vote at the Meeting constitutes a quorum for the transaction
of business at the Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
may vote by completing the enclosed proxy card and mailing it in the envelope provided, by using the toll-free telephone number provided
on the proxy card, over the Internet or in person at the Meeting. The Internet and telephone voting facilities for stockholders of record
will close at 11:59 p.m. Eastern Time on Wednesday, June 25, 2025, the day before the Meeting. Any proxy submitted prior to the Meeting
may be revoked at any time before it is voted by written notice of revocation received by the Secretary of the Company prior to the Meeting,
by delivering a later dated proxy in accordance with the instructions on the enclosed proxy by voting in person at the Meeting or by
revoking a written proxy by request in person at the Meeting. If the proxy submitted is not so revoked, the shares represented by such
proxy will be voted in accordance with the instructions contained therein. If no choice is specified for one or more proposals in a proxy
submitted by or on behalf of a stockholder, the shares represented by such proxy will be voted in favor of such proposals and in the
discretion of the named proxies with respect to any other proposals that may properly come before the Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
Proposal 1, our Sixth Amended and Restated By-laws (the &#8220;By-laws&#8221;) provide a majority voting standard for election of directors
in uncontested elections. Each director will be elected by the affirmative vote of a majority of the votes cast, meaning that the number
of votes cast &#8220;FOR&#8221; a director nominee exceeds the number of &#8220;AGAINST&#8221; votes with respect to that director&#8217;s
election. Broker non-votes and abstentions will have no effect on the outcome of the vote for Proposal 1. Pursuant to our By-laws, each
person who is nominated to stand for election as director must tender an irrevocable and executed letter of resignation in advance of
the meeting for the election of directors. If an incumbent director nominee is not elected in an uncontested election and no successor
has been elected at such meeting, the director must promptly tender his or her resignation to the Board. The Nominating and Corporate
Governance Committee of the Board (excluding the nominee, if applicable) then will make a recommendation to the Board as to whether to
accept or reject the resignation, or whether other action should be taken. The Board, excluding the nominee, will act on the resignation
and publicly disclose its decision in accordance with the By-laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposals
2, 4 and 5 will be approved upon the affirmative vote of a majority of shares present in person or represented by proxy at the Meeting
and entitled to vote on each such proposal. Abstentions will be counted for each of Proposals 2, 4 and 5, and will have the same effect
as a vote against each such proposal. Broker non- votes, if any, will have no effect on the outcome of the vote of Proposals 2, 4 or
5. However, Proposal 4, the ratification of the appointment of BDO as our independent registered public accounting firm, is considered
a &#8220;routine&#8221; matter. As such, brokers that have not received voting instructions from the beneficial holders are allowed to
vote their clients&#8217; shares on Proposal 4 without having received voting instructions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
3 will be approved upon the affirmative vote of a majority of the Company&#8217;s outstanding stock entitled to vote thereon. Proposal
3 is considered a discretionary matter. Therefore, if your shares are held by your bank, brokerage firm or other nominee in &#8220;street
name&#8221; and you do not provide voting instructions with respect to your shares, your bank, brokerage firm or other nominee may vote
your shares on Proposal 3. Broker non-votes (if any) and abstentions will have the same effect as votes cast against the proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
in a proxy submitted on behalf of a stockholder by a person acting solely in a representative capacity, the proxy is marked clearly to
indicate that the shares represented thereby are not being voted with respect to one or more proposals, then such proxies will be counted
as present for purposes of establishing a quorum at the Meeting. Proxies marked as &#8220;abstain&#8221; as to one or more proposals
will be counted as present for purposes of establishing a quorum at the Meeting and for the purpose of calculating the vote on such proposals.
Such abstentions will have the effect of a vote against such proposals other than Proposal 1 (for which they will have no effect on the
voting results).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
chairman of the Meeting or the holders of a majority of the shares present in person or represented by proxy at the Meeting and entitled
to vote have the power to adjourn the Meeting from time to time without notice other than announcement at the Meeting of the time and
place of the adjourned meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this proxy statement, we do not know of any matters that will be brought before the Meeting other than those matters specifically
set forth in the Notice of Annual Meeting of Stockholders. However, if any other matter properly comes before the Meeting, it is intended
that the persons named as proxies in the enclosed proxy card, or their substitutes acting thereunder, will vote on any such matter in
accordance with their best judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
Governance Matters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board has an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. The following table lists
each of our current directors and provides membership information for each of the committees:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit</b></span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; width: 14%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nominating
                                            and</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
    Governance </b></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jill
    J. Avery</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X
    </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chi
    Chia Hsieh+</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X
    </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Murray</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Nieuwsma</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Margaret</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    Seif#</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center">X</td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Walsh, Jr*.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    Committee Chairperson</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominating
    Committee Chairperson</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
    Committee Chairperson </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Corporate
Governance Guidelines</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board has adopted written charters for each of its Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee.
Our Board has also adopted corporate governance guidelines, a code of business conduct and ethics for employees, executive officers and
directors, a policy on conflict minerals sourcing and a whistleblower policy regarding the treatment of complaints on accounting, internal
accounting controls and auditing matters. All of these documents are available on our website at <i>www.kopin.com </i>under the heading
&#8220;Investors Relations: Governance Documents.&#8221; A copy of any of these documents may be obtained, without charge, upon written
request to Kopin Corporation, c/o Investor Relations, 125 North Drive, Westborough, MA 01581.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Corporate
Governance Practices and Board Independence</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
year, our Board reviews the relationships that each director has with us and with other parties. With the exception of Michael Murray,
our current Chairman of the Board, President and Chief Executive Officer, only those directors who do not have any of the categorical
relationships that preclude them from being independent within the meaning of applicable Nasdaq Stock Market, Inc. Marketplace Rules
(the &#8220;Nasdaq Rules&#8221;), and whom the Board affirmatively determines have no relationships that would interfere with the exercise
of independent judgment in carrying out the responsibilities of a director, are considered to be independent directors. Our Board has
reviewed several factors to evaluate the independence of each of its members. These factors include the members&#8217; current and historic
relationships with us and our competitors, suppliers and customers; their relationships with management and other directors; the relationships
their current and former employers have with us; and the relationships between us and other companies of which a member of our Board
is a director or executive officer. After evaluating these factors, our Board has determined that a majority of the current members of
the Board and director nominees, namely, Jill J. Avery, Margret Seif, David Nieuwsma, Chi Chia Hsieh and Paul Walsh, Jr. do not have
any relationships that would interfere with the exercise of independent judgment in carrying out their responsibilities as a director
and are independent directors of Kopin Corporation within the meaning of the applicable Nasdaq Rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
making its independence determinations, our Board considered transactions occurring since the beginning of 2022 between us and entities
associated with the independent directors or members of their immediate family. All identified transactions that appear to relate to
Kopin Corporation and a person or entity with a known connection to a director are presented to the Board for consideration. In making
its subjective determination that each non-employee director is independent, our Board considered the transactions in the context of
the Nasdaq Rules, the standards established by the SEC for members of audit committees and the SEC and Internal Revenue Service standards
for compensation committee members. Our Board&#8217;s independence determinations included reviewing the following transactions and relationships:
Dr. Hsieh is a director of KoBrite Corp. (&#8220;KoBrite&#8221;), in which Kopin owned a minority interest which we sold in 2025.
Dr. Hsieh is also a director of Bright LED, which is the majority owner of KoBrite. The Board determined that these relationships are
not material and that it does not impair Dr. Hsieh&#8217;s independence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nomination
and Election of Directors</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
seeking candidates for director, the Nominating and Corporate Governance Committee (the &#8220;Nominating Committee&#8221;) may solicit
suggestions from incumbent directors, management or others. After conducting an initial evaluation of a candidate, the Nominating Committee
will interview that candidate if it believes the candidate might be suitable to serve as a director. The Nominating Committee may also
ask the candidate to meet with our management. If the Nominating Committee believes a candidate would be a valuable addition to the Board
and there is either a vacancy on the Board or the Nominating Committee believes it is in the best interests of Kopin Corporation and
its stockholders to increase the number of board members, it will recommend that candidate&#8217;s election to the full Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
nominating a sitting director for re-election at an annual stockholder meeting, the Nominating Committee will consider the director&#8217;s
performance on the Board and whether the director&#8217;s re-election would be consistent with our corporate governance guidelines and
our continued compliance with applicable laws, rules and regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board believes that it should be comprised of directors with diverse and complementary backgrounds, and that directors should have expertise
that, at a minimum, may be useful to us and may contribute to the success of our business. Directors also should possess the highest
personal and professional ethics and should be willing and able to devote an amount of time sufficient to effectively carry out their
duties and contribute to the success of our business. When considering candidates for director, the Nominating Committee takes into account
a number of factors, which may include the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independence
    from management; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Background;
    </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Relevant
    business experience; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Judgment,
    skill and integrity; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Existing
    commitments to other businesses; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Potential
    conflicts of interest; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
    governance background; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    and accounting background; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    compensation background; and </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Size
    and composition of the existing Board. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stockholder
Proposals</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nominating Committee will consider candidates for director suggested by stockholders by considering the foregoing criteria and the additional
information referred to below. Stockholders wishing to suggest a candidate for director should write to Kopin Corporation, c/o Investor
Relations, 125 North Drive, Westborough, MA 01581, and include the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    name and address of the stockholder and a statement that he, she, they or it is one of our stockholders and is proposing a candidate
    for consideration by the Nominating Committee; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    class and number of shares of our capital stock owned by the stockholder as of the record date for the annual stockholder meeting
    (if such date has been announced) and as of the date of the notice, and length of time such stockholder has held such shares; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    name, age and address of the candidate; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    description of the candidate&#8217;s business and educational experience; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    class and number of shares of our capital stock, if any, owned by the candidate, and length of time such candidate has held such
    shares; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
    regarding each of the foregoing criteria the Board generally considers, other than the factors regarding Board size and composition,
    sufficient to enable the committee to evaluate the candidate; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    description of any relationship between the candidate and any of our customers, suppliers or competitors or any actual or potential
    conflict of interest; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    description of any relationship or understanding between the stockholder and the candidate; and </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    written statement by the candidate that the candidate is willing to be considered and willing to serve as a director if nominated
    and elected. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Time
for Submission of Stockholder Proposals</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Under our By-laws, nominations
for directors may be made only by or at the direction of the Board, or by a stockholder of record at the time of giving notice who is
entitled to vote and delivers written notice to the Secretary of the Company at its principal executive offices at 125 North Drive,
Westborough Massachusetts, 01581 along with the additional information and materials required by our By-laws not less than 90 days
and not more than 120 days prior to the first anniversary of the preceding year&#8217;s annual meeting. For our annual meeting in the
year 2026, we must receive this notice no earlier than February 26, 2026, and no later than March 28, 2026 to be eligible for consideration
at the annual meeting in 2026. You can obtain, without charge, a copy of the by-laws by writing to Kopin Corporation, c/o Investor Relations,
125 North Drive, Westborough, MA 01581.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our By-laws, stockholders may present proposals other than director nominations that may be proper subjects for inclusion in the proxy
statement and for consideration at an annual meeting. For business to be properly brought before a stockholder meeting by a stockholder,
the stockholder must have given timely notice thereof in writing to the Secretary. To be timely, a stockholder&#8217;s notice shall be
delivered to or mailed and received at the principal executive offices of the Company at 125 North Drive, Westborough Massachusetts,
01581, not less than 30 days nor more than 75 days prior to the first anniversary of the preceding year&#8217;s annual meeting. For our
annual meeting in the year 2026, pursuant to the requirements of our By-laws, we must receive such notice no earlier than April 12,
2026 and no later than May 27, 2026 to be eligible for consideration at the annual meeting in 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Rule 14a-8 of the Securities and Exchange Act stockholders must deliver proposals to Kopin Corporation not later than January 13,
2026 if the proposal is submitted for inclusion in our proxy materials for the annual meeting in 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, stockholders who intend to solicit proxies in support of director nominees other than the Company&#8217;s nominees must comply
with the additional requirements of Exchange Act Rule 14a-19.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stockholder
Communications with the Board</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has established a process for stockholders to send communications to our Board or any individual director. Stockholders may send
written communications to the Board or any director to Kopin Corporation, Board of Directors, c/o Chief Financial Officer, 125 North
Drive, Westborough, MA 01581.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Related
Party Transactions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee reviews and approves certain transactions or relationships involving Kopin and its directors, executive officers and
their affiliates. Kopin has adopted policies and procedures that apply to any transaction or series of transactions in which Kopin, or
a subsidiary, is a participant, the amount involved exceeds $120,000 and a related person has a direct or indirect material interest.
In reviewing a transaction or relationship, the Audit Committee will take into account, among other factors it deems appropriate, the
nature and terms of the transaction, the dollar value of the transaction, the business reasons for the transaction, whether it is on
terms no more favorable than to an unaffiliated third party under similar circumstances, as well as the extent of the related party&#8217;s
interest in the transaction. Our Code of Business Conduct and Ethics for Employees, Executive Officers and Directors prohibits any transaction
or relationship that would create a conflict of interest, unless approved by the Board. Conflicts of interests are to be reported to
the applicable employees&#8217; immediate supervisor or our Chief Financial Officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not currently provide personal loans to our executive officers or directors. Other than Proposal 1, none of our directors, executive
officers or their associates have a substantial interest in any of the matters to be acted upon at the Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
1</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ELECTION
OF DIRECTORS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
By-laws provide that the Board shall consist of not less than three nor more than 13 directors. At the Meeting, proxies cannot be voted
for a greater number of individuals than the five nominees named in this Proxy Statement. Unless authority is withheld, it is the intention
of the persons voting under the enclosed proxy to vote such proxy in favor of the election of each of the nominees to serve as director
until the 2026 Annual Meeting of Stockholders and until their respective successors are elected and qualified. If any nominee is unavailable
or unwilling to serve, such votes will be cast by the proxies either for a substitute nominee selected by the proxies or to fix the number
of directors at a lesser number. Our Board currently has no reason to expect that any of the nominees will be unavailable or unwilling
to serve. Each of the nominees has consented to being named in this proxy statement and to serve if elected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Election</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
election of directors requires a majority voting standard for election of directors in uncontested elections. Each director will be elected
by the affirmative vote of a majority of the votes cast, meaning that the number of votes cast &#8220;FOR&#8221; a director nominee exceeds
50% of the number of votes cast with respect to that director&#8217;s election. Any &#8220;non-votes&#8221; and abstentions from voting
received will have no effect on the outcome of this Proposal 1. Directors are elected by plurality vote in a contested election of
directors (as defined in our By-laws).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to our By-laws, each person who is nominated to stand for election as director must tender an irrevocable and executed letter of resignation
in advance of the Meeting for the election of directors. If an incumbent director nominee is not elected by a majority of the votes cast
in an uncontested election and no successor has been elected at such meeting, the director must promptly tender his or her resignation
to the Board. The Nominating Committee (excluding the nominee, if applicable) then will make a recommendation to the Board as to whether
to accept or reject the resignation, or whether other action should be taken. The Board, excluding the nominee, will act on the resignation
and publicly disclose its decision in accordance with the By- laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Board of Directors has nominated and recommends that you vote &#8220;FOR&#8221; the election of each of the nominees listed below to
serve as our Directors until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors (the &#8220;Board&#8221;) currently consists of six (6) members: Michael Murray, Jill Avery, Chi Chia Hsieh, David
Nieuwsma, Margaret Seif, and Paul Wash, Jr. Dr. Hsieh will not be standing for reelection as a director and following the 2025
Annual Meeting (the &#8220;Meeting&#8221;), he will cease to serve as a director. Set forth below are the name and age for each director
nominee, his or her principal occupation and business experience during the past five years and the names of other publicly-traded companies
of which he or she served as a director.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Age</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Served
                                            as</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Director
                                            Since</span></p></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Position and
    Offices with the Company</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 26%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Jill J. Avery</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">57</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 42%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lead Independent Director</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Michael Murray</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">50</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">President and Chief Executive Officer, Director</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">David Nieuwsma</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">61</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">Director</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Margaret Seif</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">64</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">Director</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Paul Walsh, Jr.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">61</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">Director</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Jill
J. Avery </i>&#8211; Dr. Avery has over 30 years of experience in marketing and brand management as well as management. Her expertise
in marketing provides a complementary skillset to the technical, operational, financial and legal experience of our other Board members.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Michael
Murray </i>&#8211; Mr. Murray has served as our Chief Executive Officer and President since September 2022. Mr. Murray is an engineer
and has served as President of businesses working with defense ministries and governments. Mr. Murray has always been associated with
technology-focused companies and at these companies Mr. Murray was involved in overall strategy of the business, product development,
manufacturing, sales and marketing and acquisitions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>David
Nieuwsma</i> &#8211; Mr. Nieuwsma, a former US Air Force officer, had a 32-year career with Collins Aerospace where he held numerous
roles including Executive Vice President, Information Management Solutions, President, Interior Solutions and President, Avionics Solutions
Mr. Nieuwsma accumulated a broad range of experience in engineering leadership, product line management, sales, marketing and strategy
development. A significant portion of Kopin&#8217;s revenues is derived from the sale of our products for defense applications and Mr.
Nieuwsma brings a deep understanding of our end markets, customers and U.S. Department of Defense procurement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Margaret
Seif</i> &#8211; Ms. Seif served as Chief Legal Officer and Chief People Officer of Analog Devices, Inc. a leading semiconductor manufacturer.
She brings extensive experience in mergers and acquisitions, talent strategy, governance and risk management to the board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Paul
Walsh, Jr</i>. &#8211; Mr. Walsh&#8217;s qualifications to serve as a member of the Board include his extensive experience of more
than 30 years in the global semiconductor industry, with service as Chief Financial Officer for two public companies in the industry,
which we believe provides our Board with valuable executive-level insights and broad and diverse operational industry experience.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board considers diversity in terms of education, business experience and reputation when considering candidates for our Board. There
are no family relationships among any of our directors, officers or nominees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Background
of Nominees for Director and Certain Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nominees</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Jill
J. Avery, Director</i>. Dr. Avery has served as one of our directors since 2021. Dr. Avery holds a Doctorate in Business Administration
(marketing) from Harvard Business School, a MBA (marketing and finance) from the Wharton School, and a BA (English) from the University
of Pennsylvania. Dr. Avery is a Senior Lecturer of Business Administration and C. Roland Christensen Distinguished Management Educator
in the marketing unit at Harvard Business School, a position she has held since 2013. She is an authority on brand management, customer
relationship management (CRM), and digital marketing. Prior to her academic career, she worked in consumer packaged goods brand management,
managing brands for The Gillette Company, Braun Inc., Samuel Adams, and AT&amp;T, and spent time on the agency side of the business,
as an Account Executive managing consumer promotions for Pepsi, General Foods, Bristol-Myers, and Citibank. She is Lead Director
of the Board at Amica Mutual Insurance Company, a Director of the Harvard/MIT COOP, President Emerita of the Board of Trustees
at the Museum of Fine Arts, Boston, and a Trustee of the Boston Ballet. During the past five years, Dr. Avery has not served on the board
of directors of any other public companies or registered management investment companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Michael
Murray President, Chief Executive Officer, Director. </i>Mr. Murray has served as one of our directors since 2022. Mr. Murray joined
Kopin in September 2022 from Ultra Electronics Group (Ultra), a British Defense and Security company he joined in 2020, where he
served as President of the Cyber business, working with defense ministries and governments. Prior to joining Ultra Mr. Murray from
2017 to 2020 worked at Blackridge Technology as a Senior Vice President and General Manager, IloT. An engineer by training, Mr.
Murray has always been associated with technology-focused companies. Prior to Ultra Electronics, he worked at Aceinna Inc. as
Executive Vice President and Analog Devices, where he led the Industrial Sensing business unit. At these companies Mr. Murray was
involved in overall strategy of the business, product development, manufacturing, sales and marketing and acquisitions. During the
past five years, Mr. Murray has not served on the board of directors of any public companies or registered management investment
companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>David
Nieuwsma, Director. </i>Mr. Nieuwsma has served as one of our directors since November of 2023. A former US Air Force officer, he was
employed with Collins Aerospace from 1991 to 2022. Mr. Nieuwsma led numerous lines of business at Collins Aerospace including roles as
Executive Vice President, Information Management Solutions, President, Interior Solutions and President, Avionics Solutions. Mr. Nieuwsma
holds a Bachelor of Science, Management from the US Air Force Academy in Colorado Springs, Colorado, a Bachelor of Science, Computer
Science, from Chapman College, Orange, California, and a Master of Business Administration from the University of Iowa. He spent five
years in the US Air Force, completing his military career attaining the rank of Captain, as an Acquisition Project Officer, Ballistic
Systems Division, Norton AFB, California. During the past five years, Mr. Nieuwsma has not served on the board of directors of any public
companies or registered management investment companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Margaret
Seif, Director. </i>Ms. Seif has served as one of our directors since May 2024<i>. </i>From 2014 to 2022 Ms. Seif held various positions
including Chief People Officer and Chief Legal Officer at Analog Devices, Inc. (ADI) a global leader in the design and manufacturing
of analog, mixed signal, and DSP integrated circuits. In her roles at ADI Ms. Seif&#8217;s responsibilities included talent strategy,
all legal matters, structures and negotiating multiple mergers and acquisitions, corporate governance matters, developing cyber risk
mitigation strategies and protections of ADI&#8217;s portfolio of intellectual property assets. From 1998 to 2005 Ms. Seif was Senior
Vice President, Corporate Development and General Counsel &amp; Secretary at RSA Security Inc. Ms. Seif serves on the Board of Advisors
for Community Servings Inc., and the New England Regional Council of the Smithsonian Institution. Ms. Seif has a Bachelor of Arts from
Brown University and a Doctor of Jurisprudence from the University of Michigan Law School. During the past five years, Ms. Seif served
as Corporate Secretary of ADI.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Paul
V. Walsh Jr., Director. </i>Prior to retiring in February 2022, Mr. Walsh served as Chief Financial Officer, Senior Vice President
and Treasurer, at Allegro MicroSystems, Inc., a publicly traded global semiconductor company that designs and manufactures advanced sensor
and power management integrated circuits for the automotive and industrial end markets, from 2014 to 2022. Prior to joining Allegro,
Mr. Walsh served as the Chief Financial Officer and Senior Vice President of Rocket Software, Inc., a global software development firm,
from 2013 to 2014. From 2004 to 2013, he served in several financial leadership roles at Silicon Laboratories Inc., a publicly traded
global technology company that designs and manufacturers semiconductors, including as: Chief Financial Officer and Senior Vice President
from 2011 to 2013 and Chief Accounting Officer and Vice President of Finance from 2006 to 2011, among other roles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Walsh currently serves on the board of directors of Semtech Corporation (NASD: SMTC), which designs and manufactures semiconductors for
IoT and connectivity applications, serving as the chair of its audit committee as a member of the Nominating and Governance Committee
as well as the Strategy and Technology Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Walsh served as an advisor to the board of directors and audit committee of Anokiwave, Inc., a late-stage semiconductor company, from
October 2022 to February 2024, where he was also an investor. Anokiwave, Inc. was acquired by Qorvo, Inc. in February 2024. Additionally,
he served on the board of directors of Nitero, Inc., a venture-backed startup semiconductor company, from 2012 to 2015, and Grande Communications
Networks, LLC, a broadband communications provider of cable and internet services, from 2008 to 2010, including as chairman of the audit
committee.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Officers</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Michael
Murray, President, Chief Executive Officer, Director. </i>Mr. Murray, age 51, has served as our President and Chief Executive
Officer since September 6, 2022. Mr. Murray served as President of the Cyber business of Ultra Electronics Group, a British Defense and
Security company. Prior to Ultra Electronics, he worked at Aceinna as Executive Vice President and Analog Devices, where he led the Industrial
Sensing business unit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Richard
A. Sneider, Treasurer and Chief Financial Officer. </i>Mr. Sneider, age 65, has served as our Treasurer and Chief Financial Officer since
September 1998. Mr. Sneider is a former Certified Public Accountant and was formerly a partner of the international public accounting
firm, Deloitte &amp; Touche LLP, where he worked for 16 years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Paul
Baker, Chief Operating Officer for Kopin Government and Industrial and Strategic Business Officer</i>. Mr. Baker, age 62, has held
his present position with the Company since January 2020 and previously served as the Company&#8217;s Strategic Business Officer
from February 2019 to January 2020, Senior Vice President, Business Development from January 2017 to January 2019, and as Vice
President, Business Development between March 2014 and December 2016. From 2007 to 2014, Mr. Baker served as Executive Vice
President, Business Development &amp; Sales at ZINK Imaging Co., a private company headquartered in Billerica, Massachusetts that
invented ZINK Zero Ink&#174; Technology. Mr. Baker holds a B.A. in economics from Colby College and a M.B.A. from Boston
University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
Structure and Risk</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board leadership structure is commonly utilized by other public companies in the United States, and we believe that it is effective for
us. We believe this leadership structure is appropriate for us given the size and scope of our business, the experience and active involvement
of our independent directors, and our corporate governance practices, which include regular communication with and interaction between
and among the Chief Executive Officer and the Chief Financial Officer and the independent directors. Pursuant to our By-laws, our Board
selects the Chairman and the Chief Executive Officer that it determines to be in the best interest of our stockholders. Our Board has
determined that each of Jill J. Avery, David Nieuwsma, Marnie Seif and Paul Walsh, Jr. are independent as that term is defined under
the applicable independence listing standards of Nasdaq Rules and the applicable SEC rules and regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our directors provide effective oversight of risk management functions. Annually, we perform a risk review where the management
team evaluates the risks facing us in the upcoming year and over a longer-term horizon, typically three years. From this risk assessment,
we develop plans to deal with the risks identified. This risk assessment is provided to the Board and their input is reflected in the
annual risk assessment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, members of our management periodically present to the Board the strategies, issues and plans for the product lines they manage.
The Compensation Committee also reviews our incentive plans to determine whether they result in management behavior that may result in
additional risk beyond the plans&#8217; intended purpose. While the Board oversees our risk management, our management is responsible
for day-to-day risk management processes. Additionally, the Board requires that management raise exceptional issues to the Board. We
believe this division of responsibilities is the most effective approach for addressing the risks facing us and that the Board leadership
structure supports this approach.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
and Committee Meetings</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2024, our Board held seven meetings. For each director that was voted to the Board at the 2024 Annual Meeting of Stockholders,
overall attendance at Board meetings and relevant committee meetings, either in person or by conference call, was greater than 75% during
the period they were on the Board of committee during fiscal year 2024. All directors attended the Company&#8217;s 2024 Annual Stockholder
Meeting. Mr. Walsh, Jr. joined the Board of Directors after the 2024 Annual Meeting of Stockholders and attended the two Board meetings
after he joined the Board. Although we currently do not require our directors to attend annual stockholder meetings, we do encourage
directors to do so and welcome their attendance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Audit
Committee: </i>We have established a separately designated Audit Committee as defined by Section 3(a)(58)(A) of the Exchange Act. Our
Audit Committee is composed of three directors: Jill J. Avery, David Nieuwsma and Paul Walsh, Jr., each of whom the Board has
determined is independent under the Nasdaq Rules and the applicable SEC rules and regulations. The Board has determined that Mr. Walsh
is an &#8220;audit committee financial expert&#8221; as defined by Item 407(d)(5)(ii) of Regulation S-K of the Exchange Act. Our Board
adopted an Audit Committee Charter, which is available on our website at <i>www.kopin.com </i>under the heading &#8220;Investor Relations:
Governance Documents.&#8221; Our Audit Committee Charter delegates to the Audit Committee the responsibility, among other things, to
engage our independent auditors, review the audit fees, supervise matters relating to audit functions, review and set internal policies
and procedure regarding audits, accounting and other financial controls and review related party transactions. The Audit Committee pre-approved
all audit and non-audit services provided by BDO for fiscal year 2024. During the 2024 fiscal year, our Audit Committee met in
person or through a conference call seven times. Ms. Avery attended all seven meetings. Mr. Nieuwsma joined the Audit Committee in June
2024 and attended two of the three subsequent meetings. Mr. Walsh joined the Audit Committee in September 2024 and attended the
two subsequent meetings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nominating
and Corporate Governance Committee: </i>Our Nominating and Corporate Governance Committee presently is composed of two directors: Dr.
Avery and Ms. Seif, each of whom the Board has determined is independent under applicable SEC and Nasdaq Rules. The Nominating
and Corporate Governance Committee is responsible for, among other things, considering potential Board members, making recommendations
to the full Board as to nominees for election to the Board, assessing the effectiveness of the Board and implementing our corporate governance
guidelines. The charter of the Nominating and Corporate Governance Committee is available on the Company&#8217;s website at <i>www.kopin.com
</i>under the heading &#8220;Investor Relations: Governance Documents.&#8221; During the 2024 fiscal year, our Nominating and Corporate
Governance Committee met in person or through a conference call five times and all members participated in the meetings. In addition,
the Nominating and Corporate Governance Committee engaged and paid a fee to a consultant, Egon Zehnder, to identify possible Board of
Director candidates, The Nominating and Corporate Governance Committee members periodically met with Egon Zehnder for status updates
and to review potential candidates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Compensation
Committee: </i>Our Compensation Committee presently is composed of three directors: Dr. Hsieh, Mr. Nieuwsma and Ms. Seif, each of whom
the board has determined is independent under applicable SEC and Nasdaq Rules. The charter of the Compensation Committee is available
on our website at <i>www.kopin.com </i>under the heading &#8220;Investor Relations: Governance Documents.&#8221; During the 2024 fiscal
year, our Compensation Committee met in person or through a conference call nine times. Dr. Hsieh participated in eight of the meetings.
Mr. Nieuwsma and Ms. Seif were added to the Compensation Committee in June 2024 and participated in all seven subsequent meetings. The
Compensation Committee is responsible for the approval of remuneration arrangements for our executive officers, review and approval of
compensation plans relating to executive officers and directors, including grants of stock options, restricted stock and stock grants
under our 2020 Equity Incentive Plan and other benefits and general review of our employee compensation policies. Dr. Hsieh will not
be standing for reelection at the Meeting and will cease to be on the Compensation Committee after the Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained on the Company&#8217;s website at www.kopin.com is not considered incorporated by reference in this proxy statement<i>.
Compensation Committee Interlocks and Insider Participation.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of our executive officers serves as a member of the board of directors or compensation committee, or other committee serving an equivalent
function, of any other entity that has one or more of its executive officers serving as a member of our Board or Compensation Committee.
None of the current members of our Compensation Committee has ever been an employee of Kopin or any subsidiary of Kopin.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below contains information, as of the dates below, regarding the beneficial ownership of all those known to us to be a beneficial
owner of more than 5% of our common stock as well as our directors and nominees, named executive officers and all of our executive officers
and directors as a group as of May 1, 2025. The address of each holder listed below, except as otherwise indicated, is 125 North
Drive, Westborough, Massachusetts 01581.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name and Address
    of Beneficial Owner</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount
                                            and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature
                   of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Beneficial</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ownership<sup>(1)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ownership<sup>(2)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><i>Directors and Named Executive Officers</i></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Jill J. Avery</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">94,500</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Chi Chia Hsieh</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">321,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Michael Murray</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,667,608</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">David Nieuwsma</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">129,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Marnie Seif</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">64,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Paul Walsh, Jr.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">64,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Richard A. Sneider</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">630,883</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right">*<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">                                  </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Paul Baker</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">544,531</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right">*</td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">All directors and executive officers as a group
    (8 persons)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,517,022</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.8</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif">5% or Greater Stockholders</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royce &amp; Associates LP<sup>(3)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,981,832</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4.9</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    than 1% </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
    otherwise indicated in these footnotes, each stockholder has sole voting and investment power with respect to the shares beneficially
    owned. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percentages
    are based on 162,797,922 shares of our common stock outstanding as of May 1, 2025.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    information is based solely on information reported on a Schedule 13G filed on April 29, 2025 with the SEC on behalf of
    Royce &amp; Associates LP. Royce &amp; Associates LP reported sole voting power with respect to 7,981,832 shares of common stock
    and sole dispositive power over 7,981,832 shares of common stock. The business address of Royce &amp; Associates LP is One Madison
    Avenue, New York, NY 10010. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delinquent
Section 16(a) Reports</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
16(a) of the Exchange Act requires the Company&#8217;s directors and executive officers, and persons who own more than 10% of a registered
class of the Company&#8217;s equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership
of common stock and other equity securities of the Company. Officers, directors and greater than 10% stockholders are required by SEC
regulations to furnish the Company with copies of all Section 16(a) forms they file.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
solely on a review of reports of ownership on Form 3 and changes in ownership on Forms 4 or 5 furnished to us and written representations
from our directors and executive officers and other information, we believe that none of our directors, executive officers or 10% stockholders,
failed to file on a timely basis the reports required to be filed pursuant to Section 16 of the Exchange Act during the fiscal year 2024
except for the following: On September 3, 2024 Ms. Sief filed a Form 4 for her initial equity grant of 64,500 shares of the Company&#8217;s
common stock which occurred on June 6, 2024. The Form 4 was late due to delays in obtaining her EDGAR filing codes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COMPENSATION
DISCUSSION AND ANALYSIS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is considered a &#8220;smaller reporting company&#8221; under Item 10 of Regulation S-K promulgated under the Exchange Act and
provides scaled compensation disclosure intended to comply with the requirements applicable to smaller reporting companies Although the
SEC guidance permits us to follow the rules applicable to a small reporting company for purposes of this proxy statement, we are committed
to providing the compensation disclosure necessary to enable shareholders to understand our compensation plans, plan design and programs,
as well as 2024 compensation decisions made by the Compensation Committee, and make informed voting decisions</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Named
Executive Officers</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
NEOs for fiscal year 2024 were:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Murray, President and Chief Executive Officer (CEO) </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
    A. Sneider, Treasurer and Chief Financial Officer (CFO) </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Baker, Chief Operating Officer (COO) </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
Summary</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provided
below are key Company performance and executive compensation highlights for fiscal year 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2024, we continued the reorganization of Kopin under a program we call One Kopin. We have three manufacturing and assembly locations
and previously the business development and engineering staff concentrated on the products made at those locations. In 2023, we
started the process of creating one Business Development group that would sell all of Kopin&#8217;s products and one engineering group
that would work on the design, development and manufacturing of all of Kopin&#8217;s products with the understanding that there are limits
because of the nature of some of our products. Below is a summary of certain financial and development performance highlights that occurred
in 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    fiscal year 2024 revenues were $50.3 million, an increase of 24.6% over the fiscal year 2023 revenues of $40.4 million. Our fiscal
    year 2024 product revenues increased to $43.6 million as compared to fiscal year 2023 product revenues of $25.9 million. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    fiscal year 2024 gross margins increased to 17% from approximately four percent for fiscal year 2023. Our operating loss was approximately
    $43.1 million, which included $24.8 million for litigation accrual. Our fiscal year 2023 operating loss was approximately $17.2
    million. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            fiscal year 2024 we received orders in excess of $40 million. The orders we received in fiscal
                                            year 2024 were for eyepieces used in thermal weapon sights, displays used in fixed wing and
                                            rotary aircraft, training and simulation headsets and contracts for display and application
                                            specific optical solution design and development. We also received initial orders for our
                                            medical headset.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            fiscal year 2024 we used government, customer and internal funding to develop new displays
                                            including our bidirectional Neural&#8482; display that is intended to provide biological
                                            information to artificial intelligence software to adjustment the display image and thereby
                                            improve user performance. We also commenced development on day and night modules that can
                                            be used with current soldier helmets to provide additional capabilities.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
Highlights:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summarized
below are highlights with respect to executive compensation for fiscal year 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Messrs.
    Murray, Sneider, and Baker received base wages increases from $450,000 to $495,000, $349,048 to $359,520, and $324,450
    to $334,184, respectively.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Mr.</span><span style="font-family: Times New Roman, Times, Serif">
    Murray was awarded a bonus for fiscal year 2024 performance of $668,000.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Murray received a grant of 1,200,000 shares of restricted stock (2026 Performance-Based Equity Award) which shall vest based on the
    attainment of corporate performance goals and targets, including a minimum revenue for the fiscal year 2026, and his continued employment
    through December 31, 2026. The target number of restricted shares is 1,000,000 and the target performance goals are fiscal
    year 2026 revenue of $65 million and a consolidated 6% operating profit. If any of the applicable performance goals are attained
    at less than 80% of target, the number of restricted shares earned for the portion of the 2026 Performance-Based Equity Award
    attributable to that performance goal will be zero. If any of the applicable performance goals are attained at between 80% and 100%
    of target, the number of restricted shares earned for the portion of the 2026 Performance-Based Equity Award attributable
    to that performance goal will be between 50% and 100% of target. If any of the applicable performance goals are attained at between
    100% and 120% of target, the number of restricted shares earned for the portion of the 2026 Performance-Based Equity Award
    attributable to that performance goal will be between 100% and 120% of target. Performance between performance levels will be interpolated
    on a straight-line basis Performance achievement will be determined by the Board in its reasonable discretion exercised in good faith.
    Performance between performance levels will be interpolated on a straight-line basis</span></td></tr>
</table>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            primary objective for fiscal year 2024 was to continue to increase revenues and cash flow.
                                            To that end, as part of the annual incentive plan we granted our CFO and COO 45,300 and 40,800
                                            shares of restricted stock, respectively, which could have been earned if certain revenue,
                                            cash flow and individual goals were met. The number of shares granted represented approximately
                                            35% of their 2023 base wages divided by approximately the Company&#8217;s share price on
                                            day of grant. 20% of the shares could have been earned by meeting certain revenue targets,
                                            70% of the shares could have been earned by meeting certain cash flow targets and 10% could
                                            be earned based on meeting individual goals in fiscal year 2024. The revenue and cash
                                            flow goals had a minimum base amount, a target amount and a maximum upper goal amount. If
                                            the minimum base amount was not achieved, then no restricted stock was earned. If the minimum
                                            base amount was achieved approximately 30% of the shares could be earned, if the target amount
                                            was achieved approximately 75% of the shares could be earned and if the maximum upper goals
                                            was achieved all of the shares could be earned.</span></p></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Messrs.
                                            Sneider and Baker earned 25,505 and 22,972, respectively, of the shares granted which represents
                                            achieving approximately 56% of the goals.</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
    our long-term incentive plan, each of Messrs. Sneider and Baker each received restricted stock grants of 75,000 shares that at the
    rate of 34% on December 10, 2025, 33% shall vest on December 10, 2026 and 33% shall vest on December 10, 2027, subject to the Company&#8217;s
    2020 Equity Incentive Plan and remain employed by the Company. These grants were issued to incentivize the individuals to remain
    with the Company and further align their interest with those of stockholders. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>President
and Chief Executive Officer:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2022, Mr. Michael Murray joined Kopin as President and Chief Executive Officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Murray received an annual base salary of $450,000. Additionally, Mr. Murray received 800,000 shares of restricted stock, which vest
in 20% increments each December 10 beginning in 2023, and a sign-on bonus of $100,000. A more detailed discussion of Mr.
Murray&#8217;s initial employment agreement is discussed in the <b><i>Employment and Other Agreements </i></b>section
below<b><i>.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 15, 2024 the Company and Mr. Murray signed a new Employment Agreement (the &#8220;New Agreement&#8221;). The New Agreement was
entered into to provide more specificity that was incorporated in his initial employment agreement. This summary of the New Agreement
is subject to the terms of the New Agreement which is filed with the SEC as an exhibit to Form 8-K. Under the New Agreement, Mr. Murray&#8217;s
salary was set at $495,000 with eligibility for a target cash bonus of 100% of base salary up to a maximum of 150% base salary based
on a formula and the determination of achievement of goals as determined by the Board. Mr. Murray also is eligible for the Company&#8217;s
standard benefits package and to participate in all applicable group employee benefit plans and programs offered. Mr. Murray is eligible
to receive equity awards covering the Company&#8217;s common stock. Provided that Mr. Murray continues to be employed by the Company
on the date of a change of control (as defined in the New Agreement), all outstanding equity awards held by Mr. Murray immediately prior
to the effective date of a change of control which vest based upon his continued service over time shall accelerate, become fully vested
and/or exercisable, as the case may be, immediately prior to the change of control, and all outstanding equity awards held immediately
prior to the change of control which vest based upon attainment of performance criteria shall vest based on target performance immediately
prior to the change of control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 28, 2024 Mr. Murray received a grant of 1,200,000 shares of restricted stock which shall vest based on the attainment of corporate
performance goals and targets, including a minimum target revenue for the fiscal year 2026 of $65 million and an operating profit of
6%, and his continued employment through December 31, 2026. The target number of restricted stock that can be earned is 1,000,000. If
any of the applicable performance goals are attained at less than 80% of target, the number of restricted shares earned for the
portion of the 2026 Performance-Based Equity Award attributable to that performance goal will be zero. If any of the applicable performance
goals are attained at between 80% and 100% of target, the number of restricted shares earned for the portion of the 2026 Performance-Based
Equity Award attributable to that performance goal will be between 50% and 100% of target. If any of the applicable performance goals
are attained at between 100% and 120% of target, the number of restricted shares earned for the portion of the 2026 Performance-Based
Equity Award attributable to that performance goal will be between 100% and 120% of target. Performance between performance levels will
be interpolated on a straight-line basis Performance achievement will be determined by the Board in its reasonable discretion exercised
in good faith. Performance between performance levels will be interpolated on a straight-line basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Key
Compensation Governance Attributes:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
pay practices emphasize good governance and market practice:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
    We Do</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>What
    We Don&#8217;t Do</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10004;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    Ownership guidelines for the CEO and Non- Employee Directors</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10008;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    employment agreements for anyone other than the CEO </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10004;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maintain
    a clawback policy</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10008;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    excise tax gross-up provisions </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10004;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emphasize
    pay for performance</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10008;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    excessive executive perquisites </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10004;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
    Say on Pay advisory vote </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024
Say on Pay Vote:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    2024, our stockholders voted to approve our executive compensation program (also known as &#8220;Say on Pay&#8221;) for the thirteenth
    time, and of the 37,210,088 votes cast, 26,650,929, or 71.6%, were in favor. The Compensation Committee considered the results of
    this advisory vote as it continually evaluates the Company&#8217;s compensation programs and policies to ensure that the programs
    strike a balance between internal (business strategy) and external (stockholder) alignment. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
Philosophy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our NEOs play a critical role in the operational and financial performance of our company that creates long-term value for
our stockholders. Accordingly, our executive compensation philosophy is to reward our executives for individual performance and for contributions
to our corporate performance. We have invested significant efforts and funds in developing new technologies and products for both our
traditional markets, military and industrial, and for the emerging &#8220;wearables&#8221; industrial market. In fiscal year 2023,
our strategic emphasis shifted to improving operational excellence through a reorganization plan we refer to as One Kopin. Accordingly,
we are in the process of adjusting our performance award system to be based more towards financial and operational metrics, specifically
revenue growth, gross margin improvement, on-time in-full deliveries, production yields, and cash flow improvement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
strive to counterbalance our employee retention objectives and pay-for-performance objectives. Historically we believe we have accomplished
this by compensating our executives with a combination of base salary, performance bonus awards and long-term equity-based retention
compensation. In fiscal year 2024, we maintained the same philosophy but we are striving to create a system that is based on a
cash reward for achievement of annual goals such as revenue and cash flow milestones and using restricted stock grants for the achievement
of longer- term incentives or retention purposes. To this end, in fiscal year 2024 we increased the number of employees
eligible to receive a cash bonus based on fiscal year 2024 results. We also issued restricted stock grants to certain employees for retention
purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that the quality, commitment and performance of our executives are critical factors affecting our long-term value. Accordingly,
our compensation objectives include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">aligning
    our executive&#8217;s interests with the Company&#8217;s goals and our stockholders&#8217; interests; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">attracting,
    retaining and motivating our executives and key employees; and </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">rewarding
    individuals for their performance that enhances shareholder value. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we periodically use publicly available data and surveys and peer group comparisons to assist us in determining whether our
executive compensation is appropriate in light of our compensation objectives and philosophy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Role
of the Compensation Committee</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee of our Board of Directors sets our executive compensation policies and determines the amounts and elements of
compensation for our executive officers and Board of Directors. As set forth in the Compensation Committee&#8217;s written charter, its
responsibilities include establishing compensation policies for our directors and executive officers; reviewing and approving the Chief
Executive Officer&#8217;s annual compensation; approving employment agreements or arrangements with executive officers; administering
our 2020 Equity Incentive Plan and legacy equity award plans (the &#8220;Equity Plans&#8221;) and approving grants under the 2020 Equity
Plan; and making recommendations regarding any other incentive compensation or equity-based plans. The Compensation Committee may delegate
certain authority with respect to compensation matters to our executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee considers the amounts and elements of compensation for our executive officers, both for the past and the upcoming
fiscal year based on the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Company&#8217;s next fiscal year&#8217;s forecasted development and financial results; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    evaluation and performance review process; and </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Compensation Committee members&#8217; personal experience and trends identified in the peer group benchmarking analysis. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
all employees, other than our NEOs and certain executive officers and employees, the Compensation Committee approves ranges of merit
increases, for example up to 5% of base salary compensation based on recommendations from the Chief Executive Officer related to compensation,
other than his own compensation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
all executive officers other than our Chief Executive Officer, Chief Financial Officer and Chief Operating Officer, the Compensation
Committee establishes and approves the base salary compensation based on recommendations from the Chief Executive Officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to compensation of our Chief Executive Officer, the Compensation Committee establishes and approves the compensation determinations
based on the Compensation Committee&#8217;s evaluation and performance reviews of our Chief Executive Officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the Compensation Committee charter is posted on our website<i>, www.kopin.com</i>, under the heading &#8220;Investors: Corporate
Governance.&#8221; For the fiscal year 2024, our Compensation Committee consisted of Dr. Hsieh (Chairperson), Mr. Nieuwsma and Ms. Seif.
All Board members who served on the Compensation Committee in 2024 were determined to be an independent director as determined by our
Board, based upon the Nasdaq Rules and our independence guidelines.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Role of Management</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the request of the Compensation Committee, NEOs of the Company may be present at Compensation Committee meetings for discussion purposes.
However, they are not involved in the decisions made by the Compensation Committee regarding their compensation, nor do they have a vote
on any matters brought before the Committee. The Compensation Committee meets with the Chief Executive Officer to discuss his performance
and compensation package, but ultimately, decisions regarding his package are made solely based upon the Compensation Committee&#8217;s
deliberations, as well as input from the independent compensation consultant, as requested. The Compensation Committee considers recommendations
from the Chief Executive Officer and Chief Financial Officer, as well as input from the compensation consultant as requested, to make
decisions regarding other NEOs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Role
of the Compensation Consultant</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
making its determinations with respect to executive compensation, the Compensation Committee has periodically engaged the services of
a compensation consultant to provide input on trends in executive compensation and to obtain an outside perspective on our executive
compensation practices and assist with our peer group benchmarking analysis. The Compensation Committee does not believe a formal annual
peer group assessment by an independent third party is necessary unless either internal factors, such as employee turn-over, or external
factors, such as published reports in industry periodicals, indicate significant changes in executive compensation have taken place.
In 2023, Aon&#8217;s Human Capital Solutions practice, a division of Aon plc (Aon), was engaged to review the Company&#8217;s Board
of Director compensation. In 2024, the Company engaged Aon, as the independent compensation consultant to provide the following services:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recommend
    changes to the peer group of comparable companies; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Complete
    a competitive analysis of compensation for each executive utilizing comparable peer company compensation data; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
    assistance with our long-term incentive strategy; and </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
    general executive compensation advice. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company periodically asks Aon for assistance in benchmarking the compensation and long-term incentives of the CEO and other
NEOs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
independent compensation consultant reports directly to the Compensation Committee and carries out responsibilities as assigned by the
Compensation Committee. The Compensation Committee has the sole authority to retain and terminate the compensation consultant and to
approve the compensation consultant&#8217;s fees and all other terms of the engagement. The Compensation Committee exercised this authority
to engage Aon as its independent compensation consultant and has direct access to the compensation consultant throughout the year. Aon
serves as an advisor to the Compensation Committee on topics primarily related to Board and executive compensation. Aon does not provide
us with any services other than the services provided at the request of the Compensation Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee periodically reviews the services provided by its outside consultants and believes that Aon is independent in
providing executive compensation consulting services. The Compensation Committee conducted a specific review of its relationship with
Aon in preparation of the 2024 proxy statement and determined that Aon&#8217;s work for the Compensation Committee did not raise any
conflicts of interest, consistent with the guidance provided under the Dodd-Frank Wall Street Reform and Consumer Protection Act, and
by the SEC and the Nasdaq Capital Market (&#8220;Nasdaq&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
Determinations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
making determinations with respect to amounts and elements of executive compensation, the Compensation Committee evaluates our overall
corporate performance during the fiscal year against development plans and annual budgets; evaluates the Chief Executive Officer&#8217;s
achievements against the Board&#8217;s expectations; obtains input from the Chief Executive Officer on the performance reviews of the
other executive officers; evaluates the potential for future contributions by each executive to our long-term success; and periodically
compares our executive compensation against a benchmarking analysis of a group of peer companies. In 2024, we did a formal benchmarking
analysis of our NEOs compensation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Peer
Group &#8211; Board of Director Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2023, the Compensation Committee engaged Aon to assist in selecting a new peer group with a median revenue and market capitalization
size that approximated ours for the purposes of benchmarking our Board of Director compensation. Based on Aon&#8217;s structured peer
group review process and recommendations the final 2023 peer group consisted of 20 companies with a revenue range of $15 million to $150
million and market capitalization in the range of $50 million to $500 million and included the following companies:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">908
    Devices</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Everspin
    Technologies</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amtech
    Systems.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GSI
    Technology</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aware</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immersion
    Corp.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEVA
    Inc</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">InTEST</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Coda
    Octopus Group</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intevac
    Inc.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Digimarc.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NVE
    Corp..</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">eMagin
    Corp</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ouster</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emcore</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pixelworks,
    Inc.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PowerFleet</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quicklogic</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vuzix</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Peer
Group &#8211; NEO Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2024, the Compensation Committee engaged Aon to assist in selecting a new peer group with a median revenue and market capitalization
size that approximated ours for the purposes of benchmarking our NEO compensation. Based on Aon&#8217;s structured peer group review
process and recommendations the final 2024 peer group consisted of 20 companies with trailing twelve month revenues ranging from approximately
$18 million to $163 million and market capitalization size ranging from approximately $43 million to $545 million and included the following
companies:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">908
    Devices</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GSI
    Technology</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aehr
    Test Systems</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immersion
    Corp.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amtech
    Systems.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">InTEST</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Arteris</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intevac
    Inc.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aware</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LightPath
    Technologies</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEVA
    Inc</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NVE
    Corp</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Coda
    Octopus Group</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ouster</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Digimarc.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pixelworks,
    Inc</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emcore</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quicklogic</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Everspin
    Technologies</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sono-tek</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frequency
    Electronics</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 4.5pt"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 4.5pt"></p>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following companies were added to the 2024 Peer Group: Aehr Test Systems, Arteris, Frequency Electronis, and Sono-tek. The following
companies were removed from the 2024 Peer Group: eMagin Corp, PowerFleet, and Vuzix.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Elements
of Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
compensation program is designed to be simple, straightforward and fair. We use the following compensation and benefits elements to provide
an overall competitive compensation and benefits package that is tied to creating stockholder value and supporting the execution of our
business strategies:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Base
    salary;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
    incentive (cash or restricted stock); </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
    incentives; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">401(k)
    matching contribution;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Partially
    funded health insurance; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment
    and change-in-control agreements for the Chief Executive Officer. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee does not have any formal policies for allocating compensation among salary, annual cash incentive awards and long-term
incentive equity grants, short- and long-term compensation or among cash and non-cash compensation. Instead, the Compensation Committee
exercises judgment to establish a total compensation program for each officer that is a mix of current, short- and long-term incentive
compensation, and cash and non-cash compensation, that the Compensation Committee believes is appropriate to achieve the goals of our
executive compensation program and our corporate goals and objectives. In setting the elements of compensation, the Compensation Committee
considers prior compensation paid and amounts realizable from prior stock-based awards, as well as other benefits provided by the Company.
The combination and allocation of the components and the target amount of each component is also influenced by the role of the executive
officer, individual performance, expected contributions, market practices, and the total value of all the compensation and benefits available
to the individual executive officers. The Compensation Committee reviews and considers each component for each executive officer before
making compensation decisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
Element Detail</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the fiscal year ended December 28, 2024 the elements of compensation based on the amounts in the Summary Compensation Table and expressed
as a percentage of total compensation for our CEO and Named Executive Officers was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Officer</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salary<sup style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</sup></b></span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Bonus</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock Awards</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Michael Murray</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">20.4</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">37.4</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">42.2</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Richard Sneider</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">69.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30.9</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Paul Baker</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">69.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31.0</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    &#8220;All Other Compensation&#8221; for Mr. Murray, Mr. Sneider and Mr. Baker of $7,183, $12,738 and $12,022, respectively. Amounts
    represent the Company&#8217;s matching contributions under the Company&#8217;s 401(k) Plan ranging from approximately $6,200 to $10,400
    per year and premiums paid for life insurance. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Salary</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that establishing an appropriate level of annual base salary for our executives is an important element in retaining and motivating
our executive officers. In determining base salaries for our executive officers, the Compensation Committee considers the responsibilities
of each position, cost of living adjustments and the skills and experience required for each job. The Compensation Committee&#8217;s
determinations are influenced heavily by the evaluations and performance reviews for each executive officer by our Chief Executive Officer,
as discussed above. In addition, the Compensation Committee reviews the peer group benchmarking analysis, if performed, and finally,
reviews total compensation for reasonableness prior to making any final determinations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the base salaries for 2023 and 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Officer</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mr. Murray</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">450,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">495,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mr. Sneider</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">349,048</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">359,520</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mr. Baker</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">324,450</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">334,184</p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Murray received an increase in base salary of approximately 10% based upon his performance, comparison to the market and cost of living
increase. Messrs. Sneider and Baker received a cost of living increase of approximately 3%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Annual
Bonus and Incentives</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
fiscal year 2024, under the terms of Mr. Murray&#8217;s employment agreement he was eligible for a target bonus of 100% of his in initial
base salary ($450,000) up to a maximum of 150% base salary based on a formula and the determination of achievement of goals as determined
by the Board. For fiscal year 2024, based on the overall improvement of operating results the Board awarded Mr. Murray a bonus of 135%
of his base salary of $668,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
fiscal year 2024 Messrs. Sneider and Baker received 45,300 and 40,800 shares of restricted stock, respectively, which could have been
earned if fiscal year 2024 revenue target $50 million, cash flow target $8.8 million and individual goals were met. The revenue and cash
flow goals had a minimum base amount, a targets amount and a maximum upper goal amount. If the minimum base amount was achieved approximately
30% of the shares could be earned, if the target amount was achieved approximately 75% of the shares could be earned and if the maximum
upper goals was achieved all the shares could be earned. If the base amount was not achieved, then no restricted stock was earned.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Messrs.
Sneider and Baker earned 25,505 and 22,972, respectively, of the shares granted which represents achieving approximately 56% of the goals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Long-Term
Incentives</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that including an equity-based incentive component of compensation is a critical tool for motivating our executives and certain
employees. We believe that granting equity awards to our executives aligns executive compensation with long-term stockholder value. By
awarding executive officers with equity awards that vest over time, we believe that our executive officers will have a continuing stake
in our long-term success and these awards serve as an important retention program.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
weighted our total executive compensation towards restricted stock awards that either vest upon the achievement of certain milestones
or vest over time. While our management can improve our financial performance through the sales of our current products, cost reduction
efforts, process improvements and other short-term advancements, we believe that our executive officers&#8217; focus on long-term achievements,
particularly increasing our product and patent portfolios, will create the greatest stockholder value. We believe that by granting our
executives meaningful levels of equity awards that vest both in the short-term and long-term we will achieve the proper balance between
incentivizing them to focus on the current fiscal year&#8217;s results and longer- term strategies of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
determining the size of each equity award granted to our executive officers, the Compensation Committee considers:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    amount previously awarded on an annual basis to the executive, </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommendations
    from the compensation consultant, </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    total value of unvested equity awards held by the executive, and </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    executive&#8217;s overall performance, our performance during the year and the dilution to the stockholders. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2024, we granted Mr. Murray 1,200,000 shares of restricted stock which vests based on the attainment of corporate performance
goals and targets, including a minimum revenue of $65 million and a 6% operating profit for the fiscal year 2026, and his continued employment
through December 31, 2026. The Compensation Committee determined that the 1,200,000 cliff vesting award along with the 800,000 restricted
stock grant that vests over 5 years awarded to Mr. Murray upon his joining the Company in 2022 provides long-term incentive and aligns
his interest with shareholder interests. The Board has the discretion to modify the performance goals and targets during the performance
period to account for certain irregular, nonrecurring or one-time items in order to maintain alignment with stockholders&#8217; interests
in the Board&#8217;s sole discretion. If any of the applicable performance goals are attained at less than 80% of target, the number
of RSUs earned for the portion of the 2026 Performance-Based Equity Award attributable to that performance goal will be zero. If any
of the applicable performance goals are attained at between 80% and 100% of target, the number of RSUs earned for the portion of the
2026 Performance-Based Equity Award attributable to that performance goal will be between 50% and 100% of target. If any of the applicable
performance goals are attained at between 100% and 120% of target, the number of RSUs earned for the portion of the 2026 Performance-Based
Equity Award attributable to that performance goal will be between 100% and 120% of target. Performance achievement will be determined
by the Board in its reasonable discretion exercised in good faith in 2027 based on the audited financials for fiscal year 2026, and in
no event will the 2026 Performance-Based Equity Award be earned at greater than 120% of target. Performance between performance levels
for financial goals will be interpolated on a straight-line basis. The Board has the discretion to grant an additional performance-based
equity award following the 2026 fiscal year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2024, we granted Messrs. Sneider and Baker&#8217;s restricted stock grants of 75,000 shares each that vest at the rate of 34%
on December 10, 2025, 33% shall vest on December 10, 2026 and 33% shall vest on December 10, 2027, subject to the Company&#8217;s 2020
Equity Incentive Plan and remain employed by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2024 we granted our Board and employees an aggregate of 4,388,090 shares of restricted common stock of the Company of which 1,246,590
could be earned based on achieving milestones in fiscal year 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Perquisites</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not offer any perquisites for the exclusive benefit of the NEOs. Our healthcare, insurance and other welfare and employee-benefit
programs are the same for all eligible domestic employees, including executive officers. Benefits provided include health and dental
coverage, group term life insurance, disability programs and matching contributions to our 401(k) plan. We share the cost of health and
welfare benefits with our employees, a cost that is dependent on the level of benefits coverage that each employee elects. The benefits
provided to foreign employees are typically determined by the laws of the applicable country they reside in. We have no outstanding loans
of any kind to our executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Clawback
Policy</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have a Clawback Policy that provides that performance-based compensation is recoverable from an executive officer if the Board determines
that an officer has engaged in knowing or intentional fraudulent or illegal conduct that caused or substantially caused the need for
a restatement of the Company&#8217;s financial results. Performance-based compensation includes cash payments and any other awards pursuant
to any Company incentive plan made on or after January 1, 2009 where payment was predicated on achieving certain financial results. If
the Board or an authorized committee determines that any such performance-based compensation would have been at a lower amount had it
been based on the restated financial results, the Company will, to the extent practicable and permitted by applicable law, seek recoupment
from such officer of the portion of such performance-based compensation that is greater than that which would have been awarded or earned
had such compensation been calculated on the basis of the restated financial results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Compensation
Committee Interlocks and Insider Participation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of our executive officers serves as a member of the board of directors or compensation committee, or other committee serving an equivalent
function, of any other entity that has one or more of its executive officers serving as a member of our Board or Compensation Committee.
None of the current members of our Compensation Committee has ever been an employee of Kopin or any subsidiary of Kopin</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employment
and Other Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2022, Mr. Michael Murray joined Kopin as President and Chief Executive Officer. Mr. Murray&#8217;s compensation was as follows:
Mr. Murray received an annual base salary of $450,000. Additionally, Mr. Murray received 800,000 shares of restricted stock, which vest
in 20% increments each December 10 beginning in 2023, and a sign-on bonus of $100,000. Mr. Murray is entitled to an annual performance-based
bonus opportunity in the form of cash and long-term awards, subject to approval by the Compensation Committee. Mr. Murray also is eligible
for the Company&#8217;s standard benefits package and to participate in all applicable group employee benefit plans and programs offered.
In 2023, the Compensation Committee awarded Mr. Murray a $150,000 bonus for performance in 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 15, 2024 the Company and Mr. Murray signed a new Employment Agreement (the &#8220;New Agreement&#8221;). This summary of the New
Agreement is subject to the terms of the New Agreement which is filed with the SEC as an exhibit to Form 8-K. Under the New Agreement,
Mr. Murray&#8217;s salary was set at $495,000 with eligibility for a target bonus of 100% of base salary up to a maximum of 150% base
salary based on a formula and the determination of achievement of goals as determined by the Board. Mr. Murray also is eligible for the
Company&#8217;s standard benefits package and to participate in all applicable group employee benefit plans and programs offered. Mr.
Murray is eligible to receive equity awards covering the Company&#8217;s common stock. As of the effective date of the New Agreement,
Mr. Murray is no longer eligible to participate in the executive stock program applicable to other senior executives of the Company.
Provided that Mr. Murray continues to be employed by the Company on the date of a change of control (as defined in the New Agreement),
all outstanding equity awards held by Mr. Murray immediately prior to the effective date of a change of control which vest based upon
his continued service over time shall accelerate, become fully vested and/or exercisable, as the case may be, immediately prior to the
change of control, and all outstanding equity awards held immediately prior to the change of control which vest based upon attainment
of performance criteria shall vest based on target performance immediately prior to the change of control. For the fiscal year 2024 the
Board awarded Mr. Murray $668,000 bonus for performance in 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to continued employment on the grant date, Mr. Murray is eligible for a performance-based award with a target of 1,000,000 RSUs and a
maximum 1,200,000 RSU, which will vest based on attainment of corporate performance goals and targets established by the Board in its
sole discretion, after consultation with Mr. Murray and his continued employment through December 31, 2026 (&#8220;2026 Performance-Based
Equity Award&#8221;). The Board has the discretion to modify the performance goals and targets during the performance period to account
for certain irregular, nonrecurring or one-time items in order to maintain alignment with shareholders&#8217; interests in the Board&#8217;s
sole discretion. If any of the applicable performance goals are attained at less than 80% of target, the number of RSUs earned for the
portion of the 2026 Performance-Based Equity Award attributable to that performance goal will be zero. If any of the applicable performance
goals are attained at between 80% and 100% of target, the number of RSUs earned for the portion of the 2026 Performance-Based Equity
Award attributable to that performance goal will be between 50% and 100% of target. If any of the applicable performance goals are attained
at between 100% and 120% of target, the number of RSUs earned for the portion of the 2026 Performance-Based Equity Award attributable
to that performance goal will be between 100% and 120% of target. Performance achievement will be determined by the Board in its reasonable
discretion exercised in good faith in 2027 based on the audited financials for fiscal year 2026, and in no event will the 2026 Performance-Based
Equity Award be earned at greater than 120% of target. Performance between performance levels for financial goals will be interpolated
on a straight-line basis. The Board has the discretion to grant an additional performance based equity award following the 2026 fiscal
year. The Company may terminate Mr. Murray&#8217;s employment at any time without cause or Mr. Murray may terminate his employment at
any time for good reason. Upon termination by the Company without cause or by Mr. Murray with good reason, whether before or after the
Change of Control Protection Period (as defined in the New Agreement), if Mr. Murray executes and does not revoke a written release (as
defined in the New Agreement), Mr. Murray shall be entitled to receive, in lieu of any payments under any severance plan or program for
employees or executives, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will pay Mr. Murray an amount equal to six months of Base Salary at the rate in effect immediately prior to the termination date.
Payment shall be made over the six-month period following the termination date in substantially equal installments in accordance with
the Company&#8217;s normal payroll practices. Payment will begin within 60 days following the termination date, and any installments
not paid between the termination date and the date of the first payment will be paid with the first payment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provided
that he is eligible for and timely elects continuation coverage under COBRA, the Company will pay directly to the COBRA administrator
the COBRA premiums required to maintain Mr. Murray&#8217;s continued health care coverage under the Company&#8217;s group health plans
that he participated in on the date of termination (&#8220;COBRA Payments&#8221;). The Company will pay the COBRA Payments for the period
from his termination date until the earliest to occur of (i) the end of the six-month period following the termination date; (ii) the
date he becomes eligible for group health insurance coverage through a subsequent employer; or (iii) the date he ceases to be eligible
for COBRA coverage for any reason (each of the events described in (ii) or (iii) a &#8220;Disqualifying Event&#8221;. Mr. Murray is required
to notify the Company within five days of becoming aware that a Disqualifying Event has occurred or will occur. The COBRA health care
continuation coverage period under section 4980B of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), shall run
concurrently with the period during which the Company pays the COBRA Payments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall pay any earned, accrued, and owing Base Salary up until the date of termination and any benefits accrued and due under
any applicable benefit plans and programs of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, upon termination by the Company without Cause or by the Mr. Murray with Good Reason on or within six months preceding
or 15 months following a Change of Control (the &#8220;Change of Control Protection Period&#8221;), and provided that Mr. Murray executes
and does not revoke a written Release, then he shall be entitled to receive, in lieu of certain payments or any severance plan or program
for employees or executives the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company will pay an amount equal to 12 months Base Salary at the rate in effect immediately prior to the termination date (but not
    less than $495,000 in the aggregate). Payment shall be made in a lump sum within 60 days following the termination date; provided
    that such payment shall be made in installments as set forth in Section 6(a) above over the 12-month period following the termination
    date if the Change of Control is not a &#8220;change in control event&#8221; as defined under section 409A of the Code and; provided
    further that in the event Mr. Murray&#8217;s employment is terminated as described in this Section 7 on or within six months preceding
    the Change of Control, payments shall commence and, effective upon the closing of the Change of Control, he shall receive any additional
    amount less the aggregate amount of installment payments already received.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provided
    that he is eligible for and timely elects continuation coverage under COBRA, the Company will pay the COBRA administrator the COBRA
    Payments for the period from his termination date until the earliest to occur of (i) the end of the 12-month period following the
    termination date or (ii) a Disqualifying Event. Mr. Murray is required to notify the Company within five days of becoming aware that
    a Disqualifying Event has occurred or will occur. The COBRA health care continuation coverage period under section 4980B of the Code
    shall run concurrently with the period during which the Company pays the COBRA Payments.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company will pay a prorated target Annual Bonus for the year in which his termination of employment occurs, which amount will be
    determined by multiplying (i) the full-year target Annual Bonus for the year in which his termination of employment occurs, by (ii)
    a fraction, the numerator of which is the number of days during which he was employed by the Company in the fiscal year in which
    the termination date occurs and the denominator of which is 365. Such prorated target Annual Bonus shall be paid in a lump sum within
    60 days following the termination date. </span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
2020 Equity Incentive Plan allows for the acceleration of the vesting of unvested stock options and restricted stock awards subject to
a &#8220;double trigger&#8221; mechanism in the event of a change in control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Policies
Regarding Stock Ownership and Related Matters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that by holding shares of our common stock and options to purchase our common stock, our executives will have interests that
are more closely aligned with those of our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee grants equity-based awards, including restricted stock awards, to our executive officers and other key employees.
These equity awards are generally made on an annual grant cycle in the fourth quarter of each year at a pre-established Compensation
Committee meeting following the release of earnings. We also grant equity awards in the form of restricted stock awards to the non-employee
members of the Board of Directors on an annual basis following their election as directors at the annual meeting of shareholders. The
Compensation Committee may make off cycle equity awards from time to time on an as-needed basis as circumstances warrant. We do not time
the disclosure of material non-public information for the purpose of affecting the value of executive compensation, and it is the Compensation
Committee&#8217;s practice to generally avoid granting equity awards during periods in which there is undisclosed material non-public
information about the Company. In fiscal year 2024, we did not grant new awards of stock options to our NEOs during the time period outlined
in Item 402(x) of Regulation S-K</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have share ownership and retention guidelines that require each director of the Company to own shares of our common stock or options
to purchase shares of our common stock having an aggregate market value of at least three times the cash component of the director&#8217;s
annual retainer (excluding committee retainers) for service on the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the guidelines require our directors and CEO to own shares of our common stock having an aggregate market value of at least
three times his or her annual base salary. Our directors and our CEO have five years from the time they become subject to the stock ownership
guidelines to achieve the target ownership thresholds. In 2024, our directors and CEO were on track to maintain compliance with the minimum
stock ownership guidelines.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eecd--InsiderTrdPoliciesProcAdoptedFlag_dbT_c20231231__20241228_z1EPfe0dPpWj" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBQb2xpY2llcyBhbmQgUHJvY2VkdXJlcwA_"><ix:nonNumeric contextRef="From2023-12-31to2024-12-28" format="ixt:booleantrue" id="Fact000013" name="ecd:InsiderTrdPoliciesProcAdoptedFlag">We
have an Insider Trading Policy that governs our officers, directors and employees.</ix:nonNumeric></span> The policy imposes limits as to when and how our personnel
can engage in transactions in our securities and prohibits short sales of our common stock by all our personnel. We have filed a copy
of our Insider Trading Policy as an exhibit to our Form 10-K for the year ended December 28, 2024. Our Insider Trading Policy prohibits
our directors and executive officers from engaging in certain hedging and derivative transactions with respect to our securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of our officers have established Rule 10b5-1 plans with an independent broker. These plans typically govern the sale of an officer&#8217;s
stock when our stock prices meet certain levels. These plans, generally, may only be adjusted during certain times of the year with the
Company&#8217;s approval. Officers and directors may also sell shares outside a Rule 10b5-1 plan during open windows under our Insider
Trading Policy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tax
and Accounting Implications</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of its role, the Compensation Committee reviews and considers the deductibility of executive compensation under Section 162(m) of
the Internal Revenue Code, as amended (the &#8220;Code&#8221;), which generally disallows a tax deduction to public companies for certain
compensation in excess of $1.0 million paid in any year to a company&#8217;s chief executive officer and the four other most highly compensated
officers. Certain compensation, including qualified performance-based compensation, will not be subject to the deduction limitation if
certain requirements are met. Although the Compensation Committee has not adopted any specific policy with respect to the application
of Section 162(m), we generally seek to structure any long-term incentive compensation granted to our executive officers in a manner
that is intended to avoid disallowance of deductions under Section 162(m).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Accounting
for Stock-Based Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in our Annual Report on Form 10-K for the fiscal year ended December 28, 2024, the accounting for stock-based awards requires
the measurement and recognition of compensation expense based on the fair value of all share-based payment awards made to employees and
directors, including stock options and employee stock purchases under employee stock purchase plans. We are required to account for share-based
compensation transactions using a fair value method and recognize the related expense associated with share- based payments in our statement
of operations. Stock-based compensation cost is measured at the accounting measurement date based on the fair value of the award and
is recognized as expense over the service period, which generally represents the vesting period. The expense recognized over the service
period is required to include an estimate of the awards that will be forfeited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
2004 we have only issued restricted stock awards and the fair value of the award is typically based on the closing price of our stock
on Nasdaq on the day of grant. All employees are eligible to participate in our equity award program but the number of employees who
actually participate annually has been reduced and does not typically include employees who are paid on an hourly basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
Compensation Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the total compensation for the fiscal years ended December 28, 2024 and December 30, 2023 of those persons
who served as our principal executive officer, our principal financial officer and our next most highly compensated executive officer
for the fiscal year ended December 28, 2024. We refer to these individuals in this proxy as our named executive officers (NEOs).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
                                            and </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal
                                            Position</b></span></p></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Year</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Salary
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Bonus
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)<sup>(1)</sup></b></span></p></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restricted
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards
                                            </b></span></p> <p style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)<sup>(2)(3)</sup></b></span></p></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-equity
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incentive
                                            Plan </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)<sup>(4)</sup></b></span></p></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change
                                            in </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pension
                                            Value </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-Qualified
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deferred</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Earnings
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)<sup>(4)</sup></b></span></p></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All
                                            Other </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)<sup>(6)</sup></b></span></p></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$
                                            </b></span></p></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-bottom: 0; width: 29%"><span style="font-family: Times New Roman, Times, Serif">Michael
    Murray <br/></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 4%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">481,155</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">226,620</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,007,880</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">668,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,183</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,390,838</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif">President and Chief Executive
    Officer</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">450,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">150,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">431,999</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,357</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,042,357</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Richard
    A. Sneider</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">356,701</p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">165,408</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,738</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">534,847</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Treasurer and Chief Financial
    Officer</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">349,048</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">278,800</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,211</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">638,060</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Paul
    Baker <br/></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">330,814</p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">154,338</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,022</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">497,174</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Chief Operating Officer
    of Kopin Government and Industrial and Strategic Business Officer</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">324,450</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">231,480</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,145</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">566,075</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amount represents discretionary cash bonuses awarded by the Company. In 2024 the Company awarded Mr. Murray a bonus of $226,620
    related to performance for fiscal year 2023. In 2025 the Company awarded Mr. Murray a bonus of $668,000 for performance related to
    fiscal year 2024. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amounts in the column reflect the number of shares of restricted common stock granted in each year multiplied by the closing share
    price of the Company&#8217;s stock as listed on Nasdaq on the date of grant. See notes 1 and 6 of the consolidated financial statements
    included in our Form 10-K for the fiscal year ended December 28, 2024, regarding assumptions underlying valuation of equity awards.
    </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(3)</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The amounts included as the value of 2023 Restricted
    Stock Awards in previous filings incorrectly included the value of restricted stock vesting in 2023 and have been adjusted above
    to report the grant day fair value of the restricted stock.</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amounts reflect cash bonus payments earned with respect to annual incentive plans.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company does not maintain any pension or non-qualified deferred compensation plan. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    amounts for the Company&#8217;s matching contributions under the Company&#8217;s 401(k) Plan ranging and premiums paid for life insurance.
    Messer. Murray, Sneider and Baker received $6,161, $10,350 and $9,882, respectively of 401(k) match and $1,021, $2,388 and $2,140
    of life insurance premiums paid for on their behalf.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Perquisites
and Benefits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
provide benefit programs to executive officers and to other employees. The Board and executive management believe that perquisites for
executive officers should be extremely limited in scope and value. As a result, Kopin has historically given nominal perquisites to executive
officers, including NEOs. The following table generally identifies such benefit plans and who may be eligible to participate</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Benefit Plan</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Officers</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Managers</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Full
                                            Time</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Domestic</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employees</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Full
                                            Time</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employees
                                            </b></span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 32%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">401(k)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Yes</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Yes</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Yes</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Defined Contribution to Retirement Plan</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes<sup>(1)</sup></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Medical/Dental/ Vision Plans</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Yes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Yes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Yes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Life and Disability Insurance<sup>(2)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Yes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Yes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Yes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Short Term Incentive Plan.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes<sup>(3)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes<sup>(3)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes<sup>(4)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equity Incentive Plan</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Yes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Yes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Yes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Automobile Allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income Tax Planning services</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred Compensation Plan</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Supplemental Early Retirement Plan</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Employee Stock Ownership Plan</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Defined Benefit Pension Plan</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Financial Planning Allowance</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Country Club Memberships</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dwellings for Personal Use<sup>(5)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Not Offered</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kopin&#8217;s
    United Kingdom subsidiary contributes to a government sponsored retirement program for its employees. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kopin
    pays for life insurance equal to an employee&#8217;s base salary for domestic employees. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kopin
    has a short-term incentive plan pursuant to which certain officers and certain managers are paid a bonus if they remain with the
    company during the next fiscal year. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Board has historically provided for a discretionary bonus award at the end of the fiscal year for individuals who have significantly
    exceed their performance expectations or provided ideas that have significant benefits to the Company.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kopin
    does not provide dwellings for personal use other than for temporary job relocation. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
Employment Agreement / Other Potential Post-Employment Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Equity Plans have provisions that may result in the acceleration of vesting of certain equity awards as a result of a change in control.
The table below summarizes the effects on the compensation of our named executive officers as if the termination of employment or change
of control provisions of the Equity Plans and employment agreement were triggered on December 28, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            of Equity </b></span><b><span style="font-family: Times New Roman, Times, Serif">Awards if
                                            a <span style="font-size: 10pt">Change in Control Occurs on</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12/28/24<sup>(1)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Health
                                            Care</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Benefits</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Severance</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Payments
                                            </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 39%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Michael Murray</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 17%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,381,533</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Richard A. Sneider</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">229,767</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Paul Baker</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">219,342</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Equity Plans provide for the acceleration of the vesting of our equity awards in the event of a change in control of the Company.
    The amounts in this column represent the value the executive officer would have received if there were a change of control of the
    Company on December 28, 2024, and his unvested restricted stock awards as of December 28, 2024 became vested. The restricted stock
    award value is computed by multiplying the number of unvested shares of restricted stock at December 28, 2024 by the closing price
    of the Company&#8217;s common stock on Nasdaq on December 28, 2024 ($1.39). There were no unvested stock options as of December 28,
    2024. </span></td></tr>
  </table>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OUTSTANDING
EQUITY AWARDS AT FISCAL YEAR-END</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table discloses information concerning stock options and unvested stock awards held by our named executive officers as of December
28, 2024 pursuant to our Equity Plans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="18" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Option
    Awards</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Stock
    Awards</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Underlying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unexercised</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options
                                            (#)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercisable</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Underlying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unexercised</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options
                                            (#)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unexercisable</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incentive</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Plan</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Underlying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unexercised</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unearned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options
                                            (#)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expiration</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares
                                            or</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Units
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>That
                                            Have</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Not</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vested
                                            (#)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares
                                            or</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Units
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>That
                                            Have</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Not</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Yet</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vested</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)<sup>(1)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incentive</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Plan</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unearned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Units
                                            or</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rights</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>That
                                            Have</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Not</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vested
                                            (#)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incentive</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Plan</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>or
                                            Payout</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unearned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Units
                                            or</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rights</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>That
                                            Have</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Not</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vested</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)
                                            </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Michael Murray</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">513,333</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">713,533</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,200,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,668,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Richard A. Sneider</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">120,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">166,800</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">45,300</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">62,967</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Paul Baker</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">117,000</p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">162,630</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">40,800</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">56,712</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market
    value information is determined by multiplying the number of shares by the closing price of our common stock on Nasdaq on the last
    trading day of our 2024 fiscal year ($1.39 as of December 28, 2024). </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incentive
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Plan<sup>(1)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Retention
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant<sup>(2)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Retention
                                            </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant<sup>(3)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total<sup>(7)</sup></b></span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Michael Murray</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,200,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">33,333</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">480,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,713,333</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incentive</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Plan<sup>(4)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Retention</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grants<sup>(5)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Retention</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant<sup>(6)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Retention</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant<sup>(6)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incentive</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant<sup>(6)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total<sup>(7)</sup></b></span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Richard Sneider</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">45,300</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">75,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">165,300</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Paul Baker</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">40,800</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">75,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">17,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">157,800</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
    of shares will vest upon achievement of certain milestones in the Company&#8217;s fiscal year 2026.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    vest on December 10, 2024.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    original grant was 800,000 shares and they vest at the rate of 160,000 shares on each December 10th, commencing December 10, 2023.
    </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
    of shares will vest upon achievement of certain milestones in the Company&#8217;s fiscal year 2024. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    vest at the rate of 34% on December 10, 2025, 33% on December 10, 2026 and 33% on December 10, 2027. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    vest on December 10, 2025. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    employees must remain employed by the Company, except as provided in the Company&#8217;s equity plans, and meet certain other conditions
    for the shares to vest. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PAY
VERSUS PERFORMANCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
required by Item 402(v) of Regulation S-K, we are providing the following information about the relationship between the compensation
actually paid to our named executive officers and the financial performance of the Company for the fiscal years listed below. The Compensation
Committee did not consider the pay versus performance disclosure below in making its pay decisions for any of the years shown.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-12-31to2024-12-28" escape="true" id="Fact000015" name="ecd:PvpTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88B_eecd--PvpTableTextBlock_zRpWZcajCUtc" summary="xdx: Disclosure - Pay vs Performance Disclosure" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Year</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_484_eecd--PeoTotalCompAmt_hecd--IndividualAxis__custom--JohnCCFanMember_z4wRl1hxl8k" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Table
                                            Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>for
                                            former PEO&#8211;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>John
                                            C.C. Fan</b></span><b><sup id="xdx_F55_zb6YVkpu2qb6">(1)</sup></b></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_48B_eecd--PeoActuallyPaidCompAmt_hecd--IndividualAxis__custom--JohnCCFanMember_zEMRIXLELuL2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Actually
                                            Paid</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>to
                                            former PEO&#8211;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>John
                                            C.C. Fan<sup id="xdx_F5C_zdfgBLSvTxbf">(1)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_484_eecd--PeoTotalCompAmt_hecd--IndividualAxis__custom--MMurrayMember_zHEfdEXFgGi7" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Table
                                            Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>for
                                            PEO&#8211;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>M.
                                            Murray<sup id="xdx_F52_zcnsdqsc2nXl">(1)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_48A_eecd--PeoActuallyPaidCompAmt_hecd--IndividualAxis__custom--MMurrayMember_zGkS5cGILmJ8" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Actually
                                            Paid</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>to
                                            PEO&#8211;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>M
                                            Murray<sup id="xdx_F58_zWsJJ7DYPXa1">(1)(2)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_48D_eecd--NonPeoNeoAvgTotalCompAmt_z3hVIJxlJDS9" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Table
                                            Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>for
                                            Non-PEO</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEOs<sup id="xdx_F59_zuglffXQwHhj">(1)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_484_eecd--NonPeoNeoAvgCompActuallyPaidAmt_z85v9RHtquGc" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Actually
                                            Paid</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>to
                                            Non-PEO</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEOs<span><sup id="xdx_F5C_zhRjq8b5ahai">(1)(2)</sup></span></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_488_eecd--TotalShareholderRtnAmt_pp2d_zpgChxSN4eH1" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Initial
                                            Fixed</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$100</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Based
                                            On</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Return</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_486_eus-gaap--NetIncomeLoss_iN_di_zSb71LOH3WSd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Net
    Loss</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_412_20231231__20241228_zU2eKW0ZmDpe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0016">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0017">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-12-312024-12-28_custom_MMurrayMember" id="Fact000018" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,390,838</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-12-312024-12-28_custom_MMurrayMember" id="Fact000019" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,491,558</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2023-12-31to2024-12-28" id="Fact000020" format="ixt:numdotdecimal" decimals="0" unitRef="USD">516,011</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2023-12-31to2024-12-28" id="Fact000021" format="ixt:numdotdecimal" decimals="0" unitRef="USD">427,512</ix:nonFraction></p></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2023-12-31to2024-12-28" id="Fact000022" format="ixt:numdotdecimal" decimals="2" unitRef="USD">33.25</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-12-31to2024-12-28" id="Fact000023" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,877,896</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_41B_20230101__20231230_zv7f82SojZ84" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0024">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0025">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-01-012023-12-30_custom_MMurrayMember" id="Fact000026" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,042,357</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-01-012023-12-30_custom_MMurrayMember" id="Fact000027" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,651,367</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2023-01-012023-12-30" id="Fact000028" format="ixt:numdotdecimal" decimals="0" unitRef="USD">602,068</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2023-01-012023-12-30" id="Fact000029" format="ixt:numdotdecimal" decimals="0" unitRef="USD">684,290</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2023-01-012023-12-30" id="Fact000030" format="ixt:numdotdecimal" decimals="2" unitRef="USD">49.63</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-30" id="Fact000031" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,748,219</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_418_20211226__20221231_zQcEgrBxxTEc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2021-12-262022-12-31_custom_JohnCCFanMember" id="Fact000032" format="ixt:numdotdecimal" decimals="0" unitRef="USD">609,776</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right">(<span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2021-12-262022-12-31_custom_JohnCCFanMember" id="Fact000033" format="ixt:numdotdecimal" decimals="0" unitRef="USD">254,406</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2021-12-262022-12-31_custom_MMurrayMember" id="Fact000034" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,263,936</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2021-12-262022-12-31_custom_MMurrayMember" id="Fact000035" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,223,936</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2021-12-262022-12-31" id="Fact000036" format="ixt:numdotdecimal" decimals="0" unitRef="USD">378,934</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right">(<span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2021-12-262022-12-31" id="Fact000037" format="ixt:numdotdecimal" decimals="0" unitRef="USD">89,244</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2021-12-262022-12-31" id="Fact000038" format="ixt:numdotdecimal" decimals="2" unitRef="USD">30.32</ix:nonFraction></p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-12-262022-12-31" id="Fact000039" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,326,265</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table></ix:nonNumeric>

<ix:nonNumeric contextRef="From2023-12-31to2024-12-28" escape="true" id="Fact000041" name="ecd:NamedExecutiveOfficersFnTextBlock"><p id="xdx_890_eecd--NamedExecutiveOfficersFnTextBlock_dU_zwyp40JLOSEd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_902_eecd--PeoName_c20211226__20220626_zFGJOJxTSiwi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2021-12-262022-06-26" id="Fact000042" name="ecd:PeoName">Dr.
    Fan</ix:nonNumeric></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">was
    our PEO for part of fiscal year 2022 and was replaced by <span id="xdx_909_eecd--PeoName_c20220627__20221231_zlOvYzLZSms7"><ix:nonNumeric contextRef="From2022-06-272022-12-31" id="Fact000043" name="ecd:PeoName">Mr.
    Murray</ix:nonNumeric></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for part of fiscal year 2022. <span id="xdx_909_eecd--PeoName_c20231231__20241228_zQEeWYVKwSTf"><span id="xdx_904_eecd--PeoName_c20230101__20231230_zlBst7p3SJPj"><ix:nonNumeric contextRef="From2023-12-31to2024-12-28" id="Fact000044" name="ecd:PeoName"><ix:nonNumeric contextRef="From2023-01-012023-12-30" id="Fact000045" name="ecd:PeoName">Mr.
    Murray</ix:nonNumeric></ix:nonNumeric></span></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">was PEO for fiscal years 2023 and
    2024. The Non-PEO NEOs for the presented consists of Mr. Sneider and Mr. Baker in 2024 and 2023. The Non-PEO NEOs consisted of
    Messrs. Sneider and Baker and Drs. Tsaur and Choi in 2022.</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A6_znesG12wSOWb" style="display: none; margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
    Actually Paid reflects the exclusions and inclusions of certain amounts for the PEO and the Non-PEO NEOs as set forth below. Equity
    values are calculated in accordance with FASB ASC Topic 718. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; display: none; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F09_zj4bssyAs2hj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1F_zXsbhMJnbfCk" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000046" xml:lang="en-US">Dr
    Fan was our PEO for part of fiscal year 2022 and was replaced by Mr. Murray for part of fiscal year 2022. Mr. Murray was PEO for
    fiscal years 2023 and 2024. The Non-PEO NEOs for the presented consists of Mr. Sneider and Mr. Baker in 2024 and 2023.The Non-PEO NEOs consisted of Messrs. Sneider and Baker and Drs. Tsaur and Choi in 2022.</ix:footnote></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F04_zGOUgGVNRXRh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F13_zpFx14NuJknh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000047" xml:lang="en-US">Compensation
    Actually Paid reflects the exclusions and inclusions of certain amounts for the PEO and the Non-PEO NEOs as set forth below. Equity
    values are calculated in accordance with FASB ASC Topic 718. </ix:footnote></span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
Mr. Murray:</span></p>

<ix:nonNumeric contextRef="From2023-12-31to2024-12-28" escape="true" id="Fact000049" name="ecd:AdjToPeoCompFnTextBlock"><p id="xdx_899_eecd--AdjToPeoCompFnTextBlock_dU_zHHuMAof0Bv3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Year</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_481_eecd--PeoTotalCompAmt_hecd--IndividualAxis__custom--MMurrayMember_zQ6j8WTmiJ7" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reported
                                            Summary</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Table
                                            Total for PEO</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Michael
                                            Murray)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_483_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zPrH3YDavYH5" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reported</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards<sup id="xdx_F57_zpgb0GiYdrZa">(a)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_485_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember_zA4V4Yyp6cpa" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
                                            Award</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjustments<sup id="xdx_F52_zZFn3M0v2AJc">(b)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_48A_eecd--PeoActuallyPaidCompAmt_hecd--IndividualAxis__custom--MMurrayMember_zlr9QbnM7hrf" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Actually
                                            Paid to</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PEO</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Michael
                                            Murray) </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_412_20231231__20241228_zFafbaCTnjD8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-12-312024-12-28_custom_MMurrayMember" id="Fact000050" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,390,838</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right">(<span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-12-312024-12-28_custom_MMurrayMember_custom_ReportedValueOfEquityAwardsMember" id="Fact000051" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,007,880</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-12-312024-12-28_custom_MMurrayMember" id="Fact000052" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,108,600</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-12-312024-12-28_custom_MMurrayMember" id="Fact000053" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,491,558</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_41B_20230101__20231230_zl2U9EmvEgE1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-01-012023-12-30_custom_MMurrayMember" id="Fact000054" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,042,357</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right">(<span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-30_custom_MMurrayMember_custom_ReportedValueOfEquityAwardsMember" id="Fact000055" format="ixt:numdotdecimal" decimals="0" unitRef="USD">431,999</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-30_custom_MMurrayMember" id="Fact000056" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,041,010</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-01-012023-12-30_custom_MMurrayMember" id="Fact000057" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,651,367</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_41E_20220627__20221231_zn8FSskPbaGh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">2022</p>
</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><p style="margin: 0"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2022-06-272022-12-31_custom_MMurrayMember" id="Fact000058" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,263,936</ix:nonFraction></p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-06-272022-12-31_custom_MMurrayMember_custom_ReportedValueOfEquityAwardsMember" id="Fact000059" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,032,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><p style="margin: 0"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-06-272022-12-31_custom_MMurrayMember" id="Fact000060" format="ixt:numdotdecimal" decimals="0" unitRef="USD">992,000</ix:nonFraction></p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><p style="margin: 0"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2022-06-272022-12-31_custom_MMurrayMember" id="Fact000061" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,223,936</ix:nonFraction></p></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F05_z6RhFUPa3wU2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F11_zdEDv0kMaXK6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000062" xml:lang="en-US">Represents
    the total of the grant date fair value of equity award reported in the &#8220;Stock Awards&#8221; column in the Summary Compensation
    Table for the applicable year. </ix:footnote></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 30; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F02_zr7ZhfIJyHSk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1F_z2XxxZFMjVnj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000063" xml:lang="en-US">The
    equity award adjustments include the addition (or subtraction, as applicable) of the following: (i) the year-end fair value of any
    equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change
    as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that
    are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in same applicable
    year, the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the applicable year, the amount
    equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for awards granted in prior
    years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount
    equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on
    stock awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or
    included in any other component of total compensation for the applicable year. The valuation assumptions used to calculate fair value
    did not materially differ from those disclosed at the time of grant. The amounts deducted or added in calculating the equity award
    adjustments are as follows: </ix:footnote></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Year</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_487_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember__ecd--AdjToCompAxis__custom--YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember_z0s5a8OoOWcc" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            End Fair</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            of Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Award
                                            Granted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>during
                                            Year</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>that
                                            Remains</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unvested
                                            </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_487_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_zzwtBVdwR6r4" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            over</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            Change</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in
                                            Fair Value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unvested</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_48E_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember__ecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_z94ceg9Pzne2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            as</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vesting</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Granted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vested</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in
                                            the Year</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_486_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember_zy7jwfIfeXWh" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change
                                            in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
                                            Value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
                                            Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Granted
                                            in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prior
                                            Years</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>that
                                            Vested</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in
                                            the Year</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_485_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember__ecd--AdjToCompAxis__custom--FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember_zmLfWJHSgSb3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
                                            Value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>at
                                            the End</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
                                            the</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prior
                                            Year</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
                                            Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>that
                                            Failed</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>to
                                            Meet</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vesting</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Conditions</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in
                                            the Year</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_486_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember__ecd--AdjToCompAxis__custom--ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember_zlX1Xo6lhJA9" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends
                                            or</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Earnings</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid
                                            on Stock</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards
                                            not</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Otherwise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reflected
                                            in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
                                            Value or</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_48A_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember_zOQ0Po365Q7l" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Award</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjustments
                                            </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_412_20231231__20241228_zUYYsPHu85J5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-12-312024-12-28_custom_MMurrayMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember" id="Fact000064" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,668,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right">(<span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-12-312024-12-28_custom_MMurrayMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" id="Fact000065" format="ixt:numdotdecimal" decimals="0" unitRef="USD">328,533</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0066">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-12-312024-12-28_custom_MMurrayMember_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" id="Fact000067" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">220,392</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-12-312024-12-28_custom_MMurrayMember_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" id="Fact000068" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,475</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0069">&#8212;</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-12-312024-12-28_custom_MMurrayMember" id="Fact000070" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,108,600</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_41B_20230101__20231230_zDNnbRYbENa3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-30_custom_MMurrayMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember" id="Fact000071" format="ixt:numdotdecimal" decimals="0" unitRef="USD">428,190</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-30_custom_MMurrayMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" id="Fact000072" format="ixt:numdotdecimal" decimals="0" unitRef="USD">505,600</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-30_custom_MMurrayMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" id="Fact000073" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,020</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-30_custom_MMurrayMember_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" id="Fact000074" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,200</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0075">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0076">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-30_custom_MMurrayMember" id="Fact000077" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,041,010</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_41E_20220627__20221231_zadP0vScuEd4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-06-272022-12-31_custom_MMurrayMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember" id="Fact000078" format="ixt:numdotdecimal" decimals="0" unitRef="USD">992,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0079">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0080">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0081">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0082">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0083">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-06-272022-12-31_custom_MMurrayMember" id="Fact000084" format="ixt:numdotdecimal" decimals="0" unitRef="USD">992,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">For Dr. Fan:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Year</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_488_eecd--PeoTotalCompAmt_hecd--IndividualAxis__custom--DrFanMember_zgANI7iBLIrg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported<br/> Summary<br/>
    Compensation<br/> Table Total for<br/> Former PEO<br/> (John C.C. Fan)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_484_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zT2KELBmfOJ1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported<br/>
    Value of<br/> Equity<br/>
    Awards<span id="xdx_F54_z1gHOC6GC5Qk">(a)</span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48D_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember_zw0mnUjJEqXa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Equity
    Award<br/> Adjustments<span id="xdx_F51_ziLhoKWKNyrh">(b)</span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48B_eecd--PeoActuallyPaidCompAmt_hecd--IndividualAxis__custom--DrFanMember_znoiyykjJRm5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Compensation<br/> Actually<br/> Paid
    to<br/> Former PEO<br/> (John<br/> C.C.Fan)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_418_20211226__20221231_zxDdt3m37cm5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 24%; text-align: justify">2022</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2021-12-262022-12-31_custom_DrFanMember" id="Fact000085" format="ixt:numdotdecimal" decimals="0" unitRef="USD">609,776</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0086">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-12-262022-12-31_custom_DrFanMember" id="Fact000087" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">864,182</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">(<ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2021-12-262022-12-31_custom_DrFanMember" id="Fact000088" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">254,406</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  </table>



<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="width: 0.5in">&#160;</td>
    <td style="vertical-align: top; width: 0.25in"><span id="xdx_F00_zLaKcgg2L1cj" style="font-size: 10pt">(a)</span></td>
    <td style="vertical-align: top"><span id="xdx_F14_z55aOHeFNCU4" style="font-size: 10pt"><ix:footnote id="Footnote000089" xml:lang="en-US">Represents the total of the grant date fair value of the equity
    awards reported in the &#8220;Stock Awards&#8221; column in the Summary Compensation Table for the applicable year. </ix:footnote></span></td></tr>

<tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
<tr>
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 0.25in"><span id="xdx_F0E_zAqV709ELNFf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="text-align: justify; vertical-align: top"><span id="xdx_F11_zp2CHklhu3I9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000090" xml:lang="en-US">The
    equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i)&#160;the
    year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year;
    (ii)&#160;the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any
    awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii)&#160;for awards that
    are granted and vest in same applicable year, the fair value as of the vesting date; (iv)&#160;for awards granted in prior years
    that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in
    fair value; (v)&#160;for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during
    the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi)&#160;the dollar
    value of any dividends or other earnings paid on stock awards in the applicable year prior to the vesting date that are not otherwise
    reflected in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation
    assumptions used to calculate fair value did not materially differ from those disclosed at the time of grant. The amounts deducted
    or added in calculating the equity award adjustments are as follows: </ix:footnote></span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Year</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48D_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember__ecd--AdjToCompAxis__custom--YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember_zcgB7BD4mRBk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Granted<br/> during Year<br/> that<br/>
    Remains<br/> Unvested<br/> Year&#160;End&#160;Fair<br/> Value of<br/> Equity Award</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_483_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_z1LX1UmN5x3c" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year over<br/> Year Change<br/>
    in Fair Value<br/> of<br/> Outstanding<br/> and<br/> Unvested<br/> Equity<br/> Awards</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48B_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember__ecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_zQeDQ9Awfg75" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value<br/> as of<br/> Vesting<br/>
    Date of<br/> Equity<br/> Awards<br/> Granted<br/> and Vested<br/> in the&#160;Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48A_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember_zlEngPYUEjDe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Change in<br/> Fair Value<br/> of
    Equity<br/> Awards<br/> Granted&#160;in<br/> Prior Years<br/> that Vested<br/> in the Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48E_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember__ecd--AdjToCompAxis__custom--FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember_z8sv8QaEEYgk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value<br/> at the End<br/> of
    the Prior<br/> Year of<br/> Equity<br/> Awards<br/> that Failed<br/> to Meet<br/> Vesting<br/> Conditions<br/> in the Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48E_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember__ecd--AdjToCompAxis__custom--ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember_zPWjbhLW4Z1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value of<br/> Dividends or<br/> other<br/>
    Earnings <br/> Paid on Stock<br/> Awards not<br/> Otherwise<br/> Reflected in<br/> Fair Value or<br/> Total<br/> Compensation</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48C_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember_z6Nz2eP0ZuH6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total<br/> Equity<br/> Award<br/> Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_418_20211226__20221231_zw30x4IiQsZ5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%; text-align: justify; text-indent: -12pt; padding-left: 12pt">2022</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0091">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-12-262022-12-31_custom_DrFanMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" id="Fact000092" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">94,860</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0093">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-12-262022-12-31_custom_DrFanMember_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" id="Fact000094" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">493,723</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-12-262022-12-31_custom_DrFanMember_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" id="Fact000095" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">275,599</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0096">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-12-262022-12-31_custom_DrFanMember" id="Fact000097" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">864,182</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

</ix:nonNumeric><p id="xdx_8A3_zVa1YsXrkpgk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the non CEO- NEOs:</span></p>

<ix:nonNumeric contextRef="From2023-12-31to2024-12-28" escape="true" id="Fact000099" name="ecd:AdjToNonPeoNeoCompFnTextBlock"><p id="xdx_894_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zFN0DfyZZ3Pf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Year</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_481_eecd--NonPeoNeoAvgTotalCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember_zYnhtNet5cM2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reported</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Table
                                            Total for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-PEO</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEOs<sup id="xdx_F5E_zBntIm0ubbpk">(a)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_482_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_z75OrM2woAp" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reported</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            of Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_480_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember_zSNIylIFC0i1" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average
                                            Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Award</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjustments<sup id="xdx_F5B_zw90ROD8V3ll">(b)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_486_eecd--NonPeoNeoAvgCompActuallyPaidAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember_ztvw3FN3EqX" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average
                                            Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Actually</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid
                                            to Non-PEO</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEOs<sup id="xdx_F54_zvOxqNQbwXr4">(b)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_412_20231231__20241228_zuFT2YBeL5F7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 24%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2023-12-312024-12-28_ecd_NonPeoNeoMember" id="Fact000100" format="ixt:numdotdecimal" decimals="0" unitRef="USD">516,011</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_ReportedValueOfEquityAwardsMember" id="Fact000101" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">159,873</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-12-312024-12-28_ecd_NonPeoNeoMember" id="Fact000102" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,375</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2023-12-312024-12-28_ecd_NonPeoNeoMember" id="Fact000103" format="ixt:numdotdecimal" decimals="0" unitRef="USD">427,512</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_41B_20230101__20231230_ziQGj7MPTKw1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2023-01-012023-12-30_ecd_NonPeoNeoMember" id="Fact000104" format="ixt:numdotdecimal" decimals="0" unitRef="USD">602,068</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right">(<span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_ReportedValueOfEquityAwardsMember" id="Fact000105" format="ixt:numdotdecimal" decimals="0" unitRef="USD">255,140</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-30_ecd_NonPeoNeoMember" id="Fact000106" format="ixt:numdotdecimal" decimals="0" unitRef="USD">337,362</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2023-01-012023-12-30_ecd_NonPeoNeoMember" id="Fact000107" format="ixt:numdotdecimal" decimals="0" unitRef="USD">684,290</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_418_20211226__20221231_zT2TvIYh3Wxc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2021-12-262022-12-31_ecd_NonPeoNeoMember" id="Fact000108" format="ixt:numdotdecimal" decimals="0" unitRef="USD">378,934</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td style="padding-bottom: 1pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0109">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td style="padding-bottom: 1pt; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-12-262022-12-31_ecd_NonPeoNeoMember" id="Fact000110" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">468,178</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td style="padding-bottom: 1pt; text-align: right">(<ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2021-12-262022-12-31_ecd_NonPeoNeoMember" id="Fact000111" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">89,244</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span id="xdx_F0C_zoJmxMA2MSY4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F11_zQpwRaImKLk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000112" xml:lang="en-US">Represents
    the total of the average grant date fair value of the equity awards reported in the &#8220;Stock Awards&#8221; column in the Summary
    Compensation Table for the applicable year for all Non- PEO NEOs. </ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F0F_zYv5J8d1759c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F17_zwFGwrDqsNQ1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000113" xml:lang="en-US">The
    equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i) the
    year- end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year;
    (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards
    granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted
    and vest in same applicable year, the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the
    applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v)
    for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year,
    a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends
    or other earnings paid on stock awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair
    value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions used
    to calculate fair value did not materially differ from those disclosed at the time of grant. The amounts deducted or added in calculating
    the equity award adjustments are as follows: </ix:footnote></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Year</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_488_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember_z1q7H81SMZ67" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            End</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
                                            Value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
                                            Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Award</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Granted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>during</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            that</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remains</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unvested</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_48F_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_zBu658BZKngg" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            over</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change
                                            in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
                                            Value of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unvested
                                            Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_480_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_zQcyI5rHd7yj" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair</b></span> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            as</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vesting</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Granted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vested</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in
                                            the</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_484_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember_ziEayOBWkpe5" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            over</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change
                                            in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
                                            Value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
                                            Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Granted
                                            in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prior</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Years
                                            that</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vested
                                            in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>the
                                            Year </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_489_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember_zxraYp4bQMZd" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average
                                            Fair</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            at the</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>End
                                            of the</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prior
                                            Year of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards
                                            that</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Failed
                                            to</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Meet
                                            Vesting</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Conditions
                                            in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>the
                                            Year </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_483_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember_zvb4YGl5cLy7" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average
                                            Value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
                                            Dividends or</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>other
                                            Earnings</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid
                                            on Stock</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards
                                            not</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Otherwise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reflected
                                            in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
                                            Value or</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
                                            </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_48E_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember_zzLZlLyzyM15" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Award</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjustments
                                            </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_412_20231231__20241228_zWYCWtAprAP3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember" id="Fact000114" format="ixt:numdotdecimal" decimals="0" unitRef="USD">164,090</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right">(<span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" id="Fact000115" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,840</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0116">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" id="Fact000117" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">57,187</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" id="Fact000118" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,688</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0119">&#8212;</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-12-312024-12-28_ecd_NonPeoNeoMember" id="Fact000120" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,375</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_41B_20230101__20231230_zfXUfxQAXgjh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember" id="Fact000121" format="ixt:numdotdecimal" decimals="0" unitRef="USD">260,026</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" id="Fact000122" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,130</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" id="Fact000123" format="ixt:numdotdecimal" decimals="0" unitRef="USD">45,538</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" id="Fact000124" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,920</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" id="Fact000125" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">15,252</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0126">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-30_ecd_NonPeoNeoMember" id="Fact000127" format="ixt:numdotdecimal" decimals="0" unitRef="USD">337,362</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_418_20211226__20221231_zQNDfM9nSzu4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0128">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" id="Fact000129" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">276,055</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0130">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" id="Fact000131" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">94,670</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" id="Fact000132" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">97,453</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0133">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2021-12-262022-12-31_ecd_NonPeoNeoMember" id="Fact000134" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">468,178</ix:nonFraction></td><td style="text-align: left">)</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A2_ztB0JjLiwdTb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Analysis
of the Information Presented in the Pay Versus Performance Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
illustrations below provide a graphical description of the relationship between pay verses performance figures that are included in
the pay verse performance tabular disclosure above. &#8220;Compensation Actually Paid&#8221; for tabular disclosure and the
following graphs was  calculated in accordance with SEC rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description
of Relationship Between PEO and Non-PEO NEO Compensation Actually Paid and Company Total Shareholder Return (&#8220;TSR&#8221;) </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following chart sets forth the relationship between Compensation Actually Paid to our PEOs, the average of Compensation Actually Paid
to our Non-PEO NEOs, and the Company&#8217;s cumulative TSR over the two most recently completed fiscal years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description
of Relationship Between PEO and Non-PEO NEO Compensation Actually Paid and Net Loss</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following chart sets forth the relationship between Compensation Actually Paid to our PEOs, the average of Compensation Actually Paid
to our Non-PEO NEOs, and our Net Loss during the two most recently completed fiscal years.</span></p>

<ix:nonNumeric contextRef="From2023-12-31to2024-12-28" escape="true" id="Fact000136" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock"><p id="xdx_899_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zsBe2f9AfGW2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img src="formdef14a_001.jpg" alt="" style="height: 591px; width: 800px"/></p>

<ix:nonNumeric contextRef="From2023-12-31to2024-12-28" escape="true" id="Fact000138" name="ecd:CompActuallyPaidVsNetIncomeTextBlock"><p id="xdx_89D_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zdQLge7iPOxb" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="formdef14a_002.jpg" alt="" style="height: 520px; width: 750px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
Compensation Plan Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information as of December 28, 2024 about shares of our common stock issuable upon exercise of outstanding
options, warrants and rights and available for issuance under our existing equity compensation plans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Plan Category</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of securities to</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>be
                                            issued upon exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
                                            outstanding options,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>warrants
                                            and rights</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>exercise
                                            price of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>outstanding
                                            options,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>warrants
                                            and rights</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>remaining
                                            available</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>for
                                            future issuance</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>under
                                            equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>compensation
                                            plans</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(excluding
                                            securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>reflected
                                            in column (a)) </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(a)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(b)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(c)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity compensation
    plans approved by security holders<sup>(1)</sup></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,833,611</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.19</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,913,621</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;<sup>(2)</sup></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Equity compensation plans not approved by security holders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">&#8212;</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">&#8212;</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">&#8212;</p></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">4,833,611</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><p style="margin: 0">1.19</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0; text-indent: 0.25in">4,913,621</p></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of shares available under the 2020 Equity Incentive Plan.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 28, 2024, there were 4,913,621 shares available for grant under the 2020 Equity Incentive Plan.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 32; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Compensation Commencing in Fiscal Year 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2023, the Compensation Committee engaged Aon to perform a peer review of our Board of Director compensation. Commencing in 2024
our Board-approved compensation for non-employee directors is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
    retainer: $40,000 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Annual
    stock grant: 64,500 shares of restricted stock which vest on the anniversary of the grant Committee membership fees paid annually:</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    Committee Chairperson: $15,000 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Non-employee Chairperson of the Board: $30,000</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominating
    Committee Chairperson: $10,000 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
    Committee Chairperson: $10,000 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    Committee member: $8,000 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominating
    Committee member: $4,375 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
    Committee member: $5,000 </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the adoption of the Board Compensation plan commencing in 2024 the following adjustments were made:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Annual retainer was decreased from $45,000 to $40,000 </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
    annual stock grant was increased to 64,500 shares of restricted stock from 10,000 shares Committee membership fees paid annually:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Non-employee Chairperson of the Board: $30,000</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    Committee Chairperson compensation was increased $5,000</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
    Committee Chairperson compensation increased $6,250 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    Committee member compensation increased $3,000 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominating
    Committee member compensation increased $1,875 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Compensation Committee
    member compensation decreased $1,250</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Meeting
    fees were eliminated</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
non-employee director was also entitled to receive an initial restricted stock award for 64,500 shares of our common stock on the date
of his or her initial election to the Board. We also pay expenses for attendance at meetings of the Board and committees thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information regarding the compensation earned by or awards to each non-employee director who served
on our Board of Directors in the 2024 fiscal year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Murray, who was an employee of Kopin during 2024, was not compensated for his service as director and his compensation is fully reflected
in the Summary Compensation Table above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 33; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Compensation Table for 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fees</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Earned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>or
                                            Paid</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in
                                            Cash</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)<sup>(1)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)<sup>(2)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incentive</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)<sup>(3)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change
                                            in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pension
                                            Value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nonqualified</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deferred</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Earnings<sup>(3)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All
                                            Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)<sup>(3)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)
                                            </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jill J. Avery<sup>(4)</sup></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">61,188</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,310</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">111,498</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chi Chia Hsieh<sup>(5)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">54,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,310</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">104,310</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Nieuwsma <sup>(6)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">55,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,310</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">105,310</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Margaret Seif<sup>(7)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,188</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,310</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">85,828</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul Walsh, Jr.<sup>(8)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,333</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">54,573</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">81,907</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    Board member received his or her annual restricted stock grant of 64,500 shares which vests on the anniversary of the grant if the
    person is still a member of our Board of Directors on such anniversary with the exception of Mr. Walsh. The amounts in the column
    were determined by multiplying the number of shares of restricted common stock granted by the closing price of our common stock as
    listed on the Nasdaq on the day of grant. The 2024 grant occurred on June 6, 2024, and the closing price of our stock was $0.78.
    Mr. Walsh joined the Board of Directors on September 9, 2024 and he was granted 64,500 shares of restricted stock. Our stock price
    on September 9, 2024 was $0.85. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
    were no stock options issued in 2024. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    non-equity incentive compensation, pension, non-qualified deferred compensation or other compensation payments were made as compensation
    for director services in fiscal year 2024 or are contemplated under our current compensation plan. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Avery&#8217;s annual cash fees were comprised of the annual retainer of $40,000, $7,188 for serving on the Nominating Committee,
    and $8,000 for serving on the Audit Committee. In addition, prior to the implementation of the current Board member compensation
    plan members were paid meeting fees. Ms. Avery was paid $2,000 for attending meetings of the Board and $4,000 for attending meetings
    of the Audit Committee under the prior Board member compensation plan. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Hsieh&#8217;s annual cash fees were comprised of the annual retainer of $40,000 and $10.000 for serving as the Compensation Committee
    Chairperson. In addition, prior to the implementation of the current Board member compensation plan members were paid meeting fees.
    Dr. Hsieh was paid $2,000 for attending meetings of the Board and $2,000 for attending meetings of the Compensation Committee under
    the prior Board member compensation plan.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Nieuwsma&#8217;s annual cash fees were comprised of the annual retainer of $40,000, $8,000 for serving on the Audit Committee and
    $5.000 for serving as the Compensation Committee. In addition, prior to the implementation of the current Board member compensation
    plan members were paid meeting fees. Mr. Nieuwsma was paid $2,000 for attending meetings of the Board. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Sief&#8217;s annual cash fees were comprised of the annual retainer of $40,000, $7,188 for serving as Chairperson of the Nominating
    Committee and $5.000 for serving on the Compensation Committee. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Walsch, Jr.&#8217;s annual cash fees were comprised of a prorated annual retainer of $12,333, and $15,000 for serving as the Audit
    Committee Chairperson. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    Director, excluding Michael Murray, has 64,500 of unvested restricted shares.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 34; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Committee Report</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee of the Board currently consists of Paul Walsch, Jr., Jill J. Avery and David Nieuwsma, each of whom the Board
has determined is independent under applicable SEC and Nasdaq Rules. The Board also has determined that Mr. Walsh is an &#8220;audit
committee financial expert&#8221; under applicable SEC rules and regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Audit Committee is to assist the Board in its general oversight of the Company&#8217;s financial reporting, internal controls
and audit functions. The Audit Committee charter, which is available at the Company&#8217;s website at <i>www.kopin.com</i>, under the
heading &#8220;Investors: Corporate Governance,&#8221; describes in greater detail the full responsibilities of the Audit Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
is responsible for the preparation, presentation and integrity of the Company&#8217;s financial statements; accounting and financial
reporting principles; establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)); establishing
and maintaining internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f)); evaluating the effectiveness of
disclosure controls and procedures; evaluating the effectiveness of internal control over financial reporting; and evaluating any change
in internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, internal control
over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BDO
USA, P.C.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> (&#8220;BDO&#8221;), the Company&#8217;s
independent registered public accounting firm, has been engaged to perform an independent audit of the consolidated financial statements
and to express an opinion on the conformity of those financial statements with accounting principles generally accepted in the United
States of America and also to express an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting.
The Audit Committee has reviewed and discussed the consolidated financial statements with management and BDO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the course of the 2024 fiscal year, management completed the documentation, testing and evaluation of the Company&#8217;s system of internal
control over financial reporting in response to the requirements set forth in Section 404 of the Sarbanes-Oxley Act of 2002 and related
rules and regulations. The Audit Committee was kept apprised of the progress of the evaluation and provided oversight and advice to management
during this process. In connection with this oversight, the Audit Committee also received periodic updates provided by management and
Stowe &amp; Degon LLC, an independent registered public accounting firm that the Company uses for internal controls review, at regularly
scheduled Audit Committee meetings. At the conclusion of the process, management provided the Audit Committee with, and the Audit Committee
reviewed, a report on the effectiveness of the Company&#8217;s internal control over financial reporting. The Audit Committee also received
a report of results from Stowe &amp; Degon LLC. The Audit Committee also reviewed the report of management contained in the Company&#8217;s
Annual Reports on Form 10-K for the fiscal year ended December 28, 2024, filed with the SEC, as well as BDO&#8217;s Reports of Independent
Registered Public Accounting Firm included in the Company&#8217;s Annual Report on Form 10-K related to its audit of the consolidated
financial statements and financial statement schedule, for the fiscal year ended December 28, 2024. In conjunction, the Audit Committee
continues to oversee the Company&#8217;s efforts related to its internal control over financial reporting and management&#8217;s preparations
for the evaluation in fiscal year 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee has discussed with BDO the matters that are required to be discussed by applicable standards of the Public Company Accounting
Oversight Board (&#8220;PCAOB&#8221;), including Statement on Auditing Standards No. 61, &#8220;<i>Communication with Audit Committees</i>,&#8221;
as amended, and as adopted by the PCAOB, as well as Rule 2-07 of Regulation S-X of the SEC &#8220;<i>Communication with Audit Committees</i>.&#8221;
BDO has also provided to the Committee its letter required by PCAOB Ethics and Independence Rule 3526, &#8220;<i>Communications with
Audit Committees Concerning Independence</i>,&#8221; and the Committee discussed with RSM the firm&#8217;s independence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on its review and the discussion noted above, the Audit Committee recommended to the Board that the Company&#8217;s Consolidated Financial
Statements for the fiscal year 2024 be included in the Company&#8217;s Annual Report on Form 10-K for the 2024 fiscal year for filing
with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUDIT
    COMMITTEE</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Walsh, Jr., Chairperson </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jill
    J. Avery </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Nieuwsma</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<ix:exclude><!-- Field: Page; Sequence: 35; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
2</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>APPROVAL
OF AN AMENDMENT TO THE COMPANY&#8217;S 2020 EQUITY INCENTIVE PLAN</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Equity Incentive Plan Amendment Proposal&#8212;</b> The Board has authorized, subject to stockholder approval, an amendment to our 2020
Equity Incentive Plan (the &#8220;2020 EIP&#8221;) to increase the number of shares available under the 2020 EIP by 5,000,000 shares
(the &#8220;Plan Amendment&#8221;). Currently, the 2020 EIP authorizes the issuance of up to 14,000,000 shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the 2020 EIP is to encourage ownership of the Company&#8217;s common stock by key employees and to provide additional incentive
for such employees to promote the success of the Company&#8217;s business. The Board believes that the 2020 EIP:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aligns
    the long-term interests of key employees and stockholders by creating a direct link between key employee compensation and stockholder
    return; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enables
    key employees to develop and maintain a meaningful stock ownership in the Company; and </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provides
    incentives for key employees to contribute to the success of the Company. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan Amendment is being submitted to stockholders for approval. A copy of the 2020 EIP as it is proposed to be amended is attached to
this Proxy Statement as Appendix A. The Board believes it is in the best interests of the Company and its stockholders to approve the
Plan Amendment to increase the number of shares available under the 2020 EIP by 5,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
total of 19,000,000 shares of Kopin common stock will be reserved for issuance under the amended 2020 EIP. As of April 30, 2025,
the closing price on Nasdaq per share of common stock was $1.28. Our Board approved the Plan Amendment on March 20, 2025, subject to
approval by Kopin&#8217;s stockholders. The Plan Amendment will be effective upon approval by Kopin&#8217;s stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"></p>

<ix:exclude><!-- Field: Page; Sequence: 36; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">The following table
includes information regarding all of our outstanding equity awards and shares available for future awards under the Plan as of May
1, 2025:</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Total number of shares underlying outstanding stock options</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">591,366</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Weighted average exercise price of outstanding stock options</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.76</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Weighted average remaining life of outstanding stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.75</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total shares of common stock outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">162,797,922</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total shares underlying outstanding and unvested restricted stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,492,501</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Shares available for future awards under the 2020 Equity Incentive plan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,343,521</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reasons
for the Amendment to the 2020 EIP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
incentive compensation programs play a pivotal role in Kopin&#8217;s efforts to attract and retain key personnel essential to Kopin&#8217;s
long-term growth and financial success. We are asking our stockholders to approve the Plan Amendment to assist Kopin in attracting and
retaining qualified personnel. If our stockholders do not approve the Plan Amendment, we will be limited in our ability to continue to
issue awards in numbers sufficient to attract and motivate the highly skilled employees we need to recruit and retain, due to low share
reserves remaining in our 2020 EIP and the dilution to our share reserve and outstanding equity awards from the increase in our stock
outstanding from recent financing activities, and our employees&#8217; motivation and incentives will be negatively affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering
a broad-based equity compensation program is vital to attracting and retaining highly skilled people in the highly competitive technology
industry. We use equity awards to increase incentives on the part of employees, non-employee directors and consultants who provide significant
services to the Company. We believe that providing an equity stake in the future success of our business encourages our employees to
be highly motivated to achieve our long-term business goals and to increase stockholder value. Their innovation and productivity are
critical to our success. Accordingly, approving the Plan Amendment is in the best interest of our stockholders because equity awards
help us to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">attract,
    motivate and retain talented employees and directors; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">align
    employee and stockholder interests; and </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">link
    employee compensation with Kopin&#8217;s performance. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
strongly believe that approval of the Plan Amendment will enable us to achieve our goals in attracting and retaining our most valuable
asset: our employees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
the appropriate share reserve to grant competitive equity-based incentives, we would be forced to consider cash replacement alternatives
to provide a market-competitive total compensation package necessary to attract, retain and motivate the employee talent critical to
our future successes. These cash replacement alternatives could, among other things, reduce the cash available for investment in growth
and development and cause a loss of motivation by employees to achieve superior performance over a longer period of time. Equity- based
incentives, by contrast, directly align a portion of the compensation of our employees with the economic interests of our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
that reason, Kopin has structured the 2020 EIP to provide flexibility in designing equity incentive programs with a broad array of equity
incentives, such as stock options, stock appreciation rights, stock awards and restricted stock units and implement competitive incentive
compensation programs for its employees and non-employee Board members. The 2020 EIP will continue to be the only plan under which new
equity awards may be granted to our employees and other service providers. If this Proposal 2 is not approved, then we would be at a
disadvantage against our competitors for recruiting, retaining and motivating individuals critical to our success and could be forced
to increase cash compensation, thereby reducing resources available to meet our business needs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 37; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of May 1, 2025, 11,668,479 shares of common stock, net of 4,373,315 of forfeitures, had been issued pursuant to awards under the
2020 EIP. All awards outstanding under the 2020 EIP on the date of the Plan Amendment will continue to be governed solely by the terms
of the documents evidencing such awards, and no provision of the Plan Amendment will be deemed to affect or otherwise modify the rights
or obligations of the holders of such transferred awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with our stock-based compensation programs, we are committed to using equity incentive awards prudently and within reasonable
limits. We anticipate that the share reserve under the amended 2020 EIP, will enable us to fund our equity compensation program for approximately
two years. While we believe this is a reasonable estimate of how long the share reserve would last, the actual period for which the proposed
share reserve will fund our equity compensation program may be shorter or longer than expected, depending on changes in our granting
practices, stock price and headcount growth.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
Description of the Kopin Corporation 2020 Equity Incentive Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of the principal provisions of the 2020 EIP. This summary is qualified in its entirety by reference to the full
text of the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Types
of Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2020 EIP provides for the issuance of stock options (including non-statutory stock options and incentive stock option), stock appreciation
rights (referred to as &#8220;SARs&#8221;), restricted stock, restricted stock units (&#8220;RSUs&#8221;), stock bonuses and other stock-based
awards to officers, employees, non-employee directors, independent contractors and consultants of Kopin Corporation or its affiliates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purpose
and Types of Grants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the 2020 EIP is to attract and retain employees, non-employee directors and consultants, and advisors. The 2020 EIP provides
for the issuance of incentive stock options, non-qualified stock options, stock awards, stock units, stock appreciation rights and other
stock-based awards. The 2020 EIP is intended to provide an incentive to participants to contribute to our economic success by aligning
the economic interests of participants with those of our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Administration</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2020 EIP is administered by the Compensation Committee of our Board, and the Compensation Committee will determine all of the terms and
conditions applicable to grants under the 2020 EIP. Our Compensation Committee determines who receives grants under the 2020 EIP and
the number of shares of common stock that will be subject to grants, except that grants to members of our Board must be authorized by
a majority of our Board. Our Compensation Committee may delegate authority under the 2020 EIP to one or more subcommittees as it deems
appropriate. Subject to compliance with applicable law and stock exchange requirements, the Compensation Committee (or our Board or a
subcommittee, as applicable) may delegate all or part of its authority to our Chief Executive Officer, as it deems appropriate, with
respect to grants to employees or key advisors who are not executive officers under Section 16 of the Exchange Act. Our Compensation
Committee, our Board, any subcommittee or the Chief Executive Officer, as applicable, that has authority with respect to a specific grant
will be referred to as &#8220;the committee&#8221; in this description of the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shares
Subject to the Plan</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to adjustment, our 2020 EIP currently authorizes the issuance or transfer of up to 14,000,000 shares of our common stock. In addition,
shares of common stock underlying any outstanding award granted under the Prior Plan that, following the effective date of the 2020 EIP,
expires, or is terminated, surrendered or forfeited for any reason without issuance of such shares shall be available for new grants
under the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any options or SARs expire or are canceled, forfeited, exchanged or surrendered without having been exercised, or if any stock awards,
stock units or other stock-based awards are forfeited, terminated or otherwise not paid in full, the shares of our common stock subject
to such awards will again be available for purposes of the 2020 EIP. If shares of our common stock are surrendered in payment of the
exercise price of an option, the number of shares of common stock available for issuance under the 2020 EIP will be reduced only by the
net number of shares actually issued by us upon such exercise and not by the gross number of shares as to which such option is exercised.
Upon the exercise of any SAR under the 2020 EIP, the number of shares of our common stock available for issuance will be reduced only
by the net number of shares actually issued by us upon such exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 38; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
shares of our common stock are withheld by us in satisfaction of the withholding taxes incurred in connection with the issuance, vesting
or exercise of any grant or the issuance of our common stock under the 2020 EIP, the number of shares of common stock available for issuance
will be reduced by the net number of shares issued, vested or exercised under such grant, calculated in each instance after payment of
such share withholding. If any awards are paid in cash, and not in shares of our common stock, any shares of our common stock subject
to such awards will also be available for future awards. If we repurchase shares of our common stock on the open market with the proceeds
from the exercise price we receive from options, the repurchased shares will not be available for issuance under the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Individual
Limits for Non-Employee Directors</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
maximum aggregate grant date value of shares of common stock granted to any non-employee director in any one calendar year, taken together
with any cash fees earned by such non-employee director for services rendered during the calendar year, shall not exceed $250,000 in
total value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Adjustments</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with stock splits, stock dividends, recapitalizations and certain other events affecting our common stock, the committee will
make adjustments as it deems appropriate in: the maximum number of shares of common stock reserved for issuance as grants; the maximum
amount of awards that may be granted to any individual non-employee director in any year; the number and kind of shares covered by outstanding
grants; the number and kind of shares that may be issued under the 2020 EIP; the price per share or market value of any outstanding grants;
the exercise price of options; the base amount of stock appreciation rights; and the performance goals or other terms and conditions
as the committee deems appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Eligibility
and Vesting</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of our employees are eligible to receive grants under the 2020 EIP. In addition, our non-employee directors and key advisors who perform
services for us may receive grants under the 2020 EIP. The committee determines the vesting and exercisability terms of awards granted
under the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Options</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our 2020 EIP, the committee determines the exercise price of the options granted and may grant options to purchase shares of our common
stock in such amounts as it determines. The committee may grant options that are intended to qualify as incentive stock options under
Section 422 of the Code, or non-qualified stock options, which are not intended to so qualify. Incentive stock options may only be granted
to our employees. Anyone eligible to participate in the 2020 EIP may receive a grant of non-qualified stock options. The exercise price
of a stock option granted under the 2020 EIP cannot be less than the fair market value of a share of our common stock on the date the
option is granted. If an incentive stock option is granted to a 10% stockholder of the total combined voting power of all classes of
our stock, the exercise price cannot be less than 110% of the fair market value of a share of our common stock on the date the option
is granted. The aggregate number of shares of common stock that may be issued or transferred under the 2020 EIP pursuant to incentive
stock options under Section 422 of the Code may not exceed 10% of the number of shares of common stock outstanding on the effective date
of the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price for any option is generally payable in cash. In certain circumstances as permitted by the committee, the exercise price
may be paid: by the surrender of shares of our common stock with an aggregate fair market value, on the date the option is exercised,
equal to the exercise price; by payment through a broker in accordance with procedures established by the Federal Reserve Board; by withholding
shares of common stock subject to the exercisable option that have a fair market value on the date of exercise equal to the aggregate
exercise price; or by such other method as the committee approves.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term of an option cannot exceed ten years from the date of grant, except that if an incentive stock option is granted to a 10% stockholder
of the total combined voting power of all class of our stock, the term cannot exceed five years from the date of grant. In the event
that on the last day of the term of a non-qualified stock option, the exercise is prohibited by applicable law, including a prohibition
on purchases or sales of our common stock under our insider trading policy, the term of the non-qualified option will be extended for
a period of 30 days following the end of the legal prohibition, unless the committee determines otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<ix:exclude><!-- Field: Page; Sequence: 39; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as provided in the grant instrument, an option may only be exercised while a participant is employed by or providing service to us. The
committee will determine in the grant instrument under what circumstances and during what time periods a participant may exercise an
option after termination of employment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2020 EIP, the committee may grant stock awards. A stock award is an award of our common stock that may be subject to restrictions
as the committee determines. The restrictions, if any, may lapse over a specified period of employment or based on the satisfaction of
pre-established criteria, in installments or otherwise, as the committee may determine, including, but not limited to, restrictions based
on the achievement of performance goals. Except to the extent restricted under the grant instrument relating to the stock award, a participant
will have all of the rights of a stockholder as to those shares, including the right to vote and the right to receive dividends or distributions
on the shares. Dividends with respect to stock awards that vest based on performance shall vest if and to the extent that the underlying
stock award vests, as determined by the committee. All unvested stock awards are forfeited if the participant&#8217;s employment or service
is terminated for any reason, unless the committee determines otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Units</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2020 EIP, the committee may grant stock units to anyone eligible to participate in the 2020 EIP. Stock units represent hypothetical
shares of our common stock. Stock units become payable on terms and conditions determined by the committee, including specified performance
goals, and will be payable in cash, shares of common stock, or a combination thereof, as determined by the committee. All unvested stock
units are forfeited if the participant&#8217;s employment or service is terminated for any reason, unless the committee determines otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Appreciation Rights</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2020 EIP, the committee may grant SARs, which may be granted separately or in tandem with any option. SARs granted in tandem with
a non-qualified stock option may be granted either at the time the non- qualified stock option is granted or any time thereafter while
the option remains outstanding. SARs granted in tandem with an incentive stock option may be granted only at the time the grant of the
incentive stock option is made. The committee will establish the base amount of the SAR at the time the SAR is granted, which will be
equal to or greater than the fair market value of a share of our common stock as of the date of grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a SAR is granted in tandem with an option, the number of SARs that are exercisable during a specified period will not exceed the number
of shares of our common stock that the participant may purchase upon exercising the related option during such period. Upon exercising
the related option, the related SARs will terminate, and upon the exercise of a SAR, the related option will terminate to the extent
of an equal number of shares of our common stock. Generally, SARs may only be exercised while the participant is employed by, or providing
services to, us. When a participant exercises a SAR, the participant will receive the excess of the fair market value of the underlying
common stock over the base amount of the SAR. The appreciation of a SAR will be paid in shares of our common stock, cash or both.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term of a SAR cannot exceed ten years from the date of grant. In the event that on the last day of the term of a SAR, the exercise is
prohibited by applicable law, including a prohibition on purchases or sales of our common stock under our insider trading policy, the
term of the SAR will be extended for a period of 30 days following the end of the legal prohibition, unless the committee determines
otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Stock-Based Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2020 EIP, the committee may grant other types of awards that are based on, or measured by, our common stock, and granted to anyone
eligible to participate in the 2020 EIP. The committee will determine the terms and conditions of such awards. Other stock-based awards
may be payable in cash, shares of our common stock or a combination of the two, as determined by the committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<ix:exclude><!-- Field: Page; Sequence: 40; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividend
Equivalents</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2020 EIP, the committee may grant dividend equivalents in connection with grants of stock units or other stock-based awards made
under the 2020 EIP. Dividend equivalents entitle the participant to receive amounts equal to ordinary dividends that are paid on the
shares underlying a grant while the grant is outstanding. The committee will determine whether dividend equivalents will be paid currently
or accrued as contingent cash obligations. Dividend equivalents may be paid in cash or shares of our common stock. The committee will
determine the terms and conditions of the dividend equivalent grants, including whether the grants are payable upon the achievement of
specific performance goals. Dividend equivalents with respect to stock units or other stock-based awards that vest based on performance
shall vest and be paid only if and to the extent that the underlying stock units or other stock-based awards vest and are paid as determined
by the committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Prohibition
on Repricing</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the 2020 EIP, the committee may not (i) amend the terms of any outstanding stock options or SARs to reduce the exercise
price or base price, as applicable, (ii) cancel outstanding stock options or SARs in exchange for stock options or SARs with an exercise
price or base price, as applicable, that is less than the exercise price or base price of the original stock options or SARs or (iii)
cancel outstanding stock options or SARs with an exercise price or base price, as applicable, above the current stock price in exchange
for cash or other securities, except in connection with a corporate transaction involving the Company, without in each such instance
obtaining the approval of our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change
of Control</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we experience a change of control where we are not the surviving corporation (or survive only as a subsidiary of another corporation),
unless the committee determines otherwise, all outstanding grants that are not exercised or paid at the time of the change of control
will be assumed by, or replaced with grants (with respect to cash, securities or a combination thereof) that have comparable terms by,
the surviving corporation (or a parent or subsidiary of the surviving corporation).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise set forth in a grant instrument, if a participant is terminated without cause upon or within 12 months of a change of control,
all outstanding time-based awards shall become fully vested.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
there is a change of control and all outstanding grants are not assumed by, or replaced with grants that have comparable terms by the
surviving corporation, the committee may (but is not obligated to) make adjustments to the terms and conditions of outstanding grants,
including, without limitation, taking any of the following actions (or combination thereof) without the consent of any participant:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determine
    that outstanding options and SARs will accelerate and become fully exercisable and the restrictions and conditions on outstanding
    stock awards, stock units and dividend equivalents immediately lapse; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pay
    participants, in an amount and form determined by the committee, in settlement of outstanding stock units or dividend equivalents;
    </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">require
    that participants surrender their outstanding stock options and SARs in exchange for a payment by us, in cash or shares of our common
    stock, equal to the difference between the exercise price and the fair market value of the underlying shares of our common stock;
    provided, however, if the per share </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fair
    market value of our common stock does not exceed the per share stock option exercise price or stock appreciation right base amount,
    as applicable, we will not be required to make any payment to the participant upon surrender of the stock option or stock appreciation
    right; or </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">after
    giving participants an opportunity to exercise all of their outstanding stock options and SARs, terminate any unexercised stock options
    and SARs on the date determined by the committee. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"></p>

<ix:exclude><!-- Field: Page; Sequence: 41; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general terms, a change of control under the 2020 EIP occurs if:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    person, entity or affiliated group, with certain exceptions, acquires more than 50% of our then- outstanding voting securities; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    merge into another entity unless the holders of our voting shares immediately prior to the merger have at least 50% of the combined
    voting power of the securities in the merged entity or its parent; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    merge into another entity and the members of our Board prior to the merger would not constitute a majority of the board of the merged
    entity or its parent; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    sell or dispose of all or substantially all of our assets; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    consummate a complete liquidation or dissolution; or </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    majority of the members of our Board is replaced during any 12-month period by directors whose appointment or election is not endorsed
    by a majority of the incumbent directors. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Deferrals</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
committee may permit or require participants to defer receipt of the payment of cash or the delivery of shares of common stock that would
otherwise be due to the participant in connection with a grant under the 2020 EIP. The committee will establish the rules and procedures
applicable to any such deferrals, consistent with the requirements of Section 409A of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Withholding</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
grants under the 2020 EIP are subject to applicable U.S. federal (including FICA), state and local, foreign or other tax withholding
requirements. We may require participants or other persons receiving grants or exercising grants to pay an amount sufficient to satisfy
such tax withholding requirements with respect to such grants, or we may deduct from other wages and compensation paid by us the amount
of any withholding taxes due with respect to such grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
committee may permit or require that our tax withholding obligation with respect to grants paid in our common stock be paid by having
shares withheld up to an amount that does not exceed the participant&#8217;s minimum applicable withholding tax rate for United States
federal (including FICA), state and local tax liabilities, or as otherwise determined by the committee. In addition, the committee may,
in its discretion, and subject to such rules as the committee may adopt, allow participants to elect to have such share withholding applied
to all or a portion of the tax withholding obligation arising in connection with any particular grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transferability</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as permitted by the committee with respect to non-qualified stock options, only a participant may exercise rights under a grant during
the participant&#8217;s lifetime. Upon death, the personal representative or other person entitled to succeed to the rights of the participant
may exercise such rights. A participant cannot transfer those rights except by will or by the laws of descent and distribution or, with
respect to grants other than incentive stock options, pursuant to a domestic relations order. The committee may provide in a grant instrument
that a participant may transfer non-qualified stock options and stock award to family members, or one or more trusts or other entities
for the benefit of or owned by family members, consistent with applicable securities laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Amendment;
Termination</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board may amend or terminate our 2020 EIP at any time, except that our stockholders must approve an amendment if such approval is required
in order to comply with the Code, applicable laws or applicable stock exchange requirements. Unless terminated sooner by our Board or
extended with stockholder approval, the 2020 EIP will terminate on the day immediately preceding the tenth anniversary of the effective
date of the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stockholder
Approval</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
in connection with certain corporate transactions, including stock dividends, stock splits, a recapitalization, a change in control,
a reorganization, a merger and a spin-off, stockholder approval is required (i) to reduce the exercise price or base price of outstanding
stock options or SARs, (ii) to cancel outstanding stock options or SARs in exchange for the same type of grant with a lower exercise
price or base price, and (iii) to cancel outstanding stock options or SARs that have an exercise price or base price above the current
price of a share of our common stock, in exchange for cash or other securities, each as applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 42; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Establishment
of Sub-Plans</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board may, from time to time, establish one or more sub-plans under the 2020 EIP to satisfy applicable blue sky, securities or tax laws
of various jurisdictions. Our Board may establish such sub-plans by adopting supplements to the 2020 EIP setting forth limitations on
the committee&#8217;s discretion and such additional terms and conditions not otherwise inconsistent with the 2020 EIP as our Board deems
necessary or desirable. All such supplements will be deemed part of the 2020 EIP, but each supplement will only apply to participants
within the affected jurisdiction, and we will not be required to provide copies of any supplement to such unaffected participants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Clawback</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to applicable law, the committee may provide in any grant instrument that if a participant breaches any restrictive covenant agreement
between the participant and us, or otherwise engages in activities that constitute cause (as defined in the 2020 EIP) either while employed
by, or providing services to, us or within a specified period of time thereafter, all grants held by the participant will terminate,
and we may rescind any exercise of an option or stock appreciation right and the vesting of any other grant and delivery of shares upon
such exercise or vesting, as applicable on such terms as the committee will determine, including the right to require that in the event
of any rescission:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    participant must return the shares received upon the exercise of any option or stock appreciation right or the vesting and payment
    of any other grants; or </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    the participant no longer owns the shares, the participant must pay to us the amount of any gain realized or payment received as
    a result of any sale or other disposition of the shares (if the participant transferred the shares by gift or without consideration,
    then the fair market value of the shares on the date of the breach of the restrictive covenant agreement or activity constituting
    cause), net of the price originally paid by the participant for the shares. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
committee may also provide for clawbacks pursuant to a clawback policy, which our Board may in the future adopt and amend from time to
time. Payment by the participant will be made in such manner and on such terms and conditions as may be required by the committee. We
will be entitled to set off against the amount of any such payment any amounts that we otherwise owe to the participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain
United States Federal Income Tax Aspects</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of certain U.S. federal income tax consequences of awards under the 2020 EIP. It does not purport to be a complete
description of all applicable rules, and those rules (including those summarized here) are subject to change.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Options</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
optionee generally will not recognize taxable income upon the grant of a non-statutory option. Rather, at the time of exercise of the
option, the optionee will recognize ordinary income for income tax purposes in an amount equal to the excess, if any, of the fair market
value of the shares purchased over the exercise price. We generally will be entitled to a tax deduction at such time and in the same
amount, if any, that the optionee recognizes as ordinary income. The optionee&#8217;s tax basis in any shares received upon exercise
of an option will be the fair market value of the shares on the date of exercise, and if the shares are later sold or exchanged, then
the difference between the amount received upon such sale or exchange and the fair market value of such shares on the date of exercise
will generally be taxable as long-term or short-term capital gain or loss (if the shares are a capital asset of the optionee) depending
upon the length of time such shares were held by the optionee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incentive
stock options are eligible for favorable U.S. federal income tax treatment if certain requirements are satisfied. An incentive stock
option must have an option price that is not less than the fair market value of the stock at the time the option is granted and must
be exercisable within ten years from the date of grant. An employee granted an incentive stock option generally does not realize compensation
income for U.S. federal income tax purposes upon the grant of the option. At the time of exercise of an incentive stock option, no compensation
income is realized by the optionee other than tax preference income for purposes of the federal alternative minimum tax on individual
income. If the shares acquired on exercise of an incentive stock option are held for at least two years after grant of the option and
one year after exercise, the excess of the amount realized on the sale over the exercise price will be taxed as capital gain. If the
shares acquired on exercise of an incentive stock option are disposed of within less than two years after grant or one year of exercise,
the optionee will realize taxable compensation income equal to the lesser of (i) the excess of the fair market value of the shares on
the date of exercise over the option price or (ii) the excess of the amount realized on the sale over the option price. Any additional
amount realized will be taxed as capital gain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 43; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
participant generally will not be taxed upon the grant of stock awards subject to restrictions, but rather will recognize ordinary income
in an amount equal to the fair market value of the shares at the time the shares are no longer subject to a &#8220;substantial risk of
forfeiture&#8221; (within the meaning of the Code). We generally will be entitled to a deduction at the time when, and in the amount
that, the participant recognizes ordinary income on account of the lapse of the restrictions. A participant&#8217;s tax basis in the
shares will equal their fair market value at the time the restrictions lapse, and the participant&#8217;s holding period for capital
gains purposes will begin at that time. Any cash dividends paid on the restricted stock before the restrictions lapse will be taxable
to the participant as additional compensation (and not as dividend income). Under Section 83(b) of the Code, a participant may elect
to recognize ordinary income at the time the shares of stock are awarded in an amount equal to their fair market value at that time,
notwithstanding the fact that such shares of stock are subject to restrictions and a substantial risk of forfeiture. If such an election
is made, no additional taxable income will be recognized by such participant at the time the restrictions lapse, the participant will
have a tax basis in the shares equal to their fair market value on the date of their award, and the participant&#8217;s holding period
for capital gains purposes will begin at that time. We generally will be entitled to a tax deduction at the time when, and to the extent
that, ordinary income is recognized by such participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Units</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, the grant of stock units will not result in income for the participant or in a tax deduction for us. Upon the settlement of
such an award in cash or shares, the participant will recognize ordinary income equal to the aggregate value of the payment received,
and we generally will be entitled to a tax deduction at the same time and in the same amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Appreciation Rights</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
participant who is granted a SAR generally will not recognize ordinary income upon receipt of the SAR. Rather, at the time of exercise
of such SAR, the participant will recognize ordinary income for U.S. federal income tax purposes in an amount equal to the value of any
cash received and the fair market value on the date of exercise of any shares received. We generally will be entitled to a tax deduction
at such time and in the same amount, if any, that the participant recognizes as ordinary income. The participant&#8217;s tax basis in
any shares received upon exercise of a SAR will be the fair market value of the shares on the date of exercise, and if the shares are
later sold or exchanged, then the difference between the amount received upon such sale or exchange and the fair market value of such
shares on the date of exercise will generally be taxable as long-term or short- term capital gain or loss (if the shares are a capital
asset of the participant) depending upon the length of time such shares were held by the participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to other stock-based awards granted under the 2020 EIP, generally when the participant receives payment with respect to an award,
the amount of cash and/or the fair market value of any shares or other property received will be ordinary income to the participant,
and we generally will be entitled to a tax deduction at the same time and in the same amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 44; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Impact
of Section 409A</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
409A of the Code applies to deferred compensation, which is generally defined as compensation earned currently, the payment of which
is deferred to a later taxable year. Awards under the 2020 EIP are intended to be exempt from the requirements of Section 409A or to
satisfy its requirements. An award that is subject to Section 409A and fails to satisfy its requirements will subject the holder of the
award to immediate taxation, interest and an additional 20% tax on the vested amount underlying the award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
162(m) of the Code</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to 2018, Section 162(m) of the Code imposed a $1 million limit on the amount a public company may deduct for compensation paid to a company&#8217;s
chief executive officer or any of the company&#8217;s three other most highly compensated executive officers (other than the chief financial
officer) who are employed as of the end of the year. This limitation did not apply to compensation that meets the tax code requirements
for &#8220;qualifying performance-based&#8221; compensation (i.e., compensation paid only if the individual&#8217;s performance meets
pre- established objective goals based on performance criteria approved by stockholders, including stock options).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
performance-based compensation exemption and the exemption of the chief financial officer from Section 162(m)&#8217;s deduction limit
have been repealed, among other changes, effective for taxable years beginning after December 31, 2017, such that awards paid to our
covered executive officers (including our chief executive officer) in excess of $1 million will not be deductible in future years, unless
it qualifies for transition relief applicable to certain arrangements that were in effect as of November 2, 2017 and are not materially
modified thereafter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
in prior years, while deductibility of executive compensation for federal income tax purposes is among the factors the committee considers
when structuring our executive compensation arrangements, it is not the sole or primary factor considered. We retain the flexibility
to authorize compensation that may not be deductible if we believe it is in the best interests of the company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Existing
Plan Benefits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
benefits under the 2020 EIP generally are granted at the discretion of the committee and are therefore not currently determinable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
future grants of awards under the 2020 EIP are subject to the discretion of the Board or Compensation Committee, the amount and terms
of future awards to particular participants or groups of participants are not determinable at this time. No awards have been previously
granted that are contingent on the approval of this amendment to the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
proposal to amend the 2020 EIP will be approved upon the affirmative vote of a majority of the outstanding shares of common stock present
through virtual attendance or by proxy at the Meeting and entitled to vote on the proposal. Stockholders may vote &#8220;FOR&#8221; or
&#8220;AGAINST,&#8221; or &#8220;ABSTAIN&#8221; from voting. Abstentions will have the effect of a vote &#8220;AGAINST&#8221; this proposal.
Broker non-votes, if any, will be disregarded and will have no effect on the outcome of the vote for this Proposal 2.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Recommendation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Board recommends that the stockholders vote &#8220;FOR&#8221; the approval of the amendment to the Kopin Corporation 2020 Equity Incentive
Plan to increase the number of shares available by 5,000,000.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
existence of financial and personal interests of one or more of Kopin Corporation directors may result in a conflict of interest on the
part of such director(s) between what he, she or they may believe is in the best interests of Kopin Corporation and its stockholders
and what he, she or they may believe is best for himself, herself or themselves in determining to recommend that stockholders vote for
the proposals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 45; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
3</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>APPROVAL
OF THE AMENDMENT TO THE COMPANY&#8217;S AMENDED AND RESTATED</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED COMMON</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARES FROM 200,000,000 TO 275,000,000</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board has approved the amendment to our Certificate of Incorporation, subject to stockholder approval, to increase the number of
authorized shares of common stock from 200,000,000 shares to 275,000,000 shares (the &#8220;Share Increase Amendment&#8221;) and
recommends unanimously that our stockholders approve the Share Increase Amendment. The proposed amendment is reflected in the
proposed amendment to the Certificate of Incorporation attached to this proxy statement as Appendix B. As of May 1, 2025,
there were 162,797,922 shares of common stock issued and outstanding and the Company had warrants and options outstanding to
acquire 10,591,366 shares of its common stock, leaving a total of 26,610,712 authorized shares of common stock available for
future issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
additional 75,000,000 shares of common stock will be part of the existing class of common stock, and, if and when issued, would have
the same rights and privileges as the shares of common stock presently issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s Certificate of Incorporation was amended on June 11, 2024 to increase the number of authorized shares of common stock
to 200,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that it is desirable and in the best interests of the Company and its shareholders to have a sufficient number of additional
shares of common stock available for issuance from time to time, as the occasion may arise, for future financing and acquisition transactions,
to permit stock dividends or stock splits at some future date, and for other proper corporate purposes. Therefore, the Board has approved,
and unanimously recommends that the stockholders of the Company approve the Share Increase Amendment. The proposed form of the Articles
of Amendment to the Company&#8217;s Certificate of Incorporation amending Article &#8220;FOURTH&#8221; of such Certificate of Incorporation
is set forth in Appendix A to this proxy statement. The Articles of Amendment will have no effect on the number of authorized shares
of preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain
Risks Associated with the Share Increase Amendment</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market price of our common stock will also be based on our performance and other factors, some of which are unrelated to the number of
shares outstanding. These factors include the status of the market for our common stock, our reported results of operations in future
periods, and general economic, market and industry conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal
Effects on Outstanding Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of common stock are entitled to one vote per share on all matters submitted to a vote of stockholders. Upon a liquidation, dissolution
or windup of the Company, holders of common stock would be entitled to share ratably in any assets for distribution to stockholders after
payment of all of the Company&#8217;s obligations, subject to the rights to receive preferential distributions of the holders of any
preferred stock then outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
additional shares of common stock would have rights identical to our common stock currently outstanding. Approval of the Share Increase
Amendment and any issuance of common stock would not affect the rights of the holders of our common stock currently outstanding, except
to the extent that future issuances of common stock would reduce each existing stockholder&#8217;s proportionate ownership. If the proposed
Share Increase Amendment is approved and the Board decides to issue such shares of common stock, such issuance of common stock would
increase the outstanding number of shares of common stock, thereby causing dilution in earnings per share and voting interests of the
outstanding common stock. As of May 1, 2025, 162,797,922 shares of our common stock were issued and outstanding and we
had warrants and options outstanding to acquire 10,591,366 shares of our common stock. We had no other shares of our common stock subject
to outstanding stock options or other convertible securities, thereby leaving 26,610,712 shares of common stock unassigned and
authorized for potential issuance of the current 200,000,000 shares of common stock authorized. If the Share Increase Amendment is approved,
there will be 101,610,712 shares of common stock unassigned and authorized for potential issuance. If approved, the Share Increase
Amendment will not change the number of shares of preferred stock authorized for issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<ix:exclude><!-- Field: Page; Sequence: 46; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the issuance of additional shares of common stock could have the effect of making it more difficult for a third party to acquire, or
discouraging a third party from attempting to acquire, control of the Company. While the issuance of additional shares of common stock
may be deemed to have potential anti-takeover effects, including by delaying or preventing a change in control of the Company through
subsequent issuances of these shares and the other reasons set forth above, which among other things, could include issuances in one
or more transactions that would make a change in control of the Company more difficult, and therefore, less likely, this proposal to
increase the authorized common stock is not prompted by any specific effort of which we are aware to accumulate shares of our common
stock or obtain control of the Company. A takeover may be beneficial to independent stockholders because, among other reasons, a potential
suitor may offer such stockholders a premium for their shares of common stock as compared to the then-existing market price. Although
the issuance of additional shares of common stock could, under certain circumstances, have an anti-takeover effect, this proposal to
adopt the Share Increase Amendment is not in response to any attempt to accumulate common stock or obtain control of the Company that
we are aware of, nor is it part of a plan by management to recommend a series of similar amendments to the Board or stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Interests
of Certain Persons in the Proposal</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
directors and executive officers have no substantial interests, directly or indirectly, in the matters set forth in this Proposal 3,
except to the extent of their ownership in shares of our common stock and securities convertible or exercisable for common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of the Shares Increase Amendment requires the affirmative vote of a majority of the Company&#8217;s outstanding stock entitled
to vote thereon.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Recommendation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Board recommends that the stockholders vote &#8220;FOR&#8221; the proposal to approve an amendment to the Company&#8217;s Certificate
of Incorporation to increase the number of authorized shares of common stock to 275,000,000.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 47; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
4</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RATIFICATION
OF APPOINTMENT OF ACCOUNTANTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 2, 2024, the Audit Committee appointed BDO USA, P.C. (&#8220;BDO&#8221;) as our independent registered public accounting firm
for the fiscal year ending December 27, 2025. The Audit Committee is seeking ratification of this selection by our stockholders at the Annual Meeting.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSM
US LLP (RSM), served as the Company&#8217;s independent registered public accounting firm of the Company from November 22,
2019 until December 2, 2024. On December 2, 2024, the Board approved the engagement of BDO as our independent registered public
accounting firm, effective upon the execution of a satisfactory engagement letter with BDO and dismissed our prior independent registered
public accounting firm, RSM, effective immediately prior to the engagement of BDO. RSM&#8217;s audit reports on our consolidated financial
statements for the fiscal years ended December 30, 2023 and December 31, 2022 did not contain any adverse opinion or disclaimer of opinion
and were not qualified or modified as to uncertainty, audit scope, or accounting principles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
representative of BDO is expected to be present at the Meeting and will be afforded an opportunity to make a statement, if such
representative desires to do so, and will be available to respond to appropriate questions. </span>Furthermore, a representative of
RSM is expected to be present at the Meeting and will be afforded an opportunity to make a statement, if such representative desires
to do so, and will be available to respond to appropriate questions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">RSM&#8217;s audit reports
on our consolidated financial statements for the fiscal years ended December 30, 2023 and December 31, 2022 did not contain any adverse
opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principles. During
the fiscal years ended December 30, 2023 and December 31, 2022, and the subsequent interim period through the date of our engagement
of BDO on December 2, 2024, neither the Company, nor anyone acting on our behalf, consulted with BDO regarding any of the matters described
in Items 304(a)(2)(i) and (ii) of Regulation S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">During the two most recent
fiscal years ended December 30, 2023 and December 31, 2022, and the subsequent interim period through their dismissal on December 2,
2024: (i) there were no disagreements within the meaning of Item 304(a)(1)(iv) of Regulation S-K between us and RSM on any matter of
accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved
to RSM&#8217;s satisfaction, would have caused RSM to make reference to the subject matter of the disagreements in connection with its
reports on our consolidated financial statements for such years, and (ii) no reportable events within the meaning of Item 304(a)(1)(v)
of Regulation S-K.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 40pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
affirmative vote of the holders of a majority of the shares of our common stock represented in person or by proxy at the Meeting and
entitled to vote is required to ratify the appointment of BDO as our independent registered public accounting firm for the current
fiscal year ending December 27, 2025. Although stockholder ratification is not required by our bylaws or otherwise, the Board believes
it is advisable to provide stockholders an opportunity to ratify this selection and is submitting the selection of BDO as our independent
registered public accounting firm to our stockholders for ratification as a matter of good corporate practice.  In the event the appointment of BDO should not be approved by the stockholders, the Board will consider making
another appointment to be effective at the earliest possible time but has no obligation to do so. Any broker non-votes and abstentions
from voting received will have no effect on the outcome of this Proposal 4.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Recommendation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Board recommends that the stockholders vote &#8220;FOR&#8221; the proposal to ratify the appointment of BDO USA, P.C. as our independent
registered public accounting firm for the fiscal year ending December 27, 2025.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proxies
solicited by the Board will be voted &#8220;FOR&#8221; this Proposal 4.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRINCIPAL
ACCOUNTANT FEES AND SERVICES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed above, BDO has served as the Company&#8217;s independent registered public accounting firm since December 2, 2024. Previously,
RSM served as the Company&#8217;s independent registered public accounting firm from November 22, 2019 to December 2, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><b></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Fees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate fees for the fiscal years ended December 28, 2024 and December 30, 2023 billed by the Company&#8217;s independent registered
public accounting firm, BDO USA, P.C. for fiscal year 2024 and RSM US LLP for fiscal year 2023 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Fee Category</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left">Audit Fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,038,950</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">620,124</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">99.9</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Audit-Related Fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">152,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax Fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,453</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.9</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">All Other Fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total Fees</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,049,450</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">780,827</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Audit
Fees</i>&#8212;consists of fees for the audit of our financial statements and attestation services relating to the report on our internal
controls in accordance with Section 404 of the Sarbanes-Oxley Act of 2002, review of the interim condensed consolidated financial statements
included in quarterly reports, assistance with review of documents filed with the SEC, and services that are normally provided by the
Company&#8217;s independent registered public accounting firm in connection with statutory and regulatory filings or engagements, and
attestation services, except those not required by statute or regulation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Audit-Related
Fees</i>&#8212;consists of fees for assurance and related services that are reasonably related to the performance of the audit or review
of our consolidated financial statements and are not reported under &#8220;Audit Fees.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Tax
Fees</i>&#8212;consists of fees for tax compliance and planning services. Tax compliance includes fees for professional services related
to international tax compliance and preparation. Tax planning consists primarily of fees related to a transfer pricing study and preparation
of our subsidiary tax returns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>All
Other Fees</i>&#8212;consists of fees for all other permissible services other than those reported above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Policy
on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of Independent Registered Public Accounting Firm</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee pre-approves all audit and non-audit services provided by the Company&#8217;s independent registered public accounting
firm prior to the engagement with respect to such services. The Chairman of the Audit Committee has been delegated the authority by the
Audit Committee to pre-approve the engagement of the independent accountants when the entire committee is unable to do so. The Audit
Committee approved 100% of the services listed under the preceding captions &#8220;Audit Fees,&#8221; &#8220;Audit-Related Fees,&#8221;
&#8220;Tax Fees&#8221; and &#8220;All Other Fees.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 48; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
5</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ADVISORY
NON-BINDING VOTE ON COMPENSATION OF NAMED EXECUTIVE OFFICERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with Section 951 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, as well as the provisions of Section 14A
of the Exchange Act, we are providing our stockholders the opportunity to vote on a non-binding, advisory resolution to approve the compensation
of our named executive officers, which is described in the section titled &#8220;Compensation Discussion and Analysis&#8221; in this
Proxy Statement. Accordingly, the following resolution will be submitted for a stockholder vote at the 2025 Annual Meeting:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;RESOLVED,
that the stockholders of Kopin Corporation (the &#8220;Company&#8221;) approve, on an advisory basis, the overall compensation of the
Company&#8217;s named executive officers, as described in the Compensation Discussion and Analysis section set forth in the Proxy Statement
for this Annual Meeting.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in the section titled &#8220;Compensation Discussion and Analysis,&#8221; our executive compensation program is designed to
provide a competitive level of compensation necessary to attract, motivate and retain talented and experienced executives and to motivate
them to achieve short-term and long-term corporate goals that enhance stockholder value. In order to align executive pay with our financial
performance and the creation of sustainable stockholder value, a significant portion of compensation paid to our named executive officers
is allocated to performance-based, short- and long-term incentive programs to make executive pay dependent on our performance (or &#8220;at-risk&#8221;).
In addition, as an executive officer&#8217;s responsibility and ability to affect our financial results increases, the portion of his
or her total compensation deemed &#8220;at-risk&#8221; increases. Stockholders are urged to read the &#8220;Compensation Discussion and
Analysis&#8221; section of this Proxy Statement, which more thoroughly discusses how our compensation policies and procedures implement
our compensation philosophy. The Compensation Committee and the Board believe that these policies and procedures are effective in implementing
our compensation philosophy and in achieving its goals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
provide our stockholders the opportunity every year to vote on a non-binding, advisory basis to approve the compensation of our named
executive officers. The Company expects that the next advisory vote on executive compensation will be at the 2026 Annual Meeting of Stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>This
vote is merely advisory and will not be binding upon the Company or the Board. However, the Board values constructive dialogue on executive
compensation and other important governance topics with our stockholders and encourages all stockholders to vote their shares on this
matter.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
5 will be approved upon the affirmative vote of a majority of shares present in person or represented by proxy at the Meeting and entitled
to vote on each such proposal. Abstentions will be counted for Proposal 5 and will have the same effect as a vote against the proposal.
Broker non-votes, if any, will be disregarded and will have no effect on the outcome of the vote of this Proposal 5.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Recommendation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Board recommends that the stockholders vote to approve, on an advisory basis, the overall compensation of the Company&#8217;s named executive
officers by voting &#8220;FOR&#8221; this resolution.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COST
AND METHOD OF SOLICITATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will pay the cost of soliciting proxies. Proxies may be solicited on behalf of the Company by directors, officers or employees of the
Company in person or by telephone, facsimile or other electronic means. As required by the SEC, we also will reimburse brokerage firms
and other custodians, nominees and fiduciaries for their expenses incurred in sending proxies and proxy materials to beneficial owners
of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GENERAL</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not aware of any other matter other than the foregoing to be brought before the Meeting. However, the enclosed proxy gives discretionary
authority to the named proxies in the event any additional matters should be presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 49; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will provide free of charge to any stockholder from whom a proxy is solicited pursuant to this proxy statement, upon written request
from such stockholder, our Annual Reports on Form 10-K for the fiscal years 2024 and 2023 as filed with the SEC. Our 2024 Annual Report
on Form 10-K is enclosed. Only one copy of the Annual Report and this proxy statement and notice of annual meeting is being delivered
to multiple stockholders sharing one address, unless we have received contrary instructions. Upon written or oral request, we will deliver
promptly a separate copy to a stockholder at a shared address to which a copy was delivered. If you received more than one copy of the
proxy statement and wish to reduce the number of reports you receive, we will discontinue the mailing of reports on the accounts you
select. Requests for the foregoing should be directed to Kopin Corporation, 125 North Drive, Westborough MA 01581, Attention: Chief Financial
Officer, 508-870-5959.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MISCELLANEOUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
vote is important. Whether or not you plan to attend the Annual Meeting, we hope you will vote in advance so that your vote will be counted
if you later decide not to attend the Annual Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>You
may obtain a copy of our Annual Report on Form 10-K (without exhibits) filed with the SEC for the year ended December 28, 2024, without
charge upon written request to: Kopin Corporation, 125 North Drive, Westborough MA 01581, Attention: Chief Financial Officer, 508-870-5959.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this proxy statement, we know of no matter not specifically referred to above as to which any action is expected to be
taken at the Annual Meeting. The persons named as proxies will vote the proxies, insofar as they are not otherwise instructed, regarding
such other matters and the transaction of such other business as may be properly brought before the Annual Meeting, as they determine
to be in the best interest of the Company and our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 50%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Murray</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<ix:exclude><!-- Field: Page; Sequence: 50; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Appendix
A</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>KOPIN
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020
EQUITY INCENTIVE PLAN</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
as of the Effective Date (as defined below), the Kopin Corporation 2020 Incentive Equity Plan (as in effect from time to time, the &#8220;Plan&#8221;)
is hereby established.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Plan is to provide employees of Kopin Corporation, a Delaware corporation (together with its successors, the &#8220;Company&#8221;),
and its subsidiaries, certain consultants and advisors who perform services for the Company or its subsidiaries, and non-employee members
of the Board of Directors of the Company, with the opportunity to receive grants of incentive stock options, nonqualified stock options,
stock appreciation rights, stock awards, stock units, and other stock-based awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company believes that the Plan will encourage the participants to contribute materially to the growth of the Company, thereby benefitting
the Company&#8217;s stockholders, and will align the economic interests of the participants with those of the stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan is a successor to the Kopin Corporation 2010 Equity Incentive Plan, as amended and restated (the &#8220;Prior Plan&#8221;). No additional
grants shall be made under the Prior Plan after the Effective Date. Outstanding grants under the Prior Plan shall continue in effect
according to their terms, consistent with the applicable terms of the Prior Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
1. Definitions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following terms shall have the meanings set forth below for purposes of the Plan:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) &#8220;<span style="text-decoration: underline">Board&#8221; </span>shall
mean the Board of Directors of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) &#8220;<span style="text-decoration: underline">Cause</span>&#8221;
shall have the meaning given to that term in any written employment agreement, offer letter or severance agreement between the Employer
and the Participant, or if no such agreement exists or if such term is not defined therein, and unless otherwise defined in the Grant
Instrument, Cause shall mean a finding by the Committee that the Participant (i) has breached his or her employment or service contract
with the Employer, (ii) has engaged in disloyalty to the Employer, including, without limitation, fraud, embezzlement, theft, commission
of a felony or proven dishonesty, (iii) has disclosed trade secrets or confidential information of the Employer to persons not entitled
to receive such information, (iv) has breached any written non-competition, non-solicitation, invention assignment or confidentiality
agreement between the Participant and the Employer or (v) has engaged in such other behavior detrimental to the interests of the Employer
as the Committee determines.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) &#8220;<span style="text-decoration: underline">CEO&#8221;
</span>shall mean the Chief Executive Officer of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Unless
otherwise set forth in a Grant Instrument, a &#8220;<span style="text-decoration: underline">Change of Control</span>&#8221; shall be deemed to have occurred if:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) Any
&#8220;person&#8221; (as such term is used in sections 13(d) and 14(d) of the Exchange Act) becomes a &#8220;beneficial owner&#8221;
(as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing more than 50% of
the voting power of the then outstanding securities of the Company; provided that a Change of Control shall not be deemed to occur as
a result of a transaction in which the Company becomes a direct or indirect subsidiary of another Person and in which the stockholders
of the Company, immediately prior to the transaction, will beneficially own, immediately after the transaction, shares of such other
Person representing more than 50% of the voting power of the then outstanding securities of such other Person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) The
consummation of (A) a merger or consolidation of the Company with another Person where, immediately after the merger or consolidation,
the stockholders of the Company, immediately prior to the merger or consolidation, will not beneficially own, in substantially the same
proportion as ownership immediately prior to the merger or consolidation, shares entitling such stockholders to more than 50% of all
votes to which all stockholders of the surviving Person would be entitled in the election of directors, or where the members of the Board,
immediately prior to the merger or consolidation, will not, immediately after the merger or consolidation, constitute a majority of the
board of directors of the surviving Person or (B) a sale or other disposition of all or substantially all of the assets of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 51; Options: NewSection -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) A
change in the composition of the Board over a period of 12 consecutive months or less such that a majority of the Board members ceases,
by reason of one or more contested elections, or threatened election contests, for Board membership, to be comprised of individuals who
either (A) have been Board members continuously since the beginning of such period or (B) have been elected or nominated for election
as Board members during such period by at least a majority of the Board members described in clause (A) who were still in office at the
time the Board approved such election or nomination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) The
consummation of a complete dissolution or liquidation of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may modify the definition of Change of Control for a particular Grant as the Committee deems appropriate to comply with section
409A of the Code or otherwise. Notwithstanding the foregoing, if a Grant constitutes deferred compensation subject to section 409A of
the Code and the Grant provides for payment upon a Change of Control, then, for purposes of such payment provisions, no Change of Control
shall be deemed to have occurred upon an event described in items (i) &#8211; (iv) above unless the event would also constitute a change
in ownership or effective control of, or a change in the ownership of a substantial portion of the assets of, the Company under section
409A of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) &#8220;<span style="text-decoration: underline">Code</span>&#8221;
shall mean the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) &#8220;<span style="text-decoration: underline">Committee</span>&#8221;
shall mean the Compensation Committee of the Board or another committee appointed by the Board to administer the Plan. The Committee
shall consist of directors who are &#8220;non-employee directors&#8221; as defined under Rule 16b-3 promulgated under the Exchange Act
and &#8220;independent directors,&#8221; as determined in accordance with the independence standards established by the stock exchange
on which the Company Stock is at the time primarily traded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) &#8220;<span style="text-decoration: underline">Company
Stock</span>&#8221; shall mean common stock, par value $0.01 per share, of the Company, and such other securities as may be substituted
for Company Stock pursuant to Section 4(c).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) &#8220;<span style="text-decoration: underline">Disability</span>&#8221;
or &#8220;<span style="text-decoration: underline">Disabled</span>&#8221; shall mean, unless otherwise set forth in the Grant Instrument, a Participant&#8217;s becoming disabled
within the meaning of the Employer&#8217;s long-term disability plan applicable to the Participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) &#8220;<span style="text-decoration: underline">Dividend
Equivalent</span>&#8221; shall mean an amount determined by multiplying the number of shares of Company Stock subject to a Stock Unit or
Other Stock-Based Award by the per-share cash dividend paid by the Company on its outstanding Company Stock, or the per-share Fair Market
Value of any dividend paid on its outstanding Company Stock in consideration other than cash. If interest is credited on accumulated
divided equivalents, the term &#8220;Dividend Equivalent&#8221; shall include the accrued interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) &#8220;<span style="text-decoration: underline">Effective
Date</span>&#8221; shall mean the date of the Annual Meeting of Stockholders to be held on May 20, 2020 or such other date upon which the
Company&#8217;s stockholders approve the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) &#8220;<span style="text-decoration: underline">Employee</span>&#8221;
shall mean an employee of the Employer (including an officer or director who is also an employee), but excluding any person who is classified
by the Employer as a &#8220;contractor&#8221; or &#8220;consultant,&#8221; no matter how characterized by the Internal Revenue Service,
other governmental agency or a court. Any change of characterization of an individual by the Internal Revenue Service or any court or
government agency shall have no effect upon the classification of an individual as an Employee for purposes of this Plan, unless the
Committee determines otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 52 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) &#8220;<span style="text-decoration: underline">Employed
by, or providing service to, the Employer</span>&#8221; shall mean employment or service as an Employee, Key Advisor or member of the Board
(so that, for purposes of exercising Options and SARs and satisfying conditions with respect to Stock Awards, Stock Units, and Other
Stock-Based Awards, a Participant shall not be considered to have terminated employment or service until the Participant ceases to be
an Employee, Key Advisor and member of the Board), unless the Committee determines otherwise. If a Participant&#8217;s relationship is
with a subsidiary of the Company and that entity ceases to be a subsidiary of the Company, the Participant will be deemed to cease employment
or service when the entity ceases to be a subsidiary of the Company, unless the Participant transfers employment or service to an Employer.
If a Participant has military, sick leave or other bona fide leave, the Participant will not be deemed to cease employment or service
solely as a result of such leave; provided that such leave does not exceed the longer of 90 days or the period during which the absent
Participant&#8217;s reemployment rights, if any, are guaranteed by statute or contract. To the extent consistent with applicable law,
the Committee may provide that Grants continue to vest for all or a portion of the period of such leave, or that vesting shall be tolled
during such leave and only recommence upon the Participant&#8217;s return from such leave.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) &#8220;<span style="text-decoration: underline">Employer</span>&#8221;
shall mean the Company and its subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) &#8220;<span style="text-decoration: underline">Exchange
Act&#8221;</span> shall mean the Securities Exchange Act of 1934, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) &#8220;<span style="text-decoration: underline">Exercise
Price</span>&#8221; shall mean the per share price at which shares of Company Stock may be purchased under an Option, as designated by the
Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p) &#8220;<span style="text-decoration: underline">Fair
Market Value&#8221;</span> shall mean:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) If
the Company Stock is publicly traded, the Fair Market Value per share shall be determined as follows: (A) if the principal trading market
for the Company Stock is a national securities exchange, the closing sales price during regular trading hours on the relevant date or,
if there were no trades on that date, the latest preceding date upon which a sale was reported, or (B) if the Company Stock is not principally
traded on any such exchange, the last reported sale price of a share of Company Stock during regular trading hours on the relevant date,
as reported by the OTC Bulletin Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) If
the Company Stock is not publicly traded or, if publicly traded, is not subject to reported transactions as set forth above, the Fair
Market Value per share shall be determined by the Committee through any reasonable valuation method authorized under the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q) &#8220;<span style="text-decoration: underline">GAAP</span>&#8221;
shall mean United States generally accepted accounting principles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r) &#8220;<span style="text-decoration: underline">Grant</span>&#8221;
shall mean an Option, SAR, Stock Award, Stock Unit or Other Stock-Based Award granted under the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s) &#8220;<span style="text-decoration: underline">Grant
Instrument</span>&#8221; shall mean the written agreement that sets forth the terms and conditions of a Grant, including all amendments
thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t) &#8220;<span style="text-decoration: underline">Incentive
Stock Option</span>&#8221; shall mean an Option that is intended to meet the requirements of an incentive stock option under section 422
of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u) &#8220;<span style="text-decoration: underline">Key
Advisor&#8221;</span> shall mean a consultant or advisor of the Employer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) &#8220;<span style="text-decoration: underline">Non-Employee
Director</span>&#8221; shall mean a member of the Board who is not an Employee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w) &#8220;<span style="text-decoration: underline">Nonqualified
Stock Option</span>&#8221; shall mean an Option that is not intended to be taxed as an incentive stock option under section 422 of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x) &#8220;<span style="text-decoration: underline">Option&#8221;
</span>shall mean an option to purchase shares of Company Stock, as described in Section 6.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y) &#8220;<span style="text-decoration: underline">Other
Stock-Based Award</span>&#8221; shall mean any Grant based on, measured by or payable in Company Stock (other than an Option, Stock Unit,
Stock Award, or SAR), as described in Section 10.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z) &#8220;<span style="text-decoration: underline">Participant</span>&#8221;
shall mean an Employee, Key Advisor or Non-Employee Director designated by the Committee to participate in the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"></p>

<ix:exclude><!-- Field: Page; Sequence: 53 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa) &#8220;<span style="text-decoration: underline">Performance
Goals</span>&#8221; shall mean the business criteria selected by the Company to measure the level of performance of the Company or an
affiliate during a performance period, which may include, but are not limited to, one or more of the following criteria: cash flow;
free cash flow; earnings (including gross margin, earnings before interest and taxes, earnings before taxes, earnings before
interest, taxes, depreciation, amortization and charges for stock-based compensation, earnings before interest, taxes, depreciation
and amortization, adjusted earnings before interest, taxes, depreciation and amortization and net earnings); earnings per share;
growth in earnings or earnings per share; book value growth; stock price; return on equity or average stockholder equity; total
stockholder return or growth in total stockholder return either directly or in relation to a comparative group; return on capital;
return on assets or net assets; </span>revenue, growth in revenue or return on sales; sales; expense reduction or expense control;
expense to revenue ratio; income, net income or adjusted net income; operating income, net operating income, adjusted operating
income or net operating income after tax; operating profit or net operating profit; operating margin; gross profit margin; return on
operating revenue or return on operating profit; regulatory filings; regulatory approvals, litigation and regulatory resolution
goals; other operational, regulatory or departmental objectives; budget comparisons; growth in stockholder value relative to
established indexes, or another peer group or peer group index; development and implementation of strategic plans and/or
organizational restructuring goals; development and implementation of risk and crisis management programs; improvement in workforce
diversity; compliance requirements and compliance relief; safety goals; productivity goals; workforce management and succession
planning goals; economic value added (including typical adjustments consistently applied from generally accepted accounting
principles required to determine economic value added performance measures); measures of customer satisfaction, employee
satisfaction or staff development; development or marketing collaborations, formations of joint ventures or partnerships or the
completion of other similar transactions intended to enhance the Company&#8217;s revenue or profitability or enhance its customer
base; merger and acquisitions; and other similar criteria as determined by the Committee. Performance goals applicable to a Grant
shall be determined by the Committee, and may be established on an absolute or relative basis and may be established on a
corporate-wide basis or with respect to one or more business units, divisions, subsidiaries or business segments. Relative
performance may be measured against a group of peer companies, a financial market index or other objective and quantifiable
indices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb) &#8220;<span style="text-decoration: underline">Person</span>&#8221;
shall mean any natural person, corporation, limited liability company, partnership, trust, joint stock company, business trust, unincorporated
association, joint venture, governmental authority or other legal entity of any nature whatsoever.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc) &#8220;<span style="text-decoration: underline">Restriction
Period&#8221;</span> shall have the meaning given that term in Section 7(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd) &#8220;<span style="text-decoration: underline">SAR&#8221;
</span>shall mean a stock appreciation right, as described in Section 9.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee) &#8220;<span style="text-decoration: underline">Stock
Award&#8221;</span> shall mean an award of Company Stock, as described in Section 7.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff) &#8220;<span style="text-decoration: underline">Stock
Unit</span>&#8221; shall mean an award of a phantom unit representing a share of Company Stock, as described in Section 8.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg) &#8220;<span style="text-decoration: underline">Substitute
Awards&#8221;</span> shall have the meaning given that term in Section 4(c).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
2. Administration</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Committee</span>.
The Plan shall be administered and interpreted by the Committee; provided, however, that any Grants to members of the Board must be authorized
by a majority of the Board. The Committee may delegate authority to one or more subcommittees, as it deems appropriate. Subject to compliance
with applicable law and the applicable stock exchange rules, the Board, in its discretion, may perform any action of the Committee hereunder.
To the extent that the Board, a subcommittee or the CEO, as described below administers the Plan, references in the Plan to the &#8220;<span style="text-decoration: underline">Committee</span>&#8221;
shall be deemed to refer to the Board or such subcommittee or the CEO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Delegation
to CEO</span>. Subject to compliance with applicable law and applicable stock exchange requirements, the Committee may delegate all or part
of its authority and power to the CEO, as it deems appropriate, with respect to Grants to Employees or Key Advisors who are not executive
officers under section 16 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Committee
Authority</span>. The Committee shall have the sole authority to (i) determine the individuals to whom Grants shall be made under the Plan,
(ii) determine the type, size, terms and conditions of the Grants to be made to each such individual, (iii) determine the time when the
Grants will be made and the duration of any applicable exercise or restriction period, including the criteria for exercisability and
the acceleration of exercisability, (v) amend the terms of any previously issued Grant, subject to the provisions of Section 17 below,
(vi) determine and adopt terms, guidelines, and provisions, not inconsistent with the Plan and applicable law, that apply to individuals
residing outside of the United States who receive Grants under the Plan, and (vii) deal with any other matters arising under the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 54 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Committee
Determinations</span>. The Committee shall have full power and express discretionary authority to administer and interpret the Plan, to
make factual determinations and to adopt or amend such rules, regulations, agreements and instruments for implementing the Plan and for
the conduct of its business as it deems necessary or advisable, in its sole discretion. The Committee&#8217;s interpretations of the
Plan and all determinations made by the Committee pursuant to the powers vested in it hereunder shall be conclusive and binding on all
persons having any interest in the Plan or in any awards granted hereunder. All powers of the Committee shall be executed in its sole
discretion, in the best interest of the Company, not as a fiduciary, and in keeping with the objectives of the Plan and need not be uniform
as to similarly situated individuals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <span style="text-decoration: underline">Indemnification</span>.
No member of the Committee or the Board, and no employee of the Company shall be liable for any act or failure to act with respect to
the Plan, except in circumstances involving his or her bad faith or willful misconduct, or for any act or failure to act hereunder by
any other member of the Committee or employee or by any agent to whom duties in connection with the administration of this Plan have
been delegated. The Company shall indemnify members of the Committee and the Board and any agent of the Committee or the Board who is
an employee of the Company or a subsidiary against any and all liabilities or expenses to which they may be subjected by reason of any
act or failure to act with respect to their duties on behalf of the Plan, except in circumstances involving such person&#8217;s bad faith
or willful misconduct.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
3. Grants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grants
under the Plan may consist of Options as described in Section 6, Stock Awards as described in Section 7, Stock Units as described in
Section 8, SARs as described in Section 9, and Other Stock-Based Awards as described in Section 10. All Grants shall be subject to the
terms and conditions set forth herein and to such other terms and conditions consistent with this Plan as the Committee deems appropriate
and as are specified in writing by the Committee to the individual in the Grant Instrument. All Grants shall be made conditional upon
the Participant&#8217;s acknowledgement, in writing or by acceptance of the Grant, that all decisions and determinations of the Committee
shall be final and binding on the Participant, his or her beneficiaries and any other person having or claiming an interest under such
Grant. Grants under a particular Section of the Plan need not be uniform as among the Participants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
4. Shares Subject to the Plan</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Shares
Authorized</span>. Subject to adjustment as described below in Sections 4(b) and 4(e) below, the aggregate number of shares of Company Stock
that may be issued or transferred under the Plan shall be 14,000,000 shares of Company Stock. In addition, shares of the Company Stock
underlying any outstanding award granted under the Prior Plan that, following the Effective Date, expires, or is terminated, surrendered
or forfeited for any reason without issuance of such shares shall be available for the award of new Grants under this Plan. Subject to
adjustment as described below in Sections 4(b) and 4(e) below, the aggregate number of shares of Company Stock that may be issued or
transferred under the Plan pursuant to Incentive Stock Options shall not exceed 10,000,000 shares of Company Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Source
of Shares</span>; Share Counting. Shares issued or transferred under the Plan may be authorized but unissued shares of Company Stock or
reacquired shares of Company Stock, including shares purchased by the Company on the open market for purposes of the Plan. If and to
the extent Options or SARs granted under the Plan, expire or are canceled, forfeited, exchanged or surrendered without having been exercised,
or if any Stock Awards, Stock Units or Other Stock-Based Awards are forfeited, terminated or otherwise not paid in full, the shares subject
to such Grants shall again be available for purposes of the Plan. If shares of Company Stock otherwise issuable under the Plan are surrendered
in payment of the Exercise Price of an Option, then the number of shares of Company Stock available for issuance under the Plan shall
be reduced only by the net number of shares actually issued by the Company upon such exercise and not by the gross number of shares as
to which such Option is exercised. Upon the exercise of any SAR under the Plan, the number of shares of Company Stock available for issuance
under the Plan shall be reduced by only by the net number of shares actually issued by the Company upon such exercise. If shares of Company
Stock otherwise issuable under the Plan are withheld by the Company in satisfaction of the withholding taxes incurred in connection with
the issuance, vesting or exercise of any Grant or the issuance of Company Stock thereunder, then the number of shares of Company Stock
available for issuance under the Plan shall be reduced by the net number of shares issued, vested or exercised under such Grant, calculated
in each instance after payment of such share withholding. To the extent any Grants are paid in cash, and not in shares of Company Stock,
any shares previously subject to such Grants shall again be available for issuance or transfer under the Plan. For the avoidance of doubt,
if shares are repurchased by the Company on the open market with the proceeds of the Exercise Price of Options, such shares may not again
be made available for issuance under the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Substitute
Awards</span>. Shares issued or transferred under Grants made pursuant to an assumption, substitution or exchange for previously granted
awards of a company acquired by the Company in a transaction (&#8220;Substitute Awards&#8221;) shall not reduce the number of shares
of Company Stock available under the Plan and available shares under a stockholder approved plan of an acquired company (as appropriately
adjusted to reflect the transaction) may be used for Grants under the Plan and shall not reduce the Plan&#8217;s share reserve (subject
to applicable stock exchange listing and Code requirements).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Individual
Limits for Non-Employee Directors</span>. Subject to adjustment as described below in Section 4(e), the maximum aggregate grant date value
of shares of Company Stock subject to Grants granted to any Non-Employee Director during any calendar year, taken together with any cash
fees earned by such Non- Employee Director for services rendered during the calendar year, shall not exceed $250,000 in total value.
For purposes of this limit, the value of such Grants shall be calculated based on the grant date fair value of such Grants for financial
reporting purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <span style="text-decoration: underline">Adjustments</span>.
If there is any change in the number or kind of shares of Company Stock outstanding by reason of (i) a stock dividend, spinoff, recapitalization,
stock split, or combination or exchange of shares, (ii) a merger, reorganization or consolidation, (iii) a reclassification or change
in par value, or (iv) any other extraordinary or unusual event affecting the outstanding Company Stock as a class without the Company&#8217;s
receipt of consideration, or if the value of outstanding shares of Company Stock is substantially reduced as a result of a spinoff or
the Company&#8217;s payment of an extraordinary dividend or distribution, the maximum number and kind of shares of Company Stock available
for issuance under the Plan, the maximum amount of Grants which a Non-Employee Director may receive in any year, the number and kind
of shares covered by outstanding Grants, the number and kind of shares issued and to be issued under the Plan, and the price per share
or the applicable market value of such Grants shall be equitably adjusted by the Committee to reflect any increase or decrease in the
number of, or change in the kind or value of, the issued shares of Company Stock to preclude, to the extent practicable, the enlargement
or dilution of rights and benefits under the Plan and such outstanding Grants; provided, however, that any fractional shares resulting
from such adjustment shall be eliminated. In addition, in the event of a Change of Control, the provisions of Section 12 of the Plan
shall apply. Any adjustments to outstanding Grants shall be consistent with section 409A or 424 of the Code, to the extent applicable.
The adjustments of Grants under this Section 4(e) shall include adjustment of shares, Exercise Price of Stock Options, base amount of
SARs, Performance Goals or other terms and conditions, as the Committee deems appropriate. The Committee shall have the sole discretion
and authority to determine what appropriate adjustments shall be made and any adjustments determined by the Committee shall be final,
binding and conclusive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
5. Eligibility for Participation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Eligible
Persons</span>. All Employees and Non-Employee Directors shall be eligible to participate in the Plan. Key Advisors shall be eligible to
participate in the Plan if the Key Advisors render bona fide services to the Employer, the services are not in connection with the offer
and sale of securities in a capital-raising transaction and the Key Advisors do not directly or indirectly promote or maintain a market
for the Company&#8217;s securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Selection
of Participants</span>. The Committee shall select the Employees, Non-Employee Directors and Key Advisors to receive Grants and shall determine
the number of shares of Company Stock subject to a particular Grant in such manner as the Committee determines.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"></p>

<ix:exclude><!-- Field: Page; Sequence: 55 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
6. Options</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may grant Options to an Employee, Non-Employee Director or Key Advisor upon such terms as the Committee deems appropriate.
The following provisions are applicable to Options:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Number
of Shares</span>. The Committee shall determine the number of shares of Company Stock that will be subject to each Grant of Options to Employees,
Non-Employee Directors and Key Advisors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Type
of Option and Exercise Price.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) The
Committee may grant Incentive Stock Options or Nonqualified Stock Options or any combination of the two, all in accordance with the terms
and conditions set forth herein. Incentive Stock Options may be granted only to employees of the Company or its parent or subsidiary
corporations, as defined in section 424 of the Code. Nonqualified Stock Options may be granted to Employees, Non-Employee Directors and
Key Advisors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) The
Exercise Price of Company Stock subject to an Option shall be determined by the Committee and shall be equal to or greater than the Fair
Market Value of a share of Company Stock on the date the Option is granted. However, an Incentive Stock Option may not be granted to
an Employee who, at the time of grant, owns stock possessing more than 10% of the total combined voting power of all classes of stock
of the Company, or any parent or subsidiary corporation of the Company, as defined in section 424 of the Code, unless the Exercise Price
per share is not less than 110% of the Fair Market Value of a share of Company Stock on the date of grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Option
Term</span>. The Committee shall determine the term of each Option. The term of any Option shall not exceed ten years from the date of grant.
However, an Incentive Stock Option that is granted to an Employee who, at the time of grant, owns stock possessing more than 10% of the
total combined voting power of all classes of stock of the Company, or any parent or subsidiary corporation of the Company, as defined
in section 424 of the Code, may not have a term that exceeds five years from the date of grant. Notwithstanding the foregoing, in the
event that on the last business day of the term of an Option (other than an Incentive Stock Option), the exercise of the Option is prohibited
by applicable law, including a prohibition on purchases or sales of Company Stock under the Company&#8217;s insider trading policy, the
term of the Option shall be extended for a period of 30 days following the end of the legal prohibition, unless the Committee determines
otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Exercisability
of Options</span>. Options shall become exercisable in accordance with such terms and conditions, consistent with the Plan, as may be determined
by the Committee and specified in the Grant Instrument. The Committee may accelerate the exercisability of any or all outstanding Options
at any time for any reason.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <span style="text-decoration: underline">Grants
to Non-Exempt Employees</span>. Notwithstanding the foregoing, Options granted to persons who are non-exempt employees under the Fair Labor
Standards Act of 1938, as amended, may not be exercisable for at least six months after the date of grant (except that such Options may
become exercisable, as determined by the Committee, upon the Participant&#8217;s death, Disability or retirement, or upon a Change of
Control or other circumstances permitted by applicable regulations).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <span style="text-decoration: underline">Termination
of Employment or Service</span>. Except as provided in the Grant Instrument, an Option may only be exercised while the Participant is employed
by, or providing services to, the Employer. The Committee shall determine in the Grant Instrument under what circumstances and during
what time periods a Participant may exercise an Option after termination of employment or service.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <span style="text-decoration: underline">Exercise
of Options</span>. A Participant may exercise an Option that has become exercisable, in whole or in part, by delivering a notice of exercise
to the Company. The Participant shall pay the Exercise Price for an Option as specified by the Committee (i) in cash, (ii) unless the
Committee determines otherwise, by delivering shares of Company Stock owned by the Participant and having a Fair Market Value on the
date of exercise at least equal to the Exercise Price or by attestation (on a form prescribed by the Committee) to ownership of shares
of Company Stock having a Fair Market Value on the date of exercise at least equal to the Exercise Price, (iii) by payment through a
broker in accordance with procedures permitted by Regulation T of the Federal Reserve Board, (iv) if permitted by the Committee, by withholding
shares of Company Stock subject to the exercisable Option, which have a Fair Market Value on the date of exercise equal to the Exercise
Price, or (v) by such other method as the Committee may approve. Shares of Company Stock used to exercise an Option shall have been held
by the Participant for the requisite period of time necessary to avoid adverse accounting consequences to the Company with respect to
the Option. Payment for the shares to be issued or transferred pursuant to the Option, and any required withholding taxes, must be received
by the Company by the time specified by the Committee depending on the type of payment being made, but in all cases prior to the issuance
or transfer of such shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 56 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <span style="text-decoration: underline">Limits
on Incentive Stock Options</span>. Each Incentive Stock Option shall provide that, if the aggregate Fair Market Value of the Company Stock
on the date of the grant with respect to which Incentive Stock Options are exercisable for the first time by a Participant during any
calendar year, under the Plan or any other stock option plan of the Company or a parent or subsidiary, exceeds $100,000, then the Option,
as to the excess, shall be treated as a Nonqualified Stock Option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
7. Stock Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may issue or transfer shares of Company Stock to an Employee, Non-Employee Director or Key Advisor under a Stock Award, upon
such terms as the Committee deems appropriate. The following provisions are applicable to Stock Awards:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">General
Requirements</span>. Shares of Company Stock issued or transferred pursuant to Stock Awards may be issued or transferred for consideration
or for no consideration, and subject to restrictions or no restrictions, as determined by the Committee. The Committee may, but shall
not be required to, establish conditions under which restrictions on Stock Awards shall lapse over a period of time or according to such
other criteria as the Committee deems appropriate, including, without limitation, restrictions based on the achievement of specific Performance
Goals. The period of time during which the Stock Awards will remain subject to restrictions will be designated in the Grant Instrument
as the &#8220;<span style="text-decoration: underline">Restriction Period.&#8221;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Number
of Shares</span>. The Committee shall determine the number of shares of Company Stock to be issued or transferred pursuant to a Stock Award
and the restrictions applicable to such shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Requirement
of Employment or Service</span>. If the Participant ceases to be employed by, or provide service to, the Employer during a period designated
in the Grant Instrument as the Restriction Period, or if other specified conditions are not met, the Stock Award shall terminate as to
all shares covered by the Grant as to which the restrictions have not lapsed, and those shares of Company Stock must be immediately returned
to the Company. The Committee may, however, provide for complete or partial exceptions to this requirement as it deems appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Restrictions
on Transfer and Legend on Stock Certificate</span>. During the Restriction Period, a Participant may not sell, assign, transfer, pledge
or otherwise dispose of the shares of a Stock Award except under Section 15 below. Unless otherwise determined by the Committee, the
Company will retain possession of certificates for shares of Stock Awards until all restrictions on such shares have lapsed. Each certificate
for a Stock Award, unless held by the Company, shall contain a legend giving appropriate notice of the restrictions in the Grant. The
Participant shall be entitled to have the legend removed from the stock certificate covering the shares subject to restrictions when
all restrictions on such shares have lapsed. The Committee may determine that the Company will not issue certificates for Stock Awards
until all restrictions on such shares have lapsed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <span style="text-decoration: underline">Right
to Vote and to Receive Dividends</span>. Unless the Committee determines otherwise, during the Restriction Period, the Participant shall
have the right to vote shares of Stock Awards and to receive any dividends or other distributions paid on such shares, subject to any
restrictions deemed appropriate by the Committee, including, without limitation, the achievement of specific Performance Goals. Dividends
with respect to Stock Awards that vest based on performance shall vest if and to the extent that the underlying Stock Award vests, as
determined by the Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <span style="text-decoration: underline">Lapse
of Restrictions</span>. All restrictions imposed on Stock Awards shall lapse upon the expiration of the applicable Restriction Period and
the satisfaction of all conditions, if any, imposed by the Committee. The Committee may determine, as to any or all Stock Awards, that
the restrictions shall lapse without regard to any Restriction Period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 57 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
8. Stock Units</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may grant Stock Units, each of which shall represent one hypothetical share of Company Stock, to an Employee, Non-Employee
Director or Key Advisor upon such terms and conditions as the Committee deems appropriate. The following provisions are applicable to
Stock Units:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Crediting
of Units</span>. Each Stock Unit shall represent the right of the Participant to receive a share of Company Stock or an amount of cash based
on the value of a share of Company Stock, if and when specified conditions are met. All Stock Units shall be credited to bookkeeping
accounts established on the Company&#8217;s records for purposes of the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Terms
of Stock Units</span>. The Committee may grant Stock Units that vest and are payable if specified Performance Goals or other conditions
are met, or under other circumstances. Stock Units may be paid at the end of a specified performance period or other period, or payment
may be deferred to a date authorized by the Committee. The Committee may accelerate vesting or payment, as to any or all Stock Units
at any time for any reason, provided such acceleration complies with section 409A of the Code. The Committee shall determine the number
of Stock Units to be granted and the requirements applicable to such Stock Units.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Requirement
of Employment or Service</span>. If the Participant ceases to be employed by, or provide service to, the Employer prior to the vesting of
Stock Units, or if other conditions established by the Committee are not met, the Participant&#8217;s Stock Units shall be forfeited.
The Committee may, however, provide for complete or partial exceptions to this requirement as it deems appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Payment
With Respect to Stock Units</span>. Payments with respect to Stock Units shall be made in cash, Company Stock or any combination of the
foregoing, as the Committee shall determine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
9. Stock Appreciation Rights</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may grant SARs to an Employee, Non-Employee Director or Key Advisor separately or in tandem with any Option. The following
provisions are applicable to SARs:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">General
Requirements</span>. The Committee may grant SARs to an Employee, Non-Employee Director or Key Advisor separately or in tandem with any
Option (for all or a portion of the applicable Option). Tandem SARs may be granted either at the time the Option is granted or at any
time thereafter while the Option remains outstanding; provided, however, that, in the case of an Incentive Stock Option, SARs may be
granted only at the time of the grant of the Incentive Stock Option. The Committee shall establish the base amount of the SAR at the
time the SAR is granted. The base amount of each SAR shall be equal to or greater than the Fair Market Value of a share of Company Stock
as of the date of grant of the SAR. The term of any SAR shall not exceed ten years from the date of grant. Notwithstanding the foregoing,
in the event that on the last business day of the term of a SAR, the exercise of the SAR is prohibited by applicable law, including a
prohibition on purchases or sales of Company Stock under the Company&#8217;s insider trading policy, the term shall be extended for a
period of 30 days following the end of the legal prohibition, unless the Committee determines otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Tandem
SARs</span>. In the case of tandem SARs, the number of SARs granted to a Participant that shall be exercisable during a specified period
shall not exceed the number of shares of Company Stock that the Participant may purchase upon the exercise of the related Option during
such period. Upon the exercise of an Option, the SARs relating to the Company Stock covered by such Option shall terminate. Upon the
exercise of SARs, the related Option shall terminate to the extent of an equal number of shares of Company Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Exercisability</span>.
A SAR shall be exercisable during the period specified by the Committee in the Grant Instrument and shall be subject to such vesting
and other restrictions as may be specified in the Grant Instrument. The Committee may accelerate the exercisability of any or all outstanding
SARs at any time for any reason. SARs may only be exercised while the Participant is employed by, or providing service to, the Employer
or during the applicable period after termination of employment or service as specified by the Committee. A tandem SAR shall be exercisable
only during the period when the Option to which it is related is also exercisable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 58 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Grants
to Non-Exempt Employees</span>. Notwithstanding the foregoing, SARs granted to persons who are non-exempt employees under the Fair Labor
Standards Act of 1938, as amended, may not be exercisable for at least six months after the date of grant (except that such SARs may
become exercisable, as determined by the Committee, upon the Participant&#8217;s death, Disability or retirement, or upon a Change of
Control or other circumstances permitted by applicable regulations).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <span style="text-decoration: underline">Value
of SARs</span>. When a Participant exercises SARs, the Participant shall receive in settlement of such SARs an amount equal to the value
of the stock appreciation for the number of SARs exercised. The stock appreciation for a SAR is the amount by which the Fair Market Value
of the underlying Company Stock on the date of exercise of the SAR exceeds the base amount of the SAR as described in subsection (a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <span style="text-decoration: underline">Form
of Payment</span>. The appreciation in a SAR shall be paid in shares of Company Stock, cash or any combination of the foregoing, as the
Committee shall determine. For purposes of calculating the number of shares of Company Stock to be received, shares of Company Stock
shall be valued at their Fair Market Value on the date of exercise of the SAR.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
10. Other Stock-Based Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may grant Other Stock-Based Awards, which are awards (other than those described in Sections 6, 7, 8 and 9 of the Plan) that
are based on or measured by Company Stock, to any Employee, Non- Employee Director or Key Advisor, on such terms and conditions as the
Committee shall determine. Other Stock-Based Awards may be awarded subject to the achievement of Performance Goals or other criteria
or other conditions and may be payable in cash, Company Stock or any combination of the foregoing, as the Committee shall determine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
11. Dividend Equivalents</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may grant Dividend Equivalents in connection with Stock Units or Other Stock-Based Awards. Dividend Equivalents may be paid
currently or accrued as contingent cash obligations and may be payable in cash or shares of Company Stock, and upon such terms and conditions
as the Committee shall determine. Dividend Equivalents with respect to Stock Units or Other Stock-Based Awards that vest based on performance
shall vest and be paid only if and to the extent the underlying Stock Units or Other Stock-Based Awards vest and are paid, as determined
by the Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
12. Consequences of a Change of Control</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Assumption
of Outstanding Grants</span>. Upon a Change of Control where the Company is not the surviving corporation (or survives only as a subsidiary
of another corporation), unless the Committee determines otherwise, all outstanding Grants that are not exercised or paid at the time
of the Change of Control shall be assumed by, or replaced with grants (with respect to cash, securities, or a combination thereof) that
have comparable terms by, the surviving corporation (or a parent or subsidiary of the surviving corporation). After a Change of Control,
references to the &#8220;Company&#8221; as they relate to employment matters shall include the successor employer in the transaction,
subject to applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Vesting
Upon Certain Terminations of Employment</span>. Unless the Grant Instrument provides otherwise, if a Participant&#8217;s employment is terminated
by the Employer without Cause upon or within 12 months following a Change of Control, the Participant&#8217;s outstanding Grants shall
become fully vested as of the date of such termination; provided that if the vesting of any such Grants is based, in whole or in part,
on performance, the applicable Grant Instrument shall specify how the portion of the Grant that becomes vested pursuant to this Section
12(b) shall be calculated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"></p>

<ix:exclude><!-- Field: Page; Sequence: 59 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Other
Alternatives</span>. In the event of a Change of Control, if any outstanding Grants are not assumed by, or replaced with grants that have
comparable terms by, the surviving corporation (or a parent or subsidiary of the surviving corporation), the Committee may (but is not
obligated to) make adjustments to the terms and conditions of outstanding Grants, including, without limitation, taking any of the following
actions (or combination thereof) with respect to any or all outstanding Grants, without the consent of any Participant: (i) the Committee
may determine that outstanding Stock Options and SARs shall automatically accelerate and become fully exercisable and the restrictions
and conditions on outstanding Stock Awards, Stock Units and Dividend Equivalents shall immediately lapse; (ii) the Committee may determine
that Participants shall receive a payment in settlement of outstanding Stock Units or Dividend Equivalents, in such amount and form as
may be determined by the Committee; (iii) the Committee may require that Participants surrender their outstanding Stock Options and SARs
in exchange for a payment by the Company, in cash or Company Stock as determined by the Committee, in an amount equal to the amount,
if any, by which the then Fair Market Value of the shares of Company Stock subject to the Participant&#8217;s unexercised Stock Options
and SARs exceeds the Stock Option Exercise Price or SAR base amount, and (iv) after giving Participants an opportunity to exercise all
of their outstanding Stock Options and SARs, the Committee may terminate any or all unexercised Stock Options and SARs at such time as
the Committee deems appropriate. Such surrender, termination or payment shall take place as of the date of the Change of Control or such
other date as the Committee may specify. Without limiting the foregoing, if the per share Fair Market Value of the Company Stock does
not exceed the per share Stock Option Exercise Price or SAR base amount, as applicable, the Company shall not be required to make any
payment to the Participant upon surrender of the Stock Option or SAR.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
13. Deferrals</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may permit or require a Participant to defer receipt of the payment of cash or the delivery of shares that would otherwise
be due to such Participant in connection with any Grant. If any such deferral election is permitted or required, the Committee shall
establish rules and procedures for such deferrals and may provide for interest or other earnings to be paid on such deferrals. The rules
and procedures for any such deferrals shall be consistent with applicable requirements of section 409A of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
14. Withholding of Taxes</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Required
Withholding</span>. All Grants under the Plan shall be subject to applicable United States federal (including FICA), state and local, foreign
country or other tax withholding requirements. The Employer may require that the Participant or other person receiving Grants or exercising
Grants pay to the Employer an amount sufficient to satisfy such tax withholding requirements with respect to such Grants, or the Employer
may deduct from other wages and compensation paid by the Employer the amount of any withholding taxes due with respect to such Grants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Share
Withholding</span>. The Committee may permit or require the Employer&#8217;s tax withholding obligation with respect to Grants paid in Company
Stock to be satisfied by having shares withheld up to an amount that does not exceed the Participant&#8217;s applicable withholding tax
rate for United States federal (including FICA), state and local, foreign country or other tax liabilities. The Committee may, in its
discretion, and subject to such rules as the Committee may adopt, allow Participants to elect to have such share withholding applied
to all or a portion of the tax withholding obligation arising in connection with any particular Grant. Unless the Committee determines
otherwise, share withholding for taxes shall not exceed the Participant&#8217;s minimum applicable tax withholding amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
15. Transferability of Grants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Nontransferability
of Grants</span>. Except as described in subsection (b) below, only the Participant may exercise rights under a Grant during the Participant&#8217;s
lifetime. A Participant may not transfer those rights except (i) by will or by the laws of descent and distribution or (ii) with respect
to Grants other than Incentive Stock Options, pursuant to a domestic relations order. When a Participant dies, the personal representative
or other person entitled to succeed to the rights of the Participant may exercise such rights. Any such successor must furnish proof
satisfactory to the Company of his or her right to receive the Grant under the Participant&#8217;s will or under the applicable laws
of descent and distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Transfer
of Nonqualified Stock Options and Stock Awards</span>. Notwithstanding the foregoing, the Committee may provide, in a Grant Instrument or
at such other time after the grant of an award, that a Participant may transfer Nonqualified Stock Options or Stock Awards to family
members, or one or more trusts or other entities for the benefit of or owned by family members, consistent with the applicable securities
laws, according to such terms as the Committee may determine; provided that the Participant receives no consideration for the transfer
of an Option or Stock Award and the transferred Option or Stock Award shall continue to be subject to the same terms and conditions as
were applicable to the Option or Stock Award immediately before the transfer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 60 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
16. Requirements for Issuance or Transfer of Shares</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
Company Stock shall be issued or transferred in connection with any Grant hereunder unless and until all legal requirements applicable
to the issuance or transfer of such Company Stock have been complied with to the satisfaction of the Committee. The Committee shall have
the right to condition any Grant on the Participant&#8217;s undertaking in writing to comply with such restrictions on his or her subsequent
disposition of the shares of Company Stock as the Committee shall deem necessary or advisable, and certificates representing such shares
may be legended to reflect any such restrictions. Certificates representing shares of Company Stock issued or transferred under the Plan
may be subject to such stop-transfer orders and other restrictions as the Committee deems appropriate to comply with applicable laws,
regulations and interpretations, including any requirement that a legend be placed thereon.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
17. Amendment and Termination of the Plan</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Amendment</span>.
The Board may amend or terminate the Plan at any time; provided, however, that the Board shall not amend the Plan without stockholder
approval if such approval is required in order to comply with the Code or other applicable law, or to comply with applicable stock exchange
requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">No
Repricing of Options or SARs</span>. Except in connection with a corporate transaction involving the Company (including, without limitation,
any stock dividend, distribution (whether in the form of cash, Company Stock, other securities or property), stock split, extraordinary
cash dividend, recapitalization, change in control, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase
or exchange of shares of Company Stock or other securities, or similar transactions), the Company may not, without obtaining stockholder
approval, (i) amend the terms of outstanding Stock Options or SARs to reduce the Exercise Price of such outstanding Stock Options or
base price of such SARs, (ii) cancel outstanding Stock Options or SARs in exchange for Stock Options or SARs with an Exercise Price or
base price, as applicable, that is less than the Exercise Price or base price of the original Stock Options or SARs or (iii) cancel outstanding
Stock Options or SARs with an Exercise Price or base price, as applicable, above the current stock price in exchange for cash or other
securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Termination
of Plan</span>. The Plan shall terminate on the day immediately preceding the tenth anniversary of its Effective Date, unless the Plan is
terminated earlier by the Board or is extended by the Board with the approval of the stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Termination
and Amendment of Outstanding Grants</span>. A termination or amendment of the Plan that occurs after a Grant is made shall not materially
impair the rights of a Participant with respect to such Grant unless the Participant consents or unless the Committee acts under Section
18(f) below. The termination of the Plan shall not impair the power and authority of the Committee with respect to an outstanding Grant.
Whether or not the Plan has terminated, an outstanding Grant may be terminated or amended under Section 18(f) below or may be amended
by agreement of the Company and the Participant consistent with the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
18. Miscellaneous</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Grants
in Connection with Corporate Transactions and Otherwise</span>. Nothing contained in the Plan shall be construed to (i) limit the right
of the Committee to make Grants under the Plan in connection with the acquisition, by purchase, lease, merger, consolidation or otherwise,
of the business or assets of any corporation, firm or association, including Grants to employees thereof who become Employees, or (ii)
limit the right of the Company to grant stock options or make other awards outside of the Plan. The Committee may make a Grant to an
employee of another corporation who becomes an Employee by reason of a corporate merger, consolidation, acquisition of stock or property,
reorganization or liquidation involving the Company, in substitution for a stock option or stock awards grant made by such corporation.
Notwithstanding anything in the Plan to the contrary, the Committee may establish such terms and conditions of the new Grants as it deems
appropriate, including setting the Exercise Price of Options or the base price of SARs at a price necessary to retain for the Participant
the same economic value as the prior options or rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Governing
Document. The Plan shall be the controlling document</span>. No other statements, representations, explanatory materials or examples, oral
or written, may amend the Plan in any manner. The Plan shall be binding upon and enforceable against the Company and its successors and
assigns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 61 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Funding
of the Plan</span>. The Plan shall be unfunded. The Company shall not be required to establish any special or separate fund or to make any
other segregation of assets to assure the payment of any Grants under the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Rights
of Participants</span>. Nothing in the Plan shall entitle any Employee, Non-Employee Director, Key Advisor or other person to any claim
or right to receive a Grant under the Plan. Neither the Plan nor any action taken hereunder shall be construed as giving any individual
any rights to be retained by or in the employ of the Employer or any other employment rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <span style="text-decoration: underline">No
Fractional Shares</span>. No fractional shares of Company Stock shall be issued or delivered pursuant to the Plan or any Grant. Except as
otherwise provided under the Plan, the Committee shall determine whether cash, other awards or other property shall be issued or paid
in lieu of such fractional shares or whether such fractional shares or any rights thereto shall be forfeited or otherwise eliminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <span style="text-decoration: underline">Compliance
with Law.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) The
Plan, the exercise of Options and SARs and the obligations of the Company to issue or transfer shares of Company Stock under Grants shall
be subject to all applicable laws and regulations, and to approvals by any governmental or regulatory agency as may be required. With
respect to persons subject to section 16 of the Exchange Act, it is the intent of the Company that the Plan and all transactions under
the Plan comply with all applicable provisions of Rule 16b-3 or its successors under the Exchange Act. In addition, it is the intent
of the Company that Incentive Stock Options comply with the applicable provisions of section 422 of the Code, and that, to the extent
applicable, Grants comply with the requirements of section 409A of the Code. To the extent that any legal requirement of section 16 of
the Exchange Act or section 422 or 409A of the Code as set forth in the Plan ceases to be required under section 16 of the Exchange Act
or section 422 or 409A of the Code, that Plan provision shall cease to apply. The Committee may revoke any Grant if it is contrary to
law or modify a Grant to bring it into compliance with any valid and mandatory government regulation. The Committee may also adopt rules
regarding the withholding of taxes on payments to Participants. The Committee may, in its sole discretion, agree to limit its authority
under this Section.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) The
Plan is intended to comply with the requirements of section 409A of the Code, to the extent applicable. Each Grant shall be construed
and administered such that the Grant either (A) qualifies for an exemption from the requirements of section 409A of the Code or (B) satisfies
the requirements of section 409A of the Code. If a Grant is subject to section 409A of the Code, (I) distributions shall only be made
in a manner and upon an event permitted under section 409A of the Code, (II) payments to be made upon a termination of employment or
service shall only be made upon a &#8220;separation from service&#8221; under section 409A of the Code, (III) unless the Grant specifies
otherwise, each installment payment shall be treated as a separate payment for purposes of section 409A of the Code, and (IV) in no event
shall a Participant, directly or indirectly, designate the calendar year in which a distribution is made except in accordance with section
409A of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) Any
Grant that is subject to section 409A of the Code and that is to be distributed to a Key Employee (as defined below) upon separation
from service shall be administered so that any distribution with respect to such Grant shall be postponed for six months following the
date of the Participant&#8217;s separation from service, if required by section 409A of the Code. If a distribution is delayed pursuant
to section 409A of the Code, the distribution shall be paid within 15 days after the end of the six-month period. If the Participant
dies during such six-month period, any postponed amounts shall be paid within 90 days of the Participant&#8217;s death. The determination
of Key Employees, including the number and identity of persons considered Key Employees and the identification date, shall be made by
the Committee or its delegate each year in accordance with section 416(i) of the Code and the &#8220;specified employee&#8221; requirements
of section 409A of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) Notwithstanding
anything in the Plan or any Grant agreement to the contrary, each Participant shall be solely responsible for the tax consequences
of Grants under the Plan, and in no event shall the Company or any subsidiary or affiliate of the Company have any responsibility or
liability if a Grant does not meet any applicable requirements of section 409A of the Code. Although the Company intends to
administer the Plan to prevent taxation under section 409A of the Code, the Company does not represent or warrant that the Plan or
any Grant complies with any provision of federal, state, local or other tax law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 62 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <span style="text-decoration: underline">Grants
in Foreign Countries; Establishment of Subplans</span>. The Committee has the authority to award Grants to Participants who are foreign
nationals or employed outside the United States on any different terms and conditions than those specified in the Plan that the Committee,
in its discretion, believes to be necessary or desirable to accommodate differences in applicable law, tax policy, or custom, while furthering
the purposes of the Plan. The Board may from time to time establish one or more sub-plans under the Plan for purposes of satisfying applicable
blue sky, securities or tax laws of various jurisdictions. The Board shall establish such sub-plans by adopting supplements to the Plan
setting forth (i) such limitations on the Committee&#8217;s discretion under the Plan as the Board deems necessary or desirable and (ii)
such additional terms and conditions not otherwise inconsistent with the Plan as the Board shall deem necessary or desirable. All supplements
adopted by the Board shall be deemed to be part of the Plan, but each supplement shall apply only to Participants within the affected
jurisdiction and the Employer shall not be required to provide copies of any supplement to Participants in any jurisdiction that is not
affected. Notwithstanding the foregoing, the Committee may not approve any sub-plan inconsistent with the terms or share limits in the
Plan or which would otherwise cause the Plan to cease to satisfy any conditions under Rule 16b-3 under the 1934 Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <span style="text-decoration: underline">Clawback
Rights</span>. Subject to the requirements of applicable law, the Committee may provide in any Grant Instrument that, if a Participant breaches
any restrictive covenant agreement between the Participant and the Employer (which may be set forth in any Grant Instrument) or otherwise
engages in activities that constitute Cause either while employed by, or providing service to, the Employer or within a specified period
of time thereafter, all Grants held by the Participant shall terminate, and the Company may rescind any exercise of an Option or SAR
and the vesting of any other Grant and delivery of shares upon such exercise or vesting (including pursuant to dividends and Dividend
Equivalents), as applicable on such terms as the Committee shall determine, including the right to require that in the event of any such
rescission, (i) the Participant shall return to the Company the shares received upon the exercise of any Option or SAR and/or the vesting
and payment of any other Grant (including pursuant to dividends and Dividend Equivalents) or, (ii) if the Participant no longer owns
the shares, the Participant shall pay to the Company the amount of any gain realized or payment received as a result of any sale or other
disposition of the shares (or, in the event the Participant transfers the shares by gift or otherwise without consideration, the Fair
Market Value of the shares on the date of the breach of the restrictive covenant agreement (including a Participant&#8217;s Grant Instrument
containing restrictive covenants) or activity constituting Cause), net of the price originally paid by the Participant for the shares.
Payment by the Participant shall be made in such manner and on such terms and conditions as may be required by the Committee. The Employer
shall be entitled to set off against the amount of any such payment any amounts otherwise owed to the Participant by the Employer. In
addition, all Grants under the Plan shall be subject to any applicable clawback or recoupment policies, share trading policies and other
policies that may be implemented by the Board from time to time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <span style="text-decoration: underline">Governing
Law; Jurisdiction</span>. The validity, construction, interpretation and effect of the Plan and Grant Instrument issued under the Plan shall
be governed and construed by and determined in accordance with the laws of the Commonwealth of Massachusetts, without giving effect to
the conflict of laws provisions thereof. Any action arising out of, or relating to, any of the provisions of the Plan and Grants made
hereunder shall be brought only in the United States District Court for the District of Massachusetts, or if such court does not have
jurisdiction or will not accept jurisdiction, in any court of general jurisdiction in Massachusetts, and the jurisdiction of such court
in any such proceeding shall be exclusive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"></p>

<ix:exclude><!-- Field: Page; Sequence: 63 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Appendix
B</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTIFICATE
OF AMENDMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OF</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTIFICATE
OF INCORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OF</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>KOPIN
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 242 of the</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
Corporation Law of the State of Delaware</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KOPIN
CORPORATION (the &#8220;Corporation&#8221;), a corporation organized and existing under and by virtue of the General Corporation
Law of the State of Delaware,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DOES
HEREBY CERTIFY:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FIRST:
That at a meeting of the Board of Directors of the Corporation resolutions were duly adopted setting forth a proposed
amendment to the Certificate of Incorporation, as amended to date (the &#8220;Charter Amendment&#8221;) and declaring said Charter
Amendment to be advisable and directing the stockholders of the Corporation to consider said Charter Amendment and to indicate their
approval and adoption thereof. The resolution setting forth the amendment is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RESOLVED,
That the first sentence of Article Fourth of the Restated Certificate of Incorporation of the Corporation be and it hereby is amended
to read as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;FOURTH:
The total number of shares of stock which the Corporation shall have authority to issue is two hundred and seventy-five
million and three thousand (275,003,000) shares, of which three thousand (3,000) shares, par value of $.01 each, are to be of
a class designated Preferred Stock, and two hundred and seventy five million (275,000,000) shares, par value of $.01 each,
are to be of a class designated Common Stock.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECOND:
That thereafter, pursuant to resolution of its Board of Directors, an annual meeting of the stockholders of said corporation was duly
called and held, upon notice in accordance with Sections 211 and 222 of the General Corporation Law of the State of Delaware at
which meeting the necessary number of shares as required by statute were voted in favor of the amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIRD:
That the aforesaid Charter Amendment was duly adopted in accordance with the applicable provisions of Section 242 of the General
Corporation Law of the State of Delaware.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOURTH:
That this Certificate of Amendment to the Certificate of Incorporation shall become effective upon the filing of the Certificate of Amendment
with the Delaware Secretary of State, which will occur as soon as reasonably practicable after approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, said Kopin Corporation has caused this Certificate of Amendment to the Certificate of Incorporation to be executed,
acknowledged and filed by its Chief Financial Officer this [&#9679;] day of June 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KOPIN
    CORPORATION </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Richard A. Sneider</i> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 5%">Name:</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
    A. Sneider </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 64; Options: NewSection; Value: 1 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img src="proxy_001.jpg" alt="" style="width: 800px"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 65 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="proxy_002.jpg" alt="" style="width: 800px"/>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<ix:exclude><!-- Field: Page; Sequence: 66; Options: Last -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>




<!-- Field: Set; Name: xdx; ID: xdx_088_labels -->
<!-- eJyFjjEPgjAQRncT/8OlM1KiG5samQx2YDMOBU5FS4+UE/DfS01MjAlxvve9d2JdlhVXZLWBvc7RtCIQV+YmlrLv+3DInQnJXeQyilbSkUFpPCbmM4FFGauuyXRuMMOBN4aK+zhX+gldCwrdmVytbYFwfEPgKXhjp49gXd4yUkhbqpvEfmvGy6PlGi1DRqB2B/AM2lb7fwNIiNgSe/mENiU7mtM/ciYYwYUPpD+RycYLpAFqiA== -->
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!--   -->
</ix:nonNumeric></ix:nonNumeric></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>formdef14a_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 formdef14a_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )M T@# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W2VMH'MHV
M:)"Q4$DCK4OV2W_YXI^5%I_QYP_[HJ:@"'[);_\ /%/RH^R6_P#SQ3\JFHH
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MXL OKFEZC(H A^R6_P#SQ3\J/LEO_P \4_*I0P)(!!(Z\]*0R( "74 ].>M
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M;3_CSA_W14U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;)! &+%5Y+,>I)/))]30!Y5#))HOBKQ#KGFO]CN=2FTZ\7/";D!BD]L-\O\
MP*J-A;?:W\#0MI$>KC^QYC]DE=54_,.<MQQ7K+^&=(DL]3M)+0/!J<AEND9V
M.]B ">O'0=,=*IR>!M!DBL$$$\7V"$P6S0W4D;(AZC<K G\: .<EL+;4O'^G
M:!?V20:5:Z3]IBTT']R92V#D#AMHX].]7?!Z?V?XU\3Z-9,W]E6WD211;B5A
MD=265?0=#BMZ[\)Z1>V]I%<0S.]FI6"X^T2"9 >O[P-NY]S5S2=%T_1+9H-/
MMEA1W,DAR6:1CU9F.2Q]R: .,TK3K3Q3XU\4'785N_L$\=M:V\QRL,>W.Y5[
M%CWZ\4S4_$>M1-XC;29[6ULO#:(H@FB,AN<)N.6SE1C@8R:ZO4O">CZI?_;[
MBWD2[*!'FMYWA9U'\+%"-P^M07?@CP]>W FFL.=B1NJ2NJ2JGW0Z@X<#_:S0
M!RFH^+O$,TFM7&GW%K;6UAIEOJ"Q2P;V8NA8H3D<<=>M61XIU^UN+B.ZGM)/
M/T%]4@\J$KY#C^#DG>.1R:ZR?PSI-S)J+RVN6U&!;>YP[ /&H(  !XX)Z8JO
MJ7A6RNK2;[+&(KS^S7TZ"5G8A(R. 1GGG'/6@#EK;QEKEA/I4^IR6MW;ZEI4
MMZ(;>(H86C0/@-D[@0?SH\/^+?$E_-:3SV\TUI>6LDTC_P!G/#':,$W)MD)Q
M(IZ9^GK71>'?!.E:%;6[FV22]2T6VDD+LR8Q\P16.%!.20 ,U9L/"&C:8Y:U
M@F1=C(D37,C1QJW4(A;"]>PH Y70_%7B*9_#,][-9W$6MP2@0)"8S'(B;@=V
M3G..1CC/%.TGQAJ":;J9U[4HM/U*WB61[:XT]E^SY;:"N&_>J<X!'?%=7%X4
MT:&#3(4M3Y>F*Z6JF1CL#KM8'GG(]:@3P/X?6VNH'LGF6Z18Y&GGDD;8IRJA
MF8E0#R,8YH X+5_$>MZAX1\6VDM[+&^G)#(L[6;6LSHXY4H3E>>C#M6S<ZE<
MZ-K.AO>BVOYH](NKEK@VRI+A5#!5/.T8X/K73V_@W0K:WOX%M&D34$$=UYTS
MR&4 $#)8DYYZU+;^%M)MI;.18)'>SAD@A::9Y"$?[P.XG/X]* .4T_Q/X@BG
M\/3W]Q:7%OKT,DBPQ0%3:L(_,7#9.X8X.:9H'BOQ!,_A6YU"XM)K;6Q)$T,<
M&PQ,@)#AL\YQR,8KJ=.\&:#I5S]HM+(JZHT<>Z9W$*M]Y8PQ(0'VQ4MOX6T>
MVBTJ.*V*II3,UF/,8^66!![\]3US0!1^(&K'1_!M[)&^RXN +6%@"2&D.W/'
M/ )/X5Q'ASQ+9^$-)\4V6F.UY:Z=&M[8B563<' 5@=P!P'Z_6O4+_2++4KFR
MN+N(R264OGP?,0%?&,X'!Z]ZAOO#NEZEJ OKNU$L_P!F>U)9CAHFY*D="/K0
M!POC)?$L'A&TN+G7HF:6\M3_ *-;>6068<9#<J#@^_0ULRZ]JUEX@U72YKJ*
M9;+1/M8E\D)NFRP+$9X''2M5/!6A+I4^FFUE>UFV;EDN)'*[#E=I+97';&*6
M\\&:%J#0-=VDDS0P?9PS3R9>/^ZYW9<9Y^;/- '(:CXUU1/#-A=V^I(NHG2U
MOIK:+3FGW9!^9R#B-"1C/UK,\1W1U"7Q!>NBJ]SX4AE91R!N8G'ZUWUQX$\.
MW44,<MD^V*V%H L\B[XAT1\,-P'OFIY?"&B3I,DEHQ6:R6P?]ZW,"]%Z_KUH
M XV^\9:GX>BOK!O*>5].MI=&7R_O.^(RI_O8;!^E=)XU%PGPSU<7,@:X&GL)
M748!;;R1Z<TNK^$5U3Q'X=O?W"V>D;F"$$R,V $&>F!@'FM_4M/MM6TVXT^\
MC,EM<(8Y$#$94]1D<B@#S30+.?29V\0V]F/#^D0Z.$G:YP4GFX(E,:,> ._!
M.:CO/%NHW&C^*+.\$5_%;Z>EU"U[IIAW!FQAHF/S+P"#7ID^DV-UI#:5/;K+
M8M$(3$^2"@&,>M9$?@3P_'!>1?997%Y +>=I+F1V>,'(&2Q/% '&^)M7U?5-
M)\3V-M-9VVGZ7IL0DA:')G,D>XX.?E ' P#S7HVA?\B]IG_7I%_Z *S]0\$^
M']4G::[L2[O"(),2NHD0#"A@#AB.Q/(K<MX([6VBMXEVQQ($09S@ 8% $E%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% $-W_QYS?[IHHN_^/.;_=-% !:?\></^Z*FJ&T_X\X?]T5-0 4444 %
M%%9MOK=O=7L\$44[11 _Z0(B8V920R@]R,?X=#0!I452L=5MM0DGBB$J2P;?
M,CFC9&4-R#@CH<'\C54>)M+.XF9P I:-C$P$P!"_N^/GY(''J* ->BLK_A(K
M PAU,[2&1H_(6%C*&49(*8SP"#^(]:GDU>R33X;X2F2&?:(?+4L9">@4#DF@
M"]162_B334MTFWRN&#L52%F:,(<.64#*[3P<U)'KVGS7:6\<S-O;RTE"'RV?
M&[:'Z9QSB@#2HHHH **** "BBB@ HHHH **** "BBL\Z[I(U3^RSJ5J+\_\
M+OYHW_EZT!<T**** "BL^VUJQN[R>VAE+-",LY4A#@X.UNAP>N.E$>MZ9+I_
MV^*]BDM=YC$B'<&8'&!CJ<\<4 :%%9TFO:7%:Q7+WD8AE!*, 3P/O$@#( [Y
MZ=ZEO-5L=/B26YN$1).4/+9&,D\=@._2@"Y15$:SIQO$M!=QF9\;0#D$D9 S
MTR1SC.<5>H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBL
MV7688]633TBGFDR!*\<998<C*[CVS_\ KH TJ*S/[?TSS[Z$W(#6*AK@E&PN
M<@8.,$\$<9IH\0V)B9OWXE601&W,+>;N(W ;,9^[S]* -6BH+.\@O[2.ZMGW
MQ..#@CH<$$'H001BIZ "BBB@ HHHH AN_P#CSF_W311=_P#'G-_NFB@ M/\
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M"#:Q [[AC;C'H>E=QY#?\_$OZ?X5-10!#Y#?\_$OZ?X4>0W_ #\2_I_A4U%
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M;L>$<\ 9_P#'3_P$UHO>C;JC%^Y*_1GL%%%%9FP4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M $-W_P ><W^Z:*+O_CSF_P!TT4 %I_QYP_[HJ:H;3_CSA_W14U !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<=\2?"?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 0W?\
MQYS?[IHHN_\ CSF_W310 6G_ !YP_P"Z*FJ&T_X\X?\ =%34 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8WBKP];
M^*/#MWI5Q@>:N8W(_P!6X^ZWX'],UQ_PG\0W$EG=>%-6RFJ:0QC"L>6B!Q^.
M#Q]"*])KRCXF:;<^&]>L/'NDH?,MW6*^C7HZ'@$_4?*?^ UI#5<IE/W7SK^D
M>KT54TO4K;6-+MM1LW#V]Q&)$/L>Q]QTJW69J%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %!]8LDU5--
M,I-RP/"J2JGJ%8] 2.0/:GVFJV-]/)!;7*22QC+(,@XSC(SU&0>1Q6)+'<Q^
M*<Z9%>0O)*CWHD"FVECQC>.X?"@#&#QR,<TD-[-#?ZAK6I6%W"8H3%!%M4_N
MPW0$'EW...W ]: -^:_M+>[M[2:X1+BY+"&,GE\#)Q]!45OK.FW<LL<%Y$[1
M*6?G V@X)!/! /<<5BW>DZK)XBM-0 MI(_M()W!@\,(C8;>N.K$\=R.PJ+3=
M(F@U*&017ATZPM98(XKE8]S;BORJ!R0 O5CZ>] '2V5]:ZE:)=64Z3V[YVR(
M<@X.#C\0:JQ:]IDT$\Z72F&!2\DFU@H X)SC!Z=JS-!NI-.T^WM+FQN8IY[V
M541E7.UG=]W!Z!<9],U6@TZ<1W5FMIJ/]D-;.LEO,Z[]Y;@1'.>A;J<=,4 ;
MK:[IJ6RW#W.V-F*+NC8%B!DX7&3QWQ5Z&:.XA2:%UDC=0RNIR&!Z$5Q%[IVL
MW;Q._P#:<=K'*Y@GC,?VR,% "#GY=A.[U/ Z=:ZO1()[;0[*"YABAFCA5'CB
M^ZI Z"@"_1110 4444 %%%% !1110 4444 %%%% !1110 4444 0W?\ QYS?
M[IHHN_\ CSF_W310 6G_ !YP_P"Z*FJ&T_X\X?\ =%34 %%%% !7,64]W%XB
MF@U&>[AN;CS%MAA6MY$4DKLQR'"\D-UYZC&.GK,BT&PAN9Y_+=VE###R,PC#
M#Y@F3\N>IQ0!!H-Q<SW&H!KJ2[LHY%2">15!9@/W@!4 %0W&<=<CM6,=4U.Q
M6&SOI[N+4KR98T:18FB"&4*6CVCJ R\-ZC@UN1>';*V^R):^;#!;2"00B5F4
M[00HY)P!G.!UXJ0>']+VRJUJ'$J[6,CLQ SG"DGY1GGC'0>E &)!?ZA/KTF@
MF_E58I)#]J5$\QE"1L%Z;<@R<G'0"IH-8O;W1-$)E\F>_F\F6:-1P%#DE0<@
M%MGOC-:S:!IC6R0&V^5':0,)&#[CP3OSN)(X//-1IX>L0MPDB;XY71D0$J(@
M@ 0)@_+C'4<\F@#"M]4U*]N+RP^WO"UC'.PN%1,S%7*J6!&, #G&,GTIND^(
M-0O[#3-8>8JMY>BU>SVKL53D9!QNW9&[KTXQ71R>']+E@AA:T79$K*H#,#AC
ME@2#E@3R0<Y[U)'HVGQ7WVQ+55FSN!!.T-C&X+G ..,XS0!>IDDJQ@;@QS_=
M4G^5/HH A^U)_=D_[]G_  H^U)_=D_[]G_"IJ* (?M2?W9/^_9_PH^U)_=D_
M[]G_  J:B@"'[4G]V3_OV?\ "C[4G]V3_OV?\*FHH A^U)_=D_[]G_"C[4G]
MV3_OV?\ "IJ* (?M2?W9/^_9_P */M2?W9/^_9_PJ:B@"'[4G]V3_OV?\*/M
M2?W9/^_9_P *FHH A^U)_=D_[]G_  JM?QV>IZ?<6-W"\EO/&8Y$,9Y!&/2K
M]% 'D7P[U.;PAXGO_ VJ.YBWF;3Y&4_.#S@?4<_4-7J_VI/[LG_?L_X5P/Q7
M\-3W^DP>(=+RFK:0WG(R?>:,')'X=?S]:Z;P=XE@\6>&;75(L"1ALGC'\$@^
M\/ZCV(K26JYC*'NOD?R-C[4G]V3_ +]G_"C[4G]V3_OV?\*FHK,U(?M2?W9/
M^_9_PH^U)_=D_P"_9_PJ:B@"'[4G]V3_ +]G_"C[4G]V3_OV?\*FHH A^U)_
M=D_[]G_"C[4G]V3_ +]G_"IJ* (?M2?W9/\ OV?\*/M2?W9/^_9_PJ:B@"'[
M4G]V3_OV?\*/M2?W9/\ OV?\*FHH A^U)_=D_P"_9_PH^U)_=D_[]G_"IJ*
M(?M2?W9/^_9_PH^U)_=D_P"_9_PJ:B@"'[4G]V3_ +]G_"C[4G]V3_OV?\*F
MHH A^U)_=D_[]G_"C[4G]V3_ +]G_"IJ* (?M2?W9/\ OV?\*/M2?W9/^_9_
MPJ:B@"'[4G]V3_OV?\*/M2?W9/\ OV?\*FHH A^U)_=D_P"_9_PH^U)_=D_[
M]G_"IJ* (?M2?W9/^_9_PH^U)_=D_P"_9_PJ:B@"'[4G]V3_ +]G_"C[4G]V
M3_OV?\*FHH A^U)_=D_[]G_"C[4G]V3_ +]G_"IJ* (?M2?W9/\ OV?\*/M2
M?W9/^_9_PJ:B@"'[4G]V3_OV?\*/M2?W9/\ OV?\*FHH A^U)_=D_P"_9_PH
M^U)_=D_[]G_"IJ* (?M2?W9/^_9_PH^U)_=D_P"_9_PJ:B@"'[4G]V3_ +]G
M_"C[4G]V3_OV?\*FHH A^U)_=D_[]G_"C[4G]V3_ +]G_"IJ* (?M2?W9/\
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MT445F;!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-E=.9M.E?H2>@_$#'U7WKUVB4;,(2YEKN%%%%26%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !6%XQ_Y%BZ^J?^A"MVL+QC_R
M+%U]4_\ 0A6E+XUZF&(_@R]&>7T445[)\F%>I>$?^17LOHW_ *$:\MKU+PC_
M ,BO9?1O_0C7)B_@7J>GEG\5^AMT445YI] %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!#=_P#'G-_NFBB[_P"/.;_=-% !:?\ 'G#_ +HJ:H;3
M_CSA_P!T5-0 4444 %9T.MV<][-;1^:1$I)F\MO+)4D,H;&"1CD>_P!:T:Y>
MSM[V#79I;&SN[:U4R-<V\LJF*9R,J8N3@DG)/ ZY&: -VRU.TU RK;R,7B($
MB/&R,N1D9# '!'0U6'B+2CYG^E !%+9*, X!VDH<?/R0/ESR169ITEY;2-)?
MV$ZZCJ<RI)AD*QJ%. N&/RH!U."2WOBLR70=7FAT)?L@1M$(;_6KBZ(*C"\\
M A2?FQS@>] '4?V_IOD"43.<NT?EB%S)N498%,;A@<GCI4TFJ64=C%>F<-!-
MM\ID!8R;N@4#DD^@KGXM.U.WUY]<^PL_G22 V@D3>BE(U5LD[<YCYYZ$=<5%
M86E]'8V%O':M+)I%T&E"N )2R-N"$X'R^8.N,XH WG\0Z7';1W!N28W#,-L;
M,5"G#%@!E0#P<XQ4B:UI\EXMJEP&D9MBD*=C-C=M#XVDXYQG-<[;Z3JEE=W=
M\++SFOHYP8!*H\AF?<N23@C!YQGGUIFD^'=1L+#3M'DC#16=Z+DWF\;749.
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9V\0E&)-D2KO^N!SU->9?\)1K?\ T$)/^^5_PKT'PW=3WN@6MQ<R&25]VYB
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MY@P&Z_7.:]9R['S4:/\ .['H5>I>$?\ D5[/Z-_Z$:\"'B#5])8)K.GF2/\
MY[Q?YQ_*O7_ ?C+0M1T6UL;:^4WB!MUNWRORQ/ /7KVKFQ3O#0[LO@XU6WM8
MZJSUFROKV:UMY&=XADMM.QN<':W1L'@XZ4G]NZ7Y,\HO8V2";[/(5R2)/[H
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M(_$"O1ZR=:\,:+XBA,>JZ=!<\8#LN'7Z,.1^=<',G\2/<Y)1^%_>:%M=6][
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M][X62W2&<\!1G!.,X!Z9QSC.<4 7J*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KE_B'IT.J>";^UF ^
M;848C[C;A@BNHK#\8?\ (KW?_ /_ $(5I3^-&-=VI2:[,\+\*W\GERZ3=\7-
MH2 #W7_ZW\B*Z.N7\2VTMA>6^O6@^>(A9@/XATR?Y?E71VMS%>6L5S"<QR*&
M6O7CV/EZB3]]=?S):]1\(?\ (L6?_ __ $(UY=6Y%\3]"\,^';6S5GU#41N
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M,,1_!EZ,\OHHHKV3Y,*]2\(_\BO9_1O_ $(UY;7J7A'_ )%>S^C?^A&N3%_
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MJ5J;KP[*EY"&6?4&U?SSOVG)9-QY.>F.,UZ%<+OMI5\PQ[D(WC^'CK^%>1^
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MAU!+5EDEC+" N,AO[N[IU'6J'_"2.NZ!K'%\+L6@B\X;"Q3S,[\=-OMG/&*
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MA"M*7QKU,,1_!EZ,\NHHHKV3Y,*]1\(?\BQ9_P# _P#T(UY=7J/A#_D6+/\
MX'_Z$:Y,7\"]3T\L_BOT-RBBBO-/H HHHH **** "BBB@ HHHH **** "BBB
M@ K"\8?\BQ=_5/\ T(5NUA>,/^18N_JG_H0K2E\:]3#$?P9>C/+Z***]D^3"
MNVT#1[G4;'2IIFM1;6S^=%*L7[]2'.4W9^Z>_J#CWKB:]2\(_P#(KV?T;_T(
MUR8OX%ZGIY9_%?H4!X.(C\E;T0QQ1S) \$6V0>8<_.V?FQ[8S4UGX1MXC(96
M2$-(DB0V"M;QHR@C<%!/S'=S]!Z9J]<^)-.M+F2WE>021G# 1DU#_P )9I7_
M #TE_P"_9KQW7I)V<D>_=#-/TO4M+M(],M+H&".V?%S,N\^:S?+@9Z 9R.^1
M[TMMH5Q#HS6,G]GW#&3S"\]NSB1CRSN"W+$\YSQ3O^$LTK_GI+_W[-6++Q!8
M7]TMO [F1@2 4('%"KTF[*2"Z,Z+PK)91!;"]2)Y('@G9X<A@S%BR@$;2"S8
M'(P?:M^TMH[.S@M8L^7#&L:9ZX P/Y5-16PPHHHH **** "BBB@ HHHH *PO
M&/\ R+%U]4_]"%;M87C'_D6+KZI_Z$*TI?&O4PQ'\&7HSR^BBBO9/DPKU+PC
M_P BO9?1O_0C7EM>I>$?^17LOHW_ *$:Y,7\"]3T\L_BOT-NBBBO-/H HHHH
M **** "BBB@ HHK N-9N!XICTQ7MK>-0IVW!(:Z##GRST^7'(ZGVZT ;]%<]
MJ'B"ZTJ]DAN;:"0-"TD(BD.X'>J*'R.-Q<<^QZU>TS4+BXN[RRO(HTN;4H2T
M1)1E<9!&>1T(_"@#3K&\611S^$M5BFN$MXWMG#2ONVH,=3MY/T'6MFLCQ5)!
M#X5U.2YMOM,*6[,T._9O '][M]: .:^'M]8W4UW':0:3&R1(6:QT^2V9ADC+
M;P,C(/3H<UWE>>>!;FP@U^_MF:P%Y-%'(CVNHM<1E6+MY:!L%2#N8@?WLUZ'
M0 4444 0W?\ QYS?[IHHN_\ CSF_W310 6G_ !YP_P"Z*FJ&T_X\X?\ =%34
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6'XP_Y%>[_P" ?^A"
MMRL/QA_R*]W_ , _]"%:4OC7J88C^#+T9Y=1117LGR85ZCX0_P"18L_^!_\
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MI[/41(B*T;:AID%OL)SG88P#GUKN:X3P%((M0O;%I89Y$MXI1+:ZC)=0A&+
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M9J:B@"'[4G]V7_OV:/M2?W9?^_9J:B@"'[4G]V7_ +]FC[4G]V7_ +]FIJ*
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M/^/.'_=%35#:?\></^Z*FH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M HHHH **** (;O\ X\YO]TT47?\ QYS?[IHH +3_ (\X?]T5-4-I_P ></\
MNBIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K#\8?\BO=_P#
M/_0A6Y6'XP_Y%>[_ . ?^A"M*7QKU,,1_!EZ,\NHHHKV3Y,*]1\(?\BQ9_\
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MO2C1QK#V4#7LL0(=]WF0XDD3)V$[6"JQ&,C!_"@#7HHIDB,X&V1DQZ <_G0
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M%>O&I&R.S!X.=&;E)K8X37O^0]>?[_\ 05G5Z#/X;L;J=YYM[2.<LV<9J/\
MX133/[C_ /?5?-SP%24FTUJ>@X,X*MGPK_R'XO\ <?\ E72?\(IIG]Q_^^JF
MM?#UG97 GMRZ2 $!LYZ_6JI8&I":DVM 4'<UJ*A\F7_GYD_)?\*/)E_Y^9/R
M7_"O7-":BH?)E_Y^9/R7_"CR9?\ GYD_)?\ "@":BH?)E_Y^9/R7_"CR9?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%.& A"2DF] 4 HI&944LS!5'4DX I:] L**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"&[_X\YO]
MTT47?_'G-_NFB@ M/^/.'_=%35#:?\></^Z*FH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^#_A1]KA]6_[X/\ A0!*\:21F-T5D/56&13J@^UP^K?]\'_"C[7#ZM_WP?\
M"@">F^6GF"38N\#:&QSCTS47VN'U;_O@_P"%'VN'U;_O@_X4 3T5!]KA]6_[
MX/\ A1]KA]6_[X/^% $JQHC.R(JESEB!C<>F3^5.J#[7#ZM_WP?\*/M</JW_
M 'P?\* )Z*@^UP^K?]\'_"C[7#ZM_P!\'_"@">BH/M</JW_?!_PH^UP^K?\
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MQYP_[HJ:H;3_ (\X?]T5-0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 85KX-T"RN9IX+#:T_F>:IFD9'W_>RA;:<Y]*A/@/PR;5
M;;^S!Y:RB9<32!@X& =V[/ . ,X':NCHH P;KP9H-[!:0W-I+(EH"(,W4N4Y
MSG.[)/N>:W5 50HZ 8%+10 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-D4M$ZCJ5(%.HH
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M[IHH +3_ (\X?]T5-4-I_P ></\ NBIJ "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HJMJ-V;'3Y[H)O,:[MI.,US/_  FLG_/BO_?W_P"M6%3$4Z3M
M-B;2.OHKD/\ A-9/^?%?^_O_ -:@>-9"0/L*_P#?W_ZU9?7:'?\  7,CKZ*P
MM;\0II-]90%X%$A#S>83D1E@OR^^3GZ*:2X\66%NHWQS;]Q0H0HVON*[22<
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M,B85V9MFY0I5MO.1U_2@#I**S-$OY]0M[J2XC,;1W4D00@955. #@D'ZUIT
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH AN_^/.;_=-%%W_QYS?[IHH +3_CSA_W14U8\>IM
M#&L8B!VC&<T_^V&_YXC_ +ZH U:*RO[8;_GB/^^J/[8;_GB/^^J -6BLK^V&
M_P">(_[ZH_MAO^>(_P"^J -6BLK^V&_YXC_OJC^V&_YXC_OJ@#5HK*_MAO\
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MT. 3@]14O]F67E31?9DV31K%(O\ >0# !]L<55_MAO\ GB/^^J/[8;_GB/\
MOJ@"Q=Z387SA[BW5W"A0P)4@ DC!'3J?S-1RZ%IDXD$EHI$C!W ) )"[<\'T
MX/J.M1_VPW_/$?\ ?5']L-_SQ'_?5 #QX?TH2,XLH\LA0CG&"NT\9QRH S[4
MK:)9MJ=K?",+);M(Z@#J[@*6_(8J/^V&_P">(_[ZH_MAO^>(_P"^J +QL[=F
MG8PH3<*%ER,[P!C!_ U37P]I*P&'[$A0G)W$L<[=O4G/3CVQ3?[8;_GB/^^J
M/[8;_GB/^^J +MG8VVGP&&UB$<98N0,G+'J23U)JQ65_;#?\\1_WU1_;#?\
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M!$@).ULC!)7H3COC-,.AV"VDD$4(C+Q21>9DLP#@;N3UZ#KZ"F?VPW_/$?\
M?5']L-_SQ'_?5 #E\/:6MF+7[*#&&WYW-NW8QG=G/3CKTXZ5+)HVG2Q&)K5
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M_P">(_[ZH_MAO^>(_P"^J -6BLK^V&_YXC_OJC^V&_YXC_OJ@#5HK*_MAO\
MGB/^^J/[8;_GB/\ OJ@#5HK*_MAO^>(_[ZH_MAO^>(_[ZH U:*RO[8;_ )XC
M_OJC^V&_YXC_ +ZH U:*RO[8;_GB/^^J/[8;_GB/^^J -6BLK^V&_P">(_[Z
MH_MAO^>(_P"^J -6BLK^V&_YXC_OJC^V&_YXC_OJ@#5HK*_MAO\ GB/^^J/[
M8;_GB/\ OJ@#5HK*_MAO^>(_[ZH_MAO^>(_[ZH U:*RO[8;_ )XC_OJC^V&_
MYXC_ +ZH U:*RO[8;_GB/^^J/[8;_GB/^^J -6BLK^V&_P">(_[ZH_MAO^>(
M_P"^J -6BLK^V&_YXC_OJC^V&_YXC_OJ@#5HK*_MAO\ GB/^^J/[8;_GB/\
MOJ@#5HK*_MAO^>(_[ZH_MAO^>(_[ZH OW?\ QYS?[IHK-DU-IHFC,0&X8SFB
$@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>formdef14a_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 formdef14a_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (C Q4# 2(  A$! Q$!_\0
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M:)"Q4$DCK4OV2W_YXI^5%I_QYP_[HJ:@"'[);_\ /%/RH^R6_P#SQ3\JFHH
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M*IJ* (?LEO\ \\4_*C[);_\ /%/RJ:B@"'[);_\ /%/RH^R6_P#SQ3\JFHH
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M;6YFC2*1K2\>+<J#"@A3VJ74/".EZC>_;F-U;WAC$3W%K<O$\J#H'*GYOQH
MR/AQ<3M8:Q9//)/;6&IS6UK)(Y9O+&,+D]<9(K-\&Z39^*X-1UK6XVNK_P#M
M&:.,O(P^S*C854P1M]>.N:[K2]+LM&T^.QT^W2"VCSM1?4\DD]23ZFLN;P9I
M$NHS7J"[MGN&WW$=M=211SMZNJD F@#EKKQKKBZ??^(H/L8TJQU'[$;)HF,L
MBAPC/OSPV3D#&*;JOC'Q):CQ#>6S:>;72+^.!89(FW2JVW@L&^7&[K@UU,G@
M?0I=2:]:WE^><7+VXG;R'E'1S'G:6_"I+CP?I%U;:G;RQ2F/4IUN+D"4C+KC
M&/3[HX% '+ZEXOU_1XO$]O<M9376G6D-W;RQQ%5PYP4().<8ZYI]WXUUC0+R
M^CU5+2[4:0=3@%NA380VWRR23D9(^;CZ5L^)_!T6KZ=K36.V/4M2M4MF>5SY
M>U#D<#.._:K&F^"]&L([C=;M.]U;BVF\^5I1Y0'^K7<>%]A0!S-AXRUYHKPS
M1&>/^S);Q;G^S9;=()E7(C)?AP>Q&,XJ?3O%?B+[9ID=S'971U72I+RWAA1D
M,<J*"%+$G(;(],5T5KX0TVTM9[82W\L$T#6^R>\DD$<9&"J GY>/Y4\^$M)+
M6#&.7-C:/9P8E88C8!2#@\G '/6@#F=*\97<F@W\VIZK9VFH0>5YL-Q821M:
MLYQMV;LR9_A(ZFL/6?%&M:IX)\2)]N\J73;F%/M"6KV\DT;E2!L8[HR">O<?
M6NY/@30WM+J&=+JX>Z*&2XGN7>;*'*8<G(VGIBGQ>"=$CL-3LVBGFBU/:;HS
M3N[2,HP&W$Y![YH Y[4=5FT/Q)93ZA#9WUS;:'<W3W2V_ERMM(.U3D[0>XY]
M:?9^)_$%M=:(=2>QFAUNUEGB2"%E-LRQ^8!DL=XP<9XKI8O"FF)<6T\@N+B6
M"U>T5KB9I"T3G+!L_>_&H--\$Z+I<XF@BG9DB:"$37#R""-NJQAB=H^E '.Z
M!XNU^XF\+3ZBUE):ZXDB>5#$RM$R+D-N).<XY&.*W_'VL'1?!M_/'((YY5%O
M"Q[.YV@_ADG\*LVWA+2;6/1HXHY0NCEC:9E)V[A@Y]>#WJYJ.C6>JW-A/=H[
MM8S_ &B$!R%#@8!([XSWH \R\+^);'PEIGBBRL+G^T;3385OK,EC\X90&4D\
M\/\ SJ_XPE\4P^!DO+G6+56EFMG_ -$@:-EW,/EW;^0"1SWY%=OJ'AK2]4U-
M=0O+<R3"V>T8%CM>)^JL._\ 2J:>"-&&D7&ER"[FM9E1=LUT[F,*<J$)/RX/
M3% %+^W-6L_%+Z-<3V\ZPZ.UVTJP[-TH<C.-QP,=OUK$D\;:D_A32[T:E:0:
MC<6#730)827#2$$\X4_(G&-QKJKSP7I%^UJ]U]KDEMX3;^:;I]\L9ZI(P.7!
M]ZA?P#H36]I"L=S&MM;&T4Q7+H7A)R4<@_,N>QH XS4-1;6=0_M.2)8Y+KP=
M/*R+R 2<D#VJS:^,;KPQI-O!=^2;0^'XKK3\(0S3*H4QDYYR2I^E=BG@S1D2
M-%BEQ'I[::O[T_Z@]1]??K6=K_@B/5G\,VL*PKI^DSAW\UF,A15 5!QSD@9S
MZ4 :4[WS> 9Y-2*?;VTUVG\M=H#F,D@#MBO/?!%A<HV@:MI]A-IEG;::[:E=
MW#;(KMBGRG;N.X \[N.*]<NK:.\M)K68$Q31M&X!P<$8/\ZJVFC6-GH4>C1Q
M;K&.#[.(W8ME,8P3WXH X&V\97E[>7^GS3VNIV<VDSW4<GV"2!,J/N@.?WB$
M'J*;8Z]JU]86&C:1'IUE''H*W\RM =C;A@1H ?E'OSBNIL_ >B6,F^,7;L+5
M[-3+=.^R%NJ+D\ =L=*?+X&T.:.R1H9U%G;?9$*7#J7A_P">;D'YE]C0!#\-
MP!\.M# &!]F''XFNIJGI6F6NC:7;Z=9*RVUNNR-68L0/J:N4 %%%% !1110
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M )^3_P!\"IZ* (/*G_Y^3_WP*/*G_P"?D_\ ? J>B@"#RI_^?D_]\"CRI_\
MGY/_ 'P*GHH @\J?_GY/_? H\J?_ )^3_P!\"IZ* (/*G_Y^3_WP*/*G_P"?
MD_\ ? J>B@"#RI_^?D_]\"CRI_\ GY/_ 'P*GHH @\J?_GY/_? H\J?_ )^3
M_P!\"IZ* (/*G_Y^3_WP*/*G_P"?D_\ ? J>B@"#RI_^?D_]\"CRI_\ GY/_
M 'P*GHH @\J?_GY/_? H\J?_ )^3_P!\"IZ* (/*G_Y^3_WP*/*G_P"?D_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 96L??B^AHHUC[\7T-%
M%^T_X\X?]T5-4-I_QYP_[HJ:@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK+72]4CULZ\+16E>1@UF)1E4,:H#NZ;LIGZ&J5IX7U2UTV]TLI$\>HSK<27
MDXA)(+K@\G&.,>O.* .YHHIKH77 =E]UZT .HJ#[.W_/Q-^8_P */L[?\_$W
MYC_"@">BH/L[?\_$WYC_  H^SM_S\3?F/\* )Z*@^SM_S\3?F/\ "C[.W_/Q
M-^8_PH GHJ#[.W_/Q-^8_P */L[?\_$WYC_"@">BH/L[?\_$WYC_  H^SM_S
M\3?F/\* )Z*@^SM_S\3?F/\ "C[.W_/Q-^8_PH GHJ#[.W_/Q-^8_P */L[?
M\_$WYC_"@">BH/L[?\_$WYC_  H^SM_S\3?F/\* )Z*@^SM_S\3?F/\ "C[.
MW_/Q-^8_PH GHJ#[.W_/Q-^8_P */L[?\_$WYC_"@">BH/L[?\_$WYC_  H^
MSM_S\3?F/\* )Z*@^SM_S\3?F/\ "C[.W_/Q-^8_PH GHJ#[.W_/Q-^8_P *
M/L[?\_$WYC_"@">BH/L[?\_$WYC_  H^SM_S\3?F/\* )Z*@^SM_S\3?F/\
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M.>G8<X [#%3?9V_Y^)OS'^%'V=O^?B;\Q_A6!VD]%0?9V_Y^)OS'^%'V=O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5@>,_P#D6;C_ 'T_]"%;]8'C/_D6;C_?3_T(5I2^->IAB?X,O1GF-%%%>R?)
MA76> /\ D+7?_7 ?^A5R==9X _Y"UW_UP'_H58U_X;.K!_QXGH-%%%>0?4A1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 96L
M??B^AHHUC[\7T-% %^T_X\X?]T5-4-I_QYP_[HJ:@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K \9_\BS<?[Z?^A"M^L#QG
M_P BS<?[Z?\ H0K2E\:]3#$_P9>C/,:***]D^3"NL\ ?\A:[_P"N _\ 0JY.
MNL\ ?\A:[_ZX#_T*L:_\-G5@_P"/$]!HHHKR#ZD**** "BBB@ HHHH ****
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M#>HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8$$=,$"N>\/>$O#T-XFK:3JE[=$/O+#46E1VQCYAG!./7TH ["BBB@ HHHH
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M=<]S7=4 %%%% !1110 4444 %%%% !1110 445%<0_:(&B\V2+=_'&V&'T-
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MHHH **** "BBB@ K \9_\BS<?[Z?^A"M^L#QG_R+-Q_OI_Z$*TI?&O4PQ/\
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M_9]?LLI-&XVF4#@L!Z^H_'I7>US--.S.V,E)704444B@HHHH **** "BBB@
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M0H^TP?\ /:/_ +Z% $M%1?:8/^>T?_?0H^TP?\]H_P#OH4 2UYOXY_Y&%?\
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MWAN[=X+B))89!M>-U!5AZ$&L^V\.:)9W*7-MI-E#.ARLD<"AE/L<4 :E%%%
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MMCG'O0!ZG;M,UM$UPBI,4!D1&R%;'(![C-2444 %%%% !1110 4444 %%%%
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MZSP!_P A:[_ZX#_T*L:_\-G5@_X\3T&BBBO(/J0HHHH **** "BBB@ HHHH
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M?^18L/\ </\ ,UR8OX%ZGJ99_%?I^IL4445YI[X4444 %%%% !1110 4444
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MBB@ HHHH RM8^_%]#11K'WXOH:* +]I_QYP_[HJ:H;3_ (\X?]T5-0 4444
M%%%% '/7>K7,7BB&SEN([*WRHB$L1(N]P^8!^BLO8=2:K2^)KFT%\UT84FCD
MD2WM&MWC:0!PJMO)PPY!.!T-:MYHS7]\'N+V9K'*2&TPNTR*05.<9QD XSUJ
M.[\.6VHN3?7-S<H XB1V4"(MW4@ Y'8DG% %)M<U&+5O[%?[*UZ\B>7.(V$>
MPHS$E-V<C81C=SD&IEU^X_L5IFBB^VK>?8<#/EF3S-F[UV]\?AGO4Y\.0,QG
M:[NFO?,6079*^8"JE0 -NW&"PQCG)J)/#:[9[>2YE^R,%:,*WSB8.7:8G'WR
MQ'MQT[4 5(]=U2?6KS0X_L8O;.,S/,T;>6Z$*4 7=D$DD'DXQWS44?BRZNM-
MDU6"&%;.V\GSHG!+L7"EMK9 &T,,<'.#TK2/ABW\][E;V\2]D#+-=*RAY58
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M_NBIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***1F"J68X
M&2: %HK.TO5TU7S&BMKB. 8:&:1,+.A'#+[>QYZ'O6C0 5YOXY_Y&%?^N"_S
M:O2*\W\<_P#(PK_UP7^;5U87^(>=F7\#YHYJBBBO3/G0KU7PK_R+%A_N'^9K
MRJO5?"O_ "+%A_N'^9KDQ?P+U/4RS^*_3]38HHHKS3WPHHHH **** "BBB@
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M(/WE*!.GW54X ]JWJ* "BBB@ HHHH **** "BBB@#*UC[\7T-%&L??B^AHH
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MO& \3E64]B"*ATW38M-@94>2660AIIY6W/*P &2?H!QT%7** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MPO<27/ANRDE<NX0H7)R6VL5!_$#-:KL47(1F]EZU%96D5A906D (BA0(N>N
M._O4] $'VAO^?>7\A_C1]H;_ )]Y?R'^-3T4 0?:&_Y]Y?R'^-'VAO\ GWE_
M(?XU/10!!]H;_GWE_(?XT?:&_P"?>7\A_C4]% $'VAO^?>7\A_C1]H;_ )]Y
M?R'^-3T4 0?:&_Y]Y?R'^-'VAO\ GWE_(?XU/10!!]H;_GWE_(?XT?:&_P"?
M>7\A_C4]% $'VAO^?>7\A_C1]H;_ )]Y?R'^-3T4 0?:&_Y]Y?R'^-'VAO\
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M1\PZ'IU%2K9VJ,K+;0J5=I%(0##-G+#W.3D^] $U%%% !1110 4444 %%%%
M&5K'WXOH:*-8^_%]#10!?M/^/.'_ '14U0VG_'G#_NBIJ "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JKJ+QQZ;<O-=FTB6,E[@
M$ QC'+9/ Q5JH[BWAN[>2WN(DFAD7:\<BAE8>A!ZT >86NI:G_9$"MK-XFF:
MEK*0V]Q+*#<1VI0D9?JN]EXSR :A&J:C=065K9^(+QM474)(K8F91&]K'*0T
MLW'S#:-N>YZ=Z]&B\.:'!:SVL6CV"6\^/.B6W0+)CIN&,'%-G\,Z#="(3Z+I
M\HB01Q[[9#L4= ..!STH YTW,\WQ(A@TW6+B6&$.=2ADE4PIE?W<:+C[_<XY
MQUZUV]9P\/Z,-0&H#2;'[:'WBX^SKYF[UW8SFM&@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ KRZYUG4+/\ X2?4=(UFYN]/M;,HLES(
ML@^TAOG:(8X5%.#VS]*]1K,MO#NB64[SVND6$$KJ49X[=%+*>H) Z&@#SR]U
M%[./6=/7Q'J<\<0@_L]XKE3--<2(3Y>_'*Y 8CH >>*L^)]0U;2]+TJ[DU:?
M[3;Q0&]GMKJ/RD.X!B8?O2;N1Q^%=PWAG06M4M6T73S;HQ=8C;)M#'J0,8S[
MT\>']%#6S#2;'=:C;;G[.F8AZ+QQ^% &B"&4$=",TM%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% '#WUU<O\0K6#3-7N9##E]1MWE7R
M(XROR1A<??)Y]<=>U<]IVNS&'3[S4/$EVL&H6-Q<:CME7_1BCKM$8Q\G)*8'
M)^M>D/H&C2:@-0?2K)KT.'%P8%,FX=#NQG/O0WA_1G%R&TFQ(NB#/FW7]Z0<
MC=QSSSS0!YW<ZQK]EX%BAEN-2\VZ>>47D<9FFMH%&Z-'9 <.?E!)Z G/2O0?
M#5XVH>&-+NW,K/+:QLS2J59FVC)(/J>:GM-(TVPM)+2ST^UM[:7)DBBB55?(
MP<@#!R.*MQQI#$D42*D:*%55& H'0 4 .HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#*UC[\7T-%&L??B^AHH OVG_
M !YP_P"Z*FJ&T_X\X?\ =%34 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 5M1O4TW3+J^D5F2WA>5E7J0H)P/RKGHO%M[)IEG?2Z*
M;2.[G@CA^T7<8WK+_$-N>0,?*<$YK<UFSDU'0[^RA95EN+>2)&?H"RD#/MS7
M,+X%6UT'2;*P\J*XM[NUN+IVE=E<Q?>VYSC/.!P* -]?$^ANEZZZI:E+'_CY
M;S!B/G')^O'UXJ*3QAX=AM;:ZDU>U2&YSY3E\;L'!^G/'-<J_@35Y+?4(DN;
M*V@:XBN+2S5WDA\Q)"Y)W#*!N,JN0#S4WB;PMXH\16H0W=A;B6VDBFMX9I(X
MU=CD,2%S(,<%6P.] '3Z9KG]I:QK%@L 4:>\2K('SYN]-V>G'ZUGV'C:UU&Z
ML;.*SG%[/+-'/;LR[K41<,S\],[<8Z[A4_A[0;G2-4U6YGDB9+L6_EA"<CRX
M@ASD>HXJ"+PGCQ%XCU F&./5;:.!&C!\Q,*0Q/;DD'\* -&V\4Z%>+=-;ZM:
M2+:+NG(D&$7USZ>XXJ,>,/#QT_[?_:]J+7S/)\TO@!\9VGT.!TKD=,\ :S86
M,R+>P1WL=B;.TNOM,LN!E3]QAMC'R]!G!.1TJ73? FJPSI->3VTC'5H+]PT\
MDQVI&5(WN,LV2",T >@PS1W$$<\3!XY%#HP[@C(-/HHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1"CJ5E12"0Q/()/0<#N*L:3J%UJ'BEC,RA4MIE,*HP\HB50 Q)P6(&>W7TH
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MN,<*-&Q*KC+%@VT#D#D]33QKELUA!<QQS.T\ABC@"@2%QG*D$X!&ULY...M
M&G15.'4[:25()'6"Z92WV:5U\P >P)].U-AUG2[B01PZC:R.V0%2923@9]?3
MF@"]15+^V-,-N\XU"U,*-L9Q*NT'TSFI!J%DUU]E%W ;C;N\H2#=C&<X^G-
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M* .6'@J #'VV7_O@4O\ PA4'_/[+_P!\"NHHKE^IT/Y2>5'+?\(5!_S^R_\
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M_*GV?AYCX5_LN^F+SS_-<2X!+-D'GUX 7\*WZ* ,+4/#,5Y);""X:UMH-O\
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M10 ?;[K_ )['\A1]ONO^>Q_(444 'V^Z_P">Q_(4?;[K_GL?R%%% !]ONO\
MGL?R%'V^Z_Y['\A110 ?;[K_ )['\A1]ONO^>Q_(444 'V^Z_P">Q_(4?;[K
M_GL?R%%% !]ONO\ GL?R%'V^Z_Y['\A110 ?;[K_ )['\A1]ONO^>Q_(444
M'V^Z_P">Q_(4?;[K_GL?R%%% !]ONO\ GL?R%'V^Z_Y['\A110 ?;[K_ )['
M\A1]ONO^>Q_(444 'V^Z_P">Q_(4?;[K_GL?R%%% !]ONO\ GL?R%'V^Z_Y[
M'\A110 ?;[K_ )['\A1]ONO^>Q_(444 'V^Z_P">Q_(4?;[K_GL?R%%% !]O
@NO\ GL?R%'V^Z_Y['\A110 QYI)\&5MV.F:*** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>proxy_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" C-!K8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO_T..M?]^;+_ .1Z/['U?_H<=:_[\V7_ ,CULT4 8W]CZO\ ]#CK7_?FR_\
MD>C^Q]7_ .AQUK_OS9?_ "/6S10!C?V/J_\ T..M?]^;+_Y'H_L?5_\ H<=:
M_P"_-E_\CULT4 8W]CZO_P!#CK7_ 'YLO_D>C^Q]7_Z''6O^_-E_\CULT4 8
MW]CZO_T..M?]^;+_ .1Z/['U?_H<=:_[\V7_ ,CULT4 8W]CZO\ ]#CK7_?F
MR_\ D>C^Q]7_ .AQUK_OS9?_ "/6S10!C?V/J_\ T..M?]^;+_Y'H_L?5_\
MH<=:_P"_-E_\CULT4 8W]CZO_P!#CK7_ 'YLO_D>C^Q]7_Z''6O^_-E_\CUL
MT4 8W]CZO_T..M?]^;+_ .1Z/['U?_H<=:_[\V7_ ,CULT4 8W]CZO\ ]#CK
M7_?FR_\ D>C^Q]7_ .AQUK_OS9?_ "/6S10!C?V/J_\ T..M?]^;+_Y'H_L?
M5_\ H<=:_P"_-E_\CULT4 8W]CZO_P!#CK7_ 'YLO_D>C^Q]7_Z''6O^_-E_
M\CULT4 8W]CZO_T..M?]^;+_ .1Z/['U?_H<=:_[\V7_ ,CULT4 8W]CZO\
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M'6O^_-E_\CULT4 8W]CZO_T..M?]^;+_ .1Z/['U?_H<=:_[\V7_ ,CULT4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#.\$_\ (OS?]A34?_2R:NBKG?!/_(OS?]A34?\
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M HHHH **** "H(+I+B:YB0,&MY1$^>A)17X]L./UJ>LW3/\ D(:S_P!?B_\
MHB&@#2HHHH @N[I+.%99 Q5I8XAMZY=P@_#+"IZS=<_Y!\7_ %^6O_H^.M*@
M J"[NDLX5ED#%6ECB&WKEW"#\,L*GK-US_D'Q?\ 7Y:_^CXZ -*BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH SO!/_(OS?\
M84U'_P!+)JZ*N=\$_P#(OS?]A34?_2R:NBH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_H^.M*LW7/\ D'Q?]?EK_P"CXZ -*BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH SO!/_ "+\W_84U'_TLFKHJYWP3_R+\W_8
M4U'_ -+)JZ*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y#P1_
MR(/AS_L%VW_HI:Z^N0\$?\B#X<_[!=M_Z*6@#>HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ K-\._\BSI7_7G#_P"@"M*LWP[_ ,BSI7_7
MG#_Z * -*BBB@ HHHH **** "BBB@ K-@_Y&:^_Z\[;_ -#FK2K-@_Y&:^_Z
M\[;_ -#FH TJ*** "BBB@ HHHH **** "BBB@ HHHH S8/\ D9K[_KSMO_0Y
MJTJS8/\ D9K[_KSMO_0YJTJ "BBB@ HHHH **** "BBB@ HHHH *S=,_Y"&L
M_P#7XO\ Z(AK2K-TS_D(:S_U^+_Z(AH TJ*** ,W7/\ D'Q?]?EK_P"CXZTJ
MS=<_Y!\7_7Y:_P#H^.M*@ K-US_D'Q?]?EK_ .CXZTJS=<_Y!\7_ %^6O_H^
M.@#2HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* ,[P3_R+\W_ &%-1_\ 2R:NBKG?!/\ R+\W_84U'_TLFKHJ "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **IZIJEIHVGO?7SND",B$QQ/*Q9V"* J L268# '
M>LG_ (3;2/\ GAK7_@CO?_C5 '145SO_  FVD?\ /#6O_!'>_P#QJC_A-M(_
MYX:U_P"".]_^-4 =%17._P#";:1_SPUK_P $=[_\:H_X3;2/^>&M?^".]_\
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M4 %%%% !1110 5F^'?\ D6=*_P"O.'_T 5I5%;V\5I;16T"[(HD$:+DG"@8
MR?:@"6BBB@ HHHH **** "BBB@ K-@_Y&:^_Z\[;_P!#FK2J);>);F2Y"XED
M18V;)Y52Q Q]6;\Z ):*** "BBB@ HHHH **** "BBB@ HHHH S8/^1FOO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** ,'QO_R(/B/_ +!=S_Z*:NOKD/&__(@^(_\ L%W/_HIJZ^@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *Y#P1_R(/AS_L%VW_HI:Z^N0\$?
M\B#X<_[!=M_Z*6@#>HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M#.\$_P#(OS?]A34?_2R:H1_R4/5O^P58_P#HV[J;P3_R+\W_ &%-1_\ 2R:H
M1_R4/5O^P58_^C;N@#7HHHH **** "BBB@ HHHH **** "BBB@ HHHH R#_R
M4/2?^P5??^C;2NHKES_R4/2?^P5??^C;2NHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH YWQM_R+\/\ V%-._P#2R&M&L[QM_P B_#_V
M%-._]+(:T: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH P?&_\ R(/B/_L%W/\ Z*:NOKD/
M&_\ R(/B/_L%W/\ Z*:NOH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"N0\$?\ (@^'/^P7;?\ HI:Z^N3L?!4^FZ?;6-IXMUR.VMHEAB3R[,[44  9
M-OD\ =: -NBLS_A%K_\ Z'#7/^_5E_\ (]'_  BU_P#]#AKG_?JR_P#D>@#3
MHK,_X1:__P"APUS_ +]67_R/1_PBU_\ ]#AKG_?JR_\ D>@#3HK,_P"$6O\
M_H<-<_[]67_R/1_PBU__ -#AKG_?JR_^1Z -.BLS_A%K_P#Z'#7/^_5E_P#(
M]'_"+7__ $.&N?\ ?JR_^1Z -.BLS_A%K_\ Z'#7/^_5E_\ (]'_  BU_P#]
M#AKG_?JR_P#D>@#3HK,_X1:__P"APUS_ +]67_R/1_PBU_\ ]#AKG_?JR_\
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MKG_?JR_^1Z -.BLS_A%K_P#Z'#7/^_5E_P#(]'_"+7__ $.&N?\ ?JR_^1Z
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M.BLS_A%K_P#Z'#7/^_5E_P#(]'_"+7__ $.&N?\ ?JR_^1Z -.BLS_A%K_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&O7/_!C-_P#%4 >A:U^S[JNBZ%J&JR:Y9R)96TERR+$P+!%+$#ZXKO?V<?\
MDGFH?]A63_T5%5CPW?WFI_LU7EY?W<]W=2:5J.^:>0R.V#,!ECR<  ?A5?\
M9Q_Y)YJ'_85D_P#145 'L%%%% !1110 5RX_Y*'JW_8*L?\ T;=UU%<N/^2A
MZM_V"K'_ -&W= &O1110 451N)=46=A;6=G)%QM:2[9&/'<",XY]ZC\_6_\
MH'Z?_P"!S_\ QF@#2HK-\_6_^@?I_P#X'/\ _&://UO_ *!^G_\ @<__ ,9H
M TJ*S?/UO_H'Z?\ ^!S_ /QFCS];_P"@?I__ ('/_P#&: -*BL^.;6#*@EL;
M%8RPW,MX[$#N0/*&3[9%:% !1110 4444 9!_P"2AZ3_ -@J^_\ 1MI745RY
M_P"2AZ3_ -@J^_\ 1MI744 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 <[XV_Y%^'_L*:=_Z60UHUG>-O^1?A_P"PIIW_ *60UHT %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!@^-_^1!\1_P#8+N?_ $4U=?7(>-_^1!\1_P#8+N?_
M $4U=?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\?R
M:+:^(_COJ&CWK2K;7>N74<AB(# >8YX)!]/2OL"OE'1/^3E)?^P_=?\ HQZ
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MEI&O?8_L?VK5;']QYOF;=K1I][ SG;GIWKK_ -I3_D8=#_Z]'_\ 0Z /</\
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M_1MW745RX_Y*'JW_ &"K'_T;=T :]%%% !1110 4444 %%%% !1110 4444
M%%%% &0?^2AZ3_V"K[_T;:5U%<N?^2AZ3_V"K[_T;:5U% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% '.^-O^1?A_["FG?^ED-:-9WC;_
M )%^'_L*:=_Z60UHT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!@^-_P#D0?$?_8+N?_13
M5U]<AXW_ .1!\1_]@NY_]%-77T %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %?*.B?\G*2_\ 8?NO_1CU]75\HZ)_R<I+_P!A^Z_]&/0!
M]74444 %%%% !1110!Y/^T/_ ,DVB_["$7_H+UJ_ _\ Y)'HW^]/_P"CGK*_
M:'_Y)M%_V$(O_07K5^!__)(]&_WI_P#T<] 'H=%%% !1110 4444 %%%% 'F
M7Q=\?7GA.TMM/TIA'?WBLQF(!\I!QD ]R?Y5XMIWAOQCXZ\R]MK>\U,(Q5IY
MYQC/<!I&&3TX%>I_'3PK?:E;V6NV4+3):(T5PB#+*I.0V/0<Y^M>6^$OB#KW
M@TM'ITT<EH[;WMIUW(3ZC&"#QV-13LV^;<N=TERFDFB_$OP81+;V^KVR1XXM
MW\Z(=^0I92.>_%?2FEW;2Z!97EU(-SVJ2RR-@#)4$D]A7G_A7XV:+K<T5GJL
M+:7=.0H=FW0L?][@K^(Q[U?^,FJ2Z;\.[E8'*M=RI;EA_=.21^(!'XU<Y.,"
M(I2F>>^.OC1J%[=RV'AF7[+9(2INP/WDONN?NC]?ITKD;3P;XY\6QK>K8:A>
M(V66:[F"[L]2#(PSGVK2^#WAVS\0>-0;Z-98+.$W'E,,AV! 7([C)S^%?3P
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M%6/_ *-NZ ->BBB@ HHHH **** "BBB@ HHHH **** "BBB@#(/_ "4/2?\
ML%7W_HVTKJ*Y<_\ )0])_P"P5??^C;2NHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH YWQM_R+\/_84T[_TLAK1K.\;?\B_#_P!A33O_
M $LAK1H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#!\;_\B#XC_P"P7<_^BFKKZY#QO_R(
M/B/_ +!=S_Z*:NOH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4LP9@,1W,?RRI]&[CV.1[5T-% CY[O\ P7XV^&%Y)J?AV[DO-/SF0Q+GY?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.,A,'=SQUS7K_C7P5IOCS1H=+U2>[A@BN%N%:U=58L%9<'<K#&'/;TKPR_\
MC7XD\':C<^%].LM*EL=&E?3[>2XBD:1HX28U+D2 %B%&2 !GL* /<_$O@+PS
MXON(+C7=-^URP(4C;SY(]H)R1\C#-<'^T=_R3S3_ /L*Q_\ HJ6MKX1>/M5\
M?:5J5UJMO9PO;3K&@M49005SSN9JZ+QKX*TWQYHT.EZI/=PP17"W"M:NJL6"
MLN#N5AC#GMZ4 >>_"+0_A]'8:!J5O-IY\5F!B47429MY5@W[K?C[A/&W@<UU
M7C70/AOJNLPS^,)M-34%MU2,76I&W;RMS$84.N1N+<X]?2OG*\N7^%WQ6NI-
M$"W!TJ>2.#[;\^X,A4[MNW/#'ICM6;XU\:ZEX\UF'5-4@M(9XK=;=5M495*A
MF;)W,QSESW]* /JOP+HW@;2/M_\ PA<MC)YOE_:_LE^;G&-VS.7;;U?TSSZ5
MY)XE\6?&6V\5:O!I=MK)T^.]F2U,>BJZF(.0F&\H[AMQSDYKSOP+\1]8^'_V
M_P#LFVL9OMWE^9]K1VQLW8QM9?[YZY[5]=^&M2FUGPKI&J7"QK/>V4-Q(L8(
M4,Z!B!DDXR?4T >3Q^ (/%7PRO?$WB;0[N?QK-97+LSB6&5I4#K#^Y4JN=J1
M@#;SQUSSL? +2=2T;P+?6^J:?=V,[:G(ZQW4+1,5\J(9 8 XR",^QK/U_P"+
M.O:5\98O!\%IIK:>][:6YD>-S+ME$98Y#@9^<XX].M>R4 %%%% !1110 5RX
M_P"2AZM_V"K'_P!&W==17+C_ )*'JW_8*L?_ $;=T :]%%% !1110 4444 %
M%%% !1110 4444 %%%% &0?^2AZ3_P!@J^_]&VE=17+G_DH>D_\ 8*OO_1MI
M744 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <[XV_P"1
M?A_["FG?^ED-:-9WC;_D7X?^PIIW_I9#6C0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN]?U%+V\NAYP*(@6-".%&P 'CG/O56+X7^"H;.6U7P_;F.3[Q=G9Q]'+%E_
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M24^EOG;\A+W6W'K^I'I^FS:/\.8M.N"#-;::8WQ_>"'-<5\ ?^11U'_K^/\
MZ M>K30QW$$D,J[HY%*,,XR",&LS0/#.D>%[.2TT:T^S02/YCKYCOEL 9RQ)
MZ 55_>E)]5^MQ6]U171_H>2_'*&"Y\4>&8+J7RK>3<DLFX+M4NH)R>!@>M:G
MAWP/\.=)\0V-]IOBU;B]AE!AA;4K=P['@#"J">O05WWB'P7X?\52P2ZUI_VI
MX%*QGSI$V@]?NL,]*S++X6>"]/OH+RUT;R[B"19(W^U3':P.0<%\'FE3]W?N
MQSU^X[&BBB@#PFT_Y.?;_KK)_P"DIKVW4-1L]*LI+R_NHK:VC&6DE8*!_P#7
M]J^<O%GB";PM\;M2UFW@CFFMW.Q)"0I+0;,G'8;LX]NU:5AX,\;?$^]CU+Q%
M=RV>G]8S*N.#_P \XN,?[QQGU- S8\4?&JYOKG^RO!EI)+-(=BW31%G<_P#3
M./\ J?RJ#PY\&]4UV[_MCQK?3!Y3O:W$FZ9_]]^0H]AD_2O4O"_@G0O"%OLT
MNT F88DN9?FE?ZMV'L,#VKH: *6E:/IVAV*66F6<5K;IT2-<9]R>I/N>:NT4
M4""BBB@ HHHH Q_%/B2S\(^'+O7+^.>2UM=F](%!<[G5!@$@=6'>O-_^&CO!
M_P#T#=<_[\0__':Z#XV_\DAUW_MW_P#2B.N'^!6@^';_ .'FI:AK6C:;>-!J
M$N9KJT25EC6*)L D$X&2<#U- &Q_PT=X/_Z!NN?]^(?_ ([1_P -'>#_ /H&
MZY_WXA_^.T?\)E\#/^?70_\ P1-_\9K4T#4/A#XHU1=-T;2]#N;QD+B/^QMG
M ZG+1@?K0!7TGX^^%=9UFQTNWT_65GO;B.WC:2&(*&=@H)Q(3C)]#4/Q=^%^
MM^/M5TVZTJZT^%+:!HW%U(ZDDMGC:C5YEXDL+/3/VE;.SL+2"TM8]5T[9#!&
M(T7(A)PHX&22?QKTWXNZ'\0=6U739/!LVH);I PG%KJ(M@7W<9!=<\=Z ,'Q
M)XDL_COIT?A?PO'/9WUK*-0>34U$<9C4&,@&,N=V95XQC //KTGQ(TV;1OV=
MY=+N&C:>RLK&WD:,DJ622%21D XR/05\P:;JVI:-<-<:7J%W8SLA1I+69HF*
MY!P2I!QD X]A7::UH_Q.?P6=9UF\U6?P]-%%,S3ZJ)4='*F,F/S"3R5/(X]L
M4 >G_LU_\B]KG_7VG_H%=IX*^+.@^/-9FTO2[34H9XK=KAFNHT52H95P-KL<
MY<=O6N+_ &:_^1>US_K[3_T"O)-2\(^//AS;KK%Q'=Z,DSBU%Q:WR!F)!;8?
M+<G'R9].![4 =WHW_)U\G_7W<_\ I,]>P:_\1]'\.>,M+\+WEM?/?:EY7DR0
MHAC7S)#&NXE@1R#G /%?,WPX\36^E_%'3O$'B'4)?*0S-<74V^5R6A=03@%C
MR0*]YNOB?\)+[48-1O+NQN+Z#;Y-S-I4KR1[3N7:QBR,$DC'0T <?^TU_P R
MM_V]_P#M&J@U*'XO>!=$\!^'UDMM4TBW@N)YK\!(&6*+R6"E"S$EI%(RHX!Z
M=*R_CIXV\.^,?[!_L#4/MGV7[1YW[F2/;N\O;]]1G.UNGI7I_P )=9\#7FG:
M;8Z'%8KXAATJ+[<T-@8I#@()-TFP;OG(SR<GGGK0!8MO#=YX1^ .J:'?R027
M5KI5_O>!B4.X2N,$@'HP[5C_ +./_)/-0_["LG_HJ*NTU3Q[X/A\0-X2U*_C
M;4)W2U>RDM9'5S*!M0G84(8..IQSS70:;I.FZ-;M;Z7I]I8P,Y=H[6%8E+8
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#!\;_ /(@^(_^P7<_^BFKKZY#QO\ \B#XC_[!=S_Z*:NOH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^*/%M]=:;\4/$%[97$EO<
MPZO=-'+&V&4^:W(-?:]?$OQ#MIK7XC^)(YXV1SJ4\@##^%G+*?Q4@_C0!)_P
MLGQK_P!#1JG_ ($-1_PLGQK_ -#1JG_@0U<M10!Z!X:\2?$CQ;K<.DZ3XBU.
M2YD!8EKI@J*.K,>P'^>:[;Q3X7^+GAC1)=6/B^XOH+=-\ZVUU)OC4=6PP&0.
M_?VKA/A-XVM/ WC WVH1.UE<P&VF=!EHP65@P'?E1D>AKV?QO\:_"2>%+ZWT
M>]_M&^NX'ACC2%U5-P(W,6 X&>G4_K0!X-_PLGQK_P!#1JG_ ($-1_PLGQK_
M -#1JG_@0U<M10!MZMXP\1Z[9BTU76KV\MPX<13REEW#.#@]^37U#\#_ /DD
M>C?[T_\ Z.>OD.OK_P""<4D/PET42(R%O.8!AC(,SD'Z$<T >@4444 %%%%
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MWR]CP*Q_AQ\8/^%@>(;C2?["^P>3:-<^;]K\W.'1=N-B_P!_.<]JY_7? O\
MPK?Q#J?Q3_M'^T?(NY;G^S?(\G=]H<Q[?-W-C;YN<[>=O;/  W4[#Q#\'9$T
M_P  Z+>:W:WX\^YDNK62Y,;K\H ,(0#CL<UZ%\1] \-^(_#UO9^*-7_LNQ2[
M65)OM,<&Z0(X"[I 0>"QQUX]JK_#7XA_\+#TZ^N_[+_L_P"RRK'M^T>;NR,Y
MSM7%>$?$?XP?\+ \/6^D_P!A?8/)NUN?-^U^;G".NW&Q?[^<Y[4 <?KF@PKX
MTO=%\,&?5H$E9;4P8G>90,DCRQAN 3P.U>@>%?@U_:GP\UO5]7LM<L];M?/^
MQV7E>7YVV)63Y&0LV7)'!YQ@<US_ ,$O^2O:%_V\?^D\E?5^NZG_ &)X>U/5
MO)\[[#:2W/E;MN_8A;;G!QG&,X- 'Q!J>A:QHGE?VMI5]8>=GR_M=N\6_&,X
MW 9QD=/45V'@)O'G@[43KFA^$[Z\^U6GE*\VG3R1M&Q5PRE,9SM&#G&#1\3?
MB;_PL;^R_P#B4?V?]@\W_EY\W?OV?["XQL]^M?3_ ($_Y)YX:_[!5K_Z*6@#
MY<?7-2U#XTZ;K/B>UCTJ\_M.R>ZCDC:!854Q@$B0Y4;5#9)[YZ5];Z;JVFZS
M;M<:7J%I?0*Y1I+6995#8!P2I(S@@X]Q7E?C;X%_\)CXOOM?_P"$C^Q_:O+_
M ''V'S-NV-4^]Y@SG;GIWKL/AQX%_P"%?^'KC2?[1^W^==M<^;Y'E8RB+MQN
M;^YG.>] '84444 %%%% !7+C_DH>K?\ 8*L?_1MW745RX_Y*'JW_ &"K'_T;
M=T :]%%% !1110 4444 %%%% !1110 4444 %%%% &0?^2AZ3_V"K[_T;:5U
M%<N?^2AZ3_V"K[_T;:5U% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&6CY.U<#)]*ZGXN_"_6_'VJZ;=:5=:?"EM T;BZD=226SQM1J]:HH&?-FF_
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M67^?J>1VOQ(U>Q\6^)M6N;^Y;2+RWO$TR-YV,0DBP%* \#/L.]>P_#>"_@\
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M;$VLH^QB/SV.[Y^&POWN@!Z=:B"L]>[?WQM^9I.[O;M;Y\R?Y?D>;1^-]?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8/C?_D0?$?\
MV"[G_P!%-77UR'C?_D0?$?\ V"[G_P!%-77T %%%% !1110 4444 %%%% !1
M110 4444 %%%% !6-X9U_P#X2+3[B[^S?9_)O)K7;YF_/EN5W9P.N,X[5LUP
M/A75=,\*6VI:5K>HVUC=_P!IW,L<=PXC,R.^]3&#]_(8?=SSQUI)ZN_;]?\
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MC;R>,T#_ )*'JW_8*L?_ $;=US&@6UY:7'P^@ODDCF6*\_=R@AD39E%.>X7
MKIQ_R4/5O^P58_\ HV[JEM\W^A*=W]WZFO11104%%%% !1110 4444 %%%%
M!1110 4444 9!_Y*'I/_ &"K[_T;:5U%<N?^2AZ3_P!@J^_]&VE=10 4444
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M<=O$<_N5?:Y922N3VPW/WJZWP[J;ZSX;TS4Y$"/=VT<S*.@+*":%JK^GX_\
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M.R_K;_,FHKS/3]<\0V?@C1/%>H:T]XUP;=;FS%M$L;)*ZIE=J[PXW9^]M/\
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MMM DO(AY:MMF#X#<@YX['CVK2I:$G'U_ FFW.*?>WXG?5RX_Y*'JW_8*L?\
MT;=U2AU'5]-UCPW]JU62]AUD,DL+PQHL3B(N#'M4,!P00S-UJZ/^2AZM_P!@
MJQ_]&W=#5OQ_ (R4MO)_>:]%%%(H**** "BBB@ HHHH **** "BBB@ HHHH
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ML]=,LYD'$H'^L=?506Z^QKUJ32--ELHK*33K1[2( 1P-"I1 .@"XP*L+!"D
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M;##K:H[C_:8;F_4FNBI%4*H50 H&  . *6KD[MLF*LK!1114C"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH P?&__(@^(_\ L%W/_HIJZ^N0
M\;_\B#XC_P"P7<_^BFKKZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKE7L]>G_  '_ )%/PEX(>S\-:';:Q=7SFRCCD.FR2QM#',O.<JNYL'D L5!
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ME_P"KJ7AQ+_4AJ-MJ5]IMX8A!)+9F/,D8)(5A(C#@DX( (SUIC>$].&E65C
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M B,[HSC<&'7 XY.+\/BZ*WANUAL9Y;R36)-/M[=KLOYL@&2VY_\ 5H "2!D
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M":KZWK=UIUQ%;VEC%*[H7,]Y<&VMTY "F38WS'/"@'H>E$DMG_5]P7E_5O\
MAS1TVPBTK2[33X&=HK:%84+D%B%&!G '/%96M>$;#79[V6ZFN4:[L&T^01,H
M C+;B1E3\V?P]JR3\0EDTC3[RUTT7,MUJ?\ 9C1172E5D&[YE?&&7@>G!]1B
MK9\9?8#J\6N626ESIEJMVZVTYG22-MP&UBB'=E2,8ZXYHD^9W?\ 6W^:^\(V
M227]:_YHU)_#UI<3Z/,\DP;26+0 ,,,3&4^;CG@]L<UFC_DH>K?]@JQ_]&W=
M9USJVO2>+O#$=Y8_V?;7$DY*P7IE60>42%D&U<,.N!N''6M$?\E#U;_L%6/_
M *-NZK5J_F_^"*-MEV7_  #7HHHI%!1110 4444 %%%% !1110 4444 %%%%
M &0?^2AZ3_V"K[_T;:5U%<N?^2AZ3_V"K[_T;:5U% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% '.^-O^1?A_["FG?^ED-:-9WC;_ )%^
M'_L*:=_Z60UHT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!@^-_P#D0?$?_8+N?_135U]<
MAXW_ .1!\1_]@NY_]%-77T %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7$?\(=J'_"O;OP_YUK]KFNI)E?<VP*TYD&3MSG'MUKMF944LQ"J!DDG  K
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M@U*WM6DM%66-Y")+C;+A<<JF/F'/)R,<=<TE[MOZ\PT:=OZZ'/\ ]D>(M/\
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M*OO_ $;:5U% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'.^-O^1?A_["FG?^ED-:-9WC;_D7X?\ L*:=_P"ED-:- !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@]JB\6R0ZC9^-]3TIHY=(FTR"-KB'F*>X#G)5APY"E06&>PSQ7L-%%OZ_P#
M?_D?ZL"5G?\ K=O]3A]>LK:3Q/X'C:&/8DTKJNT8RL!QQ[8'Y5A7MM -'^*C
MB",.9'RVP9/^C(?YDFO5:*&KW\[_ (M/] @N5KRM^%_\S-TJ]MS9V-HUS$;M
MK1)?),@\PK@#=MZXSWK2HHJI.[;%&/+%+L%%%%(H**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M ,'^P-2_Z&_6O^_5G_\ (]']@:E_T-^M?]^K/_Y'K>HH P?[ U+_ *&_6O\
MOU9__(]']@:E_P!#?K7_ 'ZL_P#Y'K>HH P?[ U+_H;]:_[]6?\ \CT?V!J7
M_0WZU_WZL_\ Y'K>HH P?[ U+_H;]:_[]6?_ ,CT?V!J7_0WZU_WZL__ )'K
M>HH P?[ U+_H;]:_[]6?_P CT?V!J7_0WZU_WZL__D>MZB@#!_L#4O\ H;]:
M_P"_5G_\CT?V!J7_ $-^M?\ ?JS_ /D>MZB@#!_L#4O^AOUK_OU9_P#R/1_8
M&I?]#?K7_?JS_P#D>MZB@#!_L#4O^AOUK_OU9_\ R/1_8&I?]#?K7_?JS_\
MD>MZB@#!_L#4O^AOUK_OU9__ "/1_8&I?]#?K7_?JS_^1ZWJ* ,'^P-2_P"A
MOUK_ +]6?_R/1_8&I?\ 0WZU_P!^K/\ ^1ZWJ* ,'^P-2_Z&_6O^_5G_ /(]
M']@:E_T-^M?]^K/_ .1ZWJ* ,'^P-2_Z&_6O^_5G_P#(]']@:E_T-^M?]^K/
M_P"1ZWJ* ,'^P-2_Z&_6O^_5G_\ (]']@:E_T-^M?]^K/_Y'K>HH P?[ U+_
M *&_6O\ OU9__(]']@:E_P!#?K7_ 'ZL_P#Y'K>HH P?[ U+_H;]:_[]6?\
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M-0MGM=-O[GS+2%AAI<%L8]R6 SZYKD_#DVL^"O$>G_$/6M.ACTO7II%F6.,
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MLTE<R2+;PK&'8]6.T#)]ZKQ^&]"BU$ZC'HNG)?$Y-RMJ@E)]=V,_K7#'Q=!
M/"FJS3W%AILB7K3Q274DV[:, ,3RYST!SUP*Z:;Q3=6]A8-/I!BU+4IC%96+
M7 R1@MF1MN$PHR0-V.G)H3OK\OZ_K8+K9_UN=-6%+X)\*3S/-+X8T625V+.[
MV$19B>22=O)I^D:[+>ZE=Z5?VB6>I6J)*\<<WFQO&^0&1]JDC*D'*@@CT(-9
M.O:GK-O\0O#=A9K";&XBN'F1[ADW[0N20$.=H.0,\D\XP#3ZKS_X/^0[Z/R_
MX'^9T\FG64U@UA+9V[V3+L-NT2F,KZ;<8Q[5D?\ "">#_P#H5-#_ /!=#_\
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M[!UY7ZBLE?%NIW.J:MI^FZ'%/_9:Q-))/?>6'5X]^%PC'=VP>#_>'2E=*_\
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MW.!@8)QDXI_U^-@NOZ_KR.NHKAYO%\M[8:_ISK:P:C:Z:]TLFGW_ -H0*58
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MYB1TQ5WNU+U_-_K?_@DV5N7^MO\ (H>+=(N->\)ZGI5J\23W4!C1I20H)]2
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MM=]/PL86K^$M6\06FMW5[]@M]2O=-;3[:**9Y(HE))):0HI))(Z+P!WK3O\
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M4_Y&Y_\ L7[#^<E=U4,UY:VTT$,]S#%+<,4A1W"F1@,X4'J< G HBK/^O/\
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M$?AZR\3Z-)IE^9EA=E;?"^QU(.<@]O3Z$T7WA^ROCI6\R1KIDPF@2,@ D(4
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M%9WC+_D;?!/_ &$I/_1#UT>D:-;Z-#,L3RS37$GFW%Q.P,DSX W,0 .@ P
M .!3=3T*UU74=+O9Y)EETV=IX0A #,4*X;(.1ACTQ5_:B^UOU%;W6N]S@HM>
M\1'P=J_B5];D+Z;>W*I:BVB$<L4<I&USMW$[> 5*]LYJP]S)IGQ"\3:VUY=/
M#;:)!<FVQ&%8#S2%SMW8&,CG.2<DC '3+X,TY?#.HZ )KK[+?RS2RON7>#(Q
M9MIVXQD\9!_&K+>&K1M;.J+/.K26HM;B ;#'<1C=M#@J3QN/W2.O.:BSMIO;
M_P!M2?X_YCZZ[7_]NO\ D<?IGBG5W&D7@FUF_EO)(A=V3:%+%;PHXY:.0Q+@
M*2#EG8$ XQFHI-;\0MX7\7:V-=F1]+N+R&V@6WAV )]PME"21VY^H-=7:^#;
M2WDM%DU#4;FRLG5[6RGD0Q0LOW3D*';';>S8X]!3CX.T\Z%K.D>==?9]6EFE
MG;<N]3+][:=N /3(/XTY:WM\OO7Z7[A&Z:OY7_'_ ('];Y4>I:OI>K>'6N]5
MDOH=85DFA>"-%B81&0&/:H8#@@AF;K6#;>-M6O\ 2/[=M9=9EN'D+1:5#H<K
MVSQ!\;?-$1)<J/O"3;GM7?3^'K2XGT>9Y)@VDL6@ 888F,I\W'/![8YJ@W@F
MR8/;_;M0&EO*97TP2)Y#,6W'^'>%)_A#;?:J^U?I?\+_ .6G]74)/EL^R^^W
M^>O]6>;H%M-_PL[Q+<&_NBA@M3]G=8POS*V <)N^7MSW.<\5V]9(T&*/7I]7
MM[NY@EN(5BFBCV&-]H(5CE201N/0@>H-:-M$\%M'%)<27#HH#32A0SGU.T 9
M^@ I+X4NW^;*2=W?^M$<C\3_ /D4HO\ L(V?_H]*T?%6K7EC+I&G6$@AN=4O
M!;BX:/?Y*A&=B >"V%P,\9.<'&*OZ]H=KXATY;&[DF2)9XYP8B =R.&'4'C(
MYI^L:-:ZU:QPW)E1H95FAFA?;)%(.C*?7DCG(()!!%);?._RLAO>Z[6^=V8^
ME7VH6/B^;P]>WTFH1&R%Y#<S1HDH^<JRML55/8@@#OUZU>\3S:I!I:-I22EV
MG19G@17ECB)^9D5N&8>A!^AZ5)I>@0Z;>37\MU=7^H3(L;W=T4W[ 20H"*JJ
M,DGA1GOFK6I:?_:-J(1>7=HZL'2:UDV.I'U!##V8$'TH=[+O_P '_(%N_P"N
MG^9Q%SXFN+?P1XANK'7[FZO[*#S$%]8+!=6Q(Z2(44'D'!V <=^M7H-0UG7]
M0UI;/57TZ+2MD,:)!&XFE,0<M)N!.WY@ %*G@\\\:$O@JRNM/U2WOKZ^NY]3
MA$%Q>2F,2[%SM5=J! !D_P /?FLS6-)U!-5NSI^F:JJ7,:QO+I]Y;K'< +M!
MF$F'0CINCR2!UZ"IG>SMO;3UL"3NNW_!_K^F9.C>(/$.M2^#[1]8>W.IZ5/<
M7<L5O$79U*89<J0IY/8CVKJ_"6IWEX-7LKZX-S-IM\UJ+AD56E7:K L% &<-
M@X ''2H/#_@JWTB'P_++/*]YI-BUHNPCRVW[2Q((SU7CD5LZ9HMMI5SJ,\#R
MLVH7/VF4.00K;57"X XPHZYK65N9V\_ST_"Y"3LGZ?D[_H9>KZK>VOCGPYIT
M,VVTO$N3/'M4[RBJ5Y(R,$GH:Y?6/%.OQ+XF2SOTCEM-9L[2U9X498TD\O<"
M,<@[CUYYX(KM]9T&'6)+2?[5=6=W9N7@NK4KO3(PPPZLI!'4$&N6\0^ B=$O
MH-,DO;NYU'4K6ZN6FG4, CH&93\N/E7./R'05$=U?O\ G*/Z7+E>SM_5E+];
M&I;7NI:1XQLM%O-2EU*#4+:69'FAC1H7C*Y \M5!0AN^2".IS3/B?"\WPYUK
M9<RP;;<L?+"G>/[IW \'VP?>M;3O#T5EJ3:C/?7FH7OEF&.:[*$Q1DY*J$50
M,D#)P2<#).*LZWI%OKVBW>E73RI!=1F-VB(# 'T)!'Z4-727];W_ "''1W_K
M8YBWGU2]UT>&[?6KJVCL=/BN)KP00M/,\A8*.4\L* ISA,G(Z8YRIO%&NW+:
M3IZ7XMKDZ[+I=U<PP*?-149@P5P0I^Z>.,CTXKL;_P -PW=Y%?6U]>:??1P^
M1]IM2FYX\YVLKJRGGD$KD9.",U O@S2XQI8C:X0Z?>->JWF M-,P8,TA().=
MQ/&.W;BGNTW_ %J_TLK?\.9V:C9=OT7ZZ_U8V[2&6WM(X9KF2ZD1<--*JAG]
MR% 7/T KS8^,M4U"/5;^UN=6BFM+F:&SL+;19;BWF$9*_O)5B;)8@_===N1D
M'!SZ?7.7/@VTGDNUBU#4+6RO7:2[L8)$$4S-]X\J77/?8RYYSU-)WN::6.<U
MOQ#-I&L7VO"S<3Q>'$F%M(""',IPK#KP3SWJQIGB#5$UC2XUGUK4XKMREXMU
MHDMLEM\I(=',2 *"-N&+'D'/'/2W'AC3+J[FFFB+QS6/]GO;G'E^5DG&,9SS
MCK4-GX5AM[VVN;K4M0U#['G[)'=NA6 D8R-J*6.#C+EC[T1T?]=Y?YK_ #[Q
M9V_K>RU_!_Y=L?P_>>(_$.GP^(+;4XTCENW4:=)$JPB!9"I^8*9/,VC.=VW/
M&.]<VUUJOA_P_P"--1L=7N/M*ZT(X_-BA95):(%L!!DD-CKC XP>:[5O!&G-
M(8S<WG]FFX^U'3-R?9S+NW[ON[\;N=N[;GM1?>"+"_BU2![R^2VU*9+B6"-H
MPJR*5.Y24+9.P9!)'7 %)+;^NL;_ )/[_DFT_P"O^WK?FBG-+K'_  D5KX:C
MUVZ!DMI+Z:^,$/FA0RJL:#9LQDDY*DXP/>L;4O%6O6EO=:='?)]MLM;M;'[8
M;=3YL4H5OF3INPV#MQTR,9KM=5T"'4[BWNTNKFROK966&[M2N]5;&Y<.K*0<
M#@@]*HOX)TR2R2W>6Z:3[='J$MP9 99YD((+DC&. ,   # Q36ZO_6J_33^K
M@T[.W]:/];&5=ZKJ^BZGK>FOJDMZ(]'?4+:>>*(21."RE?D55*_=(R">N2:9
M9:SJ^OZIIVCPZG)8$:/#J%S<PPQM)*[G  WJR@<$GY<\C&*Z._\ #5GJ.H7-
M[-+.LEQ8-8.$8 "-B22,C[W/T]J@E\)6Q6Q:SO[ZQNK.V%HEU;LAD:(8^5@Z
M,AZ9^[D'IBDK]?Z^+_-?TM6T[Z?U\/\ D_Z9J:4NHKID*ZL]N]\H(E>WSL;G
M@@'D9&"1V-<Z;O4]>\2:U86FJ2Z=;Z5Y4>(H(V,TCIO)8N#\F"!A=IZ\UT&D
M:39Z'IL=A91E84)8ECEG8G+,Q[DDDDU3O_#<5YJ+WUOJ%]I\\R+'<&T= )T&
M<!@RM@C)&Y<-[T35_P ?R_K^M 6W]?U_7S//M$\076E>&/"&@QS75O\ :;6>
M2XN[*Q:ZE58VQA$"/C)8?,RD #IS5S5-6OM0\-WEO=I?216NJV(M[R\L7M7N
M$::,\HR+\P.02% /' KJX?!6GVNDZ98VEU>VTFF!EM+R-U,R!OO Y4JP/<,I
M' [BG-X-L)-/FMI[F\FEN+F*ZGNI'7S97C967.%V@?*!@ #&<8JT_>N^_P"L
M?R2?_!$T[??^4OSNOZWP+WQ)K%K?^(+K[5NL='U*W$D/EI_Q[-$ID&<9X+;\
MYS\N.G%2ZQXOO["V\2ZQ;,);&P\JSM(O+W![@D!WX^9@"Z+@'^$XYKI8O#=A
M'+K3OYDJZPP-S'(05_U8CPO'3 [YJ'3_  CI6G>%/^$;5)9[ HRN9GS)(6))
M8L,?-DYR,5%G;Y+]+_EIZE?:OY_\-_P?)&#IFO:E'KEE;)<:WJ=M=+(+A[W1
M)+5;9@NY65S$@V9!7:VX\CFLW2M7\2'P%9>+KC7)[GRSYMW:?9H5C>!9"'(V
MINW!<G@\XZ"NPL_"\4%]#>7>I:AJ,MNK);?:W0B ,,':$1<G'&YMS8SSR:+3
M2(O#/A--+L+.ZU**%"BPEX_,D#$YR6*KCD_AZFFVU=K^M=ONT_X:Y*5[)[?\
M#_/7^K#-+U2YU7Q3J0AF!TFSABB4!1^\G8;V.<9P$*#K_$:Z"N6\/>'KGPWX
M#&FV[O\ V@(7<M$X9A,P) 5I 0<<*"PQ@"NCM%G2S@6Z<27"QJ)7 P&;')_.
MJ:MHN@1ON_Z_K<XZ";7]9\6^)+*+7I+&ST^2$6Z0VT3-N:(,0Q=3E<GIP?\
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M,JXW1R3JK#(SR"?2H_\ A(M$_P"@QI__ ($I_C0!I45F_P#"1:)_T&-/_P#
ME/\ &C_A(M$_Z#&G_P#@2G^- &E16;_PD6B?]!C3_P#P)3_&C_A(M$_Z#&G_
M /@2G^- &E16?'KNCS2I%%JMB\CL%5%N$)8GH ,\FM"@ HHHH **** ,@_\
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ML"I'X5O Y&1TH) &2<"A@8N@>&++P^]W/%-<W5[>,&N;N[DWRRD# R0  !V
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ9X[ $E02,'TI]%Z+\A]7ZLXN[^(2V>BVM[+I;^?)J+V,]NLN?(V,P>0G;R
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MBEN7U2VMGE(R3$6.4/L<UV6@>&++P^]W/%-<W5[>,&N;N[DWRRD# R0  !V
M %3Z_H-EXDTE].OO,$;,KK)$^QXW4Y5E/8@TWNGVL"TOYW':/H.E>'[5[;2;
M&*SA=][)$, M@#/Y 5Q<.G6OC'XA>(K;7HOM5GI0@BM;.1CY8WIN:0KG!)/
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M5+5V_K>*_7\/F)RM&_\ 6TG_ .V_B>MR>*?#T5DE[)KVEI:2.42=KR,(S#J
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ML<,RMN!Z=!C%=-<ZE8V<T<-U>VT$LBLZ)+*JLRKRQ )Y [^E<C\(/^27Z/\
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M''/M3CJVOZ[_ / "6BO_ %V_X)ZE1112 **** "BBB@ HHHH **** "BBB@
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M55MVMOSTOH*^RZZ_*VAJ45X18:G\5_%6K^(FT+Q/I]M9Z;?RVXCNH(P0 3@
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MHKRZR\7:Y-\4/&.CO?9L-.L/.M8O*3]V^Q3G.W)Y)ZDUY_H?C#XAZYI,5_\
M\+-\+:?YA8?9]0DMXIEP<<KY)QG&1[5*=[6[7_%K]"GHVO.WX)_J?2-%8_A5
MM0?POI[ZKJ%KJ-ZT0:6[M"#%,3R&4@ $8QT K8JFK.PD[JX45S?C/Q-<^&=,
M@>PTFXU2_NY?(MK>'IOVDY8]E&.36!\'O$^M>*_#%]>ZY<+-=1W\D0VQJ@10
MJG:-H&<$GDY/O2C[U[= ;M;S_K]#T.BN*^*7BO4/"'@\W^EQQFZEG2!995RD
M.[/S$?ACGN:YS0/%_B+1?&][X=\0ZM!K=O%IAU'[9%;+"T>!DJ0G&,9]^1ZX
MJ5):^5_P5W^ WI;S_P [?F>L5GZ7H]OI,E^\#RL;VY:ZD\P@X8@ @8 X^4>M
M>.0>/O&EOH.G>.[S4+631+Z_^SMI(ME'DQ%BH82_>)^4]?\ ZPZ/7/$7BC7_
M ![?^&_"VJP:7'I5F+F>=[99FF=@"$PW1<$<CFFWRZOSOY62;_"S%=/^O.WY
MZ'J%%<G\-_%<_C'P7:ZK=QI'=[FAG"<*74X)'IG@UR7Q(^(EUI'BRU\-V>M6
M^A1?9_M-WJ<MM]H9!D[42/!R3CT[]L4Y>Z^7^N_Y!%W5_P"M[?F>LUFZEHT6
MJW-J]S<3FWMW$OV0;/*D=2"K-\NXX(R & ]0:\MN?B-KVD?#*+4CJ>D:SJ%Y
M>K:6-[:JP4@\YE0JNUP >,=Q5[1_%OB3PU\0D\*>+-4@U6.ZLC=P7B6ZPLA
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MA^/;+PQXFU.'5UU.R-S;SI;) T4@!)CPO!'!YIK5Z?\ #Z<WY:_AN2W97?\
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M*OO_ $;:5U% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'.^-O^1?A_["FG?^ED-:-9WC;_D7X?\ L*:=_P"ED-:- !1110 4444 %96O
M^&])\4:<+#6;3[3:B02!/,=/F&0#E2#W-:M9NO1:G-I$RZ1?1V5X,,LTD(E
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M,Z1X<29=+M/*:=@TLCR-))(1TW.Q)./K3=:\+:/X@EAFU"U9IX 1%/%*\4B
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M)]3Q-:2&.XC2WD=HR!DD@*?E&?O=/>JEI*SW_P"&_P" %OZ^_P#X)TU<O?\
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MOEHU;().>@9>M>P@8&!62?"^@-J/]H'1-.-[NW?:#:IOSZ[L9S[TVVY-]_\
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% &#XW_Y$'Q'_ -@NY_\
M135O5@^-_P#D0?$?_8+N?_135O4 %%%% !1110 4444 %%%% !1110 4444
M%9GA;_D*^*O^PJG_ *1VU:=9GA;_ )"OBK_L*I_Z1VU '25QGPW_ .05K/\
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M@(E^1%3G=[D@?6MO_A/]2U70_#__  C^FV\FLZU"\J1W<A$-NJ<.SD<D D
M<FMO0?#EWI6I^)KF:2 QZI=": 1L<JOEA<-D#!R.V:YVT\ Z[I?AKP\=,U"Q
MA\0Z-'+&&E5GMITD.61N P'W>0,C%2M$D]K1]>M_T'K=M;W?ITM^H7?CGQ'H
MFE:[;:YI^G1ZYI]@;Z![5G>VN$SMZ'##!ZC/>I+?Q;XPL-7T9_$&F:1%I.L3
MK;P+:RR-<0.REE\S/RG./X>E,NO WB/6]*URYUS4--DUS4+#[#!':JZ6UNF=
MW4Y8Y/4X[5O^(/#=YJH\-""2!?[+OXKF?>Q&Y50J0N <G)[XJE?1ONO2VM_T
M^8G?6W9_?I;]?D<?>?%/49M0NYM*NO"<.FV<SQ&WU/4_*N[G8<$HO1,D'&[K
MP:]*T;5;?7-%L]4M<^1=PK*F[J 1T->:WGPPU.UU&Z31['P=<V%U.\WG:MIG
MFW5OO.2%(&' ).-WL*]+TC3DTC2+33T9&%O&$W)"D08CJ0B *N3V Q1#X-=]
M/^#^/_ *E?GTVU_X!P>MOXB'QJT5;1M-^Q"PE.)C)O\ *WIYIXXW_=V]NN:4
M>+_&VI6TVOZ+HVDR>'H6<K%<3N+NY1"063'R+G!P#6]KF@ZO/XRT;7=*DL2E
MO%):W<5WO!,+LI)0J/O?+WXK!'A'QOIMO/H&BZSI$?AZ8N$FN(7-W;(Y)*(!
M\C8R<$U"YN6RWUMZWZ^5OUZV&_BN]M/NMT\[_IYG=Z1J<&LZ/9ZG:Y\BZA69
M,]0&&>:X'SO$R?&R_P!C:8=/CTQ&96,GF"'<V,=M^\'/;;CO7?:1ID&C:/9Z
M9:Y\BUA6%,]2%&.:Y^_\/ZR/'J:YITM@;*XL?L=Y'<;Q(H!9E:/:,9RW.?2J
MJ?$W#^];[G84;N%I;Z?FKF)H7C'Q?J/A1_$USINBBQ:UW01"X,3F0-@N[N=B
M1CD]2V!^%4O"OQ.U#4/&%IH>IW?AN^6]$GE/HLDS&$J"<.7&#G'45J#P#?O\
M*;/PM)=6@O[8I(&(,D#LLF\*P(!*GH>*JV'@[QA-XHT/6-7N/#T,.G2R%K+2
MXI(TPZ%2X+ EFZ<' QWJM.?R_P"!_G_5B7?E\_\ @_Y?U<J#QSX[GT._U^UT
MK0SI6FS7"SB6259ITC=AF,#(4@#G<>3G %3^)OB1J5IJUC9:4^A:>EQ9Q78N
M-=FDC24/GY$*# (P,DG'-;-IX/U"#X=:QX>::U-W>F\,;AF\L>:[%<G;GC<,
M\'\:I:WX3\4S:;I]G8GPUJ-M#:102V6MVK21HZC!>-E&XYP.#Z=JC71>G_I.
MOX_+Y%=?O_/3\"QJGC'7[6P\,-;:39M?ZM.T$MNUP'0$(Q!61"1MRH.<'CMF
MJ5OXG\?75YJ'A^+3= _MZR"3/<&:7[(87SM 'WR_!'8=_:I])^'MYI%OX8AC
MNK9QIE_->7  9$'F(XV1+S@ L, D<5O:?H%W:^.]9UQY(3:WUK!#&BL=X9-V
M<C&,<C')JFM?O_)6_&_KZ$J]ON_-W_"W_#G.0^+KK68?"5RNF:<+^]FNH6^T
M(7^SS1HX)C8'(!9<$\\&G?"!M=?P[?-JS6#1&_N/*-N7+E_-?S-V[MN^[CMU
MJ;2? ^IV'_"-^;/:'^S+Z[N9MCM\RR[]H7Y>3\PSG'XUJ>"]"UCPZFI6-]+8
MRZ>UU)/9/!O$N)'9V$@(QD$\8HCU?=?K%_Y@T]/)_P#R2_R+_B35[K0XK&]C
M2)['[4D5Z7!W1QO\H=2#@88KG(/&:RM;\:/I&H:NRPQS6&E6:/,%SYCW$C?N
MXU.<#C!.1_$*V/$]WHUKX?NUUZZMK>PGC:)_M$@0/E3\HSU.,X YKD_#'A67
M6_AE/#JTCQ7VM?Z5+,%^=&X\HX/<*J'%3KKY?KT^6K7R+>Z\_P!/Z2)(O$_C
M/1KRRG\5:7HZ:5?7"6ZM832&6U9SA?,W<,,X&5K6T3Q->ZE!XG>:*W4Z5>S6
M\&Q2-RH@8%LGDY/;%9$/ACQIK-Y90>*]4T=]*L;A+A5T^*02W3(<KYF[A1G!
MPM))X0\56>L:U%I&JZ9%HNL3-/.9H7:YA=E"L(\';SCJV<>AHG?E:79V_"U_
M/?\ 44=U?RO^-[?@4[;QWXIU6'PW;Z59:2VH:QICW;&Y\Q(HG5EYX);;@GCD
MYQR*]*M_.^S1?:3&9]@\SR\[=V.<9YQFN%\.>!]2T?4/"]Q<3VC)I.ERV4XC
M=B6=BI!7*C(X[X^E=]6DK:V[O\]/P(AS=?+\M3DD\7RV5KXG;5HHUFT61F58
M5(\V%EW1$ D\G[I]P>E9DWB;QE>W-OHNC:?I']LQ645UJ,UZTBV\+/G$:JI+
M$\'O5OQ/X(N-=\5Z9J-O=I#8_(NJ0'K<I&_F1 <'H^<\C@]^E.U[P]XD@\1R
M:_X2O--CNKF!(+JVU-',,@0G:P*?,&&XCWK-;*_]66_S9H[W=OZN]ODK_><C
MXR\2>(=8\"WMM]DL;'5=/U*"VU&)I'9&!92C1D<[6)7(/;/>MW4O$>JZ-J&H
MM=V.D-JMGX<-[)<0PL=T@=OD#$AC'D9QU]Z=<> -4N/"6KP3ZE;3^(-3N8[R
M2<QE( \94H@ R0@" 9Z\YJ34O".O:S)J%W>2Z:EW>Z =.<0O)Y8G+$Y&5SLY
M^OM2=TG;?_[6VGS_ *L$;<ROM^G,M_E_5RG!XR\9V<NB:CKFE:/#HNJS0VZI
M;RR-<PM(/E9L_*1GL.1GK5N[\3>,=2U343X6TO29=,TR9K>9KZ9UEN9% ++%
MMX7!.,MUK2USPO?:GH'A^PAEMUETZ[M9YB[,%98OO!<#D^F<?A7%ZIJ\WA[7
MM>M="\8^&[&UFN&FO+;5E=+BVE906,(X\S/7TS3J.U[=.:WX6O\ C_5B87LK
M^5_QO^AZ%X)URZ\2>#].U>]BBAN;E"SQQ A5(8C R2>WK575M4-MX^TFR%G9
MN9;"ZE%Q)%F:/:4^56SPISR.^!47PPMYK;X;:''.&$A@WG>,$AF)!(]P0:MZ
MGH%U>^,M-UB.2$6]K97%NZLQWEI-NT@8QCY3GFJJIIM+S_\ 27^M@@[QO_6Z
M_0X>W^('CG_A%;7Q;=:/HBZ( IN(UED%PZE]I=!RJCV))XJYXE^(FL6?BR71
M],D\.V20+&V-:N)(GN]R[OW1'RC^[ECUK3D\$ZD_PA7PD)[3[>+=8O,WMY60
M^[KMSC'M47BKPIXHU6Z$=JOA?4M.=5 AUNS9WM2%P3$R#G/)^;D>M$M]._Z?
MY_(:[_UO_E\S.UB\\57GQ(\'S6L.F6T<UG+(UO<2NY3A?.!*$JQ (V$<=<U<
ML/%_BS44UK4([31X]*TJ6\A=G,AFE:+=LVJ#@#@;B3SS@"I(/ NL:(OA-]&O
M;&>71TD@N/MH=5DCD(+E-N2",84'BM;P_P"%)]/T/7=-OY8F74KVZF5H23MC
ME/&<@<@?_KJ97Y9*/]ZWK?3\/R".ZYO*_HD[_P!>93O_ !EJ-K\/=$\0)#:F
M[OGM%E1E;8/-90VT;L]SC)/XU#>>)O%^K:UJ5OX2T[2)+/2IO(N)-1E</<2!
M0S)'MX7&<9;C-9)\!^-;GP]8Z%>ZOHS6&F3V[6WDQ2)).D;@_O2<@$*#@*.3
MC)K6N_#7B_2-;U*Y\):AHZV>J3>?<1:E%(6@D*A6:,IP<XSAN,U<K.3:VN[?
M<K7_ !^>Y,>9))]M?O=_T,R\N?%=Q\6_#L@M].M8WTQWDMIY'=XT+)YPRA*E
M\X"D<8SFI]/\8Z@OAK3+?1='T[^V-2O+J*WMT!AMXUCD;=(X&3V!..236M=>
M&O$2>(/#VKV^HV5[<6=N]IJ#WB&,RHY4L\8C& WR\ C%9T7@/6K/0--;3[^S
M@U[3+JYGMY'5G@D25V)C?@-@@CD=".]3TMT_^V;_ "M\K]0UO=>7_I/^?Z!)
MXT\2Z):ZM9>(K#3$U>VTV74+2:R9VMIU3JI5L,""1GGG-10>,O&=G+HFHZYI
M6CPZ+JLT-NJ6\LC7,+2#Y6;/RD9[#D9ZU+)X+\2ZW:ZM?>(K[3'U>YTV73[2
M&R5UMH%?J2S98DD#/'&*V-<\+WVIZ!X?L(9;=9=.N[6>8NS!66+[P7 Y/IG'
MX4UNF^Z^[6_X6^8W>S2\_OLK?B<SJWQ'UV+Q;?:7IX\.0)92^5]CU.[>&ZN^
M <QDXC&<\9)S7J$+M+!'(\9C9E#%"0=I(Z9'!_"O.O%G@WQ1K^H3PC_A%K_3
M9B?+EU2Q9KFT4CI&4P#CJ"<'US7<Z+IHT;0['3%F><6D"0^:_P!Y]HQDTH?!
MKO\ U_7Y#E\>FW]?U^9EV>OW5QX_U307CA%K:64-PCA3O+.S @G.,<#M7-2_
M$#64T22\AL+6XN%\0MI20J&7?&&(');AO?I[5I:UX;\31>,6\0>&+W2XVNK9
M+6[BU&)V 56)#IL(R>>AP*Y?5_"VI:!X;LK&;44:[NO%*7,5U&,D;V)!92 ,
MYZ@<>]2KZ7\E\^;_ "%*ZO;S?RY7^IU6C^(?$UKXE@T;Q99:9&;]))+*?39'
M9,I@F-]_.[!SD<'%=-K-Y)IVAW]["JM+;V\DJ!QD$JI(SCMQ7-Z-X>\27/B.
M#6O%E]IDLEE')'9V^G1NL8WX!D8N2=V!C X&374ZA9IJ.FW5E(2$N(FB8CJ
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M@-IXCTZ,R01;7FR8SND.?F/.,^@%:47@7Q!8>$_"MM87.F'5]#N&E(N#(8)
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MUI/2=EY_FO\ ,SIN]--^1ZI:ZUI5[>S65IJ=E<7</^M@BG5W3_>4'(_&KI.
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MZ>WG"HV%5!(05^;@_(.N>]:P_P"2AZM_V"K'_P!&W=<'H/\ R#?AU_V%KO\
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M*/NCO[475K]?SU:_JX)N]OZV3_S/2;CPYH=W8P6-SHVG36=O_J;>2U1HX_\
M=4C _"IHM'TR'SO*TZSC\]!'+L@4>8HX"MQR!V!KRKPG\27N-6ET<>+H/$AF
MM)IHKI=,:SD@D1<A2I&U@1G&.>.:2'7?'EEX.TGQG>^(+2>TD%N)M,%BB^8C
MLJEO-'(?G.  *JUW;O\ J[?G_5A<R7R_17_K_,]4T[1M)T2*1=,TVRL(W^9Q
M;0)$#[G:!6+X<U'P9XBCU6UT"+3[B$2XOUBM-L<CG/+$J%DS@\\UJ^(K>\N_
M#E]#I]]]AN7A.RX\D2[.Y^4\'C(_&O+O"5WXFL/!'A?1-/UB![S659[>>>T4
M+80(F6 4']XV3P6]:F]VT_+\;_AH-NR37]6_X<].DL]!\-Z%>,+"RL=+CB>2
MXCAM@$V8^8E%'/&>QJ.*X\/7DEGHB0VT@^S)>VUJ;;Y%B4C8Z@KM7!Q@<$5P
M6NZAXATC2=?\->(M3@U<W&B7%W:WT=L('.T89'13M_B&"*MP7Z:5XHL]0D4L
MEKX1\YE'4A6!Q^E',EJ]O\E)_@T'DEK_ )N*_%,]&DLK6:[ANY+:%[F ,(IF
MC!>,-U"MU&>^*GKRR;4O'NF>'E\:7>MV$]EY2W,VBK9!52$X)VS9W%P#WXS6
MY+XCU2STO6K82"YU59T733(JKO2X_P!22%'13N!..D9--Z73Z?U_7S!23M;K
MU.Q-G;->+>&WA-TJ&-9R@WA"<E0W7&0.*KWD&E1RFYO8;-9)U%J99E7,BL>(
M\GJ"3]WOFL&R\0W6NZEH<5BY@C:V-[J"[5)4?<6(YR0=^[IS^[/-8_Q7LM4N
MX?#O]G:O]@_XFT*?\>RR_O&/R/\ -_=P>.ASS2?1>=OQM_7<$]&^RO\ A<ZR
MVET'4KJ;2H8+::31Y(\P&W^6V?;E"N1@$#H5Z5I?8[87AO/L\/VHQ^49]@WE
M,YV[NN,\XKRK3]-\4WGC7QA;Z-X@M].DCEM3/=O9"9Y7$"\!"=J@\DGD^E1:
MC\4KRV\#Z#/<WUKI=_J4LL$^H/;/-'"(B59UC4$L2<8!XYYHYM$^NGXW7Z!U
MM_6EG^O0]0M]!T>SU"2_MM)L8+V3[]Q%;HLC?5@,FGW>JV5C?65E<S;+B^=D
MMTV,=[*NXC(&!P#UQ7GWPY\?#6M=N-!D\20^(2MO]HBODL&M'&& 9&0@ ]00
M1[YKJ/$6K7UAXG\,6=M/LM[VXF2X38IWA8F8#)&1R!TQ3?NV[?\ #_Y"ON^W
M_ ->YT+2+V_COKK2K&>\B_U=Q+;HTB?1B,BK+6=J]XEXUM"UU&AC28H"ZJ<$
MJ&Z@' X]J\A36_'[>!Y?&)\16BV]EYKFP-@A^THDA!WR#!4X'&T=AFKGCOQE
MK6FZI9?\3F3PYH\MK',E\NE?;5DD;.Y'/\ 'R]!DYI7M;^MU?\5_D/J_ZV=O
MS_S/3-FFZ?=M+LM+:YOI I?"H]PX' )ZL0 ?7@5:DCCFC:.5%>-AAE89!'H1
M7C^N2:WXCN? -]:>)[%)9KF1//L;831&0(^9!OP>5!4J>A)]*W],OO%&L>+-
M=1-=CMM,T>^V& 6:.\ZF)6V;CC: ><\DYZT/1._2_P!RM_F)2UTZV^]W_P C
MM--T32=&5UTO2[*Q60Y<6MND08^^T#-*VBZ4VIKJ;:99G4%&!=&!?- ]-^,_
MK7 _\)7K?_"BQXC^V_\ $V\C?]H\I.OF[?NXV]/:K-U?^*O%'B6_TO0-<M]%
MM]*CA\Z9K);AYY77=MPQ 5<8Y'.:;^*W5?Y7'=6]?\[?F=M+%I<*&QECM$6^
M9P8&50)V()?Y?XB1DG]:P--\-> ]4%P]CX;T.3[-.]O*?[,C7;(A^8<H,X]1
MQ7*^(-.\67'C'P1]JUZUL[W$RR"UM!+'O5268;\'YUP,'[O45:;Q?KS:?<6E
MI- ^IW?B&;3+.6>,;((UR<D*!NPH.,\D]:2?;?\ R:2_,&^^W_ ;_0[Z_P!%
MTK51$-1TRRO!"<Q"XMUDV'U&X''X586TMDF29+>)94C\M7" %4Z[0>PX''M7
M QZAXK\+:M#I>N:U!K,5_;7#VUVMFMO)#+&F[:54E2I'?VK AUWQY9>#M)\9
MWOB"TGM)!;B;3!8HOF([*I;S1R'YS@ "FK-Z?TV[?G_5A-I=/^&2N>DW7@_P
MQ?74EU>>'-(N+B4[I)9K&)W<^I)7)JRF@:-'I9TM-(L%T\DDVBVR"(YZ_)C'
MZ5YGXY\8ZYI'BR2VF\0_\(WIR!/LDKZ2;J&[)7)WR?P<@C"C('->FZ'>OJ6A
M6-Y)-:S230J[26CEXF..2A(!(SZBE'6-UL-NTK!'H6D0Z6^F1:58II[@A[5;
M=!$V>N4Q@_E5*+P3X3AE26+PQHL<B,&5TL(@5(Z$';P:W:*?6X[:6*%WH>D:
MA>17=[I=E<W,/^JFFMT=T^C$9'X5//8VEU-!-<6L$TMNV^!Y(PS1-C&5)Z''
M<58HH *@M;*ULED6TMH;=9)#*XBC"!G/5CCJ3W-3T4 5AIUD&N6%G;AKK'V@
M^4N9L# W\?-QQSVJG:^&= LEC6TT/3;=8Y1,@BM(T"R 8#C X;WZUJT4 0&R
MM3?"]-M";M8_*$_ECS F<[=W7&><5!J6BZ5K*(FJ:997R(<HMU LH4^HW XJ
M]10 V.*.&)8HD5(T&%51@ >@%<YXQTK7];L$TO2;FPM[*Z#0W\EPKF41$8_=
M8XW8R/F]:Z6BDU?<%IL5[>QMK;3XK".)?LT40B6,C(V@8Q^50Z;HNE:,CII>
MF6=BLARXM8%B#'U.T#-7J*J^MQ))*R,U_#VB22W4KZ/I[278VW#FV0F8>CG'
MS#ZU:CL;2*[>[CM8$N9$$;S+& [*.BENI SP*L44AB$9!%<MX3\'V^C:/8QZ
ME9Z?<:G:&39=+$'9 TC, KLH8=:ZJBA:.X/4@%E:B^:^%M"+MHQ$9Q&/,* Y
M"[NN,\XJO>:%I&H7<5W>Z58W-S#_ *J::W1W3Z,1D?A5^B@" 65J+TWHMH1=
MF/RC/Y8W[,YV[NN,\XK"\1Z3J[:?-%X432+*ZO9?]-GN86RRE<%QL^](.,;N
M.*Z2BDTFK,:=M2AHFDV^A:)9:5:C$%K"L2^^!U_'K5YE#*58 J1@@]Z6BJ;N
M[LE))610T_1-)TEY7T[2[*S:8YD:WMTC+GWV@9_&JZ^%?#JFX*Z#I8-S_KR+
M./\ >\Y^;CYN>>:UZ*0RO!8VEK/-/;VL$4TY!FDCC"M(0,#<1UP.!FJUQX?T
M6[N9KFXTBPFGFC\J662V1FD3^ZQ(R1[&M&B@!J(L:*B*%11A548 'H*JSZ3I
MMRUPT^GVDK7*JLYDA5C*%^Z&R/F [9Z5<HH @GL;2YE@EGM8)9+=M\+21AC$
MV,94GH<<9%3T44 4QI&FKISZ<NGV@L7!#VPA7RFR<G*XP<GD\5'?:#H^IB 7
M^DV-V(/]2)[=)/+_ -W(X_"M"B@"@NB:2K%ETNR!,JSDBW3F11A7Z?> X!ZB
MK#65J]['>O;0M=1H42<Q@NBGJ W4 X'%3T4!8S9O#VB7,\\\^CZ?++<*$GD>
MV1FE7.<,2.1GUK1 "@   #@ 4M%'D QHHVD21HU+IG:Q'*YZX/:D^SP[95\F
M/;*29!M&')&#GUX %2446 IMI&FMIR:<VG6AL4VA+8PKY2X.1A<8&",CBF:C
MHFDZOY?]IZ797OE',?VFW238?;<#BK]% %=["SE>W:2T@=K8[H"T8)B.,97^
M[P<<=J465J+YKX6T(NVC$1G$8\PH#D+NZXSSBIZ* *>J?VC_ &7<?V0;7^T-
MA\C[7N\K=VW;><?2LSPEH,^AZ;.;^:&?4[VX>ZO9H5(1I&[*#SM   SZ5OT4
M+2[!ZE :%I U/^TQI5B-0/\ R]?9T\W_ +[QG]:?=Z3IM_/!/>:?:7,T!W0R
M30J[1GU4D9'X5<HH AMK.ULHVCM+:&!&=I&6) H+,<EB!W)Y)HN[.VO[9[:\
MMX;BWD&'BF0.K#T(/!J:B@"E;Z-I=II[:?;:;9PV3 AK:.!5C.>N5 Q4-KX;
MT*Q$0M-%TZW$+^9$(K5$V/C&Y<#@X)&1ZUIT4>8K="G'I&F1+;+'IUHBVKF2
M + H$3'.2O'RDY/(]36&/^2AZM_V"K'_ -&W==17+C_DH>K?]@JQ_P#1MW0,
MUZ*** "BBB@ HHHH **** "BBB@ HHHH **** ,@_P#)0])_[!5]_P"C;2NH
MKES_ ,E#TG_L%7W_ *-M*ZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@#G?&W_(OP_\ 84T[_P!+(:T:SO&W_(OP_P#84T[_ -+(:T:
M"BBB@ HHHH **** .'^&7_(/\0?]AV[_ /0A67\5=?L[.^T31-4U*;3M(OFD
MDOIX0Y=XT Q&-H) 8G!QVKTRBA]/*WX*P+2_G?\ %G'>"O%/@G4!_8GA.XBQ
M;Q&3R([:2,!<@$Y91DY([YK1UWQIH7AJ]BMM9NI+3S4WI*T+F,\GC< 0#QT.
M.U=!2%0PP0"/0TV[@M#SCPQ/#XA^)=WXCT.VECT7^SQ;RW+0M$MW-OR"H(!.
M!QFM77_"NNWWC&VU_2M6LK<V]J;>**ZMC*$+'+,,,,$C _"NSZ# HI=K=/\
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MN0-BG )KTNBJ=F[^5OR_R$KVMYW_ #_S.'^%,4</A">*)%2--1NE55& H$I
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M-A#$G@<YQ7144+3;^OZN-JX4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7+C_DH>K?]@JQ_]&W=
M=17+C_DH>K?]@JQ_]&W= &O1110 4444 %%%% !1110 4444 %%%% !1110!
MD'_DH>D_]@J^_P#1MI745RY_Y*'I/_8*OO\ T;:5U% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% '.^-O^1?A_P"PIIW_ *60UHUG>-O^
M1?A_["FG?^ED-:- !1110 4444 %<UX^U.32_!.IS0$BYEC^SP8Z^9(0BX_%
MJZ6N(\=Z5<>(]6\.Z&(;P:>]RUU>7$&Y1&(U.P%Q]TEB,?2DU>R_K^K#3MKV
M&?#N*31I];\+S322MITZ2Q-*Q9C'*@/4]?F#5C?%!=5/BSP[-H\SK=VD%S>+
M$I.)O+V,4([Y&1^-:-AX:D\*?$>QGL!J=W8ZE9R074T\CS^4Z$,A9SG:#R!F
MM;5[.YE^)/ANZ2VE>VBM;M9950E$+!,!CT&<'&>M4[MQ?7_*_P#P"=DU_6MO
M^"94.L0ZU\1O#%_9RL;6[T>>91GC[R]1ZCD5=\>P7.FBQ\66 =IM)<M<PH?]
M=;-Q(,=R!\P^AKG-!\-:KH7QA,*VT[:#';SRV<PB/EQ>:P9H]W088' ]#7H7
MB:*2X\*ZO##&\DLEE,J(BDLQ*$  #J:F3M!2CYO\=OT*C&\^5^2_#?\ 4YOP
M,9_$6I:AXRN?,6&[/V?38GR-ELI^]CU8Y/TKN:Y_P-;SVG@30[>YADAGCLXU
M>.12K*0.00>0:Z"KDDGRKH1%W5WU"N"\7QMXA\:Z-X4EGECTV2WEO;V.*0HT
MRKA50D$';DG-=[7$^+K:_P!+\4Z1XKLK"XOX;:*6UO;>V7=+Y3X(95_BPPZ"
MHTNK[?\  ?ZE]';^MOTN;'AKPM;^%ENK>QN[IK"5@T-K-(9%M\#!"$Y.#Z$U
MSGQBTNVN? UYJ;&9;NP0&!XYF3;N=0<@'!X]:Z+PUKFI:]]LN;G1KC3;%7"V
MGVL;)I1CEF3^$9Z5SGQ;OKJ3PI<Z'9:'J^H7%]&"DME:&6./:ZG#D<@\<<&B
M=]+^0Z=N;R.L\-:1::)H5M:60D$142?O)&D.6&3RQ)K@/BYX6TV#PYJ/B*'[
M5'J32P@NMU(%Y=4/RYV]/:NZ\+:P=:T9)FTO4].:(B$Q:C;^3(2%'S 9/R\]
M?8UC?%6QN]1^'][;6-K/=7#2PE8H(R[$"12< <]*N7QKU7YK]"*?P_+]/\S7
M\.>%-*\,QS'34G7[0%,GFW#RYQG&-Q..IZ5ROBS4I?A_XF?Q(L<T^EZG"8+F
M!,G9<J"8F [;N5->BH,1J#Z"N.^)]C=ZAX4BALK6>YE%_;.4AC+MM$@).!V
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M0V6K:I<:6J%R4$:J%B('3EXV_.O2_$MW=6/AG4KFRMY;B[2W<PQ0H7=GQ\H
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MJ:SI5E=ZA!I<\<-U<VRO*JIO"89@2,8XJW\(="T?_A6&G:M_95C_ &EY4_\
MIGV=/.^\X^_C=TXZ]*[^XT"U/A6;P_9!;2V:T:UBVKN$:E2H.,\XSZ\U2\(>
M%?\ A%?!EMX>^V_:O)1U\_RMF=S$_=R?7UIU/>]I;JM/_)K_ )_B$%903Z/7
M\#Y]\":;XON?#*2:/\/O#&M69F<"\U&WB>4G/():13@=N*^C/"=O<VOA>PBO
M=+L]+NA'F:SLD5(HG))(4*2,?B:\OL?@?XATNV^S:=\3-4L[<,6$-O#)&@)Z
MG"S 5Z?X4T6]\/\ AZ#3M0UBXU>YC+%KRXSO?+$C.68\ XZ]JNZ:?R%;7[SP
MB[L_$%W\5_&(T'PEHGB!EN$\U=5BC<0\<%=[KC/.<9Z"NG^#UE#%X@\6Z9K.
MG)8ZQ/M-UID42K;1Q$' 0!B"/F_(UI:Q\']7O?%6J:YI7CJ^T<ZA('DBM8'7
MH, %EE7=W[=ZZ'P'\.8O!D]]?W.K7.KZM>X$UY< @E1T&"S'TR23TK.FK02E
M_+8=2[=UW3/*&\*:O'XX/PL2^4>&Y;@:GC)W^1UV9SZC&/4 U]$VUM#9VD5M
M;QK%!$@2-%& J@8 %<PW@K=\34\9?VA]VR^R?9/)^OS;]WOTQ764U?V:3WZ_
MDOPL*WOM].GYO\3Y7\(W2^&?&D_BN61H[6/6YK&Y;/R[)%<C/I@BKO@*VG;X
MQ>'=:N-WFZU'<WY#$<;C* !^ 'YUZ1)\&8I?"FNZ(^M9?5-0%\MQ]D_U!!SM
MV[_FXR,Y'6M,?#%;?6O#^I66JB!]&TYK%%-MN\PE6 ?.\8P6)QSGUI4[P46^
MBM_Y+K_Y-I_P FN;F7>_YZ?@V>1^/=;\/>*/'7BD:UJ:VZV%F;/2@8Y'#3J<
MD_(IQ\P8<^M=/JOB7_A)_P!F:XN7<-<VZQ6T_KN21 "?J,'\:[GPG\*/#WA_
M1?LFIV.GZW>-*TLE[=V"%VR>GS;B /KZUDO\&U32O$VE6>N"VTW6I4FCMQ9Y
M%JRN&X^<9&.,<=O2I<;0=/?1?>G=_?=_<BT_WBGY_A:WZ)_-F#=_\E"^%/\
MV#O_ &G7N%>9^*?A/=:^= DLO$\VEW.CV@MDGAMR78X W B12O3ISUJ]X,\!
M:_X9UI[[4_'6I:Y T+1BUN1)M#$@[OFE89&#V[UM=.Z\Y/[W=&48N*7I%?<K
M'?4445!H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %<N/^2AZM_V"K'_T;=UU%<N/^2AZM_V"K'_T;=T :]%%% !1110 4444
M %%%% !1110 4444 %%%% &0?^2AZ3_V"K[_ -&VE=17+G_DH>D_]@J^_P#1
MMI744 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <[XV_Y
M%^'_ +"FG?\ I9#6C6=XV_Y%^'_L*:=_Z60UHT %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !6&/"FEGQ4_B29))]1\L11-*VY85
M']P8X[\]>36Y11UN'D%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!PE_X>TB+P+HMXFGP+<3?9/,D"\MNV[L_7)KL/\
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MB_PSH=EI$,MMIEO$YNX4+*N,J7 (_*H;6U\2GQIJ")J=B+L6L1>0VYVE<G
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M5.?E!.<8X%8'BM+G2]<NM/LE=8_%2);J\8_U4XPKOGMF')^L=.5[V77\]/\
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M_P E#TG_ +!5]_Z-M*ZBN7/_ "4/2?\ L%7W_HVTKJ* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** .=\;?\B_#_V%-._]+(:T:SO&W_(O
MP_\ 84T[_P!+(:T: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT;F^UCPWJ6B&\U:34X-3N#;3126\:>4Q1G#1E%!VC;C#;C@]>*;T>O\ 6_\
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M70)<@#;\VY25..,H5..]=#13>KN"T5C+M?#VFVEE>V:0!K6\XEA;[NWRUC"
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M_+ZUK446Z?UM;\M!6_KYW_/4YF'P5;QWFFW$VKZK<KIDOF6<,\J%(_E*;3A
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M^2AZM_V"K'_T;=UU%<N/^2AZM_V"K'_T;=U3;>K$E;8UZ***0PHHHH ****
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MQ;X6OM'O;2+Q3H8DGMY(E+:A%@%E(&>>G- '4UFZ'_R#Y?\ K\NO_1\E4_\
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M<=^N&%%GXM\+6]UJ$K^*=#*W%P)4QJ$60!$B<\]<H?TH UY_^1FL?^O.Y_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *Y<?\E#U;_L%6/_HV[KJ*Y<?\E#U;
M_L%6/_HV[H UZ*** "BBB@ HHHH **** "BBB@ HHHH **** ,@_\E#TG_L%
M7W_HVTKJ*Y<_\E#TG_L%7W_HVTKJ* "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "N7'_)0]6_[!5C_P"C;NNHKEQ_R4/5O^P58_\ HV[H
M UZ*** "BBB@ HHHH **** "BBB@ HHHH **** ,@_\ )0])_P"P5??^C;2N
MHKES_P E#TG_ +!5]_Z-M*ZB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ KEQ_R4/5O^P58_^C;NNHKEQ_R4/5O^P58_^C;N@#7HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH R#_R4/2?^P5??^C;2NHKES_R4/2?
M^P5??^C;2NHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P#!C#_\55^B@"A_PG?@_P#Z&O0__!C#_P#%4?\ "=^#_P#H:]#_ /!C#_\
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M/_Z&O0__  8P_P#Q5'_"=^#_ /H:]#_\&,/_ ,55^B@"A_PG?@__ *&O0_\
MP8P__%4?\)WX/_Z&O0__  8P_P#Q57Z* *'_  G?@_\ Z&O0_P#P8P__ !5'
M_"=^#_\ H:]#_P#!C#_\55^B@"A_PG?@_P#Z&O0__!C#_P#%4?\ "=^#_P#H
M:]#_ /!C#_\ %5?HH H?\)WX/_Z&O0__  8P_P#Q5'_"=^#_ /H:]#_\&,/_
M ,55^B@"A_PG?@__ *&O0_\ P8P__%4?\)WX/_Z&O0__  8P_P#Q57Z* *'_
M  G?@_\ Z&O0_P#P8P__ !5'_"=^#_\ H:]#_P#!C#_\55^B@"A_PG?@_P#Z
M&O0__!C#_P#%4?\ "=^#_P#H:]#_ /!C#_\ %5?HH H?\)WX/_Z&O0__  8P
M_P#Q5'_"=^#_ /H:]#_\&,/_ ,55^B@"A_PG?@__ *&O0_\ P8P__%4?\)WX
M/_Z&O0__  8P_P#Q57Z* *'_  G?@_\ Z&O0_P#P8P__ !5'_"=^#_\ H:]#
M_P#!C#_\55^B@"A_PG?@_P#Z&O0__!C#_P#%4?\ "=^#_P#H:]#_ /!C#_\
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M/_Z&O0__  8P_P#Q5'_"=^#_ /H:]#_\&,/_ ,55^B@"A_PG?@__ *&O0_\
MP8P__%4?\)WX/_Z&O0__  8P_P#Q57Z* *'_  G?@_\ Z&O0_P#P8P__ !5'
M_"=^#_\ H:]#_P#!C#_\55^B@"A_PG?@_P#Z&O0__!C#_P#%4?\ "=^#_P#H
M:]#_ /!C#_\ %5?HH H?\)WX/_Z&O0__  8P_P#Q5'_"=^#_ /H:]#_\&,/_
M ,55^B@"A_PG?@__ *&O0_\ P8P__%4?\)WX/_Z&O0__  8P_P#Q57Z* *'_
M  G?@_\ Z&O0_P#P8P__ !5'_"=^#_\ H:]#_P#!C#_\55^B@"A_PG?@_P#Z
M&O0__!C#_P#%4?\ "=^#_P#H:]#_ /!C#_\ %5?HH H?\)WX/_Z&O0__  8P
M_P#Q5'_"=^#_ /H:]#_\&,/_ ,55^B@"A_PG?@__ *&O0_\ P8P__%4?\)WX
M/_Z&O0__  8P_P#Q57Z* *'_  G?@_\ Z&O0_P#P8P__ !5'_"=^#_\ H:]#
M_P#!C#_\55^B@"A_PG?@_P#Z&O0__!C#_P#%4?\ "=^#_P#H:]#_ /!C#_\
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M^*H_X3OP?_T->A_^#&'_ .*J_10!0_X3OP?_ -#7H?\ X,8?_BJ/^$[\'_\
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M&'_XJK]% %#_ (3OP?\ ]#7H?_@QA_\ BJ/^$[\'_P#0UZ'_ .#&'_XJK]%
M%#_A._!__0UZ'_X,8?\ XJC_ (3OP?\ ]#7H?_@QA_\ BJOT4 4/^$[\'_\
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MA/\ Z&C1?_!A%_\ %4?\)OX3_P"AHT7_ ,&$7_Q5;U% &#_PF_A/_H:-%_\
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M=_\ 85U'_P!+)JW* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,'7_P#D->%O
M^PH__I'<UO5@Z_\ \AKPM_V%'_\ 2.YK>H **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBBB@ HHHH **** "BBB@#!U__D->%O\ L*/_ .D=S6]6#K__ "&O"W_84?\
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MEI#)D8;!8!3@_=/7Y3M^(/ .K0>!_"<&AVVGS:SX=FAN C?*DKJ,N%;Y>&D
M)R5SC).: ,CXT:F?"OBOP;X@L84%U;F=6( !DB7R_P!V3@X&'<>VXXKU:?\
MY&:Q_P"O.Y_]#AKSB_TZ^^*/B_P]=77AR_TS0](+RW']JQ+&\\A*'RQ&<[D.
MQ<D\$%AP0,^CS_\ (S6/_7G<_P#H<- &E1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!Q5K_R<"?\ L5O_ &ZKT:O.;7_DX$_]BM_[=5Z-0 4444 %
M%%% !1110 4444 %%%% !1110!R7A3_D%7?_ &%=1_\ 2R:MRL/PI_R"KO\
M["NH_P#I9-6Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-4?V9=_]!W4/^^+?_P"-4 :5%9O]F7?_ $'=0_[XM_\ XU1_9EW_ -!W4/\
MOBW_ /C5 &E16;_9EW_T'=0_[XM__C5']F7?_0=U#_OBW_\ C5 &E16;_9EW
M_P!!W4/^^+?_ .-4?V9=_P#0=U#_ +XM_P#XU0!I45F_V9=_]!W4/^^+?_XU
M1_9EW_T'=0_[XM__ (U0!I5FS_\ (S6/_7G<_P#H<-']F7?_ $'=0_[XM_\
MXU3K?2VAOENYM0NKJ1(FB03",!0Q4G[B+S\@ZT :%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% '%6O_)P)_[%;_VZKT:O.;7_ ).!/_8K?^W5>C4
M%%%% !1110 4444 %%%% !1110 4444 <EX4_P"05=_]A74?_2R:MRL/PI_R
M"KO_ +"NH_\ I9-6Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!@Z_\ \AKP
MM_V%'_\ 2.YK>K!U_P#Y#7A;_L*/_P"D=S6]0 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Q5K_R<
M"?\ L5O_ &ZKT:O.;7_DX$_]BM_[=5Z-0 4444 %%%% !1110 4444 %%%%
M!1110!R7A3_D%7?_ &%=1_\ 2R:MRL/PI_R"KO\ ["NH_P#I9-6Y0 4444 %
M%%% !1110!YQK7C;4='\9RVKR*^GQ2*&BV#.TJ">>N><UO\ C'7;C3?#<.H:
M7.H,LB!7VA@5()[_ (5RE]I4.M?$O4K&;@21':W]UA&N#^=8E]J5S;>'I_#=
M^K">TN@T>?[O.1].01]:G[*[_P#!']K^NQ[%I5Q)=:-9W,S R20([G&.2H)K
MSG_A8.H_\))N\Q?[)^T[,>6/N9QG=C.<<UT>IZI_97PW@E5L2R6D<,?U90/T
M&3^%<"+S1O\ A!C8&1_[2\_S_P#5G&>F,_[M6])M]O\ ,E:Q7F>SW4ACLII8
MS\RQLRG\*\R\-^.=8N]?L[?4+A'MIG\LCRE7DCCD#UQ76>&]4_M7P.)6;,L4
M+PR?51_48->8VMNR^%_[2B'[RUOU^;T!4?U HVGKM_P0WCY_\ [GQUXJU'1M
M2MK33951C$9)<H&[\=?H:>OB35#\-VUCSU^VA\;_ "QC'F8Z8QTKF;NX7Q#J
MVO:JHS#!9'83V) 7_P"*K07_ )(X_P#UU_\ :M3M%W\OS*WDOZZ%S2[GQWJ^
MG17UM?60AESMWHH/!(_N^U=1X>B\01BX_MV>WE)V^5Y( QUSG 'M7'>&M&\3
M76@6LUAKJVULP;9$5^[\QSV]:[;0+'5+&UE35;\7LK/E7 QA<=*MZ-DFM111
M4C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,'7_\ D->%O^PH
M_P#Z1W-;U8.O_P#(:\+?]A1__2.YK>H **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH XJU_Y.!/_8K?
M^W5>C5YS:_\ )P)_[%;_ -NJ]&H **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH P=?_ .0UX6_["C_^D=S6]6#K_P#R&O"W_84?_P!([FMZ@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#BK7_DX$_\ 8K?^W5>C5YS:_P#)P)_[%;_VZKT:@ HHHH ****
M"BBB@ HHHH **** "BBB@#DO"G_(*N_^PKJ/_I9-6Y6'X4_Y!5W_ -A74?\
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M+-H$,UQ=RB6_N?\ 6,#D*.N >_/4U1T_P_?Q^/\ 4=2N+7%C,CJDF]3G( Z
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M5A1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/_8K?^W5>C5YS:_\G G_ +%;_P!NJ]&H **** "BBB@ HHHH **** "BBB@
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M5VBCR K6%A;:991V=G'Y<$>=J;B<9.>IY[U4@\.Z5;7EU=PVI2>Z5EF<2O\
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M%%% !1110 4444 <5:_\G G_ +%;_P!NJ]&KSFU_Y.!/_8K?^W5>C4 %%%%
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MHY9S<S@AE9AL&<=!C/;UI6V7D_Q"^[]/P/+M!FEUG5=!TJ0'R[.5F^HSO/\
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MFO>:)7PIG=Z'XOTWQ!>/;6:W D1-Y\Q !C('J?6M^N?\.>((-;EG$6FS6AB
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M!8U!(._.>?I4FL:I9>+=?TV""%=-"-AYI\(3DCCCZ<?6E'6WF.6E_(]<HH'
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M%%% !1110!Q5K_R<"?\ L5O_ &ZKT:O.;7_DX$_]BM_[=5Z-0 4444 %%%%
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M.O5J*2T2L/=NYQGBJ_35/ANUZF,3+$Q ['<,C\\U%!H*:_\ #:QMP +B.+?
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MPI8>'[:SN#J,;(C1[.FT8X[\_P"->MTT(H<N%&X]3CFAZMWZ@M$K=#"DN_\
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M!)/Y"NI\->(DUWP^U]<JD)B+)/SA!@9)YZ#!KEE\(3^?+J'A#74$3.0460@
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MO4;TBV;/A'Q)>:E=7FEZHB"_M"<L@P' .#Q['^=/\5^,+;0X9;6W8RZD5^5
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M%%% !1110 4444 %%%% '%6O_)P)_P"Q6_\ ;JO1J\YM?^3@3_V*W_MU7HU
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M/$6D&W!1+F,[X9&Z ^A]C6K<7MI:%1<W4,);[OF2!<_3-2LZHA=F"H!DL3@
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M6UCF_#OA"\L]8?6M9O$NKY@=NS)"DC&<X';C&.*["HX)X;F(2P2I+&W1XV#
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M^&["6\9VG>(,[/U.>A_*M&>WANHC%<1)+&2"4=00<'(X-.9EC0LQ"HHR23@
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M444 %%%% !1110 4444 %%%% !1110 4444 <5:_\G G_L5O_;JO1J\YM?\
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M#3K7[1:(3)*A<*&8'@')!QC/2N0U6Y\0?\)7ICW6FVT&H1*@MK>/[C ,=O\
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MU3_KUD_]!-*7P)OL-?&TNYB?#;_D4U_Z[O\ TJ7Q!X3G\0:W:SW%VO\ 9T(
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MG84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M61AD$>]8,'@?P];78N4T]2ZG<JN[,H/T)Q6U>7265E/=2<I#&TC#V S7"_\
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M3_V*W_MU7HU><VO_ "<"?^Q6_P#;JO1J "BBB@ HHHH **** "BBB@ HHHH
M**** .2\*?\ (*N_^PKJ/_I9-6Y6'X4_Y!5W_P!A74?_ $LFK<H **** "BB
MB@ HHHH Y_QQ_P B=J/^XO\ Z$*A\ ?\B;9?63_T,U:\8V\UUX4OX;>*265E
M7:D:EF/S#H!47@BVGM/"=I#<PR0RJ7RDBE6'S'L:(_:^02Z?,X_QQ+-!X_TZ
M6WA\Z9(XF2/^^0YP*D\3:]X@O/#]S!>Z UK;MMWS$GY?F&/UJ[XETZ^G^(>E
M7,-G<26Z>5OE2)BBX<DY(&!70^-;>>Z\)WL-O#)-*VS:D:EF/S#H!4_8_KN5
M]LQ])_Y)-)_UZS?S:N?\':SK>GZ/)%INBM>PF8L9 2,' X_E73Z9974?PQDM
M'MIEN3;3+Y+1D/DEL#;UKG?#.K:[X<TU[,>%[^XW2F3>8W7J ,8V'TK1_%+Y
M$+X4=KX?U75]1DG&IZ2;%4 *$DG?G.:U=0E>#3KJ:/.](G9<>H!K"T'Q'JFJ
MZ@;>\\/W-A$$+>=(&QD8XY45TC*KH4895A@@]Q4R5T.+U."^%T,9TV^NR 9W
MGV,QZX !_F3767FA:9J&H07MU;+)<P#]V^X@C!R.AYY]:XJ'3_$'@C4;HZ;8
MG4=-G;<$3)8>G Y![="#4EK8>(?%'B.UU+4;:33;.V^ZF2C$9SC'7GN>.*=[
MM6_X86U[C/B"3=>)-$L)2?L[D;AV^9P#^@KT-8HTB$2HHC"[0H' 'IBN7\;^
M&I]<M(+FQ.+VU)*+G&\>F?7CBLE?&?B6.V%K)X:N&O0-OF['VD^NW;_6I7PV
M*>]R'P@HL/B%K%A;\6Q#_*.@PPQ^62*P==LOMWB[7T RT<;RK_P$*?Y9KM?!
M7AN[TU[G5-4/^GW?5<Y* G)S[D_RJAIVDW3_ !'U2:>SG6TECD42M&0C9"C@
MXP>]#6R[)A?=^:,/4M1;7/#_ (8TM6)DD?9(.XVG8/T)-:WPX18M:UR-1A58
M*![!FK,\(>&]0M_&$;7=E<QV]J78221,%8C@8)&.^:W? EA>6>MZW)<VD\"2
M/E&EC*AOF;H2.:M/6_>[_(EK2W:WZG-Z5KL6@>-=7N9K>:97DE3;$ 2/WF<\
M_2K\DMUXT\8:?=VNGS6]M:E2\LBXX5L\GIGL!6AX2TZ^MO'.KW$]G<102>;L
MDDB95;,@(P2,'BO0*F.BB^R'+5R1Y[\1[PW5WINA1. TL@DDR< 9.U<_J:J6
MHM_"_P 188K:1#8WD:Q_*V0,\?\ H0_6GP>'KCQ5XQU"[U:TNX+)01%O1HRP
M!PN,CT!-'BCP%!I^F)=:)#=27*2C<BDNQ7U  SP<41=K-_U<<E>Z_KN='\0/
M^1-O/]Z/_P!#%<)HLUQX1N],U5BS:?J$6)<#ISR/J.HKM/$7VW5_AZ2+.X^V
M2)&7@\IMX8,,_+C/8TMGX?\ [5^'UKIEW$T,XBROF*0T;@G!(//_ -8T?"VQ
M;I+U,?PE(DOQ&UJ2-@R,LA5AT(WK6CX^T1Y;:/7++*7MCAF9>I0'.?J.OYUC
M_#S2-2TWQ%=&\L;B%! R!Y(R%)W#H2,'I7=>((I)O#NHQ1(TDCV[JJ(,EC@\
M 42TBK=!K63OU.+\'V=QXFUV;Q+J84K$0D*#IN [#T'\S7HU<G\/;.YLO#;1
M7=O-!)Y['9*A4XP.<&NLJGIHB%KJSR_QQ8?VIX\L;'?L,\"H&]#EJJ0ZQ-%X
M0U?PYJ&4NK4#R@W=0XROX=1[5T&N:?>S?$G2KJ*TG>V14WS+&2B\MU.,"H?B
M'X7FO&CU73[=Y9^$GCB0LS#LV!U]#^%9_9];_F:?:]+&[X%(7P78DG  <D_\
M#:N*M+:'Q?K^NWMQ+&L8B9+?>P'S=$//L/UKH+<:CIWPP2WBL;HWSHT0B6%M
MZ[F.21C(X_I5;P_\/+"XT6"?58[E+N0%F3=MVC/ (QUQ5R5Y-_UJ1'2*_K8N
M_#74S<Z)+I\A_>6<F /]EN1^N:P/%]F-0^(4=H?^6L 4?7:V/UJ_I6CW?A?Q
M]Y=I:74FF3H$,HC9E4$=V QPP_*K.HZ=>2_%&RNUM+AK547=,(R4!"MU;&*3
M]YI_UL->ZFCF7UEG^&\>F;CYWVSR=O?9]_\ GQ6GX.LQI_Q!N;0#_4VQ4_7"
M9_6J:>%KX>/1%]BN/L O/,\WRF\O;G=UQCVKH-(L+V+XFZE=R6DZ6SHP69HR
M$;[O1L8-.+NT^]_R0I*R:[?YF%J=U=V7Q2N)[&T-W<*?EA!^]^[&?TKI[;Q)
MXGENH8YO#+1Q,X5WW'Y03R:P=435M-^(EQJUMHUY>1J1MV1/M;,8'# &M;_A
M-=?_ .A/OORD_P#B*4?A0Y;L[FO.=>_Y*OI7^['_ #:O1$8M&K%=I(!(/:N$
MUK3[V7XF:;=QV=P]L@CW3+$Q1<%NK8P*%\:$_A96^)T8FOM&B)(#EU)'N5JE
MI5]/X=.L>&-0;Y&AE-NYZ$[3T]F'ZUL>/]/O;S4]&>UM)YUC=BYBC+!>5ZX'
M%6O'WAMM7TY;VTB+WML/NH,M(G<>Y'4?C4_9?S+^TOD4_ $KP>"-0FCSO225
MEQZA!2?"Z&,Z;?79 ,[S[&8]<  _S)J]\/;"XM/#<\%[:RP,T['9-&5)!5>Q
M[5D0Z?X@\$:C='3;$ZCIL[;@B9+#TX'(/;H0:T;M)^A"UC\SM;S0M,U#4(+V
MZMEDN8!^[?<01@Y'0\\^M:5>>6MAXA\4>([74M1MI--L[;[J9*,1G.,=>>YX
MXKI?$&KZIIES91Z?ICWB3,1*RQLWEC(].G4]?2I[(?<WJS[O7=*L)S!=ZA;P
MR@ E)) #@UH5C:CX4T35KQKN^LO-G8 %O-=>!TX! H U8)XKJ!)X)%DB<95U
M.01[5Y]\0#]I\3:'8RD_9V8%AV.YP#^@KO[2T@L;2*UMDV0Q+M1<DX'U/-<[
MXT\-3:[:0SV3!;ZU):/)QN'IGL>!BAZ-/S!;-'1R6\,MJUL\:F%DV%,<;<8Q
M5.PTBPT;3Y8-/@$43 L1N+9..N237&S>(/&4]DVG#0)4NF78UR$;;Z9'\(/O
MFNA\*Z%<:'X?:WNI3)<299E#%E3CA12>S!;HYOX5=-5^L?\ [-7HU>2^%[O7
M?#/VH+X:O[GSRO6)UVXS_LGUKLM&\3ZIJ%U)'>>';NRB2)I/,97.XC^$ J,D
MU3?Y"ZLY_P 6S)K?CG3M':11;VY!F+' R?F;_P = _.E\*RIH?CK4-'5U-M<
MDF$J<C(^9?T)'X5!X?\ ",GB&^U'4-?MKN R291&!C))R3U'0<"E\0^$'\/W
M>G:AH%M=SM'+ET4&0@C!!X'3J*4=+7_JXY:WM_5CJO&GA^?Q!HRPVK*+B&3S
M$5C@-P01GMUKDY/$NL:=IW]F^(] ,UF%$;/@IE1T^894GZ8KI?%UAJNJZ/;7
M6D2W$-Q%\YA5S&74@<$<<CT/O6%=^*_$%_I<NFMX9N?M,L9B>0H^.1@G;MX_
M.EM=#WLSI=-@TG6?!\EKI(,%I/&Z!>28V/4')]:Y'3[GQ3X*A>SDTD7=D'+!
MD4L/J&7H/J*WM"\+W]GX)N-/:=K>^N"904<CRVXP,CZ<X]:RM.\1^)= M?[.
MOM!N[V2,D)-ECD9]0IW?G5/XG82V1L>"M0T&_-S)IEE]BO&P9XBQ.1GJ.Q&3
MZ"NOKA/!.BZDNL7VNZC;FU:Y#!(2-I^9LDXZ@<=Z[NA]!=6>0Z3?ZAI_C75Y
M=-T\WLK22JT8.,#S.O\ *NTTO7_$5WJ4,%YX?:VMW)#S$GY>*Y.Q?6= \6:I
M?Q:!?7:322*N(G (+YR#M.>E=':^,-<GNX89/"=[$CNJM(0^%!/)^YVI1V7H
M.6[.SHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** ,'7_^0UX6_P"PH_\ Z1W-;U8.
MO_\ (:\+?]A1_P#TCN:WJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MGR+J2,].V"<'\16.VN:O8:)IEQ?Z'8RZ* BQI(H=N!PW)X)Y.<5U&I>%I)_
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M;_VZKT:O.;7_ ).!/_8K?^W5>C4 %%%% !1110 4444 %%%% !1110 4444
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MTNCL***X36=3OH?B3IUE%=S):N(]T2N0K9)SD4+=('LV=W17F?CW7=3TKQ/
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M@ST>BN>UO7;K3O!S:H+<Q7;1I^[<?ZMFP#D>U<GI^D>)-7T<:S!XEG:=E+K
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MNR\(:X^OZ"ES, +A&,<NT8!([_B"*=@+]EI,%C=W5VKR2W%RV7DE;) '11Z
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M,$'ID>E*WN^8_M>1S6D_\DFD_P"O6;^;5S_@[PL^MZ/)<KJUU:!9BGEQ'@\
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M.(X8Y';Z!F-<'X?UJ."[U2]OM.N;Q[Y60F)<@!B2P_E7H+^%)#X.3P_'J.P
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M^PH__I'<UO4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&T#ICW%<DOP[GD\JUNM=N)M,A?<EOMP1[9S@?E3ZNW<2V5SK=%NY+_1+*[E
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M5N4 %%%% !1110 4444 8,GC3P]%*\;ZFBNA*L-C\$?A0GC7P[)(J)J:%F(
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M%LSVW4-8L-*MH[F]N%AAD(56()R<9["LW_A-_#?_ $%(_P#OA_\ "L'XD?\
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M %%%% !1110 4444 <EX4_Y!5W_V%=1_]+)JW*P_"G_(*N_^PKJ/_I9-6Y0
M4444 %%%% !1110!S_CC_D3M1_W%_P#0A4/@#_D3;+ZR?^AFNBGMX;J%H;B*
M.6)OO)(H93]0:2WMH+2%8;:&.&)>B1J%4?@*%I?S!ZV/.?%J+)\2M(1U#*PA
M!!&01O-;_CBPLX?"%])%:0(XV898P"/G'>NCETZQGNDN9K.WDN$QLE>)2ZXY
M&"1D5+<6\%U"T-Q#'-$WWDD4,I^H-*WNV'?WKG&:3_R2:3_KUF_FU87@O7/#
MVFZ-)#JIB\\S%ANMRYVX'< ^]>FI96L=H;1+:%;8@KY*Q@)@]1MZ54_X1W1/
M^@/I_P#X#)_A5-ZM]R;:)%+1?$'A[4;QK;2FC\XIN8) 4R![X'K6_5.UTG3;
M*7S;33[2"3&-\4*J<>F0*N4AGF-I<GP)XMOEOH9#I]X28Y47/&<C\LD$5=U3
MQQ<ZGJ-G8^%P[RE\R.\7##TP>0.Y/%=[/;PW,1BGACEC/59%# _@:CM;"SL0
M1:6D%N#U$483/Y4+I?H#ZM=3'\7:3/K'A>:VCP]RFV10.-S#J!]>:P/"_CC3
M++18K#59'M;BU'E\Q,0P'3H#@]N:[^J%WHFE7\OFW6G6LTG]]X@2?QH[^8=O
M(X%9G\;>.[:ZM8G&GV)4F1AC@'/YD]O2K&K)O^+=@IQC8N<_[K5Z!;VMO9PB
M&V@CAB'1(U"@?@*8UA9/>+>-:0-=+PLQC!<?1L9HT5O('K<\733YO^$J'A_)
M^SB_^Y[9QG_OFNMT08^*^J =/+?_ -EKN?[-L/MGVS[%;?:LY\_REW],?>QG
MI3DL+**[>[CM($N7X:98P';ZMC)HCI;Y@];GG/C*"*Z^(FEV\Z!XI%B1U/<%
MSD5VEKX2T&SG6:#3(1(IRK-EL'UY)K1ETZQGNDN9K.WDN$QLE>)2ZXY&"1D5
M9H6BL#U9YCXP$_B7QI;:):.!Y"X+'D*Q&YB?P J+Q3X9\01Z4;[4-52]2UY"
MA2"H) )''TKTJ/3K&&Z>ZBL[=+E\[IEB4.V>N3C)J:6*.>)HIHUDC<89'&0P
M]"#2M960[ZF3H&IC5_#%O>$YD:(K)_O#@_RKC/A_IT&K>']9L;@9CE=1GN#@
MX(]P:]%MK*ULX3#:VT,$1.2D4852?H*2UL+.Q5EL[2"W#'+"&,)D^^*IV;;[
MDK1)=CQBRM;O3O&>G:==DEK6[1%!Z8+YR/8YS^->WU5ETVQGNDNIK*WDN$QM
ME>)2ZXZ8)&15JB^B3'UN>;^"44>.]<PH&TR 8'3]Y7I%5H-/LK:>2>"SMXII
M,[Y(XE5FR<\D#)YJS2Z)=@ZMG,?$#_D3;S_>C_\ 0Q6(_A[^W?AOIS0KF\MH
MB\)'5N3E?Q_F!7>W%M!=PM#<PQS1-U21 RG\#2PP16T*PP1)%$@PJ(H50/8"
ME;1COJCR[X;2RS^*;R69BTK6[%BW4G<O6B_AO/%WCZX73[A8?L(Q'*PR%V'K
M_P!]$UZ7!IMC:SO/;V5M%,^=\D<2JS9.3D@9-+;:=8V3N]I9V\#/]\Q1*I;Z
MX'-5U3["[^9Y?XHT77=':UUJ^U%+R2&555U7!3!)&>.F:Z3QO>1ZAX!2\B^Y
M,T3CVS787%M;W<)AN8(IHCU25 RG\#43:;8M9BS:RMC:KR(3$NP=_NXQ4O56
M'UN>4:_#+8:-X;U2 [9#:>46'TR/T8U%J=E]C^'VCL1AKBY>4_B,#] *]<ET
MRPGMH[::QMI((_N1/$I5?H","B;3+"X@C@FL;:2&+_5QO$I5/H","GW]?^")
M=#B_B1_R*NG_ /79/_0#3M+\4>$8-)LX;@P^>D*+)FT)^8 9YV\UVES8V=[$
ML5U:P3QJ<JDL88 ^P-5?^$=T3_H#Z?\ ^ R?X4=_,.B\A-$U73-5M'?2F4P1
MOM(6,H >O0@>M1^*O^15U3_KW?\ E6A:V-I8QLEG:P6Z,<E88P@)]>*DEBCG
MB:*:-)(W&&1U!##T(-*2NK#3LSD/AY_R)C?]=9/Z5B_#_3H-6\/ZS8W S'*Z
MC/<'!P1[@UZ-;V=M9P^3;6\,$62=D2!5_(4VUL+.Q5EL[2"W#'+"&,)D^^*I
MZMONB5HDO,\8LK6[T[QGIVG79):UNT10>F"^<CV.<_C7:_$+2[IFL=:LXS(U
MDW[Q0,D#((/T!Z_6NPETVQGNDNIK*WDN$QME>)2ZXZ8)&15JEK9=T/2[['$3
M_$O2?[*:6%9OMA3Y82G1O<],5K>$;O5[K0OM6LD;V),?R;6*8ZD>]:HTG31<
M?:!I]H)LY\SR5W?GC-7" 1@C(H[@96B>(+'7XII+$R%8F"MO7;R:T+B(SVTL
M2N8V="H<=5)'6F6MA9V*LMG:06X8Y80QA,GWQ5BAV8+0Y#2O!NH:?J<%W+XC
MN;F.)LF%T8!_;[Y_E75SB1H)%B8+(5(4GL<<5)10]58%H[GEK>%_%>C:5J+K
M?60@EC=[G'S/(,'/)3/KW[U?^&<6IFTDD,\?]EDNHAP-WF?+STZ8]_PKT&2-
M)HVCD17C<%65AD$'L14=M9VUE%Y5I;PP1YSLB0*,^N!0NH/4\V\+:E:^$];U
MJRU20P<Y0E3\VTG&,>H(Q6A\,[65DU+4G0K'<2!8\]\$D_SKL[S2=.U%U>\L
M;>X9> TD88C\:LQ11PQ+%$BQQJ,*JC  ]A0M-^U@>OWW.;^('_(FWG^]'_Z&
M*M>#?^10TW_KE_4UL7%M!=PM#<PQS1-U21 RG\#2PP16T*PP1)%$@PJ(H50/
M8"A:7\P>MA9O]1)_NG^5>6?#G1K#4Y=1EO(!,8U"(&Z -NR<>O%>K$ C!&0:
MK6FGV5AO^QV=O;[\;O)B5-WUP.:%NP>UCSC1;J7P1XNFTB[<_8+EAL=N@S]U
MOZ'_ .M7J%5;O3+"_96O+&VN&484S1*Y ]LBK*J$4*H 4#  ' %'34.MT+11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!@Z_\ \AKPM_V%'_\ 2.YK
M>K!U_P#Y#7A;_L*/_P"D=S6]0 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %,F_U$G^Z?Y4^@@$8(R#2:NK#6YY_\+/^/'4O^NR_R-.^(7BB2R T
M>S<QR2KNGE'55/8?7^7UKMK6PL[%66SM(+<,<L(8PF3[XJ*XT?2[N8S7.FV<
MTIZO) K,?Q(IRUL):7.1\&ZQX;LC#I6F^>UU.?GE>+!=@,\G/ ZX%:_B;Q1)
MX=N;19+ RVDYP\^_[G/(QCDXYZUK0:+I5M,LUOIEE%*OW7C@56'T(%6;BW@N
MX6AN(8YHFZI(H8'\#3;OJ"5CS75;RVUOQ]I,F@MYCIL,LL:E1@-DY^B_X5W.
MK^(K#1)[:&\,@>Y)$>Q<]P.?S%6[+2[#3MWV*S@M]WWC'&%)^M9^OZ(VM36*
M%;=88I1))*RYE !!VH>V<<_2DNB!]69GC+P[JVO7%DUA/;K%!EBDS'!?/!Q@
M@_C7%ZQ;>(X_%VG17M[;R:FP3[/*B@*OS'&?E ZY[&O8JKRZ?93W27,UI!)<
M1XV2O&"ZX]"1D4+1@]48VMW-SIWA-9KZPAU2:-$^THV-I..6QMZ9]A7*^*?$
MNBZMX0@M;/;]I<ILMT0YA(ZCI^''7->ED @@C(/:L^'0M)M[G[3#IMI'-G(=
M85!!]N.*'KN&VQR>MZ-=O\,;6W>-C<VJ)*R8R0!G(_ ']*PM;UO2K[P%ING6
MS!KR,QJ80ARI ()_'^M>LU0CT32X;O[5%IUJEQG/F+$H;/KG'6AZMWZ@M$O(
MHV]XGAWPA:3:EO @@C60*,D$X&*U-/OH=3L(;VWW>3,NY=PP<5#K-I+?:3/;
M0Q6TDD@P!<KN0<]2/;J/I3])T]=*TJVL4<N($"[CW/<T[W;;%:R2.*S_ &Q\
M6=K\Q6$?RCW _P#BF_2NXU 3MIMTML<7!B81_P"]@X_6ECT^RANGNHK2!+A_
MORK& [?4XR:L5-O=Y2K^]<\E\-ZAHUGX8UFUU0(M\Y;Y95RS_+@ >X;-=-\-
MTNHO"TCS*YC,K- I[K@=/;.:Z6YT/2KRX\^YTZUEE[N\2DGZ^M7E544*BA5
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M6_\ ;JO1J "BBB@ HHHH **** "BBB@ HHHH **** .2\*?\@J[_ .PKJ/\
MZ635N5A^%/\ D%7?_85U'_TLFK<H **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M P=?_P"0UX6_["C_ /I'<UO5@Z__ ,AKPM_V%'_]([FMZ@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#BK7_DX$_]BM_[=5Z-7G-K_P G G_L5O\ VZKT:@ HHHH **** "BBB@ H
MHHH **** "BBB@#GF\$Z*9II$.J0F:5YG6#5[N)-[L78A5E"C+,3P!UI/^$)
MTC_GOK7_ (/+W_X[7144 <[_ ,(3I'_/?6O_  >7O_QVC_A"=(_Y[ZU_X/+W
M_P".UT5% '._\(3I'_/?6O\ P>7O_P =H_X0G2/^>^M?^#R]_P#CM=%10!SO
M_"$Z1_SWUK_P>7O_ ,=H_P"$)TC_ )[ZU_X/+W_X[7144 <[_P (3I'_ #WU
MK_P>7O\ \=H_X0G2/^>^M?\ @\O?_CM=%10!SO\ PA.D?\]]:_\ !Y>__':/
M^$)TC_GOK7_@\O?_ ([7144 <[_PA.D?\]]:_P#!Y>__ !VC_A"=(_Y[ZU_X
M/+W_ ..UT5% '._\(3I'_/?6O_!Y>_\ QVC_ (0G2/\ GOK7_@\O?_CM=%10
M!SO_  A.D?\ /?6O_!Y>_P#QVC_A"=(_Y[ZU_P"#R]_^.UT5% '._P#"$Z1_
MSWUK_P 'E[_\=H_X0G2/^>^M?^#R]_\ CM=%10!SO_"$Z1_SWUK_ ,'E[_\
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M\]]:_P#!Y>__ !VC_A"=(_Y[ZU_X/+W_ ..UT5% '._\(3I'_/?6O_!Y>_\
MQVC_ (0G2/\ GOK7_@\O?_CM=%10!SO_  A.D?\ /?6O_!Y>_P#QVC_A"=(_
MY[ZU_P"#R]_^.UT5% '._P#"$Z1_SWUK_P 'E[_\=H_X0G2/^>^M?^#R]_\
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M "BBB@ HHHH **X7XI?\@*S_ .OD?^@M61;?9[;QQI<?AI]T;QI]K6%RT?\
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M-NZZ:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]\*>+;K4XK2:[TR]R9/(7<\1)S]WJ><_@:J^(KN77M>T9],M;YT@D_?,;=T
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MN;2^NC901J2=MWY8,7'8')%7_".J7OA?X/>)))YS-J<6HW%K&V2=\[%4&/\
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MQO'>NI\J<L.0IQ@D=^:;6MAIW5S6HHHI#"BBB@ HHHH **** "BBB@ HHHH
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M9_T'M%_\$TO_ ,E4?V5XL_Z#VB_^":7_ .2JZ:B@#F?[*\6?]![1?_!-+_\
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M9_LKQ9_T'M%_\$TO_P E4?V5XL_Z#VB_^":7_P"2JZ:B@#F?[*\6?]![1?\
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MIJ* .9_LKQ9_T'M%_P#!-+_\E4?V5XL_Z#VB_P#@FE_^2JZ:B@#F?[*\6?\
M0>T7_P $TO\ \E4?V5XL_P"@]HO_ ()I?_DJNFHH YG^RO%G_0>T7_P32_\
MR51_97BS_H/:+_X)I?\ Y*KIJ* .9_LKQ9_T'M%_\$TO_P E4?V5XL_Z#VB_
M^":7_P"2JZ:B@#F?[*\6?]![1?\ P32__)5']E>+/^@]HO\ X)I?_DJNFHH
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M_)5']E>+/^@]HO\ X)I?_DJNFHH YG^RO%G_ $'M%_\ !-+_ /)5']E>+/\
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M]9W%C:M."S !D;;]ULCC-9\WAO6!\)/%L\^G3_VKKEQ)>BRC0O*@9AM3:O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M /8**X_P+\1]'^('V_\ LFVOH?L/E^9]K1%SOW8QM9O[AZX[4>.OB/H_P_\
ML']K6U]-]N\SR_LB(V-FW.=S+_?'3/>@#L**\?\ ^&CO!_\ T#=<_P"_$/\
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MLM5DNK79O>"*,H=R*XP3(#T8=JQ_^&CO!_\ T#=<_P"_$/\ \=H ]@HKQ_\
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MUC1E"EF7!W.ISE#V]* .\HKQ_P#X:.\'_P#0-US_ +\0_P#QVC_AH[P?_P!
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M/^_$/_QVC_AH[P?_ - W7/\ OQ#_ /': /8**\?_ .&CO!__ $#=<_[\0_\
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M'^*?C7X;\(^([O0[^RU62ZM=F]X(HRAW(KC!,@/1AVH ](HKQ_\ X:.\'_\
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MZ@.-KLAR 2.JGO4RCS1:&G9W. N/#-YX/MM!\4^&-+E,\%K%;ZIID$9W7$1
MR0@Y,BDD^M1^(KAK7XK6FO7'AC6=4TR311%MM],>8K(9"P#*1@$#J#R*T_%/
MQK\-^$?$=WH=_9:K)=6NS>\$490[D5Q@F0'HP[5C_P##1W@__H&ZY_WXA_\
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MN+$H< #N<TGBGQ)9^$?#EWKE_'/):VNS>D"@N=SJ@P"0.K#O7F__  T=X/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;N3OZ7>C\DK"E\+3=THJWK;?U;+7BBZNOA/\0CXCC$\_AS6%9+F!6R(I@,C
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M,NL^,K%9/[&@MQ:P3.A7S6PHX!Y[$_B*]GI:N$7+>WZNWX6+5E*2CM?]%?\
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MC(XKW>"9+FWBGC.4D0.I]B,BO#OBAXOTKQ]I^E^$?"MU_:5]=7:-(8HVVQJ
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M_!NL^$+[Q%%J89[>6>-;.X:16,L2 JO .1@;1@XKTJBFM'==K?C<7+I;SO\
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MTMKZUDM;NWBN+>4;9(ID#HX]"#P14U% $-I9VMA:QVMG;0VUO&,)#"@1$'H
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ML-A3[*D*B+:>HV8Q@Y/&*K#PUH*Z6VEKHFFC3V;>UH+5/*+>I3&,\=<5J44
M96G^&- TFX^T:;H>F6<V,>9;6D<;8^J@&M6BB@ HHHH QKSPEX:U&[DN[[P]
MI-U<R<O-/91N[<8Y8KD\5H6.GV6F6BVFGV=O:6R9VPV\2QH,G)PH %6:*.E@
M, ^!_"IU'^T#X=TPW>[=YOV5,[O7IU]ZW^E%%'2P=;A1110!4U'2M.U>V%MJ
M=A:WL 8,(KF%9%SZX8$9I9]-L+G3SI\]E;2V14)]FDB5H]HZ#:1C P.*M44
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M=-T*^B'&5'L*=<:/IEY?P7USIUI/>6_^IN)8%:2+_=8C(_"KM% 6"BBB@ K
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M[2UUM% ')?VAJ'_/:6C^T-0_Y[2UUM% ')?VAJ'_ #VEH_M#4/\ GM+76T4
M<E_:&H?\]I:/[0U#_GM+76T4 <E_:&H?\]I:/[0U#_GM+76T4 <E_:&H?\]I
M:/[0U#_GM+76T4 <E_:&H?\ /:6C^T-0_P">TM=;10!R7]H:A_SVEH_M#4/^
M>TM=;10!R7]H:A_SVEH_M#4/^>TM=;10!R7]H:A_SVEH_M#4/^>TM=;10!R7
M]H:A_P ]I:/[0U#_ )[2UUM% ')?VAJ'_/:6C^T-0_Y[2UUM% ')?VAJ'_/:
M6C^T-0_Y[2UUM% ')?VAJ'_/:6C^T-0_Y[2UUM% ')?VAJ'_ #VEH_M#4/\
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M_H<=:_[\V7_R/1_8^K_]#CK7_?FR_P#D>@!G]H:A_P ]I:/[0U#_ )[2T_\
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M *Z?T- #O#__ !X2?]=3_(5K5D^'_P#CPD_ZZG^0K6H **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR(/AS_L%VW_HI:WJ ,'_ (2_3?\ GVUK_P $=Y_\:H_X2_3?^?;6O_!'>?\
MQJMZB@#!_P"$OTW_ )]M:_\ !'>?_&J/^$OTW_GVUK_P1WG_ ,:K>HH P?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#G_'?_ "3SQ+_V"KK_ -%-5^J'CO\
MY)YXE_[!5U_Z*:K] !1110 4444 %%%% &#X(_Y$'PY_V"[;_P!%+6]6#X(_
MY$'PY_V"[;_T4M;U !1110 4444 %%%% !1110 4444 %%%% !6#=_\ (_:1
M_P!@N^_]&VE;U8-W_P C]I'_ &"[[_T;:4 ;U%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !7/>)?^0CX<_P"O^;_TANJZ&N>\2_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?\-"^$_^@=K7_?F+_P".4?\ #0OA/_H':U_WYB_^.5@_\,W_ /4U_P#E._\
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M^JIJ>LZ2MW=I&(U=II%&T$D#:K 'J>U;]E8VNG645G96\=O;1+LCBC7:JCT
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MSC.%)]*Y[Q2ZW^H?$^^MG#VT6F06K2*<J9 ,D9]17KFN^'-'\36(LM9L(KR
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#G_'?_ "3SQ+_V"KK_ -%-5^J'CO\
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M-2O9K#5+-[ZY\P#5;OSKB15&%9^/E..,9/2M;+FDNS?YZ?>O4R3=H_+\G?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^;_TANJZ&N>\2_\ (1\.?]?\W_I#=4 7O#__ !_R?]<C_,5TE<WX?_X_Y/\
MKD?YBNDH **** "BBB@ K'\0_P#'I%_UT_H:V*Q_$/\ QZ1?]=/Z&@!WA_\
MX\)/^NI_D*UJR?#_ /QX2?\ 74_R%:U !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y_QW_P D\\2_]@JZ_P#1
M35?JAX[_ .2>>)?^P5=?^BFJ_0 4444 %%%% !1110!@^"/^1!\.?]@NV_\
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M?4[6*]F\?2>;(H<A)>$)'3[XZ?04ENQOH;OA+1=576=1U[6((K2>\4(MM$>
M!CDX)YX'ZT5!X*U2_P#[;U+1+C4AJL%JJO'> Y)SC()R<]?4]#15=%;8C2[O
MN=S1112*"L?Q#_QZ1?\ 73^AK8K'\0_\>D7_ %T_H: '>'_^/"3_ *ZG^0K6
MK)\/_P#'A)_UU/\ (5K4 %%%% !7/^*M TO5;%[Z_LX[B>QMYFMC)R(V9>2!
MTSP,'M705%=6Z7=I-;2%@DR-&Q7J 1CBHJ1<H-+>S_)E1=FKG+?"[_DF/A[_
M *]%_F:ZZL[0=%MO#NA6>D6CRO;VD8CC:8@N0/4@ ?I3=*T2'2;K49XKFZF:
M_N#<.L\@98S@#:G PO'3FMIM2FVMC*"<8)/^MS3HHHJ"S@_B\LC^!PD,@BE;
M4+0)(5W;3YRX..^/2MGP]I'B;3KN636_%2:O R82)=-2WV-G[VY6.>.U6O$_
MANU\5Z*VEWEQ=6\9D242VKJLBLC!@02".H]*H:%X,;0]2%X?%'B/40$*^1J%
MZLL7/?:$'(^M$-+W[_I84E=I_P!;E6;_ )+):?\ 8#D_]'+7)^*8;OQ#\1-3
MLI_"T_B&STZVA6"W6_2W2%G!8R89AECT!'3!KTMM#MG\2QZ\9)OM4=JUH$R-
MFPL&)QC.<CUK/USP99ZUJ2:E'J&I:9?"/R7N-.G$;2QYR%?(((!Z<9'K4VTC
MY7_&]A]7YV_#<X2/^U;OPUX6\.ZT\L4%YJLMK<!;M9'>! [)&TD;'DX53SGB
MNNTGPAH&D7^J:19SQBQO;93+HA?<J Y4R $Y ;H>V15V3P/HK^&+?0$CGAMK
M=Q+#-%*5FCE!SY@?KNR2<^]3>'_"MIX?FN;E;N]O[ZY"K->7THDE95^ZN0
M!D\ 575W_P"'T7^77UW;(2>G]6U;_7IZ;'(_#'PKH5K)JNI0:7;QWMMJUW;P
MS*N&2,-@*/;'%3>,= TJT\:^%=8@L88]1NM75)K@#YW B?@G\!^5;]OX*M;+
MQ#)JUGJNK6R2SFXEL(K@"VDD(P6*E<\]2 <9K3U70K76+K3+BXDF5].NA=0B
M,@!FVE<-D'(PQZ8HC]AOI;\-_O&UI)+K?_@?<<MXGL8/$GC_ $KP]JFZ3218
M37CVV\JL\@95&[!&0H)./>N3UR$Z=X5\=>'K2>4:?8W-H;0%RQMQ(48HI/.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH Y_P =_P#)//$O_8*NO_135?JAX[_Y
M)YXE_P"P5=?^BFJ_0 4444 %%%% !1110!S5CX3N]-T^VL;3Q7K4=M;1+#$G
MEV9VHH  R8,G@#K4_P#8&I?]#?K7_?JS_P#D>MZB@#!_L#4O^AOUK_OU9_\
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M-%_\&$7_ ,51_P )OX3_ .AHT7_P81?_ !5=?10!R'_";^$_^AHT7_P81?\
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M1?\ Q5'_  F_A/\ Z&C1?_!A%_\ %5U]% '(?\)OX3_Z&C1?_!A%_P#%4?\
M";^$_P#H:-%_\&$7_P 577T4 <A_PF_A/_H:-%_\&$7_ ,51_P )OX3_ .AH
MT7_P81?_ !5=?10!R'_";^$_^AHT7_P81?\ Q5'_  F_A/\ Z&C1?_!A%_\
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MKVSN1W?RV0JW_ EP:E26M^E_N4;_ (.WWBG=6MU_/F2_*_S/;Z*\3^T>)XO
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJEHI:6,H0.,9PW0XR*Z&OE;0=?TG1]2\,^*5U**36KC4IFU:%2=PBF.!G/&
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT5F4]<]:Z>W^%VI&XU^[U+Q.U]>:UIILYI'M0H1CT90"!M P-OZUZ8    ,
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HK+\1Z_9>&- N]8U L+>V3<0OWF/0*/<D@5YW%X\^)>HQ)>:=\
M/$^Q3#?"9KQ5<J>A()!'Y4KW=@/6**\H/Q-\6Z!)#<>,?!9T_29)%B>[M[A9
M/*). 6 )X_+\:]5CD26-9$8,C ,K#H0:JVEQ7UL.HHHI#"BBB@ HHHH **Y[
MQGXNL_!F@G4KJ&2X=Y%A@MXOOS2'HHKBAXS^*L@#Q_#N!4;E0]ZH('OEAS^
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MLX:!@;:]2'#1;7W+\N[G ^7.1^%;UUX6T^[\(#PTX9;-;=8%*<,NW&UAZ$$
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2#/Y"O5J*5M;@>6P_"+4;^X@'BGQOJ6N6$,@E%D\?E([#IN^=LBO45544*H
M4#  ["EHJKZ6%;6X4444AA1110 4444 8?BSPKIWC'0I-*U$.$+!XY8SAXG'
M1E/K7#?\*N\9)\L/Q3U5(EX16MBQ [9/F\UZK122L!YMI'PJN5UJSU/Q1XKO
M_$+6+^9:PS)Y<:/_ 'B-S9/Y5Z31157TL*VMPHHHI#"BBB@ HHHH X[QE\/[
M?Q5>6FIVNI76D:S: K#?6OWMI_A89&1SZCJ:YO\ X5CXV_Z*MJ?_ ("'_P".
MUZK122ML#U.,\'_#V+PSJ-SK%_JMUK.M7*>7)>W/!"?W57)P/Q-=G1157$E8
M****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *QO%UY<:?X.UJ\M)3%<064LD3@<JP0D'FMFN?
M\=?\B!X@_P"P?/\ ^@&LZKM!V-*2O.*?=' ?#.?Q!J@TO6M4^(,-W%-"TDND
MM'&''!')!SQP>E=%;_&'PC<ZRFG)<W(1Y?(CO6@(MGD_NA_ZXQ7*^ _AUHEQ
M\+X-9TZP\OQ#>:9-&MUY\GWW5E^[NVC\JY.Y\0V&I_"*P^']I:7'_"4K.D+6
M7V=@T;K)DN3C'3WSS6TG[_+VMIZO7[OZT.>.L%*^_7M9?K_6IZ[J7Q4\,Z5X
MCET&YEN?[0CN(K?RUBSN:3&"#GH,C)_G7;5Y)X#L53XR^,&N LEQ;VUK'O(R
M<F-=Q_';7K=*WNI]_P#@_P"12;;?3_AD_P!0HHHI%!7$_%+Q%?:!X46/2)?+
MU?4+F.TLR "0['D\^P-=M7C7CI-<\7?%C3]'\.7%K#/H-M]L:2Z!:-96(QD
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MS<?6-_RO^>GD=KK?Q5\/:!JLEA=Q:DQAV^?/%:,T4&X C>WT8=,U'>:G9/\
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MEEABG39+&DBYSAU!&:?10 PPQ&3S#$A?;MW;1G'IGTI1&@((1<@8!QT%.HH
M9Y4>S9Y:[/[N.*?110 5!>_\>%S_ -<F_D:GJ"]_X\+G_KDW\C0!A>'_ /C_
M )/^N1_F*Z2N;\/_ /'_ "?]<C_,5TE !1110 4444 %8_B'_CTB_P"NG]#6
MQ6/XA_X](O\ KI_0T .\/_\ 'A)_UU/\A6M63X?_ ./"3_KJ?Y"M:@ HHHH
M***P/%NO7>A:3OT_39]0OYMR011CY5(!.YVZ*H R3^'>IE)15V-*[L;]%>?R
M^)M6'P/'B,78&JG31<>?Y:_?]=N-OZ5N:!XX\/\ B"X6QL-32>]$0<H8W3>.
MY0L '&>ZY%:.-I./5$*2:3[G24445)045Q/Q2\0:OX;\*PWVBN1=F]ACVA%?
MS%).5P0>N,<<UD^'?'MYXE^*/V.RGSX?.F>9& BD23#86(;&>!(%QG&0:(^\
M[+^M+_UYBD^7?^M;?UY'IE%<?8^*+;6/'265AK<@ABM9?.TZ73Y(S(ZL!Y@D
M=!P,XP#SFM37O&&@^&I88M6OQ!+,"R1)$\KE1U;:@) ]SQ2NK)]Q]6NQN45Q
M'BOQE#ID'AC5+35(8])O;]5GG 5EDA,;G&2"1R!TY[5O:'XJT3Q'#<2Z5?"8
M6YQ,KQO$T>1D95P"!COC%/OY?I;_ #%=?U\_\C9HKFM.^('A;5M633++55EN
MI"RQCR9%20CKL<J%;\":DUCQUX:T#418:GJB07.T,R"-W$8/0N5!"#_>(H[>
M8^_D=#17*>.6U6/PS=:OHNO2V'V.TEN-L4$4JSX7*Y+J<#CMZUNZ+<2W>A:?
M<SMOFFMHY'; &6*@DX'O0M;^7]?H';S_ *_4O44AZ&O YOBUXAC\#ZG&+C_B
MH([YA;R^3'G[*"Q+[<;2 $9<X].])/WN7^MTOU^X?]?A<]]HK-L]9L[B^&F>
M?NU!+6.YECV$81L@-G&.2#P#5<^+="72FU1M01+%;DVC3.C*JRA]A!R./FXS
MT]\4WI_7G;\R4TU?^MK_ )&U16!HOC;PYXAN[BTTK5([F>!=[H$925Z;ER!N
M'NN151/B3X/EO+2U37(#-=8$0V/@DG #-C"D^C$&CJEW"]CJJ*Y_7?&WAWPW
M=);:KJ/DSLGF>6D,DK*O]Y@BG:/<XJVOB32'ETN-;U&.J*6LF56*S +N.&Q@
M''."10M=AO3<U:*I1:M8SZO<:5%/NO;>))9HPC?(K9VY;&,G!XSFKM !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !5*76-,@E:*;4;2.1>&1YU!'U!-<I\7=9O="^&^I76GRM#<.4A$JG#('8
M*2#ZX)K(T[X&^"#IMLUY8W%U<M&K2SO=2 R,1DD@,!UI*[N^BT_"X.RLNYZ-
M;:C8WK%;6\MYV49(BE5B/R-6:\1^('PXT#P+X5E\3^&$N=-U/3Y8WCD2Y=@P
M+A2I#$\<U['I=TU]I%E=N &G@24@=BR@_P!::LTVNG^5Q.Z:3Z_\,6Z***!A
M1110 4444 %4&UO248JVJ62L#@@W" C]:X7XR7MXNBZ-H]I<R6R:QJ<5G/+$
M<,(SU /OQ3D^!?@!8U5M)F<@8+-=RY/OPV*2NTWTO;\O\P=D[?,] MKVTO0Q
MM;J&<+P3%(&Q^53UX?XR\(Z5\,+O0/$'A47%E,^HQVMQ%Y[.DT;9R&#$^GZU
M[A35FKKO;^OO%JG9^OZ!1110,**** "BBB@!DLL<$32S2)'&HRS.P 'U)JE_
M;VC_ /06L?\ P(3_ !KS/Q;IR>-_C%:>%-5FG_L6TTW[:UM%(4$SEL?-C\/\
MFM?_ (49\/\ _H#R_P#@9-_\525VE+O_ )V_0':]NW_#GH4,T5Q$LL,B21MR
MKHP(/XBGUY!X<TV+P)\9QX8T>6==&U'3C<FUED+K%(">5)Y_A_6O7Z>C2DNO
M^=A:W:?3]5<****!A1110 445YK\1_'5_HFM:-HVBOMGENH3?3!%810N^T*<
M@@%CGWP*.JCW=@>B;['I5%%% !1110 45YS>R>*]<^(6MZ3I7BIM(M+"WMY$
MC%A#/N+ALY+#/4>M:/A;QHLGA5;SQ)=V\%Q#?2:=)<!2L<DBN5##LH./I233
M5_G^-OS$W9V_K:_Y':T5@Z'XT\.^));F+2=4CN'MANE7:R$+_>&X#*^XR*CT
MOQWX9UK4_P"SM/U6.:Z.=B^6ZK)CKL9@%?'^R33ZV"ZW.BHKFKOQ_P"&+&_N
MK&XU/;<6C[+A1;RMY)P#ER%(5<$?,>/?BK^L^)]&\/V,-YJ=^D,,Y A*JTC2
M'&?E502W'/ I75KCZV-:BLJS\2Z-J&B2:S;:C"^G1AC).25$>W[VX'!4CT(S
M5?0O&6@>);B6WTJ_\Z:-=[1O#)$VW.-P#J,C/<9%/K85U:YNT5S%U\0O"MGJ
MYTN?5D6Z640MB&1HU<]%,@78#[$UG_$2?7=(TW^VM+UZ:TBA>"-K,6T+I)NE
M522S*6'#=CVI7V?1_P# _P QO2_E_7Z';T44R6188GE<D(BEFP"3@>PY--NV
MK ?17"^'/B9IFN^(+_3#YT>VY6&R/V*<>:NP,2Y*80Y)X;''UK;USQKX=\.7
M:6NJZDL,[KO\M8GD*K_>;8IVCW.!1T3[BOOY&_14=O<0W=M'<6\J2PRJ'21#
ME6!Z$&BXN(K6VEN)VV11(7=L9P ,D\4/3<:UV)**YFT^(7A.^U:WTNUUJ"6[
MN IB55;:Q(R!NQMW8_ASGVI=5^('A?1-2?3]0U58KE,>8%AD=8\]-[*I5?Q(
MH%='2T5QWC/Q[:>%?[/C4-+-=7$(.+:611"S89@R*06P#A<Y/H:VD\3Z5)X?
M;75EG_L]<Y<VDH?KM_U>W?U]J.C?8?5+N:]%<UX,U8ZS9:C=_P!LG4X?MTBQ
M$V;6[6Z#&(BK*I)7U(YS7%ZIX^?6/&3:7I?B.\T>SAACVR)HKS-/*S,"&#QG
M:HP.< ')YXH6LE'JQ-I)OHCUFBJ%KJ]C=:G=Z7%<;[VR5#<1E"I4,,J>1@@X
M/3-.TO5K'6K1KK3Y_.@65XB^QE!9"5;&0,\@\CB@+EVBH+R[AL+*:[N&9884
M+N51G( Y.%4$GZ 5R/@_XBV'BB\NK,B6*Z6ZFC@06DRAHDZ,SLNT,>3@D$=,
M4+5V0WHKL[6BO/8OB+I^D>*?$MAX@U81Q6MU&MK$+=G,<9B5F)V*3MR3\S?G
M76ZGXET;2-(CU6^OXH[*7;Y4B@OYFX9&T*"6)'8 TKZ*0=6C5HK-T77M+\16
M)O-*NUN(0Q1B%*LC#J&5@"I]B*TJ8)W"BN9U#XA>%=+U5M,O-62.Z1PD@$,C
M)&QZ!G52JGD=2.M6]6\7:'H=['9:A>F.ZEB\V.%(9)'D7.,J$4EOH.>_2E=6
MN'6QMT5B3^+M MM 379M2B73'=8Q<;6(#%MH!&,KSP<@8[XJ31_$^CZ]+-%I
MUV9)80&>.2)XG"GHVUP"5..".*8KHUZ*YNV\>^%[O6?[)@U>)[PR&)1L<(SC
MJJR$;">#P#FJ?BSQ3;6-[9Z3#K<FEZ@]U!EFT^29)$9L>7OV% 6Z9SQ0M;6Z
MC;M?R.PHK*UKQ)I'AT6YU:]6U%PQ2(LK'>P&<< \XZ#OT'-5[+QEH.HZ7>:C
M:7CRV]GQ< 6\HDCXSS&5W]/;FE=!Y&[17%^"OB%9>+#+;L)(KT3S!(A:S*OE
M(Y"DNR[<D#)&<YXQ5A_B9X/22:-M94/$7#+Y$N2R-M90-OS,#V&3CGIS3%>Y
MUE%8NH>+="TO1[;5KS48TLKH*;=U5G,N1D;54%FXYX%-C\8:!+X>?7DU*,Z9
M&VV2?8WR-N"X9<;@<D<$<4=_(+K3S-RBL'2?&?A_7+]K'3M0$MRJ&0(8G3>@
M_B0LH#CW7(K!T[XGZ7>^+KW26\]+=/)2V?[!<;I)'W;MWR?*.!@G ZG)["U:
M2!M)-G>4453U35;'1=/EO]2N8[:UB^](_0>@]2?84F[;C+E%8NC>+=#U^UN+
MC3+[SUMAF9#$Z2(,9Y1@&Y'3CFN"@\<S>)?',UGI_B2\TRQAEACMX$T9W^U;
MAN;>SQYC]!G;QS[TU\2B)M*+D>KT45POC2\UY_%OAS1-%UMM)6_2Y::5;6.8
MG8JD<.#ZGICK2OJEW_X/^0^C?8[JBO*KOQ5XDTSPAXS@GU..YU/0G1(=3CMT
M3S-P5N4Y7<,X/:M*SU+Q1X8UW1K?7M8BUK3-8?R(Y_LB02V\VW<H(3AE.",]
M::L_P_%7_03=OQ_"W^:/0Z*\JGUWQEJ.C:KXQTS5H(--L9IO(TEK16%Q#$Q#
M%I#\P+88C'M7I>FWJ:EIEI?1#$=S"DJCT# '^M"U5_3\5= WK;U_#1EJBN5^
M(.L7^A^&H[O3I_(G-[;1%MBM\KRJK## CD$TFIZS?VWQ(T72HI\6-Q8W,TT(
M13O9"NTYQD8R>AI77]>E_P @;M_7G8ZNBO+M'U/QQKNEQ^*-,UFTNHWN,'05
MMHU"QA]I4RD[@X'/.![5>^)_BO6/#Z:9'H;A;C+WEVI16S:Q %QR#C.X<CGW
MI[6OU_4.]NGZ:?GH>AT5%;3QW5K%<1-NCE0.A]01D5+3:MHP335T%%%%(844
M44 %%%% !1110 45Y5XR?5/%OQ+M?!%MJUUI>FQV)O;N2U;;)-EL!0>PZ?F>
M#1_PHS3_ /H;/$W_ (%K_P#$TE=J_P#78':]CU6BO)_"C:GX+^*'_"%2ZQ=:
MII=W8F[MFO&W20L"<C/IP?;I7K%/1I-=?^&%?5I]/^'"BBB@84444 %%%% !
M17BNG:+J'Q8US7[W4O$.IV&G:??/96EG8RB,#;U9N""3QV[]:U?^%&V2\Q^+
MO$RN.5;[6O!['[M)7LF^NOWZAI=I=#U6BO/?A1KNJ:C9:SH^KW9O;K1;YK07
M3?>E09P3[\&O0JK31K9Z_>)/=/II]P4444AA1110 445%<S"WM9IR,B-"^/7
M S2DU%-OH-*[L2T5X?X6\(W_ ,4](/BK7?%&KVYNII!;VME,(XX8U8C&"#Z?
M_KK8F^"D=K!)<:?XQ\1Q7D:EH7>Z!4,.F0 #C\:)7@KST$K/X3UBBN*^%?B6
M]\5>!+6^U%@]Y'(]O+(!CS"IQN^I&*[6JDK.PD[H****0PJ"]_X\+G_KDW\C
M4]07O_'A<_\ 7)OY&@#"\/\ _'_)_P!<C_,5TE<WX?\ ^/\ D_ZY'^8KI* "
MBBB@ HHHH *Q_$/_ !Z1?]=/Z&MBL?Q#_P >D7_73^AH =X?_P"/"3_KJ?Y"
MM:LGP_\ \>$G_74_R%:U !1110 55U/_ )!5Y_UP?_T$U:I&570HZAE88((R
M"*B<>:+CW0XNS3/*I-H_9J7=]W^QUS].*NWNHZ3K&N>!(M N;>>2&4S8MW!,
M5L(2&W8Z#)48/>N__LS3_P"S1IOV&V^P!/+%KY2^5M_N[,8Q[8IEGH^EZ=<3
M7%CIMG:S3G,LD$"HTA_VB!D_C6KE>HY=W?[D_P#/^KF2A:"CY-?>U_D3/>VD
M=Y%9O<PK=2J7C@:0!W4=2%ZD#(R:GJ![*TDO(KQ[:%KJ)2D<[1@NBGJ W4 X
M&14]2:'&?$8 V.A C(.N6?\ Z'69IN@V'AKXG:/INFQ&.V72;N0 G)RTR,?Y
M_E7H%S9VUXL:W5O#.(W$B"5 VUQT89Z$=C0UG:M>)>-;0FZ1#&LY0;U4G)4-
MU ) X]J(^Z[^;_*WYZBDK_=^M_\ @')7O_)8])_[ UQ_Z-CJK;7]AI'Q2\0-
MK%S!;/<V5NUI)<.$#1*&#JI/HW)'N*[=K.U:\2\:VA-TB&-9R@WJI.2H;J 2
M!Q[5!J.CZ7JZ1IJ>FV=ZL9W(+F!9 I]1N!Q2M9+Y_B#5[_+\#SB]ET?4[/P-
M+I6GM;Z9)KS-%%*H ?"RG>!D_*3R/Y"KM_=1:?XZ\9W<MJ;F*/08))(%ZR@&
M7C\1Q7?R6%G+]G\RT@?[,P>#=&#Y3 8!7CY3@D<4HLK1;N2[%K"+F5!'),(Q
MO=1G"D]2!D\>])K1I>?XI+]/ZL"6MWY?@V_U/&&OKNXOO 7VC6M':"2_A>VT
MO38?^/>/8<9D+%CC(7H,FI&%[;:SXU6Y\86&C*;MY+BUN]/29YH"@V$,SJ67
M;P !US7JT'AK0;4DV^B:;$3*)B8[2-<R#H_ ^\/7K4M]H>D:G<17%_I5C=SP
M_P"JDGMTD9/H2,C\*<E>_G?\;??MUW%%-?*WX7^[?IL<A+;BU^!4\ GFG5-$
M<++-%Y3LOEG!*Y..,<9-=7X<_P"18TG_ *\X?_0!5^>WANK>2WN(8Y8)%*/'
M(H964\$$'@CVIT<<<,211(J1HH5448"@= !V%4W>4GW_ .#_ )A&-E%=O^!_
MD*?NGZ5X=_8&GR?!W4?$#1$ZA'9WEJKYXV&Y9OS_ ,37N54_[)TW^SGT[^S[
M7["^=UMY*^6V3DY7&#D\U-M6_3\[_EH7V_KH<1;:A9:5\4;B34+N"TCFT&W\
MMYY @?:[;L$]<9%<J7@U#X':C(N);>XUIV'HR->#^8->OWVBZ5J@A&H:9978
M@.8OM$"R>6?5<@X_"E.D:8;-[,Z=:&U>3S6A,"[&?=NW%<8)W<Y]>:?K_7O<
MW_ ,U&R5OZ]WE_X).MM!&%9(8U9(_+4A1E5_NCVX'%<9\+K*U_X0.$&WB(DO
M+B5LJ#EQ.V&^HP,?05W-0VMI;6, @M+>&WA!)$<*!%!)R3@<<DDT+1M]_P#.
MY5M$NW^5CS76-8G;Q;XCAL=0TC0$M(8A>7=Y#YL]T-A(VJ65=H!QWYK.L[>0
M_ OP]K-L"UUHI2_CP.2J.V\?BA;BO4KK1-)OKV*]N]+LKB[A_P!5/+;H[I_N
ML1D?A63XCT34Y]!&C^&AIFGV]P6BN2\1'EQ-G<8U48W\GKQSFH2<8Z;Z?>FW
M]VORU[C:3EKMK^*2_KY=BA\.0VHV&H^)I%(?6[MIX]W40+\D0_[Y7/XUVE5M
M.L8-+TVVL+9=L%M$L48]%48%6:T=EI'9$QO:\MV%%%%(H**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ.CKHI/#6@RW%Q<2:)IKSW*E9Y&M4+2@]0QQEA]:;XAN]$TK09+C74@&EQ%
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MBR&-2[31HQ(ZK]G''TYKCD6]&A?#.XCUB'28%LW1;VXMQ-'',479D,P ) 8
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MO[W1?"ME-?W2PV,$\Z^;)% ?WDKD*"P09))P,FE9-6?_  -5;3\?FT#O>_\
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M/^3_ *Y'^8KI* "BBB@ HHHH *Q_$/\ QZ1?]=/Z&MBL?Q#_ ,>D7_73^AH
M=X?_ ./"3_KJ?Y"M:LGP_P#\>$G_ %U/\A6M0 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-V7$,R#!R&4;@0P)''.:I6G@'5IO#.M66K:E;'4KW4O[2@NK=&VQR#85RI[
MKC&3QWJGO*WG_P"E+;_MW^KDQYN6-]]/_27O_P!O?U8S_"/CLW/BRWT8>++?
MQ)#>6\CB5;18'MY$ .,* "I!.,\Y'6JEIXA\8IX&M/%USKL<BBZ2-K'['&$E
MB,WEY9@-P;G/&![5V>D:=XOGUE+[Q#?Z?%;P0M'':::TA29FQ\\F\#IC@#.,
MGFLP^"-2/PO@\,>?:?;8YD<R;V\O G$AYVYZ>W6CJGZ?^E?_ "/X>8-.S7K_
M .DO];?/R*?C;2]5N?B!X7:V\0W-H)Y9Q J6T+"W(A.2-RDMG_:SC/&*]#LX
M9K>RAAN+EKJ9$"O.R*ID/=B%  S[5S_BS0M4U&ZTC4]%ELUU'3)GD2.\W"*1
M70JP)4$C@Y'!K<TPZ@=.A.JK:K?8_>BU+&,'/\)8 ],=:(Z1MYLI_%?R1/<%
MQ;2F-MK[#M;&<''6O._!<WCGQ%I&D>(+GQ!9QP2D>;8"Q4K+&#M+%P<AS@G
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M+3T107M!.]S*R[CG<#M0 @<8/)YKM_!VA77A[1Y[.[DA>22]N+@&(DC;)(6
MY YP>:S-0T#Q)IWB*_U7PO/I934U3[5!J'F )(HVB1"@.>,9!].M2[Z+R_&R
M_6_E<:ZOS_"[_2WG8Q[7QKJOB?1?#-MI5U#9:CJ[3">[2,2+$L.0[(K<')QC
M/8U9\$VVJ6GQ \60ZM>)>W"Q6FVY6(1F1-KX+*. >H...*NW?A/6ETS1+FTU
M:.Y\0:4S-]HO0WEW <8D1L9*J>,8SC J;PIH&OV'B+6M9UZYL)9=12 )'9[]
ML6P,-OS#D<CGOD\"K7Q-^OZ6M^/]6)=[+Y?F[W_#^KG7UYO'>^+]0_X2F^M]
M<2"'2KR9+.V^RQLLP10VV1B,X[ C!]S7I%>3:78>*M2O?&5EI%[IT.GW6JRP
MS/<A_-@RBAFC X8D'H<8(K-\S;4=[.WK=%Z:7VNONU.CM/%5WJ?B3PE]GD\N
MPU73)KN6#:IRP$97DC(QN/0USGB[5=2U+PMX]M9)A*++4+>&T0H $!\IL< $
M_,3UYKI=5\):E:3^'[WPQ)9"XT>W>T6&^+".2)E4'YD!(8;0>E9,G@+Q#=>&
MO%-G=:C8'4=9O([F.:(.L<>W9D8()XVD#KG SC/%RLV[;:_^E1:_"Y$>9)7\
MO_29)_C;U+]G>>)/#WB?1['6]8CU2UU=9(P!:K";:95WX4K]Y2 1\V3QUJ?4
M_P#DK^@?]@N[_P#0XZ=IWA_Q'>>(;#4O$UUIKQZ6CBU2Q#_O9&&TR/N'RG;G
M"C/4\UI7FA75QX[TS7$DA%K:V4]NZ$G>6=D((&,8^4]Z:WB_7[K.W]>@K/E:
M]/ONK_UZF1\2&UG3]#FUC3M;DM8K<1JUG]EAD24F11DEU)'![>E:'C'6;_3+
M#3K32VBCU'5+M+."65=RQ9!+.5[X"G ]:L^,]$N?$7A6[TNT>))YC&5:8D*-
MKJQS@$] >U-\5>'Y]<TRV%E<QVVI6-PEU:2R*602+V8#G:02#]:CIKM=?=U-
M'>^G9_?T(] M?$^GZI<6NL:BFK:>8E>&]:%(9%DR0R%$P",8(.*Z2N9T'3/$
MAUF;5O$5[:AC ((;'3Y)# HSDN=^-SGITX%=-5]$)=3S7QIX@U/3M6O%D\96
M'AZ&*(&RMA#'<2W9VY)=6!91G@ #\:E7Q7K6OZ5X2L]-N(M/U'6[5KF>[\H2
M>2B*"VQ3P22P SP*FN?"'B*WU[7KG2I](\G6"&:ZNT<W%M\@0J@ PPP,C+#\
M:2#P5K6G^'?#)L+JQ37=#A,(,I=K>=&&&4D , < YQP140V][R_]NO\ I?\
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MP39F)"X217/0'G .*([0\K?GK^ 2^WYW_+3\3/\ '>J:S82^'K;1+N.VFO\
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M&HB1HJ(JJBC"JHP /:G444 %%%% !1110 4444 9FH^&]"U>42ZGHNG7L@&
M]S:I(1^+ U6A\%^%;:9)H/#.C12H<JZ6$2LI]B%K<HH6FP/7<**** "BBB@
MJ"]_X\+G_KDW\C4]07O_ !X7/_7)OY&@#"\/_P#'_)_UR/\ ,5TE<WX?_P"/
M^3_KD?YBNDH **** "BBB@ K'\0_\>D7_73^AK8K'\0_\>D7_73^AH =X?\
M^/"3_KJ?Y"M:LGP__P >$G_74_R%:U !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!P'Q#\<+H36FDV5]-97]S<QI+<K823^1$P)+
M*-I5F^7&WD^U:FGZ_;Z3X/M]1U76[O44F<JEX=,=)&))P##&F1C'4K5?Q[_R
M$/"'_8=B_P#0)*[)_N-]*B[5.3\W^"0/XUZ?YG/^$-1>[\'VNH76L#5=RN[7
MHMC!O 8_\L\ C &.G:J]M\1_"%YJ%I8V^N027%V%\D!7VL6&0I;& Q_ND@^U
M5/AK_P DRL/]R;_T8]-^%=E:K\,]% MXL,K3'*@Y?>3N^OO6C^-]M/Q)UMYW
M?X7+DOQ'\)0W4]M)JZB:!WCD3R)"0Z'#*/EY;/11DGMFNAT^_M=4T^"_L9EG
MM9T$D4B]&4]Z\:L(8VUS2R44D^*]38\=2(WQ_(5W_P +?^2::'_UQ/\ Z&U3
M!\T;OR_3_,<G:5O7]?\ (ZFZNK>QM);JZF2&WB4O)(YPJJ.I)K'T+QGX?\27
M$EOI6HB::-=YC:)XV*_W@'4;A[C(K,^*"._@>=MK/!'<6\ERH&<PK*I?/M@'
M/M5#4]1TW6/B#X1_L6ZM[J6%9Y9GMF#A+<QXPQ'0%MN![41U=O.WX-W"3LOE
M?\4K?UY&3X@\?M?^+QH^F>(KS1K6&#<\\>C23O+,7*[,/&<*,?> P3WKU.(,
ML**[F1@H!<C&X^N.U<?!_P EFO?^P%%_Z.:NSHC\"_KJU^@/XW_71,P?%_B>
MW\)^'KG4IE=Y%1_(C6)W#N%+ $J#M''4X ]:B\/>++3Q+H+W=F\GVB*!6G#6
MTD01RN<+YBC<,YZ9J7QM&\O@77HXU+.VGSA5'4G8:@\.ZKIVH>#K2.SOK:XD
MCTZ,ND4JLR_N\<@'(Y!J)-\D_)?H_P#(I?%'^NJ_S,/P1\2M(U31=&M=3UE)
M-:NHPLA,+*K2G/R[@H0-_LYS[5T>N^,_#_AJXCM]6U$032+O$:Q/(P7^\P13
MM7W.!7G,<,47P,\*^7&JG[;9/D#^(W R?KS4]X-1M_B1XH/_  EECH)DC@D0
M7EBDWGP"/'RLSKP&W9 [FM:CM)^3?X)/]?P,X/1?+\6U^AZDJ:?JL=I?".VN
MD7$UM,5#[21C<A['!/(]:J>)M:7PYX9U'5VC\S[)"T@3^\W8?B<5D_#:".W\
M!Z<D-W)=P'>\4LEOY!*%V(PFYL#GCGIBG?$K3Y]3^'>M6UM&TDWD>8J*,EMC
M!L#_ +YJ:ONIK;^E?]?N-*?O-7_K?^OF9VEV_C^SNM+O[W5;?5K:[91>6*VL
M< M%89W(^<MMZ$')/:MC4?'GAC2=6.F7NK1Q78(#KY;LL9/0.X!5/^!$54MO
MB#H=U'HL&FW,>H76I,J+;VTBL\2[<L[C^$+WS7*Z;J>C:;X-\8V&M7%NE]]L
MO3<P2L!)+O)\LA3RV5*@8HF^6^FU_GJE9?T]S.&J6NKM\M'K_P #38[C5O&W
MAS0K];'4M32"X:-90AC=AL9BH;(! &1R<\=\4B>.O#3Z1=ZJNJQ_8;2589YC
M&X",Q 7(QG!W##=,'.<5Y+K5M<0Z3J,=^I-W%X*MUDW#D'S#D?I5K7S;6VD>
M.C.H%K'=:477'&P+%G]*>SMY_K;\AJ3=G_6USUG2/%.C:[<2V^G7ADFC7>4>
M)XR5Z;E#@;E_VAD>]46^(7A5-9_LIM63[7YWD<12&/S.FWS-NS.>,9K&NM2T
M_5OB/X>ET>XANQ:V%S+<M;,'"Q,%"*<=,L.![5Y_J^KSW_@*WN(]2T?3M,GO
MX_L^BVT.^?/G@G>[-D,,%CA?:DG>27]?%R_UYKMJ)RM%O^OA;_KR?<]>U7QQ
MX=T2_EL+_4#'=Q*KM D$DC[6S@@*I)'')'3OC-6HO%&BSMI8AOTD&JAC9,JL
M5EVC) ;& <=C@]:Y_28T;XN>)9"H+C3K10V.0"9,C]!7*6UK(OP<L=7M4S<Z
M)J$M_$ /X4G?>H^J%A0GHG+R?R;:_P G]Y3O=I>:_!/_ ('W'JL6K6,^KW&E
M13[KVWB26:,(WR*V=N6QC)P>,YJ[7%_#D-J-AJ/B:12'UN[:>/=U$"_)$/\
MOE<_C7:4[-)7W!.^JV/-_'GCL:?JUCH6GZK<Z;.\S"[NTTR2X,2B/< @*%7)
M.,XS@>E;5YJ&@6W@RRF\67T&IVDP4K+?6 W7#')7$ 7.['8+GBH_%/\ R/O@
MK_KXN?\ T2:@\3W%O8?$?PO?:E)'%IXAN8DEE(").P7;DG@$J& J8ZQ2?5O\
M/ZT"3LVUT7YFUH^N^&CX:DO](FMHM(M%8N((3&(0O+ QX!4CTQFHK+Q]X6U'
M68](M-8@EO9!F-%5MK\9P'QM)QV!S7+V\L%]JWQ"O=.=)-.>S2-I(^4DG6)]
MY!'!(!4&NF\"65K'X!\.!+>(".RBD3Y1\K%.6'H3D\^YJD^;5]E^-_\ +\1;
M:+N_PM_G8Z:N-\8^/[/PKJ.F63K(TMS<QK.?LTSB.$[LL"JD,WRXV@Y[XKLJ
MXGXARQVTOA6ZG=8[>'6X6EE<X5 5<9)[#)%)[KU13V?HQ?%WB\6?A+3]=TR]
M-O:S7]NDDTT!3]R9 'RLBY7C/. :VM"\7Z%XEFGATF_$\L #21M$\; 'HP#@
M$CW'%<]\1;BRU3PQIK03P7=L^LV:,T;AU/[X C(XI=4CD/Q4VVWRSOX>F"$<
M9;S1M_4TN:R;MW_"-_Z]1.]UZ+_TJWZ_@;$/CWPQ<:W_ &/%JT;7ID,078^Q
MG'5!)C86]@<UT=?/^G0S3> =(L[KQK:I']HAC&E0Z4CW45P) =N?-#;@P)+$
M=,G%?0 Z#-7:R_KLG_6_02=W_7=HH:QK>FZ!I[7^J7:6ULI"[V!))/0 #))/
MH!FJ%GXS\/W^B7FL6VHA[*R!:Y8Q.KQ #)W(1N''/3FL;QO+!9^*/"-_J#*F
MFPWDJR22<)'*T9$;,3P.<C)[FJ'B._T;5]&\<)HUL9[Q--VW5Y!AHY3L;:@(
M/+*.O'<<UFY6BWZ_A;_/\MRTKR4?3\;_ .1VLVN:;;MIJRW.TZDX2T^1CYC%
M2V.G'R@GG%8=YXW\%^&[F\AGU"UL[C[01<QQP-O,FU268*N3P5RYX]^*YJ^U
MS2]0U+X<6UE?V]Q-YXD*12!BJBW89..G)QS6UX6M8&^(GCB=H4,K36L98CDK
MY(./I6C7O-+^]^#7^9G&5XIOM'\;_P"1T%_XKT+3+6UNKW4X(;>[1I()6/R2
M*%W$@].G/OVJ/2/&'A_7=-N=0T[4XI+6US]H=U:,Q<9^8. 0,<\BL'QQ:6\G
MB#P/ T$9A753MCVC:-L+D<>Q _*I?BE:2O\ #[5C9J$=S$]PZQ[BT:NNXD?Q
M84'CT&*AOW6_.WXK?[_P*5^:WDG^?^1KZ'XT\/>)+F2VTK41//&N\QM$\9*Y
MQN4.HW#W&15-?B1X2:X2$:PNYI3"6\B38C[MNUVV[4.>FXC/&.M<GIB277CC
MPW)/XVM-9ECBFD@BL-,1 L)3!#NLAVK]W&0>15!8HU^ VNLJ*"UY<N3CJPN3
M@_7@?E5=?Z_F4?U^]"3;T[_Y-_I]QV/BSXA67AC7-+TV19&-Q,!<M]EF?RXM
MC$%2JD,<@# R1UQ75V%];ZG80WMJSM!,NY"\;(2/=6 (_$5QWC::.UU;P3=W
M$BQ6\>I_O)9#A5S"X&2>G-=I:W=M>P">TN(IX22!)$X920<'D>A!%"^%W[O]
M 3NUZ+]1\LBPQ/*Y(1%+-@$G ]AR:\K@\<S>)?',UGI_B2\TRQAEACMX$T9W
M^U;AN;>SQYC]!G;QS[UZO7&>%?\ D??&_P#U\VO_ *(%)?&O1_I_F.7PZ>7Z
MC_$?B>WAUW3=&MM;DTZ^^VQ"56TZ25)T8']T)-A12WKG(Q6[KGB'2O#=FMWJ
MUVMO$[[$^1G9V]%506)^@K ^('7PQ_V';;^35#\0X[5[C0BVM2:+J2W+FQOS
M$KPH^PY60,0,,,@4DWR_.WY#>_R_S.ETOQ%I.M:6^I6%['+:1EA)(P*>65ZA
M@P!4CW JCHOCGPWXAOC9:7J:SW 4NJ&)TWJ.I0LH#CW7-<!+>:AJWP^\:VDD
M.GW-Y;2@7%]I:82^&U6<^[A 5/-=<FO^%+_5/#<-FL6H73JS61M&5OLJ;.6;
M!&U<?+WY(&*I:O[OQ3=_P_,AMV^_\&E^I<U#XA>%=+U5M,O-62.Z1PD@$,C)
M&QZ!G52JGD=2.M4/B--K>F^'KG6](UZ:Q%I$";=+>&1926 R2ZDC@]J\\\2:
MS->>"?%$MOJ.D:-IIN;B(Z:L/F75S+OP2Q9OE+$9X7@?G7?^/3GX07QSG-G%
M_-:F.L5+SC^-G^O^9=_?Y?7\'8[:)BT2,>I4$TR[NH;&SFN[ABL,*&21@I8A
M0,DX )/X4^'_ %$?^Z/Y4KHLD;(X!5@00>XJIWUMN33V5_(S)?$FD0:/::L]
MX/L5VT:P2JC-YAD("  #/.1VX[U!KWC#0?#,L,6K7X@EF!9(UB>5RHZL50$@
M>YXKSCPO!<7'BZQ\&3(QMO"]U/=L2.&0_P#'L/? D;_OFK>K+J,/Q4UID\4V
M>@--90&![RS2831+G<%9G4##9) SU%)M.S6SN_DE_P /]S&KZI]++YM_Y6^\
M]#NO$NBV6A)K<^HPKIKJK)<*2P?=TV@9))] ,U#HOBW0O$5M=3Z9?><EK_KU
M:)XWCXSRKJ&Z>U>;6EW%I?@GP]%9SVM^]YK$K66HZC;&""V8EV\P('/'W@OS
M<YK2\&W$T_Q&\4"YUFUU:=-/MUEGM81'&&!?Y0 3G&>N:4G\7H_P2?ZVZ"3V
M^7XMK]/,V=(\4_#B#688M(FTF"_U +MDMK3RS(6Y"LX4 ,?[K'/M7<UQ/PKL
MK5?AGHH%O%AE:8Y4'+[R=WU]Z[:M)*V@+77^NO\ D%%%%24%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %07O_ !X7/_7)OY&IZ@O?^/"Y_P"N3?R- &%X?_X_Y/\ KD?YBNDK
MF_#_ /Q_R?\ 7(_S%=)0 4444 %%%% !6/XA_P"/2+_KI_0UL5C^(?\ CTB_
MZZ?T- #O#_\ QX2?]=3_ "%:U9/A_P#X\)/^NI_D*UJ "BBB@ IDTL=O"\TS
MJD4:EG=C@*!U)I]<]XQ\/P>(=%>WN[BX2UB#2RP0OL$^%.%<CDKGG'?%14DX
MQ;0XJ[L:^FZC::OIMOJ%C+YUK<()(I-I&Y3T." :M5YYH.MMX=^!NFZK'$LL
ML&FQ^5&QP&<X50?;)%:FD67C2PU2RDU'68=6LKA&^UQFV2#[*V,@QE>6&>,'
M)[UK))3<5T=C.,KQ4NYU]%%%269>O>(M*\,:=_:&L7)M[4R+&'$3R$L>@PH)
M_2HO#_BS0O%4,LNBZC'=B([9%"LCH?=6 (_$5@?%#_D$:)_V'+/_ -&4S5XH
M['XP^';FV0)-?V5U%=;>/,5 K*6]<&E%WW[M?A<4M-NU_P ;'=T5X[K7C;6-
M&NQ<W'C#3C?B]6-O#UO#'*JQ&0+@R#+AMIR22.>,5VDOB&YTCQQJ-CJ=R#IL
MFG?;K/*J-GEY$JY R>JMSGK2YER\WK^"O^7Y-#>]OZWM^9UK,%4L> !DU1T;
M6=/\0:7%J6EW'GV<N=DFQES@D'A@#U![5SNB+XAU_P "V=Y-K4VGW]VQNO,C
MMHF*1,25CVLI'"E><9XJMX=\37-I\(_^$AU!A<W%O;32N1&L8<JS8X4 #.!T
M%-OEYN;I;^OT]07O6MU_K_@^AUM_JUEIDEG'>3^4UY.+> ;&;?(02!P#C@'D
M\5=KR74[/Q2+WP7?:SK45]!<ZK#));K:K$+9RC$!&7DKR1\V3TKUJG;1W[M?
M=8E23>FUD_ON9USKVF6>M66CW%TL=_>H[V\)5OW@7[V#C''H34EGJUC?WM]9
MVT_F3V,BQW";&&QBH8#)&#P0>,UY=\5+.\F\;Z'?:<S"]TNPN+^%5_Y:&-XR
M5_%=PK7\%W7_  D%_P",[O2[YK7[;/;R07,:*YCW6Z$'# @D>A%*+NK^OX-6
M_7[@D[2MZ?D[_H=QIVM:?JMQ?065QYLEC-]GN5V,NR3&<<@9X/49%7ZXWP'=
MZC)/XCM-3U WTECJ1@2=H(XF9?+1N0B@$Y)KS^Y^*\S+>:Q'XNLH'@G?R- -
MH&\V)&QAI<;@[ $C!P..*+K1>2?WE:Z^K1[E17)Z9KMW?>/[JQ$Q.G?V1;W<
M411>'=V!.<9Z <9Q7$1>/?$%I!>7-U>^=&]OJ:VR&&,8F@FVQ]%Y^5@,'KBA
MNW]>;7YH2DG_ %Y)_DSV.BO-_!WBK6];O--M[BX$DUMI,LFH1"-!YER)3&O(
M'R\H_ P.:S_!WB[5]9UNS2?Q3:O>O*RZAH-W:+;M;+@\1-C<[ XZD@@]JI:R
MLOZUL+FTO_7<]8HKR/5/$WBY?$]_#8ZO%':IKD.F10/:HP598@Q8MC)*GD?4
MYR,"M"W\3:]<^!H+B;6K*PDCU">TO-7N5C7RXXW90ZH<*7;:!C&.>E2G>/-_
M6O\ PXV];?UI_P ,>F45P7P[\3W.LZCK>G2ZY'KD%DT3P:@MNL)=7!RI"@ X
M*]0*[VJ[/N"=[A1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1J/7'4GW)Y_&A)23O_77[MOO"[35OZZ?G^1+IUC!I>FVUA;+M@MHEBC'HJC
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M4>0$-U:6U];/;7=O%<02##Q3('5AZ$'@U'8Z;8Z9:"UL+*WM+89Q#!$L:#\
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M&V2VM+>*WMXQA(H4"*H]@.!4U%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5!>_\
M'A<_]<F_D:GJ"]_X\+G_ *Y-_(T 87A__C_D_P"N1_F*Z2N;\/\ _'_)_P!<
MC_,5TE !1110 4444 %8_B'_ (](O^NG]#6Q6/XA_P"/2+_KI_0T .\/_P#'
MA)_UU/\ (5K5D^'_ /CPD_ZZG^0K6H **** "H;R%KBRGA0@-)&R GIDC%34
M4I14DT^HT[.YR5EX.=OAC;^$]0F02K9+;O- 20KCHRY )P0#T%1:7H_C&?5=
M/EU_4[!+33PQ"::TJM=L5V@RAL #OM&1GZ5V5%4VW)R[D<JY5$HS?VK_ &S;
M>3]B_LORW^T;]WG[^-FS'R[>N<\],5>HHI%'+>/- U/Q#HMI#I#VBWEM?0W:
M?:V98SY;9P2H)JOHGAG6IM?D\0>*+RRDU!;=K6U@T]6$-NC'+$%_F9C@<\=*
M[&BE9:^?ZJWY ]?Z\[_F>4-\//%*>%3X;@N-#CM(IUF%T!()[K;)O D^7"GU
M(W9QVKH_B#X+NO&%IIRV5U':SP3%9G8GY[=QME0$ \D8_+M7:44_7NG]V@K?
MK^.OYD<<*0VZ01*%1$"*!T  P*YC0_"+6WP\_P"$7U5XW\R&6&5H"2N'9CD$
M@'H?2NKHI-7O?J-:6MT_X8\Z'A;QI=W7A^+4M0T=K#1KR.;=")!+<JJE06R,
M*P!Z#()/45Z+113N)12V.>O= N+KQUINMAX?LEM93VTB,3O9G*$8&,8^4YYK
M+^'_ ('E\$RZ]$)87L[V]\^U6,G<D>/NMD#!'3C/%=K10M-O/\7?\P:O^#^Y
M6_(Y_P .:%<Z1J/B"XN'A=-1OS<Q",DE4V*N&R!@Y4],USL?A3QAIEK/H6CZ
MKIUOHDL[2173"07=LC-N9$ &TXR0"2.O2O0J*26WR7W U?\ ,XW5?#_B&W\5
M+KOAVXTYWFLELKF/42_ 5BRNI0')Y.0<9]:YV3X8:M/X=T>PGU"T>ZM-8DO;
MB92RB6!W+,H&.&/''3WKU2BFM'?^M[_F#2:M_6UOR.,\+>"IM U_Q1J$EQ'L
MU6??;>4Q+1)\Q(.1@'<['C-9D7@WQ/?7VCQZ[=:1<6VE7*3IJ$:R&]G"9VAL
MC"YR,X)S7HU%)*UO*WX; U>]^M_Q. G\#:G+K5S>+/:>7+K\&IJ"[9\I(@A!
M^7[V1P.GO5(_#[68+#3I()=+GO+#5+J]6WNBYMY5F9B-Q"Y#*&]#SFO3**$K
M;?U8&D]_ZN<AX6\/:YIOB;6M7UBXL93J,< 5+7<!"4##8 PY&".<Y)SP*Z^B
MBGT2"P4444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH \W^.O_ "2V]_Z^(/\ T8*]!LO^/&W_ .N2_P JSO%/ART\
M6>'+S1;TLL5PN Z=48'*L/H0*\_A\.?&+3H([*Q\4Z%/:P*$BDN8F$A4=-W[
ML\_B:479./=W_"P-7:?DU^-S8^-?_))]8_[9?^C5KK?#G_(L:3_UYP_^@"O.
M+CP)\0_%2QZ=XQ\2:8=&\Q9)H=/C.^;!R%)*+@<5ZO#$D$,<,2A8XU"JH[ <
M 4XJR?FU^"L)N\EY)_BT_P!!]%%% PHHHH **** /,/C#_Q\^"O^P]!7I]<S
MXY\'Q>,]!%D;E[2[@E6XM+E!DQ2KT..XKD/[&^-4?R1^)?#DB+P'>)@S#U/[
MH\THNR<?-O[TO\@:]Y/RM^+_ ,QWQS_Y%W0O^PS!_)J]3[5Y9;> ?&7B#5]/
MN/'>O6%S8Z?,+B*SL(R!)(.A<E5Z?C7J=.*M%^;O^"7Z";O*_96_%L****!A
M1110 4444 >81_\ )R,W_8!'_HRO3ZX3QEX'U/5->L_$WAG58]-UVVB,!:9-
MT4T?)VL,'N?0UB_V3\;/^AB\,_\ ?MO_ (S2B_=4>U_S;_4&O>;[V_*P[4?^
M3D=(_P"P,_\ -Z]3K@O"'@?5[+Q'/XH\5ZM%J.MR0_9XQ;IMB@CZD+P,_D._
MK7>TTK14?7\6V*]Y.7I^"L%%%% PHHHH **** "BBB@ HHHH X_5=!\0V?B:
MYUOPQ/II:^A2*[MM0WJFY,[9%9 3G!P01SQS4;^$]8EM_#/VO5$O;K3M0^V7
M<\Q*[P5<%8Q@\ L  <<#K7:44+2WE_P7^HFK_P!?(Y*\\'OJ7B/7[F\>(Z?J
MNF1V.U6/F*07R2,8Q\PQS6./"WC2[NO#\6I:AH[6&C7D<VZ$2"6Y55*@MD85
M@#T&02>HKT6BDE:WE^E_\V#2=_/_ ('^2.?\2:%=:QJ/A^XMY(533M0%U,)"
M0678RX7 .3EAUQ1?Z%=77CC1];22$6UE;7$,BL3O)DVXP,8Q\ISR*Z"BFM/S
M^_0&K_UVU/./$'AM+'1?%UWJU_%:VU_?0WEO<QJTAMV41JK.N.@=<G&>.]4-
M+O=:U;XI:"^HZCHMY]FL;EF32)&D2,':N]V/0L> /8]:]4DCCFB:*5%>-P59
M6&0P]"*IZ;HNE:,LBZ7IEE8B0Y<6MNL6X^^T#-**L_3_ ":_7^MPDKKU_P T
M_P!/ZV+U<%K'A[QA%XYO-=\.RZ(L5W916K&_:4O&59CN"JN#U[FN]HHMK<?2
MQPI^'TUOX5M;2SU$'6K:^_M);Z:/Y9+DDEBRC^$@E<#H*TM&TOQ+<:A=7GB:
M\L_*DM_L\=AI[.T(&?F=BX!+'ITX%=1119._]=+?EH*W]?._YGGMEX2\76EE
M:>'EU>RAT&TE4I=6[2I>M"K;EB./E'92P/3M5_4- \2:=XBO]5\+SZ64U-4^
MU0:AY@"2(NT2(4!SQC(/IUKLZ*'KO_73^OOWU"R_K[_Z_P M#A9?!FKR3Z'+
M/JB7LME8W<%S/<,P>2290 0 #\H(/?@8ZUEQ?#G5TTBXM#<V/F2>&4T@$.^!
M,"Q+?=^YSUZ^U>G44-)W&M+,X/3_  OXHNKS18O$5]IDFGZ.RRQ&T5Q+<R*N
MU3(&X4#)/!.3Z4DWAGQ;ID^JVGAO4-,BTW4IGN/,N1()[-W^^8PHPW/(R1@U
MWM%-ZN[_ .'O_P ,)125EY?@<S>^&[R?6?"]TETLL>DF3SY)V/F2[HM@(P,$
MYY.2*Z:BBC_@_B"5OZ["/NV-LQNQQGIFO+M#\-_$C1+V]O57PE<WE],9+FZG
MEN6D89X0$( %4< 5ZE10M'<;U5CGM;T*ZU;Q!X=O=\(M=-GDGF1F.YG,95-H
MQ@X)/4BMV=F2WE="@94)!?[H.._M4E%)KW;+S_$%O?\ K0R?#%_>ZIX9T^^U
M&.%+N>$/(L*LJ9/=0W.",'GFM:BBJ;NQ)61YOJGAOQR_CNY\06(\-W,:((K!
M=0EGS;)CYB%5<!F/4Y/'%;.JZ%XAU&UT754ETR'Q+IK,Q4%S:RAQM=,XW@$8
M.<=177T5*5DEV_K]=0:NV^YQ$/AOQ);:#K]S%>V*^)]7;=YJEQ!!A0BA3M+'
M:N3G')-5O!FA^-?#BV>FSVWA>/248F=K62X:XD)'+Y8 ,Q.,DUZ!136CT\OP
M_K[]0:O_ %W//K_PKXQN+74M"CUBRFT2_D<M<W;2O=PQ.?FC4?=8 9 )(P#T
MXKK;NUU"QT&.T\/BS%S L<<(O=WEA 0#G;SG:#CWQ6I10M%;T_#^OZW';6_]
M:@,XYZT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %07O_ !X7
M/_7)OY&IZ@O?^/"Y_P"N3?R- &%X?_X_Y/\ KD?YBNDKF_#_ /Q_R?\ 7(_S
M%=)0 4444 %%%% !6/XA_P"/2+_KI_0UL5C^(?\ CTB_ZZ?T- #O#_\ QX2?
M]=3_ "%:U9/A_P#X\)/^NI_D*UJ "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "H+W_CPN?^N3?R-3U!>_\>%S_P!<
MF_D: ,+P_P#\?\G_ %R/\Q725S?A_P#X_P"3_KD?YBNDH **** "BBB@ K'\
M0_\ 'I%_UT_H:V*Q_$/_ !Z1?]=/Z&@!WA__ (\)/^NI_D*UJR?#_P#QX2?]
M=3_(5K4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MRN;J#S)K&4S6[;V&QRI7. >>">N:NT44#"BBB@ HHHH **** "BBB@ HHHH
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MR8I%;:TC'KY8'S>N#^-0^'?%>KW&O:IHFKOI%Q<VEFMW'/IA;RR"2"K!F)#
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M)I%V-(\KRL%Z[078D+[# K>KS_3?%^NP>))=$UJ30[F9K"6[ADTPOB,H1E)
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M$.[:.?XMO7O765PNCSZJOQ+FM-:@T:6Z_LOS8[NRMI(Y!'YN A+.V1WZ#FK
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M_2^G]>8G:TNW_!L=%>^%-$U&>[GNK+S)+MH6G/FN-YB.8^AXP?3KWS6!XO\
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M/^NI_D*UJR?#_P#QX2?]=3_(5K4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% ')>,M.U9]1T+6M(L!J$VF3R,]IYRQ-(KH4.UFXR
M,@\U%K%CK&NOX3O7TIK66UU(7%W;M.CF!-CKG<#ANH^[GK5K7?'NAZ!KVGZ3
M=W]DDMR["9I;M$^S*$+!G!/&> ,XZTOB#Q4-,?P[-9S6<MCJ=Z(9+AFW((C&
MS;E8''\(YY&*4>C\_P 126]^WX&??^%;O5?%/B8W$?EZ?J>D164<X93\X,F[
MC.>-P/(K!T;PGJ27>D6<G@7P_IS6,J-=:NL5O)YZH.L:A=ZLQP<G&*]*T[5=
M.U> SZ9?VM["&VF2VF610?3*DC-1VVN:3>W\MC:ZI93WD/\ K+>*X1I$^J@Y
M'XTXKE:M_5KO]0:33_KLOT+]<=XITO6;?Q)IOB?0;*/4+FVADM;BR:80F:)B
M""KMP""._K78USGC3Q?8^$-!N;R>YM!>")FMK::=4:=A@8 )R0"1G%2W:S_K
MM^I25]#!N_#_ (H\3>'-4DU5HK*^GGAN+"P\T21VQB8,H9P.2Q')' [5+%9^
M)/$WB+3+_6=%32+;2EE=8S=),T\SH4!7;T4 GKSSTK1\+^(KB[T>[U+6M<\-
M7%M"1FXTN8B*$8R1(S.0#R.XJ[X:UJ76VU*;[;I%Y9QW)2TDTV<2_N\ _O""
M0'YZ#'&*;CO'^MK??9_J0FFK_P!=_NT_JYYW;^!_$::%96S:=B:/PW>6+KY\
M?$\C@HN=W<=^GJ:MQSZ_HGQ MHM.T==1EB\.6T=S:BY2)P0[#*LWRG!SGGZ5
MZ.VO:.NJ#2VU:Q&H'I:&X3S3_P  SG]*K7Y\/Z+J9UW4KJTL;J6$6OVBYN1&
MK("6"@,0O4D],T7U3]?U7ZCMNNO_  4_T.)O_!NNMX-BB>VCO+JXU5M2U/38
MYQ&MPC$DPAS@''R]< XJ7PQX9U&Q\6W^H+X9M=$TZXTH6T-O;R1$JX8GY]G&
MXYZC(P.M>AM>VB61O6NH5M GF>>9 $V_WMW3'O4&G:SIFLPO+I6I65\B'#/;
M3K*JGT)4FDXJS7];<OY;7_5AV=_ZO?\ /M^APO\ PBVL_P#"J- T7['_ ,3&
MTN+1YH?-3Y DP9CNS@X SP:K^.M!?4_B-X?@MI5$6I)LU&(=7A@=95/TS\OX
MUT&A:UXB/C6[T#7&TN18[!;N.2QADC/,A7!WNV>GM6W9^&](T_6KS6+:R1-0
MO,"><LS,P'89.%'L,5=[R4_._P"%OT_ EQT<?*WXWO\ B:M5M1CNI=-N8[&5
M(KMHF$,CKN57QP2.XS3I+VUANH;66YACN)]QAB:0!Y,<G:.IQWQ0MY:M>/9K
M<PFZ1!(\ <;U4\!BO4 X//M4M75BT[,\TT3PMJTWC#2M5D\*VOAZ:TWF_O+:
MYC*WV4V[1&G8M\V6 (Q7J54+/7-)U&[FM++5+*YN8?\ 6PP7".\?^\ <C\:;
M>>(-%TZ\CL[[5]/M;J3&R">Y1';/3"DY-5?1+^M?ZZ"M9M_UI_74R;K2;Z3X
ME:?JZ09L8=,F@>7>O#LZ$#&<] ><8KF[_P *>()_#WBFUMX=DM[K/VJ.+SPG
MVFW^3<FX'Y=P4CG'O7H=QJ%E9L%N;NW@)1I )9 N57[S<GH,C)[4ECJ-CJEJ
M+G3[RWN[<G EMY5D0GZ@D5-M+?UO?\T-[_UV:_)GF>E^%-2B\66U_:>$+30]
M-73;FV\J&:$R>8VT@R;3@YQ@8+=.<51'@;Q'_P (X;3^SOW_ /PBO]G;?/C_
M ./C>3LSNQT[]/>O8ZH?VYI U3^R_P"U++^T,9^R?:$\W_OC.?THM?3^NK_4
M5K:_UT_R//\ 5/"%U:>(&U8>#].\2Q7EG#%+!<F$26TL:[<@R#!4C&<'MWJS
M_P (KK=CH.@WUI8::-8TNZDN6T^S1+>%TD!5HU( 4,%(^8]2*[6]U_1M,:1;
M_5["T:/;O$]RD97=G;G)XS@X]<58FU&RM[ W\UY;QV87>;AY5$87UW$XQ[T[
M]?ZW;_5_(2BM%_6R7Z(Y'PQ:>(I_'&K:YK6DKIUO<V4$-O$+E)678SDABO?G
M/''(YZUV]<QI'BH:QXQU#3;2:SN=-AL8;F&XMVW[V=G!^8$J1\HZ#UK8MM<T
MF]OY;&UU2RGO(?\ 66\5PC2)]5!R/QI]$O+]7_P05KM_ULCS[5_"-U8^)=8O
M8/!6E>)8M4<312W1A#VLFT*0WF#)3(!^7WXJW?\ A#5M5T70O"EW!!#I"Q^;
MJL]D$@C=ARL,:+@@%CDD #CWKL=5U[3=*!AN-1LH+V2-F@@GG57E('\*D@GG
MTJ'PCJ]QK_A'2M6NDB2XN[999%B!"@D=@23C\:A).-NBM^MON_17&_BOU=_T
MO_7J<['X;UK6/AOJ'A;60JW48:WMKMV5UN$4@Q2$ DCH 0?0U1\/^';]M>TV
M9_ FA:!'9Y:YNHH[>1YVVX'E%%W(,\Y.#CBNK\;:Y=>&_!NIZQ9)"]S:Q;XU
MF!*$Y Y (/?UK#TSQ1XET[7=-TWQ99Z9Y.J96SO--,@02!=WENKY()&<$''%
M5%WDWUT^;L_QM?R%))1MTU^ZZ_#8IPV'C/P[:ZCH&B:7#-!<7,LMGJIND5;8
M2L6.^-OF8J2<8!!XJ_JUAXATOQ=8Z]ING#6\Z=]AN4$\<#A@X82?-A<'G('X
M"NIGUS2;748].N-4LHKZ7_5VTEPBR/\ 12<FI-1U73M(MQ<:E?VME 3M$ES,
ML:Y],L0*2T2_KI;\OZN.UVU_6]_S.3\)>']7@\):W8:O#%;7FH7=W+B.0.@$
MO0@CMSWP>.E6? SZ_::9:Z+K&@&RCL+5(5O!=QRI.5PORJIW $#/.*ZA+RUD
MLQ>1W,+VI3>)E<%"OKNZ8]ZK66N:1J5K+=6.J6-U;PY\R6"X1T3')R0<"FM+
M^B_#1!:Z7J_Q,G^RKW_A99U?R?\ 0?[)%MYNY?\ 6>;NVXSGIWQBL'QIX-U/
M6O&&E75@J_V;<A(=7^8 F*.02)P3SD@KP#UKKU\2Z"_W-;TUOWBQ<72'YV&5
M7KU(Y [UCP^,[:W\4ZYINKWNG6-K9- EL\THB:0R)N()9L$YZ8 I+1Q7;_A_
MU_('9I^?_#?H0>/?#,VLG2=0MM+L]5ETV9F;3[L+LN(W7:R@L"H8<$$^E+X*
MT6ZLK[4+^?PWI?A^"94C@L[2*'S0!]YI)(Q@Y/09.,5U=S>VEG9M>75U#!:H
MNYII9 J*/4L>,5':ZKIU]8F^L[^UN+0 DSPS*\>!U^8'%"]V_P#6_P#PW4&K
MV_K;_A^A;KS8Z7XMT.TUCP_I.C0WEGJ$\TMMJ#72(MN)B2PD0_,=I)QMSGBN
MZCUS2)KY+&/5+%[QT$B6ZW"&1E(R&"YR1CO5^AQ3WV>G]?UW'?MZG&>(/"]R
M/A5)X:TN/[3<16<=O$NX+O*E>[$ =#WKL(E*PHIZA0#7.^)M9UBUO].TC0;6
MVDO[W>_GW@?R($0#);;R2<@ 9'>LN'QS>V/A_P 1S:U9P'4]!;;,EHQ$4^Y0
MR%=V2H.1D'.*;E?F;ZZ_II]Z$HI62]/OUU^XTO FDWVC:%<6VH0>3,^H74RK
MO5LH\K,IR">H(HU+2;ZX^(>A:I%!NLK6TNHYI=ZC:S[-HQG)S@]!5/1/$/B*
M+Q-;:+XEM]-#WUJ]U:RZ?O 781N1PY.3AA\PX/I79T[6L^WZ+E$K--=_U?,<
M7JUCKNB^,9O$&BZ2NK17UHEO<VPN4A=&0DJX+\$88@C.:H:SX6U_7O"-F^K1
MV.H:O:W_ -O6QG"F IDC[.3MP<*V-Q!YKT.L/Q5K5WHNEQOI]F+N_N9TMK>-
M\A [G&YR.BCDFHM96^[[[_F_NTV*ZW^_[K?E_5S!\(Z'=0Z]<:E)X2TGPW:B
MW$,5O!% T\CDY9FDC'"\ ;<^]:O@+2KW1?"4%CJ$/DW*S3L4W*V TK,.02.A
M%4])\2:Q9ZW=Z-XH33Q/%9&^BN+ .(VC!PP*N200<=^<UG:?XS\0D:1J^IV6
MGQ:!J\ZPP+$7^T6XDSY32$G:=W&0 ,;AUJD]=.J2_%_K=$.RU?3_ "_RU(?&
MFA:OJVI7L-QX1L?$-E-&!8W'G1P2V3;<$,S88C=\V5)^E=5817_ASP-!',?[
M1O["Q&[=+L\YT3IO;IDC&363J>N^*[O6M2M/#EEIJV^F*OG2ZB),W#E=VV/:
M0  ,#<<\]JU+#Q%IVL^!H]?O8DBL)[0S3QS ,JK@[E/8C@CWJ%I3=G;^G9_G
MYOKT+T<U?^MKK^M/Q-72KTZEI%G?-"83<P)*8R<[-R@XS@9QGTJW7*?#_P 4
M7/BW0)]0N;1+0I>2P1PJI!5%(VALG[V.O3Z5U=:2WV)AMO<\HU+0_&-AX3UK
MPCI6B0WEK<&<VM^;Q(P(Y&+%"AYWC) /3H216WJ&G>(-(\3:;KFF:.NJ+_9@
ML+BW%RD+Q,&#!@6X(Z@XYKO**E*W]>5OR_S&U?\ KSO^9YI;>&/$!^&'BG3+
MNRC&K:C<7<L4,<RE6\PY&&) Q]<?A7H=A&\.GVT4@PZ1*K#/0@#-6**:T5EY
M?@K!;6_K^+N<Q=:3?2?$K3]72#-C#IDT#R[UX=G0@8SGH#SC%&G:3?0?$+7=
M4D@VV5U9VT4,N]3N9-^X8SD8W#J*Z>BE;2WK^(-7O\OP/*H]"U71/#WAF7RK
M<:WI^I7,D-A-<HANED,F41\[=VP[A].:T/"%YJNH?$[Q#<:KIZV$BV%JBVZS
M+*8UW.0&9>-QY.!V(KM-:T+3/$-C]BU6T6X@W!P"Q4JPZ%64@J?<&F:'X<TG
MPW;26^DV:VZ2-OD)=G=VQC+,Q+'\33CH]?/\4E^G^0I*^W]:M_J:E%%%!044
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %07O_ !X7/_7)OY&IZ@O?^/"Y_P"N3?R- &%X
M?_X_Y/\ KD?YBNDKF_#_ /Q_R?\ 7(_S%=)0 4444 %%%% !6/XA_P"/2+_K
MI_0UL5C^(?\ CTB_ZZ?T- #O#_\ QX2?]=3_ "%:U9/A_P#X\)/^NI_D*UJ
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M$BHBZP0JJ, #RH^@KM54*H4= ,"J=CI-CIL][-:0>7)>S>?<'>QWO@+GD\<
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M>.$6UE:V\T;*#O+2;\Y.<8^48X%>83^ ]>?0'LO^$0M)=:6Y2:XUN6ZB>2Z
ME#9C).Y21@8;: !WKMM0L_$>D>-[[6-)T5-4@U*SA@(-TD)MY(RV"V[JIW?P
MY/'2DKI??_Z2K?C?>VOD)WN[?U[W^7KIYFEX;U)O%G@]+_5+6U:1I)AL6/*#
M8[*" Q/.!4'PM_Y)GH?_ %Q/_H;5+X#T?4M&\#P:=JD2QWRO.75&# EI&8$$
M'H00:G\!:7>:+X'TK3M0A\F[@B*R1[@VT[B>H)!Z^M5:TGZ(>Z7JSHSR*\I\
M'^+K/PU9Z;H%RNZ6\UJ^M$._'EA9&(..^2RCMUKU:O(;KX:ZK>MXWF=2DMU+
MYFC?O%^5MPE+ @_+EP!SCI4-M-M=OR?_  ?P&U=)>?YIHO\ AJ^UVT\%:6-"
MM;,R:A/=7<U[?[OL]NIE9AN"D$EL@#D5T7@[Q!/XHLM5M-6BT^:XL+HVLSV>
M7MYAM#!E#$]CR"3R*Y6X\&ZM'I'A"&ZT-=:L]/LC%>:4UQ&@$Y"XD.X['P=P
MZ]^,UT'P]T+4M$G\0-?Z5;:;'>7BSV\%JZM$J>6HVC;C&,8/ YZ<5HE:3737
M\+)?@OZ9%W9-?U?F;_0?\/XTBNO%<<:*B+K<H"J, #8G:LNR\<>(M6UFZ&FP
MZ+-;VM\;632VE9;_ &*^TR<L% _BQCIWKHO"6E7NF77B)[R'REO-5DN(#O5M
M\950#P3CD'@\UQ>O>%/$&M7TL%QX9LGU$7>^V\2P3QPM%%O!7<HPY95XQR#Z
MU,=XW[+]/^#^FHY;2MW?Z_U_P"_J3^(!\8+^+P_'I_G/H\!DFO\ >40"1\#:
MA!)/U&*ZSP=K\_B/P['>W=O'!=I++;SQQL2@DC<HQ4GG!(R*K6FD7T7Q(O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%%% !1110!YUXR\+^(X/&%IXR\(K;7&H1VQM;FRN6VK-'G(PV1@Y]QT%9_\
MPDOQC_Z$/3/_  .C_P#CM>JT4DK*P/5W/-_"7AGQ-?\ C67QGXOBM;2[6V^R
MVEC;/O$2$Y)9@2">3T)ZUZ1115=$ET$EJWW"BBBD,**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *@O?^/"Y_ZY-_(U/4%[_P >%S_UR;^1H PO#_\ Q_R?]<C_
M #%=)7-^'_\ C_D_ZY'^8KI* "BBB@ HHHH *Q_$/_'I%_UT_H:V*Q_$/_'I
M%_UT_H: '>'_ /CPD_ZZG^0K6K)\/_\ 'A)_UU/\A6M0 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5!>_P#'A<_]
M<F_D:GJ"]_X\+G_KDW\C0!A>'_\ C_D_ZY'^8KI*YOP__P ?\G_7(_S%=)0
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M:TZ!A1110 445G:3K=CK8O&L)#(EI<M:R,5P/,7&X#Z$X_"@#1HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BL"3Q-Y?CV'PQ]DSYE@U[]I\SIA
M]NW;C\<Y_"M^CI?^NP=;!1110 4444 %%%% !1110 445G:KK=CHQLEO)"KW
MMREK JKDO(W0?ED_A0!HT444 %%%>>:A\0?$0\3ZMH^A^"6U9=-=$EG74DAY
M9 P^5E]SW/2E?6P=+GH=%<-?>/M0TS2M+6\\+W \0ZE(Z0:/%<H[87JQDQ@#
M&#G'>HXOB6K>&=?U"XT:>UU30US=:;-, >1E<. 00?7%#:5_+_@?YH.R[_U^
MC.]HK@=!^(M[>ZYI^E:]X8N-%EU*-I+*0W23QRX&[&5 P<<UWU4U82:>P444
M4AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445P6E?$ZVU7PQXD
MU:.PV7&AO,LEJ9\^8$S@[MO&[![''O2;2OY*_P"@=O/0[VBN'U7XA2VTVFV.
MD:!<:OJU[9K>M:0S*@AB('+.PQU.!QSBB#Q[?ZOX775/#WAF?4+Y+IK6ZTZ2
MZ2![=ESNRQ!!P<?G3[^7^=OSTN)-.UNO^5_R.XHKSKPG\0O$?B>^53X':UT]
M9Y+>XO/[3200NF0PV[ 3SQQZU6TCXE>+->@2[TWX>//8/*T8N!JT8'RL5)VE
M >,&A:[!?2_]?UH>G44#H,C%% PHJO?7L&FZ?<7URVV"WC:61O15&3_*N,T[
MX@:C+>::=6\+7&FZ9JD@BL[QKM)26890.@&4W#IR:%J[ W979W=%%% !16/X
MIUW_ (1KP]<ZM]F^T^24'E;]F[<X7K@^N>E:ZG*@^HHW 6BBB@ HJKJ6H0:5
MIEUJ%T6%O;1--(5&2%49.!^%$%]'<Z5'J$2MY<D G56X."NX ^])M)-OI_7Z
M!U2+5%9/AC6_^$D\,Z?K'V?[/]KB$GE;]^SVS@9_*M:J::=F)--704444AA1
M16-X?U[^W1J?^C>1]AOY;/\ UF[?LQ\W08SGIS]:.M@-FBBB@ HHK-DOK]/$
M,%BFEL]@\#2/?^: (W!P$V8R<CG.:/(#2HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBJ&L7.I6ECYNE:=%?W.X#R9;GR!
MM[G=M;IZ8I-VU OT5B>$M??Q-X=@U62T%H\CR(T(E\P*4<J?FP,_=]*VZIJP
MD[A1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !4%[_QX7/\ UR;^1J>H+W_CPN?^N3?R- &%X?\ ^/\ D_ZY'^8KI*YO
MP_\ \?\ )_UR/\Q724 %%%% !1110 5C^(?^/2+_ *Z?T-;%8_B'_CTB_P"N
MG]#0 [P__P >$G_74_R%:U9/A_\ X\)/^NI_D*UJ "BBB@ KG_'7_(@>(/\
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MU9W,MS;2VZ-'/-]^08'+<#GU]ZQM8\!6.K:I<:A'J>K:=)=H$NTL+D1I<@#
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ME*^'KC6="GM]JK81;YHYL_Q@G[A'?''-3_#K1K_0/!4%MJ$(BN7DEN#;*<B
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M-2BBB@H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^/%+X(TC6KO0?&=AI]MK$/A^XLVATJWU?Y9!(4(( [#MQQT[YJ)7<'??EO\
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MO=;M?#7B'PV/"VKM=ZA>WJ6<XMCY#+*[#>[G[@&2>>HQC-3=INV]OOU7]?\
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M^8[Z:>7Y._XV_(ZP'(!P1[&LCQ'KDFAV,+VVGS:A>7$RP6]M&=NYSG[SGA5
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MP5KQCJ!MW4 +PH",3^8KGM1?6=&\!Z]X.3PUJM[=N;D6UQ;VY>"6*1F8-O\
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M*** "@C((/>BB@""SL[?3[2.UM8A'#&,*H)/ZGDGOD]:GHHH **** "BBB@
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MKI:*/,!%4*H51@ 8 I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW%]/U5PHHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *@O?^/"Y_ZY-_(U/4%[_P >
M%S_UR;^1H PO#_\ Q_R?]<C_ #%=)7-^'_\ C_D_ZY'^8KI* "BBB@ HHHH
M*Q_$/_'I%_UT_H:V*Q_$/_'I%_UT_H: '>'_ /CPD_ZZG^0K6K)\/_\ 'A)_
MUU/\A6M0 4444 %%%% !1110 4444 (?NGZ5P_PH_P"1!3_K[N__ $<]=9JU
MM?7>F30:;?K87;@".Y: 3!.>?D) /&1U[USW@?PCJGA*RGL;OQ NI6C%GBC%
MD(/+9F+,<AF+9)Z=JFS][T_6X/9>OZ6."M3K-M\-K+Q;)XDU>74$NT"QM=,8
M3$;@)L9.C<$\G)]ZZZ\MKSQ;XWU73'UG4M.T_2H80J:?.8'EED!8LS#D@
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M?'!\T/DA1Q\W).WKVST-:.C>$[ZVUQ-7UO7'U>Z@A:"TS;+"L*,1N) )W,<
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M]?C?4U****8PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2\C96:_G>-XQ:+MX4Y RY; V_6N,&M6EI\,KOP)-%,?$Q26R2Q\EM\K.YVR
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H+W_CPN?^N3?R-3U!
M>_\ 'A<_]<F_D: ,+P__ ,?\G_7(_P Q725S?A__ (_Y/^N1_F*Z2@ HHHH
M**** "L?Q#_QZ1?]=/Z&MBL?Q#_QZ1?]=/Z&@!WA_P#X\)/^NI_D*UJR?#__
M !X2?]=3_(5K4 %%%% !1110 4444 %%%% #)IH[>"2>9PD4:EW8]% &2:BL
M[VWU"P@OK63S+:>,2QN 1N4C(.#STK'\:Z<FI>$M0C>XNX!'!)*#;3M$6(0\
M$J1E?4=#69\.=%CTWP;IUTE[J$YNK"%C'<W;RQQ_)G$:L<(.>@]JEO23[?\
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MF/A#PK!%X^\3$:KK3?8;JV*[]1E;SLP@_O<GY_Q[<4E\:3VU_3_,<M(W6_\
MPYZC17G>KV6IZW\3[G1D\0:G8:9_9<5S+'9S>6Y?S'4;6P=@]<=<"I=8M]3@
MN/#?@]=?U#%X9WN=1#!;EXHQD*' X)W %NN!0G=+S_X/^3&]&_+_ ('^9W]%
M>0Z_?ZOX;T[Q=H4&LW\ZVMC!>V5W/,6GAWOM93)U;E<C/KBJ4=SK6F^(IO\
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MBBB@ HHHH **** "BBB@ HHHH *@O?\ CPN?^N3?R-3U!>_\>%S_ -<F_D:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX.>*TX)H[FWCGB;='(H=&QC((R#4E%-N[;!*R2"BBBD4%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5!>_\
M>%S_ -<F_D:GJ"]_X\+G_KDW\C0!A>'_ /C_ )/^N1_F*Z2N;\/_ /'_ "?]
M<C_,5TE !1110 4444 %8_B'_CTB_P"NG]#6Q6/XA_X](O\ KI_0T .\/_\
M'A)_UU/\A6M63X?_ ./"3_KJ?Y"M:@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS9W1VWD M8[?['E<AD8'+@'C!R>:T[[QYX8TW6/[)N]6CCO RHR['*HQZ!G
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M?^2:^'?^O&/^5..[?DOE?^O^&);V7F_P_K_ASJ:***"@HHHH **** "BBB@
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M(T0%FD5#P25 P#P":GT74=<L?$6H^&M7U%-0E2Q%[:7_ )"Q.5)*E61?ER"
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M2E=GD\+Z([L<EFT^(DG_ +YI*Z372]_R_P @=F[_ "/,OB'XJT7Q]+X=\/\
MAF\_M&\;4X[A_)C;;'&N02Q(&.OZ5[76=IN@:-HQ<Z7I-A8E_O&UMDBW?7:!
MFM&FK)67>_Y?Y"U<KOM;]0HHHH&%%%% !1110!Y)XDU.W\'?&^T\0:SO@TF^
MTO[(EUL+(D@;.&Q^'YUTW_"W/ 7_ $,EM_WP_P#\3777EC::A;-;WMK!<P-]
MZ*:,.I^H/%8W_"">#_\ H5-#_P#!=#_\325TE%]/\V_U!VNWW_X8X'1M3M/&
M?QU36]#=KG3--TPV\MT$(0R$M@ GK][]#7KU5K'3[+3+9;:PM+>T@7I%!&(U
M'X 8JS3T245T_P [BU;<GU_16"BBB@84444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ J"]_X\+G_KDW\C4]07O_'A<_\
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M*'NN+\_Q5M1I^\I+R_!W/+I]<TN]TKX:VEI?V\]Q]MMF,4<@9E"Q,#D#D8)
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M49'2N7TJ=/$OQ*FUG3QG3-,LWL#=+]VYF9P6"GNJ;>OJ:UO'6EZ[K?AB;3=
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M HHHH **** "BBB@ HHHH **** "BBB@ J"]_P"/"Y_ZY-_(U/4%[_QX7/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %07O_'A<_\ 7)OY&IZ@O?\ CPN?^N3?R- &%X?_ ./^3_KD?YBNDKF_#_\
MQ_R?]<C_ #%=)0 4444 %%%% !6/XA_X](O^NG]#6Q6/XA_X](O^NG]#0 [P
M_P#\>$G_ %U/\A6M63X?_P"/"3_KJ?Y"M:@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT[33I.DZ?;QQR:<OC65(TQE=HWX'TXJ7P):6]KXE\,R01*CS3:N)"HP6"R
M'V  H@^9+Y?DA2;7X_F_T1Z3I_B1=7\5R6FFZIH=[I<=KN<6UT)+E9MV.0K$
M!,>W6M*\\0Z+ISNE]K&GVK1L$<3W*(58C(!R>"1R!7-6]M;VOQA9+>"*%3H>
M2(T"@GSSSQ5/3M'TZ_\ B/XUN+RSAN)%AMHE,J!MJF+) STS@?E4N5HI^3?W
M7*ZOU7XG:W^L:;IE@MY>ZC9VML^ D]Q.L<;$C(PQ(!S57PO?WNI^';6\U";3
MIKF3<6DTV3? PW$#:V3GC&>>N:POAQ;PW?PMT-+F&.9%@.%E4,!AF Z^E0^
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M&<6L%D\JI^^)(*LYX !5N?;I6MX=UO4=5:[@U71)=*N[5E#*9?.B<,,@I(
MWN,<4[;K[_P^_="NM'_77_)E*Q^'/A/3KR&[M-(6.>"430MYTA\MA_=!;"C_
M &1Q[<5N0:596VJ7>I0P[;R[5%GDWL=X0$+P3@8R>@J[7$ZEXZU"'5=4MM)\
M-R:G;:25%[*MTL<@)4-B./!+\'U&3P*+ZV_KI_P LMSMJJ:IIEGK.F7&G:A#
MYUI<)LECW%=P],@@C\#6;-XD$7B;2-'%F^-1M9;CS7;:T6S;\I3'4[O48Q55
M?&MK''XFGO8#!;Z%-Y;NK[S*/+5\@8&#\V,<TGY^?X.WYV&GV\OQ5U^!LSZ/
M87-Y87<T&Z?3RQMFWL/+W+M/ .#QQSFL2[^'/A*^N+J:YT=)&NBS3)YT@1F/
M5@@;:&_V@ ?>H=)\7ZK<ZK96FL>&9M+BOU9K287*SY(&[;(% \LX^OIFN-\-
M^+]2\.Z/KMPGAR6[TFSU>[>[O!=*A0&4Y*(02^ <GD4==?ZU2?XV_K4FZMI_
M6C:_X!Z)<^#M!NQ<>?8E_M$$5O+F:3YHXCN0?>['OU/?-3GPSHSQ:G%)81R1
MZH^^\20EEE;:%S@GC@#ICI6G%(LT*2H<HZAE/L:?3:W3&K:-&'H/A#0?#,DL
MFDV @EF 5Y'E>5RHZ+N<D@>V<5%/I5U;^.;;6;2+S(+JU-I>@, 4VDM&_)YY
M+*<9/S#TKH:X?XE_ZCPS_P!A^T_F:/M1];??H%EROYO[M?T-C6_!/AWQ'>)>
M:IIPFN%3R_,2:2)F7^ZQ1AN'L<BI]:L[FW\*SZ?H-JBS&$6]NBD*L0/R[N2.
M%!SCJ<<5E:IXPU&/6KO3=!\//J[V"JU[)]J6!8RPR$7(.]L<XXZCFIIO$=SJ
M_A&WU;0=*348[I2)(;BZ^S&-<$-D[6Y!&,5$K<C[?\/^#UU]2E\:[_U_P-/0
MV](TV#1M'L]-MAB&UA6)/H!C-7:X?P_K5GHWP>M]:L--:*TM=/:XCLFN"Y &
M3M\PCGZXI^G>.;Z?4M'BU'P])866L9%E<&Z61BVS> Z #;D XY/X5K*[FUU_
MS_IF<6E!/^M"_>?#[PKJ%]<WEUI*22W))F7S9!&[$8W% VW=_M8S[UD:WX$M
MM7\6:$D^G&;0['3IK?=]H*M$^4V ,&#YPIY'XFJ;>(?& ^)UU8Q:+!-;QV*L
MEL=3VKL,I'G?ZO[Q  V]O6O2>U1%+E36W_#HI[M/?_AF<5XL\'QR?#V7P]H&
MFQ^6982+<, &42JSDECR< DY.36UH?A'0O#<TTVE:>MO+, KN9'=MHZ*"Q.%
M]A@5-XCUZW\-Z-+J,\4DV&6.*&(?/+(Q"J@]R2*PK;QIJ27DVG:QX=;3M1:T
MDNK.(7:S)<!!RN]5^5AQQ@]>]',ES/\ K;_)7L%ME_6_^;W+UUX \+7FLG5K
MC2(GNV<2,=[A'<=&:,'8Q]R#4^L>#M!UZ^CO=1L!+<HGEB1)7C+)_=;8PW+[
M'(K MOB?97&JZ=9?8RJWFCG5#+YO$?!/EXV\G"MSQTZ4RV^(6JZA?6NGZ?X6
M,U[/IL.HE'O@B1JY(VLQ3J,#& <Y[8IVMIVO^J?Y,7,GKW_X'^:.BC\':!%H
M<FBQZ<J:;)/YYMTD<*'W!\C!R!N .!@>U;M<<GC^WD\(0ZT-.G-W-<FRCT\,
M"[7 <H8PW3&0>?09JWH?BB]OM3N=(UC1CI>J10"X2$7*SI+&3C*N .AX(QQ1
M??\ KI^.EOD.Z_KU_P _Q)1I5U9^.FU6VCWVE_:"&[^8#RWC),;X/7(9E./0
M4FM>!?#?B&_%]J>F+-<[0C2++)'O4=F", P]FS6'H_Q!U;7([6[L?!UY+ISS
M?9[BX%TFZ)]VUMJ'EU4]6X[^E6]6\:ZC;ZUJ&GZ-X=;55TR-7O7^V+"R[EW
M(A!+G'TYXI:)+^O/[M?Q'U?]>7WZ&OXCL;N7PM/I>C0*DDZ+:IM(18(V^5F'
M^ZN2 /05J6%G#IVGVUE;KMAMXEB0>BJ,#^5.M+@7=G#<B.2(2HK^7*I5UR,X
M8'H?:J^LZK!H>BWNJ708P6D+3.$&20!G IR?+=L45S6L7JR/^$7T?^QK[2/L
M?^@7SR/<1>:_SM(<N<YR,GT(]JR] \4ZOJ6HP6VI^&I=/BNH#/;7,5T+F,J,
M<.54;#AACKGUKB?#?B_4O#NCZ[<)X<EN])L]7NWN[P72H4!E.2B$$O@')Y%%
MM;/M^J7YAS:)K^M&]/D>CZSX2T/7[:V@U*P$RVO$#+(\;Q\8X=2&''OS3AX5
MT1?#C>'TT^--+8;6MT9ESSGE@=V<\YSFL[6/%MS;ZG;Z5H6CMJ^H2VXNG0W
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M<27R3<M<7*V,L>__ %A=9 H&WG;P<]J]WC01QH@& H  IU%5=VL_ZZ!;6_\
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MSV\%M=K+*J$I&65,!CT&<'&:ZZLW3+Z_O+G4([S2VLH[>?R[>0RA_M"8!W@
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M.K;<9KI**(^ZFOZ_K] :NT_Z_K]3#\9P377@C7+>WBDFFDL9DCCC4LSL4.
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M7DYS@XSC/:L[.R7DE]SB_P!&6K7OYM_FOU+OCW_DD%]_UYQ?S6NUA_X]X_\
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M>5K/29&%DS2%FB4QK($#'G"L>*Z_PQX'T?29K37(/M1U.6W_ -)N'N7;[2S
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M<$D\\]3GFK]DD]A86]G%+&8X(EB4M&<D*,#/S=>*KK+SM^6OW_UL2E\/E?\
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MA_[]G_XJC[1=_P!^'_OV?_BJ -"BL_[1=_WX?^_9_P#BJ/M%W_?A_P"_9_\
MBJ -"BL_[1=_WX?^_9_^*H^T7?\ ?A_[]G_XJ@#0HK/^T7?]^'_OV?\ XJC[
M1=_WX?\ OV?_ (J@#0HK/^T7?]^'_OV?_BJ/M%W_ 'X?^_9_^*H T**S_M%W
M_?A_[]G_ .*H^T7?]^'_ +]G_P"*H T**S_M%W_?A_[]G_XJC[1=_P!^'_OV
M?_BJ -"BL_[1=_WX?^_9_P#BJ/M%W_?A_P"_9_\ BJ -"BL_[1=_WX?^_9_^
M*H^T7?\ ?A_[]G_XJ@#0HK/^T7?]^'_OV?\ XJC[1=_WX?\ OV?_ (J@#0HK
M/^T7?]^'_OV?_BJ/M%W_ 'X?^_9_^*H T**S_M%W_?A_[]G_ .*H^T7?]^'_
M +]G_P"*H T**S_M%W_?A_[]G_XJC[1=_P!^'_OV?_BJ -"BL_[1=_WX?^_9
M_P#BJ/M%W_?A_P"_9_\ BJ -"BL_[1=_WX?^_9_^*H^T7?\ ?A_[]G_XJ@#0
MHK/^T7?]^'_OV?\ XJC[1=_WX?\ OV?_ (J@#0HK/^T7?]^'_OV?_BJ/M%W_
M 'X?^_9_^*H T**S_M%W_?A_[]G_ .*H^T7?]^'_ +]G_P"*H T**S_M%W_?
MA_[]G_XJC[1=_P!^'_OV?_BJ -"BL_[1=_WX?^_9_P#BJ/M%W_?A_P"_9_\
MBJ -"BL_[1=_WX?^_9_^*H^T7?\ ?A_[]G_XJ@#0HK/^T7?]^'_OV?\ XJC[
M1=_WX?\ OV?_ (J@#0HK/^T7?]^'_OV?_BJ/M%W_ 'X?^_9_^*H T**S_M%W
M_?A_[]G_ .*H^T7?]^'_ +]G_P"*H T**S_M%W_?A_[]G_XJC[1=_P!^'_OV
M?_BJ -"BL_[1=_WX?^_9_P#BJ/M%W_?A_P"_9_\ BJ -"BL_[1=_WX?^_9_^
M*H^T7?\ ?A_[]G_XJ@#0HK/^T7?]^'_OV?\ XJC[1=_WX?\ OV?_ (J@#0HK
M/^T7?]^'_OV?_BJ/M%W_ 'X?^_9_^*H T**S_M%W_?A_[]G_ .*H^T7?]^'_
M +]G_P"*H T**S_M%W_?A_[]G_XJC[1=_P!^'_OV?_BJ -"BL_[1=_WX?^_9
M_P#BJ/M%W_?A_P"_9_\ BJ -"BL_[1=_WX?^_9_^*H^T7?\ ?A_[]G_XJ@#0
MHK/^T7?]^'_OV?\ XJC[1=_WX?\ OV?_ (J@#0HK/^T7?]^'_OV?_BJ/M%W_
M 'X?^_9_^*H T*@O?^/"Y_ZY-_(U6^T7?]^'_OV?_BJBNI[DVDP9X=IC;.(R
M#T_WJ *'A_\ X_Y/^N1_F*Z2N;\/_P#'_)_UR/\ ,5TE !1110 5Y!JB0RWM
MU)X+M?%VSSV,KZ3-'%9O)GYMHER"<YR4&,UZ\RAE*GH1BO/;>^\0^ M,BTI]
M#@U/3K8E+>[@OHH'\O/ =)"/F&<$@D'KQ4]=0Z%7PF+"#Q!9C7H/$B:TRLMG
M)KTJR(3CYA$4_=AL9[!L9KM?$/\ QZ1?]=/Z&N>MQKWC'4-*NK[2H-)TVPN!
M=@&[2XFFD (51L^55^;).2>V*Z'Q#_QZ1?\ 73^AJ];:DK=V*^D?\>C_ .^?
MY"K]4-(_X]'_ -\_R%7Z104444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%-=UC1G=@J*,EF.
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MH P?M?BS_H":+_X-Y?\ Y&H^U^+/^@)HO_@WE_\ D:MZB@#!^U^+/^@)HO\
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M+/\ H":+_P"#>7_Y&H^U^+/^@)HO_@WE_P#D:MZB@#!^U^+/^@)HO_@WE_\
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ME_\ D:C[7XL_Z FB_P#@WE_^1JWJ* ,'[7XL_P"@)HO_ (-Y?_D:C[7XL_Z
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M:SKEKJNF6NIZ3IT4-_.UNLMMJ+RLC"*27)5H4!&(R.O<5T-8.O\ _(:\+?\
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MEDU;U8/A#_D"W'_84U'_ -+)JWJ "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K!M/\ D?M7_P"P78_^
MC;NMZL&T_P"1^U?_ +!=C_Z-NZ -ZBBB@ HHHH **** "BBB@ HHHH ****
M,&T_Y'[5_P#L%V/_ *-NZWJP;3_D?M7_ .P78_\ HV[K>H **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "L&T_P"1^U?_ +!=C_Z-NZWJP;3_ )'[5_\ L%V/_HV[H WJ
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@#!U_P#Y#7A;_L*/_P"D=S6]6#K_ /R&O"W_ &%'_P#2
M.YK>H **** "BBB@ HHHH **** "BBB@ K!U_P#Y#7A;_L*/_P"D=S6]6#K_
M /R&O"W_ &%'_P#2.YH WJ*** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ KSCP XLO$VM6%P=MPS<!NIVL<_SS7H]<UK_@NRUNZ%ZDTEG>C'[Z+OCI
MD>OOD4+1W#=6+VN>)+#P_P#9_MI?]^Q4",9( [D>E<]\3/WOABUE4''VA3R,
M<%6ZU/IOP^MK>_2]U*_FU&9""OF#"Y'3.22?SKI-6TNVUG3I;&[4F*0=0<%3
MV(]Z36@T]2'0V4^&=/8$8^R)SG_9%<;\+>FK-VW1\_\ ?56%\ :I# UG!XFG
M2R;(\K8V,'MC=BNH\/Z!:^'M/^RVQ9RQW22-U<U=[MR[D]%$Y.XT#P]XRO[J
MZTJ^EM[R,@RD1D*6/?:<'/'8U5L[S6_"7BJSTF\U WUK<E0 S%L!C@$9Y!![
M=*V-2\ ^;J<FH:1J<VG32DEPF<9/7!!!'TJ31? RV.J+J>HZA+J%VG*&0' /
MJ<DDFICI8<M;F1KW_)5]*_W8_P";4SXI@FXTD X.),'\5KIK_P *_;O%=KKG
MVW9Y 4>3Y6=V,_Q9XZ^E)XI\)_\ "2RV;_;?LWV?=QY6_=G'N,=*%M%>8^K?
MD8MSX2\4ZK +;4=?B:U8@LJJ>?PP,_G79:5IL&D:9!8VV?+B7 )ZD]23^-6P
M, #TI:9)PWQ'U"&WT_[(VG^9-.@"71C!$?S<C/8D URCWMLVJ:-"-!N MC$#
M-!Y \R8X'S$8Y&1WKTK7] _MYK$-<^5%;3B9D\O=YF.V<C'?UZT6V@>3XINM
M;DNO,::(1)%Y>/+''?//3T'6E'0;-#394GTVWECMS;(\8(A*[2@],=JM444,
M J*Y_P"/2;_<;^52U%<_\>DW^XW\J */A_\ X_Y/^N1_F*Z2N;\/_P#'_)_U
MR/\ ,5TE !1110 4444 %8_B'_CTB_ZZ?T-;%8_B'_CTB_ZZ?T- %?2/^/1_
M]\_R%7ZH:1_QZ/\ [Y_D*OT %%%% !1110!@^$/^0+<?]A34?_2R:MZL'PA_
MR!;C_L*:C_Z635O4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB@ HHHH **** "L&T_Y'[5_^P78_^C;NMZL&T_Y'[5_^P78_^C;N@#>HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** ,'7_P#D->%O^PH__I'<UO5@Z_\ \AKPM_V%'_\ 2.YK>H *
M*** "BBB@ HHHH **** "BBB@ K!U_\ Y#7A;_L*/_Z1W-;U8.O_ /(:\+?]
MA1__ $CN: -ZBBB@ HHHH **** "BBB@ KC]6\>)::G)IVFZ;-J-Q$2'\LD
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MJ'F7<1^>%('YUT/A[Q18>(X7-MNCGC_UD,GWA[CU%:.FVL5EIEM;0*%CCC4
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M]X,U.ZUKP;I.I7KJ]S<VZR2,JA02?84?\#\;_P"0]OZ]/\SR7_AF_P#ZFO\
M\IW_ -MH_P"&;_\ J:__ "G?_;:[&34/%VM^/O$&D:3KMKI]IIH@*B6R68MY
MB9/.1W!_.N@EO=3\+>#=1U#7M2BU"YMHWE66*W$(/'RKMR><_P Z-E<=GS<I
MY=_PS?\ ]37_ .4[_P"VT?\ #-__ %-?_E._^VUZ!X$\3ZIJ.B:E%X@5?[8T
MQS]H2-0NY60.A 'J#C\*R-,U#QYKOA]/%>F:SI\BRH9(M$6S!5@#]PS;MP?
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MG<^.M1TB^\0VDUMI?D23!+!4,ZR*3@'/RXQUYI)7_'\!O17]/Q.0_P"&;_\
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M)FBN-.M'N-@Q]X[1QU[^E2WI<=M;'E'_  S?_P!37_Y3O_MM'_#-_P#U-?\
MY3O_ +;7J.@ZU:6OP^M]9FU"YOK2&U:=[N:/$LBC))*^O%58/B3H5Q=VL8AU
M*.UNG6."_ELW2VD=NBB0\$YX]/>J:UL2GI<\X_X9O_ZFO_RG?_;:/^&;_P#J
M:_\ RG?_ &VNZ\>^-KGP_>Z79VEIJ&Z6_@2>5+)I$DB.2R1MC!<XQ@<]:Z_2
M=335[(74=K>6REBOEWENT,G'?:W.*2U5QO1V/%O^&;_^IK_\IW_VVC_AF_\
MZFO_ ,IW_P!MKT_Q[KMWH7AZ/^SF1=0OKJ*RMG<9"/(<;L=\#)KEM>EU3X:3
M:9K$OB#5=7TVXN1;W]O>%9"-P.'B  VX(^[0O/T'9G,_\,W_ /4U_P#E._\
MMM'_  S?_P!37_Y3O_MM>K#QMHADT)/M#[M;7=9?)]X8!Y].H_&JEW\1M LK
MUK1WNGG$TL")#;M(99(]NY4 Y8_,/U]*!'FG_#-__4U_^4[_ .VT?\,W_P#4
MU_\ E._^VUZOHGC+2];2]"K=6,]DH>YM[^$P21*1D,0>V >:I6OQ$T:YG@!M
M]2@L[EQ';ZA<6C);S,>@#GIGL2 #VHMK8/,\U_X9O_ZFO_RG?_;:/^&;_P#J
M:_\ RG?_ &VO4=6\=:1I&JSZ5+'>SZC%&DBVEK;-+),&S]P#KC!R>@I1XYT@
M:"=6ECOH5\\6WV:6T=9S,>D8CQDM]*/,/(\M_P"&;_\ J:__ "G?_;:/^&;_
M /J:_P#RG?\ VVO6=%\6V.M:A+IWV:^L=0BC$IM;Z Q.8R<;EZ@C/H:J66H7
M&G>/;O1+F>26VOH/MUD9&+%""%DC!/;[K =LFG;6P=+GF/\ PS?_ -37_P"4
M[_[;1_PS?_U-?_E._P#MM>[T4@/"/^&;_P#J:_\ RG?_ &VC_AF__J:__*=_
M]MKW>B@#PC_AF_\ ZFO_ ,IW_P!MH_X9O_ZFO_RG?_;:]WHH \(_X9O_ .IK
M_P#*=_\ ;:/^&;_^IK_\IW_VVO=Z* /"/^&;_P#J:_\ RG?_ &VC_AF__J:_
M_*=_]MKW>B@#PC_AF_\ ZFO_ ,IW_P!MH_X9O_ZFO_RG?_;:]WHH \(_X9O_
M .IK_P#*=_\ ;:/^&;_^IK_\IW_VVO=Z* /"/^&;_P#J:_\ RG?_ &VC_AF_
M_J:__*=_]MKW>B@#PC_AF_\ ZFO_ ,IW_P!MH_X9O_ZFO_RG?_;:]WHH \(_
MX9O_ .IK_P#*=_\ ;:/^&;_^IK_\IW_VVO=Z* /"/^&;_P#J:_\ RG?_ &VC
M_AF__J:__*=_]MKW"]9DL+AU)#+$Q!'8X->4Z);>+#\.[7Q79>*[ZXO1;&ZD
ML[Q4DAE"YR@X##('7-*^]^@=DNIB_P##-_\ U-?_ )3O_MM'_#-__4U_^4[_
M .VUZ/#\0].DTO2YX[.^N[Z_M%NEL;& S2*O<GH ,Y&21FJVJ?$:T'A74=0T
MRTU)KNW66-HFL7+6TJIN'G+_  KT.3Q3E[M[] C[UO,X'_AF_P#ZFO\ \IW_
M -MH_P"&;_\ J:__ "G?_;:]+\'^+5UCP_;37MOJ$$L5DDUQ=7=HT,3G:-S*
MQ 4CJ>.U):_$31KF> &WU*"SN7$=OJ%Q:,EO,QZ .>F>Q( /:FU:7*).ZN>:
M_P##-_\ U-?_ )3O_MM'_#-__4U_^4[_ .VU[O12&>$?\,W_ /4U_P#E._\
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M/$2^)=*^R-(]X85WVK9&U#*O#9Y..M:>NH;CXL>%4A^_;6MW--CLA"J,_P#
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M6H\G4?\ GE=?]\M77T4 <AY.H_\ /*Z_[Y:CR=1_YY77_?+5U]% '(>3J/\
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M:CR=1_YY77_?+5U]% '(>3J/_/*Z_P"^6H\G4?\ GE=?]\M77T4 <AY.H_\
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M_/*Z_P"^6H\G4?\ GE=?]\M77T4 <AY.H_\ /*Z_[Y:CR=1_YY77_?+5U]%
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M/_/*Z_[Y:CR=1_YY77_?+5U]% '(>3J/_/*Z_P"^6H\G4?\ GE=?]\M77T4
M<AY.H_\ /*Z_[Y:CR=1_YY77_?+5U]% '(>3J/\ SRNO^^6H\G4?^>5U_P!\
MM77T4 <AY.H_\\KK_OEJ/)U'_GE=?]\M77T4 <AY.H_\\KK_ +Y:CR=1_P">
M5U_WRU=?10!R'DZC_P \KK_OEJ/)U'_GE=?]\M77T4 <AY.H_P#/*Z_[Y:CR
M=1_YY77_ 'RU=?10!R'DZC_SRNO^^6H\G4?^>5U_WRU=?10!R'DZC_SRNO\
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LR/\ /#,,]6:-C_2NPHH I:5 +>Q5=I5BS$[EP3R<''TQ5VBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>proxy_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" C-!K8# 2(  A$! Q$!_\0
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M_OS9?_(]']CZO_T..M?]^;+_ .1ZV:* ,;^Q]7_Z''6O^_-E_P#(]']CZO\
M]#CK7_?FR_\ D>MFB@#&_L?5_P#H<=:_[\V7_P CT?V/J_\ T..M?]^;+_Y'
MK9HH QO['U?_ *''6O\ OS9?_(]']CZO_P!#CK7_ 'YLO_D>MFB@#&_L?5_^
MAQUK_OS9?_(]']CZO_T..M?]^;+_ .1ZV:* ,;^Q]7_Z''6O^_-E_P#(]']C
MZO\ ]#CK7_?FR_\ D>MFB@#&_L?5_P#H<=:_[\V7_P CT?V/J_\ T..M?]^;
M+_Y'K9HH QO['U?_ *''6O\ OS9?_(]']CZO_P!#CK7_ 'YLO_D>MFB@#&_L
M?5_^AQUK_OS9?_(]']CZO_T..M?]^;+_ .1ZV:* ,;^Q]7_Z''6O^_-E_P#(
M]']CZO\ ]#CK7_?FR_\ D>MFB@#&_L?5_P#H<=:_[\V7_P CT?V/J_\ T..M
M?]^;+_Y'K9HH QO['U?_ *''6O\ OS9?_(]']CZO_P!#CK7_ 'YLO_D>MFB@
M#&_L?5_^AQUK_OS9?_(]']CZO_T..M?]^;+_ .1ZV:* ,;^Q]7_Z''6O^_-E
M_P#(]']CZO\ ]#CK7_?FR_\ D>MFB@#&_L?5_P#H<=:_[\V7_P CT?V/J_\
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MCK7_ 'YLO_D>MFB@#&_L?5_^AQUK_OS9?_(]']CZO_T..M?]^;+_ .1ZV:*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5G>"?^1?F_["FH_^EDU:-9W@G_D7YO\ L*:C
M_P"EDU '14444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '(>"/
M^1!\.?\ 8+MO_12UO5@^"/\ D0?#G_8+MO\ T4M;U !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %9W@G_D7YO^PIJ/_I9-6C6=X)_Y%^;_ +"FH_\
MI9-0!T5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!R'@C_D0
M?#G_ &"[;_T4M;U8/@C_ )$'PY_V"[;_ -%+6]0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !6=X)_Y%^;_L*:C_Z635HUG>"?^1?F_P"PIJ/_ *63
M4 =%1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <AX(_Y$'PY
M_P!@NV_]%+6]6#X(_P"1!\.?]@NV_P#12UO4 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5G>"?^1?F_["FH_^EDU:-9W@G_D7YO\ L*:C_P"EDU '
M14444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M117)6WB/Q#J'VF6QT/2VMHKNXMD:?59$=O*E>(L5%NP&2A.,GK0!UM%<S_:O
MBS_H Z+_ .#F7_Y%H_M7Q9_T =%_\',O_P BT =-17,_VKXL_P"@#HO_ (.9
M?_D6C^U?%G_0!T7_ ,',O_R+0!TU%<S_ &KXL_Z .B_^#F7_ .1:/[5\6?\
M0!T7_P ',O\ \BT =-17,_VKXL_Z .B_^#F7_P"1:/[5\6?] '1?_!S+_P#(
MM '345S/]J^+/^@#HO\ X.9?_D6C^U?%G_0!T7_P<R__ "+0!TU%<S_:OBS_
M * .B_\ @YE_^1:/[5\6?] '1?\ P<R__(M '345S/\ :OBS_H Z+_X.9?\
MY%H_M7Q9_P! '1?_  <R_P#R+0!TU%8WA[6;O5O[2BOK*"TN;"[%LZP7!F1L
MQ1RA@Q1#TE QCM6S0!R'@C_D0?#G_8+MO_12UO5@^"/^1!\.?]@NV_\ 12UO
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5G>"?\ D7YO^PIJ/_I9
M-6C6=X)_Y%^;_L*:C_Z634 =%1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %<EX4_P"05=_]A74?_2R:NMKDO"G_ ""KO_L*
MZC_Z634 ;E%%% !1110 4444 %%%% !1110 4444 %%%% &9X6_Y"OBK_L*I
M_P"D=M725S?A;_D*^*O^PJG_ *1VU=)0!R'@C_D0?#G_ &"[;_T4M;U8/@C_
M )$'PY_V"[;_ -%+6]0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6
M=X)_Y%^;_L*:C_Z635HUG>"?^1?F_P"PIJ/_ *634 =%1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<EX4_Y!5W_P!A74?_
M $LFKK:Y+PI_R"KO_L*ZC_Z634 ;E%%% !1110 4444 %%%% !1110 4444
M%%%% &9X6_Y"OBK_ +"J?^D=M725S?A;_D*^*O\ L*I_Z1VU=)0!R'@C_D0?
M#G_8+MO_ $4M;U8/@C_D0?#G_8+MO_12UO4 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5G>"?^1?F_P"PIJ/_ *635HUG>"?^1?F_["FH_P#I9-0!
MT5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P"1JZBB@#E\^,/^@+H?_@XF_P#D:C/C#_H"Z'_X.)O_ )&KJ** .7SXP_Z
MNA_^#B;_ .1J,^,/^@+H?_@XF_\ D:NHHH Y?/C#_H"Z'_X.)O\ Y&HSXP_Z
M NA_^#B;_P"1JZBB@#E\^,/^@+H?_@XF_P#D:C/C#_H"Z'_X.)O_ )&KJ**
M.7SXP_Z NA_^#B;_ .1J,^,/^@+H?_@XF_\ D:NHHH Y?/C#_H"Z'_X.)O\
MY&HSXP_Z NA_^#B;_P"1JZBB@#E\^,/^@+H?_@XF_P#D:C/C#_H"Z'_X.)O_
M )&KJ** .7SXP_Z NA_^#B;_ .1J,^,/^@+H?_@XF_\ D:NHHH Y?/C#_H"Z
M'_X.)O\ Y&HSXP_Z NA_^#B;_P"1JZBB@#E\^,/^@+H?_@XF_P#D:C/C#_H"
MZ'_X.)O_ )&KJ** .7SXP_Z NA_^#B;_ .1J,^,/^@+H?_@XF_\ D:NHHH Y
M?/C#_H"Z'_X.)O\ Y&HSXP_Z NA_^#B;_P"1JZBB@#E\^,/^@+H?_@XF_P#D
M:C/C#_H"Z'_X.)O_ )&KJ** .7SXP_Z NA_^#B;_ .1J,^,/^@+H?_@XF_\
MD:NHHH Y?/C#_H"Z'_X.)O\ Y&HSXP_Z NA_^#B;_P"1JZBB@#E\^,/^@+H?
M_@XF_P#D:C/C#_H"Z'_X.)O_ )&KJ** .7SXP_Z NA_^#B;_ .1JO^%M-O-*
MT/[/?B 73W5S<.L$A=%\V>24 ,54G <#.!TK9HH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KDO"G_(*N_P#L*ZC_ .ED
MU=;7)>%/^05=_P#85U'_ -+)J -RBBB@ HHHH **** "BBB@ HHHH **** "
MBBB@#,\+?\A7Q5_V%4_]([:NDKF_"W_(5\5?]A5/_2.VKI* "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "N2\*?\ (*N_^PKJ/_I9-76U
MR7A3_D%7?_85U'_TLFH W**** "BBB@ HHHH **** "BBB@ HHHH **** ,S
MPM_R%?%7_853_P!([:NDKF_"W_(5\5?]A5/_ $CMJZ2@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ KDO"G_(*N_^PKJ/_I9-76UR7A3_
M )!5W_V%=1_]+)J -RBBB@ HHHH **** "BBB@ HHHH **** "BBB@#,\+?\
MA7Q5_P!A5/\ TCMJZ2N;\+?\A7Q5_P!A5/\ TCMJZ2@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KDO"G_(*N_\ L*ZC_P"EDU=;7)>%
M/^05=_\ 85U'_P!+)J -RBBB@ HHHH **** "BBB@ HHHH **** "BBB@#,\
M+?\ (5\5?]A5/_2.VKI*YOPM_P A7Q5_V%4_]([:NDH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *Y+PI_R"KO\ ["NH_P#I9-76UR7A
M3_D%7?\ V%=1_P#2R:@#<HHHH **** "BBB@ HHHH **** "BBB@ HHHH S/
M"W_(5\5?]A5/_2.VKI*YOPM_R%?%7_853_TCMJZ2@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ KDO"G_ ""KO_L*ZC_Z635UM<EX4_Y!
M5W_V%=1_]+)J -RBBB@ HHHH **** "BBB@ HHHH **** "BBB@#,\+?\A7Q
M5_V%4_\ 2.VKI*YOPM_R%?%7_853_P!([:NDH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *Y+PI_R"KO_L*ZC_Z635UM<EX4_P"05=_]
MA74?_2R:@#<HHHH **** "BBB@ HHHH **** "BBB@ HHHH S/"W_(5\5?\
M853_ -([:NDKF_"W_(5\5?\ 853_ -([:NDH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *Y+PI_R"KO_ +"NH_\ I9-76UR7A3_D%7?_
M &%=1_\ 2R:@#<HHHH **** "BBB@ HHHH **** "BBB@ HHHH S/"W_ "%?
M%7_853_TCMJZ2N;\+?\ (5\5?]A5/_2.VKI* "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "N2\*?\@J[_ .PKJ/\ Z635UM<EX4_Y!5W_
M -A74?\ TLFH W**** "BBB@ HHHH **** "BBB@ HHHH **** ,SPM_R%?%
M7_853_TCMJZ2N;\+?\A7Q5_V%4_]([:NDH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "N2\*?\@J[_P"PKJ/_ *635UM<EX4_Y!5W_P!A74?_
M $LFH W**** "BBB@ HHHH **** "BBB@ HHHH **** ,SPM_P A7Q5_V%4_
M]([:NDKF_"W_ "%?%7_853_TCMJZ2@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ KDO"G_(*N_P#L*ZC_ .EDU=;7)>%/^05=_P#85U'_
M -+)J -RBBB@ HHHH **** "BBB@ HHHH **** "BBB@#,\+?\A7Q5_V%4_]
M([:NDKF_"W_(5\5?]A5/_2.VKI* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "N2\*?\ (*N_^PKJ/_I9-76UR7A3_D%7?_85U'_TLFH
MW**** "BBB@ HHHH **** "BBB@ HHHH **** ,SPM_R%?%7_853_P!([:ND
MKF_"W_(5\5?]A5/_ $CMJZ2@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ KDO"G_(*N_^PKJ/_I9-76UR7A3_ )!5W_V%=1_]+)J -RBB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#,\+?\A7Q5_P!A5/\ TCMJZ2N;
M\+?\A7Q5_P!A5/\ TCMJZ2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ KDO"G_(*N_\ L*ZC_P"EDU=;7)>%/^05=_\ 85U'_P!+)J -
MRBBB@ HHHH **** "BBB@ HHHH **** "BBB@#,\+?\ (5\5?]A5/_2.VKI*
MYOPM_P A7Q5_V%4_]([:NDH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *Y+PI_R"KO\ ["NH_P#I9-76UR7A3_D%7?\ V%=1_P#2R:@#
M<HHHH **** "BBB@ HHHH **** "BBB@ HHHH S/"W_(5\5?]A5/_2.VKI*Y
MOPM_R%?%7_853_TCMJZ2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ KDO"G_ ""KO_L*ZC_Z635UM<EX4_Y!5W_V%=1_]+)J -RBBB@
MHHHH **** "BBB@ HHHH **** "BBB@#,\+?\A7Q5_V%4_\ 2.VKI*YOPM_R
M%?%7_853_P!([:NDH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *Y+PI_R"KO_L*ZC_Z635UM<EX4_P"05=_]A74?_2R:@#<HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH S/"W_(5\5?\ 853_ -([:NDKF_"W_(5\
M5?\ 853_ -([:NDH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *Y+PI_R"KO_ +"NH_\ I9-76UR7A3_D%7?_ &%=1_\ 2R:@#<HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH S/"W_ "%?%7_853_TCMJZ2N;\+?\
M(5\5?]A5/_2.VKI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "N2\*?\@J[_ .PKJ/\ Z635UM<EX4_Y!5W_ -A74?\ TLFH W**** "
MBBB@ HHHH **** "BBB@ HHHH **** ,SPM_R%?%7_853_TCMJZ2N;\+?\A7
MQ5_V%4_]([:NDH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN2\*?\@J[_["NH_^EDU=;7)>%/\ D%7?_85U'_TLFH W**** "BBB@ HHHH
M**** "BBB@ HHHH **** ,SPM_R%?%7_ &%4_P#2.VKI*YOPM_R%?%7_ &%4
M_P#2.VKI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N
M2\*?\@J[_P"PKJ/_ *635UM<EX4_Y!5W_P!A74?_ $LFH W**** "BBB@ HH
MHH **** "BBB@ HHHH **** ,SPM_P A7Q5_V%4_]([:NDKF_"W_ "%?%7_8
M53_TCMJZ2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MDO"G_(*N_P#L*ZC_ .EDU=;7)>%/^05=_P#85U'_ -+)J -RBBB@ HHHH **
M** "BBB@ HHHH **** "BBB@#,\+?\A7Q5_V%4_]([:NDKF_"W_(5\5?]A5/
M_2.VKI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N2\
M*?\ (*N_^PKJ/_I9-76UR7A3_D%7?_85U'_TLFH W**** "BBB@ HHHH ***
M* "BBB@ HHHH **** ,SPM_R%?%7_853_P!([:NDKF_"W_(5\5?]A5/_ $CM
MJZ2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KDO"G_(
M*N_^PKJ/_I9-76UR7A3_ )!5W_V%=1_]+)J -RBBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#,\+?\A7Q5_P!A5/\ TCMJZ2N;\+?\A7Q5_P!A5/\ TCMJ
MZ2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KDO"G_(*
MN_\ L*ZC_P"EDU=;7)>%/^05=_\ 85U'_P!+)J -RBBB@ HHHH **** "BBB
M@ HHHH **** "BBB@#,\+?\ (5\5?]A5/_2.VKI*YOPM_P A7Q5_V%4_]([:
MNDH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y+PI_R"
MKO\ ["NH_P#I9-76UR7A3_D%7?\ V%=1_P#2R:@#<HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH S/"W_(5\5?]A5/_2.VKI*YOPM_R%?%7_853_TCMJZ2
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KDO"G_ ""K
MO_L*ZC_Z635UM<EX4_Y!5W_V%=1_]+)J -RBBB@ HHHH **** "BBB@ HHHH
M **** "BBB@#,\+?\A7Q5_V%4_\ 2.VKI*YOPM_R%?%7_853_P!([:NDH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y+PI_R"KO_L*Z
MC_Z635UM<EX4_P"05=_]A74?_2R:@#<HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH S/"W_(5\5?\ 853_ -([:NDKF_"W_(5\5?\ 853_ -([:NDH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y+PI_R"KO_ +"N
MH_\ I9-76UR7A3_D%7?_ &%=1_\ 2R:@#<HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH S/"W_ "%?%7_853_TCMJZ2N;\+?\ (5\5?]A5/_2.VKI* "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N2\*?\@J[_ .PK
MJ/\ Z635UM<EX4_Y!5W_ -A74?\ TLFH W**** "BBB@ HHHH **** "BBB@
M HHHH **** ,SPM_R%?%7_853_TCMJZ2N;\+?\A7Q5_V%4_]([:NDH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y+PI_P @J[_["NH_
M^EDU=;7)>%/^05=_]A74?_2R:@#<HHHH **** "BBB@ HHHH **** "BBB@
MHHHH S/"W_(5\5?]A5/_ $CMJZ2N;\+?\A7Q5_V%4_\ 2.VKI* "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "N2\*?\@J[_["NH_^EDU=
M;7)>%/\ D%7?_85U'_TLFH W**** "BBB@ HHHH **** "BBB@ HHHH ****
M ,SPM_R%?%7_ &%4_P#2.VKI*YOPM_R%?%7_ &%4_P#2.VKI* "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "N2\*?\@J[_P"PKJ/_ *63
M5UM<EX4_Y!5W_P!A74?_ $LFH W**** "BBB@ HHHH **** "BBB@ HHHH *
M*** ,SPM_P A7Q5_V%4_]([:NDKF_"W_ "%?%7_853_TCMJZ2@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KDO"G_(*N_P#L*ZC_ .ED
MU=;7)>%/^05=_P#85U'_ -+)J -RBBB@ HHHH **** "BBB@ HHHH **** "
MBBB@#,\+?\A7Q5_V%4_]([:NDKF_"W_(5\5?]A5/_2.VKI* "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "N2\*?\ (*N_^PKJ/_I9-76U
MR7A3_D%7?_85U'_TLFH W**** "BBB@ HHHH **** "BBB@ HHHH **** ,S
MPM_R%?%7_853_P!([:NDKF_"W_(5\5?]A5/_ $CMJZ2@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ KGF\$Z*9II$.J0F:5YG6#5[N)-[
ML78A5E"C+,3P!UKH:* .=_X0G2/^>^M?^#R]_P#CM'_"$Z1_SWUK_P 'E[_\
M=KHJ* .=_P"$)TC_ )[ZU_X/+W_X[1_PA.D?\]]:_P#!Y>__ !VNBHH YW_A
M"=(_Y[ZU_P"#R]_^.T?\(3I'_/?6O_!Y>_\ QVNBHH YW_A"=(_Y[ZU_X/+W
M_P".T?\ "$Z1_P ]]:_\'E[_ /':Z*B@#G?^$)TC_GOK7_@\O?\ X[1_PA.D
M?\]]:_\ !Y>__':Z*B@#G?\ A"=(_P">^M?^#R]_^.T?\(3I'_/?6O\ P>7O
M_P =KHJ* .=_X0G2/^>^M?\ @\O?_CM'_"$Z1_SWUK_P>7O_ ,=KHJ* ,_2-
M$L=#AGCL5G N)?.E:>YDG=WVJF2TC,WW44=>U:%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJTTJUU"&2VC$CFZC1003CC:[<T=6NPKJR?1G;445'//%;6\D\\BQPQJ7=W.
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MN7\:2^$EU/PI=^$=)>WT:VND$VHFU>-)6++A=[@,Y4(Q.?6M6E[5]N:WRO\
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M6O)Q?>_RZ_DOO!.T5)=K?/I^;^X]_P!+BNX-)M(K^X-Q>+$HGF*JN]\?,<*
M!SZ"O._'WCW7;;Q78^"_"%O ^LW2;Y+B<96!2"1@=,@ L2<\8X.:]/KQ7Q[:
MZKX,^*UGX^M=,GU#2W@\F\6W7<T8"E23Z<8()XXP2*EM.2OM_7ZE)-1=M6/B
M\9^.O 'B33-/\>S6.I:;J3[$OK50IB;('95&!D$@KT/!XQ7+_%&R\6/\8]%1
M-3M/.GE4Z.Q48MQN'W_DY^;G^*K^N:Y<_&[7M#T_0-)OH-&LKCS[N\NXPH!X
MR,J2,XZ#.23T&,UK?$H8^-W@,#LR_P#HRFDW*%][O[K$S=HRMV_&YZUH4.J6
M^A646M7,5SJ:1 7,T0PCOW(X''X"O#?C1?Z=I?Q;\-7VKVGVO3X+57G@\M9/
M,7>_&UB ?QKZ"KP_XDVEM??'CP=:W=O%<6\L2K)%,@='&]^"#P14N[G'U_1E
MJRA*_;]4<)X]\7>!O%6DV^F^$_![V>IO.NR9+2* XZ;0(R=^>F#7H/CWQ3XG
M^'OA?P/;V=SBY,:Q7L11'\XHL?R98$CJ1D>M>JZ?X9T#2+@SZ;H>FV4Q&#);
M6D<;8],J :\J^/G_ "$/!G_7\W\XZI/X8KK)?Y"[R?1/\KG2:=JGB_PEX=UK
MQ%X\U&RNH(XUEMK2S0 QD_P%MH[E5'+?6N5L=9^,?B72/^$JTR;2K73RK20Z
M8T8+3(">A*D\_P"^N<=!7I/Q"\.3>*_ NJ:/;$"YFC#0Y. 75@P'XD8_&O*_
M#_Q>F\)^%;;PMJ?AK5AXAM(3;V\(A 67&0A.3N[=E.<5+>_=6M^/WCMHO.]_
MP^XZ_1?%^L_$7X:W-]X<N1I?B&V;8Z>6KH9%&=N'!PK \=P?ISQ,?QB\3:QH
M.F^&],B>/QK-=&VN)6@7"!3RVTC:"><\8&UCQQ6SX*$WPF^%FHZ[XB3R[Z^F
M,T=HW#%B,(A'8GDGT'TKA4TGQ9X9M+#XM2OYMS<W3375L5QB&3@$^S<CVRM7
MISZ[:7\GV_S\B5?ETWUMYK^MO,].^(&N^*O MKX7U'^V7NK%9U@U=C;1#SB2
M#NX3Y1@,.,=N]7_BOXPU30M(TFS\-W"IJ^K7216S!%?Y>Y 8$<DJ.G>M/78+
M#XF?"^Y^P,)8[ZV\VV)/*RKRH/H0PP?QKS'X8377CSQEH]UJ$3"'PKIRP$2#
MEIR2H/Y#/U6A*\N671W^77\5;YA>T5)=K?/I^?X'O5E'/#8P17,YGG2-5DE(
M +MCDX  &3Z"OGKXE:,GB#X\PZ4Z;OM&G%5XSAO*D*G\" :^C*\1U:/S/VIM
M(YQML]W_ )"DJ;<U1+U_)E)\L&^UOS1F7?B.77/@5X=T-'(OM1O8M)<9.Y0C
M\Y_ )^=2?!&SBT[XG>,;*!=L5N7B1?15F('Z"LGPIX>N(_V@IM&D9C8Z9>W&
MH1Q?PKN *D#\8_RKH_A>CQ?&/Q^J8,@>0KGIGS215*5WS_S)O\$O\R9QLN7^
M5I?>V_RL='?CXCZE/J=[-KEEX1T^W=ELXG@@N3.@&0SN6(7IV]3QQ7/:;XR\
M3^/_ (.:_+#/9VNIV1:.><+\DT 3<X PV&*Y'&/J*YGPO=:(NIZT?B'IM_JG
MBX2L+6TGMI9S(O7;&@!7&X'KQCIQFM?X,6TLW@/QMHWEE-0W21FW(PRL8RH&
M/J"/PK-KW)?X;_U^O0T5E-?XK?+^MB;X)R^(-'\'W&N7^IVQ\)6\%Q(MHJ#S
MED4@EL[,XP&_B/7I3['Q+\6?%NF3^+-#ETRTTB,N8=.D16>=4)SR5))[?>7D
M<54^%NHQ:[\/]6^'#6EY;ZH+>Y+RR1@1)N. #SD-D]".QYKC=)7P9X;LGT;Q
MKX%U6?Q'&[*ACFD03Y)V])!CGC*JP/7FM)ZR^2M_77_(B*M'YZ_UT/79_B3>
M:S\$;_Q7I;+9:I;@1OM57$<@=0<!@000V>?6HOAWJ7Q&\5'2M?U#4K&'P^T9
M22V\I?.N"H(,G"<98=F  '3UI:[INEZ?^S_K3Z3X?N]#@N0LS6EW(S/G>@W?
M,S$9 '''TKM/A3_R2WP__P!>O_LQI/1S?:WY.Y/V8KO?\+'/_"?QAK_B1O%'
M]JW)OFL;G9;1B..,@?/\N0 .<#DU2U>[^)EKX>O_ !)J?B+3_#\ENKRQ:-]F
MAF5T7D RDD[CTX]NF:POA*=1&C?$0Z0,ZB)6^S?]=,2;?UKG="D\-W'@O5X-
M2TC4-5\?S)+&\=Q;2S2H3PCY8%4"@@DG!X^E2_A37\J?]?J:12YG?;F:_K]#
MT"_\57'C+]G?5-8O(8XKEX'CE$?W2RN!D#MGTK+M?&E_X)^ OABYTR&![N[D
M^SI)<?ZN++.2QZ>GK[]JS_#4\<O[+VM1HX+Q&97'=274_P B*WM#U&VT[X!Z
M(U[X8N/$%HZ,LEM#&'"_.Q#,#R!GN <54K)S_P"W3-:\G_;Q9T2'XQP7]I<S
MZQX?UK3Y2/,56551>^&2-3G'3&X>U>MU\I2WNAW^H6@^%.E>)=.ULS+YBK+F
M+9_M?.QP#C[Q QG-?5-N)1;1"X*F;8/,*]-V.<?C3^S<.I\[?&6S\3M\3]"'
M]HVOEW%PHT=2H_T=LQ@E_DY^?!YW<?E7;>*?''B?P9H6@Z"XM=6\9:D2GF*N
M(OO8#8 7KD < <$GISE?&/\ Y*;\/O\ K['_ *-CJ_\ %W1-9MO$?A[QKHUA
M)?MI3A;BWB4LY3=D' R<<L"<<9!J8V4(WVYG?^OS+EK)M;VT,W4/%'Q.^'#V
MFI^+I].UC1[B81S"V0*\&<\ A$Y^NX<8R,UI?%7Q_KGAW4?"DOARX$EOJ.YV
M@\M"+D93:N64E<[NV.M<UXO\=3_%[3;?PMX4T/40\MPC7<]S&H2$#.,E20!G
MG)QTP <U;^*UBNE^)/AIIZ-N6VE6$-Z[7A&?TJHJ[BG_ #?A8EZ7MV?WGIG@
MFS\:6L%X_C+5+*\EE<-;QVB "%>ZD[5S^O3J:XC]H:#67\'P36MW"FD1R 7D
M##YY'+#RRIVG@<YY'7O7L5>=_&[3[K4?AA?QVD$D\D<L4A2-=QVAADX'IUK*
MH]+^A<%J<;K-IXFM?V>=2_X2/4;:\62*U:R$"@>5#NCPK81>?S^M9]AJWQ.L
M/A;INN:1+IMAHNG6H/D,HDGN$4X+MN4@ \\ @XK0UCQ=9^*_V=M0^R6UU";"
M*UM93.H 9U:/)4@G(_(^U=#'_P FT-_V V_]!-:U';VC7=?J13^&FGY_H6F^
M*@M_@[;>,I[5#>3#R5MUR$:?<5^NWY2?I7+7?B7XM>&-&A\7ZQ-I=WI$GEO+
MIRH%>%'(QR%!!Y ^\V,\BL^T\+7OBK]FG3;?38FFN[6YDN4A7K)B20$#WPQ/
MX5@:;>?#6=+337^&^MW&O#:ES;13S#YL?,0/-W=>Q4=:)*U226]U;TMV_JP*
MW*K[:W^\^E])U*#6=(L]3M23!=PK,F>N&&>:Y?XK>(V\,_#S4[N)]ES,OV:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.?3'UJ/X=>!T\">'GL6N?M=Y<2F>YN,$;V/&!GG ']:Z^BA:7MU!ZV"BBB@
MHHHH **** "BL\:MGQ VD_V??C%O]H^V&'_1S\V-@?/W^^,=*@\.>([/Q/83
MWEE'/''#<R6S"90"60X)&">/2C^OT#8UZ**QM>\2V?AV33$NXIW.HWJ64/DJ
M#M=LX+9(P..V3[4=; ;-%%8]SXCL[3Q38>'I(YS=WL$D\;JH\L*F,@G.<\^A
MH\@\S8HHHH **** "BJ.KZO8Z%I<^I:E.(+2$ NY!.,G &!R220*N@A@".AY
MH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJGI
MFJV>L6K7-C-YT*R/%O (!93M;K[@U<JI1<7RR5F 4445(!1110 4444 %%%%
M !69K^FW>K:-/:6&IS:;=M@Q74(R8V!R,@\$=B/2M.BDU<$['C>H>!?BUK4,
M^E:EXVTU](G!CE9+<+*R>X6(=>XW_B:]-\+^'K;PKX;LM%M&9XK5-N]NKDG)
M8_4DFM>BJOI85M;A1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM;06]J)R?+C B!:1L<D*.U8OQ>T6^T&#4_%.B1;H-0LVLM8MQT964JDWU4D
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M/QJK\,9G\00ZGXSN(6BEU>8+ K=4@B&Q1^+;S^--;Z]+_CM^-_N$]KKK_3_
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M?U]Q:6J3.\\8^,]9M?#/A'5=#1%N-6O+=&MY "KK)&3L)() SCD<\56UN_\
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MU:?P;_Y)O!_U\W/_ *-:CX-_\DW@_P"OFY_]&M0]+^23^9<M[^;7RU-GX?\
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M_P 767Q T27PCX:AO+G4KR2..Z$MI)$+) P9FE+@ 'Y2,#.:U]3B$/QF\*1
MY":7=*#]-HI+=>NG_@+_ %%.W*_37_P)$4>I>+O'&I:D?#VM6V@Z/8736J7)
MLUN9KF1.'X<A57)X[\5M^$M>U2YU+5/#^OK;G5M-V/Y]NI6.XA?.UPI^Z>""
M/6O*9?#/@/PUK6L0?$/1[B-I;V2>RU,&Y,-Q$Y+!?W1P'7G(Q7=_#/2O#L%[
MJ6H>&O"]QI>GNJ10WUQ/-NO!U)6.0DJH.,-WHAM\OQT_7I_PY4M'\_P_X;^N
MAWNI3W5MIES-8VAN[M(V:&W#A/,?'"[B0!SW-><ZK'\0[#2'UN]\;:387$<!
MG;2FL(Q!D#)3S68M[9%=?XY;5U\$:NV@A_[3%N?)\L9?WV_[6,X]\5Y)9)\.
M+C0KJ'0?#UWK?BB2 B6*YM9I94G*G+2-*-B8.22#V[U#;U:Z%+I?^MC9^(&I
MZEXL^!UGKT-XMBDR127=JL(<3$R*H 8G*@-\W'7H:]0\/V>I6&C0V^K:K_:E
MXN2UU]G6#<">!L7@8'%>3[)=0_9A@2SADGDB@3=&@RPV3@MQ[ &O5?#GB'3/
M$^BPZGI%S]HM6R@?8R?,.",, :V:2YDN_P"AFFW&#?9_F9VIZGJ&F>.M'A>8
MMI&I126_E[%Q'<*-ZG=C/S*&&,XXJ.3Q-.GQ"CTC"?V<8O(+]_M17S O_?L9
M_&KOC'3Y;[P]));*3>63K>6P7J9(SN _$ K^-<@;:XG^&[^)EB8W[7O]NH,8
M8*'R%_[\C;7KX>G1JTXRDE?X/F[VE]W4F5[V77]/\]/O-/7]2\17VI:]#X?O
MC;II-DI"K"C^=<GY]IW*> @ XQR]6]8\57)\"6>K:.BM?ZBD?V6-_P"\PW,/
MP4,?PK2\)6$MGH2RW2L+R^D:\N QR0\ASM/^Z,+_ ,!KE] TVXA\=-HLD;?V
M?H@FNK8L,AA<'Y /]T><M5#V$KJRM2U_Q)*SOWO*WR8K_:[_ *[?UYFUKOB*
M>7PKIUQHDRI>ZP\,5FY4-MW_ #%L'@[5#'GTI?"NJ:@+W7=)UJ[:XN--N T=
MQ)&J&2W==R,0H XPP) [5C>#]*NE\2W-G<QNMEX?EFBL\GY6\X[U('^S&0O_
M  *G_$&TO+:\AN].63?JT/\ 8T[1C[GF,-DA_P!W,@_X$*?L://]3C;752ZK
M5-:_X+W7<-=WT_IFIX-\43:W9:C+J 6)H)?.CXQ_HL@WQ,?^ Y'X5<\'7NH:
MKH(U34)2WVV5Y[>/:%\J G]VO Y^7!R<GFN:\6:/<P:]IUGID3);:S:?V5<M
M&<>6B$.&XZ?N_-'XBNTU35-,\,Z,U[?S"VL+8*A8(S;1D*!A03W Z5AB84W%
M.A'6HU9+5JVEOFQJ][/U^_\ I_@<[X^UW6M%GT!-$599[R^\AH' VR J< G!
M( ."2.<"L[4;_P 7^"V@U?6-9M=7TF2=([N);18#:!S@,C DL 2/O<_SIWQ(
MU&2SN_"%_:VTEVRZD'6&,?-(IC.0 >^"<"J7B;Q'8_$+3D\,^'DN;F:>XC%Y
M(UN\:V:*X9BY8#YOEQ@5W86BW1HWIIP?-SNRNES/KNK='U>FNQ$Y*[UZ:?C_
M , T-;U?Q)<_$;_A&M&U"&T@FTQ;@SR0++Y!#L"ZKQN)^48)QWQ3]0U;Q)#J
M6F>$-.O[>?6'M6N;W5)[<!8XP=H98QQN)[=.*6,;?CBP';0 /_(U1^(Y9?"W
MQ M_%4UM/-I$]@;.\D@C+FW*MO5V YV]L_\ UJF*@Y4Z:A&_L^9:+65G:_?R
M5[-I;]:=_>?I^EP75/$OA#6]+M/$&IP:SINIS_9DO%M5MY()B/E!53@J>?>I
MM5\37WA#Q@?[=NP_AS4(R;:=HU7[)*HR8R0!D,.F<GMZUEZGK-O\1M8T&S\/
M)/<:=97R7UW?M \<2^7T0%@,L2:?XDC;XC^))?"UO(R:)II\S4;F,<O-@[(E
M/3CJ?IBKC1@YQ^LP4?=?M-$N57]UV6TGT6E^JU%=:V>FGW_UN7](N_%>O>&=
M8UI+MK.2\C9]'M##&3"@'R,Q*G)?'0Y !_*W9>,U?X7CQ1-M,T=F6D7IF=?E
M*X]W&/QH\#Z[<SI<>'-8.W6])Q'+D8$\7\$J^H(QGW^M<@VGSQ^.Y? PB9M+
MN=076B3]T0@;F3Z>:!4*A"I5J4ZD4N5J6G6"6MGUNN5I]6V][AS-)2Z]?7_A
M_P &=&FK^(-&U+PB-7O3-;ZE";:]!B10MT1N0Y"@CNN.G'K6QJ^JWK>,-&T/
M3IA'N#WE\VT,?(7Y0O(.-S,.>#\II/'ND3:QX.OH;7(O8 +FU*]1+&=RX]^,
M?C67\/)I-?\ [0\7W$11]29(;=6'*0Q#;^&7WG\JY_W=2@\4TDXWC:W5OW7;
MR3?_ ("ANZM'O^F_]>9#_:?B;QAK.JVV@:I;Z-IFFW'V4W;6HN)9Y5'S@*Q"
MA1D#UJ;2=8\03:GJGA#5+V"'68K43V>IP0 K)&?EWF,G&X-U'0_SR],UVU^'
M.JZYI_B)9[73[N_>\LKX0/)$XDY*$J#A@1T-7O#9G\2_$&[\6):SV^EQ6(L;
M1YXRC7&6WLX4\[>W^3755I*,)OD2I**<966LO=MKU;?-=.]NRMJF]=];_A?_
M "ZF7\.)+[0/!NI:UJ>LFYTVW:Y;[(+54*.DC;GWCD[B#QT&:TK*+XA:UI\6
MNQ:YI]@9H_.@TDV0DC*D94/*3N!((SBLCPPUOK/@WQ#X($K0:V&NRT$L;+M#
M2$JV<8P=R]ZY^QL/AA9V,%GXB\/WMGKZ($ELC]K9Y9!QE-K;2&(R.:[9TE.M
M5FXWGS+:$9>[:Z=FXZ/K)7]5N3>VBVN^OF>O^%M>'B/P_!J#0^1,2T4\.<^7
M(A*LOTR/RJEXT\1W>@V5E!ID$4VJ:E<K:VJRD[%8]7;'. *J^&Y=+\)^ _MU
MSI3^'[!2TTEL\LEPT89@ 6X+9/'R]LU4\>P7%W:^'_$FEVTE\FF7:7;0Q*=\
MD+#YBJ]2<8.*\6G0I/&_#^[YFE?:Z3:5[VWLM]NO4N[Y--[,3?XV\-ZE82W]
M^/$-A>7 AN([?3O+>TW='79G*#N6I;C5/$GBGQ#JFF>'M0M](L-,<0S7SVPN
M)))L9*JK': .AS39/B-%K=S:Z?X.B:^OGG5;HW%K*L=I'_$7)V\\$ 9ZU1M-
M7M_AUXDU^+78YX-*U*[-];7Z0O)'N8 ,C;02#D<5V1HU6FYTHJK;165W[RUY
M-KI;::J[L[7%=='V_7_@7_0V/#VNZU:>*9O"GB.2"ZNA;"ZM+^&/RQ/&#M;<
MG0,#Z<5BZ!>^-O%UAJ/V;7(-+2TOYX$N6LDFDF"MPN#A54 @9P235S0[B;Q;
M\0QXEMK:>+1;*Q-M;33Q&,W+N0Q90>=H'>K7PN_Y &I_]A>[_P#0Z5;EHTYU
M%"/.E"ZLFE)N5]-4M$KK9/IV5]4D]+_I_F9F@ZEXU\::*[P:I9Z)+9S/;2SI
M:B<W$J'!(#'"+T]3G/2NE\"Z]>>(?#GVC44B6]@N);:<Q?=9D;&1]:S?A=_R
M -3_ .PO=_\ H='PN_Y &I_]A>[_ /0ZSQR@XUXQ@DH2C:RMOOKN_GMT"+?N
M^K7W7_R.WHHHKP#<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]A7H%% 'E6K?!^ZNKS3)+?QGXFF2"Y\R9KS5"SQK@_-"0G#^Y[5J_P#"K/\
MJ??'/_@X_P#L*] HJY3<HJ+Z?U_6PK:W//\ _A5G_4^^.?\ P<?_ &%'_"K/
M^I]\<_\ @X_^PKT"BH&>?_\ "K/^I]\<_P#@X_\ L*/^%6?]3[XY_P#!Q_\
M85Z!10!YQ>_"N[^PS_8/'OC+[9Y;>3Y^KGR]^.-V$SC/7%9NA?![4E#7VO\
MC?Q$=6=?+,VGZBRXC'(4NZEF&>>P]N]>LT5K&JXP<$EKUZ^E[[>5A-7//_\
MA5G_ %/OCG_P<?\ V%'_  JS_J??'/\ X./_ +"O0**R&>?_ /"K/^I]\<_^
M#C_["C_A5G_4^^.?_!Q_]A7H%% 'G_\ PJS_ *GWQS_X./\ ["C_ (59_P!3
M[XY_\''_ -A7H%% 'G__  JS_J??'/\ X./_ +"C_A5G_4^^.?\ P<?_ &%>
M@44 >?\ _"K/^I]\<_\ @X_^PH_X59_U/OCG_P ''_V%>@44 >?_ /"K/^I]
M\<_^#C_["C_A5G_4^^.?_!Q_]A7H%% 'G_\ PJS_ *GWQS_X./\ ["MCPWX+
M_P"$<U&2\_X2;Q'JF^(Q>3J=_P"?&N2#N"[1AN,9]"?6NHHH **** "BBB@
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M_L+[?YUHMSYOVORL9=UVXV-_<SG/>N/_ .&FO^I1_P#*E_\ :J /H"BOG_\
MX::_ZE'_ ,J7_P!JH_X::_ZE'_RI?_:J /H"BL_0M3_MOP]IFK>3Y/VZTBN?
M*W;MF] VW.!G&<9P*\?UW]H?^Q/$.IZ3_P (MYWV&[EMO-_M#;OV.5W8\LXS
MC.,F@#W"BOG_ /X::_ZE'_RI?_:J/^&FO^I1_P#*E_\ :J /H"BO#]"_:'_M
MOQ#IFD_\(MY/VZ[BMO-_M#=LWN%W8\L9QG.,BO8-=U/^Q/#VIZMY/G?8;26Y
M\K=MW[$+;<X.,XQG!H T**^?_P#AIK_J4?\ RI?_ &JC_AIK_J4?_*E_]JH
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ME[MT:O\ =\LXQNQU[5S_ /PTU_U*/_E2_P#M5 'T!17S_P#\--?]2C_Y4O\
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M[[0/^$<^V?9?+_?_ &[R]VZ-7^[Y9QC=CKVKG_\ AIK_ *E'_P J7_VJ@#Z
MHKY__P"&FO\ J4?_ "I?_:J/^&FO^I1_\J7_ -JH ^@***^?_P#AIK_J4?\
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M&QO[F<Y[T >H45\__P##37_4H_\ E2_^U4?\--?]2C_Y4O\ [50!] 45\_\
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MVA]O\W_EY\K9LV?[#9SO]NE>?_\ #37_ %*/_E2_^U4 ?0%%?/\ _P --?\
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MV7R_W'F^7NW2*GWL'&-V>G:O'_\ AIK_ *E'_P J7_VJ@#Z HKY__P"&FO\
MJ4?_ "I?_:J/^&FO^I1_\J7_ -JH ^@**\_^&7Q-_P"%C?VI_P 2C^S_ +!Y
M7_+SYN_?O_V%QC9[]:/B;\3?^%<_V7_Q*/[0^W^;_P O/E;-FS_8;.=_MTH
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M_P J7_VJC_AIK_J4?_*E_P#:J /H"BOG_P#X::_ZE'_RI?\ VJO0/AE\3?\
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MY]L^R^7^_P#MWE[MT:O]WRSC&['7M7/_ /#37_4H_P#E2_\ M5 'T!17S_\
M\--?]2C_ .5+_P"U5H:%^T/_ &WXATS2?^$6\G[==Q6WF_VANV;W"[L>6,XS
MG&10![A117S_ /\ #37_ %*/_E2_^U4 ?0%%?/\ _P --?\ 4H_^5+_[51_P
MTU_U*/\ Y4O_ +50!] 45Y?\./C!_P + \0W&D_V%]@\FT:Y\W[7YN<.B[<;
M%_OYSGM7J% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %175U!96DUW=2K%;PH9))'. B@9)/L!4M>4_M!:M+I_P .DM87
M*F_O$ADQW0!G/ZJM 'GWC/\ :!UF]O9;;PL$L+%"56Y>,/-+[X8$*#Z8S[]A
MQI^)/Q"E/F?V]J9#<Y48'X8&*]"_9\\$Z9J<%[XFU&W2YDM[C[-:QR*&5&"A
MF?!ZGYE ].?P^AZ /C7_ (6+\0_^@[JOZ_X4?\+%^(?_ $'=5_7_  K[*HH
M^-?^%B_$/_H.ZK^O^%'_  L7XA_]!W5?U_PK[*HH ^-?^%B_$/\ Z#NJ_K_A
M1_PL7XA_]!W5?U_PK[*HH ^-?^%B_$/_ *#NJ_K_ (4?\+%^(?\ T'=5_7_"
MOLJB@#XU_P"%B_$/_H.ZK^O^%'_"Q?B'_P!!W5?U_P *^RJ* /C7_A8OQ#_Z
M#NJ_K_A1_P +%^(?_0=U7]?\*^RJ* /C7_A8OQ#_ .@[JOZ_X4?\+%^(?_0=
MU7]?\*^RJ* /C7_A8OQ#_P"@[JOZ_P"%'_"Q?B'_ -!W5?U_PK[*HH ^-?\
MA8OQ#_Z#NJ_K_A1_PL7XA_\ 0=U7]?\ "OLJB@#XU_X6+\0_^@[JOZ_X4?\
M"Q?B'_T'=5_7_"OLJB@#XU_X6+\0_P#H.ZK^O^%'_"Q?B'_T'=5_7_"OLJB@
M#XU_X6+\0_\ H.ZK^O\ A1_PL7XA_P#0=U7]?\*^RJ* /C7_ (6+\0_^@[JO
MZ_X4?\+%^(?_ $'=5_7_  K[*HH ^-?^%B_$/_H.ZK^O^%'_  L7XA_]!W5?
MU_PK[*HH ^-?^%B_$/\ Z#NJ_K_A1_PL7XA_]!W5?U_PK[*HH ^-?^%B_$/_
M *#NJ_K_ (4?\+%^(?\ T'=5_7_"OLJB@#XU_P"%B_$/_H.ZK^O^%'_"Q?B'
M_P!!W5?U_P *^RJ* /C7_A8OQ#_Z#NJ_K_A1_P +%^(?_0=U7]?\*^RJ* /C
M7_A8OQ#_ .@[JOZ_X4?\+%^(?_0=U7]?\*^RJ* /C7_A8OQ#_P"@[JOZ_P"%
M'_"Q?B'_ -!W5?U_PK[*HH ^-?\ A8OQ#_Z#NJ_K_A1_PL7XA_\ 0=U7]?\
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M_"OLJB@#XU_X6+\0_P#H.ZK^O^%'_"Q?B'_T'=5_7_"OLJB@#XU_X6+\0_\
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MB'_T'=5_7_"OLJB@#XU_X6+\0_\ H.ZK^O\ A1_PL7XA_P#0=U7]?\*^RJ*
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MS+_\BT?VKXL_Z .B_P#@YE_^1:U:* ,K^U?%G_0!T7_P<R__ "+1_:OBS_H
MZ+_X.9?_ )%K5HH RO[5\6?] '1?_!S+_P#(M']J^+/^@#HO_@YE_P#D6M6B
M@#*_M7Q9_P! '1?_  <R_P#R+1_:OBS_ * .B_\ @YE_^1:U:* ,K^U?%G_0
M!T7_ ,',O_R+1_:OBS_H Z+_ .#F7_Y%K5HH RO[5\6?] '1?_!S+_\ (M']
MJ^+/^@#HO_@YE_\ D6M6B@#*_M7Q9_T =%_\',O_ ,BT?VKXL_Z .B_^#F7_
M .1:U:* ,K^U?%G_ $ =%_\ !S+_ /(M']J^+/\ H Z+_P"#F7_Y%K5HH RO
M[5\6?] '1?\ P<R__(M']J^+/^@#HO\ X.9?_D6M6B@#*_M7Q9_T =%_\',O
M_P BT?VKXL_Z .B_^#F7_P"1:U:* ,K^U?%G_0!T7_P<R_\ R+1_:OBS_H Z
M+_X.9?\ Y%K5HH RO[5\6?\ 0!T7_P ',O\ \BT?VKXL_P"@#HO_ (.9?_D6
MM6B@#*_M7Q9_T =%_P#!S+_\BT?VKXL_Z .B_P#@YE_^1:U:* ,K^U?%G_0!
MT7_P<R__ "+1_:OBS_H Z+_X.9?_ )%K5HH RO[5\6?] '1?_!S+_P#(M']J
M^+/^@#HO_@YE_P#D6M6B@#*_M7Q9_P! '1?_  <R_P#R+1_:OBS_ * .B_\
M@YE_^1:U:* ,K^U?%G_0!T7_ ,',O_R+1_:OBS_H Z+_ .#F7_Y%K5HH RO[
M5\6?] '1?_!S+_\ (M']J^+/^@#HO_@YE_\ D6M6B@#*_M7Q9_T =%_\',O_
M ,BT?VKXL_Z .B_^#F7_ .1:U:* ,K^U?%G_ $ =%_\ !S+_ /(M']J^+/\
MH Z+_P"#F7_Y%K5HH I:)K>HWVKW^F:GIUK:36L$%PK6UVTZNLK2K@[HT((,
M1['J*WJYG2O^1^UK_L%V'_HV[KIJ "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BLBX\4:-:^)K;P[->;=6NHC+#;^4YW(,\[@-H^
MZ>I[5#XA\8Z!X4-LNM:BML]RVV&,1O([GV5 3^.* -VBJMQJ5G9Z<VH7=PEM
M:*F]I;@^6%'ONQCZ&N6L_BSX%O\ 4/L,'B.V\_=M'F(\:$YQP[*%/X'FCK8.
MESLZ*SM;U[3/#FD2ZKJMS]GL8MN^4(SXW$ <*"3R1VKE(?C/\/IYDB3Q$@9S
M@%[69%_%F0 ?4FCR#S.\HK%UWQ;H7AO2H-4U74%ALIW5(ID1I0Y8$C&P'@@$
MYZ5'K?C/P_X;N;"WU?45M9-0.+8-$[!^0.2 0OWAUQ3M_D'2YO45FZ[K^F>&
M=)DU35[K[-91E5:7RV?!8X'"@GJ?2KEI=0WUG!=VS[X)XUDC;!&Y2,@X//0T
M@)J*I:IJ^G:)8O>ZI>P6=LA ,LSA1D]!SU/M6#H?Q+\'>([T6>EZ[!+<L<+%
M(CQ,Y]%#@;NG;-"UT0/34ZNBH+V^M=.LY+N]N8K:VB&YY9G"JH]R:Y.S^+/@
M6_U#[#!XCMO/W;1YB/&A.<<.RA3^!YH6KL&RN=G16?K6N:=X>TB;5=4N?(L8
M=I>4(SXR0!PH)/)'05R ^-GP\9@!XA&2<<V<X_\ 9*/(.ESOZ*RY?$>D0^'G
MU\W\3Z4D9E:YBS(NT=2-N2?PKE4^-7P]DD5!XA4%C@;K2<#\24P*.M@Z7.^H
MJ"TO+:^LXKRTN(Y[:50\<L;!E9?4$5RE]\6/ NG:C]AN/$5MY^=I\M'D0'.,
M%U4J/Q/%'6P=+G9456L]0L]1L4O;*ZAN;61=R30N'5A[$5Q+?&OX>JQ4^(.0
M<'_0KC_XW1UL'2YW]%8_A[Q3H?BJT:ZT348KR)#A]F59#_M*P!'XBD\2>+-$
M\(V45YKM\+2"63RT;RW<LV"<84$] :'IN"UV-FBJ>EZI9:UI=OJ6G3B>SN$W
MQ2 $;A]" 1^-<?-\9_A_;SR02Z_MDC8HX^QSG!!P?X*'H[,%JKG>45RF@_$G
MPEXGO);31]6^TSQ0M.Z_9I4PBXR<LH'<<=:U?#WB72/%6FG4=%N_M5H)#&9/
M+=/F&,C# 'N*=F*YK45QVI?%7P/I%^;&\\0VPN =K")'E"G.,%D4@'ZGBNGT
M_4['5K%+W3KN"ZM7^[+"X=3^(I=+CV=BU16'X=\8Z!XK-T-$U!;HVK!)E\MT
M*$YQPP&>AY'%/@\5:+=>)[GPW#>[M7MH_-EM_*<;5X.=Q&T_>7H>] =_(V:*
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N?\ '?\ R3SQ
M+_V"KK_T4U=!7/\ CO\ Y)YXE_[!5U_Z*:@#P#]G'_DH>H?]@J3_ -&Q5]/U
M\P?LX_\ )0]0_P"P5)_Z-BKZ?H **** "BBB@ KQ?]I+_D3])_Z__P#VFU>T
M5XO^TE_R)^D_]?\ _P"TVH ;^SU_R(-]_P!A23_T5%7K->3?L]?\B#??]A23
M_P!%15ZS0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!E:5_R/VM?]@NP_]&W==-7,Z5_R/VM?]@NP_P#1MW734 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 >#_$SQ)!X2^.&C:U<0O,EO
MI;8B3J['S54>W)%.^$ZP^,O'.L:_XI,C^)+)QY%C.A5;6/L54]P>/;KU.:W_
M !'H%UJ/Q_\ #M])I,]SID-B=]P;<M"D@\PKEL;00=I'X56^(_A[6- \;Z7X
M\\+6%S>7&X0ZA:6L;.TJ8Z[5!."O!/8A33@[*-_->FO]?(=35M+LOG9;?UU#
MXJ1GQ'\1/"'@ZXED73+EFN;F-"1YF,X&?HK#\?I73>)/A?X0OO#%W:0Z#86D
MBP,8KBW@5)$8#(.X#)Y]<YK-^(?AC5_$46A>+?#$;1:YIF)8[:Y7RVD1L$HP
M;&&'3!QU-8.J>-_B1XDTZY\/V/P_N].O9T,,M[,[")0>&*EE5>_!W'\:AI\C
MBM[O_@#37,I=++_@G-IK=UK/[+U^MW(TDEE=1VJNQR2@DC*_D&Q^%3ZAXF^$
M;_#@V:66GR:S_9ZQCR-,:.7S]F,^9L'\7).[GWKH_$/@*\\._ &X\.6,$NH:
MB7CEE6UB9VD<RJ6VJ!D@ 8^@KM_"W@WP_9Z'I%P_AO3(-02UB+R&QC659-@R
M2=N0V<Y[UI-*3EZK\C.+Y>7Y_F>,^+[6^LOV=/"T.H*ZSB]5@L@P50B4H/\
MODBM[XUZ0=?\0^!M)$OE&\\V$/C.TGR\&NC^/&DZCK'@JRM],T^ZO9EU!':.
MVA:1@NQ^2%!..1S3?'VDZE>>/OA[<VNGW<\%K.3<2Q0LRPC,?+D#"]#U]*=^
M=Z]9?^VE2O&&G2+_ #.+\0>)[G5_@7J^BZN2NMZ)=0VETK=6 D 5_?(&,^WO
M7N/A3_D3]%_Z\8/_ $ 5Y!\<O &IW=TFO^'K*YN7NU%OJ%M:1,[28(*.54$G
M[H!^@KV+PS%)!X5TB&:-XY8[*%71U(92$ ((/0TD[Q;>]U^7Z[D-6FDMK/\
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MHKQ?]I+_ )$_2?\ K_\ _:;4 -_9Z_Y$&^_["DG_ **BKUFO)OV>O^1!OO\
ML*2?^BHJ]9H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH RM*_Y'[6O^P78?\ HV[KIJYG2O\ D?M:_P"P78?^C;NNFH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!E:5_R/VM?]@NP_P#1MW735S.E?\C]K7_8+L/_ $;=UTU !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%(S!%+,0% R2>PH \<^+%M)XU\;>'O
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M'_HP5S/P<U8^&/"?B'3[]\_V?!'JB'H#'+"'P/H1^M=-\=_^24ZA_P!=H/\
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M8S210VQ*W*7*^6\! R=PSCIW!(KA?A:H_P"%H_$5L<B\49_X')7.>&K&YO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M51Y3SRQ RQY/7UJ'^R8-/MK^30[+3[._N0SF3[.%627G#2;<%N3SSGDUI44
M>-WNG^.[_3]5TZ7X>:!#J.I1O;S:U:7442%&&,E3F1L#U/X5Z/X,\/?\(IX0
MTW1#(LKVL6)'7HSDDL1[9)K=HIIV5OZT$U=W(Y[>&Z@>"XACFA<8:.10RL/0
M@]:K:;HVEZ-$T6EZ;9V,;G<R6L"Q GU(4"KM%(9332M.CU.34TT^U74)$V/=
M+"HE9>."^,D<#C/85<HHH S=2\.Z)K$B2:IHVGWSH,*UU:I*5^A8'%7XH8H(
MEBAC2.-1A410 /H!3Z* *-KHNE6-[->V>F65O=S_ .MGAMU223O\S 9/XU'<
M>']%N]034+G1]/FO4QLN)+9&D7Z,1D5I44 (0&4J0"",$&L^Q\/Z+IEU)<Z?
MI%A:7$O^LEM[9(W?ZD $UHT4 5!I6G+J;:FMA:C4&3RVNA"OFE?[I?&<>V:9
M_8FE&ZNKHZ99?:+M/+N)?LZ[YDQC:YQEACL:O44 4H='TRWTMM+@TZTBT]E9
M3:) JQ$-U&P#&#DYX[U-:6-I86:6=G:P6UK&,)##&$11Z!1P*GHH SK/P_HN
MG7DEY9:186UU+GS)H+9$=\]<L!DU-/I6G75];WUQ86LUW;9\B>2%6DBSUVL1
ME?PJW10!2U'1]+U=8UU/3;.]6-MR"Y@60*?4;@<&EATC3;>_>_@T^TBO701M
M<)"JR,@QA2P&2.!Q["KE% &=<>']%N]034+G2+":]CQLN9+9&D7'3#$9%3:A
MI6G:O L&I6%K>PHP=8[F%9%##H0&!YY/-6Z* $*JR%"H*D8((XQ6;9>'-#TV
M\>\L=&TZUN7SOF@M41VSR<L!DUIT4 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7/\ CO\ Y)YXE_[!5U_Z*:N@KG_'?_)//$O_ &"KK_T4U '@'[./_)0]
M0_[!4G_HV*OI^OF#]G'_ )*'J'_8*D_]&Q5]/T %%%% !1110 5XO^TE_P B
M?I/_ %__ /M-J]HKQ?\ :2_Y$_2?^O\ _P#:;4 -_9Z_Y$&^_P"PI)_Z*BKU
MFO)OV>O^1!OO^PI)_P"BHJ]9H **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH RM*_Y'[6O^P78?^C;NNFKF=*_Y'[6O^P78?^C;NNFH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7NM7JLT-JF[8G5V)PJCZD@5Y9X(L9_ 7Q@G\%V6I7-WHUQ8_:4BN&#&%NO;
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3F__ .$9(V?8#9Q&79UV^=UQGVQCBM[Q'\.-)U[PYINDPRS6$FE;3I]U"<O
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9S1O#YT&K:,))+-O]@LV<-CGK^'(IM>\TNE_P)3]U-]4OQ.\HJ&[E:"SGF4
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M"(^3))N(QG[BG'4=:YWX.KK2> -.&I+IJV7D(;$6@<2;#G/F[N-V?[OO7/\
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M=& *LIR"/4&N1E^%G@J71#I?_"/6*1^7Y8G2%1../O>9C=GW)IVKZEI'PL\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7/^._^2>>)?^P5=?\ HIJZ"N?\=_\ )//$O_8*NO\ T4U '@'[./\
MR4/4/^P5)_Z-BKZ?KY@_9Q_Y*'J'_8*D_P#1L5?3] !1110 4444 %>+_M)?
M\B?I/_7_ /\ M-J]HKQ?]I+_ )$_2?\ K_\ _:;4 -_9Z_Y$&^_["DG_ **B
MKUFO)OV>O^1!OO\ L*2?^BHJ]9H **** "BBB@ HHHH **** "BBB@ HHHH
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MC7A/5/$WP]\,-X5NO!VK:A>0/(+*ZL(Q);2AF)!=\_(,GN.GI4FF^!M6\._
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MG:3XGN-&O=&T;2(F$*:A&(YYY#G/R9)4=.OI[\>KT4HNUO*]OG_P[!J]_/\
M3_ACR[X7:5J.G^,_'D][I]U;0W.H;X))H6195WR<J2,,.1R/6L#5]'O8OBKJ
ME[XG\):KXFL)U TG[.GG0P],A@2%0>I/H3@]:]PHH[>2M^%BF[W\W<\9^%GA
M_5]/TWQOI=]HT^G374C&!'B*Q$,K@!'P%8#@<<=*B\(QZO%\&=<\)77AS6+;
M4;2RN5#2VI$<[.6(6(C[YY[#Z9KVNBAZIKNDON!.SOYW^\\3F\":SKOP(T&P
MM[62#6=.?[2EK<J8F8AG^4AL8)!R,XJQXKU+Q+\1O#L?A6T\(:MIES-+']NN
MK^(1V\04Y)1\_O.1V'2O9**;=V[[-W_+_(F*Y4DMUI_7WGD_B+P[?6_Q-^'P
ML[*[N+'3H&AEN4A9DC 7 +L!A<X[U/XDTK49_CUX5U&'3[J2Q@M)%EN4A8Q1
MG$G#,!@'D=3W%>HT4)NZ?9M_??\ S!))-+JDON"BBBD,**** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5S_CO_DGGB7_L%77_ **:N@KG_'?_ "3SQ+_V"KK_ -%-0!X!
M^SC_ ,E#U#_L%2?^C8J^GZ^8/V<?^2AZA_V"I/\ T;%7T_0 4444 %%%% !7
MB_[27_(GZ3_U_P#_ +3:O:*\7_:2_P"1/TG_ *__ /VFU %+X">';'5_ M[<
M74NHJZZE(@%MJ5Q;KCRHCRL;J">>N,]/05ZG_P (3I'_ #WUK_P>7O\ \=K@
M?V<?^2>:A_V%9/\ T5%7L% '._\ "$Z1_P ]]:_\'E[_ /':/^$)TC_GOK7_
M (/+W_X[7144 <[_ ,(3I'_/?6O_  >7O_QVC_A"=(_Y[ZU_X/+W_P".UT5%
M '._\(3I'_/?6O\ P>7O_P =H_X0G2/^>^M?^#R]_P#CM=%10!SO_"$Z1_SW
MUK_P>7O_ ,=H_P"$)TC_ )[ZU_X/+W_X[7144 <[_P (3I'_ #WUK_P>7O\
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M ,(3I'_/?6O_  >7O_QVC_A"=(_Y[ZU_X/+W_P".UT5% '._\(3I'_/?6O\
MP>7O_P =H_X0G2/^>^M?^#R]_P#CM=%10!SO_"$Z1_SWUK_P>7O_ ,=H_P"$
M)TC_ )[ZU_X/+W_X[7144 <[_P (3I'_ #WUK_P>7O\ \=H_X0G2/^>^M?\
M@\O?_CM=%10!SO\ PA.D?\]]:_\ !Y>__':/^$)TC_GOK7_@\O?_ ([7144
M<[_PA.D?\]]:_P#!Y>__ !VC_A"=(_Y[ZU_X/+W_ ..UT5% '._\(3I'_/?6
MO_!Y>_\ QVC_ (0G2/\ GOK7_@\O?_CM=%10!SO_  A.D?\ /?6O_!Y>_P#Q
MVC_A"=(_Y[ZU_P"#R]_^.UT5% &5I/AW3M%N+BXLQ=&:X5$EDN;R:X8JA8J
M9&8@ NW QU-:M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %<_X[_P"2>>)?^P5=?^BFKH*Y_P =_P#)//$O
M_8*NO_134 > ?LX_\E#U#_L%2?\ HV*OI^OF#]G'_DH>H?\ 8*D_]&Q5]/T
M%%%% !1110 5XO\ M)?\B?I/_7__ .TVKVBO%_VDO^1/TG_K_P#_ &FU %C]
MG'_DGFH?]A63_P!%15[!7C_[./\ R3S4/^PK)_Z*BKV"@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV%9/_145>P4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "KC_"/CZ_\ %WAC5=3M?#K1W]E,T,=@UX,S,%# ;RH"YSCD&COY!YG<T5'
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MIOSC!W9Z=10M?Z^8&_1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTE_R)^D_]?\ _P"TVH L?LX_\D\U#_L*R?\ HJ*O8*\?_9Q_Y)YJ'_85D_\
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MD\$5=U?P%9Z)X(?Q1:WU^OB6QL5N1J)NGR^Q0WEE"=GEG&-N.E=)<^$-;O/
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MW]C7.DSWJ6,DS2+!+%SE"Q) 8$Y&>M1>([/59OC79#0;R"TO8-"9XA<1EX9
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MISDBL/\ X1;Q?X<OKQ?!VH:/_9E[<-<-:ZI'(3;.W+>64/()YP>E+M?S_/\
MR$^MO+\G<X_5[[5[[X&ZQ!J-MJMM);7T<-I)JL!CG>'S4,;/G[Q .">^*O\
MB[PG;>%=0\.ZKH][?V^KZEJ45C>WQN7=YTD4AB0Q*@C&1@ #CC@5T^L^"=7U
M'X>W.AOK'V[5+FX2XENKMF5,B17*J!NV* ,!1Q6CXR\-7OB(:!]DE@3^SM4A
MO)?-8C<B9R%P#D\]\#WJU:^O=?=9)_\ !#I\G^>G_ ['+GP[8^"OBAX:70FN
M8(M76Y2_CDN))1.40,KMO8_-GO7J5<UK?AZ[U+QEX:UB&2!;?2VN#,KL0[>8
MFT;0!@\]<D58TK4=5N?$^MV5W':'3[7R?LLL"OORRDLLA)P6'!^4=&%2M4EZ
M_F#M>_I]^INUX_XOM]%UCQG?6>JZ?KWBR1!&L6G:>CQVVGG;G]XXD5=[9)R>
MW%>P5P4WAGQ=I'B34KSPQ?Z,+'59A/<IJ,,C20/M"DQ[" V<9PQ%3U'?0YCP
M5+KT_A3QOH6EQ75C>6,K1Z=:W%R)'M@R?*@DR>>..< GK6;X;/@C3-:T]=0M
M/$7A7Q+YRB2XNI90MY(,;E+,61D8]<@=1@UVVA> -3TW_A*X;G7)6.M,DL=_
M;R&.XCDVG<<  * W0 GC@U5O?"7CKQ'9C0O$FJZ$^BAD,EQ:V\GVJ<(P."&.
MQ"<<D9JHOWDWY?\ !U_JY+6C7K_P-/ZL>E5YQ\3["74]>\%V<-Y+9O+J3CSX
MOOH/+).WT.,C/;->C*H50HZ 8%>;_%&VN;S7?!4%G=M:7+:DWE3JH;8PC)!(
M/4>H[BE]J/JOU']E^C*]_H%A\.?$OAZ\\/O<V]OJFH"ROK1[EY4G,BDB0[R?
MG! Y%0:)X2TWQ-X^\83:PLMS!9ZG%);VXF=$27RE)<A2-QX YR.O'-=!I_AK
MQ/J?B"RU3Q?J&F/'IKL]G::9&ZHSD;1)(7.=P!. .!GK6IX<\/W>D:]XDOKB
M2%HM3O$GA$;$LJB,+AL@8.1VS5)VM\_TM^OH2_+R_6_Z>IQ^B^%=-^)$FJZW
MXG^TW@34)K:RMA<R1QVL<;;05"$?,<$DFK&@:8VOZ1XE\'ZC>W-Q_9%\$LKZ
M1BTT0VB2)MW=D/?TJ[+X7\7:!JE_+X/U'2/L&HW!N9;75(Y#]GD;[[1E#SD\
MX/%2IX,UG3_"E[IUAJL3ZMJUT9=1U*4&,@/@.8U /(4;5!( ZYJ5MIV7WZ:_
MF[E/?Y_AKI^2L8O@K4;OQ_XA^TZP]LR>&F\@0PR!EFN^5-QC^[@?+[D^E1#6
MI?#L7Q1U:#'GV]TK1$C.',*A3^9%=7)X._LK4]&O_#0M[5K*,6=Q!(Q5+BU]
M"0#\ZGY@?4D'K3+3P499O&$.JM#+8Z].&18F.Y4\L(<Y P<C(QFB6JT[/[[K
M\_PVZ MU?NONU_+\=SRDIIZ:;_:-AX1^(O\ PE7E!TUAK64F27&1N'F%2A/;
M;TKI?&::CJZ>']4\1>'=8U'P\^GAK[3+'>DD5R=IW/&&5B!V].];L7ASXC1V
M:Z"/$6DII*1B%=12"07XC'' SL#8XW9SWK6US0?$T-S9W_A;6HUGM[<6TEIJ
MKR2V]P 1AVVG(<<_,!D]Z;:Z=_\ /I_7<%?KO;_+K_7;J4OAG<^%9+6_@\+:
ME?26\<B[].O'<FR(&-JAQN ./4C([5WE<CX7\,ZK:Z[>^(_$5U93:O=P);F.
MPC9((HU). 6.YB2>IKKJ;Z"1XWXGMM#UOQAJ5KJ>EZ_XOG255CM;%7BM=.PO
MW&<2*N\Y)R?7'%8UO>WDWP7\<Z==+<1+I]Z\$$%Q-YKV\>Y"(R^3NQS7>IX7
M\8:'KFIMX:U+1ETO5+IKN;[?!(\T$C !MFT@,,C/S$5G+\--7@\)>+]%74;>
MZFUFY%Q!=3L5))VEO,"KA>0<;<\8Z5,?AMY+[[K_ (.O4TNN:_G^%G_5C-\6
M^#K'PKX4@\6:?<7P\16SVQDOGNY&:?<ZAE92VW:<]  *W=<L(_&WQ#D\.:K)
M,=%L=.2ZEM(I6C%Q*[D#>5()"A>!GJ:WO&GAN\\1^"9-%LY8$N6,)#3,0GR.
MK'D GHI[57\1^&=9?6K?Q%X7O;.VUB.W^RS17J,T%S%G(#;?F!!R01ZXJFU?
M7:[_ "_S,TG96WM^J_0YWPWH47AWXT7=A:W$\EF-#5K>.>4R&!/-QL#-DE00
M2,DXSBO4JX;P]X4\16OCN?Q+KFI65TUQIPMFCMU9%B</NVHI'W .Y;))/ KN
M:'LK_P!:L.KM_6B/)/&\>CZIXRN+#5;37/$Y6*(1:/IL;I#9DY.^5UD49;L3
MT'YU0\&6D>IZ?XY\*:GIUU;:5:>4]OIMS=&1K=2A8+O5L]54XSQT]:ZZ]\,^
M+-,\5ZCJOA6^T@6^K-&UY%J<4C&)D7;NCV$9X['%/\+^"-1T77O$=[J.I1WZ
MZS'$6FQL<.%8,-@& O(V\DX'/K46]QKNG]_3_ARV_>3[-?=_70\JN?!^@Q_L
MZV^L)88OY#%.TOG/RYEV$XW8^Z2,8Q^-=_JNAVL>I>&/ &FM<:?H<T,]W<QV
M\[AY57!\O>26VEG)/-.M?A]K\OPROO!FHWFE^7&%73KBW63)"OO!E![Y ^[^
MM:E_X6\1ZMIVC:G+?Z=8^*]+9RDMLCO:R*W!C8-AMI 7)[$<5HVKOM=/Y6_1
M]#-)J*777\_U74RFT&R^''B[PZOAXW%MIFJW+V=U8&=Y8RQ0LLBAB2&!7D^E
M5/ /A/3=:U37-6U19;F6P\0W+6*&9U2!@P);:I ))/?/05T6E>&?$NH^(+'6
M_&%]IKR:>'^R66F1N(5=A@R,SG<3C@#&!6EX-\/7?AZ'6$NY('-[JD]Y'Y3$
MX1R" <@<\<]?K26F^^OYK_@C>JLO+\G?]#S_ ,%_#_1_%6C:K<ZX;JYVZM=B
MUC6ZDC2W(D/S*JD#=DDY.>U02>+-4L_@KI8>[U":]N]0.F?:+8;[IHQ*X.S)
MYD*+@>YKTCP7X?N_#FCW=G>20O)-?7%RIA8D!9'+ '('.#S6%9?#J9_AVOAZ
M_NXX;^&[DO+:[MLN(9?-9T8;@,XS@CZ_6I6UNEH_A:Y2WOUN_P!;?C8X.*6T
MT.]M;_P?X'\>:?J?VB,W+W5I*T5U&6^<2@NV3@D@@#!KT6V)T#XIW4#-MLO$
M%K]I0'@+<0@*_P":%3_P&H[?1?B!J5W;PZ]KFEVVG6\RR,VD)*EQ=!3D*[,<
M(#@9"]>1TJ/XNV[R^&+26RF$6KI>QQV!'WF>3]VRC_@+,3]*=VDK?U?3\[/[
MQ)7;O_5M?RN8B6>M:[X)\6>(=!WC4]:NS]F,;[':UB81J%;L2JN0?]JJ/@Z3
MP'8^*+%+6VU_PMKKR$-:WSRJMZ<8P^\LK#)./NG->CW7AA_^$*AT#2]1N-,E
MMH(X[>ZMV(9&3&"0"-P)'([@FN=D\+>-/$=U90>*]0T(:9974=THTV&3SKAD
M.5W%SA.<$[?<4U92LMM/NV_I=Q.[C=[Z_P!?DKFG-\5/!=OKC:++K.W4%G^S
M&'[+,?WF=NW=LQU[YQ7&:I_R!/BY_P!=?_:"U[)7 WG@?4[C3O'-ND]H'U]]
MUJ2[83]V%^?Y>.1VS6;6C]'^<2NJ]5^IROB/P58Z%\.T\76MS?#Q+9VL$PU
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M>0L0F3G[N=IYYY!Q6U111Y %%0+>VCWLEDMU"UW&@D> 2 NJGHQ7J <'FIZ
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M<M<0@6XS,2X_=C&<MZ<<\T 345%;W,%Y;1W-M-'/!*H>.6)@RNIZ$$<$5+0
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M9]/M 96:9&QA2!D@Y!SC@9]*PM5\:^,_"QAU'Q':>&QI<LL<;6EI<R?:XPY
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MV\!$RDKM=PIZ$<X/%8VK^*_%!\>7GA?0-.TV9TL8[E)[QW1(B202^W)8=,
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M9S:LP;+1LIQO&.&'K3=0\3>)]3\17NE>$+#3)(],94O+O4I75&<C/EQA!G<
M1R>!Z5RD[ZS)X3\ -KIN#>'Q!%@W(Q,8_GV&0?WMN,UK6NOV/P[\5>(;?Q +
MFWM-5O1>V5VEN\J2EU ,?R X<%>G<5;6OS?_ +;I^+_(CI\E^<O\E^9-IOQ
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M2Q4=)KU7W:?\/Y$/@WQ!JWAKX0Z=>ZG;6=T[I#!I5M9LRO-OPJ+(6X#9ZD<
M5JCQ+XST"YM[GQ9IVC#2+F=(/,TV60R6I<X7S XPPR0"5Z=:XIK:W\8_!71K
M6QAFU"30)X#J.GJCI(^P$21#H2VUCT/;UJ&TTGX3ZI?VMGX9\*WFIZF9T66
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M R>PJ'L-;GFFG>,/'/B6*?5_#NEZ!+I,4LD:VES<R+=R[&(ZXV(3C@-^=/\
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MU^#9U>H>-?&&@:A87.LZ'IQTG4YA;VL%I.S74<K*2BR%L(<D8..!Z\<WM/\
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MCU>[7'VJ+>]MF-B3&>,,",9]*C^&O_)%[+_KVN/_ $-ZYG2O^16^$W_7X/\
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MTU\/S_R&]UZ?J%%%%( HHHH **** "BBB@ HHHH *Y_QW_R3SQ+_ -@JZ_\
M135T%<_X[_Y)YXE_[!5U_P"BFH \ _9Q_P"2AZA_V"I/_1L5?3]?,'[./_)0
M]0_[!4G_ *-BKZ?H **** "BBB@ KQ?]I+_D3])_Z_\ _P!IM7M%>+_M)?\
M(GZ3_P!?_P#[3:@"Q^SC_P D\U#_ +"LG_HJ*O8*\?\ V<?^2>:A_P!A63_T
M5%7L% !1110 4444 %%%% !1110 4444 %<MX@\-WFJ^,?#&KP2P+;Z5).TZ
MNQ#L'3:-H (//J174T4+1I@%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% %.YTV"[U"SO)B[/:%FB3/RAF&W<1
MW(!('^\:N444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5Q&J:-XZL-<O;WPSJ^FW%I>LKM9Z
MUYS+;,!@^44/ /7;TKMZ* .<\(>&9O#UM>RWU[]NU/4;@W-W<!-BEB,!57LH
M  %='113; ****0!574K"+5-.GL9GD2&==DAC;:Q4]1GMD<?C5JB@!J(L<:H
MBA54  #L!3J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"
MKJ5L]YI=W:QE0\T+QJ6Z E2!FLSP9HMSX=\':5I%V\3W%I (Y&A)*$CT) /Z
M5NT4+2X!1110 4444 %%%% !1110!S%[X<O+GXBZ7XA22 6EI936\B%CYA9R
M""!C&./6NGHHHZ6#K<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ KG_ !W_ ,D\\2_]@JZ_]%-705S_
M ([_ .2>>)?^P5=?^BFH \ _9Q_Y*'J'_8*D_P#1L5?3]?,'[./_ "4/4/\
ML%2?^C8J^GZ "BBB@ HHHH *\7_:2_Y$_2?^O_\ ]IM7M%>+_M)?\B?I/_7_
M /\ M-J +'[./_)/-0_["LG_ **BKV"O'_V<?^2>:A_V%9/_ $5%7L% !111
M0 4444 %%%% !1110 4444 %>>_$/XCVO@_6=#L'O8X//N%DO=T#N5MN<D$
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M^R#XBM/MF[9CYO+W>GF8V9_&LKXA?$>T\'ZSH5@U]'!]HN%DO2T#N5MN<L"
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M9<: -=BNU.F& W N""!Y8&2<$9'';&:=J6LZ?I&F?VC?7 CM,H!(%9\ER H
M4$G)(Z"O/S"MO%=^ #TNM3_=H#_RY29F?Z#Y9(_RJ+1)IM;O/#WAB<ECH,\L
MM_N/)$#&.#/^]E7_ . U22;T_I=?NV!Z?C_P/O.TTC5(GU+Q!YVNK=16<X#Q
M/;>2+$; 2I<_?'\6[MG%4]+^)G@W6=7_ +*L->MY;PMM5"KJ'/HK, K'Z$YK
ME[>RL]2;XG6-_?QZ?;7%VL;W4CA5BS"H!)) QG'?FH+C4_$_@_3+-?%OA_1M
M9\/V4D834++ :W ("2&-QRV2/NXQZ^LQUM?LOQ!WUMW?X'K=<EX\US4M)MM+
ML]+FAM;G5+U;,7LZ;TML@G=MX!/& #QDUUBL&4,.A&17G?BRWE\<>*YO!$ET
M;'3(+-+VYDC13-,Q8A A8$*%(R6 SVXI=4OZTW!/2_\ 7D:'@O5M;;7=;\/:
MUJ$.K2:9Y3+J,5N(=_F G8Z@[0PQV[&NUKR/PGKNH^$]:L_AZ^D0OJ/VDR->
MK\B7%J06-P2.3)Q@@]3WKURK>R?]?U_D+9M?U_77YA1114C"BBB@ HHHH **
M** "BBB@ KG_ !W_ ,D\\2_]@JZ_]%-705S_ ([_ .2>>)?^P5=?^BFH \ _
M9Q_Y*'J'_8*D_P#1L5?3]?,'[./_ "4/4/\ L%2?^C8J^GZ "BBB@ HHHH *
M\7_:2_Y$_2?^O_\ ]IM7M%>+_M)?\B?I/_7_ /\ M-J +'[./_)/-0_["LG_
M **BKV"O'_V<?^2>:A_V%9/_ $5%7L% !1110 4444 %%%% !1110 4444 %
M8?BCPK9>++""VN[B\M7MYA/!<V4WE31. 1E6P<<$CI6Y10!B:?X8M-.UV76%
MN;N:[ELXK-S,X8,L>2&/&2QR<G/X5+:>'K.S\1ZEKD<DS7.H1Q1S(Y!0",$#
M:,9[G.2:UJ*+@M#@YOA-H4EQ*(=0UNTTZ9F:;2K;4&CM)"Q).4'(!ST! KM[
M6U@LK2&UM8DA@A0)'&@P%4#  J6BCI8'J[F5XA\.Z=XHTE]-U.-VA+*ZM&Y1
MT=3D,K#H17/V7PRTFUO=-OYM1UB_O["?SH[N^N_.D;@C821PG/1<<@5VM%"T
M=T#U5F9.G>'K33-=U;5X9)VN-4:-IU=@478NT;0!D<=<DU%:>%=-M;C6Y&$E
MPNLR>9=13X9#\@3:!@<$#OFMNBC_ (8/,\^E^#OA^>PGL)M0UN6Q=0MO;2WQ
MDBL\=XE8$ ]LG/7BNB\0>#]+\26=K#>&YAGM.;6\M9C%/ <8RKC_ /5[5OT4
M <UX<\$:;X;NY;Y;K4-1U&5/*>^U*Y,\VS.=H)P /H!5_0/#UIX<L)[.T>:2
M*:XEN6,Q!.Z1MS#@#C)XK6HHN!P<OPFT-YY5AU+7;739F9I=*M]09+1]Q);*
M#D YZ @5T$GA337U?1=1C$D#:/%)%:PQ$",*ZA2",9X &,$5N44)V!Z[GB&J
MZAX/3Q)J!\0-XA\-ZI+<.DVFV$TYAU4=%?Y$PVX>A7KSFNC\'>!8[[X82:/J
MMO<Z=#?WCWHMXR%D@0R!T4Y! X5<C%>F441T7W?AK^?_   >KO\ UV,GQ!X>
MM/$FF)87DDZ1)/%.#"P#;D8,.H/&1S5/Q+X,TWQ.\%Q/->V5_;@B"^L)S#/&
M#U 8=CZ$&NBHH Y_PYX/TWPT+B2"2[O+RY %Q>W\YFGE Z!F/;V  K$?X3>'
MFDN8UN=5CTZ<.3I:7A^R*[<[Q%C&03D Y /:N[HH>H+0HZ-I4&AZ+9:5;/(\
M%I"L,;2D%BJC R0 ,_A5N6))X7BE4-&ZE64]"#P13Z*)>]>X+38YU_!6CMX)
M/A+RY%TSRO*P"-X&<YSC&<\YQ6I?:/I^I:/)I-Y:I-8R1>4T+="O8<=/J*O4
M4/7<%IL<3I_POT:RU""ZN=0UG4X[6026EKJ-\TT%LPZ%$XZ=LYZ5H^)O!&G>
M)[JVO9;O4=/U"V4I%>Z=<F&94)R5SR"#]*Z6B@#EM(\ Z/HFH7U[9O=^=>VJ
MVTYEEWE\9^<L1N+G/))/0<5*/ VC-X-MO"UPDUQ86R*L3R/B52IRK!E PP/<
M8KI**'KH"TU.)LOAAI%I?Z=J$VI:S?W]A/YT5U?7?G2$8(V$D<)SG"XYQS7;
M444[BL<=J_PWTG5]<O-:-]JMGJ5RD:"YLKKR7A" CY"!GD'D'(.!TQ6QX?\
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MS3ZF+R&:XVPN%MH,$LY?&WE25&#U:O2Z*=]4WWO_ %]R#II_7]78U$6.-8T
M55   [ 5P_QC_P"25:U_NQ_^C%KNJ*3U'%\K3.&TWX9Z''<VEX]SJD]K#LEM
M],GO&>T@<<ADC/3!Z D@>E=')X>M)/%4/B(R3?;(K1K14##RRC,&)(QG.1Z_
MA6M13;U)2LCG?$O@S3?$[P7$\U[97]N"(+ZPG,,\8/4!AV/H0:=X=\&Z9X;6
MX:%[N]N[H!;B\OYS/-,!T#,>WL !7044EH/<X(_"70O-:--2UV/2F)+:0FH.
M+,YY(V=<9[9Q6[K_ (-TCQ%96MO<)-:O9?\ 'G<V4IAEMCC'R,.G';D<#BN@
MHHZ6#K<YKPYX(TWPW=RWRW6H:CJ,J>4]]J5R9YMF<[03@ ?0"K^@>'[3PY83
M6=G),\<US+<L9F!(:1MQ P!QD\5K44 <J/A_H_\ PADOA9I;QK&21I1+Y@$J
M.9/,#*P  (;IQVYS6[I&G?V3I5O8?;+R\\E=OVB\E\R5^>K-@9-7:* >I@>)
M_"&G^*H[8W4UY:7=JQ:VO;&8Q3PDC!VMZ$=1BLZQ^&^BV&K:;JRW&HSZG8LS
M?;+FY\Z6?<NTB1F!R,'("XP>G6NPHH6FP/7<YZ#P?96OC"?Q);7NHPSW*@7%
MHEQBVF8+M#LF.6 QCFNAHHHZ6#K<XZ+X;Z5!8ZY81ZAJHL=85A):FY#1VY8D
ML8E*G:22<YS6QJ_AJSUKPK+X>N99TM)(5A+QL!)M7&.2",\#M6S11TM_6FP=
M;F!X@\'Z7XDL[6&\-S#/:<VMY:S&*> XQE7'_P"KVJ'PYX(TWPW=RWRW6H:C
MJ,J>4]]J5R9YMF<[03@ ?0"NEHHO8.E@/2O.HOA!9V]Q=3VOB_Q=:O=3-/,+
M;45B#N>K$*@YKT6BCS"^ECF;3P38Q^&;S0-2U#5-:M+MB9'U2Z,T@! X5@ 0
M 1D>AJEH_P --*TG58-0FU/6M4DM3FTCU*],T=MP1\BX&.#CG/2NSHIWUN'2
MQP^M?#*SUGQ+/K__  D?B.PO9HUB/V"\6$*@_A&$SC/."3S6EX<\&CP[<SS-
MXB\0:J)H_+,6JWOGHO.<J-HP>U=-126BL#UW.&;X5Z)]I/EZCK<.F,27TB+4
M'6S;))(,?7!ST! ]J[>.-(8DBB14C10JJHP !T IU%'2P=;F9?:%:ZCK.FZG
M<23,^G%VAAR/+WL-N\C&20,@<]S6A+$DT3Q2*&C=2K*1D$'J*?11TL'6YRFG
M?#_2]-30DBN[]UT2662T$DBG_6 @JWR\J >,8^IK5OO#UIJ'B+2];EDG6YTU
M95A5& 1O, #;AC)Z<8(K6HIW8&3HOAZTT.XU2:UDG=M2NVNYA*P(5R "%P!@
M<#KGZU5LO!VE6>E:OIC"6YM-5N)KBY2=@<F3[P&T# ]._O7044O+Y#OU^9Y\
MWP?T&73WL;G4M<NH RFW6YO?-%H%8$"(,"%Z8S@G&1GFMKQ'X%T[Q'>P7YO=
M3TS4(8_*%YIER8)6CSG8QP<C//2NGHHN(Y72OA_HFBZV-7LC=+=M;-;3/)-Y
MAG#$'=(S LS<<'/3BM7PYH%KX8T&UT>RDFDM[8,$:9@7.6+<D #J?2M6BG<#
M'\3>'+/Q5HDFE7TD\<#NDA:!@&RC!AR01U'I4&O>#]*\1ZCH]]?I(9M)G\^W
MVD $\<-D'(R >,<@5OT4EI^8&1<>'+.Y\56?B%Y)Q=VEN]O&@8>65<@DD8SG
MCUK%U?X;Z7JFJS:E;:EK.D7%P0;K^R[TP+<G_;&"#]1BNQHHL!C6WA31+7PT
MWAZ.Q0Z8Z,DD+DMOW<DL3R23SGK6#8?"[1K.]AFGU+6]1M[=Q);6-_?M+;P,
M/NE4]NV2:[>BB^MPZ6.>UWP?9:[K&G:JU[J-E>V)PDMC<>49$)!,;\'*D@9%
M1/X'TQ]+\0:>9[OR==F>:Y8.NY&8 '9\O X'7-=-11TM_7]:#N8VK^&K/6O"
MLOAZYEG2TDA6$O&P$FU<8Y((SP.U<1\19]#M-5T^+Q#!JFF64%N3:^(].E<2
M029"F([$.W(QR<@^E>H44.[=Q+16/)?AUI5C=^/+WQ%HJ:A)HZZ>MJNH7^\R
M7\Q?<TF7 9@  ,X'M7K5%%-N]D+S.*U'X8:/>ZG/>6VH:SI:W3F2[MM.OFAA
MN6/4NOOWQCK6I?>"]'O/!Q\*QQR6>F;%15MF 90K!N"P/)(Y)SGFNAHI+16'
MUN(JA$51T Q6?KFA:;XDTJ73=5M5N+63!*DD$$="".01ZBM&BAZ@M-CA(OA3
MI!F']H:SXAU2R5@RZ??ZDTENN#D?+@9 QT)/OFMSQ-X1L?%%I:0SW-]8RV<G
MFVUSI\WDRQ'&#M.#@$''2M^B@#E]?\!Z9X@FM[M[O4K#4H(A"FHZ?=&&X*=U
M+#A@?<=S5OP[X2TKPU:W$5FLTTMT0UU<W<IEFN&QC+L>O';@>U;M% '!_P#"
MI?#_ )^U;S65TLN7.CK?L+(DG/\ J^N,]LXKHH?#%C;^*W\11-,MTUDMEY0*
MB)8U;<,#&<_CCVK:HIIV!JYS$_@72YK7Q!:K/=Q6VN_-<PQNH5'(PSIE3AFX
MSG(XZ5>U?PU9ZUX5E\/7,LZ6DD*PEXV DVKC')!&>!VK9HI>7]:;!UN<_P"(
M?!NE^)+6U2Z:Y@N;/_CUO;28Q3P$C!*N/Y$$>U1^'/!.F>&IYKN*>^O]1G01
MRW^HW!GG9 <A=QX ]@!7244 <Y:>!]&MO"4OAF:.2[TV5I&=;A@6)=RYY4#&
M">".1@5C)\*-%W6SW.IZW>RVES'<6TEY>^<8-AR(TW#"H<#/&3CK7>44[V=P
M>O\ 7<YKQ+X(TSQ+<PWLEQ?Z?J,*&.._TZX,$RH3DKN&01]0>IHTGP-I.CZ5
MJ%G#)>32ZC&4N[VYG,MQ-E=N2[>@/'&/:NEHI6T:'=WN9FGZ%9:?X;M]!"M<
M6,-L+;;/ABZ ;?FP #D>U<M!\)M#BE2.74M=N=,C*F/2;C4&>T3:00 G4@$=
M"2*[RBG=WYNHNE@    & *Y[Q'X/LO$E[I][+>ZC8WE@S&&XL+CRGVMC<A.#
ME3@9KH:*76X=+'(Z[\/-+UK5'U2&_P!6TB_F"K<3Z5>&!IU'0/P0?KC/O6UH
M/A[3?#6FBPTN Q0[S(Y9B[R.>K,QY)/J:U**%HK ]=64M7TR'6='O-,N6D6"
M[A>&1HR P5A@XR",\^E<A#\)/#T)MXC=:O)IT(3_ (E;WK?9'=>=[1@ 9)&2
M!@$]J[RBA:.Z#R,7Q%X5TSQ/8Q6U\DJ- WF6]Q;R&.6!\8W(PZ']*I>'? NG
M>'KYM0-YJ>J:B4,8O-4NC/*J9SM4\ #Z"NGHH6FP/4*R=%\/6FAW&J36LD[M
MJ5VUW,)6!"N0 0N ,#@=<_6M:B@#"T[PCI>G:=JMAMDNK75+F6YN8[@A@3)]
MY1@#Y?3O[UA6GPIT.VN8C+J&MWEA RM!IEW?M):Q%2"N$[XQT)(KNJ*%H[@]
M=S)?P]:2>*H?$1DF%W#:-:*@8>7L9@Q)&,YR/7\*P;CX8:%/JEQ=K<:I;VMR
MYDN=-@O&2TG<]6>,=<]QG!]*[2B@#*\-^'[3POH%KHUB\SVUL"$:8@N<L6Y(
M '?TI?$'A_3_ !-I3Z=J4;M"65U:-RCQNIRK*PY!%:E%#UW!:;'"_P#"J=%E
MMXA>ZCK6H7D,J2PWU]>>?-$58, NX%5!Q@X7D5LZOX.LM6\16&N_;=0L[ZS
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M@$<$# _2NVHHHN 4444 %%%% !1110 4444 %%%% !7/^._^2>>)?^P5=?\
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M?M7VEK(,PE?RP!L! .6)'&.IKH?"\M_KNCWGC*[U:5_MML_V.RMIW$%I& <
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M8;:2$*"'9MA#Y/7<<=JZ+Q=JFM:7\/-*GM-;EU")YXUO]9TZ!2XMCG=*BC<
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M@#DL>@!)HL_!-N_@+2O#.I7%PT-M#&DXMYFC$V!RC$<E"3TSV%/H[?U_PW_
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M0 4444 %%%% !1110 4444 %%%% !7/^._\ DGGB7_L%77_HIJZ"N?\ '?\
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M!>"<9#*P!7R\9Q\P^;..<4[PYX:L?#&GO:V;W$SRR&6>YNI3)-.Y !9V/4X
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M+6X&TK@,> PSD$\5S^J:7XU\3:WX8U>_T:VT^WT[4%DDL([M)I54C!D9_E7
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M =\G(;;CH.O:M^BBJ;NVV3%622Z!1112&%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %<_X[_Y)YXE_P"P5=?^BFKH*Y_QW_R3SQ+_ -@J
MZ_\ 134 > ?LX_\ )0]0_P"P5)_Z-BKZ?KY@_9Q_Y*'J'_8*D_\ 1L5?3] !
M1110 4444 %>+_M)?\B?I/\ U_\ _M-J]HKQ?]I+_D3])_Z__P#VFU %C]G'
M_DGFH?\ 85D_]%15[!7C_P"SC_R3S4/^PK)_Z*BKV"@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG_'?_)//$O_
M &"KK_T4U=!7/^._^2>>)?\ L%77_HIJ / /V<?^2AZA_P!@J3_T;%7T_7S!
M^SC_ ,E#U#_L%2?^C8J^GZ "BBB@ HHHH *\7_:2_P"1/TG_ *__ /VFU>T5
MXO\ M)?\B?I/_7__ .TVH L?LX_\D\U#_L*R?^BHJ]@KQ_\ 9Q_Y)YJ'_85D
M_P#145>P4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %<_P"._P#DGGB7_L%77_HIJZ"N?\=_\D\\2_\ 8*NO_134
M > ?LX_\E#U#_L%2?^C8J^GZ^8/V<?\ DH>H?]@J3_T;%7T_0 4444 %%%%
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M<C&(6R,$=32ZV\KCZ7/?**\J\!>,/%:>.[[P3XP>UN[VW@\^.\ME"AAP<'
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MY0U"[4,9F'7&5;@]<!?3)YQ5SP[XX\6:!XTM/"7CV*UDDO5Q9ZE; !96]#C
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MM3\0W6N3M%/(+FY#;E4QXV_,[' P3U[UY5\.OAQXC\0>![+4;#X@ZKI-K*9
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MD"YSCD$$?4'&30^@+J><V"Z]\,_B9H?AY?$TVMZ9JK%&M;@DO;KG ."3CZC
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MM=?ZMZ'E5Y8ZW\(/%F@6]AXIGU/3-1N5MSIER261,A<A<D=^" O( P:WX?\
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M@"#_ &EKG'_3>+_XU1#3[_\ (J6MO2WYC_%/_)QG@_\ Z\I/Y2U-\?[ZV3P
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M84444 %%%% !1110 4444 %<_P"._P#DGGB7_L%77_HIJZ"N?\=_\D\\2_\
M8*NO_134 > ?LX_\E#U#_L%2?^C8J^GZ^8/V<?\ DH>H?]@J3_T;%7T_0 44
M44 %%%% !7B_[27_ ")^D_\ 7_\ ^TVKVBO%_P!I+_D3])_Z_P#_ -IM0!8_
M9Q_Y)YJ'_85D_P#145>P5X_^SC_R3S4/^PK)_P"BHJ]@H **** "BBB@ HHH
MH **** "BBB@ HHKF/&_CK2_ 6FVU]JD%Y-%<3>2HM45F!P3SN9>.*3=@.GH
MKR2W_:)\&SW"1R6NL0*QP99+>,JON=LA/Y UVOB3QUH_AKPK%XCG\Z[T^8H(
MVLPKE@_0C<P&/QIO178+5V.FHKQ__AH[P?\ ] W7/^_$/_QVNJU_XHZ)X<\+
MZ1X@O+74'M-456@2&-#(N5W#<"X X]":.EP\CMJ*\KTS]H'P9J-_%:R)J5B)
M" )KJ%!&#[E78CZXQ74>-OB#I'@.SL[K4X+R>.[<I']D1&Z#.3N9>*'HKL%J
M['645Y-:?M$>#+FZCADMM7MD8X,TUNA1?KM<G\@:['Q9X]T?P?X?MM;O%N+J
MRN9%CB:S57+;E+ _,P&,#UH>BN"U=D=117C_ /PT=X/_ .@;KG_?B'_X[7>:
MQXZT+0/#5IKVJ7+6]K=HCPH4W2.67<%"C/..O8>M#T5PZV.DHKSCPU\;O"'B
M758M-B:]L;F9@D(O8E59&/8%68 _7'6M?QS\1]'\ ?8O[5MKZ;[9O\O[*B-C
M;C.=S+_>%#TW!:['845Y'!^T3X1GGCA73M;#2,%!,$6,DX_YZUUWB'XCZ'X7
M\3Z;H.I+=)/?JK1SJB^4@+%1N)8$<CT-.ST\Q7W\M3KJ*YSQGXTTWP-I$.I:
MG#=30RSB!5MD5FW$$Y.Y@,<'O6+XQ^+>@>"-3M[#4K34I99[=;A3;1QLH4DC
M!W..>#2*LSO:*\C@_:)\(SSQPKIVMAI&"@F"+&2<?\]:V?%OQD\/>#->?1]1
ML]4EN$C60M;Q1LF&&1RS@_I0+R/0Z*\V\,?&WPWXK\0VFBV-CJT=S<E@C3Q1
MA!A2QR1(3T'I4?B'XY>&?#6OWFC7ECJ\EQ:/LD:&&,H3@'@F0'OZ4/2U^H'I
MM%<;X,^)WAOQS(]OIDTT5XBES:W2!)-N>HP2#^!.*[*FTT*X45S'C?QUI?@+
M3;:^U2"\FBN)O)46J*S X)YW,O'%<;:?M#^#+FZCADM]7M4<X,TUNA1/KM<G
M\@:2UT0WH>LT5RWBOQ[I?A'2;+5;NWO;K3[M@JW-FBNB9&5+98<$=",]/I6I
MJOB/3-(\-3>(+B<-I\4/GAX\'>I'&WU)R /K0]$V^@+5I+J:M%8_ACQ#!XJT
M&WUBUM+NVM[C)C6[15=E!QNP&/![<TSQ9XIL?!OA^;6M1BN);:)D5EMU5G)8
M@# 8@=_6A^[N"UV-NBO'_P#AH[P?_P! W7/^_$/_ ,=KH)?C!X?A\'67B=K/
M4S97ET;2.,11^8'&>2-^,<'O32;V ] HK/UK6+?0M!O-8NDE>WM(6FD6( N5
M SP"0,_C6')\0M)B^'R^-&M[W^S64,(@B>=@OLZ;MO7_ &NE+OY M6DNIUE%
M>/\ _#1W@_\ Z!NN?]^(?_CM>E^&]?M?%'A^TUJRCFCMKI2R+,H#@ D<@$CM
MZT[.UQ75[&K15;4;Z+3-,N[^97:*VA>9P@!8JH).,XYXKRG_ (:.\'_] W7/
M^_$7_P =J;ZV*L[7/7Z*YZR\:Z+J?A"X\36$[W6GV\4DL@C7$@V#++M.,-['
MU':N _X:.\'_ /0-US_OQ#_\=IO1V$M5<]@HK!\*>,-&\::6=0T:X:2-6V21
MNNUXVQG##_(KF?$WQJ\'^&-1DL)9KJ^NHFV2I91!Q&1U!9F49^A.*'H[,%JK
MH]$HKFO"/CWP_P"-[=Y-&NRTL0!EMY5V21Y]1W'N"1[U%I'C_2]6\7W_ (7-
MM>V>J68+%+I%595'="K'(P0>W!^M.SO85]+G545R=I\0=*U#QK=>%K"VOKN[
MM5+7$\2)Y$>!R"Q8'.<#IU_'#_"?CW2O%]UJ-G:07EI>Z?)Y=Q;7B*D@[9 5
MFXR"*2UV]1O3<ZFBN6'CS2Y/'9\(6]O>W.H)'YDTL2*881C/SL6!!Z= ?O"N
MIHZ7#K8**YO0_&NG:]XEUC0;>"[AO=*8+-YZ*%<$D93#$D?4#J*S[+XGZ#?^
M/9O!\*78U")G3S61/)9E&2 0V<]>H[&A:VMU!Z7OT.THKF[GQKIMMXYM/"/D
M74FHW$!N-\:J8HU ;[Q+ @_+V!ZBJFC_ !&TC6]#US5K:VODM]&:1;A9$0,V
MQ2QV ,0>!W(HOI?^NWYCMK;^M3KZ*R/#'B*T\6>'K76K".>.VN0Q19U <88J
M<@$CJ/6H/%_BVP\%:$=7U*&YEMQ*L6VV56?+=.&8#'XTVK.S$M=C>HID,JS0
MQRJ"%=0PSUP1FGT@3N%%8'C#Q=8>"=".KZE#<RVXD6+;;*K/ENG#,!CCUK@H
M?VB_!LLR1O9ZS"K'!D>WC*K[G;(3^0-"=] >FIZY16'J/BS2]/\ "$OB=7>Z
MTU(1.&MP"SJ<= 2.>>Y%>=_\-'>#_P#H&ZY_WXA_^.T=;!TN>P45C>%?$UEX
MO\/6^M:?%/%;3E@JW"A7&UBIR 2.H]:G\0:U#X=T&\U>Y@N)X+2/S)$MU!?:
M.I ) XZ]>U$O=W!:[&E167X=UZR\3Z!::SI^_P"S72;D$@ 9><$$ D9!!'6L
M_0_&VF^(?$>L:+80W1ETI@EQ.RJ(BV<84AB2<@]0.AIV=["OI<Z2BO-_$7QP
M\'>'M1DL6EN[^>)BDOV&)65&'8LS*#^&:Z7PKXYT#QE8RW.C7GFF$#SH74I)
M'GIE3_,9'O26JNAO1V9T=%>0M^T9X01V4Z=KF0<?ZB+_ ..UO^%?B]X?\72:
M@FGV>IQ&QM6NI?M$4:Y1>H7#GGZXHZ7!Z.S._HKQ_P#X:.\'_P#0-US_ +\0
M_P#QVNMT+XEZ-X@\(:GXFM+:_2RT[?YR2QH)&VH&.T!R#P>Y%'1OL'6QV=%>
M0K^T;X/9P#I^MJ"<%C!%@>_$E>EZ#X@TOQ-I,6IZ1=+<VLF0& (*D=00>0?8
MT[=17Z&G117/^,?&.F>!]$_M75%G>$RK$L=NJL[,<] 2!T!/7M4MV*2N=!16
M'X3\5:?XRT"+6=,$RV\C,FR=0'5E."" 2/?KT-9'C+XH>&O \Z6VIS3S7C*'
M%K:QAW"DXR<D*/Q/:F]'9B6NQV=%<AX,^)7ASQT9(M*GF2ZC7>]K<Q[) N<9
MX)!'T)QD9KKZ;36XKW"BN.\<_$K1O #V2:K;7\QO YC^RQHV-N,YW,O]X5AZ
M'\=_!NMZE'8DWU@\I"I)>Q*J%CT&59L?4X%):[#>FYZ;17.>*O&NF^$)-+CO
MX;J4ZE<"WA-NJMM8XY;+#CGMFL;QK\6=!\":O%IFJ6FI332PB=6M8T9=I)'.
MYU.?E/:E<=F=Y17F.A?'?P?KFJ0Z>!J%C),P2.2\B14+$X RKMC\<"M[QS\1
M]'\ "R_M6VOIOMF_R_LJ(V-N,YW,O]X4WIJQ+5V1V%%>1P?M$^$9YXX5T[6P
MTC!03!%C)./^>M>B>(_%.C^$]+_M'6;Q;: G:N069V]%4<DT/178+5V-BBO,
M]$^.W@S6M12R,E[8O(P2-[R%51B?=6;'XXZU=\9?%[P_X(UP:3J5GJ<TYA6;
M=;1QLFUB0.6<'/'I1L!W]%>3V/[0?A._O[:SBT_6A)<2K$I>&+ +' S^\Z<U
MJ^+OC'X>\&:_)H^HV>J2W"(KEK>*-DPPR.6<']*-@/0Z*\V\,?&WPWXK\0VF
MBV-CJT=S<E@C3Q1A!A2QR1(3T'I4?B'XY>&?#6OWFC7ECJ\EQ:/LD:&&,H3@
M'@F0'OZ4/2U^H'IM%<;X,^)WAOQS(]OIDTT5XBES:W2!)-N>HP2#^!.*[*FT
MT*X445A^)_%^B>#]/6\UJ]6W1SMC0*6>0^BJ.3_(5+=BDKFY17F6B?'?P7K5
M^MFTE[I[N0J/>Q*J,3_M*S8^IP*ZGQIXVTWP+HT6J:G#=302S"%1:JK-D@G/
MS,!CY3WIO178EJ[(Z2BO(X?VB_!LLR1O9ZS"K'!D>WC*K[G;(3^0->IZ=J%I
MJVG07]C.L]K<('CD7HP-.SM<5];%FBF32K!!),P)6-2Q ZX S7':=\3=%U/P
M+>^+H;6_73[-F62-XT$I(QG #X_B'>IOOY#[+N=I17C_ /PT=X/_ .@;KG_?
MB'_X[7J.BZM!KNB66K6J2)!=PK-&LH 8 C(R 2,_C56=KA<OT5G:]K-OX>T*
M]U>[25[>TB,LBQ %R!Z D#/XU3\)>+=,\::$FKZ49!"79&CF $D;#LP!(!Z'
MKT(I=_(-C=HKG/"7C33?&45_)IT-U$+&X-O)]H15RP[C:QX^N*YKQ%\</!WA
M[49+%I;N_GB8I+]AB5E1AV+,R@_AFBX[;GI%%<[X3\;Z#XUM))]%O/-:+'FP
MNI22//3*G^8R/>NBIM-;DIW"BN&\;?%70_ >IV]AJEIJ,TL\/G*;6-&4+DCG
M<Z\\52\,_&SPCXGU2/38GO+&YE8+"+V)561CV!5F /UQGM2C[VPWIN>C45S>
MO>-M-\/>(]&T.[@NWN=7<I \2*44@@?,2P(ZCH#6)XR^+V@>!]<&DZG9ZG+<
M&%9MUM%&RX)('+.#GCTH#R._HKS7P[\<O"'B+5H=-3[=93S,$B-Y$JJ['H,J
MS8/UQUK3\;_%'1/ -]:VFJVNH327,9E0VL:,  <<[G7FAZ6OU!:G;T5Y5I?Q
M^\*ZMJUGIT&GZRLUU,D"-)#$%#,0!G$A..?2NV\5>,]#\&6*W6M7@A$A(BB4
M;I)#_LJ/Y]*'HKL%J[(WZ*\Z\-?&SPAXFU*/3XI+NQN9G"0K>Q!1(QZ ,K,!
M^)%.\7?&/P]X,U^31]1L]4EN$17+6\4;)AAD<LX/Z4/2U^H+4]#HKRK2_C]X
M5U;5K/3H-/UE9KJ9($:2&(*&8@#.)"<<^E=EHOC73==\3ZQH%K!=)=Z40)WE
M10C9./E(8D_B!3L_Z\@N='17G_BKXR>$O">H/I]S-<WEY&VV6&RC#F,^Y8JN
M?8'-:_@_XA^'?&\;_P!D7;?:(U#26LZ;)4'KCH1VR"126NJ!Z;G4T5R,OQ&T
M.#Q^/!LZW46HL!LE9%$+$KN"@[LY(]NM6?$OC?3?"NJZ-IU]!=R3:M-Y$#0(
MI56RH^;+# ^8=,]Z%K:W4.Z['2T45S?C#QKIO@FULKC4H+N5+NX%O&+9%8AB
M"<G<PXXHZV#I<Z2BN;\7>.M"\$6,=SK-RR--GR8(DWR2D#)P/RY) Y'-8OA+
MXP^%/&&I+IUI)=6E[(2(H;R(*9,#/RE68?@3GBA:Z('HKL[ZBBJU_?VFEV,U
M]?7$=O:PJ7DED.%447L!9HKRF3]H3P2E_P#9E75)(MP'VI;8>7CUP6#X_P"
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M=X/_ .@;KG_?B'_X[2N.UCV"BN=\*^,]+\6^&VUZS6>VLE9U8W85"NWJ3AB
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M('48Q[UNZUX&:Z^#9\*6\2R74-BBPJ2!NF0!ASG RPZYQS41?+'FZK3Y7O\
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M@'*DCL:TNG*;75?^W$I6IQ3[_H</XG\0ZAX:^/\ >WVF:!=:W.=-2,VMMNW
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M#^#=#"Y&2)EZ?^!%>NKG:,]<<U-M+E7Z"T444AA1110 4444 %%%% !1110
M5S_CO_DGGB7_ +!5U_Z*:N@KG_'?_)//$O\ V"KK_P!%-0!X!^SC_P E#U#_
M +!4G_HV*OI^OF#]G'_DH>H?]@J3_P!&Q5]/T %%%% !1110 5XO^TE_R)^D
M_P#7_P#^TVKVBO%_VDO^1/TG_K__ /:;4 6/V<?^2>:A_P!A63_T5%7L%>/_
M +./_)/-0_["LG_HJ*O8* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JR6%K
M'J$M^L*_:I4$;2GD[1T4>@]A5FB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** *U[I]IJ*1)>0+,D4BRHK]-Z]"1T.#
MSSWP>U6:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *Y_P =_P#)//$O_8*NO_135T%<_P".
M_P#DGGB7_L%77_HIJ / /V<?^2AZA_V"I/\ T;%7T_7S!^SC_P E#U#_ +!4
MG_HV*OI^@ HHHH **** "O%_VDO^1/TG_K__ /:;5[17B_[27_(GZ3_U_P#_
M +3:@"Q^SC_R3S4/^PK)_P"BHJ]@KQ_]G'_DGFH?]A63_P!%15[!0 4444 %
M%%% !1110 4444 %%%% !7C_ ,?+2._LO"]G*6$=QJBQ,5/(##!Q[\U[!7D/
MQXN8K.W\*7,[[(8=661VP3A0,DX'/2EIS1OM=?F&MG;L_P C'\2_!JU\%:!=
M^(_"FNZM;:CI\9G_ 'LJ$.B\L/E5>P[Y!QS5;XG^(7\4_ WPYK,H437%Y'YH
M48&]5D5L?B#6[XZ^,'A+5/!NI:5HE]+J.H7\)MHH8[653E_ES\RCUZ#FN9^(
M&@W'AKX!>&=,NUV7,=ZCRI_=9UD8CZC./PJX7Z_S1M]^OZ%1MS*W:7Y&C\9;
M#3M4\8>!['5[O[)I\\<B3S^8L?EK\G.Y@0/QKE_%WAKP=X)TR'6/!'C6:XUI
M)T6.*&^AF9@3SQ& 0.!UX/2NT^*.EV>M?$3X?Z;J$/G6ER'26/<5W+\G&001
M^!K'\5^$['X2>,],\4Z;I45WX>DD$<]O.GG&U;^\C-D@]P<]01GD5*W6MM7K
M\_Z1FMN]DM/D:_QP+WW@CPF=3_<//>Q?:>=NPM&=W7IC)ZUF+\*_A"2 /'F2
M>@&KVG_Q%:WQWO-/U'PCX9O?-673I]0CD,BDX:(H23QST].:RE;]GI&#*<$'
M(_X_Z:M=WTU_R#MK?1?J=;\2=5U6*Y\.>!O#MZ]G<:L?+DO ?GCA0 $@C')&
M3D8Z=LUG2_ A=-(O_#7BK5K36MZL]S/*"K_,"V0J@GUP2<]_6I?B69+'6?"7
MQ#TZWEO=-L/^/D1J=P@<9#X/(X)Z^V<5>U'X\>#8+-'TR:YU2\D956TBMY$<
MY(!Y90,^PSDT+O\ :N_7R_KU*[);67IY_P!>AI>+/A7IGCDZ?<:_J%]]LM+<
M0L]D4C20]2VUE;'/O7DOPT^$>@>,;/5Y]0N]2B:RU![:,6\D:@JH!!.4///M
M7T?97+WFGP7,EM+;/+&KF";&^,D9VM@D9%>7? C_ )!7B7_L,2_R%$=)OTO\
M[H&_=3\U^3(_'%WK/BCXA6'P^TC4IM,LH[87-_<PMB1E[*,8[8^I;GI6+XD^
M%,GP[T*X\2^#O$&J0W=B!-/%/(I69!UX55'&2<$$=:T?&D\O@#XOVGC:XM)9
MM%OK86EU+$N3"W3)_)3[X-1_$#XN>']?\)W.@^%Y9]4U/4U^S)'';2+M#=?O
M 9.,@8S47?(G'XOUO_D.RYK/X=/R_P RA\5]>3Q7\%O#NL,%C^UWD1E53PK!
M) P'L"#6)K_@'X:Z)X>O-4T7QR[ZK;1&6V1-2@D9I!T 5%#<GC@\5J?$?P_)
MX<^!OA?1[D?OHKV+SESG#LLC,,^Q8BG_ !%^%NF^$[*S\5^%]*B>.P8/>V%S
MNN(I$_O$.2<#N/3GC%7)).5M%S;_ "7X KN,;ZNVWS9JZEXC\5-^SE;:LLMP
MFIO&JS7" B00[R/,SU!*[?F]\UR&D^&?".I6L=_X.^(%U:>*W*G_ (F5SY =
MR064_(&.?8MD^M>FZ[\0+T_#&S\5^%+"UN[8%1>6LT;-Y4>,. %(P5.!W&.>
ME><^-=;^#^N^&+FZTVT$&O/$3!%:VLD++*?[V (R,]>O?'6B3M.3MU^?_#"B
MKQBO^&_I'T-IHO5TNU74FA:^$2BX:'.PR8^8KD XSGM7E_Q%_P"2Q?#S_KM+
M_-:[3X>QZG%\/]$36/,^W"V7S!+G>!_"&SSG;BO/_BUJEGHOQ.\"ZEJ$WDVE
ML\KRR;2VU<KS@ D_@*<M*J]?\R-Z3MV_R/9J\@^'>?\ A<OQ!V\G>N/^^C74
M6'Q>\"ZIJ%O86>N>;=7,BQ1)]DG7<S' &2@ Y]:Y3P%YW_"WOB)]GV>?D>7O
M&5W9.,^V:A?%?RE^A;^&WFOS9Y[8Q>&_%VMZF/B1XGU73]<CNY$AA)VPQ*.P
M+(P7D8QE>@ZYKUKPGX1U#4/ FJ>']=\11:QI%VY%E?6=SYLODDYP692,\#^]
MC)'I7(Q>.O!'B"&[M/BAHUE8Z_;R-!+LLI<E1TVNFYQ^?N.M7_@7&!JOBB31
MUNU\+M.OV'[1GEN<XS[8SWZ9YJHJZY?+Y=/Q_P""$WKS>?SZ_@<AK_PCT#2O
MB=X<\-07FI-9:G&[S.\D9D4J&QM(0 =.X-=IXU\$:9X#^"/B#3M+GNYH9IHI
MV:Z=68,7C'&U5&/E':K?C+_DOG@?_KA+_)ZVOC7_ ,DFUK_ME_Z-2HDW[+U;
M_P#2D:07[U?+\F>8:)\-?A7>Z#I]U?\ C;[/>36\<D\/]JVJ>6Y4%EP5R,'/
M!YK<^+&D:;HOP1TG3=(NVN]/BO(O(G:19#(I#G.Y0 >O4"L/1/\ A1']@Z?_
M &K_ ,A'[/']J_X_O];M&[[O'7/3BMSXKWNA7GP2TJ7PW)OT>.]BBMSAQA4#
MKCY_FXP>M:SM?RYEZ;F=+=/R?Y,=J/P(T[2-#FU?PYK>KVVK6T)GA>29,9"Y
M(RB*1GIG/YUWWPM\47'B[P%8ZE>D->*6@G8#&YE.-WXC!_&N9UWXV>"T\*W<
M6G:D][?/;&**!+65<N5P,EE QGWK;^#GAZ[\.?#FRM[Z(Q7-P[W+QL,%-QX!
M'8X XI*_O=M/ON_T)Z1[_P# 7ZG/?'#_ (_?!?\ V%E_FM<I\79M5L_C-I^H
M:*I>]L=-6Z"CNJ-(6&._RYR/2NK^.'_'[X+_ .PLO\UI=657_:8TA&4,K:0P
M((X(Q+4POI;O+_TDJ;LG?LO_ $HR/BYKUIXG\!>$-8LF!AN=1C;;G)1MK!E/
MN#D?A7N:_='TKY6^(VC7O@WQ##X;C!.@W.H)J-AG_EF3\KH#[9''L#WKZI7[
MH^E4K.%UU?Z(AIJI9]OU9\_7?@73/'OQV\56.J3WD,4$,4RFU=58G9&.=RMQ
MS5WPUI9^'?QIL?"VBZM=7FE7]LTEQ;3R!C"P5B"0 !GY1S@'!JE=^!=,\>_'
M;Q58ZI/>0Q00Q3*;5U5B=D8YW*W'->G^#/A?X;\#3/<Z9%/->.I0W-U('<*>
MPP !^ S2IZ*+\OOW_KY%3U<EY_=M_7S/(=5\-^%O$GQI\6P^*=:_LN"+RWA?
M[5%!O;:H(S("#QZ5/H=IIW@[XMZ!IG@7Q'-JVGWV?MT*W"3(H[DE %Z#/3(Q
M[UIV/@_0_&/QO\:VNN69N8X4C>+$KH48JHS\I&?QS3?!*0_"OXG3^%M4M;<V
MFI'.G:FT2B0@GY4+XZ$\$?W@.QHI:<GI]^^G]=A3UYO7[MM?Z[FKXF;5OB-\
M3KOP9;:I<Z9HFEP![UK9L/.S <'V^8#!R."<'BL?Q3X!NOA)I:^*?!^NZB([
M:5/M=I=.&2520O(4*".0,$=\@C%7]5U'_A6'QFO]=U6WF.@Z]"J_:HTW>5(
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MUBM-%@L6GO-1=_FD&#F)!ZD=3[]17H^DZK9:YI=OJ>G3>=9W"[XI-K+N'T8
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M7GZ5O^$/AS\-M,\56%]H?BYK[48'+PVXU*WEWD Y^5%R>,GBL'XC_P#"+?\
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M9&#7NT/A/1_!W@75=/T:U\F$VLSNS,6>1MAY8GK_ "KR+P7\)M$\8_"%+^*
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MMJ/@#XJ-X#GU.:_TB\M?/L?/.6B(!( ].%88''0\5['=3I:VDUQ(<)$C.Q]
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\+V5S'<VOAO1X)XF#1RQ6,2LA'0@A<@UMT4;!N9%]X4\.ZI=M=ZAH&E7=RX
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MY>OLR>;_ -]XS^M2WVE:=J?D_;["UN_(?S(OM$*R>6W]Y<C@^XJW10 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %<_X[_Y)YXE_[!5U_P"B
MFKH*Y_QW_P D\\2_]@JZ_P#134 > ?LX_P#)0]0_[!4G_HV*OI^OF#]G'_DH
M>H?]@J3_ -&Q5]/T %%%% !1110 5XO^TE_R)^D_]?\ _P"TVKVBO%_VDO\
MD3])_P"O_P#]IM0!8_9Q_P"2>:A_V%9/_145>P5X_P#LX_\ )/-0_P"PK)_Z
M*BKV"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KG_'?_)//$O\ V"KK_P!%-705S_CO_DGGB7_L%77_ **:@#P#
M]G'_ )*'J'_8*D_]&Q5]/U\P?LX_\E#U#_L%2?\ HV*OI^@ HHHH **** "O
M%_VDO^1/TG_K_P#_ &FU>T5XO^TE_P B?I/_ %__ /M-J +'[./_ "3S4/\
ML*R?^BHJ]@KQ_P#9Q_Y)YJ'_ &%9/_145>P4 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*], DGGIUZ@U5M?B;?Z;\*H?%WB.RM_M=V^VSL[4,@DR?D!+%NH!8GT[4?\
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MXPZ_J&M^!O#NJ:/-;IH]_<1,RNSB4R$$JK8^4H,'(ZY Q7K^A?VS_8\/]O\
MV#^TN?-^P;_)QDXV[_FZ8SGO3L[._1V%?:W57-&BN%\6^.+^P\367A3PW86]
M[KMW$9B;ERL-NG.&?')Z'@>GN*@T7QSK-IXRA\)>,;"RM]1NHC+:7>GNY@GZ
M_+A_F4\'KZ=LBDM=AO0]!HKRC2/'GC3Q-XFU_1-&L=$1M*O6C-S=^:$$(8J
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M0P 8YZG(HZI=P.^K(E\3Z/#XGA\.27F-6FA\^.W\I^4YYW8V_P )[]JX>_\
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M\6\9:_XUU?X2:EJ6L:-I<6E7\4;PK:S/]HMT+J5:0,-K \="",]/3TSX<_\
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M?1[+Q'9^'[B\V:I>(9((/*<[U&<G<!M'W3U(Z5/H>L6WB#0[+5K,G[/=Q"5
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M]@LV<-CGK^'(K/3QQXL\3:IJH\&:9I+Z;I4Q@EFU&20/<N.JQA?N_5N.10]
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M/^L)ROICD>U.3;O;=M/TL**2M?LUZW.;^"=C<WFEZMXPU #[;KMVTG^[&I(
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG_'?_)/
M/$O_ &"KK_T4U=!7/^._^2>>)?\ L%77_HIJ / /V<?^2AZA_P!@J3_T;%7T
M_7S!^SC_ ,E#U#_L%2?^C8J^GZ "BBB@ HHHH *\7_:2_P"1/TG_ *__ /VF
MU>T5XO\ M)?\B?I/_7__ .TVH L?LX_\D\U#_L*R?^BHJ]@KQ_\ 9Q_Y)YJ'
M_85D_P#145>P4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %<_P"._P#DGGB7_L%77_HIJZ"N?\=_\D\\2_\ 8*NO
M_134 > ?LX_\E#U#_L%2?^C8J^GZ^8/V<?\ DH>H?]@J3_T;%7T_0 4444 %
M%%% !7B_[27_ ")^D_\ 7_\ ^TVKVBO%_P!I+_D3])_Z_P#_ -IM0!8_9Q_Y
M)YJ'_85D_P#145>P5X_^SC_R3S4/^PK)_P"BHJ]@H **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y_P =_P#)//$O
M_8*NO_135T%<_P"._P#DGGB7_L%77_HIJ / /V<?^2AZA_V"I/\ T;%7T_7S
M!^SC_P E#U#_ +!4G_HV*OI^@ HHHH **** "O%_VDO^1/TG_K__ /:;5[17
MB_[27_(GZ3_U_P#_ +3:@"Q^SC_R3S4/^PK)_P"BHJ]@KQ_]G'_DGFH?]A63
M_P!%15[!0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N?\=_\ )//$O_8*NO\
MT4U=!7/^._\ DGGB7_L%77_HIJ / /V<?^2AZA_V"I/_ $;%7T_7S!^SC_R4
M/4/^P5)_Z-BKZ?H **** "BBB@ KQ?\ :2_Y$_2?^O\ _P#:;5[17B_[27_(
MGZ3_ -?_ /[3:@"Q^SC_ ,D\U#_L*R?^BHJ]@KQ_]G'_ ))YJ'_85D_]%15[
M!0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5S_CO_DGGB7_L%77_ **:N@KG_'?_ "3SQ+_V"KK_ -%-0!X!^SC_
M ,E#U#_L%2?^C8J^GZ^8/V<?^2AZA_V"I/\ T;%7T_0 4444 %%%% !7B_[2
M7_(GZ3_U_P#_ +3:O:*\7_:2_P"1/TG_ *__ /VFU %C]G'_ ))YJ'_85D_]
M%15[!7C_ .SC_P D\U#_ +"LG_HJ*O8* "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO8*\?_9Q_P"2>:A_V%9/_145>P4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %<_X[_Y)YXE_[!5U_P"BFKH*Y_QW
M_P D\\2_]@JZ_P#134 > ?LX_P#)0]0_[!4G_HV*OI^OF#]G'_DH>H?]@J3_
M -&Q5]/T %%%%  0""#T-9^AZ3'H>DPZ;#*\D,)81EP,JI8D+QZ X_"M G R
M>E<<OB;Q'K*FX\.:!:RZ?N(BN[^],/G@'&Y$5&.WT)QGTH BUKPWI=MXMT?4
MH]2.G27%\'>S5-T=[,$;!Q_"^"?F[@<YXQQO[27_ ")^D_\ 7_\ ^TVKOK/Q
M'JUMJ=I8^)-$BLC=N8[:ZM;GSX6DP3L.55E) .."#CK7 _M)?\B?I/\ U_\
M_M-J?0.I8_9Q_P"2>:A_V%9/_145>P5X_P#LX_\ )/-0_P"PK)_Z*BKV"D 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N?\=_\ )//$O_8*NO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3^5=+10!@67@CPMIMY%>6/A[3;>YB.Z.6*V564^H(%>;?M)?\B?I/_7_ /\
MM-J]HKQ?]I+_ )$_2?\ K_\ _:;4 6/V<?\ DGFH?]A63_T5%7L%>/\ [./_
M "3S4/\ L*R?^BHJ]@H **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)WBDD<@#<Q@))X]Z?3^OZZ ^G]?UN;W[./\ R3S4/^PK)_Z*BKV"O'_V<?\
MDGFH?]A63_T5%7L%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^2>:A_V%9/\ T5%7L%>/_LX_\D\U#_L*R?\ HJ*O8*D84444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S_CO_DGGB7_
M +!5U_Z*:N@KG_'?_)//$O\ V"KK_P!%-0!X!^SC_P E#U#_ +!4G_HV*OI^
MOF#]G'_DH>H?]@J3_P!&Q5]/T %%%% "$X!->?:)XHU9;"'7=5\+12PW<>XW
MVD+YDBKSQ)&?GXQ_"7^@KT%L;3DX&*YO0KO2= \!V=PVII+IEM!Q>,A0.,]0
MO7D\ =Z7=CZ6_K8?X:D\)7TMQJ/AV/3#<2G%S);1*DN?208# Y[&O.?VDO\
MD3])_P"O_P#]IM79Z?J/@_Q)XEM[E+*6#6H@7@EN;.6UEE4=<%@N\<\CGZ5Q
MG[27_(GZ3_U__P#M-JKH3U+'[./_ "3S4/\ L*R?^BHJ]@KQ_P#9Q_Y)YJ'_
M &%9/_145>P4AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !7/^._^2>>)?^P5=?\ HIJZ"N?\=_\ )//$O_8*NO\
MT4U '@'[./\ R4/4/^P5)_Z-BKZ?KY@_9Q_Y*'J'_8*D_P#1L5?3] !1110
MC ,I!Z$8KRS5TU?0/#]IHLF@:AJ$.E7<5Q9W%C%YR7$4<FY8W4'<K@<9P1D
MY]/4V.U2?09KAM,M?$'C#38M9?Q-=:7;70+P6FGPQ?NTSQO=U8LW'., =*%>
M^G]:Z#Z:_P!:?Y#OMU[XQU/1)(- U/3;6QN1>2W.I1"%AA&7RT3)8D[N20!C
M/-<?^TE_R)^D_P#7_P#^TVKM<ZWX5U;2X[K7)-8T_4+D6A2ZA19HG*L0RL@
M8?+R".^<\5Q7[27_ ")^D_\ 7_\ ^TVI]-"=;ZEC]G'_ ))YJ'_85D_]%15[
M!7C_ .SC_P D\U#_ +"LG_HJ*O8*0PHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH5?# L8?$%J-<@\1)K3*RV<FN2+(A./F$1C/EAL9[!L9]ZYW]I+_ )$_2?\
MK_\ _:;5VD*Z[XLU'2[F^TN+2=-L;@70#723S32!6"CY,JJ_-DG<2>F*XO\
M:2_Y$_2?^O\ _P#:;53V)ZEC]G'_ ))YJ'_85D_]%15[!7C_ .SC_P D\U#_
M +"LG_HJ*O8*0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M +27_(GZ3_U__P#M-J +'[./_)/-0_["LG_HJ*O8*\?_ &<?^2>:A_V%9/\
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M **** "BBB@ HHHH **** "BBB@ HJ*XN(+2VDN;F:.&")2\DLC!511U))X
MJ+3]3L-6M1=:;?6UY;DE?-MI5D3(ZC*DC- %JBBJ%EK>DZG<SVUAJEE=SVYQ
M-%!<)(T9SCY@#D<@CF@"_1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7/^._\ DGGB7_L%77_HIJZ"N?\ '?\ R3SQ+_V"KK_T
M4U '@'[./_)0]0_[!4G_ *-BKZ?KY@_9Q_Y*'J'_ &"I/_1L5?3] !1110 4
M444 %>+_ +27_(GZ3_U__P#M-J]HKQ?]I+_D3])_Z_\ _P!IM0!8_9Q_Y)YJ
M'_85D_\ 145>P5X_^SC_ ,D\U#_L*R?^BHJ]@H **** "BBB@ HHHH ****
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MM!Z9(!.2,D  _AFO(?BIXT7Q9>^&8Y])OM)U*TF8W%E>1%60,8]I!(&0<'G
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M=R BX'ZFHAK)WV23_$N6D4_/]#L/&7Q+LO"'V*S.G7.H:W>1[XM-MN7''\1
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOC)Q^=9_CCP3IOCO0QIFH/+$8Y!+#-%C=&V"._!&"017344Y>]N*/N['CR?
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M2T::Z;?D/OYGG_C3X56'BK5H]<LM2N]&UN-0HO+7^+' ) (.0.,@C\:;X/\
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MOBO_ +ZG_P :/[$^*W_/KXK_ .^I_P#&OL&B@#X^_L3XK?\ /KXK_P"^I_\
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M/BM_SZ^*_P#OJ?\ QK[!HH ^/O[$^*W_ #Z^*_\ OJ?_ !H_L3XK?\^OBO\
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MK?\ /KXK_P"^I_\ &C^Q/BM_SZ^*_P#OJ?\ QK[!HH ^/O[$^*W_ #Z^*_\
MOJ?_ !H_L3XK?\^OBO\ [ZG_ ,:^P:* /C[^Q/BM_P ^OBO_ +ZG_P :/[$^
M*W_/KXK_ .^I_P#&OL&B@#X^_L3XK?\ /KXK_P"^I_\ &C^Q/BM_SZ^*_P#O
MJ?\ QK[!HH ^/O[$^*W_ #Z^*_\ OJ?_ !H_L3XK?\^OBO\ [ZG_ ,:^P:*
M/C[^Q/BM_P ^OBO_ +ZG_P :/[$^*W_/KXK_ .^I_P#&OL&B@#X^_L3XK?\
M/KXK_P"^I_\ &C^Q/BM_SZ^*_P#OJ?\ QK[!HH ^/O[$^*W_ #Z^*_\ OJ?_
M !H_L3XK?\^OBO\ [ZG_ ,:^P:* /C[^Q/BM_P ^OBO_ +ZG_P :/[$^*W_/
MKXK_ .^I_P#&OL&B@#X^_L3XK?\ /KXK_P"^I_\ &C^Q/BM_SZ^*_P#OJ?\
MQK[!HH ^/O[$^*W_ #Z^*_\ OJ?_ !H_L3XK?\^OBO\ [ZG_ ,:^P:* /C[^
MQ/BM_P ^OBO_ +ZG_P :/[$^*W_/KXK_ .^I_P#&OL&B@#X^_L3XK?\ /KXK
M_P"^I_\ &C^Q/BM_SZ^*_P#OJ?\ QK[!HH ^/O[$^*W_ #Z^*_\ OJ?_ !H_
ML3XK?\^OBO\ [ZG_ ,:^P:* /C[^Q/BM_P ^OBO_ +ZG_P :/[$^*W_/KXK_
M .^I_P#&OL&B@#X^_L3XK?\ /KXK_P"^I_\ &C^Q/BM_SZ^*_P#OJ?\ QK[!
MHH ^/O[$^*W_ #Z^*_\ OJ?_ !H_L3XK?\^OBO\ [ZG_ ,:^P:* /C[^Q/BM
M_P ^OBO_ +ZG_P :/[$^*W_/KXK_ .^I_P#&OL&B@#X^_L3XK?\ /KXK_P"^
MI_\ &C^Q/BM_SZ^*_P#OJ?\ QK[!HH ^/O[$^*W_ #Z^*_\ OJ?_ !H_L3XK
M?\^OBO\ [ZG_ ,:^P:* /C[^Q/BM_P ^OBO_ +ZG_P :/[$^*W_/KXK_ .^I
M_P#&OL&B@#X^_L3XK?\ /KXK_P"^I_\ &C^Q/BM_SZ^*_P#OJ?\ QK[!HH ^
M/O[$^*W_ #Z^*_\ OJ?_ !H_L3XK?\^OBO\ [ZG_ ,:^P:* /C[^Q/BM_P ^
MOBO_ +ZG_P :/[$^*W_/KXK_ .^I_P#&OL&B@#X^_L3XK?\ /KXK_P"^I_\
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M/BM_SZ^*_P#OJ?\ QK[!HH ^/O[$^*W_ #Z^*_\ OJ?_ !H_L3XK?\^OBO\
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MK?\ /KXK_P"^I_\ &C^Q/BM_SZ^*_P#OJ?\ QK[!HH ^/O[$^*W_ #Z^*_\
MOJ?_ !H_L3XK?\^OBO\ [ZG_ ,:^P:* /C[^Q/BM_P ^OBO_ +ZG_P :/[$^
M*W_/KXK_ .^I_P#&OL&B@#X^_L3XK?\ /KXK_P"^I_\ &C^Q/BM_SZ^*_P#O
MJ?\ QK[!HH ^/O[$^*W_ #Z^*_\ OJ?_ !H_L3XK?\^OBO\ [ZG_ ,:^P:*
M/C[^Q/BM_P ^OBO_ +ZG_P :/[$^*W_/KXK_ .^I_P#&OL&B@#X^_L3XK?\
M/KXK_P"^I_\ &C^Q/BM_SZ^*_P#OJ?\ QK[!HH ^/O[$^*W_ #Z^*_\ OJ?_
M !H_L3XK?\^OBO\ [ZG_ ,:^P:* /C[^Q/BM_P ^OBO_ +ZG_P :/[$^*W_/
MKXK_ .^I_P#&OL&B@#X^_L3XK?\ /KXK_P"^I_\ &C^Q/BM_SZ^*_P#OJ?\
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MOBO_ +ZG_P :/[$^*W_/KXK_ .^I_P#&OL&B@#X^_L3XK?\ /KXK_P"^I_\
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AP['I-@3(<^9/.XPTTAZL?3H !V [\D]%110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>kopn-20241228.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaOPObP9z5Z8mekhvWB+bfla/ysukFqFkStr3Iu28bAO -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:KOPN="http://kopin.com/20241228" elementFormDefault="qualified" targetNamespace="http://kopin.com/20241228">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://kopin.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="kopn-20241228_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="kopn-20241228_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="kopn-20241228_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="KOPN_JohnCCFanMember" name="JohnCCFanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KOPN_MMurrayMember" name="MMurrayMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KOPN_ReportedValueOfEquityAwardsMember" name="ReportedValueOfEquityAwardsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KOPN_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember" name="YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KOPN_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" name="YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KOPN_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" name="FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KOPN_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" name="ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KOPN_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" name="FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KOPN_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" name="ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KOPN_DrFanMember" name="DrFanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KOPN_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" name="YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KOPN_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" name="AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KOPN_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" name="YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KOPN_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" name="AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KOPN_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" name="AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KOPN_EquityAwardAdjustmentsMember" name="EquityAwardAdjustmentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>kopn-20241228_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://kopin.com/role/Cover" xlink:href="kopn-20241228.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosureWithAdditionalMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpTable" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsToCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListsByExecutiveCategory" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpExecutiveCategoriesOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TradingArrangmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ForgoneRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#OutstandingRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardsCloseToMnpiDisc" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangemenstByInd" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/Defaults" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#Defaults" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kopin.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_ReportedValueOfEquityAwardsMember" xlink:label="loc_KOPNReportedValueOfEquityAwardsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNReportedValueOfEquityAwardsMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember" xlink:label="loc_KOPNYearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNYearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:label="loc_KOPNYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:label="loc_KOPNFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" xlink:label="loc_KOPNChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" xlink:label="loc_KOPNFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" xlink:label="loc_KOPNValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" xlink:type="arc" order="60" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:label="loc_KOPNYearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNYearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:type="arc" order="70" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:label="loc_KOPNAverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNAverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:type="arc" order="80" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" xlink:label="loc_KOPNYearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNYearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" xlink:type="arc" order="90" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" xlink:label="loc_KOPNAverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNAverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" xlink:type="arc" order="100" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" xlink:label="loc_KOPNAverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNAverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" xlink:type="arc" order="110" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_JohnCCFanMember" xlink:label="loc_KOPNJohnCCFanMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_KOPNJohnCCFanMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_MMurrayMember" xlink:label="loc_KOPNMMurrayMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_KOPNMMurrayMember" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_DrFanMember" xlink:label="loc_KOPNDrFanMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_KOPNDrFanMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember" xlink:label="loc_ecdNonPeoNeoMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_ecdNonPeoNeoMember" xlink:type="arc" order="30" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>kopn-20241228_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="ecd_IndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_IndividualAxis" xlink:to="ecd_IndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_IndividualAxis_lbl" xml:lang="en-US">Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_JohnCCFanMember" xlink:label="KOPN_JohnCCFanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_JohnCCFanMember" xlink:to="KOPN_JohnCCFanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KOPN_JohnCCFanMember_lbl" xml:lang="en-US">John C.C.Fan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_MMurrayMember" xlink:label="KOPN_MMurrayMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_MMurrayMember" xlink:to="KOPN_MMurrayMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KOPN_MMurrayMember_lbl" xml:lang="en-US">M.Murray [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="ecd_AdjToCompAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAxis" xlink:to="ecd_AdjToCompAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAxis_lbl" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_ReportedValueOfEquityAwardsMember" xlink:label="KOPN_ReportedValueOfEquityAwardsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_ReportedValueOfEquityAwardsMember" xlink:to="KOPN_ReportedValueOfEquityAwardsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KOPN_ReportedValueOfEquityAwardsMember_lbl" xml:lang="en-US">Reported Value of Equity Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember" xlink:label="KOPN_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember" xlink:to="KOPN_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KOPN_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember_lbl" xml:lang="en-US">Year End Fair Value Of Equity Award Granted During Year That Remains Unvested [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:label="KOPN_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:to="KOPN_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KOPN_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_lbl" xml:lang="en-US">Year Over Year Change In Fair Value Of Outstanding And Unvested Equity Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:label="KOPN_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:to="KOPN_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KOPN_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_lbl" xml:lang="en-US">Fair Value As Of Vesting Date Of Equity Awards Granted And Vested In The Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" xlink:label="KOPN_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" xlink:to="KOPN_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KOPN_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember_lbl" xml:lang="en-US">Change In Fair Value Of Equity Awards Granted In Prior Years That Vested In The Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" xlink:label="KOPN_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" xlink:to="KOPN_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KOPN_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember_lbl" xml:lang="en-US">Fair Value At The End Of The Prior Year Of Equity Awards That Failed To Meet Vesting Conditions In The Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" xlink:label="KOPN_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" xlink:to="KOPN_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KOPN_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember_lbl" xml:lang="en-US">Value Of Dividends Or Other Earnings Paid On Stock Awards Not Other Wise Reflected In Fair Value Or Total Compensation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_DrFanMember" xlink:label="KOPN_DrFanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_DrFanMember" xlink:to="KOPN_DrFanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KOPN_DrFanMember_lbl" xml:lang="en-US">Dr. Fan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember" xlink:label="ecd_NonPeoNeoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoMember" xlink:to="ecd_NonPeoNeoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoMember_lbl" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:label="KOPN_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:to="KOPN_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KOPN_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_lbl" xml:lang="en-US">Year Over Year Average Change In Fair Value Of Outstanding And Unvested Equity Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:label="KOPN_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:to="KOPN_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KOPN_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_lbl" xml:lang="en-US">Average Fair Value As Of Vesting Date Of Equity Awards Granted And Vested In The Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" xlink:label="KOPN_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" xlink:to="KOPN_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KOPN_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember_lbl" xml:lang="en-US">Year Over Year Average Change In Fair Value Of Equity Awards Granted In Prior Years That Vested In The Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" xlink:label="KOPN_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" xlink:to="KOPN_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KOPN_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember_lbl" xml:lang="en-US">Average Fair Value At The End Of The Prior Year Of Equity Awards That Failed To Meet Vesting Conditions In The Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" xlink:label="KOPN_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" xlink:to="KOPN_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KOPN_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember_lbl" xml:lang="en-US">Average Value Of Dividends Or Other Earnings Paid On Stock Awards Not Other Wise Reflected In Fair Value Or Total Compensation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="ecd_PvpTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTable" xlink:to="ecd_PvpTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTable_lbl" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="ecd_PvpTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTableTextBlock" xlink:to="ecd_PvpTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTableTextBlock_lbl" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="ecd_CoSelectedMeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureName" xlink:to="ecd_CoSelectedMeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureName_lbl" xml:lang="en-US">Company Selected Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="ecd_PeerGroupIssuersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupIssuersFnTextBlock" xlink:to="ecd_PeerGroupIssuersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupIssuersFnTextBlock_lbl" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="ecd_ChangedPeerGroupFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChangedPeerGroupFnTextBlock" xlink:to="ecd_ChangedPeerGroupFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChangedPeerGroupFnTextBlock_lbl" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="ecd_PeoTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoTotalCompAmt" xlink:to="ecd_PeoTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoTotalCompAmt_lbl" xml:lang="en-US">PEO Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="ecd_PeoActuallyPaidCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoActuallyPaidCompAmt" xlink:to="ecd_PeoActuallyPaidCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoActuallyPaidCompAmt_lbl" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="ecd_AdjToPeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToPeoCompFnTextBlock" xlink:to="ecd_AdjToPeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToPeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="ecd_TabularListTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TabularListTableTextBlock" xlink:to="ecd_TabularListTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TabularListTableTextBlock_lbl" xml:lang="en-US">Tabular List, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="ecd_TotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnAmt" xlink:to="ecd_TotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnAmt_lbl" xml:lang="en-US">Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="ecd_CoSelectedMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureAmt" xlink:to="ecd_CoSelectedMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureAmt_lbl" xml:lang="en-US">Company Selected Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="ecd_OtherPerfMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OtherPerfMeasureAmt" xlink:to="ecd_OtherPerfMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OtherPerfMeasureAmt_lbl" xml:lang="en-US">Other Performance Measure, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="ecd_AdjToCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAmt" xlink:to="ecd_AdjToCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAmt_lbl" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="ecd_PeoName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoName" xlink:to="ecd_PeoName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoName_lbl" xml:lang="en-US">PEO Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="ecd_MeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureName" xlink:to="ecd_MeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xml:lang="en-US">Non-GAAP Measure Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="ecd_Additional402vDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Additional402vDisclosureTextBlock" xlink:to="ecd_Additional402vDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Additional402vDisclosureTextBlock_lbl" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="ecd_PnsnBnftsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PnsnBnftsAdjFnTextBlock" xlink:to="ecd_PnsnBnftsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PnsnBnftsAdjFnTextBlock_lbl" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="ecd_ErrCompRecoveryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompRecoveryTable" xlink:to="ecd_ErrCompRecoveryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompRecoveryTable_lbl" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="ecd_RestatementDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDateAxis" xlink:to="ecd_RestatementDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDateAxis_lbl" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="ecd_RestatementDeterminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDeterminationDate" xlink:to="ecd_RestatementDeterminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDeterminationDate_lbl" xml:lang="en-US">Restatement Determination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="ecd_AggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompAmt" xlink:to="ecd_AggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompAmt_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="ecd_ErrCompAnalysisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompAnalysisTextBlock" xlink:to="ecd_ErrCompAnalysisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompAnalysisTextBlock_lbl" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="ecd_OutstandingAggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingAggtErrCompAmt" xlink:to="ecd_OutstandingAggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingAggtErrCompAmt_lbl" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="ecd_ForgoneRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_ForgoneRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="ecd_OutstandingRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_OutstandingRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="ecd_OutstandingRecoveryCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryCompAmt" xlink:to="ecd_OutstandingRecoveryCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryCompAmt_lbl" xml:lang="en-US">Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xml:lang="en-US">Restatement does not require Recovery</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="ecd_AwardsCloseToMnpiDiscTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTable" xlink:to="ecd_AwardsCloseToMnpiDiscTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTable_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="ecd_AwardTmgMnpiDiscTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiDiscTextBlock" xlink:to="ecd_AwardTmgMnpiDiscTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiDiscTextBlock_lbl" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="ecd_AwardTmgMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMethodTextBlock" xlink:to="ecd_AwardTmgMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMethodTextBlock_lbl" xml:lang="en-US">Award Timing Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="ecd_AwardTmgPredtrmndFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgPredtrmndFlag" xlink:to="ecd_AwardTmgPredtrmndFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgPredtrmndFlag_lbl" xml:lang="en-US">Award Timing Predetermined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xml:lang="en-US">Award Timing MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="ecd_MnpiDiscTimedForCompValFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MnpiDiscTimedForCompValFlag" xlink:to="ecd_MnpiDiscTimedForCompValFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MnpiDiscTimedForCompValFlag_lbl" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="ecd_AwardsCloseToMnpiDiscIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="ecd_AwardUndrlygSecuritiesAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardUndrlygSecuritiesAmt" xlink:to="ecd_AwardUndrlygSecuritiesAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardUndrlygSecuritiesAmt_lbl" xml:lang="en-US">Underlying Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="ecd_AwardExrcPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardExrcPrice" xlink:to="ecd_AwardExrcPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardExrcPrice_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="ecd_AwardGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardGrantDateFairValue" xlink:to="ecd_AwardGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardGrantDateFairValue_lbl" xml:lang="en-US">Fair Value as of Grant Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="ecd_UndrlygSecurityMktPriceChngPct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_UndrlygSecurityMktPriceChngPct" xlink:to="ecd_UndrlygSecurityMktPriceChngPct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_UndrlygSecurityMktPriceChngPct_lbl" xml:lang="en-US">Underlying Security Market Price Change</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable" xlink:label="ecd_TradingArrByIndTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrByIndTable" xlink:to="ecd_TradingArrByIndTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrByIndTable_lbl" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis" xlink:label="ecd_TradingArrAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrAxis" xlink:to="ecd_TradingArrAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrAxis_lbl" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_TrdArrIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl" xml:lang="en-US">Title</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl" xml:lang="en-US">Adoption Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="ecd_TrdArrTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrTerminationDate" xlink:to="ecd_TrdArrTerminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrTerminationDate_lbl" xml:lang="en-US">Termination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="ecd_TrdArrExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrExpirationDate" xlink:to="ecd_TrdArrExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrExpirationDate_lbl" xml:lang="en-US">Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="ecd_TrdArrDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrDuration" xlink:to="ecd_TrdArrDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrDuration_lbl" xml:lang="en-US">Arrangement Duration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="ecd_InsiderTradingPoliciesProcLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingPoliciesProcLineItems" xlink:to="ecd_InsiderTradingPoliciesProcLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingPoliciesProcLineItems_lbl" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_JohnCCFanMember" xlink:to="KOPN_JohnCCFanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KOPN_JohnCCFanMember_doc" xml:lang="en-US">John C.C.Fan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_MMurrayMember" xlink:to="KOPN_MMurrayMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KOPN_MMurrayMember_doc" xml:lang="en-US">M.Murray [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_ReportedValueOfEquityAwardsMember" xlink:to="KOPN_ReportedValueOfEquityAwardsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KOPN_ReportedValueOfEquityAwardsMember_doc" xml:lang="en-US">Reported Value of Equity Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_EquityAwardAdjustmentsMember" xlink:label="KOPN_EquityAwardAdjustmentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_EquityAwardAdjustmentsMember" xlink:to="KOPN_EquityAwardAdjustmentsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KOPN_EquityAwardAdjustmentsMember_doc" xml:lang="en-US">Equity Award Adjustments [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember" xlink:to="KOPN_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KOPN_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember_doc" xml:lang="en-US">Year End Fair Value of Equity Award Granted During Year that Remains Unvested [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:to="KOPN_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KOPN_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_doc" xml:lang="en-US">Year Over Year Change in Fair Value of Outstanding and Unvested Equity Awards [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:to="KOPN_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KOPN_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_doc" xml:lang="en-US">Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" xlink:to="KOPN_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KOPN_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember_doc" xml:lang="en-US">Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" xlink:to="KOPN_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KOPN_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember_doc" xml:lang="en-US">Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" xlink:to="KOPN_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KOPN_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember_doc" xml:lang="en-US">Value of Dividends or other Earnings Paid on Stock Awards Not Otherwise Reflected in Fair Value or Total Compensation [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:to="KOPN_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KOPN_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_doc" xml:lang="en-US">Year Over Year Average Change in Fair Value of Outstanding and Unvested Equity Awards [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:to="KOPN_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KOPN_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_doc" xml:lang="en-US">Average Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" xlink:to="KOPN_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KOPN_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember_doc" xml:lang="en-US">Year Over Year Average Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" xlink:to="KOPN_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KOPN_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember_doc" xml:lang="en-US">Average Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" xlink:to="KOPN_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KOPN_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember_doc" xml:lang="en-US">Average Value of Dividends or Other Earnings Paid on Stock Awards Not Otherwise Reflected in Fair Value or Total Compensation [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KOPN_DrFanMember" xlink:to="KOPN_DrFanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="KOPN_DrFanMember_doc" xml:lang="en-US">Dr. Fan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryIndName_2_lbl" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryIndName_2_lbl" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_2_lbl" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>kopn-20241228_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://kopin.com/role/Cover" xlink:href="kopn-20241228.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://kopin.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="loc_ecdPayVsPerformanceDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="loc_ecdPvpTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_JohnCCFanMember" xlink:label="loc_KOPNJohnCCFanMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_KOPNJohnCCFanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_MMurrayMember" xlink:label="loc_KOPNMMurrayMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_KOPNMMurrayMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_DrFanMember" xlink:label="loc_KOPNDrFanMember" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_KOPNDrFanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember" xlink:label="loc_ecdNonPeoNeoMember" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_ecdNonPeoNeoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="loc_ecdAdjToCompAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdAdjToCompAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAdjToCompAxis" xlink:to="loc_ecdAllAdjToCompMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_ReportedValueOfEquityAwardsMember" xlink:label="loc_KOPNReportedValueOfEquityAwardsMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNReportedValueOfEquityAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember" xlink:label="loc_KOPNYearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNYearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:label="loc_KOPNYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNYearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:label="loc_KOPNFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" xlink:label="loc_KOPNChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" xlink:label="loc_KOPNFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" xlink:label="loc_KOPNValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:label="loc_KOPNYearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNYearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:label="loc_KOPNAverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNAverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" xlink:label="loc_KOPNYearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNYearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" xlink:label="loc_KOPNAverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNAverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="kopn-20241228.xsd#KOPN_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" xlink:label="loc_KOPNAverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_KOPNAverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="loc_ecdPvpTableTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="loc_ecdCoSelectedMeasureName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdCoSelectedMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="loc_ecdNamedExecutiveOfficersFnTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNamedExecutiveOfficersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="loc_ecdPeerGroupIssuersFnTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupIssuersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="loc_ecdChangedPeerGroupFnTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdChangedPeerGroupFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="loc_ecdPeoTotalCompAmt" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="loc_ecdPeoActuallyPaidCompAmt" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoActuallyPaidCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="loc_ecdAdjToPeoCompFnTextBlock" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToPeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="loc_ecdNonPeoNeoAvgTotalCompAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNonPeoNeoAvgTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="loc_ecdAdjToNonPeoNeoCompFnTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:presentationArc order="2140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" />
      <link:presentationArc order="2150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" />
      <link:presentationArc order="2160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="loc_ecdTabularListTableTextBlock" />
      <link:presentationArc order="2170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTabularListTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="loc_ecdTotalShareholderRtnAmt" />
      <link:presentationArc order="2180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="loc_ecdPeerGroupTotalShareholderRtnAmt" />
      <link:presentationArc order="2190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="2200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="loc_ecdCoSelectedMeasureAmt" />
      <link:presentationArc order="2210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCoSelectedMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="loc_ecdOtherPerfMeasureAmt" />
      <link:presentationArc order="2220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdOtherPerfMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="loc_ecdAdjToCompAmt" />
      <link:presentationArc order="2230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="loc_ecdPeoName" />
      <link:presentationArc order="2240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="loc_ecdMeasureName" />
      <link:presentationArc order="2250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="loc_ecdNonGaapMeasureDescriptionTextBlock" />
      <link:presentationArc order="2260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdMeasureName" xlink:to="loc_ecdNonGaapMeasureDescriptionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="loc_ecdAdditional402vDisclosureTextBlock" />
      <link:presentationArc order="2270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdditional402vDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="loc_ecdPnsnBnftsAdjFnTextBlock" />
      <link:presentationArc order="2280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPnsnBnftsAdjFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="loc_ecdEqtyAwrdsAdjFnTextBlock" />
      <link:presentationArc order="2290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdEqtyAwrdsAdjFnTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:title="995440 - Disclosure - Recovery of Erroneously Awarded Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems" xlink:label="loc_ecdRecoveryOfErrCompDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="loc_ecdErrCompRecoveryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdErrCompRecoveryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="loc_ecdRestatementDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdRestatementDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="loc_ecdRestatementDeterminationDate" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdRestatementDeterminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="loc_ecdAggtErrCompAmt" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="loc_ecdErrCompAnalysisTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdErrCompAnalysisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="loc_ecdOutstandingAggtErrCompAmt" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdOutstandingAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="loc_ecdAggtErrCompNotYetDeterminedTextBlock" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdAggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="loc_ecdForgoneRecoveryIndName" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="loc_ecdOutstandingRecoveryIndName" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="loc_ecdOutstandingRecoveryCompAmt" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:title="995443 - Disclosure - Award Timing Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems" xlink:label="loc_ecdAwardTmgDiscLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="loc_ecdAwardsCloseToMnpiDiscTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="loc_ecdAwardTmgMnpiDiscTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiDiscTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="loc_ecdAwardTmgMethodTextBlock" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="loc_ecdAwardTmgPredtrmndFlag" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgPredtrmndFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="loc_ecdAwardTmgMnpiCnsdrdFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiCnsdrdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="loc_ecdMnpiDiscTimedForCompValFlag" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdMnpiDiscTimedForCompValFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="loc_ecdAwardsCloseToMnpiDiscIndName" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="loc_ecdAwardUndrlygSecuritiesAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardUndrlygSecuritiesAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="loc_ecdAwardExrcPrice" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardExrcPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="loc_ecdAwardGrantDateFairValue" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="loc_ecdUndrlygSecurityMktPriceChngPct" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdUndrlygSecurityMktPriceChngPct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable" xlink:label="loc_ecdTradingArrByIndTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTradingArrByIndTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis" xlink:label="loc_ecdTradingArrAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdTradingArrAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember" xlink:label="loc_ecdAllTradingArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrAxis" xlink:to="loc_ecdAllTradingArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrAdoptionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="loc_ecdTrdArrTerminationDate" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrTerminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="loc_ecdTrdArrExpirationDate" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="loc_ecdTrdArrDuration" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrDuration" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="loc_ecdInsiderTradingPoliciesProcLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001641172-25-011816-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001641172-25-011816-xbrl.zip
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MQ7"O !  **#?I0PQ8P_5UF!,,(-V.(JL$%9D!1+ ]HLW\&I(8P"H C#U$4D
M)XBL$SI)_"7EL" ]."7[D-$[D>D87N>G)=J],P0SC7P4SH!?W!J'6P(X%HP#
M0)WW1D%FS8C(B3;&D 9PA>]1G!(.E,(=X*"9C1L\\AZ>%3Z3R"RG*G$"1H4!
M1^.,N&'Y)1E=RC >RV(=A).7,;IB@3C :8V',3 70!Y%+ Y1"HF <3E>S<YK
M]X<<.4\N&$'UV(BR;GD&/;20ES)"ESV<AAB'Z+ O<6]-FWX:TI<TJWWQGN1K
MK$4_ZF3^&1]"K=E)+7>'3+6+.N^?<"I,+YM!9%$K/PNB/C#Q<.*J:G-SB22=
M\[6MUE4M=K7-K?SPK:R,:>!3T!]Z,K1*6=[\YU.>)-[$)OET@'.,<R*K^'I
MX*J1@;?!N[VA%X#^@M&\[Y;:B;NDFL>BO,)51UVG<=0UCKJ50(@'+MZS2+?=
M0^]M_H6)'G)##^726S)<6]&- #@>'9\?[ATXQQ]$]^CH<_>C^'1P<'YX]*N
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M_!@^B>*,XNFS(,O1U4X%;5@&JED,3A7P2X$):F,"8::CA(8@:JC%/&'P1LO
M=JUEX":]_J8C_G%3PL.9"LI/4G+N(JP',R(M&HO"RB,]\)]*,NM*6P]F.Z)T
M'NX*;V[5R^O"%BK^@97>R]JEUQZ.4&OTHDP7QSR5%Z"-H^' E(SK7GI!Z/6"
M$--!L"4<"4U%XU4=]5C*8M+!C%PG\S<KZ?+XVJ1+YZ>*NLXNW7I-SB7KJ;0K
MYZPD"J(Q P-Y*SHVMBZM!DE2<3^/3RJDK#%\60FF./?5U57K&V:LMOKQZ#D)
MGJW5Q86E$1SG:*X-TBE[K58]:E(%^U0.$FZ> VX'6!(R';*B PI'I"RNQB"B
M*E^RI4,5?*Q)*D13JS8_T==V!O2=,IX)+]$D=TW&=37W\)H,;.?VY9GGD#Y]
M'28[%B:7$9EU12^;"I]V27D,8._*")N(,4P^CB,Y%5X]K1:Z,V# Z>N2H/%4
M)=^[%>\MP"A(TFQFS=V9<=NE2]29[E[ZC0>Y0SZYOEIU^4UZ>9->WJ27;]XV
MO?S'D\;OD#!.RUAPTOBBFZTOX'X:[%Y*[&[2\)<E#;_!Z0:G'U5A@RZWV$UB
M$/6!?6+2XGW6.-"M3"MU#NY<XZ#!VP9OFZH1E:H1K7F6B:B4B*#9?Z!,1(.H
M#:(VA3?6M/#&0]FQUM'4W@U#IV0.QTC?*,57.#(3K[L?IQP4.4[DV$NXG$::
MPF6'ND@&FDD+@[P.+H51M 6T%R>1U,9V!6\M<4AU,CBZ&,0T"F&UEU-84$>>
MCY&F 9P=;+1HK=3+,S+Y&LN/6T!K$2@I1^,PGDBINK%1*RJ>AE:,$9AV(R@*
M>@LB[&2?HE4</0=HZ46BB\L"N+?1J"6Z28*1FSIDW%HR.1UZ2?Q-8B<O <.D
MI3C8/EQT[ <8%2VB>!1$4GT]"/R\'\!N9>H@<ZR<K/+FI878'. S<&G!F X>
MQ[B2O)A$!J->GF# ,8;F\K:,MQ!>1/$9MH7<1@, [A^.RH_G4D]DB4!^_9 8
MTQON4BMGZ&%M&@G(GB(99E^9$N*J-71\B<;0P'1B*WE!INOI.%/U=&P?QBR?
M4.'SZ1JSK+40E[\'<(:_VKL=]\6K%^[+5]M:EX,WD 2P@N?0"LF.([5'*(-]
MLOR(O]NKQD6VQ&]%)>.Z(7G34Q6$L)\;;1+/B:S']+*(KR*@95[=3H@O T)J
M%P]YA$;H<<+PK^FCNK;T$ 9Q4Q2DH52J@1V3"IC=JJSDP9Q_@C;,<0,DKM>?
MT#4'4#VXZNT6P9T8$_Y7'B?YR CV&5#(U"-/K&.#:7F,AM(L]8Y*];J0B^H^
MAT4/QW+K1=M!;XD)058T:>3>C/CD94!94C < @>/E,5AN#%(I+2:*"H3CW[#
MB>T\%)P+9 !03TJ-'"EOQ>!)!>@(G<R31+_,9+!#TEE!_PHY5P,ANKX!*U<V
M9U(,4[3;KW=>B7%=5^,OT@?HMSSJ.W8A,_B\AB0 =8PT<G,CS8Q..$ ,B^TG
MZ6IZ2'DN8W0\*Y*;!06I"4CRPNNCD.JK!$>+K*IH^&Z?94+,;@$UP-?BVYGL
M)S+SDDE5B:];B^O 6[X,80#VIHD091@BAQH^X&+0/)#X9'DW<1H!D),D[ZLX
M@:@.LGH3?4&S+I=IHD-'P?/KO9H1,/D$6.$U\'$XL#.=S-FK^'00D]1)\_4I
M$@K",E%H*\].1;5H"9&/_S:[5YF*TF<6$$2TI@C8QS#&"PM,P+WR8ZAFHR.\
M:VUW)9G.4P$3Q2Y@;?0"K&CHA0,RG=H ?M.FQ(Q-#;S+.-%)=M8BE'"-T368
M?P2@9*FBK'IJH;S:CY:RE$AN+H8CI0$!'C^223B9Q5(;WK+4._H0)\Z)]A"
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M=%^&,G)2*8F9]['N+1888W-IH5YEUS2KJ+7HECK)6&^:!TQ;&:M]J)/F%Q=
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MK"7[\#0F-#NZ #7;0%1EI8LP[F&+[Q);@>. X\%85I)E<0$HBQIN-E5(B!-
MKF(5:FFI9FH:,Z+#\997$J-& Q#:"E-)43:19J46O%3I2$O$&R$*AC!6BD$S
MJ;+5H%Q*+6*H3K:TS2AF6NLXUBJ6<ZVKY:FD9]W\65TP);U'19TT"3#K<89+
M7;0P9R&,\XSUIJLAU=;D(:GQM.Z2Q@J!@4%*@P&DP:CF*!:\CTH-/B[R9O6
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MNQ^F.8ZVWKNE RAO' YN#S1]'3RAU "QN:L&:Y>;0-)1-5KKM3MZ(+JY\CM
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M.*_'/>#G*IF@EI7198*E@V:L/A:A;&&?AB8<EHQ !UFLBV-/"RQ:P')%@K5
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MBW(YY\Y;O*F(-SUPM=;K%5H/3?5Q%2+Z+M$1FJX93$OO<-KZ6: *FUT)CMN
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MY4FV,!SH5PY=154"CA?SQ@L@6S6XEN#7,N3&EH6YF>):$2;@5"$+<(A"UG
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MK6/8%;,/#EQ82AXMN%O,<H5AIEAF^> _SQS2<N' #%:.7)C,0JH8;Z5G5&K
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MV4EGH-4DW$L8@P^BT0NI) M]_@4.R:U?6G&7*?/B+CB3Y"49$Y&,J8"Y B/
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MH7#WU3ZQ2Q"V**0O2/:>W7@L"$?.A$3S)\8A"#^8$2Q@N&4$E37/6>[9;J'
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M@'NQ"[MG8TZE'[S0@\O!LU:C8[3:?:/5[3Z?S9*\WUYBB>N=.YED<;:.?WC
MDGQPK)')..^*CE(_#8(??YXC8N0['_+*NW/PQ%LZ/ZPUA_W)SYBBO'ABS1]F
MMV)3XGJK:[GFB3U=/*?BS@68BOB UW7Z3:/9[:J]J^'>M5H]H]=JJ+VKX=XU
MC4;CR.CWU>YM;6+KWD*"[VG=\5*U@94\?KU>'[M]J[U3AT]MX+8/WY'1[+?5
MSM5PYUI&^[AA]-O]Q]Z]S3H7I&\$Z>9.!NFDP;^_T)T(7F*M=8[G 4.<1($]
M\YH  4]EX2[1)P!4"RN_299=MX=@WIG?]$'?UAIMZ"RO];K?;2RP>]1&;&TC
MFFHCJK$1G7;3.#X^5ANQEN#89LUZM1M;.Q9J(]2QJ-EN;$5M-XQV]TCMPZ/O
M@]'HM!YM*QYR^_PR<B*VU7CV ^;^"6/8 4_&/3G4+SR&6/XUOH+."U*KH[OR
MT7T(7-B3G]O=GG'4:-Z5K:+V0MD5^[ 1S5[7Z#3FN5751BASNW*[H>13139"
M'8LJ[<96M$7+.)H;@U/[L+5]Z+8[1K^S,W?01PA[?@YX)X8@$_9\*^&55=A3
M'=3U'-1VY]AH=)3$?/2-4"9$13:B==0W^BK^K"SK^NR&DD\5V0AU+*JT&UL*
M>[::3;4/C[T/O7;?:/0>1VO7MI[W(5FY9LQOH:_,*X2>**G?K=--5$4_UW:"
M'QC];#>,?K.CHI_*V%,;@<G0':.M'-K*ZJ[/;BCY5)&-4,>B2KNQI>AGH]52
M^_#8^] Y/C*:1X]SI]BY^D\>^CSC_>V]2QGV),K\H?Z;/W$\_1?L N^-997H
M.\^.L>V0Z=*O%Q%\EUTZEOXJ#AV/A:$*GJISOH;@::MC=+HJ5/3H&Z$LD(IL
M1*O=-#ISH9O41BC#O'*[H>13139"'8LJ[<:6@J?-SCR$3;4/V\O6[?6,QM'C
M;(2\K_X8F0.7_:QI#PH@P:/)O_E;Z#>X$#K#J?C0\1!1"+YPV.HZWOIF-,$)
MT$S@CN<B.KD%=];_/6D\H=_%]9E^7WF2$D*JT?CA2>&*O_P@16= Y$_6%7).
M5E@0^L"U+4'_YLVFYYZZ!Y&]3CH_CS@PE3GV8R_2 S8)6 C\%NJV$UH!P]8&
M9C#5+3,<Z0/L( [#F]@0D]GZ8*I'(Z9C&P33FQ[J[SP= ]39#Y-G/P2'$D';
MY .A2^2I@+\E&@+FFA$\&OGZA 5#/X )6 QH#O0A$&.Z^I29 ;ZB+=_57>5=
M B^2!LR^('TOD5%X5^=0+Y,"VA[R=*N./!UB2S7D$LMWX[$'NSUTF1711UX\
M'K  F2,<F<#X^%.0= &';XS'/M+D6U?Z96!Z^"&,QDQKQ/EC'+N1,W&=]#!8
MKA^B[X\&)#(F,!K#D3.L2G;=T<M0C&V&NNN$.#J\[J,9VN9_^!-^P0;6Q"_3
MZP]ASD"U'P&I3?(7]N3 EN]1WPCBY*&LOH#QX0-T-O(F1HYGN;'-9^''@?X6
MS@"LVL%O="APG"SW,P\??<,L1LO4ZAMT( Q8HTLX:3A-,PSC,34&#O48'@_<
M*7Y\;;JQB9\B>;Q/*#^=X2%GFQJ=J <GBE!G[<E&#@VP>H;-Q=X"-^%.7E,S
M/5A_%)AZH;D]M7O7>6=C9 80^]>.#X)RZ+C8\@I'\X, #HH[34?.#9LY*)R+
MK^$#W'S'XZ]$_AR9UTP?,.;IIHU4(WD#7Z A@J 'A>,'_# 2AP._3_6AZ03I
M>_!OQ7<=9CBGHFRS24'<J:<@EJ(W-2;TB3DEZ00R-?!@=V^<:(2[/2$1[0,/
M>3&((T=VW-4GKNF%AW62'YMDA&Z]&$$::K8/7P<U!E+2\2+X5\=/)[QCJ Z:
MR/.]@_]D&TG=%DT542$G#;>($Y1M)CFA5P].>,=529B3"]+V*!I'8S.R1JA1
MP+@!\3^(,W9&Z1<ZC>:SJ^>\TS9HDTNR4$ +@78;._$8Q8UCT^N LQA(E3 .
M\ K C9(/+ Q9<G4P)%(2C<!SAT$?,A!"-MPEC&:O:>A/"4NL08\\/3;Z_98A
MI1<\!ZH3])<@BB;#'VP:C19^N66T^WW^4<MH=AHR4)PGKH1Z;AN"DARPD>D.
M2\5AXJ;82.^L232;H_V YE,EG%+FKEB7O^6)'/#_#@[TMPYS[1?ZN7G)7L*W
M_HL9+/H+O77TDO<CAA_U@P-QI&SG6M)P5_^VN]:K1^N5>F"R'I>B1R;_2KC)
MN.8D!,KD3SF72UDSLODY%D!?:1+$HG2 @H<GNXQR 5_JGZ<3>/])8 XPS>*C
M.69\D3_ZN)RM3O9;/\JOX9]2-I8\_-./L.XE.Q P\^I@P.!(P-@3VL#LJO?F
M<FG"2!GV2%ENDGMAEDRDGYA!G:J[O)@/\K_.:RD>P%4R=.#ZJY%09AX;.E%8
MZ)SWD"DMW(BU]ELKGZ+<G[5-J'R/UN14+IG#%Z9- O\:%"<H)]H>T%\^W.U
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M)J4]V#+$1>OOV]M_WW[X]I>W)I".Q4J[7:*T/X]X>49.!YMIBC*O!+<9UYW
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M?6\(;R:/0@3 FB,;Y$X,$QD:I]CS[E,X< (FM-U(P*%W_+1+IV_AQ_1[N==
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MKCCKNUX$RG,<PJ'\V#A<Z3VZ *)=".6OAL@7-%%)6L_ZRJ5IN1@DH&0G63Y
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M'D37PO!:%>(,.N45--N!W6,0HA$,59/66J_H8[1K?4RCR!TY=,PD^H!&% W
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M:DJRQ55%8R#L>)7"6.;G'[VD3P.(KQU!T)GXSL=HE\W37?L.YS, TSG1G87
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M"=TV=F/?W6D<OA*O7^<'LXJ#%5F=)$:55)AYS!Z-^0!6#\=2*=6KUP-+UGL
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MC'7;PO?$@X@SOZE:XL\;>FI;"659J'96:WR65;>T"NK__9_3H^/3B9"R:U,
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MUBOZ#*(@3!-*H"-Z&48>JHUYGQ+0!ACT$M=8&>)L;4DW0&9?LP\N3'U,-,7
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M-\40+PF"W9 !+R,7N\ROEN0#C#W]K-[0V3Q3<DVDG]7@O1)W.V/X-Y</XR"
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MJ:1'X\OKO@G?)YLC.]#DBBQ1RLCLAB(N%@1EY)XKCRN'B,:U_C#+0AR:1R&
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MWR%Y?W"ZL_?N7>=P[^AC"Y&_?V?>%WFJZ-RY3E"O>)_/0O2GT@S=+M <0%_
M(,&0@44N<@)URAFT*(;+4;G0DS&.3$B^E.+/4SC,\(^E#)6(2 U"46,FU6,/
M#F(8P:P7MQ"->STCN7FDF F(+*9=:GJOS[.*4>/:-$M@J*3%Q LOSZ)N-,F7
M:PP8??2H-G%UW0E\CQ\EV)RK,[VDE/UQ)P>4UW1 /2QM\O!DMY.KVAW@&](9
MZ8HA+S7?]R1%ZJ\D52$IT%M0^XZ@X1@YCP9AQNU\D8\#*X>T70BAHIYJH$LX
M-[JV&XI)\%W**:?N2NH/\7$46%<IMR#7X2BCB#E]#[_Z8 BG@R#CVJ6I)DS2
MK7FUJ0QX9$KC _H3'1,[\I9KG"GRU00] ZC65W:+/$K " YTA@%P!,BF5A.9
M*Y\K:HS]$'#0\DF"@GH<:>O"UD4^GC"?E-,4&/0O :O^_H%1%]:XAK7XZQI]
MV &@<H!H[MDZ\:'&.%*YT<=UGU_E";W^R&H#4CS<30POW=5ZU[!@WGS8BE35
M&?G"H+_>2^T5A#$NQ_LBRX*I+96X2 LSE^JNNM7QW^90%76*-=AZFM0[=K-^
M 1^J]NCFBL)OKK91^+N,PC]KH_!S"N["J,$V=#;/!V JZ]LEI1A##5]T*3H/
M!?_V,,A"WAX='QR*G:.3XZ.3%OAV#Z:POKJ^*O;^_'CPX8MW<+BS=XBT+,?O
M.NV7N7_QE#U552H"A0[T]&_>+L18EC O-HB@F+T;QNG%,@%SJAP0\.6] UT4
MO?>C $S.,<2IX2'R:JXQP(SJ1(X,,['R?WV[!!AN4"704)M]%F9A=^H!V7DW
MCO*SVX/FW(M/\/""=(!S'Q=2+G)=/X)"0&6G*IWOH%)K@KR!MQO&A"_K.40C
MZ9!R(1ASAGKFO.@!:0+B7IMI2'S$F]+US,R,@;>>M-X#(N6'8OA ,Y83UA[8
M)S4E@*&,5#%NJURQ^FA%]JFFZHTP"*YCF%0,(/^QJX"[I6B9;P+K)=XASAM[
MPPP'+&\S; 086I,W8%(= +7)CT**P" "#GCG;X+^"54&82^B!4;C2=[&?Y(?
MH*__!:_G>5$@$7\FD@2^M-V;]WI&'RSX-S,06#4HN$TQ0*W+7"E*'8"'&XU1
MUJ3T(7PCZD(O"06NCC7Z<IBE%U ]6Y+D">MQ F!/D+J@KD;%#@S[IDR-6$40
MR"G?GHZBG@XQZUWC#)-WCJ6$;C?D?(\^ZL,44W5F!$;!*Q&KLSW65I7%84P0
M> 01IXPH#TG\.9@HZCN<5<=(F6R;'BO>86I!A05KVOPLH SY*)"'F*$,-@_P
M@L&$?W1-*4!V3: _#=8I\/-JGT OT3@@;3DQ?Y[IVA/)6\-L!,<8L=-KFF=$
M"(W'<=0C>F2X2I_&^DWM-KC1C""@]RMZ$3!GH5A;D<:0-,%1%K$G0?O=[O.,
M0'T9KD3:>[2G=64WE%!A;R?#.8?>%74[(>LYM\WGV^)(O!<+=*=<B>M-?'EW
M/JVE8%D=*,Y#\;5]:;C0:?4':?U8^M3_HOIM56O+*X*R(D!$KN<GW)$:_XTK
M^5 %I#N_@.P$11[R2JB. O7*!*NC$C(-P*(GDCH$LBAD%;FBA%,>9B'#9=(!
MM#6*0ZK<DFX=U%\1,Y^Z2&JGR47(?1CVR*'-A(*:'!O+VT=?&'$WB#@Q3P@O
MJ7T._AG_1B/,$>BB8DSH)T0)F?Z,'S<@&'450TU>@1$E#A 90U/!U6)EBQLH
M +X[-)E,;PW5E$+[/6;XWE*T3%TN,F#SD*\"@!%3X%FKAZN$P0 &LTOK3!M>
M:GU\^31^''6[P('WHUS^-8A-P9JYGCI?$7J3L79Q)(?+09%!%A1]WX,PPL^?
M,7\]^83!Q*>N&,B6)Y#P9""/$XI,((< OA>*>Z7(X;AX8  XIPH[.8D^4F1F
M(7TF.;%!!%L!('-1@I2%-KV &C:3)A+>*9TXU"@J4('?VWH&#.&\M-*VH$+<
M1--EPN7P ]=R\ .BY)SP?=CX<9BH[V(/6_H#HEZ&[6^NQ%A/2#YEZ;SRX6P$
M52@W'UC1_5!ZPO!PZ#I&7[/BEYKMDI<D4".H[LHA;57XK:OPW@U4^-Z1TMSV
M">_I$Y[PJ7N:)(_QJ>TQOYC36NHO>Q_QZ!+FZ'+(I0,ZNCS[Z KFERNBKY=2
MLI-BFU[73##!"B9JE0H*;8:TIW@3!G?D5CQ4F?I](B6/ZTXR5;VDZ+A5WQG2
M:XY!5>2*%(-*Z[RUIR"3<,ZM;<!_U71 6):" IQ?N1'$,EF&4F)V3E"^Y:2(
M0_F&_N.G5CC+>;3/-6<Q94H2]2\?@<E2Z\E3/PK+;HWA8@/SS53@;6(/+\'$
M9$CZD5X8;3F!=F&I%6IK?,$+TWB->N)ZE1W%>XCI*LT^PBTD#0\1,(LRL<S9
MF&NY,H0D=VA:]!K3&MCK8?<,Q6),LC6.B:.%N7S-(^UXMBB'VZ.1'&@43$)L
M8&WU@[-&J)GAU%>&SW.1N#>;:*9SIV*WM''E@D<Z\[-Y-_QLEO%%K[FKT[!5
M7+>LN*3F@H 8)EA'QH-8ZBP#+6.8#<G@-HVDJPQF%-,N;8@+\!2;A+7AN;ZH
M<*U=>^<T/=(FM*WLI 0W-:25.4G&K(X"B1LS=E^8B^@L&M_@];P5R>O"C5,J
M5B=>^O(^A! 3$D5:)2]Q7+LV>2$]7>0/5TNO2HF5JZ=95F)#RF[3467TM7@B
MF 57#\?HEB]NONSSB@!Q!D<32%^ZO*!0SMU5P;9^.=A6607P$E^"$.>!390E
M/>IQFD=J&6!1TZPD!O@C]U7/\W!R5Q&]!XOX_"5-46Y$-K,I#;(C EC\ >]2
MC:?J$.^W!F!OQ,S?4X![Y_%-(.YKOP3A?I_0[/^\_?LK#!+PI02[)WQP0:S1
M4MI6VN4<"$0@OAFE>"ZLK>,!HD(U(_G\,PR78JB:W#!R)DI'"S]0'7\]ZK@B
MNN#G!#DW7DCP(,'#&N+*(78F5J<JG:23,VB3$R;6']2U\@+('SHODD:%SZQK
M,,DL M\0 6-2AJ-^ <2(%V>I"",\O< LPR !MGDN#9D0"6F1RR,LCQ*F-NF&
M\OLFS%)"]->\6G1 FL?A>,,^\1B,HB10+-AJ(A B==_9+S)MT_!CNTC('<M%
MNWJ5G190O1BS S!%0/5=@$4BA2Z&Z#939G)-KR!XJGZ<9AG'<1@K1\\C:AV2
M!9D5YAWJ'!+JSQ6'$V1*U_T-86='/XIZQZ3]YO<>:\"01\ZX0+G[*.W+%Q.-
M@(;58,RG$OVA5I8$+"SB(..P;4TB)QSEI"6DA@V(O1O%B7U7CL2)C=7MCI&A
MOG$;($8,F+,)7*YC(!.;PHD8_7D(QHG!6!P1&3@DX-+C^ 91)3D2U2J+WR[T
MVU7FBY[)T3""-X\#RG0B,T=-9 P3CXE? :R0IN:;30]6R.!5'R*N#%'3ZQ/F
M[W34>32!18?(**)'(1 *>YNH'#AU/-'4G^2S(C&QXP"2'2#@!-!..)Q(&KO7
M8UE(!WC\JCN4Y6#=-4"PHO;S[$9JCJ?G.[$-BIDV"4@+T;O_*8>E\ 8Y0?EM
M:U$=.BEX /9\@E0\4H +I2^D!;K]?,N&M?IZ&TM%(;44A?R!'J^(A]35$((O
M^/(VA[@@TUH:W$2F^#R:+5@-_0E=MR?3X=:>Z6 X'J>1ZHQCK@7ZG+ZT@@%_
MG&G HNX31S<+#6H&G+(;8 -C' I]>+Y.S8R^2B6[K-P3:4Y*/VUU'S]U9+X^
M%860)7X/?#S5F=,$*YWW,#R#NRBZS<L)ZZ$>@8U1Y<.A",8N5E-+114T(0]%
MI'7)(6QTAYAWPB6A$R+M"2F;$<2. :!S5]5O[0Z^]1T\O-$.!DD0* FUV7S<
MQ7:S A_,4VJ'Y_W7ZLKJ&KC)E!3P*\D-D'XKDV:EV P5%%HP:!WUL>&U*YTV
MBZX*;6XL]99;L5R0:2V=S2^6NU'.O81+)XMI7CS?L^*PWRC=?A7V66G,7H>>
ML1!]NIH,T^W(8,QO19 F/T3!9DLP/7VS:?7<U_,GWDV[LB8MPPG;G; @TU*>
MXWS2"QYRTA=0;':./=B;U33\OQ$PJ=J6A+0'F$%[JCQ\PPUM8!6NUK5\^8!_
M^IA$@!X11ZC)\;?'+[$2MW.!#:;)[I"'P6-\JM<+\C.OS^.GUN@&$DU5S E6
M,=L@#&<8OFK+:AZZ'T29]S[(OH<3@>1.JAN(^Z*KGNQQ!;:\A2OZK 8B,'!D
MY-:D@M)$ZF5A7W5$DI99,0+'1^YO>F_?"_7WX;)PW,C\N=57],Q7=#\?X; I
M BR?GA5H M+;V_V](--:^C;__C:,&%"RV;RU)PX':9DCL]RUFO,O9V&,\OI>
M&EKKJSXQ9B V0%MD^$PBPU7N@2K8KBV1=MIXWV%)9RN=MRZ=WV\@G>P5-_OW
M0:*9-2IE&DNZN@0N2Q7&/-/.+SKBX'Y"D-1ZTK+O=9'UV=P^5:WC^)9>#$48
MP#$A^%#1KPTL1*FJE4D5EM0S%J1AX- ^N"'O/4LOL/.'O%>NYT_C5U>B9*=4
MEN,3])J;>W.%1C"4COJ4H[AID4U6 %2K KK<7(1?8?)"B94KO>JU%#B9TM/A
M>#;O5V^WBK=,WUW=O5@M9*_A_;":B5K<L*9<%#KTQI85/7'R'Z;BQ$H[M&"C
M>ZLE;@9!JN?7;-%&<Z&-UO]Q:*/[*O:M1KI'GV8IOK'= K:!KRI2(P;YT[$Y
M27W':FBVO.N+<-UCT??>AE.O0Q1>"*@*E8>MTQ9BB=N?5%/8X668]:(<QL=(
M3@R<GG9.Z#\@=9(/T'V71@M1Q##CD'00Q^RHDV/;808MX[0SK1'Z[:+BM^>E
M4)9;@*)\9"M33N<YICSJEZ9()E%<J7DE^!FW,VA<.AAHS=HMV]9%;3VK#6HX
M&#1$Y[*0DY4(?,^I@#HHE<'8 0K*<P9<8CQU)C'K1K\R?=7HQL .\%G6$@IK
M"2_.N&IX[O=:RV2_'FMI!N"_U7\S[&ZG-\.**"\AEB:/("(I7^I[>21E*PX1
M.*%@Z-TT@=KW?DA_:%B"2F%3>1FL40EYRB/$'@QZ4_6$WBN^HUQ/9?[B]=.0
MB\,O>R%EI#&^2H*UO2H=WVENA9< Y\?0/Y,G"[I0523J1<D:LN*PBS 4Y6-N
M<5@$$#,.R7, "BB ?U!Q +HD*]X'"N5*/18RP,9F5+)BOG%PX0M7\B%WHJ@-
M<>ZOB-_)-'-+O7,(72&BB$H"@C) Q(!,S<IQS$T^$6ZG1FX,F9E(XPHB7A9"
MDA8;"?H2[' "F2(T6[2#4;]ZDR)+/-/J$)_SRT,)[>E[]>D[NO'IFUV-"E Z
MMLQEV0:5%F1:2\D-Q$-A$CH]%07G=2D'/$]-NMC&5! FZ>F&C4EJ)69!IK64
MWD1BT#X.Q7$FS8+907(-1@ @"^'KZ4!O2G6IAE1%)B4LUT >^3BRQ7U"Y@#C
M2V"@2";$U4K>@DQK:3R_Y$&Z45"ZD7K)-"JLEMAB,0H.( E_,+"I@ T,;EQT
MI<FMD6_DPE@99Q(!2\58:'*=;X<NV\C%F/^!E3\1V]K2: 8K.,:'(U,!9;'+
MU-X&E.=1G8^\Q<)-*42?S]'[%,,&4!&<L\9C^YRPN9E^W5E:9+J9L_2$PW-P
MRBBGF/F"ABGGA%5*24IKP#<$="&]$_+>.4#MPUZ(3R[G$+E &3I<4P]I6$JN
MS8H&]9,%5TTO43P5] 4PV0Y=U[$*RIEY#-58ZO'T0IH^H>+Q\U1T_=Q+XPMK
M$BH7<_1AQWM92%](ND<4GVC+<A9B5L@-T;3Y40)=!0 ; R2VHA?X<@LEHV7$
M8BU!D*.!DF&=B-$I8@Z=4D,E2-UGB;4&JCDQ4 "H3,KCC<+)F73M@T+^#^4O
M#3[Y#LL\'JC$_D:CY<?\1LNK3N>XV?>&D+ 4AU,@)<^]89B$&5%$]'KA&/X"
MN/."R'18(\>M1[XPTUK*;B P$#N<B?%0KM!IY\2W$PV^"P[TFL"!R#[O**$6
M.[1 TUK*;RA4%E?N;+==\; :\E2*Z$,!(QV?"E-)*3$K#Y;J(E6+SQ9CWA@;
M@H?E FW;2=I*W(),:VDRO\3I1AR4Y62E-1,N39>0K$4Y0FZQ<0<06(7AA!V"
M'T64H5#F&A]5U_S(K:SU-M;7Q=T7UK:B=^NB5\PO>F_#J> <=G-(.[":?F$^
M3N$%7-QD*R@+,BV@[)Y74 [3Y+&"/@C57V&&BJI#0R@,++B@%I*BE9L%F=;2
MQ8WD1G?5N_'Q!@)C'W&0TP\N*68YQZGV"^@B6J&[=:&[G%_H2'R:J>0!U<\2
MENH$6E.B3>71#)^**N?=:H5H0::U-+V!$-7C#F?IK2G7VU*C3X@[R#_D14:1
M4.(*PG@G=N6SX[A+5AF?';;000I?.-$+^:S3SLERLVRNK;;"N2#36OHYOW!:
MX+29\:]&H*]MS^E^656X@!VZ3TWCT(EF=;K-<-@-4.@&_/];96&^JI.G;=7)
MWZ\Z>?J/JSIIBS3NHA/A#5H1'E.7<V X$J_2(,YGAXB[10Y(?RC%C[ )M/1)
MF-^UQ"N T3LT& @J$)Z'2'\^-B\L(_VQ]D $@T$4(YTB(P4"YQ["2_L,<P#@
M&-?M4[UJ@, )[J"&'I;O$.SR*TVG3C61/X@K82!_?B$&61A:__;"(*/.G58Y
M[3!+\YR%P#=7T!8TM 58OB =O+QZ3?W/0MWJJPOZH>G5[@.[A%1;7*J*87AI
MZP^9P-%NSFX30S8/L/8MR)AEOTB^M@]R# 4G\SS(*S\(?TC"B7[,LK6Z.@'_
M0G!'<6B#K/X*!(W5*^5)D'YG*B2ZZ06[S@A%>:%P[O+5(?6*!C&#7H=#IRD$
M_U7NTG02Q,+^BWI"YIE1X55>S55,J>SVOM%5+T3F 5\F@,UXCF,NQO8H>\$X
MDL]^(<Q/BD0RPY6C?^G&H1D5(_O6X/@GN,$\!.%)+]3_A)<@&Q!8[Q>:UUC]
MR.R7+X3Z <$5]$S4(2]@TZ4C^5(8$/TW15-92,S/+Z1[BOP><LO8-U5_U3?K
M/PGSY+I;5-^'X-)^R3A+!Y0(=>^AW^TK:>^^X)W,]ZD?]<()<T/MNE;?P(R,
M:3;U0)5)>75^(_8&J6I]J:4FT=#L"^LBN:.8C%@,02V_X H??AL@TGS[>C1X
MP:;EJO<443%2P.2=W:(_#"<L=1&T;'QA"8LMP[2-2%BAS"P5-JL='%VXPRVB
MP'$89B3#Z!.:?^'%+^2@I-Y/QU0+#U4&P+:,8U1%,/E$3B@<1CVD6<+,XI,T
M$VDV#!)6&G(^H&$R*:ET)/"27/UP.=WOI"3E?T6@KA.Y[Q5-[3 +1O(Q\C:@
MT\!?H=M2FGV7FDT>B-(8"K,<M0+R^D9X CFY*,J#6G^+HW  NVP02E7#XY2/
MQUUV'IG?]%OL,3%5&W2^AR\/"Y)8\Y5'.%"/]_@[22L:6MJ;(VDR'8,]RSN)
M!FA*FN(IU3,!_3H4_<R$G0@#.U$3QG"E!D35#\8^J?GX!PVO_A/I%N30Y.;-
MN*)2-9=2O!/"_AD+T2;2(K _M?O=X6!'$!=59DHGH,MV3HY%GL3UC6_^!D26
M'A #TU@R= *9R5<5H@DF!&<!8LX\:4TP6-$ R^PH;IB<!8H:OTS=8FD-TA"*
M5@PT+M\'Q3=J800<WR]4*QL\0'OR U"C BD%6.GE#$L;8RY_9=GM7?$L:X]D
MJL1JQCE\<1W\&U6T,G+?5A/$W1QT48&QLF2%(F<6Y;/NDZN?C>'[A8\OH*R.
M;@"6DE*AK6W3::.TH$I;X,U@_FF[H FNUY?FX1#WQXIWPH,3CNS2\'3(*Q@&
M48*M!UC7#4C7H4Y-HA K> =1(F\&$FB22-*!ICI3ZV1<@1_ J!@-(EA[ 60?
M/41XM65W]\:?ZMZ@<S>UB9H5QYH"I+S(@"H<KX7>5"3SJ >5XR(/%%83/557
M;&DK:6QG!=C<I-/(X-47:BGGB^2^2/3&Z@MI0*;:G7"4HE^BSB'D*JDJDN$X
M',H_<$DTT[[A?*!@.ICD*;01;\.U"S*MI=X-.AN?@"D6$7/],7KCM7"+ID[U
M=IMZ%>%_MA2T9+*+,JVE?G]^H3GMG,S(8;(" \](1PZPH+\Y*;3=RLN"3&LI
MO$&K!,P0"LP0S@!SR?]WP:T;KYGG?M:*S8),:VEP@VX()#:09)[-T*ND)O#&
MT@&3;A?Z#FX7XZ8*MF;A>MX*UX),:VEX Z+^4TV23XHI_]MV3TNB/^^T?A,U
M7?0?_F1B?<7K<.,3$I'_?A+=%G7=O9CK0]WQP;)WXZ8Z*^(#XT-,::AI?P/Q
MH82YPN7Y48<X,2Q9/M#:@I/L<\M0A;2BCMTU?;*]D5PB?*,N) 6^W88NF*46
M/!C)ZH?@MD]"RZ$OA=#RHJM;_N1XP$63:H.[%>_45-N:J+>HX<K2[:FLG]UV
M.%Y6Q/ N/7*?^KOET'FAEX44GD".+0K,X5(%NM6XB^@QS:Z$2^E%>M>\(W#F
MJMC'=O:.2L=Z-XS3"^LCYQHB!'F7@7R=G'EN0X=46XC;[>#D$+7AB]5[=-,F
MZOU>/ZOV=%F0:2UUY]!/N[2AX3R2PB _L])3]1NTCLR.$@O-F]-*<OFEO>:J
ME#A6F12HM(+]:[0,O&,LU9V66;7/ZK2+7PGR&[VHX'T8Q+?@?Z:/&/$,<H=F
MP43G>0DXO[:E"WTL+JMVCRS(M*2U?(,S7'24/.I=XAZ1);L=&"_=DQ+X:DSB
MDWO Z4;:\@(IA",EK5IMCX)^6"JV]@727[C/FDS'(=!Y_@1BBH;B6MW_2!&0
MXL,A\1B@[N^=64/R/>IW7GJ-7%M-:BKX88H2%1^GCNQ^H?JQ4'S?TA+,DLM9
M/1T'UJ@L*Q<-S#@J+XGMONE6E=60+Q/<:46J$O-"]S(Y%>CN"C7$5O$QCTO:
M6N<1-2:/\AS:M7 %LL4)0K0_JB$M]NA0NN 9G?'RFYP[BX6*L9^.R5V3XC@L
MI.$&0L4LOFZ#6P*ZN+RAVB0H*5D@$66S;PQM@N4 +4D2<D6)(1EZYD1]C59S
MZ2) XP'O#R02^3.6I Q?*V>%TPIB5O^ L,,<#K57D&*6$=_QW1 "W#N(YW4A
MS1LMI/GO0YHW6DCS[Y;WQ0(1/#QCI7\C8V4W5.3N<,!<;;$,BCAF&QNT?G@)
M$6S;AP:&<L>:L?KV.F$+Z_R8I&(4?)</E^XV-*#I.X,B0R'E0Q+ @'@^HQ7"
M3KW5E-HW?"(YOU#1D1!F6:/VE-F@3T[Y5[01P!8JB',6_ L-;[ =B20$U%Q
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MMA_O#!07VP'!<&A>C/@(SM4[-/D7(Z+18C ;C^TLP5 "+)KLJ;[1RD*LZNC
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MK"YH&FX#<V#%B/HL>)XT]'J*$<$ O\V<^N53AX)8ADP@*Z#J' X6>5I(WZ&
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M!1#0N>S90XB+.M];6-^;C[0]*C2?53<JST[LH^L3<J]L0H)2U?%H;+*A3.2
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M'U*44[Y6*UD;&UI=+0* B)HBHFX&Z9,)>=A\VKD!K]V(S@ (TV5&3>N?JZL
MV=2!(I& >W3&!!G;':<9+5EVRN7B S[%_KNOC&]ZD'S7,$RPY:;S%'E1:0S*
M_G1?9H]*\)-)2T,C=.*H,\H>@LRY//IN2V%1&%Q>KG]0R07\K1K:OZO<R]PJ
M9;Z,S-,V(W,+&9FG_[B,S WVQV*<X>[8T76\5;Z&[G\ZX['TQZ)+\?*_GW1O
MJWCHMWX/.2GU26YM0C,_RYU,86?OY,,!M(3^L">.]KW.^[W#7?E_'W[YI!9N
MY1[ QS_:7^CA_Z8OL'#K5-KC!X<[1R?'1R>=#P='APLM  L]^%9__.[AM_KC
M>NOT]NCXX% \%*6QZ/ONV(+M*[[H]0U59+N8<WI%,1.Q8W&8OH/24XH58: '
M_K$;QH"=6M!9/CQVZHIF\):LZ@+K:W)9 >0X':):)H_EV&=X&5$2E6* \%-W
MZIU'V<1DG5A4/.OA8I:H^ ]IO1^>!.T>[9V*UWLG>R^_>&2G?OGC(<WO@69>
M]@].3C_\(3Y@B1PP$T.5A*K&UYDUV(;,368E*,SNS\(\C;D>&-NU]XN8 8Y0
M@N?@& /D04ISJ)W632Y4 MZT!H77'"0.%3BDV$>ZU!OSU(Z6.@LR*+_0/3>4
MKN+L2R\.J"@-TL)\L>C80\#:0>Z!2C?AI!42PV[?4K<*U!86T^[.2TK-((%W
M)>G3).4C(JLW'Q63,W.VSM1\H-P[KW!I.2D9K)X?8=*9JA/S.]I_#S7]^=MF
M=;)W>O3NT]ZN3]L0<9M1ED\\J/C!4+P4M@YD"Z18[D-&24,R3D(LX>G/W#EU
MLMH-F4,9^?[DX1SIS240:Q3T?X$D/4Q!>O8;IX6:</_HX\F'UW]@Y]%)"IQ*
M7.KJ]/HC6GY"(I;%P[2]=@L>B# *"K@O4N],6G<96WPY I>FCP?1>2CDX&,#
MBT82EK.TR!%/OOYLTU]=?2K_;W59([.P60.-P[VZ=-TXR)CZ7M[Q7RNK:XCE
M]K',@O1W.A ! $_RW! 8]+WC+.2FT=S!$4=6/P4/IN"I*?!X5Z\U#F&/PZL9
M!R7U:1 K?#P]0"%\D);2Z=[.T>'N'UI':\2KC5ZTCFGN-5<UH+"K5) DA=R7
M)6NK;&&@%>'T P%.!&E;B9[<GRRW +/U":>9I!-NJ%B&EW" (??6U];PKG5#
MYU7CB<UTVJ6A*!C S,.'RTSY1D79!+E+<R ?" AEM!3/TPD!8@;!>9JI=VJ+
MIH5P+<BT/KP^.+%VAQ< %*#!"E92K#V$!CQ4(R==-5SFS1MY:@5K0:9EC!F4
M+&E[E&S=SCQ>I 9=85NH4#<"U3!W8!TP"KGI54++J%:*4B8!4T@5!J=46,_5
M4  [PZZ-2#"8I@EI1.C?)(4;2E, B$>"SFT=V2-LI?3^1X8.#L7G@P^'>Z>G
MWF<(@!WM^W1POTW'V/[-"!\4$6,M7/\6))D,S? R[ &!DC0^>]^3]$):!4,V
M#*0HTX$+=LC.610.O/THD2H6>B$<#>1S%0/B__T__VM[Z]GVB_^''77EF]X4
M2>BMKZYO_GT!K$.M70/U<]<R9_" -OZOC ^<>[8._*\1)O@O +E96,#K/O]?
M#(XSF,#KCZP&;WB':SSIFZ'*6<.O__[7^@T6M#QL$I';SWW 8.W\AST31$#>
MDR^FUOG.%]AZT7V:_R^1V'LHI2^G?\P::@FQW"TCEN_35/X[^L^3_ G.X$3:
M1^ ?=U:\TR2$R#GTPKVGFT]K]TT 6R^2()J1RX$C_OMN7[.Q>:L+Q%*"PS62
M<D^E9+$DXU9# %"Q.%-+W:?1HD&, ZP8Q;6"Q040+4KEE\"[;M08<N.%:F_P
M![R+HT0OJ-I9/KJM%K*KA5[>K%KH'U<L="W1OYWRN9O4P42CH9=GO7__:YRE
ME]/_65U=6_DV'O[+"^+)O_^E992__//5U?'EOY[<V4Y=S J@6]64O[>6Z49Z
M<_,?I1@=)5CV<A^6ZFIWU2TYK&4=NWX-'?O;YS^?$MBRC*=W03YI=<(LG7#?
MMJUM?\C_S[7L)LJ,N^Q?OO .=O$__F?U^?/_B8-N&.?XJ?&6\,UT_]NWO>/A
MM\Z?)TGOPY/G1_'[M;?1J\T\&/UYN?YE]_W1RX^;^Z<;CS[N/=D=G*ZNO?_6
MB2_/S\/M_OJ;?GSVZ:^O[SZ_/.\].YGL'/SYZ=&749R].W_T=/<@^3-Y\U?X
MYS2*NZ??/^Z/CW>ZH_<;^_NO@J*8_G52O)>//MP(WC[Z>?;7HV'<W[G(^J-/
MTTGWR_[%0 [I[5]GW\8;V\._^AO3C]_/NC_&YWN#T?FKZ=9Q_"I:VSWY\7+]
MY9/.^_6X^VQP<7@0'0Y/PR>CO</HX[/1Y/V37O3ER\67C\?CW4<GT]Z7=^/.
M_H^H\^]_F]E?N6 O_P?[ U$>VEJTG_N?BNUB72[:8./MHXN-Y'C_S[6#[$/P
M*/_8R2:3-Q^_O=L_7/VYM;'9V3F_^!RLI^'GDT?C+\_6+T;?+\*USJMHLG,Z
M.A\\&3SK'7WN_YCTCX.X^_/[J]-L8WNT?['[\:CW[N>;T5[GR\:?7SY%WU[^
M>;+]<VMM^&9C-WG]9K+_\OC5DT_Y]\OQF^GWUP?%UF2OGW7/#_;[X9=)U-DZ
M7I_TDMV_C@_^ROZ*)IN[Q=KS9_F@N-Q_>12FWW9Z7WLO]W:R_MMW9R>O+[8_
M! <7/[^FER?3\^3K^X.UT^!T^]7.R;>GT_75)W]^>SD^+-[L9=O1[J?S+]UL
MZ]G9>J]('[UY]C%[\[7W+I+__>KLS_6]9^G7GVE\].C1S\G:UO>O[YY]/GF^
M_?7UT<GAY>!]O/?Z4?_ICU?#;]$X.SR9G*XGK[]\V$C&O?'3IQL;IX>/SK,W
MX<OPR=-X]<=E_\]HZZ\G_6>;@P]_?C[[-!UVBO'NVR_?XFCU<O37R9-WS^*O
MD\M'7TZ3SP?CX?#U_L7VM/-M8W>P]^/KUI?=/W_\B$ZCI+L5;7_MK7\\W)J.
M7_X91>O?GET>?O@TZ/1'X8^WVV_>7$X^%5_?/IULO0]7\_V3_H=7/T>]]Q^.
M.T?AX<[@<B];>_?GU[W19'?X:??E1=I]U_GV?3U\_?+B[9?N\* 7OA[^V/EQ
M/.H,/P>OIC^??GMU^?+D65K\.?I\,IYLO5D]^Y9]/=AY/GW2[S\:Y\%9&#_O
M[;^+?KPZ+7:+\_[EP>#\8^=3YS*_?/=U[?U9?'+\8W\M>#M\?KQUN%GTONU.
M]U^O7K[>>?4IEM=^_QZOKGU-=X?YY_Z34(KS^L7^M^G6Y/-XM'6X_N3=M^T_
MGV_L%DDF=^4[J6[^*@ZVO^U>?IR\WEV/DO?O/WQ[LSY^]'WX;"W_O+Y_\.KE
MT^'7O7?'WP;ODI\_+@Y/\^'%ZU[Z*,WC[,/[]UN;7X+1C\.M9R>][CA_]/S=
M>O?P27?\-'^5=(^.=YY_V?GZ=7-U>V.R??%J]'SKZ]JC]UGX/HB//NV]_?HC
M+SX>[%UN3Y]&0?1^^]6WXM'V\&PR_NO]R[^*[#A]FD\NGNW^V'S6?1Z<YN^G
MX?,G)_W>VSS9[[P\/'_:V^L<;L9G7[[NC+8N-O<Z?WW_\?[\[??.SL5.O''0
M^7SQ_5-G^^V?/WJ[T?#=T>>=SY.CY,TXB7(I=;NOGX:KFSLGKT>[._M/CI]O
M!H-N]C-[_O5XV%_?VAC^#(+P]<GE]F':WWKT[,NWM_O=IR?CG>S'WM?-+].O
MDZ/L8'-KXZ2_<;+]^>QY]/Y9?O1A^&38&;_Z_N@#:0%0_$F:'!8CJ<9[_ZG^
MNYOVIW#=V604_^?_ U!+ P04    " #"B[1:TFN!];9W  !%KP  $@   &9O
M<FUD968Q-&%?,# Q+FIP9^R\!5@>6;8N7$B0X,&=X.XDN 8+\@$AN 0+[NX6
M(+A#(+@[(;B[![<$=POVH1_^DSZ=GIZY,_?OGG/.7)OB63R[J%5[U]JUU]KO
MDN+^Z_TR@/Y20EH"@(*" MX\_ #W<X 8@  '!P_W" $>'AX1$>$Q,A8*,A(2
M,OX33#0L8@)2$F("(B(R2F8:,G)&"B(BVN=TC*QLG)R<I#0\ MSL_,P<G.P_
M.H%"0$1$1D+&0T'!8W]*])3]3Q_W;0 & K0EC!0,%#D C0$%@P%UWP60 @#4
M(ZA?#N#7 PH:!O81'#P"XF.D!X9J=  :"@8&&A;FT2-8V(>KG@_7 5B,1T^>
MLHG 82KJP9/;8K'[1F<B4(A6M&,KC1U1<NC;^2$^QL'%PR>@HJ:AI:/GY'KV
MG)N'5^R%N(2DE/3+5\JO5535U#4,#(W>&IN8FMD[.#HYN[BZ^;\+" QZ'QP2
M$QL7GY#X(2DY*SLG-R^_H+#H<V55=4UM77U#1V=7=T]O7__ ^,3DU/3,UV^S
M*ZMKZQN;6]L[N^#CD].S\PO(Y=4/N:  &*B?Q]^5"^-!+FA86!A8^!]R04$[
M_V# @'WTE WNB8@BO)XM)CF[+P*6:'1F13LB!8?2$;:^W=AC'$K.%2KP#]%^
MD>R/">;W3TGVFV!_D6L60(:!>GAY,!B $' A8VY",OO,)*I"09JB5.9<QOMR
M-3T>)QV\A7:=E9>!X-5O?0_POSK.WDNX!TZZA>B30X"@GVW!7R\6%OQ?S^AG
MP^ZF "MD6'L/I-%=*OXZ3U+$:D]*$(BE.!G?]S[>!55D(-S][9UQ[ GT>(:.
M^+E_</A\25ODS_U8]A+'+X2C7_O2@L@P9M/4H*'(,"<6?<BOJ5IOP*"!R,^:
M]\ (UDV1&2TTZ:_M@E^OY67Y//T#;+GSSRW[1K04$'C:X8E-H%G^0"^BVSG0
M;9A?D_''4/'C/.4 R5]G@?3765'.G61>;6,I,W4+^WOS*@8M!?N$]V0\JL\'
M6EM8@.>[,,9MS-*=2_Z&Y#>F>V KQ.LU\]E<H\W<]S0Z$5A#HK_7APS]FBV,
M8%["'Q+Q#\Y$7D'R)FR=C%,R5VJ[8=@GY#9',D=.(/UO7K6<."#VM_).^OHC
M%\*ZA0"A?VP1%0]ZFL+TQ2R($$JD&?JN UGW@,L5FAO@_*O\RI[_,1]*Q0P%
M1D_CPOQ01;!R?-CE'_V/0Q<-=-*W11K(IKE89KKFQY,'PZFOORG*GD\&K/^F
M,_D8%WV?$<J"J*(#=@X@PVTKCV[[.SE#-IP*/C*J"$D5%.[?W/!*41C];U\,
M%Q84VO^5;-C,EADRIOCZPNW2L(_I-5LA)Q]O)\2!GP:PP%)H;9CT0EQ.^!&6
MXI\C/<B7Z.54>WC2;?:3>P"*J_[U84G&9 DS8UFL9W.7)5%H#'O.FP=%.;:D
MD&C0YM^MT=!*ED].(XGA*_U2?-XOZXJ*+7UUP,T_V2 ZE.W!5C_-V,3S*&#/
M3=BD&F^!0#H8ALF'7:AY)-<M9"<A- >%4?PND.Q:*+'N=JC1-JV9@4_F*"$V
MNU!&O('U0YB@[(S=()[8G &;[K@/MYR[Q,0I*92IQF8,LEM#<W'N:OV)E7;?
M/-$]@&Z1AN*<1CN%&I^3$^J18"]#WTU(Z)2:%'F4!9-@,)M9>209M&>5D49(
M+61L>0[NYVNRJ2VB>%+DY5=5[8G3J56E:0Z1?1^#:&#D)"%)C*\N17;M+TR$
MTAK.M5/U7K0?H8G@: *Y<O;#18^$W=@6_7P$QVPZ2^C9=Q.KT[SD:3EQK@]5
M?8>R? J,H8VNLF<P8<9P#7W\A)F:HE'=)NU/CG21OZQ?MAG84JY/E'E09.E0
M78'>JNG*UV*FL_F>8 $E.42%>/LA0/L1O5;O:B0>U?J8G$VM35 "Y2SIA0>1
MX?(:/DEU/^1"Q>][-T' JG9?H@ZIE%<G <6G&,OVC7X@LC%@LQDD=72>E"DP
M:#J]25UO9!H<_:$1*BQ&>FOR(E_=Q,TKW=S9TAJ.O#%!.A^YNZG'NTF:IAFP
MF4V,+-^+^!3=Q"[0G5L]_/ZQYSW ^6[6NTF,Z):N(3V,7RJY+-<HOY=QPE3Z
M"5[FA(ZM,YWP4'W<W1Z)_TE9(3_*RKHE54"@IO3JEZHRCXJ4M7(RDJ1A^NY[
MX-VIIZ2"^>5RO)6A0DP3[A/QS8)M(@:@\[LPT1PDM M7D*&Y)F1U$#1A8;'<
M7(]KD^" G//91M*V?S\DTW2M5(4P55IVT/NQ*4N!IC17K+K?@ WT@1 [481Y
MPT/?[C+7VOO]U2HQYX]JZY"[BGLR?.IV1I,[FR#NN2CTYR@L7ZH;TX9*QE?5
M=2RC8U#G.4BX>VO-@*T2#X/R3H/B[YCSH;>\@R#UQ%O8N< ZJXKUE*@FPXB>
M&GZ:\N\7LQV:9NA:(\9<Y:GG^1-I4WJQ%.N/(H=S2-!T:(\.??,F#O,3;KXQ
MI=2D&[DC@=BR$M.T+V)/#"(>.?"" JN&GKRBBI$G-$[(TDRB0FA=4/@B&@$/
M>@DLWVAC3^IBK$];A(7;YIA6:%^^])[NWF2-%L*FO!47RX&$K#YJDB-1>Y<\
M\WX1S\I0^_L3O$ZK'@EYWL>G(WL?6?9=N4 TS^V$F5('GR"_B0USV)4S$E^V
M1FW/Z<_MSG]7Y1Y9%?"$FX[EK<JP<L173JA!+4BG;F7$"8A#0\;3J$13[3:G
M0U2&*)N_@!]C":Z&,Q)+5V/^>X)&PZ#7E>.D+67-,XLONSMU;[F&V2:XRDG]
M3Z7V#*HT.39RQQ<-!S86C7A0O\BKW<KI5HU;[%D?EENN,MAZ#%R@U*5V2XRU
M[_3F JZ1P621:N#]W?#':TH)GJ@<UABO)6J=WG;6'#\V$*@GB2=*%E]UJ92<
MJ!:@)D5?U(1XJIAL)@G/4[9;M"KQNLT4Y$4;)L\G=W2)GT8A.<7:;D#UX>W,
M-"M-\=/EFEW%F.'2V=6:XL90U3;$8%;R]/9U-@-V8SOG#3-=[JD4RM4J$Z<+
M[#A5$W,?E&L7+9M1!;=/BUN@F2R+(?DO_20MG_5<*DVIAR+4,JM#"?CNSW$U
MNJ_(42A<<XP@+WI6>2FK8LQ+Q<*>LM,A2TY.+;!(?QJS"$A+M8@2QJMXO5Y)
MDA/;3S,Y"A\O1IG,$M(D5N9:?LZ7^M*2%VS?826L'SN'<GP/M!6%!]3.+K6-
MUD23E E5; H9QD\IWW2FU!*IEK0&.@0SGO%),\&T%_89-4@X\7WU0?S>*S)!
M3)^2!C=J&-(.B]E]CB"+,X0R&?WYZ>YS!FAO F"+ZE/-9)-WO@GNN31<O'G.
M;1X3)^E\DLR;=51"D[6)9NTC-V]CR$S7%5?L\_/7M=&4BE94>M&3":]/B5$9
MW X[W,3WFW-4T;\<OLU]4W?]PL\0OOP0QFIK?FJ(1GSB5.:M/ZA&37&^_VG_
MV^A(E;<\C)[]&:@<+R=*^5^MZ6(1.V$W7L."YS3FOMA]ZJWEBW?'$;@"RT[>
M2):^6*2PI';7U&1!R:+U,PD+W$*LVZB,QULVH&YHENEP$RST/K\.=7VRER&9
MO.@<D"IY5"'Z'*U4Q'DY$DUG'C'OTY:^Q&Y,0TY1N@.O?Q#,;<DH/%T!I+&+
M0[I4R_0"IV9ZFL"H):-"!NY<?ULMDX?(=J94G81N9M^*F:(A;1PD).*IA$;_
MI$4L<GD]=2VZO^RS-_+.<W8S%J8R345?RP.;/9@'>P# 1R#NA)07NJ@,[(Y;
M?^XA;[H;\N1%5/_Z+BP""G\KQ7[:A\?<&M\\ 7/GU:Z=QL+<KH9R;1:A2PB>
M!B>:SS<^7_B3[,X[)C#5S73LB#7G=&+"9SF*>\"8GVV65:Z_1M26/"WIRFU&
M?&4)=D<#N[KQHV',&1/.K#12)37;":P*MX*\-( \]1$-P636(*':SU [+!A3
MJV^LIW22'*?C;(\6)G[TYO4J77HGQ^*0L2U.+6R&<-2'+W;D5O!.\O81$MPC
M6/LT/01^I@U),]6T5;<O%ZFB]\LXSW4K-VK\ZJP7"X>AB,':6CI88YG^L@%,
MH,0\AMRB)+P]U$8U$M>^LP+,MCM23?,"DOY-S1RU==.M&(FO^?292<$*:!1X
MFS[<3+I=;HN9*Z0XLS+NC-;YE.R,^V^G*WFY-UYBQF]EHTY5VA=J;<\.!UYD
MS=Z9G(86)]0]&XA9469]S;^/MWPU [)>7G@\NWCWJ,H44T&$>":5H\\(0&=7
MBTUSFZRYPQFWS*V,?A.].(Q/%I"7M/Z4]!"F+N5.@!8F;N(&M(J0?W1Z<8&3
MB'-URB[UJ1OJE5F'$)O--[Y ;IX\$Q(&,.S(BF:JZ.JXN:6%-*88$2&RK$_4
M2N6P;5\/0^%$$W[&CJJ02=5G^MUP(O<\9_1BSXTPMJ=0Y]TRUBN6)+-,]-RE
M(7EQ7Z8-OAAL),"2W)P)V MC>9&9]4H>6>Y%MPR&^C#IO4%\FL-GW\L/#5K1
MD@SBES%>0:'I?J9A4+U1EDJP^#7X=:R-#;;O/%2;5ZO&&=(M^:!2_>>ZQO?]
M5'$M'J1L4+IXP_#PY6Z!UYT-.KD%2-\;%1GO@;?N2NH1!-3KA<0(5Z/P2&M4
M8$82C*JZ^IFLMPG'D_= MJ:K(8Y>CYA=QO+U*5<E<W.QNHO_Z_'-AA"CSV."
MTU3'HE8?&9$PTN")&5[S8V<RQPLF6QJYJ]=8J3-3VC6BJIHRQ?=:Z"><M"?C
M9(QR+>3$<K)ZIG" J'6$#NH7$O&W-D<XH?K,!+FF,#N?X3I=Q3!G.52W),\R
M\>0O1'D9DZUR4AH(:7P!$X]-4H$??<\JGH<HX:M+DEGIVU[->-HN@U 7Q)'M
MO@E^+0W(0.(/;7DZ1HK\'.HP.4T7P20VIY\J&SNYWX+THO0+TIC;7;,)3'@+
M."%_9;N\A'# 55>^)E%"E^60;Y4]__JK!6FN0QH7+N+1B"HN.UP=@3NBM@24
M95/TSA!S^0KV%+_DRMS2/%-:=+T?NFS85R@XMS=O2,R]E2;VJRV?K8&:POHM
M;0)YT-GP7TT:VM'"#'$B\9PFS74].S?HO'K!RRT]N_6(YJ,?%5LV"7#8SE-P
MR*]9,&]R1UO9A*';;9V?.\GDGO?!&<Y"+\O@A 7PUTD2C#5PS'D6+] PJ#^&
M( N*>0P5YC;]P@OVZ,9&1_Q<74M'F&G+E-G0R:6]#Y\1A 75 _FH.G4F1]-U
M_FQ"?<[T2N<C>@Q.$+4]I7L$JI<"/ QPHA.>Z=W7G.<]DZ-[!93<BK4+DD[1
MF);MR31VD,4^:0A&1Z9]@XH7T77,8+>(L&^951OLU/L$5B1E&<I7^(FB.!;P
M)PD*9>G&=>AN)ROT_P_EJUBVU%H[NO-CB/.)HPOM0),;O%42HQ7HZX4X<$+E
MBBM53%E6(]*$/*67@5MBY\DV-$+IXZ;(;+\)?TU"/3Z\^M8&.B$\3!:V#;VU
M<6UKW;>W( /%C8'A[@D##((C1U6@1&2?FMH OH047=@1@M#[L\+UJ;U84"#D
MI6&@9Q8IDPP^XC86JG0&TJ2*#"163L;AHT<9'A^VE'HR:Q"JNO# /C_19/3W
M68\94VNB+W-S@]*BI$SIA#5!.RGV(<!X5@@M\#_2".]!#!=HK[)0(_3!&6&^
M,UFZ=!O%Y:3-"@%H2ZXMS7H.CMU-C!A'PRKCGZ*BHDYOV[BMY6)\=S-L\)Y;
M;0Z1T=YD(R=N_T#TQJ!PA$@!+@ [E;HYM]L<>W!1XFG<DS H?K0F*1@RU,N=
MQ=RF*0L'2(SFQW<O8N/X:R380<0^A^,^S(K*$I7YA%U5N+9)Z83"/+#141P3
ME/9A6]AN/H]IL_X74LDWQP\&4[$@J?QD65^&7GRC( J&NO.1>Z#,A[.@9&3_
MEF.DY=V\SS0]P7*<!;,='"HK"-8VV02,$AS\\6+U==0+RR],FP<4-H1LZ8TC
MXSY<)@6,AV2M51&[WRZZUOS]>(G01;9%8/7S,Z!#:'\A!*M[8&W8^D(.2_L>
MZ$U9.DBF!:KN@4AN[P5L+C'3>X#$YAYHH#<#?KP=A@]5GUM"==-6QP<TN;'Z
MK,C-P[H=UHW4X?GDY67>..-Q38P)$U7'X29[Y3)X!JJM3N*3'VMX<XT&Z!\G
M;L$0"FN=G0XIQ';.-AUM%XV^*,V,&KN[",UZ'(9VX%<$$NB[FK$5!^QL=]QR
M6ZIFMZM4$XRCN#(^0(<H8LL?O-L4](ST4'92P06KJVMV6U#&2M6C>GD6\QA:
MKG#<+G'XN:U5.V$IP)/"A1=]T]9:DK0D&E^29.]'2P9\DRY8!'K0N \G.!<8
M.MT" M+2LQNR-=5UD,JK#Z^7#0/F)HE[23Y@?WO0-G:I0=]@8K;;>7M0EL_3
M8\([+ZI;H8[(IZU;J[H3-_0_ C:_MFE_7LS[9QA;K,'._ER'C[^?F">:'']%
M6F%M#FZWTJ6@*+!:3"K/+4HKSM,TYWT]G.KR<?^ @JWN7*"W[KLJXG$E?=SE
MZ!Q^YF0)67-54XR,ZZ@TH1\/K*%3,8F8]TA7:SY$-?&&??+ @Z_,C 1Z:NFB
M9GA<K='!@3]*,'N3](CEY9F94GAJR+OZ^&$9J>KZ(,5D/L[)IQ/HTEMSVK!D
M4E)DXI-1=M^VK&5?FVL+*6B:Y%T3K]Y^5([9;IN#X;=N@FY:H[#A7FMVFE1.
ML#DRY4V-7Y@"5]<E66>G,#[N;R _K!<S7(-UI.#FXL<A2$@Y9R?4; RHJ3#'
M0>A/L'B*RNZUTDYTTK;:2$ +XSONP5.DME,SRUE(Y] 2L5,6GSB(\*P"IF4E
MO*XW<T>[-VKI!,RR<X?](U3R:QO+%>4>$'IRE[[R(Z9R^?-$\M^L_V;]U[%"
MUNA2^@[3#PU"/+$ 5:Y"M86A5=J-BNKD61L#XQ;I"JQH_Q.*?##1$W@B8Q[L
M\0>3F%:89Y9XE98S]NU=A-I3*4-75>0Q*=TH'JC/C^C&SYY-][2>BVP& ]>D
MR<^Q,#YO.2\L) P+P&O-J(H#;[=5.-1,6[1[EGBE#9.FY$43[>9$#L-6JPK^
MLFT\;7PPV#RM"YR*S@_VVMZ[P20#>N*.?^4><%">0LF_<>V\VRXL^#L;\3\D
MF"$O1A>OC5)+#\T<Z.2\J/:O!1M9\$(1:$*BYI^/6M\S-2FNS,FIS &RK4VR
M]T"Q[47B$5?)=DS/6%]FM*^*$CN"0'&?!__AT=RJ[!U1:LAV<J-K@E7O._LV
M_(==!G0#.QVZ&-Z0C7OP\A9_#TM1_*W%PR_@?T<2^SFE68=W_)L/,SHF_.C7
M&2TB!$%.@F['7BE B6/]<=)R[DI'O <Z7J^XXBQXKQJ\E3TOX4T@5A5<.X-N
M)*#+-W:@$Y=63_'N],;Q[E!=<5E<:5TU,'F!:^9V0$P()BTS_U1..C/60G#S
MTK\+G4X;3<V:&:QL2Y@F?0]\"[I!4"VG*(DNSH:3 (IAHD0.7W--6?3ETUBI
M-A"+8RD3_.G \;^ T!=^(H^?ZU@!ZB_ (_#G2I[\TQ [?+4<31.2W5GK]KH'
M/KD^O.\>4%D[J%WVEITA/4KO>OY$?<'EE<J 6;(87D?%P_HFC4 C%648-Q\0
MI#:M%22<*>%WS\D\85K0;PEWXR6!$E(\3H>@F**HTL7=S@RWYK@U8[^2F2RM
M#F>>4ZRT.;_ "$:_)NF==RAV3"KX)SR"/RV>R%DHY=0K.?98N[:CHI>%N]B1
MPE+K:&:>><4&GOQ1FEHY,3WL?>RH'&%A9_CPT=WZ,L1?O.B&D[#762@++K*$
M\V;5P.%K=1ZT,'C\=FQ#E,\KQ;P+S#7B ^:I:645Q*M!!YT.L"3:P]S[;6<9
M*)?E^TP'^_O4=2_JZAF?AJ7IPM"0BBAJ?N>UG/_<^VA=?HS.> O&A)L2LQVX
M(%)A6HPMZE]ED!-&,J6XEJ*Q>7/40:%76\9;P>],\:F@:H'<A(O6$$.'F+=C
M6HTB9,-@?B[DI@B>$FA6NW(?A9<Q\C0OU*":BML1:-RR>&_WX ,(H9N5:)PG
M<6(.)[[4\Y7IIYY^#"RGK,'GFWT9M<J9J+IVE_E(^"$_[?SU"R.M?6/GA?9M
M7/S3(15_^11)Q[<UR9'G8IJ\_=8<9;<;=1A$6YE6^<1LPH2E93N%%K5H]C7/
M]$,;GCUZC\^M90A>PG;#SZX+H Z8EEH08RCL>^.&H25^D%JRT"1_#\S:SO8R
M?* )ZSWO:Q=&X+ETPFR</.)U+"M_X>=NB3J ]$$_T&1%V67UNDAXFQ;Z]K]R
MY:NR&0G,ZY GHTBXUUE9\7?7X*G41F/%-++UV31%+;CNLD6D59*/6CRM3_-F
M6LA%9CWF0.A$^T -&DS+QX*"\[>U%^C)(-B5::1=5_9SQ19Y"W/A@PU@H_38
MSE!4&Q"_>E6A9G&8WQBJU)1D(!&M;^*'+YH0:;(+PX*RR\U5CQMD4=K2E]!B
MP:HI18D>K!ZW#TN[G@*5LNRXFD-".GX^4&I&]+)1K6^O"WGKL?2EA.L:,7PN
MH"_B70 JE\[X>/E:/T;L//?%";ZH1+N;91^[G>WHXV04_?.+%V.(B?UI=];4
MZMF*;0KK\?!D.-\.PZ8K30@,-"GAYC8D36$0\037VOE.ZF*X^4\4\X-*1.<I
M@UMXM/'1GV21^< B^A^O$4OR)P,=M5-<#'.A@VBU34P&1'O,V)@<V'9%:AAA
M $\/NR== ^@]%](U"H>::TCIQG:UNT!QA?*Z(9'50G1CN3R;-E$:Z?B&'Y[&
MF-.+DB(85FZ#!%C_!-ACD6'WR>CM60_5)0N9U^J5=>CRHU][ENO;N->XAP"=
M/&GZ'KCE7J$%)>]XP1 @:%_Z]IO0X;=[X+'@9/I"[-UM^M$ON=>?)]E_84C^
M%[*7>A.GY>?/JRUT'&N.X$>\8$L3P3LM/E6 C_;@F]P\"@H^O$$IXOM0FU1U
MB0\:1N,F51R9Y')KG8V]_NR]5'F'W7:C>C1Y<25+\G3\.+DF:M&.W7,SC"@:
MXGAS:YYWY!S\!FP<:.DH]8E2[[-+[Y&4X-%=]M>0<8TR UKW\NB;\,AJF@O#
M>Z#5^(;V6LG;"71][OW@"U5R/?WM["\<OSA.?Y??Y]_L_V;_'7MV\MTLWI?8
MB@BVJ50I&#"7V:<F@WN O'MF2NCTZ6N$$VD*WLIU_T1#S;NE\=:M*]+KW<C]
M6X8[[\Q[H*6XGU6 MNVT[+!(LG[M'C #7:JNNBV=W\6FW-80W0/-*OJMM6EL
ME(SC$@OX6%'>!. FM)=G+ CW0%^YT:GU+<(T5P&];8.Q"B8A_8FMV2Q!JQGH
MH/\>\!J!*)[GW.VE7^S= P%RXG9IT6@_E0C+LU"HD>;V6N@7!^/VYXGD;TKV
MP\/XC1FRH<Y1Q=I[$1>Y!?HE+-3/%4]0-[%2DV;W#BG8@)21,%!58-BSP3D#
MA9<!N^E57B\%(G(_W@GT2X-+2EJ;=MM^,O!$VI13YZL@!0YR2<97PNU&@4:S
M@]'1$ QA7),?@;9?*? GK!7_-1[I@_0KJE5^]K/NZF>LZ,\0+!DKF8_(LO]B
MDS>(9B6RZY)SBXI?J(QX%/-"W^-("-KI]O&5ZJ<9!C!\1_#J$A+()$1P#NVP
M5'>L;2==E/NFF7YY;^_\K2/Y;,,"\6OL+@]6L*9+;*?^(OC]%.<Q6;W*=2\1
M VD9JV=[V6)N,1][-A65PP-<)_?[)Q[U#]/O5YAF=< :Z24.<TOA/9#Y>#RQ
MIUF6C;0],9N_)82VW/"2M5SI*/(FY%Q7XAX8#7>U=$M\Y[VN^OGJ^=T[\UC<
M(Y97$X-"(;<H#;1931/;?S5(_9",7$,C&!934X.I*3K.>A\VQ6_,[[E$'_Q0
M=!1'%$=:]=B#1TG9@CIIU)!L:$)>YTJB;GRBGK"VA1RZL89Q7!S#L]9BGC>^
M5Y;=VCK)/,V=VW \*1K91)Y!9O2)79JF-M=L[%\"OW_#J>N"S(&@H'3T4@]M
MD_#;^(+:V *);)_>PAO;.G?_[SJUR&/S(D2C=2XY"MN[=G@84>+&D""Q&C")
MOW.N=N3"\ >4",6&8C0;&W-_R*LRK5FN0[]J_UJ%\:_OG4E;<=S0M PQ]B1S
M36ZWEXK8=-9+Q^Z,\\?$L9,^_7?";Q7<,.]UM8:K_+MW#$Z_7Q8:2I"9PD *
M"/NI<>+#4^RE4V/OZF#< ]$Z@]M+5QCE3'^U+NST[Q[MNKD:@W4S:\6Q5),]
M_^NR!O\$N5IW"Y!_EVK]!%Z,J&O\Y*B92]I+*@RJI0)5G)<K%9259C97)4^O
MLE%R/)7&:&"/]J//9N"+YCYAP':0TYG1&;-TE'FV\*A+K[<H;?G:/QKR^NJ8
M!49K:!E$I ,AOY-XIBK_=B+7ZUV:/QB&]/5%N7:68B6"3))YG:(X-E7 ?Y=_
MJ>?2>R<>6E[DO2U::X[4(W3,J.WYZAX0Q<YE"7?[H"_DSR+AZHFEJ--_K*>3
MNT)ZB;W7$OZ@T03'L[\W^#/4+,LZ^?D)WMA7A Z*XJ[YH_^E3JV* ^]"RD6E
MIN1F]).8M\=S@U32R)D5?A(\)/> QEB9SO#B.8J3J87%P7ZI<M_,L^.!/+J4
ML,+06#_I?G[4>OP,E#DF^0D%]M*F,!URV/?@S^SKAH:L\+ .7&HNH2\%C:\4
MH+!J7K*B0LV^)/*XB1+4.A9_:SJNHRDUKOM5OB$BGSWG@R$#00 W4J 0/=3D
M<LPBI*3?@5C'Q('JFDQB#,'ZK/A'D)Z%'QHK_2/1\H.#IGC;FG<)K<B1TBBY
M\5ZKOUY"#:MGQ;=_+5>.NM"(.$PUSV94KG; \%'8QX9',#&@C#(O)KY7M3/I
M6M=(0JF4/K.(F&YT4E.:E/O#!EMI[QR[Q?5,/8G# YJ<2AF3Q4=-1>N@E?KF
M_#!]CR_]RSA"@$5O]!W;.4D;*^GP3M8Y0C:%?&0UJ'C@R#Y,.;C4]%B'J4@+
M+OJC?E2^P;/GEFCA.6LIQES#<SN\N?$+"T>?3Y*O>-I]7F;WO?4<C)%':-_"
MWYI.RH$X*W[Z-%'E2H&"G;I=__QCSXQBK ]'HY,\KP%,N1FP3YN51,[A6R,A
MZP8ULB6,EI5Y;'0/I"<^@ ?5&]K?MZ'-Z$FI=2\OO:\W'C#,;RT?ZO\#;X$)
M@A2NF'(U0W')\;/OSJJ?+!M>?\E.4#SLD:R[*"V'AN0)X;KHS"D\$A^(9-Z
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M8@9AJU4F_U06%8T:$JYGN\*"]=7E0B8L#O7I)(4.3.$:S2[W54"YPL1AZ9F
MX.+5N A5<Y>^U%=GV%>. KQSJA/,#M=]G7/S$@:.YT+332,K>=GV*^GH2Q D
ME:B$@%E-1,+LS'7?,U+6>\!7)1W+8RRR78CF,JU<'$OE;?O_M"(3.ZG4)4CZ
MZ*Q\EDMSVS(6(I:>U+J@V']#6]VU4,NY&UA<:MI G-DP>:A7_<X;*SSL&FHR
M/=<U=Z0K'</E\\I>$TI6G\'P=&N] K;GY:7DJO1YL0:H@\W5B4L(WRQV]R(_
M%N>80M?BC.+K&Y64!$C8;79B6_DENLZ-TE23F,.5MZ^#>EDZ]_/*/ P!\*AW
M6^2*^FQDI[:$Y3-+^^ZKR9F+P:K2)LOKJD&HL#L!K,?G2 R$<KQ33"6E6;6^
M<#C<4?21;2JJ84+K:HT_; /]3K]]3G2XBY 1G?3WMZZOFZMPHA%*5Z6R23O\
ML9FP5$L\ZM 1R'Q$=M'<YFLAFBM+3US<I@\'8WHN_4FK-(D,#[BI0/!'W7HS
MA2Z2=^+N0MG>VQ+UMG(%U)$RS"]?:WA&"MP-0Y*6O2R88[MXS;P'Z=C''UUA
M-A[3[&C,TO0(/#FP_FRN ,K6*>QDZHA)NEJC $,WDWQV+$<V:2%_UUNT,ZH%
M]MFK<[QB7?=R;/^2WA5I'Z,(T5TTT=367&RKG!W!.JIEH)3'!ZW2FQV[EP<0
MY/GSZ;C0=#W'L9[9FT$YKJV1A ?#?Y<+734.]F"AGW.9Z1Q_?Q)9,UL^X/F@
MRM[0@G%VNBMZ^TS@8I)J<3T30?91_I<^.\EQ['T2LHQ.?4++-,D+!::E0Y@@
M92Q%\:=_E73\ER8*]2$UA/@>3(7>)GR]5DQ+#A5Y6R(110*>Q68533+6!3JF
M(%,]8TN'2G\B\+P6)X4>T4H<9C+0>?0"MU>QI7&2K"7".)"V/;F'3VV@T$)/
M<8YIA/*\K6RZ7A=A^RHPGJEWCC&K)CQ:18A%,7F+>P0O-N"&H>C/?>[S!0Q7
M;[RR0*(M<6EH@EX4'^[\1&T9U88W+6>USAIA5I(E3,.<%.6;:90(0GR:3$V:
M]N>#W@2LN$@J>>%]G3AP3H'2"U4)//I.LAF6_!U!]%KPDP53CF]SNT+L53C.
M(B]2B +#Y5%Y!+@S4(O^*THSFI96>X.LJ#_7@.5CXZ8X Y]8*0Y*H()F3+>V
MY=S$*;+ZPB(RXP,1*,A""AKY8FE/&(B$ CTL/$ "\0/S8L;(_F]J8\@]+F:1
M]F.YD?/)6+3LYPVR)[@(YU*-E2L;0V U#?!#!RAC2M 6:5J)F]UGXG?.;2%H
MJV;;JJ5DHUSXTYN#3.^D?2\Y3H58;H_EW-[-$NU09]L;%\PS+>S",E$O%(;Y
M2.#R "GV9UDO1^0"$+7-&TC=O=V-2[ZVH31%+0P8H <(ZA>(RFQQMY%!L\W;
M*TH6[,*H-'Z*+C5DF[U<60NOP& 45L'G^PPGP>K"[U!,EU7BUF@F>KX]T%<1
MKQ_@%+F"K^4#HH&/E:T<5>EG5F$2/;W-3%KXD+>_?KL_9Q_=AM_7UD,O0YAI
M5KE+YT9]_'5N:*.8TA+?MHHH3O]E2@S/][!IG8^K[HV#'Y:]*Q&-:Q+TGO1<
MER8A#$AQG! ]M[!#,:,.I6H>EWNTU[V>:M28(/I\H"B'W@: R1<6TDB\QI<]
MGI=V=Z;JE#"0EJ%E+22+\J&%B>(AVX+V89WH=J8**,;SV*QWF=:SI,$H8L!A
MW7+AL0! \FZJBL8VB4X*\Y*<]I3O\:3Q.FKK\+E+1B 2^S=K#LP'W>!8UT;D
MQI'!6KRY6KS]2*_J7 ,CN%0#E-3/\8%4LQDIZ5U7HX]"_O+U'"F&RZ#H4175
MF0QD+19?#7,SNB6$YP:$-6ZM]RRA9+'$T[V;ER70\F9?Y8Z6G;UBB_D>$"=*
M/LD')X8W.>W#OZNJS#/M6EZ:?S#7:? WL)B'&K-H'<3,TVO78EVX[-\U0HF_
M3,1N;&W+:X*% G3I=3$YMNP@&/$LD4WJ:](Z,^T:?',:QN9FN,(V A)>B@]Z
M13 ZYH4^2UB^SX*M.U1JAC*(B'?YYHZ_=EN@>%P_A)M<+3.<(AP.&\,&.(=.
MEQ22VGZ<>I:0HS(]JCZ7@S/:BTS+6M&3J8SVAEZ#MF1(]%.3WH^8Y=+/ B2T
M2QSFN_]Y 9+W7Q4@5?Z# J0D1L413'%.4TH+UKY=!(KY'Y&OK:N+#C14LW'"
M4.Q8Z:9A%1FQ@)&RQ?0$!B3CKD.8VQ[0$]/"KQLY, \V\F&(XAF3XE?N K*I
M7 VC)PM(:_!!U3R/:G(W=W!]5K(;2*F]%_<AOMJG'-WVCX=@"QEEV<O"\##V
MQ W-6]!'/:3QM5_)!1KWP&981GN%\93!60>2D!U]&7)<3D<?(M@2,FBPCF^N
M#,\'DX;SB>]GZ-@NO9HV*:>NA1260)R,JL"U0?DU/&V-M;KQS> 4TK8[[&U>
MTI J(8SNUI>3&77<_6'/B+V*7+&94; )HA/>?\T*H9?Y%P:(2G@<DT:"$V4"
M+*,-'H\S'EO&O'[C^MX@JF[K. -E@"&M&:RD8?8<IV,L)P0O&!,>QB,SWN.3
M8%D]S_*Z4RD*GU+"[N[!\.:CP,W)/##AH80*OA(B<$Z1;P:,E>@^00'MU0SE
M[29<.1^VI9FNJ1(B4(1W(6]A5VOE1[P9-ZZ=0"U%KE7,732HB(!AJ[<,>[8/
M_XGJLPM>!B*G#+'.1-<,J-#<=I?VW/;]E*(^K7,+* %Q^1YP;Y6?FIA!6OZH
MR5V]+[[_=I)<N3:"]G1?%#I&4[+^@Z6^EV&_A6,/F_;4'_](!E:5EK(Z"1%@
M9^WG)A9P5TV"/-[\QB4C]VP>8@>J[&F3LS9EM!\ V@V= )XSBG*N;8WF=96$
MD$I-;2VJSLM'EFO,RJS\Z2*'6J0!:\ER]E*U]1_5$B9 JCAT@O'GCJ"H@B5J
M^3UFX>6W/@+,_T45?ZABJT+O>D-N6"@56&YDF;P]33K+5J;L#[BO5BOYB==F
MIOAA+RK)8E]-A+0[$A+G1@@C>V6?P34_;A+JO;)81 2[FZN\*8LNN3O8Q[+Y
M;,AVTS<OM/RZFD&ZH&^S? BAOM/=NY.X_(81_Q[8)B:]O15:D?S]B=:;IW'L
M4<IA?GPA&J>"Y:"*Y5MGC)NEZ&_>'>WI=[YC]\#2Q!WVM$F#OUF#\O-2O+#^
M]#BB-=B(U@!7%+?(=P^@L/(!#3]T)U$/QLI$6*0]:-.GGRJ87)@*'Z#-J@,9
MTF;5@S ]7AP=!OA+.KM0-Q(S61X=IGL-0B:DF]^MQS3R-FS>R*RUHD%>(TQ:
MQ\T;A)IXN:*MS(&[;?)?08+ 2!L33/? "LG8TIUFGU3TS-<SH2-T^&8'+T*(
MXLHM8O?4^+-"[]0>]XHZXTD6T AU>3Q+<-+)@.[CR\H400KP1>1(XLIWTCTY
MN@C!.;;.3V?P]T P:;@5Q'F%.CA7EL51Q=- @<9>QG' Z@QI"3SD]N,_'K81
M [DYF^<:T'FU"24OQ,.AR0->XP'( )U)5L;DSYI6!J0>T@?X=OL+?&M4TWEP
M"J+U#W?3K]!+Z3S,)SLQ;O#=. 8?5/4<%/OX5_1F_ MZ2_@KY,OF#7TFP%\)
M*1^=RPKYD>6G_5WA;,CJ+%(= =('@V1J/,-H,;HK?QWO,@_B4>N-YQHO8DTN
M_./=#8YA[@ZMVT).->CCDK\FB;(OD(B?MP:WP.,U^/)+YN7?5,E6^7A*#EWZ
M:\/Y@NT[-081F/,\F0^YV;1OL@5]&[Q<RL[K][W;24C [!6355^3]85F>IY)
M"2V+E:\EEYDTCQ'%1';<G7CQ/%&;EEK0QC-D3_$3K-H]EH38KXX@]AD?&;\G
MD8(:^5KV'KBV/T[O4Z[QQCFL,@_X#,[SM==C 56)OLMV?]!V49/UULX"=QF/
ME[W%O\N1T0^'KPJ0=J&[SJID/QJ_4+9.>C"BI.^+%ME^S.?W'_.9E5PMOBO_
M-%]"9>\_GPHOT9:4K)\\P_.X7+E&5J+<SB)=HBB$?>1QA,JS)E!L%@)L,=\0
MZMD^@^35^2 LO'Y1UJZ=JNN%2!&HM8;'4RK )^<N$UI<> ![H4KET:O\-8.V
MPZ>>>]?]HO0Q+5#VJE<.OW)B19OW^/A<LT0C5":]LI\P0%]->FX#UJ#9T=%_
M5<YK4#11UE)<#V=B>.#MA^47@X3LT;U*$D($0-?1Z\U4YD9/:XL&_\72$DM'
MZFP^:5M,*[T-5@&@1X*;KU)[R$X'%_P H;05%P=FYU].LP[Q%X@XOGU+\HH(
M>;_WN[;E'S>4CXC?SNTG,VW4-R:,\LLB@PT<#(BBDT]TX1;F9,JVS\<'5Z7O
MAC\R)1]U)2Q_L$-0/+''[X/G)SB3";M-UJX()M3K( GO?7FBBS*G+;.:RJ!H
MC1+*Y_ANU@/\I1R3T3"QD^@1[.6;-*EM6V&25'%L492W VN*"3UT,C+H@\\F
M/D79*#\7E;2=XX3R"BDV*/BV:],TK<HV+Q'#:0%.">\L&%+5]GYIP(I;<;<A
MP\,# RQ'>8>F<8_P*\#%8Z<X[K-J,(W,)@X:T[*6:-KL/EOC(081*1_OJMA\
MHUJ;I_DV#QW1^NSFM(=W:]:'25']L_F5EDJ%5O.JJY*?H@^-[T4P8 @UGY:Z
M*S[->=&"(^,0:-^FF((9MDR2U,L];"N,6_ [#?PSQ) ("<H7*W*AOIM^(V@9
M@!=9-Q>(4);UZ>8'H&I>NH'YQ=,3"L>;<<JE;N3HN&'PIDEDCG7N'LHD@UGP
MOEKJ"]G^G@AFJJK!3;@ZR[A<??H6!A(DF[YQJ2II;H^]4:+*FM)+'JAQMO;U
MTBU8R-/QIM]\TN/I#[26?H/V"V:8JL?MND7J%"2NKE3Q%%,D]*FIV8*M:'N[
M+82<;K;53;T<<^"T,:Y8-+?G%F[;0@WYN#*"@A-PX/7-C1MG.H?#>"Q2_,YK
MJO_6?Y6FB]DZCX1X+/U.+>]%1,O:(6F7[[YV9* 7D8MSQXIA314NKG_IU##Q
MR?XW[\?+&V'. L.F,BLJ9]P+]P"&U]/;-GZ>;"&O%Q&M5P\@IE?<T0L?HO<P
M6'SZWCU@U4+T\6,&GO]N\:BWD-L^[0]CB_)*>F&W(X2V@//OI-B"'A"4]V\(
MZF<DXA\CJ-N_1E C?R+%YG<P,*-0:^X^:%+VU+J9J  ?M&SF1@LSY)CN[_;B
MY+96N+%NK%PUGK6"+CW/3@@&HLI3JG,C?M03RY56:TU2D1N3O1]]O L%:QCA
M?9@)F:GYC^?]#\3G9F\ES9'0S%UD9U[)KPD"2R1YB;JV&L?= [#S]F<[FE!Q
M*7!*MBDPLY7EI\3/E?K3OKT(NM.0/*Z]!W3J!BW15*MG#")HC5X1^6-ZHXZZ
M;>W,-C^;G;_<0)#?YR,)_>N(P<3T7Z')D5 (;N',CY ! =NNBM+\O*:D(Z:<
M%502#'*&8-5*@3JA@1WS_A=@>7 3)>/*F+OLE93+?EE9J:6S]DXA49YDS-"[
MFF$U4L88(=>4V##C#?QADT^*R&XE,?BP'%H2X,7;=S=#E? 7:LO(4(U$FP]P
M'[7^X$W$TCX:OSD<U E^FQ9)D  ]#Q<2;5,K^_$"_]B'BY?9+N=;R9M5UUWC
M'C1$F#OV@Y1 E:)GZGN/OG:\(Z>M0XP;LM,=Y8""B1)+9D:C&$L1I@4ETD\5
M(6]-D>+Q@8QY&U0).!3 V4&)CDI$SS]",I?IK^I2L(=<ALIQ.N:NN76JP8D7
M&'-M,<4I))1H;2"/,*>RA'HTHGFJXIU7X3I+LLETJ=D)FW QU -89-$^J(04
M--6 J8NCXVB88S$Q\U0(LV#77E>MS3? Z\7TODT:\G16M;OG$]TGIE<5:@D,
M1A4!H4#&>B.TI,CD:F/#'_[B!>$ >W;V==@GNW=T.AEK->8C'H390\:%&A_+
M40<2HP+5S^"F;DY:3?L-YUUY=B(X= )L&O=S=5E[ZQ$6A8)^ #!2'\O]WI L
M/V*0E*%OLM'UTUC/?@S7%S<#4/"'-8@/QD_ K]Z3E_!#]67" %(?(TR?-5G=
MK#ZSUQO]]33I_BVB4[B&$%J8A'$KZ@KS8M>JZP*":P5[X"FWA&YS)Q& M754
M4N]@J6'"B8V#&IZ%/N[W/30%&T_>M4]I?BWE\:%)!JHHH8#HDJZGP\X)YRMI
MLFOZ^!-TK' QC!3##\.NRQB'BE_G%KKS=Z9WS"G'37%%\J4&5BXHC!1B^T&L
M;@ZKC;RT,*&U$XX,#(V-:_G]K*T1CFK8B:R)G@.$-'ADQQ(VGJ;)$@&%ZFJF
M#?RC'(1\*W87'P-[16)[^6KM:_%VM)NQ@%>4875XT1.D"[V<5[30I)6U-S=R
MEY%'V7O[]X 0II?!?WSD]>\__^,_EX!P.EYUJAH.47@.(^)==\XV$'0^6-N0
M"^\CM%N$W]6R;MAU$G>Q(!<1\& 5P\P3G-QR='&86'.EV-[F?7TY!T/$ND7D
M:3[ZG>4.8Y_C6G)_Z>WM^3YDX?C@K-OM6&[/8XBGAZZ0(9MTC^"N=>ATZ4V5
MT'&W()@4!"[7@7@O#^'*C%D>EI:V3A@N-*P<C71BM%-$=M3-GI$B>/=5&-\#
M,+^41*V^SG##][@LJA[O%J!1;IIDMNY<Z"3L(,21?SF(J"3,TDN_8 <_P85=
MT^IL1X W2T=C7F&)'-(EL=2XJ%9(& A0+(413(2*U3TO=W8NZ.<$9W>;D_>$
MZ$OTV/?@;4CJ"!0&=;X\%AA<DK>>58[3"E!0SJ 'M SPWL+/"+T\B70P) CO
MFA4?ZGP9-:\I?R37'!R&;?&$E5T$C\Q]BJ+,C/0KAMGNIP\7>RXWG0UBFQ8D
M_U][7QU7U;:N/1<H+8V"M(N2DNZ61NGN3NF0[I!ND!"0D.XNZ190NKN[D?YP
M'SV;O;?G[G/NM^\]]_=]]X_Y6ZS!6'.,.=YZWA'/U, QR().LMQ5_FQ8,L&W
M;I*M*CB !JYH-1UX2)SHR;Z*N09@YC3L!;Z*GU$LQQI.C1#I-/P2O6(=$XDY
M=PR)"TIYT/ 3Z6D-1L;_]RH'?R_8*A&5]M2OW(;Q3Z:#7NZE$U\RZO,//'O0
M",:WOU"(4_AYKC-\P>[6WSK[]MLYX[[9PWWFE6_41;=A \;UQ]?0']WXY?SQ
MOZ>TZ%(-5N*!&AI#<+=%J\XNDO%:[I_,VB?,"XO9&W_R3U?'=A?DVC\II/M'
MV_JRJ-[TD4891 99GTM?O6M873#_Y.;S\MML/O+?O^(;F)]]33C$_]MYSO^X
ME(NEVX".??5B;"'Y3A ,7J!Z982LDKI^L($VW:D3,D&74H%>BJH2=%_:1+_Z
M&1[3VQA'I\W'%K7%*EXK7*,ZCSK'&L6M.N#8K7D>.=/G?2A%FU):&Q@W*LC9
MDR"3I5\M0+:"KMY4NV^A#I1=W+^:0C6LJ'$N46ZQ#-0/.S-L*T;;(3+'[,<K
MG_G\S^_A$[!!R2=!Q8#1T6SSY<%<Y1I>5J9\5!/=%PF5O/#@>4^IPD-ZL91M
M'P4CK!D)L#F0K'RL$M8^HIGLI-714YOH^/I<(<G^"46"4P*\4_A"60P#!=%K
M7H'4=YE!B'RW(=ANP9WS(;&M_T.AF7D>_79FO%7<[*._ZN#7UY9;Y6[X"GT+
M[JQ^A_-_U0W;[[J1-G]K/)0WP)S;.4HA=:'4WBVL?>BVQ_W;%9VH__CHEY;]
M;9.!#3^6D'Z=@_B'2TC7WY>0=IS!>;V4\A.F=2@,=G-7*77O=<_\"<.=LM8D
M"L6CN[X!Q/7EY#97/R,!K><+PCL$=34!P$E%YPZ<Z&.%,6&6()M[7IX2\R(&
M"X8%E(741-X@\U(H6/[LIY;1<II0*D0(3J'*MZB:.2OOBEW:18S?3U),7HDX
MJ,B]JM-\9V=]R#8'?R^";<<CS]*9NBTEL \;'OV0O@&7Z<* 0]N=>:W UEG:
MP,LVWZN'P;*+N%7=$$]1B*P1?X%5)B2N0TJE8A1E>J+%&O:3S)-.OR&4<![4
MWV_#_&\]+ZG OF#Z3':HT,9N8&>B-Z7J=<P<^<<VVJ*+_!;=,,[2^+6<D#+1
MM4IO[")^(:C^;PM>UAP&FVV P@##E7RWB(K4R*24// D0390:\>JWD2YR@U.
MXVO!PJ'ITH1+7Q(V9HPNLV4!"]6R'A)G5<'"O[#_#J+\\DN3#H6(1<Q<P1<*
MG/LZC5?"A1Q[[5ZO,^Q#1408H@:IP2%2K^W,^?VDV"V;5TDC\$EOT53#&YML
MQF#"_/Q516II_GA8I=?DG4%85NQ!(29/6D3W&4]J]5P68,O*/%N<GF.\L=(-
MCRI8H?H,2$".N+-U_U7,A'>AQ_)=V[J3Z&U\3_2$FF]57^D&:+P!CL#J:K\Q
MKCNI'C/9/T[U_L7<LM844JAZZ)5-]@<3*=-7US;2>1H-TCC+S 8[2=<IBS-5
M\;^9Y?O5HM&AO=Z$=JE\0; 4HN/9$ZC@7<&YW$Y.P!OK?6DPCVT?Y"LO_%PX
M@H@);F0_C0QL(2GQZ;7U$5Y<[B@7T6 ^M6YE]!*JH$6CX,OG-P"L?O0-P$E\
M S3HU[U6C["S$FJPH9<8.*:B'N"D&UC#!%<XJWZJ[8_O/9@S2,'JW W?%3-]
MK_H\C3$H>?P40?<0OM^LCTBGA]USJIACE4.F89YRH&$UO>%T:SCP&;*BQC15
M'>**X#UW28\VN'J2K73/M;[ YA(E_H?-QT\<".Q)#?P(O6BUNT'8PI1C.$'X
MQK-E%2%]??"*I<LMC]OC-MUIN*-?"KRB^3>=<6FL&C&##M 9Q-C.7Y3,-&TB
M+/!"="X=7.X 9Y]L?CMEP)EE[[DI6A^!G6!(] !>!";@>17N1@ ^.+BM@ZLC
M7WV0$3XPL+:'HC--+$':NXP_2L\R3- !%^:2#%*\N$X)W?JKF%R B7=E\'8B
M0V&M,8(MNP,W[TB%";A-FA?)QY:5VO3C()Q**0/[B3G@YE0YXLY:Z%<YPBRC
MUF$$%8E-)*R49W-&%><KW&,."28X6K-66W98]3![13"ZNQV7=W_IB] 3SH+4
M491H[>WEE%<8!#O:T*>EZG[_+<?G?WZ2 ?_6&A1N&W3_%FLHD&YC#<5M/QI_
MYU&EOGM4+N1O,[;]U]"_1)N-WV'W7YUJ]7]\"%W^C@W:W5V+_,=>O/\W7MSM
M]UZ\RV3V *_N!G [A^O+QW6Z?CZ:O'L#\"H-[Y6[^3^3=WIFD9\,=ZN@KL].
M\<_D&5]]5;A^ON]6=0-TYR)=*IY[3AW=>HJ/;Z?^,-UW%PK6*JK_.F/]CU<
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M<6KI%WR?FJ4_T8R;91* OB*)ZKKB5*"(P-=Y$CYA+.%?=OV$8L%DW;09.<L
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MIV$02SP^[1>K-KMBSLJDZCYHT6)NOP])*T]?;AF"_)=DO7([$DV[YJP'DZ)
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M\N4'_S1:4)4.:ZH[]\WX_P%02P,$%     @ PHNT6FDK-(L^:   UI0  !(
M  !F;W)M9&5F,31A7S P,BYJ<&?L? 54'<NR]FP@0((%@GN00-#@;DEP=[?@
M$-QU0P@:G  )P=T)[NX0(+B[NSOL_7/./7K?E7/>N^__W_O7G;UZK9GNGNZJ
MKJZJK[I[-G02N@@\EA 1%P% (!"@=_\#H#/ *P 1'AX!_@$B @+"PX>(CY Q
M49"1D)#Q,)Z@81+ADQ 3X1,2DE(P4)&2T9$3$E)S/*=[P<3*RDI"Q<7'R<S+
MP,+*_$,C(,2'#Y&1D'%14'"9GQ(^9?[3%[090$>$(8?%@@61 3#H(%AT$+0=
M( $ T /0CQ?PTP6"@85[ (^ ^/ 1TGV%BL< # @6%@8.]L$#.+C[4L_[<@ .
M_0'&4R8A^"?R^@ADMIC,/I&IB.0O2UJP%(8.*5C>V+U[^ @;!Q</G_(9%?5S
M&E8V=@Y.+NY7KX5%1,7$)125E%54U=0U# R-C$U,S<SM'1R=G%U<W7S?^_D'
M! 8%1T5_C(F-^_0Y/BT](S,K.R<WK[2LO**RJKJFMK6MO:.SJ[NG=WAD=&Q\
M8G)J>FEY975M?6-S:_OH^.3T[/SB\NKZ![Y  "SHY^MO\H5^SQ<,'!PL',(/
M?(%@G'^H@ [WX"D3/(:0/(*^[1,R9A]$S)>1J24M#\E9% ZQWM@-/<*F8%VB
M//J!M1\Y^V.,O?M/<?8+8[_R-0T@PX+NA0>+#@@ %Y(6IL33[*81)7+BY(62
MYY+@J^7D&.SDHPVTF[2L%$2O'FLHP*MXG+X;"P5..@1HXH.!@)_O^7\JS,WY
M=\6?"B/GR$6<]7+2Z;[9 &>LY!F!Q02TY,CYS[O)1^7@P(954"#I^97\3\,L
M+0R\^NF6Y*<BI?MJ O^]U>*I84A*-:' (.9MS@UET^V1;&]6FO?3GV[#?RK*
M>SLD^/@N:@'BDKTF.D4/!3:"O939,$%H/]TK>?ZE3%'^7UE-AJ6=2@TYAU*_
M6D3-BGR".(;R7\DZ[6S+DX]1+D.M>(_*O%^&%9Y>9*?_**'T/R.A@M[ @5TL
M)<,H&R KHZ3G<0R%2$AHRY@/G-NZ-]Y?559<CN5:5M>/I CU5_Z^2I**>?T_
M?PK_5RLBATICP(>\3F5&M:'.MB#Q8DQ-\V:<!G<E".P'QZ>60X%P3O <%AN
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M^EE>ZGFG@W._#7Y=A7U*L4)*_/FBB /R1%KW9@B\0'+G)K#$.@8%&G#NCJ#
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M5];2@.IS"#=C.EH='KV[#+D;%=P0*R^ZZ2[WU(5.9!K#_!(V3]L(?B)R5_1
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M:U<N\T(' $\^72K7);*>W1\.P\394F^DF3=UM#3N8:E2QP^Y"$,JLC>)#-Y
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MAH;.BS+@HPQ^763S*7D9O.8;Q_]6L3(ZA?$:9]+WLN DD-)\\<5VX\8[A/B
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M4LT_G>NKN=*(3RC3-1\9KU2K9[AQ Q@#4QTNQFWP21@@T:>0!-2GX)F&(F(
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M-   %0   &MO<&XM,C R-#$R,CA?9&5F+GAM;,U;6W?:.!!^WW/V/WB]S\9
MVFY#D^VAD/2P&T).0M+=IQQA#T$;(U%)YO+O5S(VQ=@0+I+K/'"Q1]]\FODD
MCR1R\7D^#JPI,(XIN;1KE:IM ?&HC\G+I?WXX#0?6IV.;7&!B(\"2N#2)M3^
M_.>OOUCR[^(WQ[&N,01^PVI3S^F0(?UDW:(Q-*RO0( A0=DGZPD%H;I"KW$
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M36F<8;HA$'R6IJXW*964Y_"9_<P3?# 4JX%Q7>T]>MWZKP!!":'+RD(1N0R
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M;U=,C;SM$@E1WULQ'Q+X&]!(3JBZFZ"_^9[AP9()[&'&9V#0I$>&-' :9!G
MX$G!T6I6L ?V*)+A><$.,@A7-$C/?&+>1XQLKM)B*#Y"? U_VZ2D\J>FP+B-
ML8\U=+L"J5;4S99!B&UKNJ;5]H2G !!F@.1I5!'0]42TW(HVSK@+GN-+M$[%
M1E?=+C 3V-FD\R#A:JI9BPQ"3H/T>M/*^:Y!:0%2!.;I2@X&+J]FD\;^9+J7
MS6&O.4<M"<]Y!HJ-8AJ,RW/42GK-<]0M@'?-F%@II2*_(>UG,UC.<;6L9&U:
MT])CG?H4$]V62U$!O:O#AIU&)>E*K)-VO(@OP0QNW= BG8O%O$%# PM+*%;;
M,-HR\;'KHN0[(S!A9(42Q=>%#3C7RE#2[.JB!0I*%2IF1DT( U\KV4V?-T8T
M(4/:Z )]Q)@^456 J5%!R4-);3BTC#&B:0*)-X7\ S_5U&TBC,[ M6+,Q+O*
M4:.#4I"1HDE);P W]2RGJG/%1U_).98;A&ZC3.-UC&AG-P<,4ZYN$M!#@Y#0
M,+^N?CK]6CEJ3L "D_:6+/'Y "^=7N4,P*![&K+R/QMC=E1FDR"D9L_SM1,U
M?F[<5)9+OZAEAGO5F69ARX0-:6G+@F< BUN2Y2>4D.QE>0/C#4E9"C6;4@Q8
MIT(QT6VI1 4,Q_D8V'6%P:&08T5ONX;[4,K9,XGEB0U=H1H IYKH$6L)H7H:
M3NUW*?4.8CU#$J<\PDB0C[K^2*+\J/)YE!+9@=*5185T6OMZJBT9]&'AZ$'+
MK;>GAC_/^[,@HF(/C;3T<:*W[<!>+A^8U.KX'BUGL2J #!FXTHP=\5(Z9G00
M"K*B.!Q47L!E1!X@*P[EY5]B=WUC/(GD03!"?A9;@71KU6J8L]OB#22KN^(5
MF"#$8B#6NR<^AP*.%5(H[K*Y>P'<+GU,DTV4>;JKI"Z$YIJ2+L"]-%27D[2?
M!B8'PXJS0@A^EIXO&<GFD*SH=#$G":=CFDLQ@9W-S@T2KB;GM,@@=#)(KS<U
MQWLD).4>0EK)/>Q]%3EW&X*Y?CJD\]R=TU#0JGU&XV%(,QPJ8@%,:52TYBG3
M]!W: .>UW"+6JV;Y-(@FKZ34"PWBF>M=MIL,GKR]^[\3$;42O&90MRZL13K;
M/VNF6FV65<."D(&96V\;+$<# 3\\:747"DOWUT+;B\4$=G@-M*5D],@@5#-(
M3W7=<UCBR?V?S%M_U9T*Y#:BJ BVHTH3$80XM+3Z5S7CM:\;ZYKRG9,58C9!
MI@GT$6/Z1%4AID8%(0<C-=L ,R_N-_0=8XQ2,6 ]11B]8+3 (#0SQ&Z;\.)-
M.N5(>N@^50W.;9S1T&R'FGF 5Z>:F/6&,WYO2<VIGCVO4S*LAR[,K1S4)-MJ
M:&,"$H.26'\-M@3YD\+I)F>@+4D-<%O]76+MBB^?!E3E'4J]GF8C'I10QS4^
MR3>]%M.D,YRE<0KIC.#X(D5PPN!*M=)A9>5*&UL4H12,A4D0*K+GV95685G-
M?Y>V($()$ G )#_9*1(",B77ZRI5X9)FP<S3)18VSF4W1+\G.IU!6)(;8/E:
MP14I@<\BK3 D=X59P<JTLK>%K5\)&HICEJ+",&!)ZMF^5IKB$E6+6;\]5.8O
MT]G5EW_B>S0>GT?H$J[N(&G6F>KYEP3'SJJ&Y[41W115O]! KEL3 @7&1^,C
M#@2?<ZC1!^SK75]>;GC?ZT7SIEM/PWK/*FJ]5?"C'.3U#5_#-2:\)<EM@]-%
M_IVJ?(.ZYJT/6H15$[9T^W>VY';%ADIQ#VKK&UXVE683&A_P&LGH=_+NW5]D
M!)2T&SP;7PMK5TFSF&:\BTAG3;M2D@D<EH@LF)J^^-;\X)O7UOXKC,@92JJ-
MQ*WV('<+PX2/<'GT%<CY?<2NX2I*$?V$'B'E#S4UN:-TPZKTW1:JJP]A WCR
MH+%KN^-D0)$)R',!TH3Q?$"1$2AS\BZJZ2,DXF>^,7B"&B^M^0T'E)2,+0+-
MCM(-3U2[*Y125"+Y7"MY!N(D8EMDS<]DB,YU):/M0]R^1%6]DQ&=+FXY.\Y5
MS+2V(WC10/BKNI4%F*#Y/11%UTAJ)ZF&):A=%FGP0$F1?OZUP5Z7J'170E)Y
M-D)Z[![F:O0I)T534[R>"9J1%,NV284_MQ/5#M,.2UJ[+UCO5DZ-@U+KBL-D
M5E).-(^$@>FL;HV,EY^']^F"_ZQ>4/L%BK?%#3*8S/$EA*QH76.,\H^04WMW
MMH?<PM*BBZ*:W!^3^A+]-2Y/\6NMQ+Y@I3)S O+X/Z=0N<Z:1#"B+=KVJ3BW
M U%"IV3*>9&SB"#.F,ZB-)DB^4VVO'Q7F$G OU(*K^$B@[%L\+6;('/,HJQY
MS89&P,YR#DO,KHO=%7;E9RL&XC-[6&0!2A) L  8@?QC?(6RQ=RKI/(D#B!7
M7+H>G !)J'W32BACE!'_&2WAOH8J7Y]\6&+=2]D&!BY%/M_R *8HPG[&,;M,
M/"RU[:%DO>T<A;A^/Z,;NR:ZLP'/?K,+2X].ROJ5WO";'2WU&KN+09.+3,/2
ML,,2V_C:W_-0JBBOOQ&5:P)!*MWW^*I4O7J<-?T=C[-.B7YC3.-96*KI$^M6
MZ"DY A[WPI1?@+B";()BO((7F"H_7-$"?'GG?5N8F5?O' [W[3D,?"> WX,1
M8R2]VS!QCXQP_[.(#-P,L:<M?%_U.6K_]6!!;O@#?8V;?8;N;MA3+>SD&W=A
MU(8%P6Z--"<]0JJ5G5W1&D;-6%%\_<V__NMKBRMEPJ@1-2>+BZALWG;S3Q?\
M-_[G\D_\/W<1A?PO_P]02P,$%     @ PHNT6IO:2X4F#@  E[P  !4   !K
M;W!N+3(P,C0Q,C(X7W!R92YX;6SM75MWV[@1?N\Y_0^L^^QKDMVU-VF/XDM6
M75]T;,7M/N70)"2CI@ M0-G2OR] 41)% >!0(3%V3_*0Q-8 F/F^P> R /3Q
MG]-1$CP3(2EGGW8.]PYV L(B'E,V_+3S]6ZW<W?:[>X$,@U9'":<D4\[C._\
M\Q]__4N@_GS\V^YN<$%)$I\$9SS:[;(!_S6X#D?D)/A"&!%ARL6OP7V83/1O
M^ 5-B A.^6B<D)2H#^8-GP0_[1U$P>XNH-I[PF(NOMYVE]4^INE8GNSOO[R\
M[#'^'+YP\23W(CZ"57B7ANE$+FL[F![D?^;%/R:4/9WHOQY"20(%%Y,G4TD_
M[>AV\V9?WNUQ,=P_.C@XW/_/U>5=]$A&X2YE&K:(["Q*Z5I,Y0Z/CX_WLT\7
MHAN2TP>1+-IXM[]09UFS^I0ZY N:2'HB,_4N>12F&>N5S016"?W3[D)L5_]J
M]_!H]]WAWE3&.POP,P0%3\@M&03Z7\7>LM4G/J9,L[6O/]D_Y<H9E9I9F4=!
M!I]VE 1351^]/SPZ^D57_/<UH70V5DXIJ?:IG6 ?U&AFA"31WI _[Y,HGK?=
M>QZ?41DE7$X$6==AX6,;!;5>^C^9@IERQEJ:4_)<"-U_&E#46E-SRG9>0A'W
MZ4A%DP84=M;6G-)=)FE,1%^$.@IVA C9D(P(2^76FE=7V9;Z/9[0B!+9$SQJ
M2'U3E2[UQX)(96H6;"[5+]:*D&FJ CJ)%Q5I$T"Q(:6IELQC]6&PJP/[1&.J
M_CN7S+58Z)'P:*WI1 = +@"HQ(3.45'_6:&B?OB6-=1YD*D(HW114Q(^D"2K
M_YN2*8GL>]!J@41?U6A6:EVBK%.1L8Z( BX4^PKK15VAB-9XVAP7<HG]<2A4
M1;O1(TV6% \$']G0R9'@%D6+0*DF_*!YSI2OS6[)D&HM6:JG#694S9) = \Q
MX'79A@+SJ;)'A$E7Q83I[V3FPGE#% CT$1[0%NL\([WH4STB*(_/67P6IA5Q
MHB0*1/H=9L0P6N<9Z8Y2)-;*7"3AT(QP202(['L,9(W68"%Z1F0DZ%CC4@'L
MFB00WP^H^!IL,\#\<=\XO6IH[E5CB91/Q8Z//[P_/- 3L:6$^J$7SH)G&:C>
M..!BI!>AA<^;FZ*9)Z[JAV]*@7M9:'[5N@*$=%,RD@8'4B5!!9OS>8<%S^-^
M^)"80K16<_EIE6]O>%*S'@Z%;-WOURQ83H4._""K!F+Z3.-)F'2FU.(&99E7
M@'+)'PI0EI4MS"U]X-E)DI4&\HJ,'E8+MG54S9+XV)H]HH"P6?'5"FDKF#>W
MN'Z_Z5U_^Q=_9*>G%R&S(JG%-J30YL%6>-91-"K=S&S" N35U42(<.:$L22#
M-L6M :+1K)8@/!-5?K@F 86O^8EL#?P,-K4RG;4'S&O.>H1?$^Z*E1M"T$4"
M6@\W*8V";R?^;Y_K76[[^%X2P1^"',-[2=="(/<TNB\5J!C;-^3P836ZPOK
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MD1U%% 50"B^C #Z/T7L\$2O><'(@-X),_(;<4'C<<X5M8F@?33HJBR'M%5.
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M']51 )2</>FH3>_?'W&RWZ+PV<I@:MJ*U]?W%M25?10^S&R#TMZ@ *\"2B@
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M^_G8Z4=C_&$#$3FHXC+;"Y^->^?[R@[I(ZPQB!RR17=X)>K]=I+?^,72 <M
MS6+6G:MH)UC2\9/P)U\.\6:8RET>T=9=B  MMKTB Z0OZ?!]H( C(ZU!J##8
MW/[R:JR@6P_FU)2?KRJ+2WEBB0]J4S2SX&#2P[U3J$1%1?"NJ2SPKB *T#U<
M%XABQ]=.PH^#(X]U]9!,V'G+5\I4XH[+Y'3B,G_+\US_LA%J.:6&AYPT^Q1V
M$#W[_BI(R2Y3 -GE&MVT!&3C?NSK?):U>P^N>4KI[#^["S_R5$BS*?'P2^V!
M@KJNIR7MWQ66B"?:+J@5]I;FOBY$%T2&24ZC2'9=$429W%&\6*L^IF_D8^RG
M^R6-;H\=\Q4_GJW+[R8JI^/#6X2W\H8*F0(T\KP65S[W0PL<Z^3PAIEN+9TK
ME[T#[[0R+%7'WI*E,Z, .EV#-7Z$2528T)D1FH2RI5DBUB0U O0E%&#[]FU;
MQ_8*%I\'GNB7-0YI>%6M.$3>V_&5\\>&^?SYRJ5G/BQ&(;YKT:G7XMZ\G"Z[
M8H3H^!(MS<4;_<9BZWM5I^ D\J7(0QVO\JJGAGMQAL]#Z3[<\-\+V>FBP4,T
ML%K1JH\8,(X1$Z9JBI8[/"]7B8L-9X1=SJN7?3Z1&2(1P!Q,R\)\CJ<Q29GY
M>4S,*QUE9H;_B C8>-!Q[U" PF+DXGF4"XJ^E )$)]GO+PN0H^)V;6A9NMS2
M&F197Q;4U-[^PN[;["I*+,[JJ8ZPB%PU960^M+<&&HZ/)-[<_6S6U$BEB#CQ
MN]+Q^3D*D!GIE+0;X+ D6(9U;0V#FFRL2B3'F>[5'^TD!$-*H-5;]E\P61BJ
M&>CS8=80^<]YSAPNZ:-[6-2G>5+I@D\:W6BW6)T^0\IKO_0'3..Q=:Z!NKCY
M1L'7%;5!XU8CY=F/1*@A.]!\RR&R2BVB$<:T!6'C;4' OJWC-@V_7D%ZU[[U
MEMD^\(S[Q\X0&_D\=BSI98V,:\I$A[Q+A;%4#0-U6&'A)36^W/ ![0:SPWU>
M=&E:&8M.8YT'*QB?=#Y=^L*66T@[H!-Z:G790%YW6A,$.X[K)NAP=R%;%WLU
M9E:YA%OWCM/I<R_/K0>1%7MKX#.@6^Y;7><M*_5CF]5\KN=XV\#)ERT\5*Z;
MKD=1%N^01KQ"H-LIZ]R"F6_*HXMEA5U7O[H*(I\\;?.(-\0>C2ETX^UJ=)5B
M#39'<(FF1\H&JP5?*U2_+7O4C9@7#%*%<"R21.W<1<"!ML9=^+*-XTQ7\T1
M;-$"BIF6>-6==43]QFG.#R-*3GZRELM7N+2#?:C<#%2PA:A<XR6.S]H/'THT
M(_A[6"X&W:4.:FA5S2Z4FV)M))UH&];/<,X=LSE66[K,<<20Z2J-T]=9FT!]
M/,UT :=*W8"P!"-[<G%%U+1RN+4FB_+%*U_N65+WZT.>D5F7?11+JJMZ"TOQ
MMX>O<K[,X5;GMPS+[J?">!GBM9+QD,;RJLPWKCE:\A4Y=I^=>2^_.+<:6<8\
M?TYN'R.20S3$E,&ILOSG2_L,M#7=A)J#.8-=FN_D=#B*;3#@EGL_RA*0]4D;
MVO(2/W99X3^.HF]B&D5>[ M$E!9H+.M5]9_VM!X4/UG,ZW=X/J%]H'8*?=S,
MR[7_ 18=PN?WM760+YL_[O[;V<OGF7QOO&@=U1BUD*%.@NO@VEH83]1+E<=6
M%12FB(VV/E!"<%P"N)PJ!VNJFWPX:_!,V1W3$<SJ-'-A_:K::ENM8'RYSW\P
M^ #CQ^#*KXZJ/+X<^Q--8="ILQ&P</$C\<L)VC=&9EM\%K 5;QO/CC+I17SF
M8PK@>H;)<*=%XZ!W<=#04C2SF?'=C)WX.7?1QG ^>V$EWC6:8/GH]TPM'N0*
M'%057Y'6->E]8'A_1+=_9^_R1"J_X-R'F KF1^8;K?7FVOQ/E\UTLO%VFU/P
M9H4C!$<U8?E@VVU:PA'6+XCS[9R-Q(EJ^:>+G8 GNH$"!.VW-4-6DU81"#:?
MIEEWY -5D_5-L80O$Z/<HN,U)5>Q^O$S76&)(KW;ZFM3?H(O1UX@#/3N-\X*
M'YTS#Y59732;GX0'[<.:(144X,$(7&D'*O*%8,0[[[-B@9#:A9BX%#;ZRM2*
M-1C9Q4Q*8;U.C)4G[FR.O./N_UQ^NR7\VK.D]S,1-TO=!!N,['VWK$MKA3TK
MDV.G"MD+$PS]6?3JAW-%GW/7(@+Q"3C+J[TI.%90 ?KC;WD*5!SGM[H_=E%&
M-VIR9IY]!E.@^O/^O:^"WU^2#!U^0';]'Y ]@AQ6#6+XGQN2&3U^![I?AA!?
M*PB0&PPF]B5[JT+FNGZJ_B$,/>_U\]G=_/6?V(#5'TW@^^\NU'2M%&#C%#Z"
MW. *VS^?ARI4^J7ACYT*KM/I@<W.G0'GFX0AAWKL5_W2 .Q7_55WB  IA0+,
MQH/@WOP0>HNU /Z??<V)$L/'3\.8\##=7F<$9[DMRRS3F-%;"[Y3\^LLHU(,
MNTN"NM.L88&!1(:JQ'>RI%P\[S=%:N^IA*%3_B^VUT/B"37C+MRU:_!WHSIF
M2M.HXWAT$P@.PF[:W@F[OS1UHY?3K>[.PT?T%7;2]?/L>=!C7A:H!9\#V+6,
M+/@>ZYM$>)) -*?]%\\(AO2CWC2ZO>2;$Z)"MM\+/<I8YO0]5%OI8^E'6HRN
MOFBLA)]W*MV,V.9Y30&.NU6889-:&"6']RG %^Q:BF_1VUON#XA9WZE=&?TQ
M*5FV=SQJ:;RYJHSF<W3,]'"NT[0I4V^*^L0%4QB)OIUB08/7BK:H&0[-SI)9
M*C*]KOK-3"'<4EV5'.RIU%\YO&L#+,K5Z19L9&HQPA,8XH&"]7.[<KF"S_$&
M.6XO3;"C<>@@D1L@Z7K]\L'&[4O9T@)S.N_?;V]EDX7=HO6QZ  A>W%/=(F)
MPG!KYUS:G$M1*QM3_^$<0O6>#V]@;=%$CYG[%"QD^"9J2C-,52]1SO@SVZ8K
MZVXM.YU7HNARBY,B#?Y-(;YDVN#;P_?*Z9^BQ%W\Q/>NP-\(A37ORO=5U'X2
M)-2TE?:8L+;8LXZ[&33M+&=HS2V]B0Z:NA<R2_69Z]*I'6ZY0603A!UA-+*T
M+Q#TB ($#\0?SYBY([UP]3"P9PQ-T'"MK6)<1&PK2(;@1)C'O RPX2'[!6"_
MK46A@0')A@,G.^2?F%-O%Z#HE7 P77+'P+J\:I9FAHF[DSK=ZU25T W58Z%<
M'M#6'!N(4O\"ZF2_E_+,F/%T0-X4&K(<NQ/9\";,[E2$3;9>>U=L\_NXU9HS
M66X[G\C3VBP(%];! *[KL>U4!NVSTQ(S[.NW$V8ZYYYXR'$GL$PFLN+HFBD
MNU8.HV"S?N21LYRQT^-G!.0^T/+"QM9#5A59\<NW<?I).<8V[4GV?5B&GFRJ
MAJY;TNT7/!RTTWP,]ACSY-Q'OGLHL'R''Y(W+,!G"IF7Q4^4<;KSW44_#2[E
M_D9(MDQ>-D2>D'>=EH.PJ*:ZZ4]%&7L^2EQ^(-JNS8D.XC)707*<61LF(:<:
M!,NKD4T\3<I.4 CQAI?A)$%!Q4#7A2IDGAI:8Y9%G>D&"W,<Y!'&G,5/N4]]
M$RE);PW5G_AT-6(L@##BZJQ8.ERZ=^C[KCNZ8,7C!0O71O[)C1OU,6&:7!Y4
M<3@%2 L%..9S:HG5T8JC/#JCB=H!<>EVB[;2)S&H4WW.S;66E<*N)ZE%7L+C
MIVRA/&?"OSG3O H=\6Z]><EC>TGN:;:7[32[E] 4YZK9H8-]UY)YRUW6'AVF
M;S-_WW,VM?!<EM!1OQ"<*5TK6:P4XR7K_'*94:,-?JJ%IBK;C?G]@U6=4,M*
MN\#WF))/8?S"P:?#OJD9W*+771)KF[_3IT$!!OVTI,RW#-YZ*>("*J1>EB$/
MXU,7M)%V+06SHOR>,1ZAYZA?*4%:XUVG5YT,\1\3>7I$R%T90X7V"?=5QBK>
MS+V>R3936!0RJC#U4?(P(\%0S=L<@NWSN(D0HO7TD5J1^AQ;>TM$<]R+QC6Z
MQ!H_0%J:C3_<1C")%;\^15K-<ZLWLHG3:UJ1TL^E/KW%IC?/+BW854 _CNF=
MW$)'KH@;Q+D%0(,P!JQ&Z, :S4SEE-)KGE;C$B(E]P3R55$"*(\YK].Y7G=P
MA0D2._'3B$.I ?#S+SIK;)HG>20;W;Z_*$SPUS39-1)L)_.YQ;<,TZP'/.V4
MTPLY\KF]ICI8_NTW'I/<M;U7DP\2?;T%#=1ZZBXTY0VKY[K%:R0V/-1U8';(
MMKRQ0;>F"@O*+".L[M)7B\1TJ::&G&?X9WB?6>=N(A_.[N64IG:I#2:'B4^T
M4=&:GP(X>R2AM'6OA%5-UYCC8%>PK]PXX.5+?,^LJ0_<H0#E8ZQ[!(,X&S23
M/!QW>&\K@OZ;MK7-J&@0&8O*Z^BAZ^-Y)]'O!IN,C<]D6_=2YEV22O)<F5&\
M!O7:H #A=$7)EMQ)/,1['^LI@%*/Z^: $(9N,Q(M#]78AM%YB71[\1Z?LB#8
MI<M(.67O:1..]"!UUTW3'=)U\AU24\\UYH8""D#6K5,_@ART1=+H9,K4YVKX
M\1KZ=,6N4O;Y2\E-.28?^:"7S(A;*"D*\%QJTI)(LD+B%>S)"F:1TTF,W_#5
M36\\N(G1;0CG$L_Z>NGAI9F#?K+9JV;&.>0NL^,EO2CAM'[G8FS]QCGKU(;3
MZNRDB3+ '=/*R%D_K+HC13SM.-3Q?8\"( AG]BI;Y6O??2X?1RTF>@OVKA$M
MG.@:QF@Q#1[YK(I\(9\Z.7H_?ZY,N!*FY'^2#3<1+OA=8QP;^%*$R((Z6Y39
M9"O4V-KSHE+_09/SE!JL /#0"PSV$;21#2N+"!':OH/=_I)S-!O#H=' 5G;_
M8,8L4V'+D+%0Y+.O*F(W<6W!*V1NL^%AKTL#*ZLKA6F7QX\81F'9J>H[O.?<
M5@[E)QC/K(>4)7 0-#_V;3WTVQG7=.>0?LC TI_#=YGI/51)UXL7#T]U(VCT
M%Y89%UQC+4^PN(K@/7>JT'TT[ J/4XX;PJRG8'#F3H^$(!M[X\4W^JCCL0W2
M-+[L]0(\K;5I4\)H'"^2R0UYL]^\/_!%2Z6R:]\UY;F+C',^N_>DVV]PC^(P
M$LMDB1\@M).#6^1.XAH;[T?CWR!H@^$35T$&\RY[#>QG"A#FPX]U27.:\I;]
MK!';IA*S17 7YHU,MYHZ*R%\W??D:14UP/)#,L0))^);(S9-"!*6&)-:=:Q_
MP6>OJ+;CYZC:WB310.Z9V- 6IP"$PVT4(#6C /7<3'' RSO#QL"HH/:]B*UL
MJ]\ ^P^^\]UFH08Q62#5%B<N:Y:C,'I)^4G%X<'"W!:_XLDU?;:FQ/'75//H
M0Z6PP)XA*XZ8FF%WG.&S8.5^]7AW?49" 9[P'%?QK-/93*);D7.IZHL8OM%6
M0H*FXDZHJ8W*6$W!%Q5FV5D[H:\*WH+S@I_?X$UQ1DM:QX0:>K.BI!5'-M<8
M7MQ<K79JXGF[:E@G@2O,F.E\Q*U[QZ^7?;K"V-GXSL/;*>^*7<6XYKJ0&L ^
MJKY*ZEEI!(C.&UF%0A/MW^R@B^'Q[RU<OLR-V!ML=2G&S":>P5FV&MNSV&"M
M788[^F9JWPG=\+A0]=;_U5O[<VN<#E]O(KX2CX#<!(\$W<!*/(*];FQN+PFA
M^OCQ6*CM0_+><N+ ]D1 V?FRI,.+'!F-K27CWY0<>%L/W?KZ+(B=?T:@OYLN
MNFWRD+P>]M-N\_C9[K5Y7/Z@@?"7Z;L/K6_)-A%B+E0.1_I*;K:9;!9ACZCW
ME]H?F#!>BO,>"UW-:5_F[A<ZP;*1RD[E*]W.I]A:LDT!7LKNQ.!B1>@:K#/+
M$W?+8[^KAGVI?L@4*W.4UL<I7$$64_R_CY68?/QQ0C(/.70!7%65,8S.+PW=
MM+6_<Y2$G8ZLP1/]@U*NDSBM394=YW^N_Z$SBTYU/Y^_&73]Z?2E^!\ZK_@O
M*%3^,\B]8UZJ/Y*[DTC, QC,Z5\:_MA)(OBYA:0-QR@*,.2S#$ZY@K?IKRV
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MB-_M-L$6+9(8NHZ?$)I;-O<L0#79%F&,B /$PX^4GCWLZW/QWGS>,HT;V:.
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M\RB(HH?VK*,K>%[NGTL+F'UE;/-T0AP)WG0;.0/IGM'ZX; LN3;)886]V:U
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M@>457QS:19RQ<*\UPYE&E0$OKZZR%L+V]?5.U:HA4UW(/]/8SPG1:,TFOQM
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M>/<63ZG=NH:]RZ]92U.9/[E%;6US;H>6;H/W;2GJLH[Y&"QK(W0*U!, $3<
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M[SXO>$GK/&3$1@XO^]1#'R!2"Z]*L"D'VO=3%EZS39?-2_;->/0RRKE2<$+
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M=B[ZN8KQ5X[7-X"FHHJ+EB=S)T:CM=)/WHF'IZWR)M3LFA7[,&Z.$AF\1T5
M/[2.+DR(E6Q_&/M>6)!@YM<=A&[G8**'T!+G6B5$'_5[0JGGL>[=\HADEW/K
MOI&ST@#R?<OD60Z5E^^2Y8BY, B6VNN6NUY0[-C$Q!'(&:9U03':E^!7U?_]
M*\4WU^42.5M5QYF?0,X_(@+_\U_-OBUPN9+(?ZT!HTACL64XBL@IZ)#/I-=T
MYI',%20PF!Y>I>T:F4PEBOU<Y'+:=7"BO>=2Y5><3*]C N1P&D:"2;467/U8
M7G9S6,?6"@*5,XIN .%G]+2#@A:IR]>V7GO.Z;FU(,QB(:/<\/;@R!GC/ HQ
M+,J$"@^:^]=-^^&PX]V,HYXY9DOR6,"U#/D.(T*42?"IR;U*+U8D5$MVCR^Q
M=OP2> .X3Q^VK,Z>[7<$Y$B<K25^1/583AU7S?D35J_.KZ8%<0MPR9ERDS62
M/,Y,Q17!$P=(1!$>APL!W^\BK:5PV;R9NJ/C07(HQ4W&+B!V\\SB_&(H'3U!
MQB3E+/#!"+ZHQ.Q6^=^<3=WZOSB7 !5;>',268841X@8D1/O*K"GR^,@VN/]
M$=Q]:?U]COK8=G[UV(=0^_OD:PXKT8F2?,EZ[0RL)=TL#LW[5.#SH_3 L3M2
M*I_G"MN3=K>EO#"Q+T@SUU%.NM_@NXJ2I[+7A9RW%BJ^)/R@#W[F:?SXN2VK
M>K"M=DD/NZ*.BAUP\?3YA.>@B7]&FLO1J4TH8R0!JRLA/8&:(O?F)YS1M&%L
M6&GA!I)0TQ=1RU=<YV^0E!'X*:J:I7E!Z,=J\"#7Y?-1B<SS)?";N2= 4B94
M+8'$WPOR/('Z?S+K0=LP"EG(U<>@NNL:0TV8Q>1_17\S2>V/];.?-(\HSQ36
MC@]/FR5/^CHOMA%%.S.])&0A7@:5$D7X<'1MV<<DO[>TS'@4O1)"[ZT=D"BU
M0+J\,"'>N1_W%7YT\11'\NQ"-D[AJ)/9T;K7J&NB_TG][S@],ZV8<A V71Y1
M[,BL[)KQN[Y#Z,/#>NFGH=Q;"!0BIS#\OP82BXDEB,G;QSL1_H5F<A%W9P3(
M8R@)@MF)B4)$3PULGC"."=SJD4L+A)];<%D8'[^EY]/]W?3PM_LJQY6>P[8%
M[0(A,V(/?I^2?9E>):M1<:7GU9Z?C9TMSYX,4"MUJ8]3#>[F4& +&;)6R'W.
M2<1N&1!3I>7ZWI<YDSGAU2P(CGJ->I$$A(Q>/SQC4>G^XKPZ)N3R8ZR6Z36J
MO1F)]+PO389TXR3C:2/D[D<GSO\6_@>6"<HIPCZ&1_[K7.GF$%'MG+PJ]+3A
MFG<)W$ST3;E>UFNI0HN50#E&?Y--).[VO?<VP["?,?E;$V?E)PR;0C;.X:W(
M I"C049SQI>YW##&0*4G/U:":#C@Q?B65M _,11^]73;!AE2LV\-AMX=G&V>
M0#I_3'7HL165P&UCOI7.,'P^N!+^I-VT%]/2V8GI*'64<)W+FO2>0+,">P%4
M[H7Q\=+<AN(99;X[9MS:/K<9N:.X72AE'MQRX)+I@FEAY3GDD1=92/CK.5C:
M_*YD<$E 0Q5]Y.MB6Q7&&%T]Y\?=WK[\Y0-3K%0[G@:1CL+_NA*X5JJ^;KK%
MMT$^"XI_QI"(,LQ]]@3^E,YGNG*U$2#7MBX/#%S?XAZX?S%+[26U66#*M7%A
M\HG@GLV'P1I<EXAOCV*,07A7_KM?(T-)5NOSC@ER(Y@9S57^-]\?F(54,7 \
MH%D9"R)O'8.*PV@$\SC5PG7TU1];L_UI?</\['J3(_MSY4M'N/=DY5K.VHX
M+7SU3/R,C\7)@3U&QYX4P%B!@RK73<)QN8U^"<ZW<*),"4A5G2'HD;.'NQM^
MC,U3>#X7V/+EHT):L<#\#I[1FK0AH$FUC.Z5]S*$"L!(E!0Y'M4YF5"4XU>R
M\7OT[9A-+/=S>J559:Z90^OI.RL+ 17_>H:XM8YA$SOSD<0.LYXW@$^5"X-P
M996ZL5H6D6/[9-O10O 'DI?DQJ0L4\S1PIN10S> +Y):MP]O"NJAQ@LQ20U/
M>(-/*M79#VHDPVRW5DZ61VFI1="Z)%+N%(X;W@5];X4F5<X>;YI4^TZL.@GB
MOXNY27QVV/DU<U7L-$ 9V50 <NTCD3>ECB58%F5\CD#!<]8F!U@RD/CQ($,)
MV[W5+^>=._E2?B8'@TY%H3W"-995F]$K.])K9<:GJG/32R-KMP[]CU\=H@$I
MI4R\<X^ B-N>]0E9]8=2"]]%IPJOJ1M ]4#B9I=0]9]J#V].PG[VN%3^-T?R
MO,=92U_QFAJ:M37(N=2/,,Q*ZL -0+>@1"G:W2CEZ**HU \&0AT>W1LUN<53
MH0.\S!T"!GF^-&W"S8V$Z8S^$W3^-\TG*6B>3T82BY>R?9][=#L#RU 1>)8/
MDYUS]+6C$W1U]>E0:?/5_/FOO>T$3*P/U$H)BTTZ1^3T*L"-S^$ELU.!U9HU
MXX(ID(C*N/2$"'6F1Z5W];WY6Z1H\G9VKUQ2U[JY1FX AMI':E:0Q7Y9(+XT
M/]%]NCG;9O&[E59;CA"SJ^QZ.K( '+\Q+9^=YH(6HXNOX$8_,BJ+)E\@R/G]
MZW^O.L$.Z<V/=Q+NY;I41#U75CV=92KE[7/K4B)RV]1TOMVS*)W_:LE3+^\@
M"A?_H,;"\IU++<#(L&=$B5/?#SDL$VF_?.T(T2(!1..+)+\<+18:&[6-8FJC
MTIQ=K%UM8Y4S6XT>_=EQVB%BSHS\?>LR?Z=F!%H02?P'LQ /<!LP0(M1IV[/
MB*6\>Y;YP=2&I^*B"$36&7H!T@;YM[#19CO BP\37UN^2;;35_RMU,/0^0:2
M@CV?ND;%E7@A\9BCJJ#Y#KJ?(:-F9F:F\G]\J$W?]K;::=<S.8:2OGA \T"M
M8=#9HGVSW#=LWN3Q1#'8PYDREN;+R_WN[(IR#NTPA1:PU81X4Y;"CE[AU'.!
M.0T_'/ZI!%M'7L-!N]Z1 ;,7 MJ1_6*27FDOJV#:27(ZMA+"$24ZG_R4K=S%
M8S7Q?F\/8)F0<?O\/ AID?@!/;E[;GQ=LK6V][>Q.D1VT.!Z:6=:3[SE@L3
MP2A$"L/PZH5ZN^X#OT&.(-J:/W$>'EX^7OSQO>)CG42))!GN/--EN4K;@*U
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MT[+\T]=[D\<;S76--?;J2[X(:J?H 6**3+=$+=$VL92<R4#%2GFE\MTKD)[
MY=,2R4_B5^2:D&/XJZ4UHQP/IW<<H:ENF,R%PV#8XRC=/3:%)K<RM3R'QTWF
M*E1]Z64>9'FXF9C55B6&,]?FZ+7&\BR8:G4ULJEQO(*UKKX[00S)72KHQV24
M^?1W97[%5T0T(X.-2&8(-Q*_ 3^[=ZL6LVX HG&_]IP'8TL7TY83_R@7=KMS
M&;$^X@&_[$Y]+/B78-@\J%B\/,\!*>/2M$2VF?T\ZEU#K-$K*N-7?TI\;%S=
M'[X=QV3YJU6/L8_NU$(8A&PN4@YF\GKF5;B>1^'\U48?JXR)0\A4H_FDZAO4
M^\(X>*39&5F7)VE&L=C3Z1M (IGGT97S677B_FJT25UU@9'1K&ICP<#$B;#0
M+<];Q0<=_23F55 *D[./Q5?#<N=-3L,$/%['#JY?L%:G3Z^I1K 0NNBRO*]+
M2.H:S3Q&A/%89W.D\-"IS[@8*L=WC#W!ZV)-T!50J^JFL6W<3O$-X#W1:)E<
MSDZIM&(H![SX%APL)DMDY0-BM:!$%N)1LQ7'<7")BL8J8O<V,]61)ZX@)E5)
MZTHIG(F,0D1Y][+L%4SW@ASB94O;V.[,WF-M8\?%W]<4/CA)N#FS%6.MP!U(
MWW-1]P$[-+^UZKW\9&K($2( >3.VGDY&H36TY?" ,_;^A&KT^0OBN*ZO&*\K
MSRLB-/;*Z^JM(N7IQT.=_7M999CIS>E(DTX.U>%W"0FTWT,X7E'N=1"YMSQ\
M9RQQ330V&%8@Z%*1<JQI)JZA&@KJ?Q49S,ZS_I3'7+3KX<_M&T"=)PJGO3V,
MXU/$432U]J]79L29I0TIDO:@ ]SR'!,=^\3)N/6T&BYDJV>YV(.?5@*J>.75
M+[G-+2;*\<@5:8Z3ZQI885]Z:GCM,#48>7S>.0O/ZTNX2ID8CQ[I8)/89Y=^
M;=<+<&X#/#0'3YX_:%J",&%9W)?00WW^JDBZ8\UU8G<EJFH9'H9N$A%IZ>=U
M<5^/Q$?G=9SMM>C4UR3K)8&KY;%E("GBZ0H6/2VZ^-F,BW?.PF0T<^[;[A_O
M.BTDX522<_!7L X_XMNG16G/QC49Q,RD;_-(B'PS;R!%%#Q1@IYA?B3MD-K'
MO$YJ=#PD U\/%9?7-JYKJJ\:<19DK0=JP3_LI(JPU2V%2K@RY0Y$R^P/LXC)
M[&0$6GMY%6W)!$YCPN8V/8O$+$7#;8?F@Z2."C- HQ6>6/]9#9V?-9&VNAR)
MJZ_?J@_18IC"<W>USHLQ^&O4@K"Q<256^?MD,T\I%AD^6#7"GFQ'\:"*3,['
ME=4IN/SGRG+T6?#3G6-$,6@45GM$H?SV4(*I',PZY]>URJX(-U,#LAM3)B>$
M*?/TL$^*$Q_'Q/T+FCW&P*J6%1T.#?N[W$ZJ8YOUZQ&&Q%>>U\V7?5IH/8M)
MO72TG'RY,L+A/&;O5[0Q.,Z:PU7KP#;J^011WOX7Z2,NE,EP\RF,$Y_5TV"F
ML&0[83.&6ZQ7YJ#BHVCB(/(A.B!H;U\O]*8WF4NV]:?(FBNVA7I)GI=PUNO[
M*<[JNL-(AQKVO3,@2QL!TIR=C;/]3J-Q(HOZ*X_N.&,318(^MTCL[&+/#D7T
M]=^W*/()M94OYI!G<;UK0#GSO49?_DOAK$4OF)(SIX #:NRX8E\ NCT&N6*:
MA7R60/ZT50V1<T9V?*+J#X==M@ST&8A6/G=KJ8 [EP1$Y&7FUFX >FC<P,^T
M7ZEE(]\8[B;WF/6)*#@]J/5F>?-[69M^;PX#M#'TK0?J=R,G7:4Z)=?_@CUW
M/*9]0KEJ]EMSRWO%-(N!3YPMB78BU4A^)76]> V.]:^U[-@;<;:\'@Q7V>MO
MX^1/KSB.XD3G.N&$:VR-@Y?]8(&ULT:0=*VR=D^<;M_>M[F[+;^!R4.B!TE=
MOH,R_OC/NLA:L "M;<P*FT;,KT6WOB(%JV$N=F:O0<X=S/DAQ6/OZT;F&\"Q
MVM=;M'@$H9_^L.D!VKKS*,*-KVN$1K,P=NP9:G;Y:A%D_F1D].5?IZ.:;_TK
MSQ^_$FZ)X(R5M4GJ%$!^]=3HK\<)>,4H^*?I )F%3?-E<S?:E7J?'&W6SCZ9
MU]64"#3HXCM36"V?8>N;?\W%=5"47'-=@[I\]&O^_+I&VAGT^V-V=:D:_X2)
M0,W^#$=$Q713X;\84XFV#-GHTH$O[EJR[[P6<)IAI?PB)F)H[#O'E)X#D7)>
M7HK8=J"N=_9+E_%*XN@COP!@F<.P'X2FT5.#'W'"+4+">3I,\)*1J\C?X,L3
MMA'!0DH0]G$ 6BR$-6$FGVK%A2SX8_S][A^%M'E(?-D-0&AKD2-K]PIZ;<\%
M6]![CH25(D(79W4UU:S[Q,5F)M!W2=](IG2.!GMG-:]G^V)KY$4OGKZN&3UY
MW<5PG$1.1DH]AE,!< ];&>@>C.\4U6E\-UFBI>!_]=+\Q4<ZEI=24L.%]L"E
M+$K/_HM3+Q#35Z?WZ0L=[C&K"9?\2FWR#7E;PH$H;>PULW?3H533/ %$=^-Q
M5X+S@XBUN5[^SP;),S-O6)#.7O?;N_OKI1<"Y\;'-DWNSL9%B0<:&#][86Z"
M47Y<SM*>3\[$SM ](#RHD>^;/6GZ"^V">_Y3>+[+M!A#X&7Y(UF'>$A)RD65
M[Q4+Y$W]F,UH[MAV06O<+H;S=YKAUH^5(/TSYYU+%%F0Q9I6XN3YW T@YXPY
M)6,!IZ=:,R*(,^ER-M2,]7TBS>$5Z5 8^(>8]$W\JTR<?)=TS]1>5USIYF3C
M[%K)<9B9ZJ:]?IW=,QK5TIH40BG,),I<AN+^I4H>Z.VS^@G/TT*1[Z^ GI%=
M6@IOJ4\:F+W6*OOY75\=:K!U4_'8^TB1$NMJ6[WR-KQNA"6R-,+,8(.9X[NA
MH'?[3RJ]//>S%'70B6UY58<$Y*MQ;ZW)A0?U;@!?H*9C_$<M7.\#I<#GGG_[
M7%A]1&;.3'\()]]1>#D\<"5K5W$*[98P?U8])OY45A,Y*F!C0QW88M9&KKI)
M[V#4WJ4VX/[ %_ZO%LX;*+;USM';W4@(5)#U5OF:.#.H1D#@X)9*SS[75![>
M +C.F)=.M4[]_%(PJY,9>HJBL#+IY>*Y]6+MCXAKZHF\OT(!0F#.X)&=Z!]F
MLJ@L<G=A.R4&LPK5)4(HRZ\'TIMJ$9YT,05F4$WA\E^B9 5MMHQ6F7C"1%G=
MA]0.]YC\PAJ*OB- -@^/ZX_[YB(]#I]:Z>:E1/4?(5=014RR-P SV$ G:L_S
MT+=<!553'RF@,,$9NT-'')#'_]WM4RQ#XD?OTN:GB_XY#_I+6V;V!NPR;$NC
MG\YB>)Z+2;,H>>.Q9IJT&IJ!,'HW]\K^/8,7XE=LYX?O1[SX"%P.-@]EQ?1Z
M1LKY<O7"2&>BUQG6QPR43Q5UH'<@YPSIDSB3T,Z!*H6U?WE ,L%EI'3[.F#2
M684#?N57?%9@>"LZS RW7--3/U'B,3&Z\M0OQZ</N%/TQ_6^F]&[K$ %#DBZ
M^T-7[,7'?/V!UW_^XBH>3IVHWH=6@PHH=SB2:FD Q(H6INFC>>DCH//K6MI4
M_$E0.$DKZ5A8*=AK?=HIW")#SZKEUP=/7L!9T+&V5C8>(2:O^I0:DE[;7/<9
M5Q>O#$@V;O.<S]H2;I^1>6JRR5V0G)R*S[/((X/ L-ZWH3EB5([=,YO564N#
M14C- )G"DXM>M0?5!5BMW!-C9)!:R/XX)O/T,]Z?*8<THZB*TL%UV*6+)RNZ
MK*>L@D#I<WO/\).BICX>N&*EQ:'E^ V@4OM C4OA<X6);[AA"[KS2\IY\[N*
MKC5#PT\C;W;>OW_6SK#,-PJW!P>1CWMJ/*28F6[Y=HY(LCEV[^1 Q ]$*TFY
M%I3>52(&#[//-4WS<#JCX#> P<_ W2OG:_7ERF;%);(:=&514W7CF),77=,C
M689<HRE&N5JO5]T.3CM\B6I.^\27SWRV.)IB_=^CPDV2]&IF&^++$>BX-G9>
M;78I*;DCQ%*DP.VRJ/[S>O' &\!_ZV<*5BZR6/RA.Y^=Q1J!MB0;K<$3?U7X
M@#0O$S7$0@FIM&2XVUBP!H<=DS[TV?1I',&"2<_ !UJ@%[\"FCUZ=V/Y"O/2
M1Z%8V.T7./FO\XO#]22;9@PO;S>]L]2M4E,?LL@I4QO5:-H3B8FDF6IS"1=Y
M@>V6\U3@07-,-HO""CO8N@7^@-[E[(0-J;IA(B?SDEOF++#%9P_A_]U;I)<4
MISY9X>7GE<$7*(R _HCEZP>Z9+U[+!?J&:^JX>JJ]"[3B[9X,8:BAH(37IAF
M7Y_NY^+"H3)=!&2H=F9>(%^P.8:G_V>AG#4^(>S.9:SL-24.JJEITJ$FXV&T
MI:<AE;(X:U,')A[^0OKZLS3[VEM[YE&!2Z%RA\>%T><,/^MK:]!)V@<NJ[YI
M?74^+OK.J(3A6P:]]214)5_0R_^,GK/A1NTKJ1/WMCKEOK/]^+/Q(3AO#XY&
M1-;E+N'=#S_NM4E)=\L[RL;==[P!3)O,[&$<1H&EE[TPSR'[FK,[V^^G#KE9
M$\*U6N3]&WFDBN!73JD;J/*XX?-9U'BV;P!Q&8M(%V:X>IXXW!:=N>O$:/J<
MY"QHM\\/BP-)/F%L21G^[5I1=U'CMY2XD")E627"DNG1R^+6Z:7_'NDSN [K
M1(TGYB4B^P\L<E.7A(L4PRMS)^S#R.[G.13Z9?(&SWC)'_B>(+25]PHGJO9V
M'+S WEL?,P1&M48>O4^")AH#APFHV15J-VCT,;#4Q5)M$#/R^'E5.=;$=J>^
M,4!X,WJ7RN3-05J!+4]]ROM_ *Y5I@;VM:6?A7N&7Q^&_M@;$RJ,XM/H60];
M+4H:2!3_#JQ-LJ,-7I;-D-H0[<Y_I^EPFUQA@U1+Z==-H -[Q1\./B8&#4M\
MFRNA>6,(M.\KJC<E,?H[/0S2Q$5@KY8'Z[K[].&U).:TX9K9QL\-.43O19=@
M/@USM?(%1=*E'%PI+G8[7PX]-=J3T5Z2'307H%8:CSGHXM TE@[]YOP_^+'/
MTETT/5F.Q:>H,W=VLUO;64V#JC2JCZ[NH (5^#)&._5S-$N%[[KTH+>G[IN^
M_O/YRW]SB-WSZXK85\L=TWC,U-8D?5U<^=2LW/'Q2M BN\T_JSD:889U/UT/
M#/-[%OOV]+H6V\I9,Z#U@])2XVY[<N$>'#EW-"B--.P#4 ['$B8[Z:]"=]VZ
M>Z!T*_S]AAP;:3?'Q5H@;R_XMNA>M#0INV\G##+A>N;*.M5Y262UW6+=>38;
MGZ <TO$#W<"47=TFX 3=W-]MRKQOUL$>!SD9Q)-01^Q&\57@SC:0 [YYZA"K
M_7N.(4=MO!(ZC>[0"%GBB 8W>D;OW2-*XN+^[-;#S+TYEVJVM[JZ'H'S^BH@
M-OM&"C[PU';,AOMGXI2(ZBO% 34B2QL?VO$1-:@0%D\&7?/#5WZJ]<7AZ/S+
MZ5,4'[$8_%_LO750VU_7+YJ6%BA::*$X;;%2K+A;6[Q H<6M6+%"<(<@!5K<
M*9KB&AR"!W>7(,'=70*$Y/*;>^:>]WGFGO>^<V?N/>>/,YF=F>]W9F?6RMY[
M?=9:>\G[U"GO2N+^;)R8--,\'-UQN#<U,Q1BPZO*9V4!RI/['N1HID V"_T6
M_LW<Z[*T)51S? G>Y_N+X\X;<:?RT4J"L66Z6FGHHY6:WD[9*P<@7^0$>?C?
M;WB 9M]#5:/F'E[B_^"C<R$;^(\NNW<*#(:A;_X:RZC5C54WUL]YI0L,6^E1
MY\0^_BY$L1ZSHX8!M(MF@4;I53& 5C,,  \PGE4%6J$=D]PFOK>*EWE 0?3'
MD=O@<YP)#."84K+=CZ^@9 DIYZQZ@[6# 2 )P"MR*(8&EKL'YQ@ "EOU^"_A
M6S8)<7RYX*^)'&_OS56"TMIMO)C1P$A"R__N\9+^IX15#@8P\_86 Y"=TU+3
MK__W-_^YS^N_#9JC?ZDKQ9^^!KQ^L8(!E.>E8P"YT?"(_\]:!/Q/;S&@%8UX
MNDBM9X6G0!;RVSQ5HQK+*X?9"B]).@XJ2ATS:I'K>?&\86GBV VG"'I19538
MN3.MV0#K#)H\%\ZLGYC^9%EZ""D?4V ^-C58"_Z&=;,F7J6TJF,Z@?+XN]N0
M4]&1W6'K0 _F?OC&PB15B7M%X7/KL_,C \CSRYH&4!L&(/[89O$.M R*V9C&
M &8%!3-(;=]V:_^@[U1O\.A@Y7T>G<SP"!Q=*[\MZJ^^RS._0R<&/^3BCZ!7
M"MC%51^[$&5., ]G7:!ZE\B=COBMHM#+OQ.O7IMX@5(WRM\FGX*IMD%O,I2?
M1V3OH)^%;EYR2 "@7'3%!0@*]04EPHH2V?>_%--8'>75PLUB=$[[F$:"F^PU
M5PZSHS1KTH9/?G6\.=69!P#P_52\_-,R:@[XONR!]MQA=] ;8UN..Y]<# !*
M9UZP2ZKGOKFGC5X:*ZE&#$F0531-<@P>R]>;[%'__OQ0Y0G-(46/XDX3E@U3
M?M#KB-R$-:M<=S>$3QK[C_4"^:N*KUL;C[8HEK549?!E@/]H1Y^M#S$ .%Q,
MSV@RH4EP%4FM#ITX)(#BW-()>0\4VJLPF6S\"6X5UL K'@TW<Z&C_UB'3'<3
MJ\A6NO.W"&9@- <+25QL\ZF'5J)AB4O3\Z1:Z*8)8:[@]?L32O,;Q;VP(!MX
M6\1BC[/,%I5^R/[]1".RN,2*O-)HH7_)O&F"SN-P]>TCD]?,JKSX?L]9YSRG
M2\<4BN_@*%BOC6K+/U9(AEKQC/6XWJ(V0L&)\_YLXV;)U4^R#R.&';%HN"F7
MN;=@GA5Y W>%9>X.'/P+/ ?[E%5$";G5P$>^.@1Q52J+NG%1\:5*#WIH/'W(
M#/2NT:!-.8Z$%J.D:Y"F&$RZ?JSD'+?:Y_O"(?_Z%)5%I=]!@\>GSI)6._4O
MCVAGN^>CK(=/",JY@L6 ^0.,1E8BG4[4KL:P?HN?V&S35A<[AATRC+77OC0P
M5-2%<<V=YQGHU,B_RT9==T="9+Q&7"T3.LY0D2BTE83__%FBBDX4GB+!0Q_<
M(_W@PH?ZNHLCS]\ZVXP\UVG.BN]TC(J6[R=^K.._12&6X638)X,O"P:>J9[C
M4.<U8@!Q1H5;&4P:85V>AZTO!H\[4UN/:F:(!YB+=I+(&U0:LW8]UT?U=B K
MV\8U=?6O3!4<\4O7VJLX%WF'Q8LG+'.R@7LH(U32A4.-VQW(#14.Q*=^MK('
MW$=0I[+10&,(>PBA#FV BE>JGXE-A&C9PF\9[Z5F(OWC:A7G-9^[4FH<X"P:
M/7@O*HT0X\T\H675X(L-9/'OXNZEZ8OO8YLQ"SN>MDEA?$=/J^GGW*!?*C^P
M>WCUAD:]D:T;_$-!H;\<RK=4;:5[%!*GEVS2&->1-Y.<AL6X$AU/*58KZK(\
MG3OV>>T0T;\4:%0PUP@;.5$]%PML.Y'CA!P?]U'5*Y-O)-D/3\2O>U)E6.9P
ME3QLK&XT>M[#OR_MQA6WD4WZE4C*L<3WYW2)AKABZZY QOM% UVA;P/\):D&
M\CN33^6J'A([:+&4\9RAS,#;G$9[Z].[#@W*Z+A"E&Y]X[AYP J]K!K34 LE
MTVO#=VO!+QVZ'<9+W)/0BMAA&,"W^_]^@]99Q# XQ65R.G9Q86EQ,(QZ?N'Y
M0CGI>[_0(FR%[6SQ,]T:GHC5[#WD_>K+R.[4WB".H==T"L;/[T\7;A,9.W>.
M'12N0OD5JS[W0=1D@--%<</"7>EOAR*Y_%U/V_/*!?[.!NQ<V^1#)E'[UXS!
M#&RGZ:7BQT+GNV_7CUBX1-%&&W?:0?AL'B#P-0:@)3:@7Q])J]3S>5Y$VL$M
MJX?Q7:/?^.-0982<-UV.<[XU]P?3>R@!6+-7M)F:BA$["3PLD?_VC3+*?,!E
MF]<P2491$S%PO(D!<-<M@22[N$[%0C03:NX^]/1\<'+;LJH-$ AD_ 266 [)
M?EA/24.ON[V( 70TU#N/+@NZ%>8,X:1_![G9_:$(E:(P_MW]/$"66/%PN]"^
M2=\;)@LSVMW@8!JZ<_['H](3/S>/?VN$Q9SL]#SI2;Y^:TDDA=P[J%KU6B9.
MP8&RU;Y=$_%?2T^[$:3\02F'0@W6W>LY&1>>QLBB=_3L]D2>:=,E:KI&BXZ'
M1\CYH??]BYHH=H^(A!+2;0R =*#]9Y^;?2G"XZ54'>5EZ5Y'Y#C22"%FIJHF
M[6/<_#Y9X3V3FJ=*A\HO;(%[2 0JBF&\@BAL96_O'@%(PPRLKP]G@]5Y6]2H
M85G!A^Z/ N>R3GY$[PKX"DZ>YT4:O+;EP9U;I3/)6!;NTZ01QOM*3KG/V^5%
M^%SOYE[9 %W3[[8FW.,TY%[)H3>LK(WK1.-$9$:9*+,5'5#TMSKTU.)L:&O5
MCA+2KV;_8B R\ZYMBT.'AUS'VDQ99A8O#6, 8:KGN)R:31"D$6IPX>WE_.S,
M'/^@[ &$U(BQ5ZR]#LMUL6[$<SPKM%"TMHOBM(NS[3]+N?U_,]B2Z$\_7P!O
M'VMC -N(AMU_>_[GRO-_G*#[$@/H^S .VB>[-RRS;=D*2O7_[<5_3]#]3P:1
M14]%=<L+[7&+H"6UB:E[5#5C/J7_8_?(S&6=9)=0$]TZ"=L&PF%'4V ,@&%J
MZ5];XV'AW&*I8P"9,%T, *8)0D7)76+?P^,'WQH,P+<$ [BF@Q;\):#?)U1"
M!]_9H.]T,(!3<?H9JJ0[PIOINYLJ#&#=<S'+[QVHG)_KAOJB[/;" @/H/0=]
MLS8Z%]PSNMH=P0!B]CQ# 6W_2L?8G7\A:'0) EHJED3+07;?_&]"_C<A_YN0
M_TW(_R*$"($H+%-^&CZ97@<]WSU[;35-,*9 ]E?KH<"URLR#MITVG-'0>0S@
MIWH'&L0_@J*[A_:3.>"_1&UH7@",[S5WUOLOR90M-#$0A#R@/P[5!HULUO_3
M[6D)+:H7_QF;'O4ZD?[LNA2T?'F% 42.W2LZN2$HM T8*=Z, :S5U,O\K_XS
MRLOG-EY1)#IW68>6MC7\\KY33HS[H;:V\W[CW#_LO@N-..E.):\ K_&0Q>CV
M0@P@QW7RP;A6:,<)SFHDM&1/ $U]O!GA995OV/?#H$^66ML_?8)3!<?8<,KH
M35N>MT3+B=SOI6[=P\Q\_=+"=_X<G\O-%F=92"1!#E\N#S9N,F'!]X:()[QB
M+8H&:;%2,UQ?9GECGE=!NRI#@\5%\KOBC+8RPPF\>C#>+##\O:X"FMY*R&B]
M3I3,P+]LR'J_A+KT?FZ:OJ23ARZ$$DMJX7Q07(V.1 *Y-QG9-9YTOT_<6J&L
M^5:C>ZFEZR2M,7>Q#DE" +,\D:MA-IGBV#V7>W;*)H</=)KOMY;DJ7"A-^B$
M]\N);&.^NVG'C?A%:;+KZ(OX^&\\#O=,J=(&.9.XKW7Z4AVK9)>ZW\K55-8'
M?TZLA=L1@Z/?\38?.X%;G<OHFR:\'X-.L+IZNCT7T.FOK;DN':R# L/39SN!
M!SL&1!4Y[IYK*X\JW/%NSK1KQFOXFNN>=;?=.+Y3<P2T;7O!U4 -RLWCC0>N
MI4-,*-FFI20Y\[/O>][*R*@\IMJ*$B3SHU$[6K*/[)]V*?QX!.,R/)]3KN4:
MGDQ'H!G<'9465)6/T7_0U$$,S@T-&(!.,'YZ+Q-A>@\%0ET?Y76<XZE1G>)H
M8+3+4\DR0THNIRZ/L\E6'3-#L!694'%BK0E>1I?Q?CRNCO[8+7C;JU38=O5\
MUY#;UAFT<743FM3,"-:X\W1]=PZD1LG&=7AF-$.V191KP>2)5XE.'YTV)1Y\
M[F?B"."=\9$Q17A_1-8+^&6\-,*S'-^ATYHC*)@QI=A]?]T5 L  B%<,7)90
MJ7L8P$R+Y+FRQZ-%XA,9< >MH)'J,^OI!H+R8D,K>Y63ZW?/AD=U$OPP &>?
MM[M>52D&[$U0KS@<]ZX6*"JQI]3:B!S"CJ:W,GP=T';(5?-E0W>&S2S9*9BR
M1THN7YBN)I"E<^07'=6[73J>8Y?FEC"VHFIXU%D[\?L.+R_[]W!@6/9$-8S8
M':<K@Q8:>]1Q(U;OWCJ_&_XU$7A9F4/O676"OUH6C-)8GJTF)A:[2<POC \6
M=?BQ:\KDOV4/R!"U2%%WM>TR6(2?3IQ-S3,4*:HJ&6( H(W,LC7B,"VZ%R?P
MB/P<\BI+K<2Q>66);IXBT7?S1/O? ,0,\-H:,(TU.?WS<V("A(P%,[A0CV]<
ML;];VF_=]E5%5+PK?[OR2F_J*C0()5KX-T%RA>J6?6UZW=[FV0>1='#W$:&E
M2.E6W5BL'E\R;*-:S\P2@;Y^Z?N<S>G-]<!F$@^*_4^J-P0#</$Y8 %E%)Q+
M$J,T8E4?(P,[15#DVRGF9P@9VJ($GC5JN<&>3<:+.S:R%A:4?%5-B"'L6*8!
MZ:FIG"7(;%\B1=^I*KSV1B1TG=TY;,%T^2@LMOU%BIZ/2RF!)8^.EMT^$1)'
M,LCMWD)N:6+%">$PK]%+A7PJL71>_YT0:$\\*+LHW/UDB&FIK#&_Y MP\VC[
M*]0F=P,I_F+>,S>]?U%'VOGW:_:Q$G\S]9*_X<N!H]-A<RA99':IM6ZG+^W_
M*506^NR&9S6I%;H_?.*Q%\6[M,%/;)XX.,Q85')-88KNX!3LEA^>B%QM8EN9
MCD+Q+M_)=<%O#G-LOZ=J)LJ/2C.F^GVGU9"GN1G% '[!YR2'G@CVIDQK7/.6
ME2-SW0I08B?897?IM!GU6<%Z8<*GO33.0KU"8B<9"S;/5$ZBNM.U5*"3[$T,
MF0,V3A2)K&*MC?'A@8'VN"@;O+XEW>.H+F*R+ORN?&M3VW*7-OOD =_LDR$G
M*LZ08U<#JGY;O2[/KI:LT6+]#II/&HP]@SB'Q)17DKH.4[=S5O0)$RW@:>-K
M#A=0$*R,%[%ZDE<)>^X\@F>@.YLC2*7=6/=*NS=V>4-Z7G8^ZL,%Y(C&!FI(
M=?R]L&2VAR")O (H\X?TYSJ1U,NKBS*V:3'5S&U)FFI;ZYOSKMQT0E<5$]=>
MVUM?#76/&\VC"#&OE3(*;[X3/BKRW,OZE]7$KZ])Y:K) 3X7E 4%2Y4-2T9W
M;*@ <(]%+?A&\4ZAVNBW2.<B^_%P>A%"N\>X=*?0B:"\>[?=L9XMMM.484(L
MTD;KRTEIGL3;'33)>&:UN\2@G<N3[[+?(SQ:]=\!SG>)%\DZW*L44E0##$E/
M:!-E+D,>-[?S7,R\#T;Q5J/):HX]66MNRYXB#V]HXW:K_D#:A!&DKO1_,0 _
M> )??-+I&>@2!D8KO@<F2&Y"4?1MOLPJ42?$J]._;;<:1U'<60:S/:(=F^0S
MCLWE$X$[<[4HI;6R>^AHO5&^N(S*DUG%1V  E<W%YEEX'VS;=#S3B""&PBO-
M+"NY![GS+1PG1/G&A3Y%4J]J(Y)=+0([54<,+Q#(50ZBK16+GR7>;$7ZROG,
MI;7'AO(EE6S&I_8:1-(2 ;%(K=2H-;N\.-?XIGH8/N*#]=JJ7&<4_OSL/'*@
MO<&V-DYL#VO AEE'X:BS#,'RR"FR9E)I+5U5#IG^(L2EEWUMW(7BRBHIAHV-
M%^329\*+\!.)TCWC,&J'MKPX:?E-'.4M76SC2YORS?;0< 55_<>9E(&\]88N
M'<F_+4G+AQ ]"A9T<^PLXT_M86H*+(I=41'_Q9<&>2Q^87-JY.EYXQD0%C\O
M,'%SK2>W:>G^H3NE+%Q,J_@N<F[*F]MD\9.6#/507;Q+VT)$L^K"^44QZ*F8
M:PM^9962S8M)?KUK[V+1CT*+[GWBQSR2S[2\'^3.[M ]&H.49))TPROZ9W:'
M^RE_7S%.$Y_8YHYZZZQP4?39,G6GY@V>+.!.,XO/=( D._&<]"L_ R&IMQB
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MI?XZ4#.3/'[)J\7%#N&G5N#@@A@WU$8;KV2\VUZX_M)61$<%AZV\/H:#2WS
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M)SA5%6KENRF31$JNBVZC8,N@Y(F^?!WE;W#2641S'&>'W1AK>%G>_/WFBL$
M<%D",8#MKZ,8P+$!,0;P["OS":1_QF#OG>6J+?;8@GG]K<KL'P8R-_G:E?BG
MGG4L-%C=GB$-JN4U\R 1#T.3RWGN&(7JN%1T-6P=WU?CSIFW%,6R,B2]YK5$
MO*/%\=SDS2#<H?XC[7,S>YS<I^Y*':[E^M+ E;NW%*4OS$YZS*E*BM-6_&C"
M+_E#\I&'JR!\/?> 6WDE&[VNWS]60X^&$G7,;#-QWV3*JNIGB/AK372I:R\J
M6*Q2OW&^#LI)BFD2E/ &4IFZSZOAFO<*=0LOIU$YCE^A&V!GI%9S2].J(Q^
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M[):,X25:8\AJD;-ILBOWG(HF*FMAT#AX5Q@Z$![-:!FP8LKH<] 9'B"5"U\
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M!MTT#,[5"/DT<7"TU1+0/<<VX/=H^@EI2:S_A-.#N"C/+>\''CY>>=:QUMA
M<1>;')*A5TY4(2L/SFDKNC3KI_@+6AB69JW@,-MPJVA%AHS]#@*+P>AG[=!!
M]^VFM=@W!F+3VW]N)+G.*B9!ICO@N?O/+!P\)^KJ4]9K) C\!.QV0$X*HFE&
M:Y02ZB?Y#$0.5WSWH>2%#,29+U/Z*T[2M*8]]4V&5H.OMVJMZ*3_V)F(=4I1
M"..MTV  Q"HVJG)P4,TA/[^23^*EF^PL\U+C\%OLLW"'8"9/<(,E].+.LZQ)
M"WUOHIR"'$QNY<8OE#Y63_(A1!LM>UD)._%?L](\?/ (SV<S.7]7P,BDI:*V
MH7KMZEEG&3VMA#IWEYF!>_"ELLG>I['JWK+<RJ\V^2E[O5_9G^#6:;(CMQX]
MZ-TLUG%?)'R/ ;R'0JM\&HKF[7B$".V.C_NE'CU+BR2V.T\ CZ")K^T($1MW
MOGFW.Y[>*<#+'XGD9<;E<I>:09_TY&1FPTT19/S-U>2N8PB]#S1//V8RA#+A
M%63_!=@_=K@!1R%4H_3,Q\.'\JS)+U_)="\)#51M;OCJ W>&'2:UM/('?#@*
M;-_#\6TB.BF6TP;K]MW(C ;HT_D.2ZE8C#G/FT4_IRS:(/#UDFW!WL1\;P^>
M>18R;(@1R>7*W87D7$_'@<QG/:#%E3OHX>1T3^-A">.+(6-HV.%6RJFMZ,?8
MJT\5]0)50S2SR6E/*;J>?FEB%=N(/[8G5)+\?937-,DP=N[2$J@"XMQ4X&Q*
MM)BCR%&J#GY)DMXEZSZD/%5V!](CAD0H@8@M$Y,$K@3F), $EV/7]DJTE6P?
MTU!%4OV1JEB3DS>1"?G6EZM+7\IKFOW>.= .LKT.OK@',/W1D\Z4X.P\G6U/
M$T.0Y<XFFM6.TSM(A@";?MU$Y!(G8V$7U]O'^49?MZ2!(DSU!=BXWLF5(*9O
MT^-C5E#'7[N-^#6D-=05#85N(>_6SYC*+NX1DVMR]\@Y75 ]F**L^E:I(//;
M">-Q\:\9Y[>XRU%J2@4[NJYE/SAJ1/'U9K"P2?3;*SGEO-\Q\(] 0UWT(D!:
MX]5#V*)1^]U1@RDV2ZSZ(MCM?N%N7C3$ER&*7LC6^1U/E\VD;TPO*BB]!_HB
MFIY^\]-4>%A+S_) BG'YDC+7^9]4+Z-62#JL;$]]TA?W.(TGI\+=2$;A:;"F
M@<3+KY$_:6L*B9+S$4LC/H\CJK62 $]*29ETF+#R-K%8Z"[ZH)V,5$]A4:I*
MOZ>_*/-HVQXF3 R:8*M_ G3$3'*UO)U<Y)ADWYCBX#S7Q@"JV??1"S0"5]]E
M,MBCI4Q"/X0[M]%$>F3M@?;,, !F</[?:M!T.DRR<R'NPS@SS.O:N9&EV7U0
MV1Z^;6;&\%C)E-$T_.MGI(TTU$8S\..$B0V/<H72QR\/6%B^XPS$C9 ].&'D
MV=7ER$TS6;9V$&_UN?6NTY!>"J=9KR1PF)Y+786HB'.V#^N\3#3FN&L"R#B.
M1AM*_8UMBN;MSR#^H )W/8.N 8?0OB8-UF@M%-<U@SH&H%HYQ4$U\;D*VEAK
M@O_!@;0WA":\\)&FS_1/;W[O[2M?VG$[VJ>R$1SQ=AHX#V2U_$3QVB1$80)4
M+;ET/T-4Q^WR C9EFSO#*S)T^7#='/H(M&92#EXGL/@SAV_0?BB\>&2FKFF-
M <"7UK7TGO,=$5NF2/VQ2I$ FS$#%#D@L9+OB(:J"2[$?:P2?2E'^?8ZW$PS
M=VJA+,(I^/)CPYZHUN_U[BVOEB0BR"L7Z>AG1SPN>33/*<.N\]YIX#U^JR+,
MCGLN;F-(3*;?XU4TLRNBE+L14;3(KJE.#1818 <8Q:B@"JD=YK^E6%V@:U5/
MK<*489"#ZV):?K*^&62W#O^M.-OGFO)@I5&T5,WDHU-6Z5A&Y;#RM='R$<J=
MM %"1^7W1QT\")^\N2<UU#/F08>+0-YOT=Z#\S$)O3C^K;1OT#!I8<:R.S?1
M&[: B29;7I"YCM4-[Y! MOCN2_#G[R1_],.K*N.JSUJ'%P'8U5K= V1!U\WE
MW+L"6E9F\.B!S2?,]KD/A?&CW8CD*=K.<]+OMVHI>#/$&?I/Z2QFEW@M;M-5
M X4F+2+_PNTQW0&FU(4GRTUGV:]TM"S[64>&AJ4NAW1.)'_E'I][.H2HVNP
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MG?WN6,"5O(F@T*XA=G1K_HX[S]SV=7W4_ /M0L(75X!FJ!.  ET48QLBW]"
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MU_61\' IR;G ]70QM=:.VI_\^C!G'O)*P]Y-!M:<#,(WUW2A+SL0=OY&TO<
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MK2_.O2HS2Q6*K*>M!TA_]0*U9'>B0P\(Q619?%\Z[)Z _9GA!_< S-/;WW0
MXYU0_<FZ[=='F%:[SQ5!XC#;;=8&>;/%KDT:W!%^KAAC#25M1: -<]<-\ 8T
M=K*%LV:!0H@/(]R/*F,DQ\]L,)TXH97BQ:+==OB/NDC>NVEB97G'*\E K*Y;
M%VY?(F5;KGWB<N4"=7S^ G&:E 9#:'-&K\&&':YH.(D/GJ>EBZE'@][=9NE3
M%Q,YG^\J-GWSSNW<Y^P2PEMMG'_'#.7RC/BG=D1VDJ=[!?=U30&U/AV2[>#S
MYAGM%01^6X1WR8Y[<Y#QCE?$J\;T7\1,S[YHJK[PQREEJO H[BI=M:/:8]I
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M)VJU2Z_P6'9#"(>V+VWMEN$>P(C?)W%V9',/R+-IK!!CZ$+\,7HUPV]<[XE
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MNH-K&N8ONC_]N>CQTB15E ,;7]*Y(3Q%F\'&$BU'0YPLFS.BPC6]E?G=:?F
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M0D%!$_ER/N3##/I'[\.X)O[)A5^/$9DZHV'BD#DSE.BAU*RX:(C+EROI9FR
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MSA3#?'^5]9FYL+"3).$ ++$B3RMS15]\L11K02HM[">.SG&4XTM3/.\NB*T
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MDNLWQ-\QO<UH_D)HA'1N6G[T:XQ1MC8,WA2H_T/K35[,EZCS0-)HC5C9M=&
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M*])8@;2R_"O' 1>[T=0^<5'D<63$"6:LO"H1]9.=E4.M;)N"[62!%.V&<5!
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M;D^+,^MSWH%!I_;-A/IZRM93[EN&91N5QZ'1@]K3G) _ HSU&_T>>5O O&#
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M?]]J/%F.SMN]#K5CA]#,XT[@F\Q/?BWIV)?#ND8M]0CO=+01#LYX&LC:,-
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MA@&3I]F@F9K<'V6CU.\I9\W_:_(&WN6]JPHVCATGV'_5Y\#-D#H*QE<:TU8
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M0MEZQ9I: WVS[*CYZMX^?Z7U;SM4IHV"IS1 IK$R"NA9GUN)$672B.X(AGK
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M@IA_9C7]-F7W=XRMBSMN.)385F XF''*'4J?FWI>OW-'?V[A&.^D-B Q=.D
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M"EK[).E:\?J3=%,+'U7DALO'[&UU,C[^]DH8<;K12X>9(LK[_,CYFQ!UY6G
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M&9SF1V<O6HVK>-IH::<-A6DYAF6YQ;?3G7$#-IJ?3X0;3S"VO>+<K^,V(>H
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M?+8+6^-LGYJ#Q6:\C,ITS-$?M@SDL#$+#\*2>V!4,SGKOBR:DPP391R'GV/
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MP2H'P\R-UO@(56,.:?(V=]CFI[:)A*,K30 V'SW;84:+=;F&YFW+VK0=/6>
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M.8D5B(W!>P@U?T#3^2*&N19> R<5SIBCO"N"W*"^%RHV0B2Y%()%D.2,/LS
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M[9?$/$/+JQA'K*T["2Q_81&:3UOP#<;W^(>EVA=;P<PX@"3B:#++LLR^J70
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MY2VW@)4_)Z4C%F1V\:*U/.6[2+[9H-'@74*UD)!:VZW.^Z[&?.>:DRV$ZK>
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M[=$:_:.-_?.G!2E_4=6,B3&:_*JPLM@(&-&:.&^EPNHT^.0GB8NFS%J=)2I
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MO!)]TYB5D/'I:7C]ER)/M\RR!YNSR9X/LSSXG#9BRG62%S>KL+S>O;Y'H0%
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MKIJK^R,YFQ=\+>_HH0#;BSR+:?X P6(%@7 !Y,0J<T%"DH/_3]JI*8Q<\2W
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M9!/NS='\(LZIECA9)*G=CAKYNMD_A$S[LDAPU$Y_?^Y=CA=;9G*%N8L;T>V
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M0?T70CCQ*4/R)@']."WH=="U;L(P7<H[TI-.X-?F:#&#61>1/EJLO$$K1P"
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M?P0$9"].W5;O:=K>6L#F1 ]D)\5K"?2OQO*&V*ZD/MTW#?1Y;^573]NY"1J
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M:E]RA<QIU(\2+4GN-F[0Q)\.NR@U*65@$Z%_,'X$;'A@Y\U#0\UG(X8O$QM
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M[1/4B#4.;!E^&/UF0PYOF1M^\@0'#8/CJ]) (MJ<P=TSM;0:"-QD MG=X?8
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MQT>W^J[[&YB,Z.XXKL6/I=Q;'@'=^(?W;\ N3I['>\)1F6TG;%X@,'.Y2SR
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M_,=@\:=;XV],Z!];XQ\C7)!H.F0LS^>5E2UU9NC"U^!^YCO60   !!(KP!^
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M)WU&.T6IICFIC=GQJ=25'VJ\PGAL'5ZJV YK_#!U#^MC/HZ$AA_EA71Q1@'
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M;E>U,5*%,ME@_1B"DU!_&61OK'Z4N5BXVBJC#;T;&64-2:)4+,MREMS>RRF
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M7H.2/7'NEH6EK;_2J0E[E.^'AIH]WAB%^T + 81&^)0LS#O4?-?#PBF"H"@
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M,]XQ U)C %R@J:9G*ZD1&V&B@VEB*>PQ6 "? V&,V)QDQJ+VKF*\9SEJ$C9
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M$Q_=*'XKRN!G2,97D0[42&]DR?3I35G;GCAFI4NWU_R@HEJ_%*[ZJSGUI2%
M\$@P(34"!1(2IB'R.@!$J'H-+MR_JET1:Q)4);TMROJJ/:0&H-V06=V8G$#<
M+V8-=,0D-\3\@4X_GJ]+12O]!T@9%?_?PR@.VC\T:V^+.R1R_#88D@P%202N
M4+ JS%+EQ4(EWU>75ID.2%!.NC\!7O:5VOW2,<J+<N)*8I8H*%'S1BWR9;R(
MZ2RPX2A:EE&T(K/F'Y4]6U.,W:!1^3Z2)YL<K(2^5H+*U]H9(BC&[R(."X/<
MG"CQBM'5B@.[M@T@$=\I6-^&:I,!L $L]AEM+2SZ>L\4)?O?NZI?^%4G_9XS
MD($S-:/ H@0_VHK*=UH.P22;;A6I\=>M1OWGD.83X$5YMF 8XUE8;B\#3H,/
M)N]5J-PZF843Q@*O?&C=?3+YW4[$#;)&9;0L#PSWPQ$U;)JVT8\9&UP)U2*^
MB457"_AU4E[64[ _O684SC40LX0.9, [-/'8_)Y@O?D@LC<X_;(@\O*]3E_2
M5PWOC,&R<N_ G6$[KWAR@<=SN1MY,AHPJ^Z5TZSG5>7D2>7%DDH6X)"9\8XY
MII"N="5TW'NBP0S<.S8)WLW:?;BEO=>6^\^E1[O?Q(#H,84C3IS)+IYCW &(
M7#IGH0?6]*MT1G^6K-5P^(-@/VF<P^>F%Q]4=_](H?-@E%U4WN[>"\-?\K?8
MX-O5&Y %,0P'.4Z4;!L*UF> L"*[1Z+>N5QC3Z=$;1JTD;6NQ?#%X+HYB26J
M.DL@/S%;=&DHODB51:0D5:MN&;8G&%F^9?GQ8NTC 8Y;%\X7\[:P.^T6N?3C
MDD7J0<5-AK@R_NG5:Z!J![3RPG15VNT5QA4#LRO>/\T[697-U7[S"^FVE1L^
MQ0F6D>@[GD( W3>2_6.XY'_LJ)=_X]WV1P,"T^AF:8G>,X8K0!KDW]C\.!UR
M+BC94=@VED@HT+=;_$"28#C0-$HY\LDKTQ58R5@YOYHBBXRQ[S-JX)U78_CD
M_%N>')A''%?J?:4PX\%2X4AR.!;96*O78_3H,:'7GXXQ(%!73\GAJ/MS2 KS
M9&A=SNWQ;;U@-@=,ZFZR_*/DNJC;[>?D2S TI/'P=O:BTE"O80H"[6IE-T?#
MB[?*1 YH3OIKEEQ'[JHP9I))<>R44KO-).T;<;;]DJC?,,69I]\Q3,5\ FC?
M"-^KV3^SNFT*CJ5A9. !3^DMNKE62B7!:F2&H"D^GZ%*2V6A2A</*?.2)=FP
MD/C!2=RF.*5!*TGCC(A:'QM5&:1IIL$YG;.R9.]1$,HTF_'EXWG^?6C+7][)
M !P5'P\07))ZO\Y6YPCM2PQ[GH -3F*_'RZ/G8*A3ZR!Z3!R3.53B/+,3D<+
M@^SK40=RIL9_-";;E<SAS#M^[[E\&##TB5 G9&=AO(BW%]LJ. 3+.X9ELCQQ
M'S<4X,!]+?<(R0W\ZV"^XZ&CI@36,J8R^F>8#'@A24%?_LHV]DYGC@/I(*)R
MF+M#-HQA-K*U>3OK*]!@4ZWW4#7R,]>BHHKKMT)I14X$[?F[57 '[6,86_A9
MP\-0J <;BV/<O4J#4 _'O%OT@_3AD6UL96Y*).\TN[^292E(T$"+37"1H\F)
M/?<]!@:&Q 5)#KQ2\A.4<3K9)NQ<;/N=5 M]*1G3H5%7J*(D@4<OKC0!>,^B
MXOI0,7T:CD=HU^<P4(\GA#*+&PU.N"S(=RI=/:8OA/DKE5S[O '-O+&+?)E0
MI;=9=C@-.=ZYDVMW\W&BN<"I'22S@;;O2H4Y45P778S.-RX8K,OA;SE28W25
MW;--ERV.:CA5A>%6PH]YY6;A->U_4Y2(]41R65$8K#+O=%**RJ2+[.K6)EKR
M(EYX8B>^0HT;;]\<:N2Q-Q&$U'_[R@ ]*,].&U5';[T*1)GC^]ZK<SE"+.58
MA/KUYMF6J#XL7;"N7L0I3%\P\P>(L!V:P<G=($(]ZPD/;*+&",>TC<.(W/:_
MZ4JDWOC,0N1#8E'AW3GG[_0"_AUPQM\_8O'(C^!L<OWVLW+#.BBDQ[P7;PAM
M)B6QCLA#U^;7T@3U'$077V!O^]-!@#0Y<4C%]8S*9 .JM6<3^J>\+L^@:-K!
M,G^1V<>EC;6ZEH?CC!LKFC8@_6U<;PN88B%+=BA_-F"?H]NT"DI_0:2B8(4_
M9^^K<G!9E@\&D3C5W4AX2NTZ\LY Z_E,R>W2+Q#U]89?F66> .U2Z.CB#X=A
M28;OSQI%Q=<Z[H +$:<0_R? .BL8[=FDV%R?^*DAEEZO&7&"#3ROTO>?D1C>
MU08^]*/^7+;90:\X^[FV1:6 [P/Z AE]/%YUA[9II"\AUZ?4-";:@_ G +%1
M9WGINU2$#/Q$Q:99BYZ;;D0X&G/ON-W!SLT+&U6J59;^V_)4-':FU71L&:Z!
M@&?W%JK>E0EC;3TL=ZI(OW-.Z!_ETJ5QEZ0<^_EJ85C75OF^Z<G0_6(H@@%O
MX\LA_RGAO+='KN'<SYL%MNU2<>[,<W'0A[6E&+X#S*7C?GFST7%=<G@S;10^
M>36?]]<>U\.<C\FE_I*_@"5VMT-A_(2-MF8_>I)@VPREER>2%+I7I@$*3C[^
ML:<?8!S\=^_:Z@DBYG[3<DL) V@U#[7XNRCL**AV5GT8TM<#]G(_#006QO]C
MX2^1N>3->>O,8Y&B0!N,^NF>OS;LA/)89YL$U)ACZT5.'YTH43C'?ZI/D)TJ
MPH$W:*#6(9C@>"[G$AU1_ DK@$N1?U*'^/0;<FG%?DW[88N4*Q[L*A-.=V88
M"_),E0XETJ2P36B$E)9,UA !;JO] AQ*#,3GED>)F'G^K.VF9^EQ_:-(AWS;
M?@4GBO&ILEU4X7ZMO)'IFV+6<H\.%A$I;(W[,_D$",W("R@8/3\5L*%Q2N&^
M&'2[U=5U\'/RLTKUG*ZH$3G1-8'GILK-%,U0J@DD8%EDO$"C\HL#^U87VNJL
MTDX701I2[.B%P:LU3$+'02R"5OU-,K;/BX0@S;ED_.F#AOZ7"+=E4%@BN=;$
M[:R\N/S?*0N?J^5_V?<:*[>FY*$GEXSYN2J&O4E9Y %^P2S*\T[LZU?_<VEB
M=JZ(6\>,D1U>5F4#ESO\G4+!V/*G22/,FB:M-ZX_9[IT_S6XEQZ!9K<4M^#T
M5EL#J*& \7B+%LA74$X%4<@]$$DN3K:Z\JJ+R%,K_)NTA^%F! $3N@OFC-I6
MX_/&<1<8!3A32A;I(RYC?"IL%1N5K1)??0A[,S?X<G,M?1LVD&ZUJ+R7?A+#
M\>L7*TFH%%L<O <0<C-M+#^AUM0<=; JO)Y@%26''5L2S)8ZV_EF+]UC:2D.
M8M1*73%9RHI7K$1^SZ8IU5@3UU<K6V34#OU2N3T\ELB;>4G6<VSB5V1BXHU[
M?H"CHL K1X]R&<0=+]DZWX,Q$^4$KTF!B1/*(FBRX"^-CZP=1F(0S7WO9\&A
M(%W"#::SE<MZM])]H O.5M3'E+K7N2_DG3&^Q ZVV7]1W*KJ?&O;F.IFJ)@:
M:,6IWCC('>_L-WOK%,<GKG;,49"N9QV_@38"X48.#U>1JD(=D)(4]E>D G5&
M!4JL_\1(TYV.^]QJI0^66<-7P*K!+W557\[[E/02)@IM[@]!?W@T_=PNNH\S
MRO_:/?!OLL[_HP?EO[Y5^:^;<ORW;24Y4AR[2IINHQ6#\OFS$  7>;OCK[2Q
M5.E[^5[@9F.&/HY'ZMN. EI.28G8M..P;5?N=>QHO_H$8_K'<JQ02]:OF;=F
MZ?Q=!/N=M!\$IYM^WA>J5^V8'SX!#JL,-TQ)*%(?/$RW0*6=9R=I'N4#%<;H
MO$M!TC8W *ISO%VMN0KE [F\ZS9E!%HQI1*#4O?*]L<VO3CU8.G[@]7ZJGE;
M@7R_?>4P(3GU%,LCMO 9S.?W$EK-0I #65UK/[#1;Y1W$9*Y5;L:4Y!C>5O'
M:H?V?8Y []B=]8L]7#PU9/9(7+D<-=X@A5J7</#<5JPSS]LTF12:>0:*M6J>
MZ5T*6+][9VO<'8_B+-EQ$9K2^]]2!Q@W%]6J)5/<'K9L-*?]BP[9#;A)#+&.
MVZPO\K=8Q'G\--OEJN1R[7B,FW%8;M[$W9WX/FMA&]P<'\M-8Q)C&1E8JF,J
M0<@]XT_$#:8Z5 EGGV3"I#E;U-#.D5$HEH%S:!(ER:CD/T_2.'@"Q%3%E'QS
M6G!KF93G?ISJ>> U>I=:IK<O8OQSSI^^<Z59L*[_E:N2,+D)6&(VI3+FR#??
M1 J*Y6O$@$.6ZH8(I1?F'U- D$HE7AN^LM%F>N$9]^K^[ZVV$XU)OQ@^?IWU
MG?CH8%G]UWIR0*!,RQ/@>/1-@9WG8DF8M8BR _XR*:N*90K9H-L$^4Z.#F?$
MA90T("3>%U_=V&C(QH[_3\OYALSQUZ0@'EL(%Z403BTZ'H=_':[\LLNM5L6O
M/?59GIH>-"M\6317R;,Z?\F'PYR[BR< K'*,U*0.=ES87,?CX](YN-KF,PA*
M0_0W7IX9VMX&9#5W=CD$5:@D&VW.1"/O#PNG(:(!3#+& H00HK=*&#H6PO8B
M M0:/(Z/;_9TFAP H,A@*K[X04R\_H2<WE8VK#MCM=^B;4HZ>@SD.K2P25B2
MOKVLU/3%RAN.E >KWP%5N.JNW'^I/!\]YJ\-5?U,452I*Z>!_/VN(GP*;_2J
M #2;M%FTUC4'">)K_1SHX]>+:>]2[1:G^]/D)(VV'@$P%0>W?[8A7@+3[/'#
M@O1EZU'G:UCV!G(YW_B_BTMOJJ2^_[E%RWO?#/"-=T-6A6]\.V4*MXF,U6$+
M)IU_C?=WC*_U57UC!8?70*MN^)9>U:I"5M@I*_%RMV]F/,:N8<.N">W;)P \
MME(LE_N;(J%XC4QT(%%*5=^"T1'2P;//Y%G;_]9CZ2O YJ%UT?' N@O@&02-
MEBQ@J[3$N1V)CSD'DKR=@:O5V[U<PHK$G9I\W1VW8W_Z_5[8HY1:5KVM$UQK
M:)C:U*CATOQ><]Y-J8-05D4G;<8V?:ZQJP1K22OY+:<F01"NPF3Z=T,$9\8&
M4C: S2?NMQS%R6>:KL?6H?^46))<';"QPG.H^UVO%=NF"1 \<0X0WJ(=_Z7\
MYV=;/@?>P*)N!"/7HM);-?135NO%?M]H KSGW]MI-3<&P[^DIV3_K&^Z._\:
MM,9B],B$)'[6VA\##%Y(H24%B4(YD^ QD@:S5145_1709<@WG&C>N!\A23=:
M@8Q3[SUF&QN";RH=>-;L%M6,7+[&/MP^-OSVEVQ2 1(?ZDSMCD;P< *%\+XJ
MB]3XTG?->K"IOALY.?V,+].AM,LTB;M3PRY!MZ=[56Y/XZV_9,\W_*+V-MCE
M&M[04(DY:MH8B[7Q)H;2]UM .[**=+!W36,6TH5GIUZ12O($>,,LL=Z]GF/&
M$\!L.$\SE&=OD%6<\!\<N6'"&YT8 #@!D2HAH-\K3"H+W_-I"O>^B@?LS@>#
M#69G^52H3:;9'.1IQ=_2Q66E9EJ*X1NAEXN :$1F-IK#[SBQ=!>H$LLTN70V
MG<AVJ< ),M<5>!LM!\1Q7G '@0F#<*5$!4'79!1U5Z+L-/&RU;>PMY-\:9S+
MZ#_NXX<>KL0Q+JIYPX'MM8BJ[YQY;T"C32J1TH\$?[SO0_&A2JC3'-D=+F*>
MC=/+RBY4BL9QN:CO6H#7^A*TCQ<3#[?/2#SW!* TI@2^7*O;=<N-MGPH"+G]
MW*SZ7J-VVKV-^]>U0D";LY-U!,%6HBM/^V- &8<AY?R%G\_TSB);Q-\Z+=R6
MPV >5N6P<16?BMS$V;(F*W3Q E1'H0%5K2O&+_]GU6O_O7-DBO-#B^Y[#BW'
MVG6? (R"SV]KE+PEKTH=>O87:T^ ;DDD?U5BE,Z5CP+8=Q?_/U\^G(;<VYEO
M'+]542GW2Z,NYD%]K<$E13V,K-;/+^LP/%&%*.Y :"GUO$,^">A K[B'7W=:
M83Y;@E<755%Z4-ML)G)=C4(_B@"BK/2:J1V1@']OOI<.VT"CY%5\^Z;N;@HS
M\[O%+K.TRDV@\L-L=@1CQ:VKT;Q=_!.@PM7;)3/SD@&)FJF;-R6S'QAT.[\C
MYI([5K479! #$SC=>480;TLT<(YRW\PC?9^Y64IZ9>CB:G<>I7T0)?6X(MTC
M\9X[-(8ZA(>%/H^^"$M*[ G0VQKPV 2/; >"48(Y_;\Y\@Y.Q9F)7O&; AL-
MNR(7_^!=T9 3AY>^4;BH5LZ/D93LYQ>SZ4DAF-AD\[.K&[4:WP;*L3T!%BQ:
M)<-SSFF?!<EA[A-@,KT#-\KN46IJAX:PH:D-<0E)Y9+C067!>HL.N F!=KS#
M4@')O5U=998^H)?J^EV<G_KAZ\G"MLS(O=-FQJYA&EU3(YG2)ZN@$E1:S20E
M>-<K8.Z"[*^!,B-C,8W2=R9E>](359(B%_8L' 0U5XZ[Y/!RY)P$9<.!)2'[
M1ZDC+^RX"7XB"DS0$P"GPJ'[!5RHJ7NH_H7W[;\M554/P=P<'%L^P#[IM]?Y
MB,_8C(:>V)2E;U(K?4DCP5MZ<Y*'4. #&K2(2$7;S$ TTZE/\H8XX['3] ;S
MJ#0_P\M">2C;._Q1.3ON<0M\2Z@M&7&+:F@$_K(83)^QU8*UT$:;]P@V0-ZR
M.N3+F>J,HP]I/8Y<JU/W-C):>6\^ 7RRPO='[MDD^R3^2;F3"[MI4"D7:+YI
ME!O4%2.<N!GS]2 &ZJRY^C+XQ'XE]%:!H^YK?)SX9_H?74=! IZ2O\/W]N.E
M;9V<>GB71$^ S4J3[W*<L#U!V!_$A^F<1\+: K<MK.,E48=QMR> /TP]'SRB
M-P=>!C^D/"\'2<HY1N7]!-,<OYX[,$J0].H5_1#YMB4J$_?7Y3B#YRT?6E0(
MGLBZ>CC/N=?VXOL$44)=W53O3RB/C48AKQ;]7WUB!T642#$UA=A?N,)]J/O[
MV[VU6P*M-7QW].P%CW*I#V<X]0X'(X?78/ICXV.BRJ+P $?GYX6PU&]G<2.,
M+E\623C2!C$!6[NN_0*\''PL^0>SV$YB;6_]J)#C(B'[)EERFK[+/R"UNRFM
MG2WP"0*#B1+&L; TO-LAIG#RD0D+H)3P@'LG'4+,Y-_B1!6;GRO<@'*4)C2\
M0\-9C2.N*AN#,X&TJ@/5  _Q1>7?1!%9,H@+36-^(A1=M=KO'V=RZT*S"D)?
ML+B^HE\C_N-]*M4V:]$P"]E^[_5Y8;Y#WQ6/IA!_NHV"V?< 2Q5/+ ?.=[[
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MMG*=Q*+VD/RU-V&8$Y.9;/?\2Z+GA>TX:H,$!'I O5,?Y6(T'SNLGE6#JCT
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M#'3>OLILHQ()R[>DPF@@^VLU?Y7%9IM#\YM5+E#0T:'M J"I[>)C:4SBU5@
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M0"_%53?#]$K*P!NS=<;&TM835GH?D\F!+X4[B=$!=_ON4OYZ?\\!=>HWZ'.
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MRQ=3XL=D@@5_ F3C3F>BAY8)JV]0BI]HU#0&]HGAV4E%5*!C1D1]4J!Z?TI
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M)_-(/'#!6JFYC0 ^ (R6KK4WD*&)A#T77?N<X.HU#P1U4+:V:L>-8CH'-JN
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MR:CV^#"J-0F65+-5?[AP_<2(HV/D"A?X $".!FPKZ]=3?_\ZYG8YV764)A[
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MP1B2=??KYV:&U&'(HN6&*0Z'JKWTGF9MJ:^&@20)'5<ZV2TA].(XJK@]1?N
MVXDKH7D!HNZ%>?<C_32J1*KP/,G"[IO.#QLGT9T9B1&%X/1W5@F"L:'"X3'
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MV?V;W^Q?;RP1OENOLEB^S>,6@Q\ >)Y4JJ]WE^SL=%O_?L>3H',?%;O$.=^
M@)F0I"L<.$:0<Q#M=(S#H9#<R&TE1MVYX!IEB.NE=TAT8S'0R0>;1XGSYS :
MOR<)M?XF;P":X8X^K&EOKV*>]5,B_J</]B_V&J^OM4O#?=D<5@7_F/$8+'R\
M_VM.VE-.N>W#WEHCA._PF)+*1K/^J8E;^.A+:#B8W<L](VCKS[>3U+OCC^G)
MYSK%YZ>B++/)ZF4 ?^(T>JKBI'0"RZO12?M071]O[WM0[$"6M8@=/2@G"L#8
M4ZT@=M=&Q4+$\F'-R2'C(M!O\4(B3]:?'!GZ#3?DE?YT]2G!\OFY#WY#&#_E
M44V2X"E(OS7=E/>W9O&S_Y^Z!=7VR")4<H\.\5=:&^)+<6V/Y42XJ-MY/B7)
M8I&1&Q@Y\O)]\IWK#1 FBS>(@78$D/$^V3,,;5G!,L&U>F-S[9[K;/^'Z5-#
M*S8NJ:'K[0CAMG=UDAUX)V'&Z/UIAJ-.4)[KVSJNX^M=B]#I&Q.0GS#^KT!:
M"F\W&O7=@^QK&ZT3HZGNDN,YU>:4.S-1!W8,XQ<C6WIDI6%KXXWO"X$7\!1J
M!S-RGJ.U30JS"0K,\SD(P_"1G!V[7& 5U\]V#O(/.[%.A@FW(B!5YND]H]IT
MI9#+=\WS;PXREOTUKQL\\&8-]UP-ZCC.%5GJ/N I8S:83<;8(+^@_DP_.\Z[
M6%V?E29CDI5FE7G1'OAB+U""K'SE-SO;K8 IX:BIX$\'W$G\$?'S14@Y&YZ0
M QX7_-:CT$IO"-9R],U$([I'(A1CS:AIHWUF1M59YSVZTHUL-FF7F2[*9!_$
MT@#7/QOB*58C3HI.[3FQ!&'D._1&LMJ1%YE_^8@V3Y95:5%G8G.'RS#ARG\B
MG@0&*CNRD;N\0<>JYM:TOPI;NP-"CJ6O@?X$"0C/M^%?%^Q7^3#!>6X]9B-\
M:O?4\W/IOWF'G($&Y%G(.(*%G@)G'B/^R!R$E;?ZC$%07U]\>DGB9)JW7HZ;
MTLI!%<?K[0OOZ)AT/S.&5)IO7I$6<68@C(\1XR@C<O;OKNNF^NO+URO2=+ZB
M::3V;\NG-ZO+:B4: QGDJ5)'^.#6WA;5\872%E;Y7Z.<0/)B?9<%WU-8AAO9
ML4WPW?(2C\I^13T F@NOM M#V=Y%=J5-]KF]&X(Z-?WZ"PX)9^+VZE&:BG9I
MV_H\E:(] 7O)>[-ONJ!#6]M3U-;U+E>UEVJ(Q)^2RK*+S0B>I,:@>OM2V@WT
M-HCD5JQD,/[MP+O*(\=<MI UQB;IE5+LCRO;FRXBA@OS% ,BV)8SF).3^X\9
MC6M#"0?/P-FJU>6:B/,_ICMX@\6,]0U<J#1TZ?1]Z9U'P(X^B.&$@HIRXG;Z
MJ6*JN"[MR*)XX8PFB'ST ;!"-2X=B_ ?"[-<JK0TGND#._P37"@9_;T-^Z?
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MV%7$/&RH97I+[_A[(5GB]VH2TJPZ#&R$BI4O;R82((ZHD24)UTJM\,9YLH6
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MV__I[VDB5<^::&LT(PXLKBAB:IENJS&#7JH:42/>JY859BKJOAO!EAO0;'?
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M?/J((#%P:6F 2\OQCQWJLR7]!T#;QM$#@#+W_G4FW;W/G@E*M.D!L 8;4_M
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M3 !!>%8M@;(;$=R))FWP/'MY]ZM+["Y6IZFX^P0''XR43)U6'5P_R%GE$.M
M2#)WSU( E[R%S0F/^B!2#BE,[K!6Z33C1>S)G)\O&CB#$]HQ1JI(H6GDT/'O
M[-[ ZF[A^J_3O[6*U2'=A)58PXF*@:H?/VT1 \U(C)C(DB(N1[/WT'XV"F!
MWQ^;JS.S;@"PM'&L7]S@D;XC&BGF5^0ZG-Q2!&P(Z? S*2BQR8PJA^CY4P!4
MJSUB?5-ZE83PUK/XN=DJ^4<]!8O3\9EC]9(?+#;(G'@A6+%%-?9S-I;.5M'Z
MPQ/H6;<'Z3E08#.6<%7Y &+0;K5:".<@"+_GPP-#;A "4WS\ZT\R$Y5'?Z8\
MI@"<Z'\HU">84;NLW%R*R_M-,D$C<!HV<FP<X-"!RHI*RPB^!S>_57Y\?Z4M
M([_X%TXBC0*P"3C?EYVB7;XN;99 Q&K7X^&M\CC[,<'ZJCB3&C_[S^EXC:6R
MRU\S/S/ZS$<.?__L_QBM,B%(W5)OM?@BPI*L6L9&_ UU\:-"PP0V-U PYA/P
M4G,/]K1P3W%-/;#K*];"']*2FEQ7HC9_?-S+RQQ08>@HWM[VO?.J>=OK*S2/
M;+E!OY$R8#_[V5[.  U#?:VE>T&@*JY'BG(VWIW**['E2[LDZ-,1\/$8&36;
MJ6$:N4T!1+?J>R,E>2KOA.L%/*$K8.Q]OXU5@LNDS:SN?D:ZWR)=+K&V68&.
M;ZMD<54BXSN%295BJ/3.K_,( ]F8?=1,V15/J-?<AA\+RPXP>'<K3"Z#/1C*
MO+;$;9Z;V*?AQ\<%4?3F8KQC\V5N9:Z*(-E:XB<'J12<?7 8T4-3V[W5;FGJ
MZ.48,"L,.@3B/97Y(I<";X JB9 ?J=5%3ECGEU%OQ*-QGC?42+1];WD$\.]M
MZ/"O5"2'MB13@)7;]O5U":O3.+7/U&9&NC.;RN=U?=>KH[;("$Z#!S5>)":[
M4U_0VB18@9^D .(@"%'K6S,-83M4R6>?C011U\&B+$-'56Y_F?W8V%C]/OH]
M#VWRH^5M0WT01+55BP)0]TE*(V<4!19X:)J,2F/!MGIUPW JF<:?K^7/WC$R
MV6OFBMS>"K6Y//0&J3FG2+3]:E#@E&ANR9K^^Y:E63#MPK:/M+:YS")T?4MT
MI:P!>W3\9?V36=0JQ^A2* %NDS!G0$QTDNM^WE;>9GRH.YCY9ENLE&BQ<>3U
M0>[.&U#-\U?+,2,Y6P(D.!$S'=/M6EF3CF(BLBKVB/4W25_K;*U#+HO2-E1?
MN?WR=I/3<CS.*CE",FR#!/IFZ:\TYESVJ.+["#BF+8YIO.5K.=./Z_/7ECXT
MV4,4 ]F.@R%)P!X*(*9I!UL(5R5Z;TP)$P9>"S   <S#"RR2;6QV!.IW+>5G
M$'G4U/!-S/O-G&5(&V=%(@[Z8W,%KDC0J"<]QV>'/<_O.+C.P]0CUDMB*_"_
M@\3_9"9FFMU>ZQ/(<.(<OS3O@_TQXQ+)=XB"*U[=):F*9>H:/MVX'HQ]7!T\
MD@CATHV_,GYX_\?"WERM)&L10:[-6JQYIU_)]TE% GE?Y-6=+WBLH9XHM;//
MCWRRQ-,39PI 37AS1W4=LJ/,&HE'7<'RGI_PSFDY<C^@TFX8$&BLJ4EXG;BQ
M+8I13Q8(TFZTGQ8.D9Z^^-N:*&>:Y&_Y0>GS+7A>4MXGW%1IZ(=.J]VKB080
MR78$\1FGX_@6T=V/U)\E4HC[&0.^_/F,Z'TKQKY84#O2(8,Y;>YDB-AT@@,;
M/PK"5O0+0)%3X\<9(W*.(D?DB[-0K[1A@G)UY#;\@G6O:HB2];[>>EK?!7XI
M1S.V*ZP?._@5PPSZJN0>H0WQS5_([-X!GQ/TLQ<2-QT/=@VV4(=T:9#48QC9
MWE+31[C= ,?M9Q6B,R3DGJ99$?!2/[PTTH4CLXP#1DQI<_7.[FQ.?1HZ43U
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MVZ]%!&GS:^;*6QU?43L1&SV52VP%T(,"^"D^N@6?MSOB,9Z=IIGP;CDV)ZC
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M>WW#>,<Z;%H:!:^!X_93L-OR=$F_F*["&X^<Y!V2ZBF I'Z';"1O*_024J[
M7Z1I4!*1%&?JL,7RXI6KUUV5P5IZM_BI>L==.J9+_G3# B.F9G[B M;J1J:/
M'MZX)TR=F94-29:P9D&Q0'_DP@5Y8(@#Q4#A(D,;RUGKB];,,VWH)@X="J!:
MAD'&6>J5A 4XW80G//'=NM5!>%7_A35'6\EP)0V5E/FKWABOIKI/>F+!<CD=
M"Q?Z^<_".D:Y%*% US6[OLT=+W+3OE_Z5?KY#,2<3A91[QDQ8I[67[](O'1@
M2JOZ&,'LK/OYW1N&5AFVL2GX9LUA\CYJ#TV* V<C^;!MF%R>"ZCA*ISIDI]E
MNH\[3-(H/DIG07XA7/GMF3.-ZVXV^,7,5K!>*Z8_?+$AU%F&9@-!DUOG8[HH
M,.]V07CIG'VTL05B?-P?8["GDS"9N%E&WB+:'_#4:/H?9F']E5+15K4$B4)Q
MF7=%DT&KA7I<Q<$:-32P$%P[R)*HP,M,DJ0 WB>V$:9U2BT==V@$$[RT'(9]
M(KZH+<Q39R"XII95$Z"^I%[=;<--S''F@A^890EX$<F0_6Q%03(B*W;^^+'?
M[2%%*T716_*'.NTO)_U5!WCG362UQ#+YP,I[;+R.@?8[]7NKN"&$2]4A;^:I
M*P>$BC5W0X'#RAF1.V+'U_S]"'>?#NPY"B=J#<)>JKZ*?1UAE_K8ZXX1[8_5
M/A<>84N<HA;!/ABV59! IX=E&YYRU)/6$8M+]+*B,B]P1^[OU@/QNLDIV].;
M=;N"+/,I-GR95D/^C.A'MB,P?S7N=-+S;4'-Y^-'>"C'OD*#QPX%( Q-[S9J
MJ$DY+ D\H^DMA #-8*>C;&X"V9TN8.ZUUXR[N1(6/G=L@-<Q<!W;V:['X:=!
MGU\SHS(@,.R(X]KD)'X.MM2],E4J<[T;^7DR%PTD*I[\+/*#E4TO9*Z=+M""
M;U@B=>LT^ZII*E?*I56+T<:?=\>16S<C+LO=BD(F,,%EVAWPQ+.\86^!#"_U
M@"Q1+]?WK=6!]_I_-2^&\<MW7MO2^V)! >"/?UM,:J,F3Z#QNS$L\;..'NPD
MT3R]DBQ]39RMW)DP&G^W^'6KS!C^M)9 @4I"^V<W^W>@4O6ZZRV/6:U\BTYN
M+M39]1QCCPXC)5.5>D=V%<3:9=)]MXRJT$TWVC:J%5[IVV6)\HHIWM:J[0Q\
M3/V]"*DS2X-DF^GR!^9- 250]@O]'FZ"PRA,R&W&LMRDY@G?BY^.&F5)GJ1;
MTZ X+X=UU"QJ/IL"X!]W@*L.2>AW=H!U[S_N'(!]E?!F=P7U(ZVOJ^*_C_D\
M4SN!%Y0L=IUAG-C!1IJ->U$ "Y]TEDTA1YCE 6FS<"LF.D??_7<4P,5IXV1K
M7<N%6#\]RW%G/E"@?\OLYR!JJP6SVM'=.K.QYK\M:;TYNA+L]'N5RU#F/H7<
M^C9'Z<IR;9!_+7UGF:Y;9D>^Y!?AZ93AJ9UM7B *K;=[&*B-,K11S=+ ]ZIG
M[)CC.[*=]\3HY,O.J6_J2!47J(K.%>"W6K$&5XFZZ#;?/-R.=S*9MZJS$#81
M"1ZO>Q+)Z6#8>:W@"&H1T$)&S9)WQAS@(OHW#3B\EW9:,_@;4X]:U;^_LXME
M WG4U7Y\U=5LJ4S]:$Q_)$5!*(3 W_)RTZ=T=_V.<I3^#:](^4L):7'WJ//T
MDA(#]>'2F;LG%\HF&YD/,[":_@?^&?3#_F(OO&8F+9X2G*]O/Z]H2C9--J[Q
MK6#EYW8;,-/(\9;M;&^2)40?E=8,V%A.M$0(Y@VWV0JQ"%^[MVXZ!O-$S8*;
MMJ_N&C2B>)9/&9XI  :"?.O/!LGYAO[*S $![48AXEX^VQ9@03KP\K" F=E,
M@%@K+;P5.J,<J+J!$AP[>'3\(&%+F--*++U+[9>^R#$&AIH! M==ZBP?H_#@
MK-4J0\WS_\\)0C/>>?B'(]73=ND[%&0)U-_?NMM[S,=O^WIBV4WRH//1P3?&
MED@"!4!TV**F  ;DK"@ U*7_Z[[Y'"0O!7!_THU,TOCCYG:JWR+PTQ_"8O'0
M$RJ/_F,"$P7 #7^(KXFX1;*>[=5W;9&?1]1/EPL_X0)[:GRDY38Y^,80*19"
M@+>G4__P_:E@4^18I*]4O?X6!N*0"KW5&U(WLBSBYVLF1P$P<,]0 $<7UC,/
MYGC)BO=YFC6]*0"2M%<(!;#"60:=_@ EXGCQ@U.G?_G-N8X""+Q! <Q7G=FX
M^E19V"C<?+#40\\C_GEC3>R<S$= L[4&X.W#7TQ%<+G1)A6BF=88I*HA1M7<
M<:-,H"8^)XPO+SXRX>[U>UV[5\^L?3*+HP!:M;U5R>_JET^(X11 [.!?Q>-C
MDT@X:*G_56F;AUT]ZNGW<^%&@@7NG*??N,H<0=MAD 5_.(H0<0=S')O4FG/0
MB?E("#S[<>OIU7(J ?H9WTA W;^:T3_&@]:9@4<I,,7)?*EJE!@V"O.&8693
MUZ2?WF0WHP*5_[+RW/O&N!W923 XW0C^V=Y&5[+\ @(QWGC]B=6FAUK00^YG
M7G"Y/V_<-Z;GV4@HF4.QF0+894"K;K6I_O$<Q)^K +!_42P.+]D6P#M'C:4
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M4I"-"2BVNA5S/@F9<N76<]:;D<_>)5QXJZP)L/I7$?^/X8"^_PT)/#G=%[=
M&4)9VHPR![>Q2?"F@V"MI8>EB>GS=O,*+ZGH%TQ0W9E_3/,O,?]7%;U$8IFW
MENM,E<;DIYR?N*WY=FRCYF%Q>W#)*_#K:ZVQ9$3<//"4)8/V/KLW&@T;I?J
MQV8MQJ3M+IJG4+L5_7JRO_L'2_X;/&0RY"'BD<[1:5)CSDJ']=[D-P?0LXS<
MICX7/7.4>LKO/JC(0!DBI$6%OV%@:P-A+@'SA'CS16=-1,Z?ZV+2XB[A_1=Q
M6I=+"L"759;^7O4\"JRHG)K0AG#JT*MI*)X_-Z?NDKCB0#4J\H\[^5_-]I?9
MR>%K.E ,Q(8VSU3NT.02[M&QDS@EP_><AE\7(FA7"A">/*($P<SW_O)>9<!.
MI>3J!KG<BW3IOPIOTU*5,.Z>*?\W(/AB!GBJ%FU,-13 *RQ08Y]7\N>Q!=]R
MX(8M2.Z R<KS#[68)WD0>+6)T'TF' BTVC2YY -]]>#-&^S733LR<35CK_//
MLPY0?S^UCW^F;^T_A0CP.\\2-PNY8DYL:$U.77SOU@GR0+U\_.T>9B/\^A6%
MHJU3\@N\M:)"-?9B:$]/7]=QL<8R%/1L\)/H:RON7P7R&MBA(,6>?QFL?]ZA
M1F.=D:PQ=Q"WT>2K9Y+@^=J85X#;9D]^<%VY&[+F<';Q[Y6FZ%_+VTPZ,ZZ)
M9<PCC5MBVF#,U _[ 3?O>..#B/WS;U\?/I8*8 #XYK$8F(YD#5:!<$:SKQQN
MP19JXVT!Y29&;?0?[[Y;$^OY-X Z0_H;F4$,>1><LO!E_.)4'91KVP*S,?51
M1,)+X=L/ <92Q3]8>/XO%!OZKV1N'?XND'^% KBD,GV2" Y@^NV/NHMSB$H_
M+H\IG9Y0=L$$*9[ZF;^1&#3OOV%(355#D3KV<UN,%J#DR_W<L+&3"(6@>5 %
M5]##M8)&E[^1EV],#_\-COXM LA&PDV)Q[/6G.9-0YO2)W8%%;4)4UJQUR*3
MM6X^_!DTSS_P]%_5;Z>EOW&\WYA,LHO6_HG@^ #_ H#_XMY:\08WG4)1:>SU
MT&Z#OB[[7 TH#%0X:%)H9\50UBGO@AVK5@*="L(/7VF%_*+S$P-Z;ZO7J@M+
MFR,K7VW:76OA(7\Z,_0O<L)?A(28\A;KJ(?$23LB]"7H:I]'SL+&G>.?1ITW
M[<+\O!/.?>) E9M=>XH ?^U!,N])R+$%Y@A2XY,!'+_,R2F[K/@%VJ1@W^CR
M;SE/6^(_,2MHWKG,F$!.?-R'S5W%8W%3O1+KM"F:'!$OOMIF*:K!<"? ;N3_
M.E,%!_WKGN3/!U<KB?]AQR4(W/GA+^R*.ST\4+;]5U]<&+&7YU/W%<7=YXD_
M3>V?,  Z[7^=WCN);',J<00J' 4P+HL>. GOW5$9^U WW7 -TW?2BN8N_/_,
M7K+T^:LC:AN)?G!+"[5;!U?&'Y:W7V&U%W 'N.J_S?R'>EKE83U5U"BDO&/9
M,VTESQK+?8$UJIBR+M<S_,49>U)QTA8<GE[WZ.+HI[Q5L&H$@S#IND=XBW9(
ML>-'+2^K!_>[:>2E1 6.1@+Y:D' R+'4O<XPF73C1XF:E\$UPSPO*]CI #U:
M9Z@*E2*'"09_:+MVFY<O]TERB>!H6=_6.<-/BO%6S[^<66E%V/YY=4<G=X!]
M9+EAPG#YY9@<B$#3.HAXQ;OCF'PE+LP7%Q8UR^W:8G?[=G" 2,MP(,&M7,OK
M$K5*4GFN=^6C8^NOEXET;9[#E;>@C@%,+[.4G,5'F(Q7GT'_%N/I*+@8PUH3
M!= VC*=^YUX$]E"<=&LUQ05B$,/\T^;!2U*'1G*,VEEPO0?/!@VOWA3Y\?0:
MP+CD'ZO24?Q*'"B05G+@RA@9%?5F;_\X9K>,;58VTR^?>%X<#A-&9.+D&!8-
MV+6:7=6:V9?JX'_KD1PMH3(OFC(>4P"A45/, \+A,Z-[B+%$/B=]EI6'>=5\
M+_54)L[>_:6E@GBMEP;CG&E*+^C.7CN02U$ CBM%6<K&S[E=YD4:]D03AE+^
MQK'__F=:."CS,W4+TOPL%R<HT8="&<?CJ[/*NO&P-U7I0D>MEL.WYD*93:H<
MDLV>LM/61L?2]'/%/^.Y.39/^!7L_AYO\SU#,""**_'W!FO%62FREQU/([$(
M^G>8+DY<2DQ<A_=W?2A[^LIW--=5P_Z<L>J7FUK%6R=SU$+(+0V\37H1<;W]
M ',0GE5GVO@!H^<#JK/V/S5NK?1W]THS_V%Y-Y3H_K!S[_8I@(TTT$I@Z^)A
M)NB!U=9D-/@U>78]=J0)+0>?AVRS2=;G8*;?4;>I,AKXS2H:9IOS&^39:/A!
M0!??T_/+W_SF\I7YW;/ZLCRYM@ ]M>%2]P#3H:%?AY+PI2:$@^GMH+D[#5MW
MA!'N*@K$N!R2ZC'U/@*Q.^V\HX2JX).5!?_RDJ( _-W[?>?_D=DL% ^GET\L
M-SG-3*UAVV3X05@\_A"12;U&!B>N8C9\&T=_9?H(J%@5^__,.A?]236^S\,4
MDUPR)QF*B=L/2_(!E9Q$^OG <M]]0F;1]-#[-]='V\-<47^'@I%[Q['<''J;
M.L"EY)RX!D&)HFE"8],.DA@ <K'#'ZM7UP<_D^"KU$P0?5)RHU.=Z3J:V6V.
M+I[@RVUUVLGVV3.$K.+X5IW5/O:F_]@5C77+2%JQ^6<\TTDLF >&D?CG%!L9
MR;U/$];0KP^"17JXN\IN/PK:?8%!N#8^A@+;DC@UXJ'6#U#)T'.DAR.(U=W>
M=9CP,T2$#4B$OH]^D!!FV'7.J\S-:% FP!EK1;@S!'D98&S\G;4ZAG8G>4K8
MJN';HEOW\C<6M[]U,A]6(>)-NQ2 GN\YM!3HE T\4#-'X=%(P6)+DO& A[[$
MF$]5 Y;H+)E\+>J6L=;%PYBX^HLU-E_-OO]%:_'=D)N_=TT6+F'[:U><-H]8
M,B_6J*TKZ2B%.<D 1?EW+ AQVMYN[O0WR9 ?S/O>B-_Z4!4C7F#-L3KE9WFO
M8S]2$[-XU8,_)'+Y[Y6OH-BP1B^0C0*XTVB) F[K[4I:Z[F<UA6K(R8I/Z70
MTM%"!M'Z15(\E375A]G!Q+B[T\W<%_H.;DM\\<WIR#1CC$=\*'OGH[2*5>7S
M],&'-.<6W/OT_RQPECRL?[A%-N_888WO%:.V]?73Y<N1MT.<[GZ-OZ%\=3\/
M!#Y1K#DZ:4%,+L(/+:;17[ K%I]2.R(<H>))?9\JM3CT0)]3Y6(:@FFHX<M/
MB,6T$DC^4FP[L[Y LO%-K9+:<I&W@$TWG;G,TY9(NS7%=Y'DU@T"5?K>_U8W
ML18"^*CP?<L&\N>H-!_DIV(6U6JE#\K+>4/A'G%!8U.\LEOGCQV[6-D_Y=PJ
M"3OS;L55<<RT!N;$<P^?RW.I>D#&SUIWH95E9]*BZBTV^[8$MI]:T;O3:O@?
MFM._9*.UX9I4,N*&Q+/<##1)W]INTY^-P"YS, R!2_O!Q&^E;WR[*RW%;^<E
MLGR.!]'GI, *+R':M_GV[\NLJ5268O3/I]U_U$(SJ;6LEG"O>Y]EA>?\'_QP
M_QBZKX_857VQ3>I'9$MX;7;(5D+?[G4Z*?WSYE,4')A)2DA9/;CX1-_<D0*@
M1^^MV#H="?8'^P,=YR095A.Z\Z>^5X]6'5^CLU7UM-/DUO:_N!OD>H9]><3L
M(_1OC)^^ ^S$EP4,.?']6P:ZVVY6/_T!R31;TKO%Z!3^I'SL!NCXX4;Z[P^M
MSAY6_CU^/%_G,O\\OTW\/VN =<62QU8AC98[U5D0]*87"9[5C5WG,/N0//\@
MI-EB/QD3BDQ>VIS7VN:_WQ.XL\^+9DG[YEUIAD>'XI"2JJ%[$8ACD9@JGJ?E
M()_R%M6T 8G;!OD,-O^SAF3X! I/WH!FN<I[ ,\1AY9MQJJP4;4R4==8U\ 2
MDWG/G&VO72_LOJBM8;(I'6!FCC^((VEAK!>DUF6S.3F%/QPN"3PZ^\25CL=E
M[!\)Y^].KCA9U-<D H6V* "J 3WM@T#>T;91_SL^LSA5=0(DS+W:VO37E,@>
M'9WW6W0\RYGF)U)6/ %.W/QM7DV\!/O(LK06&\$&Z\=S[+!''&ZXZP]RZ/N"
MD%]Y'W'LU?_5R9F"$@B:,+TMJ":0 @KDX.M(!\]1 #08U0\+0WT3]?G9!Q;5
MF6^R=;+?EUT28OII5LOMIHG\2*R98PPM6>'A'I$>?+6MD@5UL]^'R%R<T2:/
M"RQC2OZVMU ?+,!"ZL=V.<WTO::WZD[[$>J_N\!0MAT<_!?/8OUG_*^-BV;U
M'5_R=;B\CF+R2GH3.?H5.H#<;VF72MN5C%N$PDP2A-@9HR_&[[$LV]P><C\!
MS:%#2Q&*]YQQ%AVX:./K=@+@YG:S[\-9>&"[6K8CH#EG[>A-RH6?=T2O=OG8
MG2/$&_9M3E( ?GC4\@NYDNV:><B.HML\$_U9-0+/1YHUAET@Z:D*A,7;$V,@
M$0#5BWQ$A=CB-PZ68J3=I)&9Y3G7A#_'PUP=9X-O.\"$?Y$X''[DJ,& B_O,
M^%:LEE@RJ\K0B5]_.B:^:WEOZ\%E'[?#ZPHQ7=_\_)%/^US73T"0'5&Q_A0T
M'D**T_Z.EHXQU8Y[/'H+SGUAR=+O_<?"O1LZ[0:@ $>_I9.$-5I2RIWNQ8>\
MMK'%+@/'9GS5/+QXWA"(DEK!JFERHF"0#\^UEB^,$T&!L,@%,@_&BBC<MG_D
ML1O;VL;Q'/6RDVR#%E([]73?286>1HZ[I#UHPIL^78+1UJ'C495O^F9-[FIE
MYWERD1U(&K4VGS%[.7/E=)&M;"PP F W-WHQ_@\#7;,:Y2LYRCJ[\#M$C]D^
MS@X>+B2!!Y5OL2:'@4W\'+)^(. P<.>IIO!F$/4;$^ EZ2Y_WAD( T9;!H=K
M3*YQ7D4=)"31M_$%77 98&R4SP&).NR2H#V+ZU[.*23)P]][.LZX;QG7A&K#
MY L$-#EK&6Y0"3LH?672345ZKG>8-HD14V:R('EK8S8/#N2/ XK>R[XD\SSV
M-2LWW'<F40  /^SP'@7 A\+"5";W>1%J^WT9]N.DYJ4WJPT0*[^A;C\0RX1I
M@E5+RMVS+T-SSTPPYDH:QSD11,L*>$0A$<':QP*^Z'U']OF-YSZ:J*TFD-X<
M4B'*>[TUY>A4;_,=Q[SD!K^Q[ZA?O949N93@- @I(UL MRN/CVD;7Z7H(_=J
ME@LF?-N.,C+! N430,L'!,WEAQ6ZQ48J:1^$0P]6]2M&JR;U5)^/B$M\E_*/
M2,*K4MF(S\%,L58C_CK%YM7K?O +I84!T>%QA:L6-@)XS_ALD@R"8!IJSYH&
M<]S_/IG75],%#)VXQGCMDH&%I)V/3R X,-AHR;^<7 5<\N-^;3"G?W$,AY.0
M@2EP?IK-2EAE04=OYRZXF+IC<P+R,-;Q(4JB-WC2/O&NVXC*5LX$B'62I8!L
MCA\GD>CR6PQ"F?O!U)^DJ,"*.LJ5&O698CND6Q=UVG4\:N;\7AV%)L'B&VN1
M-9$#@$?;NL6?E1GG7$R>$\S"G5\_?([>K;-S"WVXQ?_:=@6@A(Y>2_78S,0K
MM@N!%*/$90/NZQ>83YSEN49?%&2RW4@LBVME4V64E$FC S'1]E[X]G![.4 \
MY^G;N^EM+D-%0EL0R78@_C=X7'A]-:=FSI>:)*1RC7='RI&7R'WJ(5E,<1Z-
M0B?9ELI&/;-YDXL?G"_WXHY_-R^SL^_"Q0GAP?YW[.=1Y\VQ#J:7+:>L?M5<
M+KU.>__^?8@5QUB:]G"5:E3@U<JAC:S*:E8SV*)Z@YFP\V-183^?ZJ;U2$CR
M_C;4KWSE]=& M7)1?0A.E#<5?QCB6W#P88VZT;B:(/O.1R02;35L'__A#%]#
M3(3*YPNU/JB%2A %L"\A20X;7;:0R)JQW K;K^<@>D]Y%^O)7@Y(T^>S_[0,
MHKU_[EVS\+VY+-VU_55H.WS ZP"VC.I6'3D2L<$@ULWI/NMC"CX/T%[ -\JQ
MK,?Y/BO#%60XW*B-U/EV78_CGC@[/_];;BEET ]GU1K_._,E#)[;I@GS6H.E
MZ*=J.VP1XPD:&8O>JJ&^O.^68N?GF&)?1[1V"NS'1BM<>G&.8U ,A<+[!JP;
MR5, !IW0ACW%DEZLOLIX&<0YJ_J=2[UY+DV.$GUBNQT%T&(["SUBEX:2&*,H
M@$@8@X'>][$W/)U&59%K8^ITFC<WC4/B.\>0.>IX@S")P%O>)8_3U+_[*8)
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M7DY*Q/N/X)EM#C7CNT8T]M;V93L;[I;FX3R%_/_^(79>[JW5(H./^_>M<\%
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M(_*,S9_QGZ2K)@#;OF!\&*L='C<).Y!GGSA'7E+(C%^>51* 92_ ^C]H880
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MS6ZB'5(P O@LB.T(:\67U5>"OK=T%4-T'5VAUA]/Z9^TW;@M.MR]\%J]B#M
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ML=1(8+1',5:Y)OAM300GJ]#J,NLJE38^^QBHO/R\"2-]U73<<@VX _NY)DI
MT7< 4HX.[9\%W1:KG/ARL-^FKS44*BJR8I#<E*)_2*CA9F_BC%?_.#[=%@N+
M#&'4FIBMO[5(&?0*FO"^-O#)[>:/I*S.X_YW/8^+7<2>+4D,_ZI)TTE"()X]
MEAF-TPW8D< "!MLQI:\S3DZBE<9]I[O.,WF=0<4>R4>=^NFM1$WC'%];,A\J
M*[OJ9E_>BX*[L0G1D\W+[V8I[-!,JI*B@CHN!,-3?M89D2*J9\MF8KRC^_,2
M0G%)$]OH4[?X54.]WA>#W3]PGA@(.<0XV+%S^-3;JW I5MSOHZ+.>U^Q*XX_
M5NM1YM-0<3P7B3T#<B[LIT]@H+N='2>I#E@.&JV.J%'W93_G]YO;/=^)=]*Q
M@P '1'S[EY)_]8>V7Q"B3'2'HSN]\H.;AY[I]:^H5F4T)8OG1;D"+BZT5$->
MTJ3DHL7'3KSQQ,D@>RXGGNN21PH20\!H5R_:4%L7/ %%-H>7:KPUB0,?+M<R
MYDI%W)F*4-YMR1C*!G;+DIU1O8]6*Y7U]00.#Q((^ILD5\G(F0&I=D!/YD;]
M\]TCQ)D-0YW;3(OX_N[FUTW@]&05FC.VI_C%TD'BYTG4TOE 2SJ,VTQH)@AJ
MSY8]>2QB0NCSYEOUN,^JA7B$14.MGA[ANV^ KY4R$O/*MIP=1M0.6+X0C9<?
MLA!8"H+"-826;FYF0D-"@[RST#FI6@?"'@CI'^!YD#M]S0M#=&QG76B_B( !
MC^9?G* O+Z?0L!]F\4B3CP,I@79\RH]\<Q9%NIP+C9:(+@T]&;XS,-.Y?#\V
MMD+97MC5#I87S&ZGQD0ZD\?HN406X%$! K$Z/7MMJ8[&72H@G30TU4C&0/V%
M9B2?>MGPD -3GVF<BX5]3[DD_#?/0OD9E 8WM<):&F>9FEH_R;.Q7DWT @ \
M'E@MCUOF?,'+-RB<\B9A=@&X? W0]SD6M,J)>/ _O3[C_X$U(503L1_WCA?$
M9[O'NKS&W29'7G SI[QWR_$'] 4Q^[^\(3[3%"E7>!=35Q?5OZWZ7\RY280K
M^3DO*$\@ER>6OS<;>&MC<BRX:W*V,W230>_^MA :\WT<MN4P"=N?R/J]O4!
M,7AXJ1R\5 K$R);OL&#A7&+= .Y7V&_]$+3!O_5#N)M_#9#R^ZT?0ME-EDT#
M+<K&I?V%IX@)N0)AKO2N ;\U0?AO&(BZ+LI/T<A83&57?]SU?DZ@HL?D^ELM
M:3>9=Z+UPXF?IXK%=FW^_=D#6R:2$_WQM_4U)D?@;;P)%_Z_>I?E3VO&_NF^
M)U..V249U$'P)[EZ [6LU[)]A0\V8Q_(EUF;VUZ8N_XAZK8\1FO:R&H4-&MQ
MFH4;P)A ]=7^"VX>%J)+RJ["8TJI+J03I2\LFO2XM--/'=#MP:!N4'4LT/S8
M%=YP?*[1@21SBWL?(WGY\_2%O# :*:U]D!Q94E%=M#O;^5A?U>,KR2S]=RRJ
M]"=#6"<YY7'-,?T1+,4L_YVOAO]AOQL.\,^N^O4:<!_V\1JP934"/C#];1-M
M(U^B6[W@=@<X\(*"SP1-=I.U=*G]XZI_7/6/J_Z5J[2U2U?8"70F?<0<"D O
M77_]\!:I<9N2I\>^).[M>R#?+;<YKY.C20I#PIVO 89IYQ0 ..3$((-4%M9:
M QB,@\N3SZ6H977POQKKJ-YQJS(>6-T6G2$2OL]Y3V[[K$<UNR*PVX"%\%#Y
M=<\IM_VBPV>>?*>7,2??%PQ1#Q03)B]4RM[-.YE](#VXDX@NT?[EBS_6IG\3
MZDX7\W,,;:2T B>T5IMQ&#;)[ZQM0HJWK,H)[AAYV/N*:QZ@9:CSR'/C_([$
M(@E5P*)J^CRD\>,CTL2,_SDM.]J1.I%\^SC;PR8[(.Y T"<H'F%039V?68*X
M6@PX294SS'8%R5X0_.U]0V.==]':&UQO(G\GY_1#$1UFI%LWN\;K$;[S[G<-
MDW9P<*X]SOD4(YS=9NTF$M6,2]K)2HY";/=DW0]G'D#1]S_8:"9#M\$-,M>
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MF'A!37EG#[VT!,+(?4K0-IF 8&S7^:\!V'4%J887]M6N!3:-[\@0D-/PZ6(
M5QQP:?#69@L#S7UGN &"]@WR;K&GL]>&G@-Z(2:VC48_YK&,^-9JN>LG]3H,
M^. :D)F=5+[F.*L:Z/!UZM=)M'>G^JX@R>-FM[>S>;>Y4+@#4,8T+/+5;:-H
M(BU#PDHU::*0_TX/<4K5"3)01@67>^0MW2=5#Q$*AB4%T0SGBE0/+1P39ZR
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M-.0N<J.I8!Z5TGFD*/JC:+O4CN1SL0-;$(/R!NQGB9:3G$8"VR((IZ.5PHA
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MJY@L41AL5_E+$[!_Y5T0H/TWC0>X[^8H]HAX5$?P3SGQ_]9K_\U2-6(=C6M
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MPMRG)6G$F$0,8ZM 71!8/:P?U?"5LE[N&_%LUV-J=G3UM-GT)% # B9Z!>Q
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MA(0ESWL?6[M- GO+FJX!:U?F2SA[5ITE+L*22&9*=2/ 1;AY\/GH$0U)QS6
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M&7;B#=H\- @=JZX(LRAE>TJR3LTL[UF$="HK7F\2'#^*L7DCF]M8\PT9[8Y
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M'/B98=I!EORGO/;>W01I0>',DZIH;.21G,S[VLI0MJADY'<:H<&>(EN%OR$
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MV*$Z2NT=AO3%.YJ&<K$%!MY1EH*2AH!%B(9IG&;U!'?RB?*W8<.:9I86?X@
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MO!VR2L"^3I_R$?A"K^2)WRI[;[7XC@ 4"7H_68H8 Y_L7^$C?$J CCS;)9_
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M2/6AR_KOGU0+P9&BC#^0P",43O&%I)GB-0#>7-J=!;/=:+:.[+Y4'-UV27*
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M>QVTSS*F!X/TVW>^9[XYN$0L%L7E7'68T4["7L"(6E]P-.;B.2V(J1%L&>*
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MI?FA^JG#0KY>&AR.A6 KS#&<5NR)W8^&N<N5@^LD&1_@E''^+#:>Z_0!,XU
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M9DT7MQ/0('U1<TM5SF1KF8^J)Z+,_BWW%QK+$(.7_F>W .$;1]%F\^G%M5L
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M.[G9X(H<$7U+2;,2?QIUL2GE,K )\3S[9<_,1=\?XT$B@@!)9HLPT#I:-C:
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M4I>(63NG[>KS;B"HP.G'\CHX]5.BSK8O^'?K6 N>K37V<6O"3U;M^['=$]>
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M%W8[>MR7VHHNOE!V)G;+ 32KNFX(1AM6ZL_($SCUS!S\"=D9H1+]H'B_2!#
M<.L=\>,L+()'OGG[? MD='4%E1^S_[4@)\Q6Z<Y"$6#,\6D<\@)8+=Y]A$]"
M:N"IS5BTW4*)B;[AI(0DV4P('VC>8*V;#2 PX[#[,)EZM<-A2/]8@!)C--1U
M\71TWXX?MB2<DZ6J0\A2F1)&1B)Y6H(@\98<]98N2M79;<C++_!08J\?WVM:
M?R7[ @TH &Z/0;O%SZW))N<%KFZ8QZC,V"7=LQ::K@-&%YZQ):?:C5F?W-H*
M8;/>J11(6[>0(6>8K3." A/-QR\Z^UZO.:B-W89F+["Y)FTGFE5<8<9'SBZ5
MQT.. N,@]LZ5^=TE5_HNWAL)Y9V -^MN"2?KM#TU5M9S=T9/?-RWB5T*I@UZ
M[P4LVNZ%J3K0;)02L/G<RV=WL<C?W$,=(34&%TI3SZY<$*OY6"(FL-AIIMNE
MG!7\$VY)^L^^R:LZ/9(;\Q\:B]6EV=[@*9GT%@ OR-_'!!N-\(O=*A#[LN]A
ME_;\$#JD27@Y=U*)(#D.1-_X8U#H2'['9WY6R.;:4S(/?R<XS1"C2,3)N*%^
MFX^E6.YO&U[R)Q&O[,)R/H:XR*Y*VUT#>CDQ^><A]T=UIJ"':CAM;"1E"SHB
M87$= _4RD>U-.WH/]TH77ET!!7.!?G,# 2<KMR:;V^M4!0+I*..ZOO;[E+QQ
MO@Q,&[$3D.GZR@]US0CC=AJ47' RG 5YRFOC+JVXNO++S%NVMX]DEKO%59?2
MOS5H!-8\M32D+6%OBKF7*Q2:B'?W_NO'4;<&N9D)P95B/6$RM%3YA8IY4QID
MTP8=GU^=;FW09+UV5+IW90,[D/]2/4^96]\8LS>]]2?6WL-"*,2J4O#S7/#P
M.(X>W9VZ")'=%3T0\8BA_93F\2#F]WJQ-%->%G=O_OI1HYI\_'Q\ K=^-3*A
MKW=^']? !$6[=1A;A+Z]8=NU)XG>,*4]U$[EK)T_&G-$*]2?EELUV?RI4D9V
M$:5!K#<S/=4K\]W!A6^,]B<9T\L8?,#R:,UF\13GB$"O\4%=3,V5\=HNAH$2
M@4VPF;\$]%P#LL--,2(=#3HASM< 6CUK5P1XE .Y%L-&)HS/$Q;UX0MRKL'X
MD;?$6!-PB70WL<;PT^ "*M12E3[S_FN_V*!S1P^YFA&K!H[TQ5T61H$W?@HV
M]]H+)-G2<F)[.2=S!5R'JHS/1=RP0?L^TOEG/ QN;1NLP8L+\##*[P+\T<\Y
M_=@^2FX;G'7LW]7#Q':@K1M*,XO4/, ^POJOX1%Y%$"-/D&/(4E.SK2:35\&
M]&Y^D&ALOAY0)BHQ)]GY-Y'%GXH-0+=&+M,_/RK;V7[*&<,L!82_::TU#&7R
M<XC5.:U/MS@KAK:1ZX-RYV?V<387RC\P6;HW7/:;U$DI+ L3_"'X3017B8[*
M,Y"E^8R%?)/QS]BVE8]:]7MB/FZOT=3!32^0\<6%HL4%JV&.:JM/I\,4?LVV
M/=LV1'SS908;/1D?S#I+2DMW83.EG5=O%+S*$AHQ[YEC&+^(]!?E4^YP37H4
MH.H%XLL;V<UYROM 2AC^UO/*Z1VE5<[$Z5C+!8YGKVI#TH8#F=ZOB-/8WW>2
M>(F.B,L6AV> I:YF'FJ019L03UJ4/Q!J$3?5<QHG[Z$<]'Z,1DYQ3(HQ[S9_
MLF?]T%![*8H$9<8^(/BY'6$N.]V83H21>(-.<>,8V"NU*_TIUK6ZTZV7]_BC
MG;U][H<J-'YZOGN2FG6_YL0N=BII"71O[U=-C-+6 ),DY[9V==S^Z#QR]>J)
MF#OV!NA!QQ#I+Q<OH90;1AP'KH50#Z8J2Q?GVI@>QPW>K_(N+[Y$=$AN)]67
M:/@LO6ZA5Y7=G4UI2*HTO$K3#)S(NMOR=>%HW#)DZ\0XL(5YHL8F=)-C/$,5
M3NIF"7$=0<W 2[Y)'>\H0N8QIAUOQT5!/<*=TS*!N]G?_%)*9P0?'T2^^:"@
MIRC/)TNNL7\-"";D=$6FM=16GD,[&$KA"^\RW:FUQKSYW,0:#57I2R0D?E,#
MPD>R*_KV $=I^3!SK%RLQBC6=-H& ]5!3V8Z6>GJ IW6]8>J5U-UUWEEE:V/
MP]U>E!\P18LG%KXRKTVXLVM:DL,0=,?Y\5E),U$;%1U'_E4.\B(OW[."QC1=
ML_XHB8V3_;T?@;VOU(32EAIB6Q5J*&<BYAR#JT&<(%><)];DGHY2&V+J\S=U
MJ!.B-\_T7X6[V#_8">72PZ?^TMI+VRT2<KSU*[FC-M:]%-6IQK9T.#>Q^PZ/
ME#?[(9"5=HBINB0EULOF7!YS5_JP&@'3P9(/>3OD=RT*$&\8T8UUESGD&5M[
M<081A@X>?$3$A.E^9+@5=HQ?N &?#@YR+J-.95:<=!Y@0JE?JH719:UT"&K2
M\.NU&(6'G8IMXEC0:^E+/B([4@&]%886$;KF3]G4I80%-Q3?H:\! :)EI(I>
MM:H#+Y;.7\P:6HLDKB8^;]4V0]TY"(E/UMS;/^?QF<0Z;U$!NU$\OA $XF)X
MI9H4W\I3"Q'L_3KII"NMT-G4*[2PM)]8(55D-6H 'CN&)Z-MSL10>U!_\*D1
M9C3'D9D_-V1O;EIOU173B7AZGT38,^6DM!&(T5N\8M6!(R(,518A!LVYN0,C
M,43:)^&D&IU)OC7HGA=(,;W]E73-&@G=2W,JMT]<I>5"EUV,[L=='ZYVJ^?F
M9YMA9Q[></,ND(\K(K7LRN9HA/5737]_^B-]O2W]KS&A99B7<RN5]2]&V1 \
M#"[KQ"==P$)"R#$IK2[L]RY-,C#=.8;:7E@M<)XM#;C6_$4;XY&UA23E:9YH
MJ(V??ALR&_?N":?,[?PUFNVQZ>(9K/"(W=+X<LP6EEAYI\5UBGSU4DX<<OYL
M$-\IW58+/ #=7JJK-X2M('B8P/GZQ#S=DTK37E&/#]Y/*95)E^LF,0Y*RNR9
MQ7BF:('7ZR8CX*5YWY=LTLFZH-RZUE3I!_NVC] 5R[\9'(YNY\,\U[$\LYR7
M[\1(JXW.BXN@UO[-XN>-XI!+A!MCP^4$1'G1U;_0.G:V5RZ?LGF\Q64R_2Z*
M'=:!=I/Q&6+\5A!BC;P&!&'^*B7O$)>VO@84[^,L):#9'4OIH8)3UMM2H*'%
MSIBU*78K>+K$7H4FR2U9D>GZ;8]2Q.(].!J)LM-N-Z:4^W%XGN^)PN?\M->T
M3+GS=#&9!JLM\RI2>)8OJN+1[9:W8>)[/P>=]B.M?]L'>[(ED61F_T9J@N;F
MFH\DHPA9XI)=W_G1M&TB#_+S(=)0U"[.>(58[N+L&@"'G%\#TLVBQF1DS1;+
MPC;SP2) XO)A-JNE^$\_0+&/-W1C"&B[?6Q2Q_B"@USXQ/<[&S@*(:X"%!+?
MG2^/9'0L?OJQ$3Q^PGG'[+!,8Z2%<5-*O+RA:'9+)P%A8:-GT5)WE&1A2F(0
M':,D*/@<KT:G!F.8.6WPLO9(.U8CP$1&R@ >"#/[['COC>6704*6%.<?H,T;
MB"&Q774-D+TKYEZ=<&+C"T6+25LO^K)V.F^*,E-TD^QRG+]:@0X1^BIC)0G0
MI5OUI-^0L<J+H%3Q>85Q,8\:KK0ILDF^7GK*Q1Q)>IWYZ3RU8K$&FXOSK7 R
M]<V=:T!9!S2Z9WY+!YQ]@_F[)WF];]ZS_-.':*-XQ?/L&N OPMP>8TRB[TZN
MB8XHS#(TDIW,]Z*L0<>LYE"'; !=[RRSTOXJO5G-%IK:,1EBBT54@::N]OC+
MS^&_'#O6A\9C]::I.V1)%29,QEGKQDOG_CP"4^Y.Q4N_52*-S\]GJB]6C='>
MA7C'[;5 YG&TM-)]U%O[F.FAE823PFX]X<A@9O+#5K-WB"WH%.5F"_DU(%I>
M\6;.--#C6[ITD>T#!)J(\3VCY0\ALJ^%ZJN#=DI(G] <W3>[&_PN)>RTM%&]
M,E1M#&)K8FD%R]*-JK_[[9U_BMO2#^>(YFP,#S6?)=2X*\]QGKSZG+^)D?VJ
M<NT(F"AV[][VST%=7YXZ;;M(US0NS'>/LK;+?C4>M0@B6V?AWRUF9CB\:E^Q
M#9%7L1ULPEQ6*YHE^74R=)WHA*_5\_A6/6_&'@P0QN4*2.,[:A0"/@, 7O=_
MI"&"B[6Q-2>$-O8]HV?8(38U.NG](#?H(\MQ>YW.S35#]KZ9\D>44?[WWBS;
MX0N%_,&$9_7"9MT%-!.T)W;96IK@_AFU]7^B8L*Z7]&<FZ_3-_,4)B]J!'-.
M&!WDC&M/ W$C'$GP5_HRB8/+S*4>VR&S!Q*!.S):><H6GF<//81+AC5L.!-X
M^6_<O%EO_@BX2GVVI 1W#=C6[AR#;#=X7C26-=KWOXS$A)W1$00<&U+1I^J?
M2C=NE.QQZ+G-#C#S=OCJ\/[I=M]^YRT58BC=I1\8D9QIDZ03G#;"%D'\AGE6
MG9X S-_S((>I^<:[+*1*K;<CT)%;U)X1F0"HH,'L3$*=#L&3KRD/%3;5T<B
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MHL@?RH[?2O$5RT>CUB>;[$6]42W5B_<V=+F(([NK3]*#]<6KD[QDNS/!+B8
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M"O^M*[CJ-2C^'_+>,ZC)/FH?#**B5$7I3:4I57IO*B B14!:J-*$ *%W"(*
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MC<(S,S6G>'5S->&.ML;J!GK2M^IG#V\WT]S8]CE!\<Y Y64J/AI.&D?R![]
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MHCZGGSV/NKV?SV7KO#S7 YIU.(36ABV+)E>KJUGTHAH#M40O0P -&9-23ZX
MYT]>$_L_@*7\R2CJF88;^.R\2ET.+V;>:?1S*/4QF_K&@TO'87YP#AH-:[LJ
M6Q,SEN*D&.=YTCQ25V7I52*=I2'A:[!M!GPW>^D[G(KSC4/\,MYU4M16Y>#6
MB[M\-#<WIL*C0Z#6_@)$$A&4]O+DENEBE>TIY\Z.Z$50:Y;G?%.<CNZX_+,E
M&KI-P7PG*36CU@S4/J,O$*:7W-7Z_5?J@"V[WW)T37K&G#!83@+\$[GUX,W^
M&M(">#&&7 %OY=3].]CUT=$GO44>"7N1O#/DLZOKGG/IE/OE" .AVAS=%NOF
MFK:+?_J!0_Z'"'F90M^3[*6_ZI%>>7Y*-E%7 &6ZU)4YT?-W?Q^G:X=C&0RE
M$BV* (O]G&YO$CS$$@*:RY])C%X!(JX OPTRW72@2!;(MSF6[O0IYNV/J-W/
M*-4='.RXPPSZZVV%VE(C2203JPW2M+^!$%&Y+3IW!; C2.[NL[ T"8*Y@(U3
M(/[[Y[5JMM(_.6,=F,0Q<ID+]'XK&A,,:N,P#!7?741[/DG$:IKR0[[RU5 2
MKL,M4W:2^N;ZNLFT;=1'9BW[70/:?+W?EH\C \*G1X$8]'5R^7$^=1I_YKAV
M*D>4O(BO90UU4Z^K2KB/2?[H\[RM(5<RW]]=]"?8A0G=-!1RD$.G3,8UV>V.
MO-=3,<GL,2-4A/)O)M5CM@@9M4:%K"]DLM1EMRZ7F),#[]JMQ'12MU!#\S.I
M-%_#SX% P>E4[MC*>Z\^J<GHR;KK.B[<$W8M'N%IPZVFF;K^P-!!^YJ-W':*
M(S=_X:BIJ3VW;WDT:\<(2+6+@JA(C>KK6T9NF%[6V?H+L=XEZ?O0Z\X55+3!
MN&C?S'\I>WHH'(6'IG8J0+&59D^_?OU\QYAVA>,I67A&<3/R!,(.(FJ>V4KN
M8#<(3^&G]:X+/;JG%EP@#/A'>P3G7:,_<^OJ]0&-THRS<I[ALY,],<&*Y04F
MEK.HX&30-T/#\)#K,'(;$ON4V]^ZT8L2G.M-$!_05"(<X6FY&_)(-FRIN884
MICR($MO1^09\H0!&@$\QFXWOU@GX9%.? /UW'R2<SZDYUE0MQ;ML*%G><$0\
M-DEHW8I,62YCW0O)Y/0#@PK)A!(<8<7C2:A1ZX#Z73XI.F]RR>S6(PGH"FEE
MPIUMR/3C^-+57$Y[*8?V67P+4V\[_^!A]C.=>'D1B'6^7Y)-W#H#XJSV>V[@
M*V5&#Y_8*P#]C=5XK?LMJ4AH+L8EQ/#N%DL-!HPA,C:MU#!9.N50XI],^X68
M'!IHN+"\8R"GQN_7WZE+_M0HF-,;/84?Q [6A)(/Y*F7;Z[_-,7'Y[G,*5/\
M"HW56>?/&;<T&6DEJ_&3D9>HF)]K:J*?HC]>6TQ[QO1-\@JP!^ARV7Z]:&2R
MLF9+4*DH+#<TE[YQYR?9C62"\ 9'GR7>&42(V3C=(K P#R'!2TAJX-QEFLG<
M1:.@RP<9?UOG6\HZ!XK?*TQU8FIX)GA&O=ONPZ :+G'C(C&I.3*%9&34@%56
M6YNVE\N7BF<;RB,UA^?V+8VCNXMMYZ+WF-_KON3;(-1V?<(:. _NQ00YWJYM
MULXO-38VUG*%EBE;)YO8\2?>.X#=PNR]0K="VY$I]>?7,?E%R4<QYL#(TAU"
M?%!#R/>JH;TNVOZ5'*A5/X8H75I^?_1V%STDEA.N.)XQ%0>N"M+GC?(:IAXL
M7[A,%2I >]2IZ:91FGP+:GQD4^UI)HFU)3Q0Q>7A>GX(BV/0UMXB#8JO7WUC
MV[P"]-"0Q2[:9GUHF7;>C>K.;!ES>0YW89;^O$;]:]F0V]=K2*8;6)^6:7XY
M6U[3>_%),JUE)OAB\@+Y)^H=OOLXVR&?25["\_C2U!=!KR7+W[7X8,"#/,M[
M)=Y_2U<33[W<JXZ_>9;V>?(L/IK3'TJ[^?H'_^7H#Q?V*T#G^/L%.I,Y,[_Z
MGP<J+N)UP/G^,=G'=K&,9C>ZO)@>>9HA8[RRWZR#.1C%SYM4)XJ3T3L1F4-\
MVHO?.$38\*.E1@?(Q14B^$S5&;M%.+ \%(>&\)II5 K&+41Q-QBT1_<O6\+Y
M[V2\G[M/"O[S>EL:O>VTGK\RL.D*YQV3EY$L+-YRM6EK!:;&1KY+OY]/%C(R
ME;1E-K&;4*&(*'_=[++"24C0_FZLW"4.8HYT<^\/DU&X9;_@ISVL.>[]6_CB
M,=0)%3$XBZ!GD/0TH_ W?)GXXV&B@!]7>*)TL:_=):CT@GWADXC+WB7XTEON
MTK)GWW3;5# ^J:BAG*?.A;N[GN(3;6C^Z]G7TC<E/=%LU(Z3[/SC1^8<[R51
M3WCJ2\V",P*?"0.4I\G<TJU_HV;.VR=RP06STWZ=/_O8<T: )HY&]_JMJ?$O
MIA/NMF[\7>'EI?/]U2"EBYD7]<>N?Q7ROO71XA4?ER7W;8.<PD>Q"6\\336$
M]X"K.TA 3(#4Y4*WW!7 G!Q)*9%[;YO(]"/=J$Z'>TDH??W@CS_:?[%D!'&@
MP-]<3;$T>#24731#,#Q7G8!6[R2_2E[7U!/,I'S-+_PR44W$'&M6=02DEC57
MPG@.MWI7^V5JXZ6BH#"HHHR@?6O'%4![OWU\'IC"0A7UD7'(PS/^G^$OIA'8
M]O"E3 Q4(F(;0[\SJ?N&2PXW_=X#H&1&/HI?97"?)00:(>J:VF+>CLMCOKC8
M''!/V]CVEZW5&KOQT=S7<5\6E.N4:LBP*+YG[L3$%;D\DVP\HADVU/8^@#6G
MRT#=%MEVEC_@2^0823^T9#";<T*<62"*(+;S)FCHS(TU!_7/R5*N *LP:C5^
MQ8%ENME!FV#?I3ZH.-4+N\@I75"J/??0_1P!N_<)+U/&];9E!2>+5R[M@KXG
MH_8Z?TVX^K!E_DGHV?T."(]>.H20F]P:]>I<=#$&/=>BM3";,YN-D3!X])VN
M*Q.8QY?GC>V^Y^M$M,S4P6D>/-Q-01P5@/!7 $[D1)!+&= O8Z\3I1.Y/GYT
MYW'\XH<MZ]B>F3Z!SK5'L21#P17!+WL8# /L4]<VI82A3K9?O)JX#>SX1+L7
M$BO(@M@+HUUS';QR'QY5]C9\=[$=<TGB>?I"C"SED=0+-77VHQ0\9V=YV78
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M3<<U> M?&J[[OICF8^G[GXG'*HS'$E)1%^\=E^^ZNDR.GOTZ1CMF#)T]9JV
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MQ\]/]C_F^G'OKO3-3Z&WM;4>G*3\"YW1P. N-7DHT [\$SGRS>+>RF)/]A7
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MIIXM:3F0D QB\*4$,]KB"A"Q<$$]7R($AYK-$3P[/4 9)84%;>/<NSO.3Y+
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M+<PDFID(]>1%I%3@4_5WSID -Y\J'(H:U">=!WN[K%T#J.Z"@8/7@+"QP&O
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M5FCG.8*&ZHF,C%7'ZD:AG1G^V1_($D,NL+I%VKO?1/)P,24A@SZ[(L]'1+>
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M)"^OFAZSK#$ ?1IG>USU!L45S P- $-^&48OR05XQ1"6IH.[V,L%)*MILUH
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M4^2(=$', E@NKVTR)D*X"[1'-Z0M*^A?#&Z?"PGO[*\=,4S6]G<P\9 U@&9
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M/6$VQ(5<G49N4 VNDX. 7/>[;=K@M;Q]2%>-,41?XJ<\!R5Z\OOS6+'>+\4
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MLZB]1<-W]L\X2.J2.3ZL5-O'2RGGHM?E!YPRL;1=OQDZD@")>#;+1=\9:SV
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MV8^^B/QRA./N/!/6-;Z*G+A\N[1YY*[^13GT-16IK +73_=$XRB">]>N&Y3
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M+,V$4V[NW0^>9;O,(884;^;$.FHX(YZQN0)<&(HK]D3G;@"1M_\T'/^J18:
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M6+%XFB\Q"S>1&9[PZ="<%!72>A0),QMGK1X_ NUR4N>\0$3^2'JW_K+Y)S_
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M^&CG2CVF(:%J3]_[K%]R@.EW.U[0Q"?&;PU2.KT:E<E+Z1*6;Q1I4"Q@BX^
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M",)F+(++#4IQU:-WM#0UB^RP]G'W-8KMZ)-T4%"]AI\@*M\;%J*0#I]WMZX
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M#D5Z=J3?-I\MSH,DJ_N.:J&/.+X@P(=ROO_U88E^R]W\[D;;MN2_7(B=)AK
M>NMA(9OKNB7Q_+KA"B(+3>"4U[K_K+C(+L4O 7H<I7Z&[:7:/K"W-IB0_VEQ
MRPC!H(.LP;0( ;$;%1VR=]<%!=,^ KHM13__>SH7BX*3:!CEH<N$/@Y+7L)
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MW\/<TAS4_G]#E@J9L9*V=43AWU> Y7VYV@/#D<.]I\V8TNUOCX ?Q39226S
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MX$\>RUG(!;H\H_2!.]C=#'YT^G@F>3Z"6IZ-*2^FOVEDB]A#=?[CLWJ1_8O
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M&D-F>^86M$?>H2=MDJ:75'SKIT$.(R#1)\4;)3]Q'I0#=+_H[]N]X0'Z@"G
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MFW3W$\^U"-SQ0BQQQFUY(/S&CR&9X6[#&S/LT0.G+J?$/E?Z'&MJBKC7MR0
MM[OEM/A5]/?LLVD:).*RUH1+IK!_JJ837"JX7U_7]NNI/S<=SS!K([#R]<)E
M])2^'LJOD6A=T\(\O#*\71-<&?5%,$,RF*)'25F9JG"9*YOI9!>(_&-RH1PF
M)O?@0\4(0IA#MTGB#>[OO9Z'61*ZJ]%,#I[L+6.%\[L/INU2:K/S[%+TC^US
M+>-ZA_-;T]DE!Q@EQG8HN.B\:J\ B-E<L\?VB6A$^9'VBDNBNB]O[^JG&LS*
M_T+\XVO$9_%W</Z*^81=0-*R;MSV+1:*N2YR&6K!<--IP=X_BE^3#(8"F[Y.
MQ*U_P&J;;9XUF-"T[(]0GC_=VOGX-\ #*_6 V_[#<V45KL#W44)_P"3J$MW'
MC^^1QUX!1'^T=HYF-'E-2)42CF>U*H=V!6I.CYX@<ZLP;]H,&C2[G_MZ/<B0
M'B\/<84:Z8;/09BI&I7^"#U\5&\8_TK9"5$_B'ZX[5UX< IOC_AI.W$$)U@@
MXN8XJ&R!W_3/W)(>H4)%\SK!;(D&YN5_NV)>#[EU*+KC9W]+GB1+ZDN+P03[
MZ)-/JFX)>%6\_U\=>TQ'Y8=!UX0L?PXAGI%K[,M;XNN_6E6R]AGU+H]"5ON-
M1\50;"S:X>U:M1H0@^#[8JRT'S>T&TJ^ZU08Y!;:'C-KUHP?ZRV\+$A16_K0
M42>35KF4D7>X;L"/'_U]9Y)9>H\SCCQ3Z+%Y6S7C]+<E. U_:4Y4>E=CI9I+
M*L^XF?Y=B\LY^GZAXY7G'?Z=CI@,QY2>O9Q-2>F'C6Y1!4K>//O(FG*QC3#[
MR.>6G/NM7C20W)R$<+O!SP6CC5/9.>#W:UYLT<DPXJ\1NC!?O$AF5YGN<(W"
M5C_("/T'<IGO$+^M##IY+Z3E'4]+$@F:J2WZ!6UPEKL"_ UZ&!]CGA/^].'_
M7X*JN^YH9Y5+#OE\^A7!Z*/TBZ#.]+DYQA$]//HW\2/?3=7!P4Z%;W4CS8\J
M*Y;F0&7.[&RH$5D9_%GOW$:8Q$\H+4,44^3+*<\[GDMX<J_4R;KELT!]-;@1
M+?YO"RTZ9?$#?LGK<\/W*T">7(UZ_&J]HW_K:F5)RZ,K0(PJ>K/P4'Q@O3$S
MX$)G 0+Y7IDT:_3MI^!R0TW\N*&N:QLGC''+^1 1\7_MH\WAL>_Z?]Q4->?C
M6:R91RC_S>#P;]"[UML?CT.LW_G1\$PF5JK+1]_7,/F,K3:W9-WK^\B[:G Y
MU^^B5WI"**VMR Q:BZ=&NN<*!^2_;-OPWR6]0D*1Z/M3_TP,E+P>U=4&K$NH
M@R(YTA-^+56VRL[I9MRK;JS=XXA8SL#:YM9C$N<][Q;%^7QG^N 5&2 JQU^6
MDS*Z4U$&;UD-ZI^GU'R^T>BZ&NB:_E$_:<.FNB' .ZCF)[>%OC?WUX\LH>:O
MUF?%1PC1O_?90.\J,%]<>WRDZ#/BNF Y8GG7@J#W)L1ONAZ0$//1--,06X $
MY_:8)YM:;V[F([\]7A5JS? ENU&LWB.LW=MWMD/K=@F706]6KIR1)<*M\(.&
ME0F_J[18=!-QZHU4AMN3F/1OF>D!AYP9*L"&.4%1(U_[,SG>0=/1"['C5+_^
MDI /U4E7@"3UI8H;7L?KIJE*,H*P,2-\W=$*/6[\?V),RKG:RF29;&P*"@(5
M ER]^QUY]C7[C(W+(BMWKP &)I9WR&;<\,[8YAFQ>YVA9#?] 84ZG]PA"IM9
M1D97 ),!A4Z\Z6O?+$AMDK/I%<!J6J8?:H_*]TB_(Z)$?"Q*(X],GI<S-8$M
M^*%=SERG(T%:2-5%5$Q?7+)+B*-I24(&K:R^T0(M#= C>IP"P=M0FS*C(][<
M7YK*$X17UIV+_A;]FG7<M38&/)?.8C"6FW3PH6D?N. =,7FB(9D48I=$ G#L
M)/?ZAA%:KD(O))_"35@B$M3EH 0% C?P4SH&_J!)T>UX5+"F5B^"]>\WKD11
M2[(UU>[!\899-H+[IZ:]J#0OU]+R0D@Q&Z+XV5/^^QV<#OU?OS:X"XNO>6E>
M 8X+8JR*//WTL>9J3<VXVIWWCADOQK,QN^5;.RZ$K</:YNB%.15'SN]\DPFD
MNYPQJ;%D+S=U)P1R,K4)"A/=J<5*R(F+N#\7BO@I2>!Q3,F,[0D6D0PEK9V@
MQWJK\L8X?D"4L/ _)[W[ZHA5+Z:]C)>2\4@#97)S4079\//M;7>!,L=GS^;$
M(KA$3-5:%Z.1N.&W+A=P-N6Q*P!M*W]\\,":CR&J66*4\MIUA6J]WQ+BL=!W
M?[>8IF^DQ/;QZ.)3\)$>L:ZAS6Z"(8.-$"-1A97(+S(T7:_$<1D8_0Q7C^ZB
M(I\FE?S8840 0WTA\U+Z.I4IO2L:Y\7 V\E4J'P+^=R,W$ LZEEVJ?&&7I*\
M?6*A$MRYGI;7*),3NN,.M<_X44RP&-V&=: QS"CT(+XR!+\PLM+5YH8WP?7#
MGF?,_5AY$WGC9_=+V7T*L6GY@77YIYOZ,5!1;$\![O&[]]^L:7E?V7^+C);;
MU/@-/">DME?850$I5>*6E+]IK-QZLJS=_S43M6[D"E/.3%Z+DVBLR]SXIR^Y
MN"VZ:X 7*@>![B5MJ,+=&5\*O28GF5IH5'\&;"2B$4&%-LX/VKT($U#C*/Y/
M%<^#]$S>#&<)J!)9CTC8(#*OJAM"NEH$&I)F+ .<(<OJW6]Z0O%N&2'DB.N>
MDHE%ER^\T8L1+IQS\)KNGPCQ>\SF>NBK_;ZR890>PR;];Z#G<;<156XLA9R7
M7GGT?#VFA753!XC3%CCX5Q]]*_+G;:Z=;=95;*/7,^C._A7 :*IF6PBV6?F'
M@&L_ 9ZT=Y=FU8$1G.>R*SC/J/S]WJ1W2W=526E4Q$/F+A]HR LAFT9D'_U:
M3SJN4+5J',NOUS=D!-P7\Z2P?Y'4*6T^4:QG'P>'^Q[/UJU#/R]--;W?^:ZV
MVBFMULHXF _T.X KC!X1D5Q)PSK;A9MG<"#SIQ7Y9P$[JYWZ.IO2[J&PPYCJ
MKLMT6+Y8 $-"^L*';^:KC *O.KQ<Z6@DIQ A\>"43Q@."@&Q;8W?\;.*;$L!
MYUJVN '5I@F9'*9;H=V<@=WK1F;46^4"N^*O8335T/F1R@A^7Y!#(O>JW]#L
M<VW41 MDR+9$6^_\"A!O5I".T(@.@QO5G05YTD:)M3DNL*E[RHJ4J93Z*U0=
MF5";G>3:MB9^Q5+8RW\>:1:=.2.:>.WWF@CF5 6+><#>987]6'7:[E26<QZ
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M3Q;X(%;2W_6-9\\L2E;QEYTD\TSJ0RA;5#&RWALFSV/\?[#WG5%1+=NZ"U!
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M&*,2GK)L\HU_>DC3RUO!:XK8MA_6L%RRO9.\V)3H6C5"^6;8/#P?]P,;!5$
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M=4IQ?(L1#6P%K@YLA1WA1Q#>V$-A,MK48L=IEY[E0Q4X+!T-,*2O'&Y /X6
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M_'=C2-A1$:P-&<D1.#L^O-:F,Q"7L6FO))"/*0[S$,Y)Z*-K>R>V\LG(L1O
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M-'2=]4ATJU\\_VW_]K_*_X\"=PZGF/'+"HLW\;GIB%A*Q\]!*8R.5MG7R*Z
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M@P? $Z2=2(Z-(D'KH4,TX*4>L(==B(=OCA.<K\34?5 E\,3#Y -;P1[*%[2
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M@/63JN&!IN\(;*0*NQ3]=SQ@CZG !<J+X:C/MF-+)J!*/V,\H,+.B =(Q?'
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M[F(OL^-PU99:^<GNEW;M&_.Z0CF8.D5/$*D?O; N,W-F$^?!MY&IO%_Q)W@
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M3O^SE$1UM7:7,V;R[2]#>;&7PJ:G_,9U]]=!7W,(,C"72'$7(&.%*]IIU_#
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M3&Q.57+VW5 %0U]+QVI2R^!UI@LNCRC3O>@'UD"[;K6(4V_8EL!Z=BD?'FC
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M4T)&><IU=C#^*2SVM='/(7^'941Q?9\N)J@$4_BMJI%Q&%9EOMYF\TC*0WJ
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M6&DQ'AS2@84>3[?72^?VP!]\5W[AUTHCXVG>IF'"6ZRO!76':GO@BLA_%)Q
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MY\SO^^.98=XA<_?[OJXG;Y['W*@%7 IS(0+M6?FK2M*8H-Q,6Z.OE1:Y-NA
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M4QF /[_-Z-9SBS6)-E:#29^K\C!^.%1+O=)C;+/<?TACZ7!<.^@2#C*K':;
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MV-V_Z/PK.:U7<FW7RO$V\"[(+)S"!F3=OV=M\>TI3:43A#-:96>ZP.%2HQ7
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M.7*\*?<4"A*VL6!+^?5Y@,@M_76V[]PW>]VY:$G/_195+C45KHN!VEQYR^Z
M/&V?"C3.AZH4602WR8N$DF0*7]@?9BX(VB\'O16K\V6_P_OJO4JT#B'EQAF
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MROW237GETE=(!Y/CW*\J&78N-.I\[9:-#/*BE&[TAJ8%O][YW[$@(N9&4Q9
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MS;*W:%:PL4O0F^4LJ2=Q)2IW$Y+)C$DK1;\TV3F%1&=VAB/._W::%B^-.?7
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MM4*<5BL&.3!/"-+B3QB;.29/+1,N(@!QFGW]^?-S='++2'B8[_F !@.-(2N
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M>>\%ZO7H=A_9#Q:U*N06?6;\(99:I\7NG=M%%2[-L >$,J&N$:E5 6F7:YI
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MUX;:UUED>W&9_[GF&%//-[TM-5^O +DK?J/)*JRXX#[PEXB3Y[V$5T*"H<0
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MYL$YI81]0?QJO@S@G!<D#;K$;.%/72?=/TPH\BXKCS:,]-%V@I0#2#R)[M\
MLFF44(^25M0P$:56B[U5KME6#;E@T:'1 JY23Q_J#?Y:)C9I!A)8ZE0^IM7C
M"&,W9<'[#MAB/<@<P1H(U5NN2<:0B"B]\ ?Q0TRGCVNO^C(6.T_=(?R?/CA5
MN'80HYW>^S"O&\U5CB\D@*OA<X\I2TS^OBA+@<!_*)*E=_DI/JG6MG"'],#W
MAE2!*_(_&HOI>P\%RD5U%7=&@Q1@,:PXBA(?4F&#IFGNADCI_8.*^1CUEZ]3
MB):(F9)6L[<=4(V)\AJ^;PCC3DF)0)FF!LM/IFW3QYH<9*SZQZARJ!J7C$P,
M:Q;U6L$[_E2MB8C+&X!-6G.Q5+\>_N)>XO>1\OT96D@M?=B(R/66W_YR+7/P
M-LV 2][1/4SS#< *<A8)JS'%"UP-U5W718^VZ#FSVH3.%;3:*OG1;5\$W *Q
MXUSR),Z3_\>I3>DO3'*WB2Q=;QW:MV(4A1;,+:<B55X>,F^V+%K:)QZF!WA:
MS=6C^7LZ&)HCQZUFU2HV4K@09@T9.)/##$/9*$0!6BFF2J(J5HJ%I2'S7FO:
MG+3J4)]&L]]V"O$@8;W/'/I3Q??$GR_8C))M@<.[^TOOJ_RD$"NWI.?>$3D%
MQK0'RHO)1Y9MU5SI--0[*?P>W_H%]>O3$ZQ.,<7[.=@NU3>735N[MJ\^;CAU
M>@.@&V6*2P7.E_6[%ML2#HUQO4*H_(,+IE]W;QEG.WHKNG*0BV.N!['&:_#I
M\+%R$UPDP7-,LUP<U9D@KN!M!"9U 8KN!!5.6XV>8;@"OZ:&D]:"[L2HA]GQ
MT91G56T7(V<J*SJ%1VPP]BG_O)7QM2)!.B7D"/91[4A-69CW>S[YO/^J(=H0
M>P WNX3I.:&*!A#P$>-I">T]/<ID(:UZK<=ICDU_S*U(PHU/!NG7BB<ZF+1
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M..FE3(SS?%2D:8H*PWJ%RE>,MDT=>@/'/>?+*%?</*U66W!_B//M5</WU'/
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MXS:+X'*A0]>O,VDL:_=(^X.?*D?"CM3W8+MS:S< M8!-[^H+ADXZ"/+V'YT
MF2DG+@$QL N6IH-%"'BWP8 >F_D&PW<6M;++(;H^J1K\Z_BM'XU S6""JJ>^
M[)B*":<DTH=2%U5G4.EXO(U$9'6TOU5]EY[F,GS<VTOY1U/-B ?I@F?'3O;^
M B>--4Y*.JVUU7>:<&H-N\Y-Y(2BPM@#WUD]P]S%\Z%9.EV% ]F4]^->U >&
MJRUH/+)>HN>FOWM"(KMK.F!EG3FT"#&Z2%>"*;>.7<(&I]LP#G'U0K8&V59P
MB>8318U](1[&NK8%<_'KR4<:B*VK#D4#B$H5W6HF+KR>ZXIJ]@;PSV=QTIIZ
M#!=Y;I7WGZ9BH?]?Z,!]9^#_4.J&N0',#N"U-PMN]TC3_S3AWOL_;Z1M++1*
M3;GDW"F*[J^^6R/4F<Z[+]=V?X]#*B'_#K723^.WZA0:7__O-$:E/_">$3ZE
MD!^*JYMC=$Q3?OR1S8]F(52+ZY"UY?_Y9N#_S6%,4^ZX)%>#% $%B5=L-S%F
M5E8A I#?AUU^VURH4P-.Y^%M 8\)OZ.C(C^B3QOVFI PMZE3MD]>?NYT'S)X
M" P#'P,(+#GHW[K<B7W\D\#01X"T04\ND"7W1:3/[(.$QMJW4PZ-FEP)9C]"
M6:-K^TMC&=X! 'M$<O^-NH[_E\:=JB*7\RS+Q4I[M1&*_J+6.^_"LOZB/\9Y
MH99)G,S4YWO/&9-)UQVU'VN=\!)>&NW3"PG_UV4=)/_=QY:W!CPN+/H$[?ZO
MVSG]7QW_OVK[Y'_8JQQ]UDF-\)8GZ4BD5D+9=2P2MIB[>:H $K4&6)1'.\B;
MJ:-A1\^P3/@>X T@7Y++*:! \>%RLG224*6"0[E4484Z210*#JU"B7%S2<0O
M)$JG/N<24=;9J:>F_;?TN.;*+:Y4W=^-"F$W^#2818O(8,KXB8/#W1L ^RDP
MQM8XE?+A0J^)@Y/P[Y3#1/$#H.B2JW0_%VW1I.V\S"1W#JUH_/"&\DB2%1&3
MCO01Z,#%(\X3.!(B)1>8%Y-[KPYQ ZC=PA"56QW,&&\^AD[>6W%Y.Z *K+A[
MGU26I(!A=8EI4B'0![WS!]&]_!OZ8V'NCGKW J//^V.)KRLPBSRSDZ0[YA:S
M6"[MQK;.>EC&XSO!Q?"W@F\>\SXQ4@0/2.I+M083!<Y"OY64 >5"$A% B,=Z
M]GQ$8].M_ _.=J.IY#CUB83P=>^++6;FK0PV=(.E4US:6)HZR?J?RZS<?N:I
M3#MHGD="^YP+G6Q^>BDIDF2GLEI-J&$"DJNUZ1BDD3+8>2+DNKE'"\=G2DJ"
MHD/HQDLZ/KU%?&C,&IEXE%#H^;MFX4YHBYOLA5<B%NK*8PUOV'_BHRB,9\M^
M2'WXNH:)0\TAG:=9YF'S,MGL/*ROFGVI7@=)ZLJCR9/^EE&+\]MO7$4JHFD&
MZ[?Z64KG0]25SOU=YM_O?)+^RNPGZSL)9?I68XLNO^ %_.?1+9/@ZM7B2#PS
M MFC]* Q^,,H]\3^;>C>OUMU.H=S* ;^FL)I%X$#U>->(TY)71\\5O*G%IP9
M9=#D/5TA7\,_W0[0PBKZL:JX)9NITYFY N[*?Z&$O?(XS/J#$<50(ON$B.?5
MXS3]H2>^N?-7%EH?EDQ(GM3EK!#AQ U:CZ_9*.&9:3CD16X,:IG144FP(3"'
M^DWLD82,>WX%_[0),8=\HO,7Y?OM DIEP&+UBL*E11UT#VFL7M]$;(VRR/ @
M#S]@+1XI^=/)2M@Z1DJN)%JX_<E=J).@"'$V;X7DWZ#[.LT7C8VR^VF[1DH,
M<^9J**B;)Z.X4C7X8UJH.WNH]MF=)&411.^%_^U".& +5[)=[;;%P;'3;CWT
M//=>F_@0/Y<B'/ R8\W(?XCY&.4H6>LB_,93D*CZV]E(.570V,H\<EERRU?*
MZC$Z*6()_J='%1/U^4Y[V:_G=0KV<;2S?Y1DMU/!ET8-_47 2O N"E'X(5+>
M/%N^Y:%JFV]9C+OH/,=C7<-K[V"EY[> :_EZRGGYOL*3 F?,MEENDRLHD!_W
MRR4'=IA,:H"E81 '3_8,_[ $\K_FFCUK(IYS^JRO.L@L+-K$GTK\?*##"T8!
MA5:U"Y2.^=U[8[6X(ZWV2C@_XST/)32WRZ//G7AN0NDN.!6!Y+*U]%B+<QJ<
M/?M,2+*M:JFHS)BY\W9Y$[F0=\%9;8]AZV:-;/?6U0M F%_/O[!U-P*I>TK5
MGMW-&L=0Q]8KD\]"$4UE:@YTWQ_AZF1O /;O&)5#J]ZNNB9 J\.]^\*79/J*
M"QW.@F-)TJ_ZN(3E/$PNNS#JR/[ C7';\:S-R9=10_B98_V9V<3-. >UMO#@
M"*$3*TAXRY/3X,PMVXD3+II_>/Z:*]\X".5&I[N90GC)Q)>5LC-N8\7*(!WT
M7\TW\+V&*^O]KZY%CN.>=V-+ *)L%';!"UMS+1]K,)$YY=A,PRDWG"1G@524
MR"5G"F\G\->671&[W1J?7S"1R[R3F40> 6)Y*'16*FE+5&;@V\:!2-ZAVY92
M@SB6S1(VAH.IHFZ]*]YZZS+'X),/!=2X*T"X(% DV\?+@?W74+WPYE,R&0 !
MUO JP:H?:5@_R9]GO[':9M[_NM,]E+&K7XR W4$R"7V,UQZ+@NQQ4>/#G^3*
M-@H4F>V^%OXX4?7F).#K &VBHJW0!?G<#YU"2V$'BN:+'))Y**Q>J6M+9 Y7
M+?_GL$YF\62,P00X9SWO0Z$&CA/.81WR:V<P,0SCKJ-IRN>OYM@=._#A3>JM
MP6Z-<,VNXK8U+)?Y9WWW%T^.!ZQUAA'O4_!LQ65!4NJKE)X4%?L#S W^ '7;
M&1>3KLNLS]GXUD8H5CZ]Y'0]YP8@P+&4@N'ONCPK]QZ1MFS*0G-4L-S+'OO!
M"% V0#UJ[*\KR?&I5[F%.SJ&)J9'' GXRL;%^=K$CKJL=25!,],>].JJ"2I6
M=B^7J>9Q/O,&[6/+W*@F^GE-6TQ+^P*9>4]*AC5$9C/Z=L/C^K-R8HQOTCV5
MR^[P_6NQ(V??,89[N2^D!)_84WZ:[-NH->=/$H\P^(Q[R85JS%REOK]#HV$U
M:]?<DND"3/48!Y",D_<=T^"?@FL$[KQ5C3#G2+18.WK8,B)*N]:]3.XJ/&VN
MGQ'TI_K<3#TAWN;R>.Z+CU4C;@.O&J"LBW\-*8-;!FE-GD*->P10P<Y/5EJG
M.L?\60>BGFS4 BJJ-E@X-.1\JC6JY3$;.5\Q8V&@NQYQ8_N,T<]^VW)E:'.N
MW%?Z=E[]HKB3*_N:<#\H<\?_!*_4.![DL2H/N;^#,=N62C;+MO-FH=KI:]QG
M^_K=>XMAYM_<9N8JAZ0DY<,S@3;C%6V6?\&D"I_V_*OD7S349JX9Q+KQ)4IU
M1(Z.J_XEL']3XJO,-_)^ITZO& BC38R5>N@D.O*P]QGC>N%&*/YL@0[[;FG"
MX,\-P&>X8<-^,41*GA'[;:4/29P8I.9T!I^7PLU+.S ?B];)[F?M"O1+=/ /
M9$*H]BM=46C:?V]GPA6Z/)546Y8&B@_6+Y'%6%6!: 6NGVI^@:! !=]2J)?K
M@U19]V<L)M<K&K(5'@U(6XE#AP58F7.&G.+GS+GT!:G&VNN+CS;EB@+\/;ER
MZ+$X*Y,313.!LH<;:W,3S9QM%G<T%9_W>5K3SQOF]>92U4Q^F/PIMCC\D/*E
M;*.3H=+S*_\Q0<W.IP() @/&G(+H@X+J1;#4^+SE>U:X-MQ_JHR2]I!+2D-_
M^17EXUU8P9L)I[DMPW*<)CHQAF_!++&!H;TQ-=K^=F=$#9(0J&XT\Z0/LI1;
M"6(CBK:MJ:L4-(MVI"9CW@W8<QNE<+JP/R$L44,R'QHJ4-N[!4'6VB9ILS\%
MTUN]9X\X^K+"55;U_H<N!!#TMBE"58WC>G00&6'Q(RUL/BLFB$L ;[WY+D0D
M!R9>48O)R6U!C5'N,.;R73UI[HB=\[TB@S3H-FU%$6G\S5MCO^=AZ)T4RQI2
MB%%^@]Z>XKF2>]IE%^>&RO5H&R&*WH_W"MO.@JY:7S#AV6Z=D_[ +9"Q3HS#
MUNO ;?AV5^44Z,>.K1L *(2,1?TJYD(3XP);4::Q<%8BQL\@10H%TRS(W'@I
M6,MYXXG= 0" ;(4<5Z\!&3CI;;"\-F*EN>TE?A?X(,AGS@1PK1PEN7X\#%:B
M<#Q#E+D-^ZP2QX(:'(8$SJ*XM1-]&2F^&VNN<G"M<ISF))TU#(2Y<->W1FH)
MVP9&Y_+?>U;Z]YGXN<>R3!$0UA)"@1OA+]K?NH =*1+VAHBBSS__2-3S>A?Y
M5Q</U7+P/2?/K^7$5H+N@8OU @?D3CL:"QB64BBAE8VYK][D-[L.N+/(\K2L
M,9CW3$ '^L88]<"Q2%^TV8"SB6?-%[[&*\919VK2V=G9( M,O:\VN^.$F=8N
MYS/V"L85;_[J-1WYBE.]3[/S18F';Z:$O'.DMEYU9/YI:$PHRM K:BQEX0?0
M0LA70UB#7C1@0I+\^19/'ETBM'ES7NBQJE.MU:S'VSJ>\B/:CO_3L.XIB1V6
MR+TH=GZH0L)/D$J4K+5G_8QY5]L-6;*Z1_V?.] U;ET^_&0Y)H1R^C1IKX(C
M!&$^,F_X[$]5,$,T^< _/1^?;MS+VLD/6/,RHDC2POI0Q6_/F?XDT]1]E&-?
M\=BUC,PZ'BJ:4QSLZU&-5/DWKP$Q"^9*46P?3#.=7+9(4S=/PG[5!#0[ZCR[
MGI6Y1_7,GWD%\QQ1?UPE%2LL7BK4W.(8+CW,(J\BE%"8.SOB&2*E/),K@!Z+
M)1FFU?>>[]_?T#O7/J-B.J[R?]0*0R?U4C.;91Y79S@*YO@_7&)X3'ZM?_P6
MXGM=?0,@/,:Q&"$6]V\ )$>0,&1>#)[<$GC%C8V=W,]NM-T\.@_P_SJ;U_^K
M\T&09CTZI*[ 1/+$/?C'+?,+_1?F_QVJR6L;G[=EO'_208KCTU4AJH4G9K:C
MI?(6USN#O48#-IM[)*<'(O%TN@$FH\CQ]=HAGF$7.NP':#]\8P^YB[?V8%_:
MDO;^3Q&)(ILI!A:)4RZ>=V:M@E(V=,#)N!<JK=1EUKF)DE[/)YY"7B!/JFF=
MADL=SR>LS)K8UA2I"TC2E7H)K6P]@\S],$F]E/E]^6QQNN;@55<;'=,/-MJB
M_L%Q='G=30IL1>#8X0&SCLTV'U1]U@%<7#(WA3>[B?B!O9U'KH;& 9;S2T;K
M^5,SIW\!]Z)H6A:; +B94<7=/S@US",12IQ4;=NGWM<[9E#\1GU'1M</T^?)
M)!#!>\+C >P.'+M35<IK<];GU$?5M-87TI0"^,Z"&P"\5=O:P*!OQG76&HDV
M5A3Y;9SFK,08>0FBN0%T/^?W=3P,Z17RS%]S^TVB2LT/M9IN?_O#T3CC+*NX
M@.-G$\V08(B-3=$K^Q@7&YN E-SI&CGR8PCS[/;Y,E,0'54ANZ?&PS8P7%\E
M135]#?823[_T2]OG!L"/?P%]N'PZB1NM[LD50Y_'O3$:/]4"W;/>O4^L:>U9
M23#0*6K8<!AM18<>N339N9QB/#=(6G1U$,C-;OS4A.FSQ:;R?EH=^,S_*T%]
M#[.HZ3T4:@4(35@<I(PWYED)6]MML_QP_"*NV]Y-4B#,V^>!;+,P>T)U73Q!
M*$F1T!F^H=; 8'<(-GZ:/4;CQ"CW<%=\6?,ZZTIJ0?,;0U-RN<:X)]G#.FA[
M,,I\4/()"@']RPJ\V_:MZ:E&;S+Q*L E92;KF,-6NW,RA (;V_.F'2XL7OZ$
M9ENLK@_4ZCBL'LEB(:HLXH+,!Z_UG,U51WI?BW'H3.KF"I1R]HP-9/*6_1EH
MXO'U7PEY-[>[C?V)AY2V%NUBE7?'.U#+7%CSODQJT(_=^PNCH6DTF@F#'%K&
M@)2#)PHJ&)+N7,8V73T'T_"Y#710/I0'$,!(2O;ZP,-BNAA6O=WY>&(_R!65
M(SCFQ6-N"I2B8A?\S)4L0+F;+"M+>&F!M:6G,\?&'MEI3!4CA&W;/@(Z&6IB
M@\/7")?BK$&[YN1G^ [(X(Z;@FZA&=;_]'SJH>N3M_XM<6+""VL\CKS'VZ:O
M@K31/HCF5@FYZXIE4?)2:5>A2<<@5Z%<T>_([\ZER6#J59_T'^7;R<[,3>^N
MR@>&Q9Y> A8[=DNP:25SID$\B0) \*JY1KW4%3VU8,Q]>X_Q(XC<PVJ'28->
M5^_=ZA5?SH<8WS"4O'>VQ12JSO@J=M8!8O$T?*#TWQ,) T;'W">3CSK&&YBK
MUN+O]ZD8J8U*"P T]5=;%#^ZZARO"G2A7&\9:*ZQ)M[2V2S[SS"]\  9NW/(
M^=VM)#737#H]'>3J5JS0J>Z5^7PQ'.5O-4?]A'XK8CYME,K3?[, )S*!9^(X
MNPB1XFO$)';P]XA0..]#LJ_VW[ %Q@1]N5AS^J;5OT %8 &PGL116@V\S3IC
MT\8-"18_LWBB\28IU&.09>532E<U:]T-(%5\)>F*<OX&\.^\:NQ=ZZ>N99JB
M:0<EJ[S*[0,'V]]T\V4V(<6*R^<C0(%'AXMX[1O U\I%Z'7@""1E9A;(*)>P
M?UKT<U-[CY?&HJJ?@+W41DR#^J[WHS13A(N"<I%!V4XFI_IW  OOS$@3+T%W
M>$#*7$TG^ZP>",5<785T/:@0V)%FV6%]VTS=Y9O478K[0!["L*O2>3!3=W+,
M^$-[0+\U))-=B'_C!D#E;!ZDADY?ZKB.(6YSOHR1H?$D4%Z\IP%?WON4YUQ7
M!1[K66++*4!(\M:GV%QI4\5[<:ZT,)/P\]ZC"J[(PAQD_S0+XFA-G".U#4=,
M<_8.A/UZKM%=,I6J.!J\P\6S;\V,4Q;:<T:*@H,W+D+E[98(E*WTY($@Y0G8
M^)<36/H-@![VMF1*P0>5(Z+:@*AN<,RO:5/A:VMMW'YWG/[233'XZ4'$JAY7
M[QQDOMY5E6TX"/6-C,C 0NP[@U(O^7&"!?;'[IKBT3_1?QK_J^?2,OG?/9?E
M^$G2_:XURS=7O7-1D4(AR*(O+4WPXA3V4K=']I#G)J"Q_*)66/4N7FT79#")
M&[D!8,V4R/"S^*$;P.?;C26PT1LDXE?R+2$/Z@;,?0!7D"S)OOZ(9Y-W65&(
MRI 9I:<RN0+H^?NT*SU&^WU6K\PRBE@]).EB^OI+M<ONV5'?K/EC+#OF.V:L
ML&%?S109PHOU!5&J_13+H5\R27AO1Y.P)\U -NC>%O))8G\"8F8-2O8#72+F
M<6/:Z,,X"2Y&LX[1J#)U?U9VF5>&:3N5A%0Y Y(I_AB#+BD"/03LGMW?\3W1
M01.QU)*G3-QV-,WQ'HA:B02!OF',HX%W&")D!'<ZE"]B9=(N_6-+4CB9,9<4
M8D#Q5[ S),+,)Q]]UO2D*2%WUZB=CO&57]@# -?KQ*D\B !>BN'2'Y_)BXW#
M,$[V*#'6=4[Z4'@I%3P,SG@>:0@^%SY[(R9&OY4WB'3XZ8PP.T@'E6W779SY
M4;0^D1([8!G0 "3F](&S$V  (1Z66<X:&N*0G;BZ4,6*)4T50R#_[B7_Y2=L
MZM&UV34Y:W]3,3BDJ[H!^,]E_\O*D( M_[@?_XR1=91"( K"J"UH]JB:8:J6
M<HQ%,^'W6DX5 4_*8"6(8T$+_P"]'_FMV'1I]V!2SYX/]TNHH\:0+2==";-.
MT*_Y.G:S.*Y7*H^EG7L.7U2RL&@ \NXT3&])^&#Y32%#<%91/*GMM"RVK2D0
M#UN7=:R7:F?!R/7TXB40]6&EF@_)Z)UJB]JJL-.>>]H<7KN)W\D/?814D=J3
M;CX4LT$5YHYSIG9SYLYAJ>X$_.@J@=^P(R7P%1Z&N@%,J+:MW5)9&I;NB!:;
M!ZP;/,F+%=N%W<-IEIH[BR;X&<0ZA28N1$1(<PDF]#BM!.:9[5;B><#OW?:\
MXQ8#IGW\W\>W.W"#;&0$B<=GE?VXKXPI;@WE4!LV"K\,.[$UVDHXF9<'A8FK
M,[0[U\QV"8)?IP<5+.8=.BA<33O= '[B!?"D>PM0O,C?@X:Q^]N<K),C9W40
MRIQF&<H'&XGB$8092K_I7F']^K*8XH2LMM2F?K0G4+$_?CIT:D00I;^6=0RC
M@T57X9_\,[J4"%!;4"FL/]LRH65NRB"8E?)J!\#")(O^EQ04ZW\G!:5J>8N=
M%#> Y&SX[C#F!A"E*-R.+4D*TO/S"WQ?R1^Y9],,AD(=)N_^LBC_#DIN(5*[
M[]%46ZU296V)$=P/Y(_"R<7Y0'\EB8X]FWV"ES6H=L\QJ-DL*;.D"E".#DC!
M^DOEGV6L62?BM@6XE'07+L((J:[\1Q6C2X:]U@Q(EIV065O10I(YPD='\L"O
M?>&_$<6JJE_LE<4.N#D65LNQ;3UHL&UW"&LXL?^#.B343;@$TL$CG@.7;OD(
M!<61;6'?C$ZS"R)9BWYZ> V!)#B5 08HHR:#$9%K?MP\W_X1Z+AI/:9A*,@2
M"DX,YE)I8^5(J'Q\M.-E<K'IQ/;C!1?Y<\*T,3,%GBH@SRTHB:^RK+2U3Q;&
MVL$B11X;T'T:%G:')@=XF,O= &)<O1\0-2?J=NCO"CC9 OZFT2Q/O/.S_5VY
MSZ/FRJ./D$SP79/++63)N 3Z"#Y0?\,HTT_V0".05E]?MD]]+_L(XF_4ICN^
M6I^CV:?$T[>"S;$OO&[=!-4XP6^=LM:$0,V;MNB/@YQ1NU8-#O3H616&D8$Y
M-UI)TT<S=']M9%T+P])&!3[!.[G 9$&DD0.Z=>WUJ=-%2:^:(UX>D/+*)I?:
M*V<H$KGB9-L[8%C_@D5GP1$OOO(,7UE!.0$NSV?.^\ JQ U 9#Q[L61IZY46
M(-6=R!\9J6!?MHP=*82EZR=4Q"0FMM&['G$![X5E+"EYI TXSV(3*BR=<JE;
MHO35'I65/JO]E:!%5)262+9BXR:KX&'EM?JDW0&(ZG@PB3K>3@%[K+7$KBI:
ML>@,L**ZU%D>9,H.[+YEK/9K7-XZ=WQK9@JZ-C^<.EVT[6V5CMIH2#*")8XO
M,M%(Y$?(,WG9UT;\/GU8A@T<L&+!6!RK_'!&+XY0Z?8SI-3(A_ZFE66/C]T(
M,N:+BL89H#?7GUJ86EKHNH=%JE'S!Z"#?U=T/DS@P7:MS!:^^J4- B<.=]F3
M_B3<(2C7-5?:#^X&Z58-99EE]HZ1..Z[-UVNOQH"R39FB+-'](;>>?ZJA=O.
MDX#SM(P_UENK76KI 7XBYB3=<G.3V\["@8.>#AG_H<4ZRM=H&9T"7CT>4G._
M'.Z%,[ \9M"RN+3+6N=3CUHY3%J))XH4^K#!HS+!-*(/V'MJ-'=F<.@44F2^
MU)0#(\%KUNRT;N;\<!(J=Y;FU$O=^YO-THDA  -RM3G*.V&K.=3=9T ?J/.K
MV=X;@%>(KO)5^:U8,?P),DQA0KWX9B/=46KMM?F@&!L;>)47+87(99WTGI7<
M#9;_FWKU-L/Z*:DIIH'&0%!+ <]2C-CV:T)YTDU(S]T $A+S5#&1GU8K*.)R
M2-[&[JE2H<L-DX_C*P"::E.&RE&L??B.%2'QMU-;QX?\QF+:M<:^'*&HYQR
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MCWZ<!?2,/"GSL2T%V$_:F$>Y39>*..F,WI5VAW1%]]]')3.AP+1QGL2MU1M
M''_["V";HY!MG3#Q>FB94--,HR>0I%=(Z=N:,NL-X -W_! *5F]!JJD;:B)@
M Z&QP!L*S5H/U1;Y@20ZKR#?9FX W<-HT-G*! S%77_EX9I-O)]=E]"&J9-=
M8QE1IVHIA?7-0RFKQ(N+DS,%J/I6U1[!YVO;2EQ6*\"!ZNAI9+>0V"B>[6VA
MXF?/!1:NX9?[]T8M:#Y]_[YNS+!:H0=\BTT)=$6Q5?B(83V5E[YIBZFR)Y?V
M*#01^@;0>F4UMM@[P&\ *63'&M?[%X7M&)%XU_FNI4=MZ&O\[LA3IK=BW3J:
MCSD(Q?8\Y<.^^Y7,XC30W8LSVTRMI^4[1STLX-'G2[_=32@+?H4<J)Q5<N@<
MZK1C"4N'"LV@1?F3=@9U!)\H$CG8.M4<>$]W-?_;I IOR#9HQ<->5PP5+=T
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M_9C1V\PRG22^W\XZXU^Q8'PAQ';1Z/$^?Z B>1;KP!. AM(@<W:E#&]YJVX
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MZ=4.B@#/TP(T;MCI'> 94+T(I-GR5M_80.05NCF]E(-(EKQ$CMBX$UC==1^
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ME^DV(:)A#2GV=F 4%G</HJTKTP6XN :*<?H E'+'.X4/E[@XNL63>KO?V1,
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M+^C;VEP-VVD1^W[JV<A="LU1NK8!\V_\@:L$NG%X= KE$A_N /$FX[>MB7>
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MR"S=XI9KFE#G80[?3;8JY'?G8 YUT3@B"!5[3^#/_)B/,@\4Y_.,&T4OO<?
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M?-'+C:Y_I/$'Q;57,2':0XC)&=O+VI/5P7Z-/78\_,]][P3NN0&&#X++<!>
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M$WP3R]DU/5094M.D^7UI=&-9]-WT!G])HB9E#E&7L WTA!6!C[W2^OM\:)K
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MH+,QK64_V!<V0_%VD(]SM&6!;N+V3^Z'4:N]]80;#54Z_"[2?+2]-7PF3BX
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M<18#B#VX<[N:R5G)AJ0<ZT3D,R.,*?'6XW=B/ @N?.&_PTUKWD>\ ;[5!K
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MKXAPEMIT(5*8<!1Q66PYE,G-.TN^B&XCF:F.^]'6+:?UB\Z,;KZOQJP9:BX
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M"1FN]JXV#;$_*>B,9]V4/UFS$AS=*O78/!9ILP1W47#$#8E3V07-3*K.M[#
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M3[OM(#"NW'P!*$PS#4@[;9EG\O<N6\<H!]5H-_;B=O.J$W@-VH]^_U(Q/AB
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M0?L@LO41LS5\#W"$W2$_8.2YRL_>^4# E5Y<4B<WY:B_64"NY=R@-V>:T07
M_KW*!IFTT4)E =\RE[C.U"^1_9H+@%Y<E)4W:IV8GB)M<@(-939)$#;!:_#%
M,KYZ&/3^82>CWNS!J^1J)=_4-@PJ*E"*V$7#UX'R91PJ<1X!PW[G.+XO@"#9
M3LX>@CX<WA+KF&X48YMU9+$2'D51::#K'W?TQA4U?IU?<H_A7.1M0FCCWV7D
M$AM-",*W+:6V\W]4\<?D2U'%0*^H<BDD&?MKXH^>$00B/+9\S7:<:A2N4KM/
M-7Q_1:L"_>5&KOPEC\X[==2ZV^B!T)[O.M%^\!%!.;R&CH&$:*H8E3HM97#-
MSPW;F/;" 2R0OWZYN&]B&K,H2(H$NG"I_3$I'A['M/Z&KE]0T6OIE'PA>\_;
MX_,$HIMIX7Y=OGN;[+';14SMV5TFV)?CCW+(@D//:\#M+627Y2@C<-"LLGE\
MJ:XZ8*U*A^V)B^8=#3J$^=WL2R@#O@!\7BV&C>Z+-_/+XL,[LZC@'1DI[BN_
MM@8 ^CV]%X#W%<KXFU7XJ/L$\BB@Z:)/LXV/!Q3*P;/;&Z!,$X(OV^M2HAT%
MNF8CWCK&RC^Y9V:B[67L:9,9&BS/(.]=S,V*GPT/12M#L]?S#:$W_DKFLKS6
MXD\$L*V.?)74/?<ZWCGS"3VH02-WFUJ0?+^;&;"M.<35KK0;.;SM17V%D@3A
M4+*';^.YT8]D]Z5XMJX@H(@"^V;VFH3[XV5BPR/7Y=ZR/J3DJGQINQ8@U$ (
M;U>F)F)4E8H@O%8/G<#%=E-WN,,+E2-D?V0R$+460.16(@?)Z"/3WHQ4F43R
M-X-'*E=4C[H"UC7_SN4U>U%-H;A1)) RL2IG0Q[5D47AP.ZY.@6SJ[)7[\))
MTZIQQ@5N;WB'YR!">!ALAT2=[Z6W8S "":Z"9&_:8[ZZCLV?/LX<W\!DA7AL
MF7:>F$;:I:W#/#K>?*#_I-%:E?&S2 #Y^@'0;CY#H-O\A6]@\6IV]YT4.>B4
MR5-%67[Z8'G"4W#LY:'(08P>W$@:[06/<[L2+I^U9B?WC<I:=.(OO^AZOK@5
MX'9DM 89]2TW^0.FH@+_!P3+E *(ITPGE^.*X#LM;G*&K8]7*0V_Q),7J($S
M!8BF.<3&%R-.GI::QC;Y&K91;U*4'ZL\B:D75%467+ONKG;HAG]_YQ*T0KXB
M1N$MQ''9TQ:_,WE:JX,FY=\CQ(AF:H) 9/4.!3P%NTNUGOUXRI%"G][]HY&<
MHI;5AV<#0M$3'DV0>2PR1R</_F-1;W1[VV3N]/Y2HI=WVU)\QY5@3?.#.28X
MBRHA)8,FL\)QQ <0\2[VL)=;0U8Y]1I]]_-5M 3>L(V;=2QGC#=N^V2#F>ZV
MU2]6C?;O-W]\RRJ4S697SL(^<&RV=E=D]"@C7^2)2&^?HT7&B$07_S5KW]Q;
M=>51I[$\<%=Z@%=*QYW./EPTK$-3Y?>O:E[3S9;CN$.:+Q+(E^4K*H*D:Z+6
M9!L=+ZG2#^SF) _57[38!>#FJGD-NP\X=.R%VX(%@^6O8S5 \%QG-Y)IS4J8
M0$'0_#LK^F. W>'N!X%NTKZ9,?B C03YDQO[-C;'DSKF9KEB:QGSY(+2![OY
M6>VV8:L-Q!1JCS++H]#J\<VO=Z?>*^F/L;LY/]<ZJ#J^ +0'JE)IZ >TB!'=
M_5J5=WGAB//6(<1:A85 5_PQ%9SCO)V2-/'M A#FBD><7:L9/+U$G1< ]K(L
M2Z+A=WAXN[Q2B+=W85[9I\97\%R5O])!>PRAW!GO?WQ"*B$4SD62F.QWCZ6(
M7/U,2[4M58.AI:(+]?'Z$WWMO#W?"Z*OA21DS4Z6&JRQSQ &XZ5'L"VA(C;U
M?@[OQM#5&1(-C[W>MU_[)Y^J%EK"FN\- U4="N?\U<=KM.U94ZN^:E5:!#]R
MEZ ]7O,UU<<A;JQCA>I&"EK2-J1'1=5_\][08POBE#9:<IUF&C:(;T!O7P!4
M^ZP;28-L8;MTM.<COC%IU477S/."\W(K.1_(JJ(4ZS5X+'PGU0A(\_+10 Y'
MDU2&+F>8\>M@AG9WKI]+="I7Y,I2.ZUN#OG;V7$UH][<WXT4?UZBORA0QHH0
M3>Z#(^;M0CQH5,7\B_N?O/PC^?K$^.T3A2UC/03G"$K2B ?TZT@H;635>B)%
MEH?;(=6DA1Q]I:"?K]7-^;OES'9,I3A/1 ^I6+F;FWG2_UY @2:NA1G2,/D!
MQD\_T\O57J2Q&1PWH-A=1J=FM8D;O.& %0]NXWH"*4SYM>QL>ZKP,/'G*[)D
MH/LT$Z*#G28\LEJAE,\@IJFT;0N*?ISYNZ""/,$(6V:RB4@)53?OW8+X'P!3
M%P-JLQSP66JHD:>V(.TZ]984MSP@JI6\9:(>R6YIL99YAT 76GJ$Z'SN9$5-
M#=!EN@ \ID":U!'U<RR)C_O:)ME32N_%)G=C[GJE2/!FNM1/Q;:(+[(=E7+9
M+6Q'E\&KGA.XIBVB^R4%(R]+S:G6VYF;B2Z@UP^*W2$U!_N59WK3_D4B(R3G
M"X"&"S=%M38=AJ?CL.(]7S1(78\<<(56Z O>+K@&R01I%DE_3DCY_BV7O>0'
M 1/>D5O%F5$I!NIJJNUK-8>&QQ[0,:M)#;<TAZH)._4M Z1W 1:K2UQ:.Q96
MWT^5B(8&8V7(_#&IO)05NR]M.K?T7B:Z?CYQ-PQ 8BZYG(X(=#;01#Z>C*AF
MBO]A36/:F8JY &"D?=ZM*6^[?EUT1UG$ZR;C FGQ=I$DM7SB)0UM;Q9N'EE"
MC=TWK@C6XM.:<4_\M7AME<=C'_D:#VIKHOOIF]QYF.I=V"^,/Q86S=70>TS'
MH>^#JP7>FY]5:*T]&EH?M7R.2A5QOUOW]C7K 9ECG.S1]XV=95B'PSI,>6@/
M$:2_SO+8,762SD\@6A]=?-B2^OLC]8&!ALNSUH%G?-S)6U*]8NW]O#S</*SF
M@WZ00OFM-$'+IQ)O7FT;Y.YU_S_4G?5;U%W4[D<IZ9*& 24EE1"D1D1*! 2E
M8QX)B:%SR"$$I$M 6EIB9J1KZ)9NZ92.&<H!!C@\YUPGKO=ZSWM^/G_!S+77
M6O?ZW/N[]]JO7@#.$+4E304"AE4= 1S&T+"3]>DTRM C^+['^\+-%X</'^*)
M.O;Q+U;-U;G#PI:$)G':Q9  60Q;2^[UMQLK>$W>1R]G!=#C>WU$N<-$$O,C
M*T/2Z[UZ2\+>B+!<)T>'Q*<#?^AD&C@=W4Z 9__65JH';.ASC5-M3L+*C>0H
M$J>"N5S6FJAIRF)>K?[><;CLB;[G%Y?\]>2L/(M4Z3D[@U"UR)?THN(2+5)B
M]S2$<-K!'SEEQ8WHA%%@/I'$0=S=SVFQ]:Z=2,R<?_9<MJ(. PLXR:X[NHW
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M%?4;'[^>]VI/-V7DA#%K',9]WTF5CBT1-.+J,-:WY5QR5J:+':1Z2@1@]2K
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M6FPUPXL'>(!U""$C%_6DCWXFY6QO^\HMH$_%1'[)#XRS*Q2:@1T_:48A+UE
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M9R'-;Q)=I59B0YJI_MJCX-O[3R PXQO>>Y*A*&J,?E=ZX=3GQNPHY&\3QD,
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MKHP>8FFJ);TU?2J Q^YF>!$VHH(%1N%3&QOWXO-5=#-_?JT=^)T,P/^&[X>
M1;\C;&-+\!:P3P8[]PDYCS1O(1__]L1<0IR#XJ[Q3._?,$ZSK\/K(NA'I%_9
MAA'6G[R_ _'YK,5>J6X53&K'W$@D[D71G$T*S"Z;Y2Q=Z43[:9"!M>#+727J
M.6#KE;-(I-; +<!!:H0.IX51+EY9?*_5B(64&\R/V&'ZO9ZD6KY167KQF8SR
M1XGC78%.FM\"$$]N 87WFXU[TAV6X/\^$EH1/M147PG-BW,V'=0'6,83K4'"
M&M"?6GGW+[,9C,GV'G._=]A2F=1H.G*<G\BN+D3W^P38/\*T7]ZH]J"/NK7H
M#* 0]:HZ[,?RQ4Z"<NW"KD^FE3_>X9&]4J8T*VJ.4VK-^3 FB$246U9DK]$E
MJANZ-=*H\+O>Z[LD.983T<;.%]@^]W%H#3G]%#;^,)19;;1"%T"VMD*&V3$K
M7#7.\CGJG#Z!IO\B%3*,\AXU_LF7[S(?S-3TSYE$>=9\ &SSK6ZBPMK1!:W$
MR"4ZYPY-:J#@SEO '9VAZP+AXJ0'DCJ-35%#9!5*3#%_9:A$P7)ML@$>1V:<
MU=EWTB<-SZITRO9]81XC2KAIR4&63<3S4YYNVR@U[ :X,V<&=SCW_6VD@W'2
M[[$T?Z&C\DIF6AO,,'#R*>:J;.I&A6@EB_;=> LYM&?WIGN?X9UZV1<A$[IG
MO7_BI>3DF@,13AWL#!(@0C_Y"3@76G>Q)X?^-$[;>T[*BOOW"CM?[(;'@=G9
M6I- C'J'='=,08#54/?7BM<9@0N#G^\EM6W\15BW9Y/%^W'6H.LB[#\[CJFS
MHH_T!5+-'UAQ65I2*11['1E7XH2%!)&+-\]?:.%MI[>&XJC71>A-5<CAPR5D
MJ2G3T\<"Y6_H9E7Y56^$Y0(O];;:AGAZ9E:GBHI956=F1C@73*A37=D"\<_:
M>K7<-+#6JR.T6,=E732B]9.P.)W(N<#(BP>6%L&ABHZ D&P5(OFI*.O5N(@<
M"N;-WO:=XCT?P<K48-(Z$K0U4E]K--YGQ7+*E.>@ZLVR<,Z,N?W<C/OB+6#0
MZ<N! T[F2A%KM_XFAL-?\W&=R^O[X<,K!D%[@0%E:IAC 7^F:O!# [/KJ"ZJ
M0?/0?';QDF!-V.(([,B\UH]E181J9)T'4Q>#<%C^8'!N-&><60Z(=O5Q)F;$
M/^/E22N"BIA@)+NN<AY".[J,?QO@TDV3?B7>%W7N>L+A<[(0VY&?//>L928@
M&SSCJ7OVM9D!F7/VNPHM^6;" ?4@/0O>L0BVHQ%/K<I!L=(>LY[T[F7^+0='
M/O?*QL?((;L<2"1D>F=K&$D_6O9U5.#"_#NNIG-"<>Q(+.V:W*XM_:?U#N:<
M(U;B>/\439=00>)>S7LKL6NU+<)0WP\84*"C^!!PYD R3E:SXB(R[5ZEMSG1
MGF9^<S$[UC&&A&2H^RX#SQK JY*?_XRY,TG -:(;EZJ7[1H3&OA9DL$SO M7
M^KFZ0L E8U.*CB6K>4&]L7R$0B<!();_P.1@<'PVX'7'X9/FV76CK$DSRNOO
MA9,\'4:[Z8I]!_/N=FHXF#M(>L5]GJDZB_:N(&AY]*[>7I[TN]\"3KN'08)E
MMX!EW1T0"XJH'-NRK-8P*J0Q]*>JG_4+C^HMP'/%+87#@[&WV7'/C!""#+'N
M2,$(IK[[G==1$-1H>2_\1=L 14.O!+5?Q>9N]879+2"IPM5D_,_VWROX+0"_
M#?U)5@'3VSVWXL+%[*=F0<PFUB:%TVZ5WFIAOP7T2V"3;P&FCJVGQOI.:*?V
MRYS/* 'W]$E"MC>'.X7);Z,>S0%(4W04#GW^EL.(L )=TN!@6:=BLYT;W:5B
MKLUQD/3S$[Q'I'WFA&I'D3IZF@(7#B>-%B&HKSDG(HW3TNS!MX!CM5.MOW<\
M,H8TA+&W;J3570<H7D/2T&W8D540I=%V+9!ZW+*VEHRZN#ZZ88#^Q6-GZ9PW
MRYBBF'4G9C_NV/$KY;JX+B%/)'<AJN\'M<%*F.V#G;BULM*+PL$FY!"M^F)E
M *QDEY[]F*+F7SG%A1H@6<--L>MDS[I:R,=(\D*9TMP"G]T"0'1[*0[.Y\^/
MO)A[7<=*DAGR6E[@)?6X+478S?-(<\5)8'$NZ*%8L9LTRC.$?E<.K9]V*53^
M%J!1C[4MF3,>L3/W;0I-SH]0[3F639A &AVUB&"]]# J01F:8P[R4][GWS:H
M+R)S^(8U#8(N9X1X2C =AT/EQAWI0BC7XJ^?:!_Q/>B!S>1L!"1G8Q)/KJGA
M^VNW 'B_(\?/FNNTXG#-%N,]CY^@UG<O!<&"3[T9S94I"RVA6FOAD>*MQ+9Z
MSUO)):*VA0X2I0[S1 ^^W>O\5] G9W1:*<^$.%<<ED.%/)?L$CNZ2J5T;9E"
MJ I_/I73E-8CC/+"5+T:$ZS. !-M'Q$4") Y"&X;!#X556ICP@FH@0("/'%I
MF?H-[&E[ >R3"(^8^R/O4!-%$XZ\<>XI2=9^*G(4+T'?RU)3*L"&6K;2X6'0
M.<GWBZKM-Q[)JP)(:C,;ZJ&U#%)?MG=-1,&+02\;+C05)9U\%@JYLD:5:DI6
M6\G\7ONQKX*8;/X.]X I-00K\LEHBCGNG=VE0V^I$Z&1&=1W1;YYC6:XL:B8
M[&\1>(T)_\F- W8*% $CD]4JPQZN_>V,M]:<RHV44^C"?-=AM.8?)&;GKP.&
M-7^WJ06CXV*H<PE[]Y>MGEWVUCF"^%.]WSN5J?G/7U_2Y:6K0Y:/Y@\GUP/(
M;*:989T.HKMSC#=C/C%"7>W*6PZ]P?Z$SR+_. E]1V\="!6J%'3%JY3,)GD]
M5"11HTP*.HP,R!??HZ3T>X_U>M@(#EV;\%AD_37D6*=)KZJPE=D8\#D6]ZD6
M1[["YLE.;X(=Z=&/URH?S#9YJO#K98$%\FU0&Y[<L)I$X41ZCA:6OH)8@HBA
MZ18@]PM6S8Z+D':Z#GU\"Q@%-K/<E6O">YU; /()[!3/)+P'=.>1^=$U,=E1
MUN=E7Y#CUEH2M _H@EZ8$[F8(N .0C/A1_"/&A/J$"Z;!CS!#X&BT#U#=:R.
MF=,M0$VYY H-F^F",G0Z?6EYC/X;["!^ %J]*2DW5CZF0]6)VOM5<)&][HS-
M@HQ["/G< KIRB/P4?]@9L0U'.=L?OM]/E:D+I%IML7H?<HK@['#&?4)[A:^,
MW6G4@QW7^5>#OV88J*NRNI(2>?%:"SW1<6S0N-6M+_LH];S9V=VD^7[R3/I*
M82ZR;TSR%@"W7B[=R;]?X<C3+\4%^;N&6/6';CCNT;5D>M4E(K)HT0=+"]0F
MQ>T;IF*]V3)C#H1#\DO[XMHAQ\7#ZWCH-AR!-=;9S_;._QZ(LXB0V@HX.!:)
M9]NN6[]3>R&50<1T<[0"06%M5R Y#VS_SAC!?YE"?#*7_#?Z_[KUDTA;)VHZ
M2T_5>?\R%;H!;[S6+?G1?-CZO@')B(TJVTEO[4:20V':DT(.[HM/KQLQAY\,
M)@)$(]6IQ *E3NW.W<91D']?JP:M<F)XO]0LLV]O]'MY9$B1+R_&9:M%7#^/
MIIVK M/XWVF-R A:'$9Z,G%YTYC@QS\E* Z+ /*B:Y(/:J9SO!ZU5"3.Z2:"
M]-Y]2,BD>G;3;8P)#T59Y?DI9O2T4%9732YM$H1!(-&.;P&BH@.]OZ19S];I
M@$WH"I38&HQB;PDPAIZN(SKXZ5\FDR^%OZE_NO"4TD4/I;C*S@3UZIE9$D3S
MS]XU=)N\J&;YG> _883*;^)@*$JSAKQ+I?/&&U3ZQ ;SDME=D'/62]YWR N,
M2\1%N-Q94,75)Z?L#.)"K&*RB01ISJ[/,\D2,FDH7&8*?;F]A8-602S0J%X?
MKRA9^Y3G>!K*QA !Q?J4%TQ<8F1N.2A?9X'ITI9?O =B_?)\L'X=K,<M !QW
M"\A5,5IFJ1Z060Z33A[JXIN8LT\D?G"14!?H[-_^^(>?/OHHLD:$&FIA@&Y)
M93N=,^X7$+SSO_:Y[Q2E$RDH%0TNLZ,P%FMTE38MG!7CU7+<!?KUB8N=LI$4
MSH"$D[X1]/EFWL+H'^/%&YN""^O!\\KKMZU,BT.PE>70.GTR(UOA1\*#K@:K
MA##F&@RG(6I47GK;*#DL01[N1I_N:3B_Y9<F&A(M +PWHCDUX?<:K9S_PQ@J
M/= Y#?1 )'F&*6SF7;@(CU(.*D/9*NVFD:O^G_;68\/7^.S_VCZO%7HX [0C
M1[S.=.!UN>K\?F3$ZVUJ>Z1V@P]_/'&C>Y'M40YI'.D9TAGI=,:ZR@$UY#<T
MO(2Z1VW-S10NWI3]-^K>.ZK)MVL3#:*B5*5(!Y4F7:KTH$@78J%7%9 2BO10
M(UVZ@(" ]"XETJ6&7J57Z0F=&$BH 4(R_+[OG#7G?>><;_XYLV;-RKK_2;+R
M//=S[WU=U][9:V_O;9(MYAX/3M;*S0F\]JII,UA3]$-]DW?<O,)>6G+^ S42
M644YECE<[*K3!Q#M3ILXQE%@?JDF[%?$;Z/NG5WM.W+^Q5E/3TH"^;:51&:=
M\5SEVRP/A_R*Y<VT722Q)'3X4$'VM8^#"0=9T_P['"G_'/>BH2&!T>6 \[].
M(^CCM:_+G:)OY^R8) K-2/OZF?5<#Q&88.^340S<O1(CDB'=0+9JB=4E&L[C
M/]"SATTT'! ^_9G]6A@MQ'>/%7C7/N3V9OS28,0/L:TI@K5?B"VS%[1X6W>G
M$G5LF38#YF ?QS^]_M)AWJEN_94,9,;Z.C]'\H<S?<F,KZKD9:0 0#NI/8S_
MKK\=5KC[7D.7#F:I_'69IJ=#1Y:R1#O)"E"EUK!L487+/K&=:8@_-.=#NY#7
M&E_.9AYX$0KL+X$'0,U!3W D1 !W)_ <GW%N*(B$WMGE8,$1 7X!17:,)HM;
M.AK#%?7H]CN-+LE&JU:3K=XKMQ1D?^!,VR.+4-)PFV9&<=GXWX9GNH_="N)G
M&N,9[+* DVU"9KC\SG2&"KR;<>%/<-H:Q9CMAKB@[7V#)&@+Z!RG403WFB2T
MKN5AXKM%[^#B+76 KS#4I?FFM8Z]>ZL#/^_(<$IJR9[/J'^"K]=#B  4@SEF
MKP'KMF59$V&!:4L %]8@D1";U]N_%(*V&OR]I$:6[#GI%.2QG-WIL^'^\C9^
M3J4:N=9-60H, #>R] +WK-J41-  (<2WJ&5V5P<KP.0!C5&Z.>WXP @FLD<I
M44W)S.@&4VJ1)S^).G"AP<GW<G!C*^*C\)!Z+_B?P<"^XODO'99\FS)"B@0L
M7]RWRE_@I@-_'1:V&8.R/.WWLW?,*-.,IW+>!CH#A)?49T(K&#B:B(!OBM8;
MZW!8]RZJ3Q3]%LN(?L"04LJ4-:LS^;P>HT7R#,^VMON'"/@4KW4B=PCCP-$8
M3K4\?8>$DUOTV,.,15,,7([=^T;)0G;5?RE6:<IK E'O&Z(M9S;@T>G2F:5X
MZ>GUYH;(@IH&"=-^/>?8V2(:QR,\>!!O5;*XRUD##ZVL]%88@D2.N'5<CX+G
M16U[*M(A5[I97^7A@A>TQXZ*/)_0*B/2]<EDVKU'[[/YYQ<ZX;4P[)>G74N,
M7<O,U4^ ;YL^AXKG<0J_"GIO]$E7 [_38[JYAE.\$H?MV2TM7^$,5?VX>&1E
M,Y)="40VO"KK*%IG].(.Q45%MM^G=DT6RG/WF5;P/[T/^3#904?#++OZB<CK
MO*^+[TN(O2?[.0(D'\$EK^IA&\*H6IZ^T:_E</I:L$9-)@#*]SA?/:D0O::-
MY,54E%OP5TO/%Y .NMEH*JS**;WZ/, >T%&4E6@.55K!:! L5I*>2'&>W30G
M F89KZ2 CC\1@! ]DP;=O7K#&'J2&7##CU7;RI6%LKE[,'\JP0*(6+D&2>Q:
MM:A##&4^^5#ASAW+ ,]F7J3^[=]1'Q=16I[=!50]2VE[Y OO'\&D]M#0VV?1
M33@*![* &6<PIMRN2\]M%@2"_B_=V-2)YA9K?J!F<[UTMR N.7JU0@ZE@=&-
M+EY1W3 W-5%GJ]JCJOO4P7P]!&> =GJR#S3OC^M?;[L"?3$LXZ5/J\^3KL9"
MG'<)SG?3WFR;XU&M\M^MC>!MCW/;,\X3\!\%GR(+L,6-&8\E)4ZYO<T_^5&*
M'=YBZ$1ESLA*'_\;(C48AZ'.\P)MEQ(5N]S;;Y=?H$YUGW+-K1[QUH!2T\[]
M9QH(S2G3:$[+E!E"JRY-N^'D#IPJD,O"I)D;:S;2CYK6G>P_]ZP\7>V-?5>,
MEYX4J<B-1S.63"R^H'?V6H3PC5DQE<-"+6Y,UP)OH])!44(*"5"Q&Y0#?-_"
MI).2^58J/AA!_)#97;\*)_"B]S(JMS<-P)Y-'ZN?T2AL3!YQ>Z])F:B#'A&N
M-P]9/L'%MM2'=&77UB=S)-$^Y2C^H+/XBI*?6TF7K(G_/&:VWO ;A+5=[J^2
M4",V.P9V/]LX3>'7VY"O01I]%FFDGV[Z?4\$3V[/"RC"?SLMZ\!$^P^ ]%=Q
M5R\$2&@I(+R>RN8\0FDJW$S/C50]SIP*?+X68?;]#HV9-UX ^'F9$YN/UQCW
MUT'H<%"<_*P5(Q"L]1:U@V^)%&"6?H1MA0?RX-6S1OIZI9N\8O,61FIT&,K"
M?;!S[U86W9291Z@%7K>\3XE]0@04FC5*%D)YSL2!+&::/FO[8=X2UWB^"<5G
MO[;B+8.LF,,Q6WVH !7=<1'/C+")X&CM@(5^GH- ?:N^B:855HBVX13A/D3P
MY:30\_3 5/XGU#RJ!ZEN:\%/%4C'6+*@E& :[,Q"=[1MY@/)+E(SG](N_*+3
MR-[:]_>5I_854JG(=Q^20.9<. X?]_+=%59_]2+[L>T[.Q0%9I$NO"G;"N,Q
M!]+)!N@QTA&)J#E<Q8^E[>Q[>)Z2N1UWA]3'IAJO1]CV4^7#;S+$^Q\I"MKV
M99'-"N/MBR&S'5Y#(D5QM">SPU=D&6.=<M]-Z0V.8YJF6Y&F-S50"K,5V2*1
MV^.N&%OC$K4)Z<RO#S3@>+\%.";C..;?8;4O@R\>'TF"C7WM3_]:C 7R0;(-
M9\MK+^#A\VV9+@I!W,W?AJH?7*Y]4^Y#"DK+/)@E NQ9Y^ID4NQJ,Z5,)OC5
M],3FO %^&Z,[.P9"5T(H]K7E L]6J*01VD2?3DZK46_TM_KYTRWFOV!0[S+Y
M+"]6JCA&X8'G=;FE%HOG/\V@98WQ8Q>'*PL)4?9_2GT)IOBPIJ]^"X>7NGWZ
MF,W82ATGZ=(B4_,!APN$_1<Q%8+?FQ95(N#A2!D18.%&!&S?;)D?7%@CB_0$
M\\YP5V&F8VN;-R[H!%NZ)EF_<^IJD%92"TYZ9O@X'PD_F[^Q(ED_H1;]1;Q'
M@S1+;DK/LADJOGIY?( ?85VUQ"=F/B$T#1,!^2R-,'*S 1NL(#)L2CGM063!
M2[GUFP^;H6$LU,4(6,2,B07,Z03<O_ZU)?!]&XF;NH#&=@!8M(- -UV['ZDD
M/BW%>B?=N:CK[P'SW9;QI.ROM.H<.?I3,\Y+V>N?PQ,,]^#2;W!4A7^*@]2J
MK8RE!%&1)LB-<&M',8 S*HX(>&.L)%??@#GMXR1S,-'CIQK)Y4OVJ*)J>RMT
M)Y'L3;@"$5"M**"AP(>E0PQ/KRO=TJ:R5&W\-L"0N898Y8,9@-YUN?<QY",L
M27 9;["U%I+8J9/.DV7%^I1[?8(T9*7,;-9'?$G?IWF_KPDG$@'"H9.OOOK"
M#Q>1"DZ(C&PZO#V67IJVQ3<V*Y-](TTEV.8I,RGV>M!^E.5=7#V0:=E?8HKZ
M'E:*D_= )%S60".H'YV5C[*(+[X2M2%K165(6:&3'8D=%*4WAP/[R'5_IQ'$
M*<AYNA]2AE"JA-^37((^K:'=<5ON\?;(TWM*&G%C9(9+EE3!^OBD4%M=1['A
MR#MU$ZZBV=PH-;_B:YET"?* W;_, :Z3(58NR(L)P=.HXTTB@$E!N!Q7K#6>
M.UY.F.:ISZG14IC2*:&/P7?;PAR2L>K3@=;:B-1\_.<V7@BP6RZE)@^2W47A
MY%JR\S3BCXAKO;+/=5M21=^$!;*HC?B8W%;LAVC&;MAUS:+=.R_R1M_$KFO,
MO B68Q/?XNQN]_6LK.EK(Y_=\]<NAG1U2BP4U=C<#=<0H;[GL46J*#' EC#E
M)F9V.1JNQ(U_/B79WV)E6V1WKA_;_PN"_B8QJ%[$?MGW*F;K9J;B+&QI\YLV
MXBPP0V*^K%])<9B[R27"HR@AOZ9M2M^9B>,64SLP#1AV)5Z?FC7$XQE=UF"4
M;:E"*[:9;#I.,LP'Z\R]ZA^?WK]TL-@Y 1_R>UJ #A[AFKNSF'$NB#)Y,%K
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M?#P\6BD NH-WQR1@EL;&]XI:IK8^]]WX69^@X<7$&@UX+#&7/@SW_+7O300
M[!V^UE=?(>,;%PY4^I5C4@R[=:1Y9KB>^*6]8[+I DQ0>LA30W9&"UU9GD3X
MLY?;8RVW.>^(.K:\W8WPRG=?Y_]Z;(9>=)]\D-%@\K=%WA8)#2<"KAN<@B9S
M,U[;#R]-%_YVW'CO+"=X[1:)YM%6U%:+(9(FI.T!IJYGW4#;J7* 5,'5U&2
MHKP;>O<EE[/O>M;E[I8-O]0&J@$D.O5-L)?_[-QE]GSN5!M<5L'5:>\- Y$N
MF9CXI+IU@E)Z#(6Z[G]TS4H^#$R<3PF#YN'?-"6TM((,TT1>'AF9K0'/)0AG
M)CLM*C]0)M[MPJ0J+1)01S"U< ); E_2KR\TT.:JP%BU0LPHLF"9BM#9..NA
M>11M%Z0M^4*:[@M#RQ=OUUEOQ6'I,UO^$RC&$I'# WET2@2$6\85%_L;O"4"
MR(]/7I-GF 7+XSLK_66O&-D%L7*.B28"GC)L21,><CR\3)>ZZ2WL;@,^T>Q
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M"*C#_E"9YR)@]V1.XA/T!O1B6Q\>-_^B&O=ZM%O:BC%=>%ZWDNS!;0 1L+8
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M\7RWM2<:U/JS9JJ"8X(P05%F+];&O$8=&Y*0K,#AT$-/,DH$=-Z^4I'G#))
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MHB"Y_W?_+[OH7R7;C!.7JKX-EYUF9[%LW[%?M?4MM8D3F\O\Z +S>,H29N8
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M<\_=RM>#*T=A#B7H(DZDNA<RTE] -\>>DV6D0LC>2;C2YY-&M)'";X:XFS0
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MIR:'%(=C6W>0?'W^=]:\\YMZKQ+3?2P5G=S&DV5M'DUJ_+BH?%]$Z[C]*],
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M7U4R^+FV8@EJC;GBX,_?MR[B]NJ9.X?(AB/VW6?19 JCBX3T-#\A=%8*].2
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M]RG=>?%JGJ'!C?($(QW\G2";*S<'AM6@:$O=S8MQY3&JNDJJBP4*4!]T%DD
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M(& OX,_O$GMF%1O;TA4RTQ,2&>-+X#P",/3=)NO;^&7.DAM:!N49^71?7#A
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M1[/SM,  &OG?(/]T6G]K^Z&8.P:$K2G(SX@^&O(:7J]/:,!@FQD,3NAA? <
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M;W)M9&5F,31A7S P,2YJ<&=02P$"% ,4    " #"B[1::2LTBSYH  #6E
M$@              @ '"'P( 9F]R;61E9C$T85\P,#(N:G!G4$L! A0#%
M  @ PHNT6B.49QT8!0  OQX  !$              ( !,(@" &MO<&XM,C R
M-#$R,C@N>'-D4$L! A0#%     @ PHNT6N)/O+:?!0  )S0  !4
M     ( !=XT" &MO<&XM,C R-#$R,CA?9&5F+GAM;%!+ 0(4 Q0    ( ,*+
MM%J>_8YN0!8  % D 0 5              "  4F3 @!K;W!N+3(P,C0Q,C(X
M7VQA8BYX;6Q02P$"% ,4    " #"B[1:F]I+A28.  "7O   %0
M    @ &\J0( :V]P;BTR,#(T,3(R.%]P<F4N>&UL4$L! A0#%     @ PHNT
M6B1ZC:K0/08 CFD'  T              ( !%;@" '!R;WAY7S P,2YJ<&=0
M2P$"% ,4    " #"B[1: W/@07BR @ <U , #0              @ $0]@@
C<')O>'E?,# R+FIP9U!+!08     "0 ) #H"  "SJ L    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>formdef14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:KOPN="http://kopin.com/20241228"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="kopn-20241228.xsd" xlink:type="simple"/>
    <context id="From2023-12-31to2024-12-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="From2023-12-312024-12-28_custom_JohnCCFanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:JohnCCFanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="From2023-12-312024-12-28_custom_MMurrayMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-30_custom_JohnCCFanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:JohnCCFanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-30_custom_MMurrayMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="From2021-12-262022-12-31_custom_JohnCCFanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:JohnCCFanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-12-262022-12-31_custom_MMurrayMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-12-262022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-12-262022-06-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-06-26</endDate>
        </period>
    </context>
    <context id="From2022-06-272022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
        </entity>
        <period>
            <startDate>2022-06-27</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-12-312024-12-28_custom_MMurrayMember_custom_ReportedValueOfEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-30_custom_MMurrayMember_custom_ReportedValueOfEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="From2022-06-272022-12-31_custom_MMurrayMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-27</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-06-272022-12-31_custom_MMurrayMember_custom_ReportedValueOfEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-27</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-12-312024-12-28_custom_MMurrayMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="From2023-12-312024-12-28_custom_MMurrayMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="From2023-12-312024-12-28_custom_MMurrayMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="From2023-12-312024-12-28_custom_MMurrayMember_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="From2023-12-312024-12-28_custom_MMurrayMember_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="From2023-12-312024-12-28_custom_MMurrayMember_custom_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-30_custom_MMurrayMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-30_custom_MMurrayMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-30_custom_MMurrayMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-30_custom_MMurrayMember_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-30_custom_MMurrayMember_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-30_custom_MMurrayMember_custom_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="From2022-06-272022-12-31_custom_MMurrayMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-27</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-06-272022-12-31_custom_MMurrayMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-27</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-06-272022-12-31_custom_MMurrayMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-27</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-06-272022-12-31_custom_MMurrayMember_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-27</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-06-272022-12-31_custom_MMurrayMember_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-27</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-06-272022-12-31_custom_MMurrayMember_custom_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:MMurrayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-27</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-12-262022-12-31_custom_DrFanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:DrFanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-12-262022-12-31_custom_DrFanMember_custom_ReportedValueOfEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:DrFanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-12-262022-12-31_custom_DrFanMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:DrFanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-12-262022-12-31_custom_DrFanMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:DrFanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-12-262022-12-31_custom_DrFanMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:DrFanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-12-262022-12-31_custom_DrFanMember_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:DrFanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-12-262022-12-31_custom_DrFanMember_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:DrFanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-12-262022-12-31_custom_DrFanMember_custom_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">KOPN:DrFanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-12-312024-12-28_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_ReportedValueOfEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-30_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_ReportedValueOfEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="From2021-12-262022-12-31_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_ReportedValueOfEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000771266</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">KOPN:AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2023-12-31to2024-12-28" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2023-12-31to2024-12-28" id="Fact000004">0000771266</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2023-12-31to2024-12-28" id="xdx2ixbrl0011">DEF 14A</dei:DocumentType>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-12-312024-12-28_custom_JohnCCFanMember"
      id="xdx2ixbrl0016"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-12-312024-12-28_custom_JohnCCFanMember"
      id="xdx2ixbrl0017"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-012023-12-30_custom_JohnCCFanMember"
      id="xdx2ixbrl0024"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-012023-12-30_custom_JohnCCFanMember"
      id="xdx2ixbrl0025"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-12-312024-12-28_custom_MMurrayMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember"
      id="xdx2ixbrl0066"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-12-312024-12-28_custom_MMurrayMember_custom_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember"
      id="xdx2ixbrl0069"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-30_custom_MMurrayMember_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember"
      id="xdx2ixbrl0075"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-30_custom_MMurrayMember_custom_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember"
      id="xdx2ixbrl0076"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2022-06-272022-12-31_custom_MMurrayMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"
      id="xdx2ixbrl0079"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2022-06-272022-12-31_custom_MMurrayMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember"
      id="xdx2ixbrl0080"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2022-06-272022-12-31_custom_MMurrayMember_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember"
      id="xdx2ixbrl0081"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2022-06-272022-12-31_custom_MMurrayMember_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember"
      id="xdx2ixbrl0082"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2022-06-272022-12-31_custom_MMurrayMember_custom_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember"
      id="xdx2ixbrl0083"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2021-12-262022-12-31_custom_DrFanMember_custom_ReportedValueOfEquityAwardsMember"
      id="xdx2ixbrl0086"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2021-12-262022-12-31_custom_DrFanMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember"
      id="xdx2ixbrl0091"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2021-12-262022-12-31_custom_DrFanMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember"
      id="xdx2ixbrl0093"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2021-12-262022-12-31_custom_DrFanMember_custom_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember"
      id="xdx2ixbrl0096"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_ReportedValueOfEquityAwardsMember"
      id="xdx2ixbrl0109"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember"
      id="xdx2ixbrl0116"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember"
      id="xdx2ixbrl0119"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember"
      id="xdx2ixbrl0126"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember"
      id="xdx2ixbrl0128"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember"
      id="xdx2ixbrl0130"
      unitRef="USD"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember"
      id="xdx2ixbrl0133"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:EntityRegistrantName contextRef="From2023-12-31to2024-12-28" id="Fact000012">Kopin Corporation</dei:EntityRegistrantName>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="From2023-12-31to2024-12-28" id="Fact000013">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:PvpTableTextBlock contextRef="From2023-12-31to2024-12-28" id="Fact000015">&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eecd--PvpTableTextBlock_zRpWZcajCUtc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_484_eecd--PeoTotalCompAmt_hecd--IndividualAxis__custom--JohnCCFanMember_z4wRl1hxl8k" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Summary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
                                            Total&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;for
                                            former PEO&#x2013;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;John
                                            C.C. Fan&lt;/b&gt;&lt;/span&gt;&lt;b&gt;&lt;sup id="xdx_F55_zb6YVkpu2qb6"&gt;(1)&lt;/sup&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48B_eecd--PeoActuallyPaidCompAmt_hecd--IndividualAxis__custom--JohnCCFanMember_zEMRIXLELuL2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Actually
                                            Paid&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;to
                                            former PEO&#x2013;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;John
                                            C.C. Fan&lt;sup id="xdx_F5C_zdfgBLSvTxbf"&gt;(1)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_484_eecd--PeoTotalCompAmt_hecd--IndividualAxis__custom--MMurrayMember_zHEfdEXFgGi7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Summary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
                                            Total&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;for
                                            PEO&#x2013;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;M.
                                            Murray&lt;sup id="xdx_F52_zcnsdqsc2nXl"&gt;(1)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48A_eecd--PeoActuallyPaidCompAmt_hecd--IndividualAxis__custom--MMurrayMember_zGkS5cGILmJ8" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Actually
                                            Paid&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;to
                                            PEO&#x2013;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;M
                                            Murray&lt;sup id="xdx_F58_zWsJJ7DYPXa1"&gt;(1)(2)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48D_eecd--NonPeoNeoAvgTotalCompAmt_z3hVIJxlJDS9" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Summary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
                                            Total&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;for
                                            Non-PEO&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NEOs&lt;sup id="xdx_F59_zuglffXQwHhj"&gt;(1)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_484_eecd--NonPeoNeoAvgCompActuallyPaidAmt_z85v9RHtquGc" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Actually
                                            Paid&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;to
                                            Non-PEO&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NEOs&lt;span&gt;&lt;sup id="xdx_F5C_zhRjq8b5ahai"&gt;(1)(2)&lt;/sup&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_488_eecd--TotalShareholderRtnAmt_pp2d_zpgChxSN4eH1" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Value
                                            of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Initial
                                            Fixed&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$100&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Investment&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Based
                                            On&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shareholder&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Return&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_486_eus-gaap--NetIncomeLoss_iN_di_zSb71LOH3WSd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
    Loss&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_412_20231231__20241228_zU2eKW0ZmDpe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0016"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0017"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,390,838&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,491,558&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;516,011&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="-sec-ix-redline: true"&gt;427,512&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33.25&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(43,877,896&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41B_20230101__20231230_zv7f82SojZ84" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0024"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0025"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,042,357&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,651,367&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;602,068&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;684,290&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;49.63&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(19,748,219&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_418_20211226__20221231_zQcEgrBxxTEc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;609,776&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(&lt;span style="font-family: Times New Roman, Times, Serif"&gt;254,406&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,263,936&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,223,936&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;378,934&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(&lt;span style="font-family: Times New Roman, Times, Serif"&gt;89,244&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="-sec-ix-redline: true"&gt;30.32&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(19,326,265&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-12-312024-12-28_custom_MMurrayMember"
      decimals="0"
      id="Fact000018"
      unitRef="USD">2390838</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-12-312024-12-28_custom_MMurrayMember"
      decimals="0"
      id="Fact000019"
      unitRef="USD">2491558</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-12-31to2024-12-28"
      decimals="0"
      id="Fact000020"
      unitRef="USD">516011</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-12-31to2024-12-28"
      decimals="0"
      id="Fact000021"
      unitRef="USD">427512</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2023-12-31to2024-12-28"
      decimals="2"
      id="Fact000022"
      unitRef="USD">33.25</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-12-31to2024-12-28"
      decimals="0"
      id="Fact000023"
      unitRef="USD">43877896</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-012023-12-30_custom_MMurrayMember"
      decimals="0"
      id="Fact000026"
      unitRef="USD">1042357</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-012023-12-30_custom_MMurrayMember"
      decimals="0"
      id="Fact000027"
      unitRef="USD">1651367</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-01-012023-12-30"
      decimals="0"
      id="Fact000028"
      unitRef="USD">602068</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-01-012023-12-30"
      decimals="0"
      id="Fact000029"
      unitRef="USD">684290</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2023-01-012023-12-30"
      decimals="2"
      id="Fact000030"
      unitRef="USD">49.63</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-30"
      decimals="0"
      id="Fact000031"
      unitRef="USD">19748219</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="From2021-12-262022-12-31_custom_JohnCCFanMember"
      decimals="0"
      id="Fact000032"
      unitRef="USD">609776</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2021-12-262022-12-31_custom_JohnCCFanMember"
      decimals="0"
      id="Fact000033"
      unitRef="USD">254406</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2021-12-262022-12-31_custom_MMurrayMember"
      decimals="0"
      id="Fact000034"
      unitRef="USD">1263936</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2021-12-262022-12-31_custom_MMurrayMember"
      decimals="0"
      id="Fact000035"
      unitRef="USD">1223936</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2021-12-262022-12-31"
      decimals="0"
      id="Fact000036"
      unitRef="USD">378934</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2021-12-262022-12-31"
      decimals="0"
      id="Fact000037"
      unitRef="USD">89244</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2021-12-262022-12-31"
      decimals="2"
      id="Fact000038"
      unitRef="USD">30.32</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-12-262022-12-31"
      decimals="0"
      id="Fact000039"
      unitRef="USD">19326265</us-gaap:NetIncomeLoss>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="From2023-12-31to2024-12-28" id="Fact000041">&lt;p id="xdx_890_eecd--NamedExecutiveOfficersFnTextBlock_dU_zwyp40JLOSEd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_902_eecd--PeoName_c20211226__20220626_zFGJOJxTSiwi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dr.
    Fan&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt; &lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;was
    our PEO for part of fiscal year 2022 and was replaced by &lt;span id="xdx_909_eecd--PeoName_c20220627__20221231_zlOvYzLZSms7"&gt;Mr.
    Murray&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;for part of fiscal year 2022. &lt;span id="xdx_909_eecd--PeoName_c20231231__20241228_zQEeWYVKwSTf"&gt;&lt;span id="xdx_904_eecd--PeoName_c20230101__20231230_zlBst7p3SJPj"&gt;Mr.
    Murray&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;was PEO for fiscal years 2023 and
    2024. The Non-PEO NEOs for the presented consists of Mr. Sneider and Mr. Baker in 2024 and 2023. The Non-PEO NEOs consisted of
    Messrs. Sneider and Baker and Drs. Tsaur and Choi in 2022.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="From2021-12-262022-06-26" id="Fact000042">Dr.     Fan</ecd:PeoName>
    <ecd:PeoName contextRef="From2022-06-272022-12-31" id="Fact000043">Mr.     Murray</ecd:PeoName>
    <ecd:PeoName contextRef="From2023-12-31to2024-12-28" id="Fact000044">Mr.     Murray</ecd:PeoName>
    <ecd:PeoName contextRef="From2023-01-012023-12-30" id="Fact000045">Mr.     Murray</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="From2023-12-31to2024-12-28" id="Fact000049">&lt;p id="xdx_899_eecd--AdjToPeoCompFnTextBlock_dU_zHHuMAof0Bv3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_481_eecd--PeoTotalCompAmt_hecd--IndividualAxis__custom--MMurrayMember_zQ6j8WTmiJ7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Reported
                                            Summary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
                                            Total for PEO&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Michael
                                            Murray)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_483_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zPrH3YDavYH5" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Reported&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Value
                                            of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Awards&lt;sup id="xdx_F57_zpgb0GiYdrZa"&gt;(a)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_485_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember_zA4V4Yyp6cpa" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Equity
                                            Award&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Adjustments&lt;sup id="xdx_F52_zZFn3M0v2AJc"&gt;(b)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48A_eecd--PeoActuallyPaidCompAmt_hecd--IndividualAxis__custom--MMurrayMember_zlr9QbnM7hrf" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Actually
                                            Paid to&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PEO&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Michael
                                            Murray) &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_412_20231231__20241228_zFafbaCTnjD8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,390,838&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,007,880&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,108,600&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,491,558&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41B_20230101__20231230_zl2U9EmvEgE1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,042,357&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(&lt;span style="font-family: Times New Roman, Times, Serif"&gt;431,999&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,041,010&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,651,367&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41E_20220627__20221231_zn8FSskPbaGh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;2022&lt;/p&gt;
&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;&lt;span style="-sec-ix-redline: true"&gt;1,263,936&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,032,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;992,000&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;1,223,936&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F05_z6RhFUPa3wU2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F11_zdEDv0kMaXK6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
    the total of the grant date fair value of equity award reported in the &#x201c;Stock Awards&#x201d; column in the Summary Compensation
    Table for the applicable year. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F02_zr7ZhfIJyHSk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1F_z2XxxZFMjVnj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    equity award adjustments include the addition (or subtraction, as applicable) of the following: (i) the year-end fair value of any
    equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change
    as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that
    are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in same applicable
    year, the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the applicable year, the amount
    equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for awards granted in prior
    years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount
    equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on
    stock awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or
    included in any other component of total compensation for the applicable year. The valuation assumptions used to calculate fair value
    did not materially differ from those disclosed at the time of grant. The amounts deducted or added in calculating the equity award
    adjustments are as follows: &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_487_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember__ecd--AdjToCompAxis__custom--YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember_z0s5a8OoOWcc" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            End Fair&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Value
                                            of Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Award
                                            Granted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;during
                                            Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;that
                                            Remains&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unvested
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_487_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_zzwtBVdwR6r4" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            over&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            Change&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;in
                                            Fair Value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;and&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unvested&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Awards&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48E_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember__ecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_z94ceg9Pzne2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Value
                                            as&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Vesting&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Date
                                            of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Awards&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Granted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;and&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Vested&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;in
                                            the Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_486_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember_zy7jwfIfeXWh" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Change
                                            in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair
                                            Value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;of
                                            Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Awards&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Granted
                                            in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Prior
                                            Years&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;that
                                            Vested&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;in
                                            the Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_485_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember__ecd--AdjToCompAxis__custom--FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember_zmLfWJHSgSb3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair
                                            Value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;at
                                            the End&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;of
                                            the&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Prior
                                            Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;of
                                            Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Awards&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;that
                                            Failed&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;to
                                            Meet&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Vesting&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Conditions&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;in
                                            the Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_486_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember__ecd--AdjToCompAxis__custom--ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember_zlX1Xo6lhJA9" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Value
                                            of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Dividends
                                            or&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;other&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Earnings&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Paid
                                            on Stock&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Awards
                                            not&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Otherwise&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Reflected
                                            in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair
                                            Value or&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48A_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember_zOQ0Po365Q7l" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Award&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Adjustments
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_412_20231231__20241228_zUYYsPHu85J5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 37%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,668,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;(&lt;span style="font-family: Times New Roman, Times, Serif"&gt;328,533&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0066"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(220,392&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(10,475&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0069"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,108,600&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41B_20230101__20231230_zDNnbRYbENa3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;428,190&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;505,600&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;56,020&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;51,200&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0075"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0076"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,041,010&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41E_20220627__20221231_zadP0vScuEd4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;992,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0079"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0080"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0081"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0082"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0083"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;992,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;For Dr. Fan:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Year&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_488_eecd--PeoTotalCompAmt_hecd--IndividualAxis__custom--DrFanMember_zgANI7iBLIrg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reported&lt;br/&gt; Summary&lt;br/&gt;
    Compensation&lt;br/&gt; Table Total for&lt;br/&gt; Former PEO&lt;br/&gt; (John C.C. Fan)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_484_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zT2KELBmfOJ1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reported&lt;br/&gt;
    Value of&lt;br/&gt; Equity&lt;br/&gt;
    Awards&lt;span id="xdx_F54_z1gHOC6GC5Qk"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48D_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember_zw0mnUjJEqXa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Equity
    Award&lt;br/&gt; Adjustments&lt;span id="xdx_F51_ziLhoKWKNyrh"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48B_eecd--PeoActuallyPaidCompAmt_hecd--IndividualAxis__custom--DrFanMember_znoiyykjJRm5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Compensation&lt;br/&gt; Actually&lt;br/&gt; Paid
    to&lt;br/&gt; Former PEO&lt;br/&gt; (John&lt;br/&gt; C.C.Fan)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_418_20211226__20221231_zxDdt3m37cm5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 24%; text-align: justify"&gt;2022&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;609,776&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0086"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;(864,182&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;(254,406&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr&gt;
    &lt;td style="width: 0.5in"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 0.25in"&gt;&lt;span id="xdx_F00_zLaKcgg2L1cj" style="font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span id="xdx_F14_z55aOHeFNCU4" style="font-size: 10pt"&gt;Represents the total of the grant date fair value of the equity
    awards reported in the &#x201c;Stock Awards&#x201d; column in the Summary Compensation Table for the applicable year. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 0.25in"&gt;&lt;span id="xdx_F0E_zAqV709ELNFf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; vertical-align: top"&gt;&lt;span id="xdx_F11_zp2CHklhu3I9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i)&#160;the
    year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year;
    (ii)&#160;the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any
    awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii)&#160;for awards that
    are granted and vest in same applicable year, the fair value as of the vesting date; (iv)&#160;for awards granted in prior years
    that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in
    fair value; (v)&#160;for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during
    the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi)&#160;the dollar
    value of any dividends or other earnings paid on stock awards in the applicable year prior to the vesting date that are not otherwise
    reflected in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation
    assumptions used to calculate fair value did not materially differ from those disclosed at the time of grant. The amounts deducted
    or added in calculating the equity award adjustments are as follows: &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Year&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48D_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember__ecd--AdjToCompAxis__custom--YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember_zcgB7BD4mRBk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Granted&lt;br/&gt; during Year&lt;br/&gt; that&lt;br/&gt;
    Remains&lt;br/&gt; Unvested&lt;br/&gt; Year&#160;End&#160;Fair&lt;br/&gt; Value of&lt;br/&gt; Equity Award&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_483_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_z1LX1UmN5x3c" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year over&lt;br/&gt; Year Change&lt;br/&gt;
    in Fair Value&lt;br/&gt; of&lt;br/&gt; Outstanding&lt;br/&gt; and&lt;br/&gt; Unvested&lt;br/&gt; Equity&lt;br/&gt; Awards&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48B_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember__ecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_zQeDQ9Awfg75" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;br/&gt; as of&lt;br/&gt; Vesting&lt;br/&gt;
    Date of&lt;br/&gt; Equity&lt;br/&gt; Awards&lt;br/&gt; Granted&lt;br/&gt; and Vested&lt;br/&gt; in the&#160;Year&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48A_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember_zlEngPYUEjDe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Change in&lt;br/&gt; Fair Value&lt;br/&gt; of
    Equity&lt;br/&gt; Awards&lt;br/&gt; Granted&#160;in&lt;br/&gt; Prior Years&lt;br/&gt; that Vested&lt;br/&gt; in the Year&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48E_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember__ecd--AdjToCompAxis__custom--FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember_z8sv8QaEEYgk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;br/&gt; at the End&lt;br/&gt; of
    the Prior&lt;br/&gt; Year of&lt;br/&gt; Equity&lt;br/&gt; Awards&lt;br/&gt; that Failed&lt;br/&gt; to Meet&lt;br/&gt; Vesting&lt;br/&gt; Conditions&lt;br/&gt; in the Year&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48E_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember__ecd--AdjToCompAxis__custom--ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember_zPWjbhLW4Z1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Value of&lt;br/&gt; Dividends or&lt;br/&gt; other&lt;br/&gt;
    Earnings &lt;br/&gt; Paid on Stock&lt;br/&gt; Awards not&lt;br/&gt; Otherwise&lt;br/&gt; Reflected in&lt;br/&gt; Fair Value or&lt;br/&gt; Total&lt;br/&gt; Compensation&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48C_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember_z6Nz2eP0ZuH6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;br/&gt; Equity&lt;br/&gt; Award&lt;br/&gt; Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_418_20211226__20221231_zw30x4IiQsZ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 37%; text-align: justify; text-indent: -12pt; padding-left: 12pt"&gt;2022&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0091"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;(94,860&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0093"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;(493,723&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(275,599&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0096"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;(864,182&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

</ecd:AdjToPeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-12-312024-12-28_custom_MMurrayMember"
      decimals="0"
      id="Fact000050"
      unitRef="USD">2390838</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-12-312024-12-28_custom_MMurrayMember_custom_ReportedValueOfEquityAwardsMember"
      decimals="0"
      id="Fact000051"
      unitRef="USD">1007880</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-12-312024-12-28_custom_MMurrayMember"
      decimals="0"
      id="Fact000052"
      unitRef="USD">1108600</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-12-312024-12-28_custom_MMurrayMember"
      decimals="0"
      id="Fact000053"
      unitRef="USD">2491558</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-012023-12-30_custom_MMurrayMember"
      decimals="0"
      id="Fact000054"
      unitRef="USD">1042357</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-30_custom_MMurrayMember_custom_ReportedValueOfEquityAwardsMember"
      decimals="0"
      id="Fact000055"
      unitRef="USD">431999</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-30_custom_MMurrayMember"
      decimals="0"
      id="Fact000056"
      unitRef="USD">1041010</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-012023-12-30_custom_MMurrayMember"
      decimals="0"
      id="Fact000057"
      unitRef="USD">1651367</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2022-06-272022-12-31_custom_MMurrayMember"
      decimals="0"
      id="Fact000058"
      unitRef="USD">1263936</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-06-272022-12-31_custom_MMurrayMember_custom_ReportedValueOfEquityAwardsMember"
      decimals="0"
      id="Fact000059"
      unitRef="USD">-1032000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-06-272022-12-31_custom_MMurrayMember"
      decimals="0"
      id="Fact000060"
      unitRef="USD">992000</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2022-06-272022-12-31_custom_MMurrayMember"
      decimals="0"
      id="Fact000061"
      unitRef="USD">1223936</ecd:PeoActuallyPaidCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-12-312024-12-28_custom_MMurrayMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember"
      decimals="0"
      id="Fact000064"
      unitRef="USD">1668000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-12-312024-12-28_custom_MMurrayMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"
      decimals="0"
      id="Fact000065"
      unitRef="USD">328533</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-12-312024-12-28_custom_MMurrayMember_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember"
      decimals="0"
      id="Fact000067"
      unitRef="USD">-220392</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-12-312024-12-28_custom_MMurrayMember_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember"
      decimals="0"
      id="Fact000068"
      unitRef="USD">-10475</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-12-312024-12-28_custom_MMurrayMember"
      decimals="0"
      id="Fact000070"
      unitRef="USD">1108600</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-30_custom_MMurrayMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember"
      decimals="0"
      id="Fact000071"
      unitRef="USD">428190</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-30_custom_MMurrayMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"
      decimals="0"
      id="Fact000072"
      unitRef="USD">505600</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-30_custom_MMurrayMember_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember"
      decimals="0"
      id="Fact000073"
      unitRef="USD">56020</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-30_custom_MMurrayMember_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember"
      decimals="0"
      id="Fact000074"
      unitRef="USD">51200</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-30_custom_MMurrayMember"
      decimals="0"
      id="Fact000077"
      unitRef="USD">1041010</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-06-272022-12-31_custom_MMurrayMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember"
      decimals="0"
      id="Fact000078"
      unitRef="USD">992000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-06-272022-12-31_custom_MMurrayMember"
      decimals="0"
      id="Fact000084"
      unitRef="USD">992000</ecd:AdjToCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2021-12-262022-12-31_custom_DrFanMember"
      decimals="0"
      id="Fact000085"
      unitRef="USD">609776</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-12-262022-12-31_custom_DrFanMember"
      decimals="0"
      id="Fact000087"
      unitRef="USD">-864182</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2021-12-262022-12-31_custom_DrFanMember"
      decimals="0"
      id="Fact000088"
      unitRef="USD">-254406</ecd:PeoActuallyPaidCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-12-262022-12-31_custom_DrFanMember_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"
      decimals="0"
      id="Fact000092"
      unitRef="USD">-94860</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-12-262022-12-31_custom_DrFanMember_custom_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember"
      decimals="0"
      id="Fact000094"
      unitRef="USD">-493723</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-12-262022-12-31_custom_DrFanMember_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember"
      decimals="0"
      id="Fact000095"
      unitRef="USD">-275599</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-12-262022-12-31_custom_DrFanMember"
      decimals="0"
      id="Fact000097"
      unitRef="USD">-864182</ecd:AdjToCompAmt>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="From2023-12-31to2024-12-28" id="Fact000099">&lt;p id="xdx_894_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zFN0DfyZZ3Pf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_481_eecd--NonPeoNeoAvgTotalCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember_zYnhtNet5cM2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Reported&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Summary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Table
                                            Total for&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-PEO&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NEOs&lt;sup id="xdx_F5E_zBntIm0ubbpk"&gt;(a)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_482_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_z75OrM2woAp" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Reported&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Value
                                            of Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Awards&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_480_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember_zSNIylIFC0i1" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average
                                            Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Award&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Adjustments&lt;sup id="xdx_F5B_zw90ROD8V3ll"&gt;(b)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_486_eecd--NonPeoNeoAvgCompActuallyPaidAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember_ztvw3FN3EqX" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average
                                            Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Actually&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Paid
                                            to Non-PEO&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NEOs&lt;sup id="xdx_F54_zvOxqNQbwXr4"&gt;(b)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_412_20231231__20241228_zuFT2YBeL5F7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 24%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;516,011&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(159,873&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;71,375&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;427,512&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41B_20230101__20231230_ziQGj7MPTKw1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;602,068&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(&lt;span style="font-family: Times New Roman, Times, Serif"&gt;255,140&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;337,362&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;684,290&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_418_20211226__20221231_zT2TvIYh3Wxc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;378,934&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0109"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;(468,178&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;(89,244&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span id="xdx_F0C_zoJmxMA2MSY4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F11_zQpwRaImKLk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
    the total of the average grant date fair value of the equity awards reported in the &#x201c;Stock Awards&#x201d; column in the Summary
    Compensation Table for the applicable year for all Non- PEO NEOs. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F0F_zYv5J8d1759c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F17_zwFGwrDqsNQ1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i) the
    year- end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year;
    (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards
    granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted
    and vest in same applicable year, the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the
    applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v)
    for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year,
    a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends
    or other earnings paid on stock awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair
    value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions used
    to calculate fair value did not materially differ from those disclosed at the time of grant. The amounts deducted or added in calculating
    the equity award adjustments are as follows: &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_488_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember_z1q7H81SMZ67" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            End&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair
                                            Value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;of
                                            Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Award&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Granted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;during&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            that&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Remains&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unvested&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48F_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_zBu658BZKngg" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            over&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Change
                                            in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair
                                            Value of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;and&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unvested
                                            Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Awards&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_480_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_zQcyI5rHd7yj" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair&lt;/b&gt;&lt;/span&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Value
                                            as&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Vesting&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Date
                                            of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Awards&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Granted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;and&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Vested&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;in
                                            the&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_484_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember_ziEayOBWkpe5" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            over&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Change
                                            in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair
                                            Value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;of
                                            Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Awards&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Granted
                                            in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Prior&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years
                                            that&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Vested
                                            in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;the
                                            Year &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_489_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember_zxraYp4bQMZd" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average
                                            Fair&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Value
                                            at the&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;End
                                            of the&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Prior
                                            Year of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Awards
                                            that&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Failed
                                            to&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Meet
                                            Vesting&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Conditions
                                            in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;the
                                            Year &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_483_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember_zvb4YGl5cLy7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average
                                            Value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;of
                                            Dividends or&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;other
                                            Earnings&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Paid
                                            on Stock&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Awards
                                            not&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Otherwise&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Reflected
                                            in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair
                                            Value or&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48E_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember_zzLZlLyzyM15" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Award&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Adjustments
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_412_20231231__20241228_zWYCWtAprAP3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 37%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;164,090&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;(&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27,840&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0116"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-redline: true"&gt;(57,187&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,688&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0119"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;71,375&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41B_20230101__20231230_zfXUfxQAXgjh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;260,026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,130&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;45,538&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,920&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(15,252&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0126"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;337,362&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_418_20211226__20221231_zQNDfM9nSzu4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0128"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(276,055&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0130"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(94,670&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(97,453&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0133"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(468,178&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-12-312024-12-28_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000100"
      unitRef="USD">516011</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_ReportedValueOfEquityAwardsMember"
      decimals="0"
      id="Fact000101"
      unitRef="USD">-159873</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-12-312024-12-28_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000102"
      unitRef="USD">71375</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-12-312024-12-28_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000103"
      unitRef="USD">427512</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-01-012023-12-30_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000104"
      unitRef="USD">602068</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_ReportedValueOfEquityAwardsMember"
      decimals="0"
      id="Fact000105"
      unitRef="USD">255140</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-30_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000106"
      unitRef="USD">337362</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-01-012023-12-30_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000107"
      unitRef="USD">684290</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2021-12-262022-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000108"
      unitRef="USD">378934</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-12-262022-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000110"
      unitRef="USD">-468178</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2021-12-262022-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000111"
      unitRef="USD">-89244</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember"
      decimals="0"
      id="Fact000114"
      unitRef="USD">164090</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"
      decimals="0"
      id="Fact000115"
      unitRef="USD">27840</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember"
      decimals="0"
      id="Fact000117"
      unitRef="USD">-57187</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-12-312024-12-28_ecd_NonPeoNeoMember_custom_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember"
      decimals="0"
      id="Fact000118"
      unitRef="USD">-7688</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-12-312024-12-28_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000120"
      unitRef="USD">71375</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember"
      decimals="0"
      id="Fact000121"
      unitRef="USD">260026</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"
      decimals="0"
      id="Fact000122"
      unitRef="USD">37130</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember"
      decimals="0"
      id="Fact000123"
      unitRef="USD">45538</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember"
      decimals="0"
      id="Fact000124"
      unitRef="USD">9920</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-30_ecd_NonPeoNeoMember_custom_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember"
      decimals="0"
      id="Fact000125"
      unitRef="USD">-15252</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-30_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000127"
      unitRef="USD">337362</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"
      decimals="0"
      id="Fact000129"
      unitRef="USD">-276055</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember"
      decimals="0"
      id="Fact000131"
      unitRef="USD">-94670</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-12-262022-12-31_ecd_NonPeoNeoMember_custom_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember"
      decimals="0"
      id="Fact000132"
      unitRef="USD">-97453</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2021-12-262022-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000134"
      unitRef="USD">-468178</ecd:AdjToCompAmt>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="From2023-12-31to2024-12-28" id="Fact000136">&lt;p id="xdx_899_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zsBe2f9AfGW2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;img alt="" src="formdef14a_001.jpg" style="height: 591px; width: 800px"/&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zdQLge7iPOxb" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;img alt="" src="formdef14a_002.jpg" style="height: 520px; width: 750px"/&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Equity
Compensation Plan Information&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table sets forth information as of December 28, 2024 about shares of our common stock issuable upon exercise of outstanding
options, warrants and rights and available for issuance under our existing equity compensation plans.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Plan Category&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
                                            of securities to&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;be
                                            issued upon exercise&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;of
                                            outstanding options,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;warrants
                                            and rights&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted-average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;exercise
                                            price of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;outstanding
                                            options,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;warrants
                                            and rights&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
                                            of securities&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;remaining
                                            available&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;for
                                            future issuance&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;under
                                            equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;compensation
                                            plans&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(excluding
                                            securities&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;reflected
                                            in column (a)) &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity compensation
    plans approved by security holders&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,833,611&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.19&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,913,621&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Equity compensation plans not approved by security holders&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;4,833,611&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;1.19&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0; text-indent: 0.25in"&gt;4,913,621&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Consists
    of shares available under the 2020 Equity Incentive Plan.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    of December 28, 2024, there were 4,913,621 shares available for grant under the 2020 Equity Incentive Plan.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Director
Compensation Commencing in Fiscal Year 2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
2023, the Compensation Committee engaged Aon to perform a peer review of our Board of Director compensation. Commencing in 2024
our Board-approved compensation for non-employee directors is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Annual
    retainer: $40,000 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Annual
    stock grant: 64,500 shares of restricted stock which vest on the anniversary of the grant Committee membership fees paid annually:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Audit
    Committee Chairperson: $15,000 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Non-employee Chairperson of the Board: $30,000&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nominating
    Committee Chairperson: $10,000 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Compensation
    Committee Chairperson: $10,000 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Audit
    Committee member: $8,000 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nominating
    Committee member: $4,375 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Compensation
    Committee member: $5,000 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
a result of the adoption of the Board Compensation plan commencing in 2024 the following adjustments were made:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Annual retainer was decreased from $45,000 to $40,000 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
    annual stock grant was increased to 64,500 shares of restricted stock from 10,000 shares Committee membership fees paid annually:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Non-employee Chairperson of the Board: $30,000&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Audit
    Committee Chairperson compensation was increased $5,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Compensation
    Committee Chairperson compensation increased $6,250 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Audit
    Committee member compensation increased $3,000 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nominating
    Committee member compensation increased $1,875 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Compensation Committee
    member compensation decreased $1,250&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Meeting
    fees were eliminated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
non-employee director was also entitled to receive an initial restricted stock award for 64,500 shares of our common stock on the date
of his or her initial election to the Board. We also pay expenses for attendance at meetings of the Board and committees thereof.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table sets forth certain information regarding the compensation earned by or awards to each non-employee director who served
on our Board of Directors in the 2024 fiscal year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mr.
Murray, who was an employee of Kopin during 2024, was not compensated for his service as director and his compensation is fully reflected
in the Summary Compensation Table above.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Director
Compensation Table for 2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Name&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fees&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Earned&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;or
                                            Paid&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;in
                                            Cash&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Stock&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Awards&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;sup&gt;(1)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Option&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Awards&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;sup&gt;(2)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Incentive&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;sup&gt;(3)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Change
                                            in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Pension
                                            Value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;and&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Nonqualified&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Deferred&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Earnings&lt;sup&gt;(3)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;All
                                            Other&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;sup&gt;(3)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 37%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Jill J. Avery&lt;sup&gt;(4)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;61,188&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,310&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;111,498&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chi Chia Hsieh&lt;sup&gt;(5)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;54,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,310&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;104,310&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;David Nieuwsma &lt;sup&gt;(6)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;55,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,310&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;105,310&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Margaret Seif&lt;sup&gt;(7)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,188&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,310&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;85,828&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Paul Walsh, Jr.&lt;sup&gt;(8)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27,333&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;54,573&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;81,907&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
    Board member received his or her annual restricted stock grant of 64,500 shares which vests on the anniversary of the grant if the
    person is still a member of our Board of Directors on such anniversary with the exception of Mr. Walsh. The amounts in the column
    were determined by multiplying the number of shares of restricted common stock granted by the closing price of our common stock as
    listed on the Nasdaq on the day of grant. The 2024 grant occurred on June 6, 2024, and the closing price of our stock was $0.78.
    Mr. Walsh joined the Board of Directors on September 9, 2024 and he was granted 64,500 shares of restricted stock. Our stock price
    on September 9, 2024 was $0.85. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
    were no stock options issued in 2024. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;No
    non-equity incentive compensation, pension, non-qualified deferred compensation or other compensation payments were made as compensation
    for director services in fiscal year 2024 or are contemplated under our current compensation plan. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dr.
    Avery&#x2019;s annual cash fees were comprised of the annual retainer of $40,000, $7,188 for serving on the Nominating Committee,
    and $8,000 for serving on the Audit Committee. In addition, prior to the implementation of the current Board member compensation
    plan members were paid meeting fees. Ms. Avery was paid $2,000 for attending meetings of the Board and $4,000 for attending meetings
    of the Audit Committee under the prior Board member compensation plan. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dr.
    Hsieh&#x2019;s annual cash fees were comprised of the annual retainer of $40,000 and $10.000 for serving as the Compensation Committee
    Chairperson. In addition, prior to the implementation of the current Board member compensation plan members were paid meeting fees.
    Dr. Hsieh was paid $2,000 for attending meetings of the Board and $2,000 for attending meetings of the Compensation Committee under
    the prior Board member compensation plan.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(6)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mr.
    Nieuwsma&#x2019;s annual cash fees were comprised of the annual retainer of $40,000, $8,000 for serving on the Audit Committee and
    $5.000 for serving as the Compensation Committee. In addition, prior to the implementation of the current Board member compensation
    plan members were paid meeting fees. Mr. Nieuwsma was paid $2,000 for attending meetings of the Board. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(7)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ms.
    Sief&#x2019;s annual cash fees were comprised of the annual retainer of $40,000, $7,188 for serving as Chairperson of the Nominating
    Committee and $5.000 for serving on the Compensation Committee. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(8)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mr.
    Walsch, Jr.&#x2019;s annual cash fees were comprised of a prorated annual retainer of $12,333, and $15,000 for serving as the Audit
    Committee Chairperson. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(9)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
    Director, excluding Michael Murray, has 64,500 of unvested restricted shares.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Audit
Committee Report&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Audit Committee of the Board currently consists of Paul Walsch, Jr., Jill J. Avery and David Nieuwsma, each of whom the Board
has determined is independent under applicable SEC and Nasdaq Rules. The Board also has determined that Mr. Walsh is an &#x201c;audit
committee financial expert&#x201d; under applicable SEC rules and regulations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
purpose of the Audit Committee is to assist the Board in its general oversight of the Company&#x2019;s financial reporting, internal controls
and audit functions. The Audit Committee charter, which is available at the Company&#x2019;s website at &lt;i&gt;www.kopin.com&lt;/i&gt;, under the
heading &#x201c;Investors: Corporate Governance,&#x201d; describes in greater detail the full responsibilities of the Audit Committee.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
is responsible for the preparation, presentation and integrity of the Company&#x2019;s financial statements; accounting and financial
reporting principles; establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)); establishing
and maintaining internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f)); evaluating the effectiveness of
disclosure controls and procedures; evaluating the effectiveness of internal control over financial reporting; and evaluating any change
in internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, internal control
over financial reporting.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;BDO
USA, P.C.&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt; (&#x201c;BDO&#x201d;), the Company&#x2019;s
independent registered public accounting firm, has been engaged to perform an independent audit of the consolidated financial statements
and to express an opinion on the conformity of those financial statements with accounting principles generally accepted in the United
States of America and also to express an opinion on the effectiveness of the Company&#x2019;s internal control over financial reporting.
The Audit Committee has reviewed and discussed the consolidated financial statements with management and BDO.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the course of the 2024 fiscal year, management completed the documentation, testing and evaluation of the Company&#x2019;s system of internal
control over financial reporting in response to the requirements set forth in Section 404 of the Sarbanes-Oxley Act of 2002 and related
rules and regulations. The Audit Committee was kept apprised of the progress of the evaluation and provided oversight and advice to management
during this process. In connection with this oversight, the Audit Committee also received periodic updates provided by management and
Stowe &amp;amp; Degon LLC, an independent registered public accounting firm that the Company uses for internal controls review, at regularly
scheduled Audit Committee meetings. At the conclusion of the process, management provided the Audit Committee with, and the Audit Committee
reviewed, a report on the effectiveness of the Company&#x2019;s internal control over financial reporting. The Audit Committee also received
a report of results from Stowe &amp;amp; Degon LLC. The Audit Committee also reviewed the report of management contained in the Company&#x2019;s
Annual Reports on Form 10-K for the fiscal year ended December 28, 2024, filed with the SEC, as well as BDO&#x2019;s Reports of Independent
Registered Public Accounting Firm included in the Company&#x2019;s Annual Report on Form 10-K related to its audit of the consolidated
financial statements and financial statement schedule, for the fiscal year ended December 28, 2024. In conjunction, the Audit Committee
continues to oversee the Company&#x2019;s efforts related to its internal control over financial reporting and management&#x2019;s preparations
for the evaluation in fiscal year 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Committee has discussed with BDO the matters that are required to be discussed by applicable standards of the Public Company Accounting
Oversight Board (&#x201c;PCAOB&#x201d;), including Statement on Auditing Standards No. 61, &#x201c;&lt;i&gt;Communication with Audit Committees&lt;/i&gt;,&#x201d;
as amended, and as adopted by the PCAOB, as well as Rule 2-07 of Regulation S-X of the SEC &#x201c;&lt;i&gt;Communication with Audit Committees&lt;/i&gt;.&#x201d;
BDO has also provided to the Committee its letter required by PCAOB Ethics and Independence Rule 3526, &#x201c;&lt;i&gt;Communications with
Audit Committees Concerning Independence&lt;/i&gt;,&#x201d; and the Committee discussed with RSM the firm&#x2019;s independence.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Based
on its review and the discussion noted above, the Audit Committee recommended to the Board that the Company&#x2019;s Consolidated Financial
Statements for the fiscal year 2024 be included in the Company&#x2019;s Annual Report on Form 10-K for the 2024 fiscal year for filing
with the SEC.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 50%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 50%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;AUDIT
    COMMITTEE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Paul
    Walsh, Jr., Chairperson &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Jill
    J. Avery &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;David
    Nieuwsma&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PROPOSAL
2&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;APPROVAL
OF AN AMENDMENT TO THE COMPANY&#x2019;S 2020 EQUITY INCENTIVE PLAN&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;The
Equity Incentive Plan Amendment Proposal&#x2014;&lt;/b&gt; The Board has authorized, subject to stockholder approval, an amendment to our 2020
Equity Incentive Plan (the &#x201c;2020 EIP&#x201d;) to increase the number of shares available under the 2020 EIP by 5,000,000 shares
(the &#x201c;Plan Amendment&#x201d;). Currently, the 2020 EIP authorizes the issuance of up to 14,000,000 shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
purpose of the 2020 EIP is to encourage ownership of the Company&#x2019;s common stock by key employees and to provide additional incentive
for such employees to promote the success of the Company&#x2019;s business. The Board believes that the 2020 EIP:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Aligns
    the long-term interests of key employees and stockholders by creating a direct link between key employee compensation and stockholder
    return; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="text-align: justify; width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Enables
    key employees to develop and maintain a meaningful stock ownership in the Company; and &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="text-align: justify; width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Provides
    incentives for key employees to contribute to the success of the Company. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Plan Amendment is being submitted to stockholders for approval. A copy of the 2020 EIP as it is proposed to be amended is attached to
this Proxy Statement as Appendix A. The Board believes it is in the best interests of the Company and its stockholders to approve the
Plan Amendment to increase the number of shares available under the 2020 EIP by 5,000,000.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
total of 19,000,000 shares of Kopin common stock will be reserved for issuance under the amended 2020 EIP. As of April 30, 2025,
the closing price on Nasdaq per share of common stock was $1.28. Our Board approved the Plan Amendment on March 20, 2025, subject to
approval by Kopin&#x2019;s stockholders. The Plan Amendment will be effective upon approval by Kopin&#x2019;s stockholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;The following table
includes information regarding all of our outstanding equity awards and shares available for future awards under the Plan as of May
1, 2025:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Total number of shares underlying outstanding stock options&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;591,366&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of outstanding stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1.76&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Weighted average remaining life of outstanding stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total shares of common stock outstanding&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;162,797,922&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total shares underlying outstanding and unvested restricted stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,492,501&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Shares available for future awards under the 2020 Equity Incentive plan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,343,521&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Reasons
for the Amendment to the 2020 EIP&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity
incentive compensation programs play a pivotal role in Kopin&#x2019;s efforts to attract and retain key personnel essential to Kopin&#x2019;s
long-term growth and financial success. We are asking our stockholders to approve the Plan Amendment to assist Kopin in attracting and
retaining qualified personnel. If our stockholders do not approve the Plan Amendment, we will be limited in our ability to continue to
issue awards in numbers sufficient to attract and motivate the highly skilled employees we need to recruit and retain, due to low share
reserves remaining in our 2020 EIP and the dilution to our share reserve and outstanding equity awards from the increase in our stock
outstanding from recent financing activities, and our employees&#x2019; motivation and incentives will be negatively affected.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Offering
a broad-based equity compensation program is vital to attracting and retaining highly skilled people in the highly competitive technology
industry. We use equity awards to increase incentives on the part of employees, non-employee directors and consultants who provide significant
services to the Company. We believe that providing an equity stake in the future success of our business encourages our employees to
be highly motivated to achieve our long-term business goals and to increase stockholder value. Their innovation and productivity are
critical to our success. Accordingly, approving the Plan Amendment is in the best interest of our stockholders because equity awards
help us to:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;attract,
    motivate and retain talented employees and directors; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;align
    employee and stockholder interests; and &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;link
    employee compensation with Kopin&#x2019;s performance. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
strongly believe that approval of the Plan Amendment will enable us to achieve our goals in attracting and retaining our most valuable
asset: our employees.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Without
the appropriate share reserve to grant competitive equity-based incentives, we would be forced to consider cash replacement alternatives
to provide a market-competitive total compensation package necessary to attract, retain and motivate the employee talent critical to
our future successes. These cash replacement alternatives could, among other things, reduce the cash available for investment in growth
and development and cause a loss of motivation by employees to achieve superior performance over a longer period of time. Equity- based
incentives, by contrast, directly align a portion of the compensation of our employees with the economic interests of our stockholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
that reason, Kopin has structured the 2020 EIP to provide flexibility in designing equity incentive programs with a broad array of equity
incentives, such as stock options, stock appreciation rights, stock awards and restricted stock units and implement competitive incentive
compensation programs for its employees and non-employee Board members. The 2020 EIP will continue to be the only plan under which new
equity awards may be granted to our employees and other service providers. If this Proposal 2 is not approved, then we would be at a
disadvantage against our competitors for recruiting, retaining and motivating individuals critical to our success and could be forced
to increase cash compensation, thereby reducing resources available to meet our business needs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of May 1, 2025, 11,668,479 shares of common stock, net of 4,373,315 of forfeitures, had been issued pursuant to awards under the
2020 EIP. All awards outstanding under the 2020 EIP on the date of the Plan Amendment will continue to be governed solely by the terms
of the documents evidencing such awards, and no provision of the Plan Amendment will be deemed to affect or otherwise modify the rights
or obligations of the holders of such transferred awards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with our stock-based compensation programs, we are committed to using equity incentive awards prudently and within reasonable
limits. We anticipate that the share reserve under the amended 2020 EIP, will enable us to fund our equity compensation program for approximately
two years. While we believe this is a reasonable estimate of how long the share reserve would last, the actual period for which the proposed
share reserve will fund our equity compensation program may be shorter or longer than expected, depending on changes in our granting
practices, stock price and headcount growth.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Summary
Description of the Kopin Corporation 2020 Equity Incentive Plan&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following is a summary of the principal provisions of the 2020 EIP. This summary is qualified in its entirety by reference to the full
text of the 2020 EIP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Types
of Awards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
2020 EIP provides for the issuance of stock options (including non-statutory stock options and incentive stock option), stock appreciation
rights (referred to as &#x201c;SARs&#x201d;), restricted stock, restricted stock units (&#x201c;RSUs&#x201d;), stock bonuses and other stock-based
awards to officers, employees, non-employee directors, independent contractors and consultants of Kopin Corporation or its affiliates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Purpose
and Types of Grants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
purpose of the 2020 EIP is to attract and retain employees, non-employee directors and consultants, and advisors. The 2020 EIP provides
for the issuance of incentive stock options, non-qualified stock options, stock awards, stock units, stock appreciation rights and other
stock-based awards. The 2020 EIP is intended to provide an incentive to participants to contribute to our economic success by aligning
the economic interests of participants with those of our stockholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Administration&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
2020 EIP is administered by the Compensation Committee of our Board, and the Compensation Committee will determine all of the terms and
conditions applicable to grants under the 2020 EIP. Our Compensation Committee determines who receives grants under the 2020 EIP and
the number of shares of common stock that will be subject to grants, except that grants to members of our Board must be authorized by
a majority of our Board. Our Compensation Committee may delegate authority under the 2020 EIP to one or more subcommittees as it deems
appropriate. Subject to compliance with applicable law and stock exchange requirements, the Compensation Committee (or our Board or a
subcommittee, as applicable) may delegate all or part of its authority to our Chief Executive Officer, as it deems appropriate, with
respect to grants to employees or key advisors who are not executive officers under Section 16 of the Exchange Act. Our Compensation
Committee, our Board, any subcommittee or the Chief Executive Officer, as applicable, that has authority with respect to a specific grant
will be referred to as &#x201c;the committee&#x201d; in this description of the 2020 EIP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Shares
Subject to the Plan&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subject
to adjustment, our 2020 EIP currently authorizes the issuance or transfer of up to 14,000,000 shares of our common stock. In addition,
shares of common stock underlying any outstanding award granted under the Prior Plan that, following the effective date of the 2020 EIP,
expires, or is terminated, surrendered or forfeited for any reason without issuance of such shares shall be available for new grants
under the 2020 EIP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
any options or SARs expire or are canceled, forfeited, exchanged or surrendered without having been exercised, or if any stock awards,
stock units or other stock-based awards are forfeited, terminated or otherwise not paid in full, the shares of our common stock subject
to such awards will again be available for purposes of the 2020 EIP. If shares of our common stock are surrendered in payment of the
exercise price of an option, the number of shares of common stock available for issuance under the 2020 EIP will be reduced only by the
net number of shares actually issued by us upon such exercise and not by the gross number of shares as to which such option is exercised.
Upon the exercise of any SAR under the 2020 EIP, the number of shares of our common stock available for issuance will be reduced only
by the net number of shares actually issued by us upon such exercise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
shares of our common stock are withheld by us in satisfaction of the withholding taxes incurred in connection with the issuance, vesting
or exercise of any grant or the issuance of our common stock under the 2020 EIP, the number of shares of common stock available for issuance
will be reduced by the net number of shares issued, vested or exercised under such grant, calculated in each instance after payment of
such share withholding. If any awards are paid in cash, and not in shares of our common stock, any shares of our common stock subject
to such awards will also be available for future awards. If we repurchase shares of our common stock on the open market with the proceeds
from the exercise price we receive from options, the repurchased shares will not be available for issuance under the 2020 EIP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Individual
Limits for Non-Employee Directors&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
maximum aggregate grant date value of shares of common stock granted to any non-employee director in any one calendar year, taken together
with any cash fees earned by such non-employee director for services rendered during the calendar year, shall not exceed $250,000 in
total value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Adjustments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with stock splits, stock dividends, recapitalizations and certain other events affecting our common stock, the committee will
make adjustments as it deems appropriate in: the maximum number of shares of common stock reserved for issuance as grants; the maximum
amount of awards that may be granted to any individual non-employee director in any year; the number and kind of shares covered by outstanding
grants; the number and kind of shares that may be issued under the 2020 EIP; the price per share or market value of any outstanding grants;
the exercise price of options; the base amount of stock appreciation rights; and the performance goals or other terms and conditions
as the committee deems appropriate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Eligibility
and Vesting&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
of our employees are eligible to receive grants under the 2020 EIP. In addition, our non-employee directors and key advisors who perform
services for us may receive grants under the 2020 EIP. The committee determines the vesting and exercisability terms of awards granted
under the 2020 EIP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Options&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
our 2020 EIP, the committee determines the exercise price of the options granted and may grant options to purchase shares of our common
stock in such amounts as it determines. The committee may grant options that are intended to qualify as incentive stock options under
Section 422 of the Code, or non-qualified stock options, which are not intended to so qualify. Incentive stock options may only be granted
to our employees. Anyone eligible to participate in the 2020 EIP may receive a grant of non-qualified stock options. The exercise price
of a stock option granted under the 2020 EIP cannot be less than the fair market value of a share of our common stock on the date the
option is granted. If an incentive stock option is granted to a 10% stockholder of the total combined voting power of all classes of
our stock, the exercise price cannot be less than 110% of the fair market value of a share of our common stock on the date the option
is granted. The aggregate number of shares of common stock that may be issued or transferred under the 2020 EIP pursuant to incentive
stock options under Section 422 of the Code may not exceed 10% of the number of shares of common stock outstanding on the effective date
of the 2020 EIP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
exercise price for any option is generally payable in cash. In certain circumstances as permitted by the committee, the exercise price
may be paid: by the surrender of shares of our common stock with an aggregate fair market value, on the date the option is exercised,
equal to the exercise price; by payment through a broker in accordance with procedures established by the Federal Reserve Board; by withholding
shares of common stock subject to the exercisable option that have a fair market value on the date of exercise equal to the aggregate
exercise price; or by such other method as the committee approves.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
term of an option cannot exceed ten years from the date of grant, except that if an incentive stock option is granted to a 10% stockholder
of the total combined voting power of all class of our stock, the term cannot exceed five years from the date of grant. In the event
that on the last day of the term of a non-qualified stock option, the exercise is prohibited by applicable law, including a prohibition
on purchases or sales of our common stock under our insider trading policy, the term of the non-qualified option will be extended for
a period of 30 days following the end of the legal prohibition, unless the committee determines otherwise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Except
as provided in the grant instrument, an option may only be exercised while a participant is employed by or providing service to us. The
committee will determine in the grant instrument under what circumstances and during what time periods a participant may exercise an
option after termination of employment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Stock
Awards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the 2020 EIP, the committee may grant stock awards. A stock award is an award of our common stock that may be subject to restrictions
as the committee determines. The restrictions, if any, may lapse over a specified period of employment or based on the satisfaction of
pre-established criteria, in installments or otherwise, as the committee may determine, including, but not limited to, restrictions based
on the achievement of performance goals. Except to the extent restricted under the grant instrument relating to the stock award, a participant
will have all of the rights of a stockholder as to those shares, including the right to vote and the right to receive dividends or distributions
on the shares. Dividends with respect to stock awards that vest based on performance shall vest if and to the extent that the underlying
stock award vests, as determined by the committee. All unvested stock awards are forfeited if the participant&#x2019;s employment or service
is terminated for any reason, unless the committee determines otherwise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Stock
Units&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the 2020 EIP, the committee may grant stock units to anyone eligible to participate in the 2020 EIP. Stock units represent hypothetical
shares of our common stock. Stock units become payable on terms and conditions determined by the committee, including specified performance
goals, and will be payable in cash, shares of common stock, or a combination thereof, as determined by the committee. All unvested stock
units are forfeited if the participant&#x2019;s employment or service is terminated for any reason, unless the committee determines otherwise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Stock
Appreciation Rights&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the 2020 EIP, the committee may grant SARs, which may be granted separately or in tandem with any option. SARs granted in tandem with
a non-qualified stock option may be granted either at the time the non- qualified stock option is granted or any time thereafter while
the option remains outstanding. SARs granted in tandem with an incentive stock option may be granted only at the time the grant of the
incentive stock option is made. The committee will establish the base amount of the SAR at the time the SAR is granted, which will be
equal to or greater than the fair market value of a share of our common stock as of the date of grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
a SAR is granted in tandem with an option, the number of SARs that are exercisable during a specified period will not exceed the number
of shares of our common stock that the participant may purchase upon exercising the related option during such period. Upon exercising
the related option, the related SARs will terminate, and upon the exercise of a SAR, the related option will terminate to the extent
of an equal number of shares of our common stock. Generally, SARs may only be exercised while the participant is employed by, or providing
services to, us. When a participant exercises a SAR, the participant will receive the excess of the fair market value of the underlying
common stock over the base amount of the SAR. The appreciation of a SAR will be paid in shares of our common stock, cash or both.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
term of a SAR cannot exceed ten years from the date of grant. In the event that on the last day of the term of a SAR, the exercise is
prohibited by applicable law, including a prohibition on purchases or sales of our common stock under our insider trading policy, the
term of the SAR will be extended for a period of 30 days following the end of the legal prohibition, unless the committee determines
otherwise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Other
Stock-Based Awards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the 2020 EIP, the committee may grant other types of awards that are based on, or measured by, our common stock, and granted to anyone
eligible to participate in the 2020 EIP. The committee will determine the terms and conditions of such awards. Other stock-based awards
may be payable in cash, shares of our common stock or a combination of the two, as determined by the committee.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividend
Equivalents&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the 2020 EIP, the committee may grant dividend equivalents in connection with grants of stock units or other stock-based awards made
under the 2020 EIP. Dividend equivalents entitle the participant to receive amounts equal to ordinary dividends that are paid on the
shares underlying a grant while the grant is outstanding. The committee will determine whether dividend equivalents will be paid currently
or accrued as contingent cash obligations. Dividend equivalents may be paid in cash or shares of our common stock. The committee will
determine the terms and conditions of the dividend equivalent grants, including whether the grants are payable upon the achievement of
specific performance goals. Dividend equivalents with respect to stock units or other stock-based awards that vest based on performance
shall vest and be paid only if and to the extent that the underlying stock units or other stock-based awards vest and are paid as determined
by the committee.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Prohibition
on Repricing&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the terms of the 2020 EIP, the committee may not (i) amend the terms of any outstanding stock options or SARs to reduce the exercise
price or base price, as applicable, (ii) cancel outstanding stock options or SARs in exchange for stock options or SARs with an exercise
price or base price, as applicable, that is less than the exercise price or base price of the original stock options or SARs or (iii)
cancel outstanding stock options or SARs with an exercise price or base price, as applicable, above the current stock price in exchange
for cash or other securities, except in connection with a corporate transaction involving the Company, without in each such instance
obtaining the approval of our stockholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Change
of Control&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
we experience a change of control where we are not the surviving corporation (or survive only as a subsidiary of another corporation),
unless the committee determines otherwise, all outstanding grants that are not exercised or paid at the time of the change of control
will be assumed by, or replaced with grants (with respect to cash, securities or a combination thereof) that have comparable terms by,
the surviving corporation (or a parent or subsidiary of the surviving corporation).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unless
otherwise set forth in a grant instrument, if a participant is terminated without cause upon or within 12 months of a change of control,
all outstanding time-based awards shall become fully vested.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
there is a change of control and all outstanding grants are not assumed by, or replaced with grants that have comparable terms by the
surviving corporation, the committee may (but is not obligated to) make adjustments to the terms and conditions of outstanding grants,
including, without limitation, taking any of the following actions (or combination thereof) without the consent of any participant:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;determine
    that outstanding options and SARs will accelerate and become fully exercisable and the restrictions and conditions on outstanding
    stock awards, stock units and dividend equivalents immediately lapse; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;pay
    participants, in an amount and form determined by the committee, in settlement of outstanding stock units or dividend equivalents;
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;require
    that participants surrender their outstanding stock options and SARs in exchange for a payment by us, in cash or shares of our common
    stock, equal to the difference between the exercise price and the fair market value of the underlying shares of our common stock;
    provided, however, if the per share &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;fair
    market value of our common stock does not exceed the per share stock option exercise price or stock appreciation right base amount,
    as applicable, we will not be required to make any payment to the participant upon surrender of the stock option or stock appreciation
    right; or &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;after
    giving participants an opportunity to exercise all of their outstanding stock options and SARs, terminate any unexercised stock options
    and SARs on the date determined by the committee. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
general terms, a change of control under the 2020 EIP occurs if:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="text-align: justify; width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a
    person, entity or affiliated group, with certain exceptions, acquires more than 50% of our then- outstanding voting securities; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="text-align: justify; width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;we
    merge into another entity unless the holders of our voting shares immediately prior to the merger have at least 50% of the combined
    voting power of the securities in the merged entity or its parent; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="text-align: justify; width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;we
    merge into another entity and the members of our Board prior to the merger would not constitute a majority of the board of the merged
    entity or its parent; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="text-align: justify; width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;we
    sell or dispose of all or substantially all of our assets; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="text-align: justify; width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;we
    consummate a complete liquidation or dissolution; or &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="text-align: justify; width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a
    majority of the members of our Board is replaced during any 12-month period by directors whose appointment or election is not endorsed
    by a majority of the incumbent directors. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Deferrals&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
committee may permit or require participants to defer receipt of the payment of cash or the delivery of shares of common stock that would
otherwise be due to the participant in connection with a grant under the 2020 EIP. The committee will establish the rules and procedures
applicable to any such deferrals, consistent with the requirements of Section 409A of the Code.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Withholding&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
grants under the 2020 EIP are subject to applicable U.S. federal (including FICA), state and local, foreign or other tax withholding
requirements. We may require participants or other persons receiving grants or exercising grants to pay an amount sufficient to satisfy
such tax withholding requirements with respect to such grants, or we may deduct from other wages and compensation paid by us the amount
of any withholding taxes due with respect to such grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
committee may permit or require that our tax withholding obligation with respect to grants paid in our common stock be paid by having
shares withheld up to an amount that does not exceed the participant&#x2019;s minimum applicable withholding tax rate for United States
federal (including FICA), state and local tax liabilities, or as otherwise determined by the committee. In addition, the committee may,
in its discretion, and subject to such rules as the committee may adopt, allow participants to elect to have such share withholding applied
to all or a portion of the tax withholding obligation arising in connection with any particular grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Transferability&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Except
as permitted by the committee with respect to non-qualified stock options, only a participant may exercise rights under a grant during
the participant&#x2019;s lifetime. Upon death, the personal representative or other person entitled to succeed to the rights of the participant
may exercise such rights. A participant cannot transfer those rights except by will or by the laws of descent and distribution or, with
respect to grants other than incentive stock options, pursuant to a domestic relations order. The committee may provide in a grant instrument
that a participant may transfer non-qualified stock options and stock award to family members, or one or more trusts or other entities
for the benefit of or owned by family members, consistent with applicable securities laws.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Amendment;
Termination&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
Board may amend or terminate our 2020 EIP at any time, except that our stockholders must approve an amendment if such approval is required
in order to comply with the Code, applicable laws or applicable stock exchange requirements. Unless terminated sooner by our Board or
extended with stockholder approval, the 2020 EIP will terminate on the day immediately preceding the tenth anniversary of the effective
date of the 2020 EIP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Stockholder
Approval&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Except
in connection with certain corporate transactions, including stock dividends, stock splits, a recapitalization, a change in control,
a reorganization, a merger and a spin-off, stockholder approval is required (i) to reduce the exercise price or base price of outstanding
stock options or SARs, (ii) to cancel outstanding stock options or SARs in exchange for the same type of grant with a lower exercise
price or base price, and (iii) to cancel outstanding stock options or SARs that have an exercise price or base price above the current
price of a share of our common stock, in exchange for cash or other securities, each as applicable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Establishment
of Sub-Plans&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
Board may, from time to time, establish one or more sub-plans under the 2020 EIP to satisfy applicable blue sky, securities or tax laws
of various jurisdictions. Our Board may establish such sub-plans by adopting supplements to the 2020 EIP setting forth limitations on
the committee&#x2019;s discretion and such additional terms and conditions not otherwise inconsistent with the 2020 EIP as our Board deems
necessary or desirable. All such supplements will be deemed part of the 2020 EIP, but each supplement will only apply to participants
within the affected jurisdiction, and we will not be required to provide copies of any supplement to such unaffected participants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Clawback&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subject
to applicable law, the committee may provide in any grant instrument that if a participant breaches any restrictive covenant agreement
between the participant and us, or otherwise engages in activities that constitute cause (as defined in the 2020 EIP) either while employed
by, or providing services to, us or within a specified period of time thereafter, all grants held by the participant will terminate,
and we may rescind any exercise of an option or stock appreciation right and the vesting of any other grant and delivery of shares upon
such exercise or vesting, as applicable on such terms as the committee will determine, including the right to require that in the event
of any rescission:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
    participant must return the shares received upon the exercise of any option or stock appreciation right or the vesting and payment
    of any other grants; or &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if
    the participant no longer owns the shares, the participant must pay to us the amount of any gain realized or payment received as
    a result of any sale or other disposition of the shares (if the participant transferred the shares by gift or without consideration,
    then the fair market value of the shares on the date of the breach of the restrictive covenant agreement or activity constituting
    cause), net of the price originally paid by the participant for the shares. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
committee may also provide for clawbacks pursuant to a clawback policy, which our Board may in the future adopt and amend from time to
time. Payment by the participant will be made in such manner and on such terms and conditions as may be required by the committee. We
will be entitled to set off against the amount of any such payment any amounts that we otherwise owe to the participant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Certain
United States Federal Income Tax Aspects&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following is a summary of certain U.S. federal income tax consequences of awards under the 2020 EIP. It does not purport to be a complete
description of all applicable rules, and those rules (including those summarized here) are subject to change.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Options&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
optionee generally will not recognize taxable income upon the grant of a non-statutory option. Rather, at the time of exercise of the
option, the optionee will recognize ordinary income for income tax purposes in an amount equal to the excess, if any, of the fair market
value of the shares purchased over the exercise price. We generally will be entitled to a tax deduction at such time and in the same
amount, if any, that the optionee recognizes as ordinary income. The optionee&#x2019;s tax basis in any shares received upon exercise
of an option will be the fair market value of the shares on the date of exercise, and if the shares are later sold or exchanged, then
the difference between the amount received upon such sale or exchange and the fair market value of such shares on the date of exercise
will generally be taxable as long-term or short-term capital gain or loss (if the shares are a capital asset of the optionee) depending
upon the length of time such shares were held by the optionee.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Incentive
stock options are eligible for favorable U.S. federal income tax treatment if certain requirements are satisfied. An incentive stock
option must have an option price that is not less than the fair market value of the stock at the time the option is granted and must
be exercisable within ten years from the date of grant. An employee granted an incentive stock option generally does not realize compensation
income for U.S. federal income tax purposes upon the grant of the option. At the time of exercise of an incentive stock option, no compensation
income is realized by the optionee other than tax preference income for purposes of the federal alternative minimum tax on individual
income. If the shares acquired on exercise of an incentive stock option are held for at least two years after grant of the option and
one year after exercise, the excess of the amount realized on the sale over the exercise price will be taxed as capital gain. If the
shares acquired on exercise of an incentive stock option are disposed of within less than two years after grant or one year of exercise,
the optionee will realize taxable compensation income equal to the lesser of (i) the excess of the fair market value of the shares on
the date of exercise over the option price or (ii) the excess of the amount realized on the sale over the option price. Any additional
amount realized will be taxed as capital gain.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Stock
Awards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
participant generally will not be taxed upon the grant of stock awards subject to restrictions, but rather will recognize ordinary income
in an amount equal to the fair market value of the shares at the time the shares are no longer subject to a &#x201c;substantial risk of
forfeiture&#x201d; (within the meaning of the Code). We generally will be entitled to a deduction at the time when, and in the amount
that, the participant recognizes ordinary income on account of the lapse of the restrictions. A participant&#x2019;s tax basis in the
shares will equal their fair market value at the time the restrictions lapse, and the participant&#x2019;s holding period for capital
gains purposes will begin at that time. Any cash dividends paid on the restricted stock before the restrictions lapse will be taxable
to the participant as additional compensation (and not as dividend income). Under Section 83(b) of the Code, a participant may elect
to recognize ordinary income at the time the shares of stock are awarded in an amount equal to their fair market value at that time,
notwithstanding the fact that such shares of stock are subject to restrictions and a substantial risk of forfeiture. If such an election
is made, no additional taxable income will be recognized by such participant at the time the restrictions lapse, the participant will
have a tax basis in the shares equal to their fair market value on the date of their award, and the participant&#x2019;s holding period
for capital gains purposes will begin at that time. We generally will be entitled to a tax deduction at the time when, and to the extent
that, ordinary income is recognized by such participant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Stock
Units&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
general, the grant of stock units will not result in income for the participant or in a tax deduction for us. Upon the settlement of
such an award in cash or shares, the participant will recognize ordinary income equal to the aggregate value of the payment received,
and we generally will be entitled to a tax deduction at the same time and in the same amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Stock
Appreciation Rights&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
participant who is granted a SAR generally will not recognize ordinary income upon receipt of the SAR. Rather, at the time of exercise
of such SAR, the participant will recognize ordinary income for U.S. federal income tax purposes in an amount equal to the value of any
cash received and the fair market value on the date of exercise of any shares received. We generally will be entitled to a tax deduction
at such time and in the same amount, if any, that the participant recognizes as ordinary income. The participant&#x2019;s tax basis in
any shares received upon exercise of a SAR will be the fair market value of the shares on the date of exercise, and if the shares are
later sold or exchanged, then the difference between the amount received upon such sale or exchange and the fair market value of such
shares on the date of exercise will generally be taxable as long-term or short- term capital gain or loss (if the shares are a capital
asset of the participant) depending upon the length of time such shares were held by the participant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Other
Awards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;With
respect to other stock-based awards granted under the 2020 EIP, generally when the participant receives payment with respect to an award,
the amount of cash and/or the fair market value of any shares or other property received will be ordinary income to the participant,
and we generally will be entitled to a tax deduction at the same time and in the same amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Impact
of Section 409A&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Section
409A of the Code applies to deferred compensation, which is generally defined as compensation earned currently, the payment of which
is deferred to a later taxable year. Awards under the 2020 EIP are intended to be exempt from the requirements of Section 409A or to
satisfy its requirements. An award that is subject to Section 409A and fails to satisfy its requirements will subject the holder of the
award to immediate taxation, interest and an additional 20% tax on the vested amount underlying the award.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
162(m) of the Code&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prior
to 2018, Section 162(m) of the Code imposed a $1 million limit on the amount a public company may deduct for compensation paid to a company&#x2019;s
chief executive officer or any of the company&#x2019;s three other most highly compensated executive officers (other than the chief financial
officer) who are employed as of the end of the year. This limitation did not apply to compensation that meets the tax code requirements
for &#x201c;qualifying performance-based&#x201d; compensation (i.e., compensation paid only if the individual&#x2019;s performance meets
pre- established objective goals based on performance criteria approved by stockholders, including stock options).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
performance-based compensation exemption and the exemption of the chief financial officer from Section 162(m)&#x2019;s deduction limit
have been repealed, among other changes, effective for taxable years beginning after December 31, 2017, such that awards paid to our
covered executive officers (including our chief executive officer) in excess of $1 million will not be deductible in future years, unless
it qualifies for transition relief applicable to certain arrangements that were in effect as of November 2, 2017 and are not materially
modified thereafter.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
in prior years, while deductibility of executive compensation for federal income tax purposes is among the factors the committee considers
when structuring our executive compensation arrangements, it is not the sole or primary factor considered. We retain the flexibility
to authorize compensation that may not be deductible if we believe it is in the best interests of the company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Existing
Plan Benefits&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Future
benefits under the 2020 EIP generally are granted at the discretion of the committee and are therefore not currently determinable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Because
future grants of awards under the 2020 EIP are subject to the discretion of the Board or Compensation Committee, the amount and terms
of future awards to particular participants or groups of participants are not determinable at this time. No awards have been previously
granted that are contingent on the approval of this amendment to the 2020 EIP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Vote
Required for Approval&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
proposal to amend the 2020 EIP will be approved upon the affirmative vote of a majority of the outstanding shares of common stock present
through virtual attendance or by proxy at the Meeting and entitled to vote on the proposal. Stockholders may vote &#x201c;FOR&#x201d; or
&#x201c;AGAINST,&#x201d; or &#x201c;ABSTAIN&#x201d; from voting. Abstentions will have the effect of a vote &#x201c;AGAINST&#x201d; this proposal.
Broker non-votes, if any, will be disregarded and will have no effect on the outcome of the vote for this Proposal 2.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Board
Recommendation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;The
Board recommends that the stockholders vote &#x201c;FOR&#x201d; the approval of the amendment to the Kopin Corporation 2020 Equity Incentive
Plan to increase the number of shares available by 5,000,000.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
existence of financial and personal interests of one or more of Kopin Corporation directors may result in a conflict of interest on the
part of such director(s) between what he, she or they may believe is in the best interests of Kopin Corporation and its stockholders
and what he, she or they may believe is best for himself, herself or themselves in determining to recommend that stockholders vote for
the proposals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PROPOSAL
3&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;APPROVAL
OF THE AMENDMENT TO THE COMPANY&#x2019;S AMENDED AND RESTATED&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED COMMON&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARES FROM 200,000,000 TO 275,000,000&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
Board has approved the amendment to our Certificate of Incorporation, subject to stockholder approval, to increase the number of
authorized shares of common stock from 200,000,000 shares to 275,000,000 shares (the &#x201c;Share Increase Amendment&#x201d;) and
recommends unanimously that our stockholders approve the Share Increase Amendment. The proposed amendment is reflected in the
proposed amendment to the Certificate of Incorporation attached to this proxy statement as Appendix B. As of May 1, 2025,
there were 162,797,922 shares of common stock issued and outstanding and the Company had warrants and options outstanding to
acquire 10,591,366 shares of its common stock, leaving a total of 26,610,712 authorized shares of common stock available for
future issuance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
additional 75,000,000 shares of common stock will be part of the existing class of common stock, and, if and when issued, would have
the same rights and privileges as the shares of common stock presently issued and outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s Certificate of Incorporation was amended on June 11, 2024 to increase the number of authorized shares of common stock
to 200,000,000.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Board believes that it is desirable and in the best interests of the Company and its shareholders to have a sufficient number of additional
shares of common stock available for issuance from time to time, as the occasion may arise, for future financing and acquisition transactions,
to permit stock dividends or stock splits at some future date, and for other proper corporate purposes. Therefore, the Board has approved,
and unanimously recommends that the stockholders of the Company approve the Share Increase Amendment. The proposed form of the Articles
of Amendment to the Company&#x2019;s Certificate of Incorporation amending Article &#x201c;FOURTH&#x201d; of such Certificate of Incorporation
is set forth in Appendix A to this proxy statement. The Articles of Amendment will have no effect on the number of authorized shares
of preferred stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Certain
Risks Associated with the Share Increase Amendment&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
market price of our common stock will also be based on our performance and other factors, some of which are unrelated to the number of
shares outstanding. These factors include the status of the market for our common stock, our reported results of operations in future
periods, and general economic, market and industry conditions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Principal
Effects on Outstanding Common Stock&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Holders
of common stock are entitled to one vote per share on all matters submitted to a vote of stockholders. Upon a liquidation, dissolution
or windup of the Company, holders of common stock would be entitled to share ratably in any assets for distribution to stockholders after
payment of all of the Company&#x2019;s obligations, subject to the rights to receive preferential distributions of the holders of any
preferred stock then outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
additional shares of common stock would have rights identical to our common stock currently outstanding. Approval of the Share Increase
Amendment and any issuance of common stock would not affect the rights of the holders of our common stock currently outstanding, except
to the extent that future issuances of common stock would reduce each existing stockholder&#x2019;s proportionate ownership. If the proposed
Share Increase Amendment is approved and the Board decides to issue such shares of common stock, such issuance of common stock would
increase the outstanding number of shares of common stock, thereby causing dilution in earnings per share and voting interests of the
outstanding common stock. As of May 1, 2025, 162,797,922 shares of our common stock were issued and outstanding and we
had warrants and options outstanding to acquire 10,591,366 shares of our common stock. We had no other shares of our common stock subject
to outstanding stock options or other convertible securities, thereby leaving 26,610,712 shares of common stock unassigned and
authorized for potential issuance of the current 200,000,000 shares of common stock authorized. If the Share Increase Amendment is approved,
there will be 101,610,712 shares of common stock unassigned and authorized for potential issuance. If approved, the Share Increase
Amendment will not change the number of shares of preferred stock authorized for issuance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additionally,
the issuance of additional shares of common stock could have the effect of making it more difficult for a third party to acquire, or
discouraging a third party from attempting to acquire, control of the Company. While the issuance of additional shares of common stock
may be deemed to have potential anti-takeover effects, including by delaying or preventing a change in control of the Company through
subsequent issuances of these shares and the other reasons set forth above, which among other things, could include issuances in one
or more transactions that would make a change in control of the Company more difficult, and therefore, less likely, this proposal to
increase the authorized common stock is not prompted by any specific effort of which we are aware to accumulate shares of our common
stock or obtain control of the Company. A takeover may be beneficial to independent stockholders because, among other reasons, a potential
suitor may offer such stockholders a premium for their shares of common stock as compared to the then-existing market price. Although
the issuance of additional shares of common stock could, under certain circumstances, have an anti-takeover effect, this proposal to
adopt the Share Increase Amendment is not in response to any attempt to accumulate common stock or obtain control of the Company that
we are aware of, nor is it part of a plan by management to recommend a series of similar amendments to the Board or stockholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Interests
of Certain Persons in the Proposal&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
directors and executive officers have no substantial interests, directly or indirectly, in the matters set forth in this Proposal 3,
except to the extent of their ownership in shares of our common stock and securities convertible or exercisable for common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Vote
Required for Approval&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
approval of the Shares Increase Amendment requires the affirmative vote of a majority of the Company&#x2019;s outstanding stock entitled
to vote thereon.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Board
Recommendation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;The
Board recommends that the stockholders vote &#x201c;FOR&#x201d; the proposal to approve an amendment to the Company&#x2019;s Certificate
of Incorporation to increase the number of authorized shares of common stock to 275,000,000.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PROPOSAL
4&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RATIFICATION
OF APPOINTMENT OF ACCOUNTANTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 2, 2024, the Audit Committee appointed BDO USA, P.C. (&#x201c;BDO&#x201d;) as our independent registered public accounting firm
for the fiscal year ending December 27, 2025. The Audit Committee is seeking ratification of this selection by our stockholders at the Annual Meeting.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RSM
US LLP (RSM), served as the Company&#x2019;s independent registered public accounting firm of the Company from November 22,
2019 until December 2, 2024. On December 2, 2024, the Board approved the engagement of BDO as our independent registered public
accounting firm, effective upon the execution of a satisfactory engagement letter with BDO and dismissed our prior independent registered
public accounting firm, RSM, effective immediately prior to the engagement of BDO. RSM&#x2019;s audit reports on our consolidated financial
statements for the fiscal years ended December 30, 2023 and December 31, 2022 did not contain any adverse opinion or disclaimer of opinion
and were not qualified or modified as to uncertainty, audit scope, or accounting principles.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
representative of BDO is expected to be present at the Meeting and will be afforded an opportunity to make a statement, if such
representative desires to do so, and will be available to respond to appropriate questions. &lt;/span&gt;Furthermore, a representative of
RSM is expected to be present at the Meeting and will be afforded an opportunity to make a statement, if such representative desires
to do so, and will be available to respond to appropriate questions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;RSM&#x2019;s audit reports
on our consolidated financial statements for the fiscal years ended December 30, 2023 and December 31, 2022 did not contain any adverse
opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principles. During
the fiscal years ended December 30, 2023 and December 31, 2022, and the subsequent interim period through the date of our engagement
of BDO on December 2, 2024, neither the Company, nor anyone acting on our behalf, consulted with BDO regarding any of the matters described
in Items 304(a)(2)(i) and (ii) of Regulation S-K.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;During the two most recent
fiscal years ended December 30, 2023 and December 31, 2022, and the subsequent interim period through their dismissal on December 2,
2024: (i) there were no disagreements within the meaning of Item 304(a)(1)(iv) of Regulation S-K between us and RSM on any matter of
accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved
to RSM&#x2019;s satisfaction, would have caused RSM to make reference to the subject matter of the disagreements in connection with its
reports on our consolidated financial statements for such years, and (ii) no reportable events within the meaning of Item 304(a)(1)(v)
of Regulation S-K.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Vote
Required for Approval&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 40pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
affirmative vote of the holders of a majority of the shares of our common stock represented in person or by proxy at the Meeting and
entitled to vote is required to ratify the appointment of BDO as our independent registered public accounting firm for the current
fiscal year ending December 27, 2025. Although stockholder ratification is not required by our bylaws or otherwise, the Board believes
it is advisable to provide stockholders an opportunity to ratify this selection and is submitting the selection of BDO as our independent
registered public accounting firm to our stockholders for ratification as a matter of good corporate practice.  In the event the appointment of BDO should not be approved by the stockholders, the Board will consider making
another appointment to be effective at the earliest possible time but has no obligation to do so. Any broker non-votes and abstentions
from voting received will have no effect on the outcome of this Proposal 4.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Board
Recommendation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;The
Board recommends that the stockholders vote &#x201c;FOR&#x201d; the proposal to ratify the appointment of BDO USA, P.C. as our independent
registered public accounting firm for the fiscal year ending December 27, 2025.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Proxies
solicited by the Board will be voted &#x201c;FOR&#x201d; this Proposal 4.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PRINCIPAL
ACCOUNTANT FEES AND SERVICES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
discussed above, BDO has served as the Company&#x2019;s independent registered public accounting firm since December 2, 2024. Previously,
RSM served as the Company&#x2019;s independent registered public accounting firm from November 22, 2019 to December 2, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Audit
Fees&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
aggregate fees for the fiscal years ended December 28, 2024 and December 30, 2023 billed by the Company&#x2019;s independent registered
public accounting firm, BDO USA, P.C. for fiscal year 2024 and RSM US LLP for fiscal year 2023 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Fee Category&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;% of Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;% of Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: left"&gt;Audit Fees&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,038,950&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;620,124&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;99.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Audit-Related Fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;152,250&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Tax Fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,453&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;All Other Fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total Fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,049,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;780,827&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Audit
Fees&lt;/i&gt;&#x2014;consists of fees for the audit of our financial statements and attestation services relating to the report on our internal
controls in accordance with Section 404 of the Sarbanes-Oxley Act of 2002, review of the interim condensed consolidated financial statements
included in quarterly reports, assistance with review of documents filed with the SEC, and services that are normally provided by the
Company&#x2019;s independent registered public accounting firm in connection with statutory and regulatory filings or engagements, and
attestation services, except those not required by statute or regulation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Audit-Related
Fees&lt;/i&gt;&#x2014;consists of fees for assurance and related services that are reasonably related to the performance of the audit or review
of our consolidated financial statements and are not reported under &#x201c;Audit Fees.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Tax
Fees&lt;/i&gt;&#x2014;consists of fees for tax compliance and planning services. Tax compliance includes fees for professional services related
to international tax compliance and preparation. Tax planning consists primarily of fees related to a transfer pricing study and preparation
of our subsidiary tax returns.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;All
Other Fees&lt;/i&gt;&#x2014;consists of fees for all other permissible services other than those reported above.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Policy
on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of Independent Registered Public Accounting Firm&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Audit Committee pre-approves all audit and non-audit services provided by the Company&#x2019;s independent registered public accounting
firm prior to the engagement with respect to such services. The Chairman of the Audit Committee has been delegated the authority by the
Audit Committee to pre-approve the engagement of the independent accountants when the entire committee is unable to do so. The Audit
Committee approved 100% of the services listed under the preceding captions &#x201c;Audit Fees,&#x201d; &#x201c;Audit-Related Fees,&#x201d;
&#x201c;Tax Fees&#x201d; and &#x201c;All Other Fees.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PROPOSAL
5&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;ADVISORY
NON-BINDING VOTE ON COMPENSATION OF NAMED EXECUTIVE OFFICERS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with Section 951 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, as well as the provisions of Section 14A
of the Exchange Act, we are providing our stockholders the opportunity to vote on a non-binding, advisory resolution to approve the compensation
of our named executive officers, which is described in the section titled &#x201c;Compensation Discussion and Analysis&#x201d; in this
Proxy Statement. Accordingly, the following resolution will be submitted for a stockholder vote at the 2025 Annual Meeting:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x201c;RESOLVED,
that the stockholders of Kopin Corporation (the &#x201c;Company&#x201d;) approve, on an advisory basis, the overall compensation of the
Company&#x2019;s named executive officers, as described in the Compensation Discussion and Analysis section set forth in the Proxy Statement
for this Annual Meeting.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
described in the section titled &#x201c;Compensation Discussion and Analysis,&#x201d; our executive compensation program is designed to
provide a competitive level of compensation necessary to attract, motivate and retain talented and experienced executives and to motivate
them to achieve short-term and long-term corporate goals that enhance stockholder value. In order to align executive pay with our financial
performance and the creation of sustainable stockholder value, a significant portion of compensation paid to our named executive officers
is allocated to performance-based, short- and long-term incentive programs to make executive pay dependent on our performance (or &#x201c;at-risk&#x201d;).
In addition, as an executive officer&#x2019;s responsibility and ability to affect our financial results increases, the portion of his
or her total compensation deemed &#x201c;at-risk&#x201d; increases. Stockholders are urged to read the &#x201c;Compensation Discussion and
Analysis&#x201d; section of this Proxy Statement, which more thoroughly discusses how our compensation policies and procedures implement
our compensation philosophy. The Compensation Committee and the Board believe that these policies and procedures are effective in implementing
our compensation philosophy and in achieving its goals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
provide our stockholders the opportunity every year to vote on a non-binding, advisory basis to approve the compensation of our named
executive officers. The Company expects that the next advisory vote on executive compensation will be at the 2026 Annual Meeting of Stockholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;This
vote is merely advisory and will not be binding upon the Company or the Board. However, the Board values constructive dialogue on executive
compensation and other important governance topics with our stockholders and encourages all stockholders to vote their shares on this
matter.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Vote
Required for Approval&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Proposal
5 will be approved upon the affirmative vote of a majority of shares present in person or represented by proxy at the Meeting and entitled
to vote on each such proposal. Abstentions will be counted for Proposal 5 and will have the same effect as a vote against the proposal.
Broker non-votes, if any, will be disregarded and will have no effect on the outcome of the vote of this Proposal 5.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Board
Recommendation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;The
Board recommends that the stockholders vote to approve, on an advisory basis, the overall compensation of the Company&#x2019;s named executive
officers by voting &#x201c;FOR&#x201d; this resolution.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;COST
AND METHOD OF SOLICITATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
will pay the cost of soliciting proxies. Proxies may be solicited on behalf of the Company by directors, officers or employees of the
Company in person or by telephone, facsimile or other electronic means. As required by the SEC, we also will reimburse brokerage firms
and other custodians, nominees and fiduciaries for their expenses incurred in sending proxies and proxy materials to beneficial owners
of our common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GENERAL&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
are not aware of any other matter other than the foregoing to be brought before the Meeting. However, the enclosed proxy gives discretionary
authority to the named proxies in the event any additional matters should be presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
will provide free of charge to any stockholder from whom a proxy is solicited pursuant to this proxy statement, upon written request
from such stockholder, our Annual Reports on Form 10-K for the fiscal years 2024 and 2023 as filed with the SEC. Our 2024 Annual Report
on Form 10-K is enclosed. Only one copy of the Annual Report and this proxy statement and notice of annual meeting is being delivered
to multiple stockholders sharing one address, unless we have received contrary instructions. Upon written or oral request, we will deliver
promptly a separate copy to a stockholder at a shared address to which a copy was delivered. If you received more than one copy of the
proxy statement and wish to reduce the number of reports you receive, we will discontinue the mailing of reports on the accounts you
select. Requests for the foregoing should be directed to Kopin Corporation, 125 North Drive, Westborough MA 01581, Attention: Chief Financial
Officer, 508-870-5959.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;MISCELLANEOUS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Your
vote is important. Whether or not you plan to attend the Annual Meeting, we hope you will vote in advance so that your vote will be counted
if you later decide not to attend the Annual Meeting.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;You
may obtain a copy of our Annual Report on Form 10-K (without exhibits) filed with the SEC for the year ended December 28, 2024, without
charge upon written request to: Kopin Corporation, 125 North Drive, Westborough MA 01581, Attention: Chief Financial Officer, 508-870-5959.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of the date of this proxy statement, we know of no matter not specifically referred to above as to which any action is expected to be
taken at the Annual Meeting. The persons named as proxies will vote the proxies, insofar as they are not otherwise instructed, regarding
such other matters and the transaction of such other business as may be properly brought before the Annual Meeting, as they determine
to be in the best interest of the Company and our stockholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 50%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Michael
    Murray&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chairman&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Appendix
A&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;KOPIN
CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2020
EQUITY INCENTIVE PLAN&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
as of the Effective Date (as defined below), the Kopin Corporation 2020 Incentive Equity Plan (as in effect from time to time, the &#x201c;Plan&#x201d;)
is hereby established.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
purpose of the Plan is to provide employees of Kopin Corporation, a Delaware corporation (together with its successors, the &#x201c;Company&#x201d;),
and its subsidiaries, certain consultants and advisors who perform services for the Company or its subsidiaries, and non-employee members
of the Board of Directors of the Company, with the opportunity to receive grants of incentive stock options, nonqualified stock options,
stock appreciation rights, stock awards, stock units, and other stock-based awards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company believes that the Plan will encourage the participants to contribute materially to the growth of the Company, thereby benefitting
the Company&#x2019;s stockholders, and will align the economic interests of the participants with those of the stockholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Plan is a successor to the Kopin Corporation 2010 Equity Incentive Plan, as amended and restated (the &#x201c;Prior Plan&#x201d;). No additional
grants shall be made under the Prior Plan after the Effective Date. Outstanding grants under the Prior Plan shall continue in effect
according to their terms, consistent with the applicable terms of the Prior Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
1. Definitions&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following terms shall have the meanings set forth below for purposes of the Plan:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &#x201c;&lt;span style="text-decoration: underline"&gt;Board&#x201d; &lt;/span&gt;shall
mean the Board of Directors of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &#x201c;&lt;span style="text-decoration: underline"&gt;Cause&lt;/span&gt;&#x201d;
shall have the meaning given to that term in any written employment agreement, offer letter or severance agreement between the Employer
and the Participant, or if no such agreement exists or if such term is not defined therein, and unless otherwise defined in the Grant
Instrument, Cause shall mean a finding by the Committee that the Participant (i) has breached his or her employment or service contract
with the Employer, (ii) has engaged in disloyalty to the Employer, including, without limitation, fraud, embezzlement, theft, commission
of a felony or proven dishonesty, (iii) has disclosed trade secrets or confidential information of the Employer to persons not entitled
to receive such information, (iv) has breached any written non-competition, non-solicitation, invention assignment or confidentiality
agreement between the Participant and the Employer or (v) has engaged in such other behavior detrimental to the interests of the Employer
as the Committee determines.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c) &#x201c;&lt;span style="text-decoration: underline"&gt;CEO&#x201d;
&lt;/span&gt;shall mean the Chief Executive Officer of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d) Unless
otherwise set forth in a Grant Instrument, a &#x201c;&lt;span style="text-decoration: underline"&gt;Change of Control&lt;/span&gt;&#x201d; shall be deemed to have occurred if:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i) Any
&#x201c;person&#x201d; (as such term is used in sections 13(d) and 14(d) of the Exchange Act) becomes a &#x201c;beneficial owner&#x201d;
(as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing more than 50% of
the voting power of the then outstanding securities of the Company; provided that a Change of Control shall not be deemed to occur as
a result of a transaction in which the Company becomes a direct or indirect subsidiary of another Person and in which the stockholders
of the Company, immediately prior to the transaction, will beneficially own, immediately after the transaction, shares of such other
Person representing more than 50% of the voting power of the then outstanding securities of such other Person.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii) The
consummation of (A) a merger or consolidation of the Company with another Person where, immediately after the merger or consolidation,
the stockholders of the Company, immediately prior to the merger or consolidation, will not beneficially own, in substantially the same
proportion as ownership immediately prior to the merger or consolidation, shares entitling such stockholders to more than 50% of all
votes to which all stockholders of the surviving Person would be entitled in the election of directors, or where the members of the Board,
immediately prior to the merger or consolidation, will not, immediately after the merger or consolidation, constitute a majority of the
board of directors of the surviving Person or (B) a sale or other disposition of all or substantially all of the assets of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iii) A
change in the composition of the Board over a period of 12 consecutive months or less such that a majority of the Board members ceases,
by reason of one or more contested elections, or threatened election contests, for Board membership, to be comprised of individuals who
either (A) have been Board members continuously since the beginning of such period or (B) have been elected or nominated for election
as Board members during such period by at least a majority of the Board members described in clause (A) who were still in office at the
time the Board approved such election or nomination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iv) The
consummation of a complete dissolution or liquidation of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Committee may modify the definition of Change of Control for a particular Grant as the Committee deems appropriate to comply with section
409A of the Code or otherwise. Notwithstanding the foregoing, if a Grant constitutes deferred compensation subject to section 409A of
the Code and the Grant provides for payment upon a Change of Control, then, for purposes of such payment provisions, no Change of Control
shall be deemed to have occurred upon an event described in items (i) &#x2013; (iv) above unless the event would also constitute a change
in ownership or effective control of, or a change in the ownership of a substantial portion of the assets of, the Company under section
409A of the Code.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(e) &#x201c;&lt;span style="text-decoration: underline"&gt;Code&lt;/span&gt;&#x201d;
shall mean the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(f) &#x201c;&lt;span style="text-decoration: underline"&gt;Committee&lt;/span&gt;&#x201d;
shall mean the Compensation Committee of the Board or another committee appointed by the Board to administer the Plan. The Committee
shall consist of directors who are &#x201c;non-employee directors&#x201d; as defined under Rule 16b-3 promulgated under the Exchange Act
and &#x201c;independent directors,&#x201d; as determined in accordance with the independence standards established by the stock exchange
on which the Company Stock is at the time primarily traded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(g) &#x201c;&lt;span style="text-decoration: underline"&gt;Company
Stock&lt;/span&gt;&#x201d; shall mean common stock, par value $0.01 per share, of the Company, and such other securities as may be substituted
for Company Stock pursuant to Section 4(c).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(h) &#x201c;&lt;span style="text-decoration: underline"&gt;Disability&lt;/span&gt;&#x201d;
or &#x201c;&lt;span style="text-decoration: underline"&gt;Disabled&lt;/span&gt;&#x201d; shall mean, unless otherwise set forth in the Grant Instrument, a Participant&#x2019;s becoming disabled
within the meaning of the Employer&#x2019;s long-term disability plan applicable to the Participant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i) &#x201c;&lt;span style="text-decoration: underline"&gt;Dividend
Equivalent&lt;/span&gt;&#x201d; shall mean an amount determined by multiplying the number of shares of Company Stock subject to a Stock Unit or
Other Stock-Based Award by the per-share cash dividend paid by the Company on its outstanding Company Stock, or the per-share Fair Market
Value of any dividend paid on its outstanding Company Stock in consideration other than cash. If interest is credited on accumulated
divided equivalents, the term &#x201c;Dividend Equivalent&#x201d; shall include the accrued interest.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(j) &#x201c;&lt;span style="text-decoration: underline"&gt;Effective
Date&lt;/span&gt;&#x201d; shall mean the date of the Annual Meeting of Stockholders to be held on May 20, 2020 or such other date upon which the
Company&#x2019;s stockholders approve the Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(k) &#x201c;&lt;span style="text-decoration: underline"&gt;Employee&lt;/span&gt;&#x201d;
shall mean an employee of the Employer (including an officer or director who is also an employee), but excluding any person who is classified
by the Employer as a &#x201c;contractor&#x201d; or &#x201c;consultant,&#x201d; no matter how characterized by the Internal Revenue Service,
other governmental agency or a court. Any change of characterization of an individual by the Internal Revenue Service or any court or
government agency shall have no effect upon the classification of an individual as an Employee for purposes of this Plan, unless the
Committee determines otherwise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(l) &#x201c;&lt;span style="text-decoration: underline"&gt;Employed
by, or providing service to, the Employer&lt;/span&gt;&#x201d; shall mean employment or service as an Employee, Key Advisor or member of the Board
(so that, for purposes of exercising Options and SARs and satisfying conditions with respect to Stock Awards, Stock Units, and Other
Stock-Based Awards, a Participant shall not be considered to have terminated employment or service until the Participant ceases to be
an Employee, Key Advisor and member of the Board), unless the Committee determines otherwise. If a Participant&#x2019;s relationship is
with a subsidiary of the Company and that entity ceases to be a subsidiary of the Company, the Participant will be deemed to cease employment
or service when the entity ceases to be a subsidiary of the Company, unless the Participant transfers employment or service to an Employer.
If a Participant has military, sick leave or other bona fide leave, the Participant will not be deemed to cease employment or service
solely as a result of such leave; provided that such leave does not exceed the longer of 90 days or the period during which the absent
Participant&#x2019;s reemployment rights, if any, are guaranteed by statute or contract. To the extent consistent with applicable law,
the Committee may provide that Grants continue to vest for all or a portion of the period of such leave, or that vesting shall be tolled
during such leave and only recommence upon the Participant&#x2019;s return from such leave.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(m) &#x201c;&lt;span style="text-decoration: underline"&gt;Employer&lt;/span&gt;&#x201d;
shall mean the Company and its subsidiaries.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(n) &#x201c;&lt;span style="text-decoration: underline"&gt;Exchange
Act&#x201d;&lt;/span&gt; shall mean the Securities Exchange Act of 1934, as amended.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(o) &#x201c;&lt;span style="text-decoration: underline"&gt;Exercise
Price&lt;/span&gt;&#x201d; shall mean the per share price at which shares of Company Stock may be purchased under an Option, as designated by the
Committee.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(p) &#x201c;&lt;span style="text-decoration: underline"&gt;Fair
Market Value&#x201d;&lt;/span&gt; shall mean:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i) If
the Company Stock is publicly traded, the Fair Market Value per share shall be determined as follows: (A) if the principal trading market
for the Company Stock is a national securities exchange, the closing sales price during regular trading hours on the relevant date or,
if there were no trades on that date, the latest preceding date upon which a sale was reported, or (B) if the Company Stock is not principally
traded on any such exchange, the last reported sale price of a share of Company Stock during regular trading hours on the relevant date,
as reported by the OTC Bulletin Board.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii) If
the Company Stock is not publicly traded or, if publicly traded, is not subject to reported transactions as set forth above, the Fair
Market Value per share shall be determined by the Committee through any reasonable valuation method authorized under the Code.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(q) &#x201c;&lt;span style="text-decoration: underline"&gt;GAAP&lt;/span&gt;&#x201d;
shall mean United States generally accepted accounting principles.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(r) &#x201c;&lt;span style="text-decoration: underline"&gt;Grant&lt;/span&gt;&#x201d;
shall mean an Option, SAR, Stock Award, Stock Unit or Other Stock-Based Award granted under the Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(s) &#x201c;&lt;span style="text-decoration: underline"&gt;Grant
Instrument&lt;/span&gt;&#x201d; shall mean the written agreement that sets forth the terms and conditions of a Grant, including all amendments
thereto.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(t) &#x201c;&lt;span style="text-decoration: underline"&gt;Incentive
Stock Option&lt;/span&gt;&#x201d; shall mean an Option that is intended to meet the requirements of an incentive stock option under section 422
of the Code.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(u) &#x201c;&lt;span style="text-decoration: underline"&gt;Key
Advisor&#x201d;&lt;/span&gt; shall mean a consultant or advisor of the Employer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(v) &#x201c;&lt;span style="text-decoration: underline"&gt;Non-Employee
Director&lt;/span&gt;&#x201d; shall mean a member of the Board who is not an Employee.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(w) &#x201c;&lt;span style="text-decoration: underline"&gt;Nonqualified
Stock Option&lt;/span&gt;&#x201d; shall mean an Option that is not intended to be taxed as an incentive stock option under section 422 of the Code.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(x) &#x201c;&lt;span style="text-decoration: underline"&gt;Option&#x201d;
&lt;/span&gt;shall mean an option to purchase shares of Company Stock, as described in Section 6.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(y) &#x201c;&lt;span style="text-decoration: underline"&gt;Other
Stock-Based Award&lt;/span&gt;&#x201d; shall mean any Grant based on, measured by or payable in Company Stock (other than an Option, Stock Unit,
Stock Award, or SAR), as described in Section 10.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(z) &#x201c;&lt;span style="text-decoration: underline"&gt;Participant&lt;/span&gt;&#x201d;
shall mean an Employee, Key Advisor or Non-Employee Director designated by the Committee to participate in the Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(aa) &#x201c;&lt;span style="text-decoration: underline"&gt;Performance
Goals&lt;/span&gt;&#x201d; shall mean the business criteria selected by the Company to measure the level of performance of the Company or an
affiliate during a performance period, which may include, but are not limited to, one or more of the following criteria: cash flow;
free cash flow; earnings (including gross margin, earnings before interest and taxes, earnings before taxes, earnings before
interest, taxes, depreciation, amortization and charges for stock-based compensation, earnings before interest, taxes, depreciation
and amortization, adjusted earnings before interest, taxes, depreciation and amortization and net earnings); earnings per share;
growth in earnings or earnings per share; book value growth; stock price; return on equity or average stockholder equity; total
stockholder return or growth in total stockholder return either directly or in relation to a comparative group; return on capital;
return on assets or net assets; &lt;/span&gt;revenue, growth in revenue or return on sales; sales; expense reduction or expense control;
expense to revenue ratio; income, net income or adjusted net income; operating income, net operating income, adjusted operating
income or net operating income after tax; operating profit or net operating profit; operating margin; gross profit margin; return on
operating revenue or return on operating profit; regulatory filings; regulatory approvals, litigation and regulatory resolution
goals; other operational, regulatory or departmental objectives; budget comparisons; growth in stockholder value relative to
established indexes, or another peer group or peer group index; development and implementation of strategic plans and/or
organizational restructuring goals; development and implementation of risk and crisis management programs; improvement in workforce
diversity; compliance requirements and compliance relief; safety goals; productivity goals; workforce management and succession
planning goals; economic value added (including typical adjustments consistently applied from generally accepted accounting
principles required to determine economic value added performance measures); measures of customer satisfaction, employee
satisfaction or staff development; development or marketing collaborations, formations of joint ventures or partnerships or the
completion of other similar transactions intended to enhance the Company&#x2019;s revenue or profitability or enhance its customer
base; merger and acquisitions; and other similar criteria as determined by the Committee. Performance goals applicable to a Grant
shall be determined by the Committee, and may be established on an absolute or relative basis and may be established on a
corporate-wide basis or with respect to one or more business units, divisions, subsidiaries or business segments. Relative
performance may be measured against a group of peer companies, a financial market index or other objective and quantifiable
indices.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(bb) &#x201c;&lt;span style="text-decoration: underline"&gt;Person&lt;/span&gt;&#x201d;
shall mean any natural person, corporation, limited liability company, partnership, trust, joint stock company, business trust, unincorporated
association, joint venture, governmental authority or other legal entity of any nature whatsoever.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(cc) &#x201c;&lt;span style="text-decoration: underline"&gt;Restriction
Period&#x201d;&lt;/span&gt; shall have the meaning given that term in Section 7(a).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(dd) &#x201c;&lt;span style="text-decoration: underline"&gt;SAR&#x201d;
&lt;/span&gt;shall mean a stock appreciation right, as described in Section 9.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ee) &#x201c;&lt;span style="text-decoration: underline"&gt;Stock
Award&#x201d;&lt;/span&gt; shall mean an award of Company Stock, as described in Section 7.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ff) &#x201c;&lt;span style="text-decoration: underline"&gt;Stock
Unit&lt;/span&gt;&#x201d; shall mean an award of a phantom unit representing a share of Company Stock, as described in Section 8.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(gg) &#x201c;&lt;span style="text-decoration: underline"&gt;Substitute
Awards&#x201d;&lt;/span&gt; shall have the meaning given that term in Section 4(c).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
2. Administration&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;Committee&lt;/span&gt;.
The Plan shall be administered and interpreted by the Committee; provided, however, that any Grants to members of the Board must be authorized
by a majority of the Board. The Committee may delegate authority to one or more subcommittees, as it deems appropriate. Subject to compliance
with applicable law and the applicable stock exchange rules, the Board, in its discretion, may perform any action of the Committee hereunder.
To the extent that the Board, a subcommittee or the CEO, as described below administers the Plan, references in the Plan to the &#x201c;&lt;span style="text-decoration: underline"&gt;Committee&lt;/span&gt;&#x201d;
shall be deemed to refer to the Board or such subcommittee or the CEO.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;Delegation
to CEO&lt;/span&gt;. Subject to compliance with applicable law and applicable stock exchange requirements, the Committee may delegate all or part
of its authority and power to the CEO, as it deems appropriate, with respect to Grants to Employees or Key Advisors who are not executive
officers under section 16 of the Exchange Act.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c) &lt;span style="text-decoration: underline"&gt;Committee
Authority&lt;/span&gt;. The Committee shall have the sole authority to (i) determine the individuals to whom Grants shall be made under the Plan,
(ii) determine the type, size, terms and conditions of the Grants to be made to each such individual, (iii) determine the time when the
Grants will be made and the duration of any applicable exercise or restriction period, including the criteria for exercisability and
the acceleration of exercisability, (v) amend the terms of any previously issued Grant, subject to the provisions of Section 17 below,
(vi) determine and adopt terms, guidelines, and provisions, not inconsistent with the Plan and applicable law, that apply to individuals
residing outside of the United States who receive Grants under the Plan, and (vii) deal with any other matters arising under the Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d) &lt;span style="text-decoration: underline"&gt;Committee
Determinations&lt;/span&gt;. The Committee shall have full power and express discretionary authority to administer and interpret the Plan, to
make factual determinations and to adopt or amend such rules, regulations, agreements and instruments for implementing the Plan and for
the conduct of its business as it deems necessary or advisable, in its sole discretion. The Committee&#x2019;s interpretations of the
Plan and all determinations made by the Committee pursuant to the powers vested in it hereunder shall be conclusive and binding on all
persons having any interest in the Plan or in any awards granted hereunder. All powers of the Committee shall be executed in its sole
discretion, in the best interest of the Company, not as a fiduciary, and in keeping with the objectives of the Plan and need not be uniform
as to similarly situated individuals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(e) &lt;span style="text-decoration: underline"&gt;Indemnification&lt;/span&gt;.
No member of the Committee or the Board, and no employee of the Company shall be liable for any act or failure to act with respect to
the Plan, except in circumstances involving his or her bad faith or willful misconduct, or for any act or failure to act hereunder by
any other member of the Committee or employee or by any agent to whom duties in connection with the administration of this Plan have
been delegated. The Company shall indemnify members of the Committee and the Board and any agent of the Committee or the Board who is
an employee of the Company or a subsidiary against any and all liabilities or expenses to which they may be subjected by reason of any
act or failure to act with respect to their duties on behalf of the Plan, except in circumstances involving such person&#x2019;s bad faith
or willful misconduct.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
3. Grants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Grants
under the Plan may consist of Options as described in Section 6, Stock Awards as described in Section 7, Stock Units as described in
Section 8, SARs as described in Section 9, and Other Stock-Based Awards as described in Section 10. All Grants shall be subject to the
terms and conditions set forth herein and to such other terms and conditions consistent with this Plan as the Committee deems appropriate
and as are specified in writing by the Committee to the individual in the Grant Instrument. All Grants shall be made conditional upon
the Participant&#x2019;s acknowledgement, in writing or by acceptance of the Grant, that all decisions and determinations of the Committee
shall be final and binding on the Participant, his or her beneficiaries and any other person having or claiming an interest under such
Grant. Grants under a particular Section of the Plan need not be uniform as among the Participants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
4. Shares Subject to the Plan&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;Shares
Authorized&lt;/span&gt;. Subject to adjustment as described below in Sections 4(b) and 4(e) below, the aggregate number of shares of Company Stock
that may be issued or transferred under the Plan shall be 14,000,000 shares of Company Stock. In addition, shares of the Company Stock
underlying any outstanding award granted under the Prior Plan that, following the Effective Date, expires, or is terminated, surrendered
or forfeited for any reason without issuance of such shares shall be available for the award of new Grants under this Plan. Subject to
adjustment as described below in Sections 4(b) and 4(e) below, the aggregate number of shares of Company Stock that may be issued or
transferred under the Plan pursuant to Incentive Stock Options shall not exceed 10,000,000 shares of Company Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;Source
of Shares&lt;/span&gt;; Share Counting. Shares issued or transferred under the Plan may be authorized but unissued shares of Company Stock or
reacquired shares of Company Stock, including shares purchased by the Company on the open market for purposes of the Plan. If and to
the extent Options or SARs granted under the Plan, expire or are canceled, forfeited, exchanged or surrendered without having been exercised,
or if any Stock Awards, Stock Units or Other Stock-Based Awards are forfeited, terminated or otherwise not paid in full, the shares subject
to such Grants shall again be available for purposes of the Plan. If shares of Company Stock otherwise issuable under the Plan are surrendered
in payment of the Exercise Price of an Option, then the number of shares of Company Stock available for issuance under the Plan shall
be reduced only by the net number of shares actually issued by the Company upon such exercise and not by the gross number of shares as
to which such Option is exercised. Upon the exercise of any SAR under the Plan, the number of shares of Company Stock available for issuance
under the Plan shall be reduced by only by the net number of shares actually issued by the Company upon such exercise. If shares of Company
Stock otherwise issuable under the Plan are withheld by the Company in satisfaction of the withholding taxes incurred in connection with
the issuance, vesting or exercise of any Grant or the issuance of Company Stock thereunder, then the number of shares of Company Stock
available for issuance under the Plan shall be reduced by the net number of shares issued, vested or exercised under such Grant, calculated
in each instance after payment of such share withholding. To the extent any Grants are paid in cash, and not in shares of Company Stock,
any shares previously subject to such Grants shall again be available for issuance or transfer under the Plan. For the avoidance of doubt,
if shares are repurchased by the Company on the open market with the proceeds of the Exercise Price of Options, such shares may not again
be made available for issuance under the Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c) &lt;span style="text-decoration: underline"&gt;Substitute
Awards&lt;/span&gt;. Shares issued or transferred under Grants made pursuant to an assumption, substitution or exchange for previously granted
awards of a company acquired by the Company in a transaction (&#x201c;Substitute Awards&#x201d;) shall not reduce the number of shares
of Company Stock available under the Plan and available shares under a stockholder approved plan of an acquired company (as appropriately
adjusted to reflect the transaction) may be used for Grants under the Plan and shall not reduce the Plan&#x2019;s share reserve (subject
to applicable stock exchange listing and Code requirements).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d) &lt;span style="text-decoration: underline"&gt;Individual
Limits for Non-Employee Directors&lt;/span&gt;. Subject to adjustment as described below in Section 4(e), the maximum aggregate grant date value
of shares of Company Stock subject to Grants granted to any Non-Employee Director during any calendar year, taken together with any cash
fees earned by such Non- Employee Director for services rendered during the calendar year, shall not exceed $250,000 in total value.
For purposes of this limit, the value of such Grants shall be calculated based on the grant date fair value of such Grants for financial
reporting purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(e) &lt;span style="text-decoration: underline"&gt;Adjustments&lt;/span&gt;.
If there is any change in the number or kind of shares of Company Stock outstanding by reason of (i) a stock dividend, spinoff, recapitalization,
stock split, or combination or exchange of shares, (ii) a merger, reorganization or consolidation, (iii) a reclassification or change
in par value, or (iv) any other extraordinary or unusual event affecting the outstanding Company Stock as a class without the Company&#x2019;s
receipt of consideration, or if the value of outstanding shares of Company Stock is substantially reduced as a result of a spinoff or
the Company&#x2019;s payment of an extraordinary dividend or distribution, the maximum number and kind of shares of Company Stock available
for issuance under the Plan, the maximum amount of Grants which a Non-Employee Director may receive in any year, the number and kind
of shares covered by outstanding Grants, the number and kind of shares issued and to be issued under the Plan, and the price per share
or the applicable market value of such Grants shall be equitably adjusted by the Committee to reflect any increase or decrease in the
number of, or change in the kind or value of, the issued shares of Company Stock to preclude, to the extent practicable, the enlargement
or dilution of rights and benefits under the Plan and such outstanding Grants; provided, however, that any fractional shares resulting
from such adjustment shall be eliminated. In addition, in the event of a Change of Control, the provisions of Section 12 of the Plan
shall apply. Any adjustments to outstanding Grants shall be consistent with section 409A or 424 of the Code, to the extent applicable.
The adjustments of Grants under this Section 4(e) shall include adjustment of shares, Exercise Price of Stock Options, base amount of
SARs, Performance Goals or other terms and conditions, as the Committee deems appropriate. The Committee shall have the sole discretion
and authority to determine what appropriate adjustments shall be made and any adjustments determined by the Committee shall be final,
binding and conclusive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
5. Eligibility for Participation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;Eligible
Persons&lt;/span&gt;. All Employees and Non-Employee Directors shall be eligible to participate in the Plan. Key Advisors shall be eligible to
participate in the Plan if the Key Advisors render bona fide services to the Employer, the services are not in connection with the offer
and sale of securities in a capital-raising transaction and the Key Advisors do not directly or indirectly promote or maintain a market
for the Company&#x2019;s securities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;Selection
of Participants&lt;/span&gt;. The Committee shall select the Employees, Non-Employee Directors and Key Advisors to receive Grants and shall determine
the number of shares of Company Stock subject to a particular Grant in such manner as the Committee determines.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
6. Options&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Committee may grant Options to an Employee, Non-Employee Director or Key Advisor upon such terms as the Committee deems appropriate.
The following provisions are applicable to Options:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;Number
of Shares&lt;/span&gt;. The Committee shall determine the number of shares of Company Stock that will be subject to each Grant of Options to Employees,
Non-Employee Directors and Key Advisors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;Type
of Option and Exercise Price.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i) The
Committee may grant Incentive Stock Options or Nonqualified Stock Options or any combination of the two, all in accordance with the terms
and conditions set forth herein. Incentive Stock Options may be granted only to employees of the Company or its parent or subsidiary
corporations, as defined in section 424 of the Code. Nonqualified Stock Options may be granted to Employees, Non-Employee Directors and
Key Advisors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii) The
Exercise Price of Company Stock subject to an Option shall be determined by the Committee and shall be equal to or greater than the Fair
Market Value of a share of Company Stock on the date the Option is granted. However, an Incentive Stock Option may not be granted to
an Employee who, at the time of grant, owns stock possessing more than 10% of the total combined voting power of all classes of stock
of the Company, or any parent or subsidiary corporation of the Company, as defined in section 424 of the Code, unless the Exercise Price
per share is not less than 110% of the Fair Market Value of a share of Company Stock on the date of grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c) &lt;span style="text-decoration: underline"&gt;Option
Term&lt;/span&gt;. The Committee shall determine the term of each Option. The term of any Option shall not exceed ten years from the date of grant.
However, an Incentive Stock Option that is granted to an Employee who, at the time of grant, owns stock possessing more than 10% of the
total combined voting power of all classes of stock of the Company, or any parent or subsidiary corporation of the Company, as defined
in section 424 of the Code, may not have a term that exceeds five years from the date of grant. Notwithstanding the foregoing, in the
event that on the last business day of the term of an Option (other than an Incentive Stock Option), the exercise of the Option is prohibited
by applicable law, including a prohibition on purchases or sales of Company Stock under the Company&#x2019;s insider trading policy, the
term of the Option shall be extended for a period of 30 days following the end of the legal prohibition, unless the Committee determines
otherwise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d) &lt;span style="text-decoration: underline"&gt;Exercisability
of Options&lt;/span&gt;. Options shall become exercisable in accordance with such terms and conditions, consistent with the Plan, as may be determined
by the Committee and specified in the Grant Instrument. The Committee may accelerate the exercisability of any or all outstanding Options
at any time for any reason.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(e) &lt;span style="text-decoration: underline"&gt;Grants
to Non-Exempt Employees&lt;/span&gt;. Notwithstanding the foregoing, Options granted to persons who are non-exempt employees under the Fair Labor
Standards Act of 1938, as amended, may not be exercisable for at least six months after the date of grant (except that such Options may
become exercisable, as determined by the Committee, upon the Participant&#x2019;s death, Disability or retirement, or upon a Change of
Control or other circumstances permitted by applicable regulations).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(f) &lt;span style="text-decoration: underline"&gt;Termination
of Employment or Service&lt;/span&gt;. Except as provided in the Grant Instrument, an Option may only be exercised while the Participant is employed
by, or providing services to, the Employer. The Committee shall determine in the Grant Instrument under what circumstances and during
what time periods a Participant may exercise an Option after termination of employment or service.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(g) &lt;span style="text-decoration: underline"&gt;Exercise
of Options&lt;/span&gt;. A Participant may exercise an Option that has become exercisable, in whole or in part, by delivering a notice of exercise
to the Company. The Participant shall pay the Exercise Price for an Option as specified by the Committee (i) in cash, (ii) unless the
Committee determines otherwise, by delivering shares of Company Stock owned by the Participant and having a Fair Market Value on the
date of exercise at least equal to the Exercise Price or by attestation (on a form prescribed by the Committee) to ownership of shares
of Company Stock having a Fair Market Value on the date of exercise at least equal to the Exercise Price, (iii) by payment through a
broker in accordance with procedures permitted by Regulation T of the Federal Reserve Board, (iv) if permitted by the Committee, by withholding
shares of Company Stock subject to the exercisable Option, which have a Fair Market Value on the date of exercise equal to the Exercise
Price, or (v) by such other method as the Committee may approve. Shares of Company Stock used to exercise an Option shall have been held
by the Participant for the requisite period of time necessary to avoid adverse accounting consequences to the Company with respect to
the Option. Payment for the shares to be issued or transferred pursuant to the Option, and any required withholding taxes, must be received
by the Company by the time specified by the Committee depending on the type of payment being made, but in all cases prior to the issuance
or transfer of such shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(h) &lt;span style="text-decoration: underline"&gt;Limits
on Incentive Stock Options&lt;/span&gt;. Each Incentive Stock Option shall provide that, if the aggregate Fair Market Value of the Company Stock
on the date of the grant with respect to which Incentive Stock Options are exercisable for the first time by a Participant during any
calendar year, under the Plan or any other stock option plan of the Company or a parent or subsidiary, exceeds $100,000, then the Option,
as to the excess, shall be treated as a Nonqualified Stock Option.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
7. Stock Awards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Committee may issue or transfer shares of Company Stock to an Employee, Non-Employee Director or Key Advisor under a Stock Award, upon
such terms as the Committee deems appropriate. The following provisions are applicable to Stock Awards:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;General
Requirements&lt;/span&gt;. Shares of Company Stock issued or transferred pursuant to Stock Awards may be issued or transferred for consideration
or for no consideration, and subject to restrictions or no restrictions, as determined by the Committee. The Committee may, but shall
not be required to, establish conditions under which restrictions on Stock Awards shall lapse over a period of time or according to such
other criteria as the Committee deems appropriate, including, without limitation, restrictions based on the achievement of specific Performance
Goals. The period of time during which the Stock Awards will remain subject to restrictions will be designated in the Grant Instrument
as the &#x201c;&lt;span style="text-decoration: underline"&gt;Restriction Period.&#x201d;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;Number
of Shares&lt;/span&gt;. The Committee shall determine the number of shares of Company Stock to be issued or transferred pursuant to a Stock Award
and the restrictions applicable to such shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c) &lt;span style="text-decoration: underline"&gt;Requirement
of Employment or Service&lt;/span&gt;. If the Participant ceases to be employed by, or provide service to, the Employer during a period designated
in the Grant Instrument as the Restriction Period, or if other specified conditions are not met, the Stock Award shall terminate as to
all shares covered by the Grant as to which the restrictions have not lapsed, and those shares of Company Stock must be immediately returned
to the Company. The Committee may, however, provide for complete or partial exceptions to this requirement as it deems appropriate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d) &lt;span style="text-decoration: underline"&gt;Restrictions
on Transfer and Legend on Stock Certificate&lt;/span&gt;. During the Restriction Period, a Participant may not sell, assign, transfer, pledge
or otherwise dispose of the shares of a Stock Award except under Section 15 below. Unless otherwise determined by the Committee, the
Company will retain possession of certificates for shares of Stock Awards until all restrictions on such shares have lapsed. Each certificate
for a Stock Award, unless held by the Company, shall contain a legend giving appropriate notice of the restrictions in the Grant. The
Participant shall be entitled to have the legend removed from the stock certificate covering the shares subject to restrictions when
all restrictions on such shares have lapsed. The Committee may determine that the Company will not issue certificates for Stock Awards
until all restrictions on such shares have lapsed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(e) &lt;span style="text-decoration: underline"&gt;Right
to Vote and to Receive Dividends&lt;/span&gt;. Unless the Committee determines otherwise, during the Restriction Period, the Participant shall
have the right to vote shares of Stock Awards and to receive any dividends or other distributions paid on such shares, subject to any
restrictions deemed appropriate by the Committee, including, without limitation, the achievement of specific Performance Goals. Dividends
with respect to Stock Awards that vest based on performance shall vest if and to the extent that the underlying Stock Award vests, as
determined by the Committee.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(f) &lt;span style="text-decoration: underline"&gt;Lapse
of Restrictions&lt;/span&gt;. All restrictions imposed on Stock Awards shall lapse upon the expiration of the applicable Restriction Period and
the satisfaction of all conditions, if any, imposed by the Committee. The Committee may determine, as to any or all Stock Awards, that
the restrictions shall lapse without regard to any Restriction Period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
8. Stock Units&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Committee may grant Stock Units, each of which shall represent one hypothetical share of Company Stock, to an Employee, Non-Employee
Director or Key Advisor upon such terms and conditions as the Committee deems appropriate. The following provisions are applicable to
Stock Units:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;Crediting
of Units&lt;/span&gt;. Each Stock Unit shall represent the right of the Participant to receive a share of Company Stock or an amount of cash based
on the value of a share of Company Stock, if and when specified conditions are met. All Stock Units shall be credited to bookkeeping
accounts established on the Company&#x2019;s records for purposes of the Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;Terms
of Stock Units&lt;/span&gt;. The Committee may grant Stock Units that vest and are payable if specified Performance Goals or other conditions
are met, or under other circumstances. Stock Units may be paid at the end of a specified performance period or other period, or payment
may be deferred to a date authorized by the Committee. The Committee may accelerate vesting or payment, as to any or all Stock Units
at any time for any reason, provided such acceleration complies with section 409A of the Code. The Committee shall determine the number
of Stock Units to be granted and the requirements applicable to such Stock Units.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c) &lt;span style="text-decoration: underline"&gt;Requirement
of Employment or Service&lt;/span&gt;. If the Participant ceases to be employed by, or provide service to, the Employer prior to the vesting of
Stock Units, or if other conditions established by the Committee are not met, the Participant&#x2019;s Stock Units shall be forfeited.
The Committee may, however, provide for complete or partial exceptions to this requirement as it deems appropriate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d) &lt;span style="text-decoration: underline"&gt;Payment
With Respect to Stock Units&lt;/span&gt;. Payments with respect to Stock Units shall be made in cash, Company Stock or any combination of the
foregoing, as the Committee shall determine.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
9. Stock Appreciation Rights&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Committee may grant SARs to an Employee, Non-Employee Director or Key Advisor separately or in tandem with any Option. The following
provisions are applicable to SARs:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;General
Requirements&lt;/span&gt;. The Committee may grant SARs to an Employee, Non-Employee Director or Key Advisor separately or in tandem with any
Option (for all or a portion of the applicable Option). Tandem SARs may be granted either at the time the Option is granted or at any
time thereafter while the Option remains outstanding; provided, however, that, in the case of an Incentive Stock Option, SARs may be
granted only at the time of the grant of the Incentive Stock Option. The Committee shall establish the base amount of the SAR at the
time the SAR is granted. The base amount of each SAR shall be equal to or greater than the Fair Market Value of a share of Company Stock
as of the date of grant of the SAR. The term of any SAR shall not exceed ten years from the date of grant. Notwithstanding the foregoing,
in the event that on the last business day of the term of a SAR, the exercise of the SAR is prohibited by applicable law, including a
prohibition on purchases or sales of Company Stock under the Company&#x2019;s insider trading policy, the term shall be extended for a
period of 30 days following the end of the legal prohibition, unless the Committee determines otherwise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;Tandem
SARs&lt;/span&gt;. In the case of tandem SARs, the number of SARs granted to a Participant that shall be exercisable during a specified period
shall not exceed the number of shares of Company Stock that the Participant may purchase upon the exercise of the related Option during
such period. Upon the exercise of an Option, the SARs relating to the Company Stock covered by such Option shall terminate. Upon the
exercise of SARs, the related Option shall terminate to the extent of an equal number of shares of Company Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c) &lt;span style="text-decoration: underline"&gt;Exercisability&lt;/span&gt;.
A SAR shall be exercisable during the period specified by the Committee in the Grant Instrument and shall be subject to such vesting
and other restrictions as may be specified in the Grant Instrument. The Committee may accelerate the exercisability of any or all outstanding
SARs at any time for any reason. SARs may only be exercised while the Participant is employed by, or providing service to, the Employer
or during the applicable period after termination of employment or service as specified by the Committee. A tandem SAR shall be exercisable
only during the period when the Option to which it is related is also exercisable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d) &lt;span style="text-decoration: underline"&gt;Grants
to Non-Exempt Employees&lt;/span&gt;. Notwithstanding the foregoing, SARs granted to persons who are non-exempt employees under the Fair Labor
Standards Act of 1938, as amended, may not be exercisable for at least six months after the date of grant (except that such SARs may
become exercisable, as determined by the Committee, upon the Participant&#x2019;s death, Disability or retirement, or upon a Change of
Control or other circumstances permitted by applicable regulations).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(e) &lt;span style="text-decoration: underline"&gt;Value
of SARs&lt;/span&gt;. When a Participant exercises SARs, the Participant shall receive in settlement of such SARs an amount equal to the value
of the stock appreciation for the number of SARs exercised. The stock appreciation for a SAR is the amount by which the Fair Market Value
of the underlying Company Stock on the date of exercise of the SAR exceeds the base amount of the SAR as described in subsection (a).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(f) &lt;span style="text-decoration: underline"&gt;Form
of Payment&lt;/span&gt;. The appreciation in a SAR shall be paid in shares of Company Stock, cash or any combination of the foregoing, as the
Committee shall determine. For purposes of calculating the number of shares of Company Stock to be received, shares of Company Stock
shall be valued at their Fair Market Value on the date of exercise of the SAR.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
10. Other Stock-Based Awards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Committee may grant Other Stock-Based Awards, which are awards (other than those described in Sections 6, 7, 8 and 9 of the Plan) that
are based on or measured by Company Stock, to any Employee, Non- Employee Director or Key Advisor, on such terms and conditions as the
Committee shall determine. Other Stock-Based Awards may be awarded subject to the achievement of Performance Goals or other criteria
or other conditions and may be payable in cash, Company Stock or any combination of the foregoing, as the Committee shall determine.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
11. Dividend Equivalents&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Committee may grant Dividend Equivalents in connection with Stock Units or Other Stock-Based Awards. Dividend Equivalents may be paid
currently or accrued as contingent cash obligations and may be payable in cash or shares of Company Stock, and upon such terms and conditions
as the Committee shall determine. Dividend Equivalents with respect to Stock Units or Other Stock-Based Awards that vest based on performance
shall vest and be paid only if and to the extent the underlying Stock Units or Other Stock-Based Awards vest and are paid, as determined
by the Committee.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
12. Consequences of a Change of Control&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;Assumption
of Outstanding Grants&lt;/span&gt;. Upon a Change of Control where the Company is not the surviving corporation (or survives only as a subsidiary
of another corporation), unless the Committee determines otherwise, all outstanding Grants that are not exercised or paid at the time
of the Change of Control shall be assumed by, or replaced with grants (with respect to cash, securities, or a combination thereof) that
have comparable terms by, the surviving corporation (or a parent or subsidiary of the surviving corporation). After a Change of Control,
references to the &#x201c;Company&#x201d; as they relate to employment matters shall include the successor employer in the transaction,
subject to applicable law.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;Vesting
Upon Certain Terminations of Employment&lt;/span&gt;. Unless the Grant Instrument provides otherwise, if a Participant&#x2019;s employment is terminated
by the Employer without Cause upon or within 12 months following a Change of Control, the Participant&#x2019;s outstanding Grants shall
become fully vested as of the date of such termination; provided that if the vesting of any such Grants is based, in whole or in part,
on performance, the applicable Grant Instrument shall specify how the portion of the Grant that becomes vested pursuant to this Section
12(b) shall be calculated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c) &lt;span style="text-decoration: underline"&gt;Other
Alternatives&lt;/span&gt;. In the event of a Change of Control, if any outstanding Grants are not assumed by, or replaced with grants that have
comparable terms by, the surviving corporation (or a parent or subsidiary of the surviving corporation), the Committee may (but is not
obligated to) make adjustments to the terms and conditions of outstanding Grants, including, without limitation, taking any of the following
actions (or combination thereof) with respect to any or all outstanding Grants, without the consent of any Participant: (i) the Committee
may determine that outstanding Stock Options and SARs shall automatically accelerate and become fully exercisable and the restrictions
and conditions on outstanding Stock Awards, Stock Units and Dividend Equivalents shall immediately lapse; (ii) the Committee may determine
that Participants shall receive a payment in settlement of outstanding Stock Units or Dividend Equivalents, in such amount and form as
may be determined by the Committee; (iii) the Committee may require that Participants surrender their outstanding Stock Options and SARs
in exchange for a payment by the Company, in cash or Company Stock as determined by the Committee, in an amount equal to the amount,
if any, by which the then Fair Market Value of the shares of Company Stock subject to the Participant&#x2019;s unexercised Stock Options
and SARs exceeds the Stock Option Exercise Price or SAR base amount, and (iv) after giving Participants an opportunity to exercise all
of their outstanding Stock Options and SARs, the Committee may terminate any or all unexercised Stock Options and SARs at such time as
the Committee deems appropriate. Such surrender, termination or payment shall take place as of the date of the Change of Control or such
other date as the Committee may specify. Without limiting the foregoing, if the per share Fair Market Value of the Company Stock does
not exceed the per share Stock Option Exercise Price or SAR base amount, as applicable, the Company shall not be required to make any
payment to the Participant upon surrender of the Stock Option or SAR.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
13. Deferrals&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Committee may permit or require a Participant to defer receipt of the payment of cash or the delivery of shares that would otherwise
be due to such Participant in connection with any Grant. If any such deferral election is permitted or required, the Committee shall
establish rules and procedures for such deferrals and may provide for interest or other earnings to be paid on such deferrals. The rules
and procedures for any such deferrals shall be consistent with applicable requirements of section 409A of the Code.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
14. Withholding of Taxes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;Required
Withholding&lt;/span&gt;. All Grants under the Plan shall be subject to applicable United States federal (including FICA), state and local, foreign
country or other tax withholding requirements. The Employer may require that the Participant or other person receiving Grants or exercising
Grants pay to the Employer an amount sufficient to satisfy such tax withholding requirements with respect to such Grants, or the Employer
may deduct from other wages and compensation paid by the Employer the amount of any withholding taxes due with respect to such Grants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;Share
Withholding&lt;/span&gt;. The Committee may permit or require the Employer&#x2019;s tax withholding obligation with respect to Grants paid in Company
Stock to be satisfied by having shares withheld up to an amount that does not exceed the Participant&#x2019;s applicable withholding tax
rate for United States federal (including FICA), state and local, foreign country or other tax liabilities. The Committee may, in its
discretion, and subject to such rules as the Committee may adopt, allow Participants to elect to have such share withholding applied
to all or a portion of the tax withholding obligation arising in connection with any particular Grant. Unless the Committee determines
otherwise, share withholding for taxes shall not exceed the Participant&#x2019;s minimum applicable tax withholding amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
15. Transferability of Grants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;Nontransferability
of Grants&lt;/span&gt;. Except as described in subsection (b) below, only the Participant may exercise rights under a Grant during the Participant&#x2019;s
lifetime. A Participant may not transfer those rights except (i) by will or by the laws of descent and distribution or (ii) with respect
to Grants other than Incentive Stock Options, pursuant to a domestic relations order. When a Participant dies, the personal representative
or other person entitled to succeed to the rights of the Participant may exercise such rights. Any such successor must furnish proof
satisfactory to the Company of his or her right to receive the Grant under the Participant&#x2019;s will or under the applicable laws
of descent and distribution.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;Transfer
of Nonqualified Stock Options and Stock Awards&lt;/span&gt;. Notwithstanding the foregoing, the Committee may provide, in a Grant Instrument or
at such other time after the grant of an award, that a Participant may transfer Nonqualified Stock Options or Stock Awards to family
members, or one or more trusts or other entities for the benefit of or owned by family members, consistent with the applicable securities
laws, according to such terms as the Committee may determine; provided that the Participant receives no consideration for the transfer
of an Option or Stock Award and the transferred Option or Stock Award shall continue to be subject to the same terms and conditions as
were applicable to the Option or Stock Award immediately before the transfer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
16. Requirements for Issuance or Transfer of Shares&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;No
Company Stock shall be issued or transferred in connection with any Grant hereunder unless and until all legal requirements applicable
to the issuance or transfer of such Company Stock have been complied with to the satisfaction of the Committee. The Committee shall have
the right to condition any Grant on the Participant&#x2019;s undertaking in writing to comply with such restrictions on his or her subsequent
disposition of the shares of Company Stock as the Committee shall deem necessary or advisable, and certificates representing such shares
may be legended to reflect any such restrictions. Certificates representing shares of Company Stock issued or transferred under the Plan
may be subject to such stop-transfer orders and other restrictions as the Committee deems appropriate to comply with applicable laws,
regulations and interpretations, including any requirement that a legend be placed thereon.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
17. Amendment and Termination of the Plan&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;Amendment&lt;/span&gt;.
The Board may amend or terminate the Plan at any time; provided, however, that the Board shall not amend the Plan without stockholder
approval if such approval is required in order to comply with the Code or other applicable law, or to comply with applicable stock exchange
requirements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;No
Repricing of Options or SARs&lt;/span&gt;. Except in connection with a corporate transaction involving the Company (including, without limitation,
any stock dividend, distribution (whether in the form of cash, Company Stock, other securities or property), stock split, extraordinary
cash dividend, recapitalization, change in control, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase
or exchange of shares of Company Stock or other securities, or similar transactions), the Company may not, without obtaining stockholder
approval, (i) amend the terms of outstanding Stock Options or SARs to reduce the Exercise Price of such outstanding Stock Options or
base price of such SARs, (ii) cancel outstanding Stock Options or SARs in exchange for Stock Options or SARs with an Exercise Price or
base price, as applicable, that is less than the Exercise Price or base price of the original Stock Options or SARs or (iii) cancel outstanding
Stock Options or SARs with an Exercise Price or base price, as applicable, above the current stock price in exchange for cash or other
securities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c) &lt;span style="text-decoration: underline"&gt;Termination
of Plan&lt;/span&gt;. The Plan shall terminate on the day immediately preceding the tenth anniversary of its Effective Date, unless the Plan is
terminated earlier by the Board or is extended by the Board with the approval of the stockholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d) &lt;span style="text-decoration: underline"&gt;Termination
and Amendment of Outstanding Grants&lt;/span&gt;. A termination or amendment of the Plan that occurs after a Grant is made shall not materially
impair the rights of a Participant with respect to such Grant unless the Participant consents or unless the Committee acts under Section
18(f) below. The termination of the Plan shall not impair the power and authority of the Committee with respect to an outstanding Grant.
Whether or not the Plan has terminated, an outstanding Grant may be terminated or amended under Section 18(f) below or may be amended
by agreement of the Company and the Participant consistent with the Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
18. Miscellaneous&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;Grants
in Connection with Corporate Transactions and Otherwise&lt;/span&gt;. Nothing contained in the Plan shall be construed to (i) limit the right
of the Committee to make Grants under the Plan in connection with the acquisition, by purchase, lease, merger, consolidation or otherwise,
of the business or assets of any corporation, firm or association, including Grants to employees thereof who become Employees, or (ii)
limit the right of the Company to grant stock options or make other awards outside of the Plan. The Committee may make a Grant to an
employee of another corporation who becomes an Employee by reason of a corporate merger, consolidation, acquisition of stock or property,
reorganization or liquidation involving the Company, in substitution for a stock option or stock awards grant made by such corporation.
Notwithstanding anything in the Plan to the contrary, the Committee may establish such terms and conditions of the new Grants as it deems
appropriate, including setting the Exercise Price of Options or the base price of SARs at a price necessary to retain for the Participant
the same economic value as the prior options or rights.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;Governing
Document. The Plan shall be the controlling document&lt;/span&gt;. No other statements, representations, explanatory materials or examples, oral
or written, may amend the Plan in any manner. The Plan shall be binding upon and enforceable against the Company and its successors and
assigns.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c) &lt;span style="text-decoration: underline"&gt;Funding
of the Plan&lt;/span&gt;. The Plan shall be unfunded. The Company shall not be required to establish any special or separate fund or to make any
other segregation of assets to assure the payment of any Grants under the Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d) &lt;span style="text-decoration: underline"&gt;Rights
of Participants&lt;/span&gt;. Nothing in the Plan shall entitle any Employee, Non-Employee Director, Key Advisor or other person to any claim
or right to receive a Grant under the Plan. Neither the Plan nor any action taken hereunder shall be construed as giving any individual
any rights to be retained by or in the employ of the Employer or any other employment rights.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(e) &lt;span style="text-decoration: underline"&gt;No
Fractional Shares&lt;/span&gt;. No fractional shares of Company Stock shall be issued or delivered pursuant to the Plan or any Grant. Except as
otherwise provided under the Plan, the Committee shall determine whether cash, other awards or other property shall be issued or paid
in lieu of such fractional shares or whether such fractional shares or any rights thereto shall be forfeited or otherwise eliminated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(f) &lt;span style="text-decoration: underline"&gt;Compliance
with Law.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i) The
Plan, the exercise of Options and SARs and the obligations of the Company to issue or transfer shares of Company Stock under Grants shall
be subject to all applicable laws and regulations, and to approvals by any governmental or regulatory agency as may be required. With
respect to persons subject to section 16 of the Exchange Act, it is the intent of the Company that the Plan and all transactions under
the Plan comply with all applicable provisions of Rule 16b-3 or its successors under the Exchange Act. In addition, it is the intent
of the Company that Incentive Stock Options comply with the applicable provisions of section 422 of the Code, and that, to the extent
applicable, Grants comply with the requirements of section 409A of the Code. To the extent that any legal requirement of section 16 of
the Exchange Act or section 422 or 409A of the Code as set forth in the Plan ceases to be required under section 16 of the Exchange Act
or section 422 or 409A of the Code, that Plan provision shall cease to apply. The Committee may revoke any Grant if it is contrary to
law or modify a Grant to bring it into compliance with any valid and mandatory government regulation. The Committee may also adopt rules
regarding the withholding of taxes on payments to Participants. The Committee may, in its sole discretion, agree to limit its authority
under this Section.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii) The
Plan is intended to comply with the requirements of section 409A of the Code, to the extent applicable. Each Grant shall be construed
and administered such that the Grant either (A) qualifies for an exemption from the requirements of section 409A of the Code or (B) satisfies
the requirements of section 409A of the Code. If a Grant is subject to section 409A of the Code, (I) distributions shall only be made
in a manner and upon an event permitted under section 409A of the Code, (II) payments to be made upon a termination of employment or
service shall only be made upon a &#x201c;separation from service&#x201d; under section 409A of the Code, (III) unless the Grant specifies
otherwise, each installment payment shall be treated as a separate payment for purposes of section 409A of the Code, and (IV) in no event
shall a Participant, directly or indirectly, designate the calendar year in which a distribution is made except in accordance with section
409A of the Code.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iii) Any
Grant that is subject to section 409A of the Code and that is to be distributed to a Key Employee (as defined below) upon separation
from service shall be administered so that any distribution with respect to such Grant shall be postponed for six months following the
date of the Participant&#x2019;s separation from service, if required by section 409A of the Code. If a distribution is delayed pursuant
to section 409A of the Code, the distribution shall be paid within 15 days after the end of the six-month period. If the Participant
dies during such six-month period, any postponed amounts shall be paid within 90 days of the Participant&#x2019;s death. The determination
of Key Employees, including the number and identity of persons considered Key Employees and the identification date, shall be made by
the Committee or its delegate each year in accordance with section 416(i) of the Code and the &#x201c;specified employee&#x201d; requirements
of section 409A of the Code.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iv) Notwithstanding
anything in the Plan or any Grant agreement to the contrary, each Participant shall be solely responsible for the tax consequences
of Grants under the Plan, and in no event shall the Company or any subsidiary or affiliate of the Company have any responsibility or
liability if a Grant does not meet any applicable requirements of section 409A of the Code. Although the Company intends to
administer the Plan to prevent taxation under section 409A of the Code, the Company does not represent or warrant that the Plan or
any Grant complies with any provision of federal, state, local or other tax law.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(g) &lt;span style="text-decoration: underline"&gt;Grants
in Foreign Countries; Establishment of Subplans&lt;/span&gt;. The Committee has the authority to award Grants to Participants who are foreign
nationals or employed outside the United States on any different terms and conditions than those specified in the Plan that the Committee,
in its discretion, believes to be necessary or desirable to accommodate differences in applicable law, tax policy, or custom, while furthering
the purposes of the Plan. The Board may from time to time establish one or more sub-plans under the Plan for purposes of satisfying applicable
blue sky, securities or tax laws of various jurisdictions. The Board shall establish such sub-plans by adopting supplements to the Plan
setting forth (i) such limitations on the Committee&#x2019;s discretion under the Plan as the Board deems necessary or desirable and (ii)
such additional terms and conditions not otherwise inconsistent with the Plan as the Board shall deem necessary or desirable. All supplements
adopted by the Board shall be deemed to be part of the Plan, but each supplement shall apply only to Participants within the affected
jurisdiction and the Employer shall not be required to provide copies of any supplement to Participants in any jurisdiction that is not
affected. Notwithstanding the foregoing, the Committee may not approve any sub-plan inconsistent with the terms or share limits in the
Plan or which would otherwise cause the Plan to cease to satisfy any conditions under Rule 16b-3 under the 1934 Act.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(h) &lt;span style="text-decoration: underline"&gt;Clawback
Rights&lt;/span&gt;. Subject to the requirements of applicable law, the Committee may provide in any Grant Instrument that, if a Participant breaches
any restrictive covenant agreement between the Participant and the Employer (which may be set forth in any Grant Instrument) or otherwise
engages in activities that constitute Cause either while employed by, or providing service to, the Employer or within a specified period
of time thereafter, all Grants held by the Participant shall terminate, and the Company may rescind any exercise of an Option or SAR
and the vesting of any other Grant and delivery of shares upon such exercise or vesting (including pursuant to dividends and Dividend
Equivalents), as applicable on such terms as the Committee shall determine, including the right to require that in the event of any such
rescission, (i) the Participant shall return to the Company the shares received upon the exercise of any Option or SAR and/or the vesting
and payment of any other Grant (including pursuant to dividends and Dividend Equivalents) or, (ii) if the Participant no longer owns
the shares, the Participant shall pay to the Company the amount of any gain realized or payment received as a result of any sale or other
disposition of the shares (or, in the event the Participant transfers the shares by gift or otherwise without consideration, the Fair
Market Value of the shares on the date of the breach of the restrictive covenant agreement (including a Participant&#x2019;s Grant Instrument
containing restrictive covenants) or activity constituting Cause), net of the price originally paid by the Participant for the shares.
Payment by the Participant shall be made in such manner and on such terms and conditions as may be required by the Committee. The Employer
shall be entitled to set off against the amount of any such payment any amounts otherwise owed to the Participant by the Employer. In
addition, all Grants under the Plan shall be subject to any applicable clawback or recoupment policies, share trading policies and other
policies that may be implemented by the Board from time to time.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i) &lt;span style="text-decoration: underline"&gt;Governing
Law; Jurisdiction&lt;/span&gt;. The validity, construction, interpretation and effect of the Plan and Grant Instrument issued under the Plan shall
be governed and construed by and determined in accordance with the laws of the Commonwealth of Massachusetts, without giving effect to
the conflict of laws provisions thereof. Any action arising out of, or relating to, any of the provisions of the Plan and Grants made
hereunder shall be brought only in the United States District Court for the District of Massachusetts, or if such court does not have
jurisdiction or will not accept jurisdiction, in any court of general jurisdiction in Massachusetts, and the jurisdiction of such court
in any such proceeding shall be exclusive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Appendix
B&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;CERTIFICATE
OF AMENDMENT&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;OF&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;CERTIFICATE
OF INCORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;OF&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;KOPIN
CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to Section 242 of the&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;General
Corporation Law of the State of Delaware&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;KOPIN
CORPORATION (the &#x201c;Corporation&#x201d;), a corporation organized and existing under and by virtue of the General Corporation
Law of the State of Delaware,&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;DOES
HEREBY CERTIFY:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FIRST:
That at a meeting of the Board of Directors of the Corporation resolutions were duly adopted setting forth a proposed
amendment to the Certificate of Incorporation, as amended to date (the &#x201c;Charter Amendment&#x201d;) and declaring said Charter
Amendment to be advisable and directing the stockholders of the Corporation to consider said Charter Amendment and to indicate their
approval and adoption thereof. The resolution setting forth the amendment is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RESOLVED,
That the first sentence of Article Fourth of the Restated Certificate of Incorporation of the Corporation be and it hereby is amended
to read as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x201c;FOURTH:
The total number of shares of stock which the Corporation shall have authority to issue is two hundred and seventy-five
million and three thousand (275,003,000) shares, of which three thousand (3,000) shares, par value of $.01 each, are to be of
a class designated Preferred Stock, and two hundred and seventy five million (275,000,000) shares, par value of $.01 each,
are to be of a class designated Common Stock.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SECOND:
That thereafter, pursuant to resolution of its Board of Directors, an annual meeting of the stockholders of said corporation was duly
called and held, upon notice in accordance with Sections 211 and 222 of the General Corporation Law of the State of Delaware at
which meeting the necessary number of shares as required by statute were voted in favor of the amendment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;THIRD:
That the aforesaid Charter Amendment was duly adopted in accordance with the applicable provisions of Section 242 of the General
Corporation Law of the State of Delaware.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FOURTH:
That this Certificate of Amendment to the Certificate of Incorporation shall become effective upon the filing of the Certificate of Amendment
with the Delaware Secretary of State, which will occur as soon as reasonably practicable after approval.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;IN
WITNESS WHEREOF, said Kopin Corporation has caused this Certificate of Amendment to the Certificate of Incorporation to be executed,
acknowledged and filed by its Chief Financial Officer this [&#x25cf;] day of June 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;KOPIN
    CORPORATION &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;By:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;/s/
    Richard A. Sneider&lt;/i&gt; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 5%"&gt;Name:&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 45%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Richard
    A. Sneider &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Title:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chief
    Financial Officer&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;img alt="" src="proxy_001.jpg" style="width: 800px"/&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;img alt="" src="proxy_002.jpg" style="width: 800px"/&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;








</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="From2023-12-31to2024-12-28" id="Fact000138">&lt;p id="xdx_89D_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zdQLge7iPOxb" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;img alt="" src="formdef14a_002.jpg" style="height: 520px; width: 750px"/&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Equity
Compensation Plan Information&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table sets forth information as of December 28, 2024 about shares of our common stock issuable upon exercise of outstanding
options, warrants and rights and available for issuance under our existing equity compensation plans.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Plan Category&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
                                            of securities to&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;be
                                            issued upon exercise&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;of
                                            outstanding options,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;warrants
                                            and rights&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted-average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;exercise
                                            price of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;outstanding
                                            options,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;warrants
                                            and rights&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
                                            of securities&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;remaining
                                            available&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;for
                                            future issuance&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;under
                                            equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;compensation
                                            plans&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(excluding
                                            securities&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;reflected
                                            in column (a)) &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity compensation
    plans approved by security holders&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,833,611&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.19&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,913,621&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Equity compensation plans not approved by security holders&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;4,833,611&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;1.19&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0; text-indent: 0.25in"&gt;4,913,621&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Consists
    of shares available under the 2020 Equity Incentive Plan.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
    of December 28, 2024, there were 4,913,621 shares available for grant under the 2020 Equity Incentive Plan.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Director
Compensation Commencing in Fiscal Year 2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
2023, the Compensation Committee engaged Aon to perform a peer review of our Board of Director compensation. Commencing in 2024
our Board-approved compensation for non-employee directors is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Annual
    retainer: $40,000 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Annual
    stock grant: 64,500 shares of restricted stock which vest on the anniversary of the grant Committee membership fees paid annually:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Audit
    Committee Chairperson: $15,000 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Non-employee Chairperson of the Board: $30,000&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nominating
    Committee Chairperson: $10,000 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Compensation
    Committee Chairperson: $10,000 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Audit
    Committee member: $8,000 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nominating
    Committee member: $4,375 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Compensation
    Committee member: $5,000 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
a result of the adoption of the Board Compensation plan commencing in 2024 the following adjustments were made:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Annual retainer was decreased from $45,000 to $40,000 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
    annual stock grant was increased to 64,500 shares of restricted stock from 10,000 shares Committee membership fees paid annually:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Non-employee Chairperson of the Board: $30,000&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Audit
    Committee Chairperson compensation was increased $5,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Compensation
    Committee Chairperson compensation increased $6,250 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Audit
    Committee member compensation increased $3,000 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Nominating
    Committee member compensation increased $1,875 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Compensation Committee
    member compensation decreased $1,250&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Meeting
    fees were eliminated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
non-employee director was also entitled to receive an initial restricted stock award for 64,500 shares of our common stock on the date
of his or her initial election to the Board. We also pay expenses for attendance at meetings of the Board and committees thereof.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table sets forth certain information regarding the compensation earned by or awards to each non-employee director who served
on our Board of Directors in the 2024 fiscal year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mr.
Murray, who was an employee of Kopin during 2024, was not compensated for his service as director and his compensation is fully reflected
in the Summary Compensation Table above.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Director
Compensation Table for 2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Name&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fees&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Earned&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;or
                                            Paid&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;in
                                            Cash&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Stock&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Awards&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;sup&gt;(1)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Option&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Awards&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;sup&gt;(2)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-Equity&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Incentive&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;sup&gt;(3)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Change
                                            in&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Pension
                                            Value&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;and&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Nonqualified&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Deferred&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Earnings&lt;sup&gt;(3)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;All
                                            Other&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)&lt;sup&gt;(3)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;($)
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 37%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Jill J. Avery&lt;sup&gt;(4)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;61,188&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,310&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;111,498&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chi Chia Hsieh&lt;sup&gt;(5)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;54,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,310&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;104,310&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;David Nieuwsma &lt;sup&gt;(6)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;55,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,310&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;105,310&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Margaret Seif&lt;sup&gt;(7)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,188&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,310&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;85,828&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Paul Walsh, Jr.&lt;sup&gt;(8)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27,333&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;54,573&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;81,907&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 20pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
    Board member received his or her annual restricted stock grant of 64,500 shares which vests on the anniversary of the grant if the
    person is still a member of our Board of Directors on such anniversary with the exception of Mr. Walsh. The amounts in the column
    were determined by multiplying the number of shares of restricted common stock granted by the closing price of our common stock as
    listed on the Nasdaq on the day of grant. The 2024 grant occurred on June 6, 2024, and the closing price of our stock was $0.78.
    Mr. Walsh joined the Board of Directors on September 9, 2024 and he was granted 64,500 shares of restricted stock. Our stock price
    on September 9, 2024 was $0.85. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
    were no stock options issued in 2024. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;No
    non-equity incentive compensation, pension, non-qualified deferred compensation or other compensation payments were made as compensation
    for director services in fiscal year 2024 or are contemplated under our current compensation plan. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dr.
    Avery&#x2019;s annual cash fees were comprised of the annual retainer of $40,000, $7,188 for serving on the Nominating Committee,
    and $8,000 for serving on the Audit Committee. In addition, prior to the implementation of the current Board member compensation
    plan members were paid meeting fees. Ms. Avery was paid $2,000 for attending meetings of the Board and $4,000 for attending meetings
    of the Audit Committee under the prior Board member compensation plan. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dr.
    Hsieh&#x2019;s annual cash fees were comprised of the annual retainer of $40,000 and $10.000 for serving as the Compensation Committee
    Chairperson. In addition, prior to the implementation of the current Board member compensation plan members were paid meeting fees.
    Dr. Hsieh was paid $2,000 for attending meetings of the Board and $2,000 for attending meetings of the Compensation Committee under
    the prior Board member compensation plan.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(6)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mr.
    Nieuwsma&#x2019;s annual cash fees were comprised of the annual retainer of $40,000, $8,000 for serving on the Audit Committee and
    $5.000 for serving as the Compensation Committee. In addition, prior to the implementation of the current Board member compensation
    plan members were paid meeting fees. Mr. Nieuwsma was paid $2,000 for attending meetings of the Board. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(7)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ms.
    Sief&#x2019;s annual cash fees were comprised of the annual retainer of $40,000, $7,188 for serving as Chairperson of the Nominating
    Committee and $5.000 for serving on the Compensation Committee. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(8)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mr.
    Walsch, Jr.&#x2019;s annual cash fees were comprised of a prorated annual retainer of $12,333, and $15,000 for serving as the Audit
    Committee Chairperson. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(9)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
    Director, excluding Michael Murray, has 64,500 of unvested restricted shares.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Audit
Committee Report&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Audit Committee of the Board currently consists of Paul Walsch, Jr., Jill J. Avery and David Nieuwsma, each of whom the Board
has determined is independent under applicable SEC and Nasdaq Rules. The Board also has determined that Mr. Walsh is an &#x201c;audit
committee financial expert&#x201d; under applicable SEC rules and regulations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
purpose of the Audit Committee is to assist the Board in its general oversight of the Company&#x2019;s financial reporting, internal controls
and audit functions. The Audit Committee charter, which is available at the Company&#x2019;s website at &lt;i&gt;www.kopin.com&lt;/i&gt;, under the
heading &#x201c;Investors: Corporate Governance,&#x201d; describes in greater detail the full responsibilities of the Audit Committee.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
is responsible for the preparation, presentation and integrity of the Company&#x2019;s financial statements; accounting and financial
reporting principles; establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)); establishing
and maintaining internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f)); evaluating the effectiveness of
disclosure controls and procedures; evaluating the effectiveness of internal control over financial reporting; and evaluating any change
in internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, internal control
over financial reporting.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;BDO
USA, P.C.&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt; (&#x201c;BDO&#x201d;), the Company&#x2019;s
independent registered public accounting firm, has been engaged to perform an independent audit of the consolidated financial statements
and to express an opinion on the conformity of those financial statements with accounting principles generally accepted in the United
States of America and also to express an opinion on the effectiveness of the Company&#x2019;s internal control over financial reporting.
The Audit Committee has reviewed and discussed the consolidated financial statements with management and BDO.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the course of the 2024 fiscal year, management completed the documentation, testing and evaluation of the Company&#x2019;s system of internal
control over financial reporting in response to the requirements set forth in Section 404 of the Sarbanes-Oxley Act of 2002 and related
rules and regulations. The Audit Committee was kept apprised of the progress of the evaluation and provided oversight and advice to management
during this process. In connection with this oversight, the Audit Committee also received periodic updates provided by management and
Stowe &amp;amp; Degon LLC, an independent registered public accounting firm that the Company uses for internal controls review, at regularly
scheduled Audit Committee meetings. At the conclusion of the process, management provided the Audit Committee with, and the Audit Committee
reviewed, a report on the effectiveness of the Company&#x2019;s internal control over financial reporting. The Audit Committee also received
a report of results from Stowe &amp;amp; Degon LLC. The Audit Committee also reviewed the report of management contained in the Company&#x2019;s
Annual Reports on Form 10-K for the fiscal year ended December 28, 2024, filed with the SEC, as well as BDO&#x2019;s Reports of Independent
Registered Public Accounting Firm included in the Company&#x2019;s Annual Report on Form 10-K related to its audit of the consolidated
financial statements and financial statement schedule, for the fiscal year ended December 28, 2024. In conjunction, the Audit Committee
continues to oversee the Company&#x2019;s efforts related to its internal control over financial reporting and management&#x2019;s preparations
for the evaluation in fiscal year 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Committee has discussed with BDO the matters that are required to be discussed by applicable standards of the Public Company Accounting
Oversight Board (&#x201c;PCAOB&#x201d;), including Statement on Auditing Standards No. 61, &#x201c;&lt;i&gt;Communication with Audit Committees&lt;/i&gt;,&#x201d;
as amended, and as adopted by the PCAOB, as well as Rule 2-07 of Regulation S-X of the SEC &#x201c;&lt;i&gt;Communication with Audit Committees&lt;/i&gt;.&#x201d;
BDO has also provided to the Committee its letter required by PCAOB Ethics and Independence Rule 3526, &#x201c;&lt;i&gt;Communications with
Audit Committees Concerning Independence&lt;/i&gt;,&#x201d; and the Committee discussed with RSM the firm&#x2019;s independence.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Based
on its review and the discussion noted above, the Audit Committee recommended to the Board that the Company&#x2019;s Consolidated Financial
Statements for the fiscal year 2024 be included in the Company&#x2019;s Annual Report on Form 10-K for the 2024 fiscal year for filing
with the SEC.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 50%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 50%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;AUDIT
    COMMITTEE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Paul
    Walsh, Jr., Chairperson &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Jill
    J. Avery &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;David
    Nieuwsma&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PROPOSAL
2&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;APPROVAL
OF AN AMENDMENT TO THE COMPANY&#x2019;S 2020 EQUITY INCENTIVE PLAN&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;The
Equity Incentive Plan Amendment Proposal&#x2014;&lt;/b&gt; The Board has authorized, subject to stockholder approval, an amendment to our 2020
Equity Incentive Plan (the &#x201c;2020 EIP&#x201d;) to increase the number of shares available under the 2020 EIP by 5,000,000 shares
(the &#x201c;Plan Amendment&#x201d;). Currently, the 2020 EIP authorizes the issuance of up to 14,000,000 shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
purpose of the 2020 EIP is to encourage ownership of the Company&#x2019;s common stock by key employees and to provide additional incentive
for such employees to promote the success of the Company&#x2019;s business. The Board believes that the 2020 EIP:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Aligns
    the long-term interests of key employees and stockholders by creating a direct link between key employee compensation and stockholder
    return; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="text-align: justify; width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Enables
    key employees to develop and maintain a meaningful stock ownership in the Company; and &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="text-align: justify; width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Provides
    incentives for key employees to contribute to the success of the Company. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Plan Amendment is being submitted to stockholders for approval. A copy of the 2020 EIP as it is proposed to be amended is attached to
this Proxy Statement as Appendix A. The Board believes it is in the best interests of the Company and its stockholders to approve the
Plan Amendment to increase the number of shares available under the 2020 EIP by 5,000,000.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
total of 19,000,000 shares of Kopin common stock will be reserved for issuance under the amended 2020 EIP. As of April 30, 2025,
the closing price on Nasdaq per share of common stock was $1.28. Our Board approved the Plan Amendment on March 20, 2025, subject to
approval by Kopin&#x2019;s stockholders. The Plan Amendment will be effective upon approval by Kopin&#x2019;s stockholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;The following table
includes information regarding all of our outstanding equity awards and shares available for future awards under the Plan as of May
1, 2025:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Total number of shares underlying outstanding stock options&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;591,366&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average exercise price of outstanding stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1.76&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Weighted average remaining life of outstanding stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Total shares of common stock outstanding&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;162,797,922&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total shares underlying outstanding and unvested restricted stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,492,501&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Shares available for future awards under the 2020 Equity Incentive plan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,343,521&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Reasons
for the Amendment to the 2020 EIP&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity
incentive compensation programs play a pivotal role in Kopin&#x2019;s efforts to attract and retain key personnel essential to Kopin&#x2019;s
long-term growth and financial success. We are asking our stockholders to approve the Plan Amendment to assist Kopin in attracting and
retaining qualified personnel. If our stockholders do not approve the Plan Amendment, we will be limited in our ability to continue to
issue awards in numbers sufficient to attract and motivate the highly skilled employees we need to recruit and retain, due to low share
reserves remaining in our 2020 EIP and the dilution to our share reserve and outstanding equity awards from the increase in our stock
outstanding from recent financing activities, and our employees&#x2019; motivation and incentives will be negatively affected.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Offering
a broad-based equity compensation program is vital to attracting and retaining highly skilled people in the highly competitive technology
industry. We use equity awards to increase incentives on the part of employees, non-employee directors and consultants who provide significant
services to the Company. We believe that providing an equity stake in the future success of our business encourages our employees to
be highly motivated to achieve our long-term business goals and to increase stockholder value. Their innovation and productivity are
critical to our success. Accordingly, approving the Plan Amendment is in the best interest of our stockholders because equity awards
help us to:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;attract,
    motivate and retain talented employees and directors; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;align
    employee and stockholder interests; and &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;link
    employee compensation with Kopin&#x2019;s performance. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
strongly believe that approval of the Plan Amendment will enable us to achieve our goals in attracting and retaining our most valuable
asset: our employees.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Without
the appropriate share reserve to grant competitive equity-based incentives, we would be forced to consider cash replacement alternatives
to provide a market-competitive total compensation package necessary to attract, retain and motivate the employee talent critical to
our future successes. These cash replacement alternatives could, among other things, reduce the cash available for investment in growth
and development and cause a loss of motivation by employees to achieve superior performance over a longer period of time. Equity- based
incentives, by contrast, directly align a portion of the compensation of our employees with the economic interests of our stockholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
that reason, Kopin has structured the 2020 EIP to provide flexibility in designing equity incentive programs with a broad array of equity
incentives, such as stock options, stock appreciation rights, stock awards and restricted stock units and implement competitive incentive
compensation programs for its employees and non-employee Board members. The 2020 EIP will continue to be the only plan under which new
equity awards may be granted to our employees and other service providers. If this Proposal 2 is not approved, then we would be at a
disadvantage against our competitors for recruiting, retaining and motivating individuals critical to our success and could be forced
to increase cash compensation, thereby reducing resources available to meet our business needs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of May 1, 2025, 11,668,479 shares of common stock, net of 4,373,315 of forfeitures, had been issued pursuant to awards under the
2020 EIP. All awards outstanding under the 2020 EIP on the date of the Plan Amendment will continue to be governed solely by the terms
of the documents evidencing such awards, and no provision of the Plan Amendment will be deemed to affect or otherwise modify the rights
or obligations of the holders of such transferred awards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with our stock-based compensation programs, we are committed to using equity incentive awards prudently and within reasonable
limits. We anticipate that the share reserve under the amended 2020 EIP, will enable us to fund our equity compensation program for approximately
two years. While we believe this is a reasonable estimate of how long the share reserve would last, the actual period for which the proposed
share reserve will fund our equity compensation program may be shorter or longer than expected, depending on changes in our granting
practices, stock price and headcount growth.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Summary
Description of the Kopin Corporation 2020 Equity Incentive Plan&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following is a summary of the principal provisions of the 2020 EIP. This summary is qualified in its entirety by reference to the full
text of the 2020 EIP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Types
of Awards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
2020 EIP provides for the issuance of stock options (including non-statutory stock options and incentive stock option), stock appreciation
rights (referred to as &#x201c;SARs&#x201d;), restricted stock, restricted stock units (&#x201c;RSUs&#x201d;), stock bonuses and other stock-based
awards to officers, employees, non-employee directors, independent contractors and consultants of Kopin Corporation or its affiliates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Purpose
and Types of Grants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
purpose of the 2020 EIP is to attract and retain employees, non-employee directors and consultants, and advisors. The 2020 EIP provides
for the issuance of incentive stock options, non-qualified stock options, stock awards, stock units, stock appreciation rights and other
stock-based awards. The 2020 EIP is intended to provide an incentive to participants to contribute to our economic success by aligning
the economic interests of participants with those of our stockholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Administration&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
2020 EIP is administered by the Compensation Committee of our Board, and the Compensation Committee will determine all of the terms and
conditions applicable to grants under the 2020 EIP. Our Compensation Committee determines who receives grants under the 2020 EIP and
the number of shares of common stock that will be subject to grants, except that grants to members of our Board must be authorized by
a majority of our Board. Our Compensation Committee may delegate authority under the 2020 EIP to one or more subcommittees as it deems
appropriate. Subject to compliance with applicable law and stock exchange requirements, the Compensation Committee (or our Board or a
subcommittee, as applicable) may delegate all or part of its authority to our Chief Executive Officer, as it deems appropriate, with
respect to grants to employees or key advisors who are not executive officers under Section 16 of the Exchange Act. Our Compensation
Committee, our Board, any subcommittee or the Chief Executive Officer, as applicable, that has authority with respect to a specific grant
will be referred to as &#x201c;the committee&#x201d; in this description of the 2020 EIP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Shares
Subject to the Plan&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subject
to adjustment, our 2020 EIP currently authorizes the issuance or transfer of up to 14,000,000 shares of our common stock. In addition,
shares of common stock underlying any outstanding award granted under the Prior Plan that, following the effective date of the 2020 EIP,
expires, or is terminated, surrendered or forfeited for any reason without issuance of such shares shall be available for new grants
under the 2020 EIP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
any options or SARs expire or are canceled, forfeited, exchanged or surrendered without having been exercised, or if any stock awards,
stock units or other stock-based awards are forfeited, terminated or otherwise not paid in full, the shares of our common stock subject
to such awards will again be available for purposes of the 2020 EIP. If shares of our common stock are surrendered in payment of the
exercise price of an option, the number of shares of common stock available for issuance under the 2020 EIP will be reduced only by the
net number of shares actually issued by us upon such exercise and not by the gross number of shares as to which such option is exercised.
Upon the exercise of any SAR under the 2020 EIP, the number of shares of our common stock available for issuance will be reduced only
by the net number of shares actually issued by us upon such exercise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
shares of our common stock are withheld by us in satisfaction of the withholding taxes incurred in connection with the issuance, vesting
or exercise of any grant or the issuance of our common stock under the 2020 EIP, the number of shares of common stock available for issuance
will be reduced by the net number of shares issued, vested or exercised under such grant, calculated in each instance after payment of
such share withholding. If any awards are paid in cash, and not in shares of our common stock, any shares of our common stock subject
to such awards will also be available for future awards. If we repurchase shares of our common stock on the open market with the proceeds
from the exercise price we receive from options, the repurchased shares will not be available for issuance under the 2020 EIP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Individual
Limits for Non-Employee Directors&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
maximum aggregate grant date value of shares of common stock granted to any non-employee director in any one calendar year, taken together
with any cash fees earned by such non-employee director for services rendered during the calendar year, shall not exceed $250,000 in
total value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Adjustments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with stock splits, stock dividends, recapitalizations and certain other events affecting our common stock, the committee will
make adjustments as it deems appropriate in: the maximum number of shares of common stock reserved for issuance as grants; the maximum
amount of awards that may be granted to any individual non-employee director in any year; the number and kind of shares covered by outstanding
grants; the number and kind of shares that may be issued under the 2020 EIP; the price per share or market value of any outstanding grants;
the exercise price of options; the base amount of stock appreciation rights; and the performance goals or other terms and conditions
as the committee deems appropriate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Eligibility
and Vesting&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
of our employees are eligible to receive grants under the 2020 EIP. In addition, our non-employee directors and key advisors who perform
services for us may receive grants under the 2020 EIP. The committee determines the vesting and exercisability terms of awards granted
under the 2020 EIP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Options&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
our 2020 EIP, the committee determines the exercise price of the options granted and may grant options to purchase shares of our common
stock in such amounts as it determines. The committee may grant options that are intended to qualify as incentive stock options under
Section 422 of the Code, or non-qualified stock options, which are not intended to so qualify. Incentive stock options may only be granted
to our employees. Anyone eligible to participate in the 2020 EIP may receive a grant of non-qualified stock options. The exercise price
of a stock option granted under the 2020 EIP cannot be less than the fair market value of a share of our common stock on the date the
option is granted. If an incentive stock option is granted to a 10% stockholder of the total combined voting power of all classes of
our stock, the exercise price cannot be less than 110% of the fair market value of a share of our common stock on the date the option
is granted. The aggregate number of shares of common stock that may be issued or transferred under the 2020 EIP pursuant to incentive
stock options under Section 422 of the Code may not exceed 10% of the number of shares of common stock outstanding on the effective date
of the 2020 EIP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
exercise price for any option is generally payable in cash. In certain circumstances as permitted by the committee, the exercise price
may be paid: by the surrender of shares of our common stock with an aggregate fair market value, on the date the option is exercised,
equal to the exercise price; by payment through a broker in accordance with procedures established by the Federal Reserve Board; by withholding
shares of common stock subject to the exercisable option that have a fair market value on the date of exercise equal to the aggregate
exercise price; or by such other method as the committee approves.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
term of an option cannot exceed ten years from the date of grant, except that if an incentive stock option is granted to a 10% stockholder
of the total combined voting power of all class of our stock, the term cannot exceed five years from the date of grant. In the event
that on the last day of the term of a non-qualified stock option, the exercise is prohibited by applicable law, including a prohibition
on purchases or sales of our common stock under our insider trading policy, the term of the non-qualified option will be extended for
a period of 30 days following the end of the legal prohibition, unless the committee determines otherwise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Except
as provided in the grant instrument, an option may only be exercised while a participant is employed by or providing service to us. The
committee will determine in the grant instrument under what circumstances and during what time periods a participant may exercise an
option after termination of employment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Stock
Awards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the 2020 EIP, the committee may grant stock awards. A stock award is an award of our common stock that may be subject to restrictions
as the committee determines. The restrictions, if any, may lapse over a specified period of employment or based on the satisfaction of
pre-established criteria, in installments or otherwise, as the committee may determine, including, but not limited to, restrictions based
on the achievement of performance goals. Except to the extent restricted under the grant instrument relating to the stock award, a participant
will have all of the rights of a stockholder as to those shares, including the right to vote and the right to receive dividends or distributions
on the shares. Dividends with respect to stock awards that vest based on performance shall vest if and to the extent that the underlying
stock award vests, as determined by the committee. All unvested stock awards are forfeited if the participant&#x2019;s employment or service
is terminated for any reason, unless the committee determines otherwise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Stock
Units&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the 2020 EIP, the committee may grant stock units to anyone eligible to participate in the 2020 EIP. Stock units represent hypothetical
shares of our common stock. Stock units become payable on terms and conditions determined by the committee, including specified performance
goals, and will be payable in cash, shares of common stock, or a combination thereof, as determined by the committee. All unvested stock
units are forfeited if the participant&#x2019;s employment or service is terminated for any reason, unless the committee determines otherwise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Stock
Appreciation Rights&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the 2020 EIP, the committee may grant SARs, which may be granted separately or in tandem with any option. SARs granted in tandem with
a non-qualified stock option may be granted either at the time the non- qualified stock option is granted or any time thereafter while
the option remains outstanding. SARs granted in tandem with an incentive stock option may be granted only at the time the grant of the
incentive stock option is made. The committee will establish the base amount of the SAR at the time the SAR is granted, which will be
equal to or greater than the fair market value of a share of our common stock as of the date of grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
a SAR is granted in tandem with an option, the number of SARs that are exercisable during a specified period will not exceed the number
of shares of our common stock that the participant may purchase upon exercising the related option during such period. Upon exercising
the related option, the related SARs will terminate, and upon the exercise of a SAR, the related option will terminate to the extent
of an equal number of shares of our common stock. Generally, SARs may only be exercised while the participant is employed by, or providing
services to, us. When a participant exercises a SAR, the participant will receive the excess of the fair market value of the underlying
common stock over the base amount of the SAR. The appreciation of a SAR will be paid in shares of our common stock, cash or both.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
term of a SAR cannot exceed ten years from the date of grant. In the event that on the last day of the term of a SAR, the exercise is
prohibited by applicable law, including a prohibition on purchases or sales of our common stock under our insider trading policy, the
term of the SAR will be extended for a period of 30 days following the end of the legal prohibition, unless the committee determines
otherwise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Other
Stock-Based Awards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the 2020 EIP, the committee may grant other types of awards that are based on, or measured by, our common stock, and granted to anyone
eligible to participate in the 2020 EIP. The committee will determine the terms and conditions of such awards. Other stock-based awards
may be payable in cash, shares of our common stock or a combination of the two, as determined by the committee.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividend
Equivalents&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the 2020 EIP, the committee may grant dividend equivalents in connection with grants of stock units or other stock-based awards made
under the 2020 EIP. Dividend equivalents entitle the participant to receive amounts equal to ordinary dividends that are paid on the
shares underlying a grant while the grant is outstanding. The committee will determine whether dividend equivalents will be paid currently
or accrued as contingent cash obligations. Dividend equivalents may be paid in cash or shares of our common stock. The committee will
determine the terms and conditions of the dividend equivalent grants, including whether the grants are payable upon the achievement of
specific performance goals. Dividend equivalents with respect to stock units or other stock-based awards that vest based on performance
shall vest and be paid only if and to the extent that the underlying stock units or other stock-based awards vest and are paid as determined
by the committee.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Prohibition
on Repricing&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the terms of the 2020 EIP, the committee may not (i) amend the terms of any outstanding stock options or SARs to reduce the exercise
price or base price, as applicable, (ii) cancel outstanding stock options or SARs in exchange for stock options or SARs with an exercise
price or base price, as applicable, that is less than the exercise price or base price of the original stock options or SARs or (iii)
cancel outstanding stock options or SARs with an exercise price or base price, as applicable, above the current stock price in exchange
for cash or other securities, except in connection with a corporate transaction involving the Company, without in each such instance
obtaining the approval of our stockholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Change
of Control&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
we experience a change of control where we are not the surviving corporation (or survive only as a subsidiary of another corporation),
unless the committee determines otherwise, all outstanding grants that are not exercised or paid at the time of the change of control
will be assumed by, or replaced with grants (with respect to cash, securities or a combination thereof) that have comparable terms by,
the surviving corporation (or a parent or subsidiary of the surviving corporation).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unless
otherwise set forth in a grant instrument, if a participant is terminated without cause upon or within 12 months of a change of control,
all outstanding time-based awards shall become fully vested.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
there is a change of control and all outstanding grants are not assumed by, or replaced with grants that have comparable terms by the
surviving corporation, the committee may (but is not obligated to) make adjustments to the terms and conditions of outstanding grants,
including, without limitation, taking any of the following actions (or combination thereof) without the consent of any participant:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;determine
    that outstanding options and SARs will accelerate and become fully exercisable and the restrictions and conditions on outstanding
    stock awards, stock units and dividend equivalents immediately lapse; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;pay
    participants, in an amount and form determined by the committee, in settlement of outstanding stock units or dividend equivalents;
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;require
    that participants surrender their outstanding stock options and SARs in exchange for a payment by us, in cash or shares of our common
    stock, equal to the difference between the exercise price and the fair market value of the underlying shares of our common stock;
    provided, however, if the per share &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;fair
    market value of our common stock does not exceed the per share stock option exercise price or stock appreciation right base amount,
    as applicable, we will not be required to make any payment to the participant upon surrender of the stock option or stock appreciation
    right; or &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;after
    giving participants an opportunity to exercise all of their outstanding stock options and SARs, terminate any unexercised stock options
    and SARs on the date determined by the committee. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
general terms, a change of control under the 2020 EIP occurs if:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="text-align: justify; width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a
    person, entity or affiliated group, with certain exceptions, acquires more than 50% of our then- outstanding voting securities; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="text-align: justify; width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;we
    merge into another entity unless the holders of our voting shares immediately prior to the merger have at least 50% of the combined
    voting power of the securities in the merged entity or its parent; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="text-align: justify; width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;we
    merge into another entity and the members of our Board prior to the merger would not constitute a majority of the board of the merged
    entity or its parent; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="text-align: justify; width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;we
    sell or dispose of all or substantially all of our assets; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="text-align: justify; width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;we
    consummate a complete liquidation or dissolution; or &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="text-align: justify; width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a
    majority of the members of our Board is replaced during any 12-month period by directors whose appointment or election is not endorsed
    by a majority of the incumbent directors. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Deferrals&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
committee may permit or require participants to defer receipt of the payment of cash or the delivery of shares of common stock that would
otherwise be due to the participant in connection with a grant under the 2020 EIP. The committee will establish the rules and procedures
applicable to any such deferrals, consistent with the requirements of Section 409A of the Code.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Withholding&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
grants under the 2020 EIP are subject to applicable U.S. federal (including FICA), state and local, foreign or other tax withholding
requirements. We may require participants or other persons receiving grants or exercising grants to pay an amount sufficient to satisfy
such tax withholding requirements with respect to such grants, or we may deduct from other wages and compensation paid by us the amount
of any withholding taxes due with respect to such grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
committee may permit or require that our tax withholding obligation with respect to grants paid in our common stock be paid by having
shares withheld up to an amount that does not exceed the participant&#x2019;s minimum applicable withholding tax rate for United States
federal (including FICA), state and local tax liabilities, or as otherwise determined by the committee. In addition, the committee may,
in its discretion, and subject to such rules as the committee may adopt, allow participants to elect to have such share withholding applied
to all or a portion of the tax withholding obligation arising in connection with any particular grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Transferability&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Except
as permitted by the committee with respect to non-qualified stock options, only a participant may exercise rights under a grant during
the participant&#x2019;s lifetime. Upon death, the personal representative or other person entitled to succeed to the rights of the participant
may exercise such rights. A participant cannot transfer those rights except by will or by the laws of descent and distribution or, with
respect to grants other than incentive stock options, pursuant to a domestic relations order. The committee may provide in a grant instrument
that a participant may transfer non-qualified stock options and stock award to family members, or one or more trusts or other entities
for the benefit of or owned by family members, consistent with applicable securities laws.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Amendment;
Termination&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
Board may amend or terminate our 2020 EIP at any time, except that our stockholders must approve an amendment if such approval is required
in order to comply with the Code, applicable laws or applicable stock exchange requirements. Unless terminated sooner by our Board or
extended with stockholder approval, the 2020 EIP will terminate on the day immediately preceding the tenth anniversary of the effective
date of the 2020 EIP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Stockholder
Approval&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Except
in connection with certain corporate transactions, including stock dividends, stock splits, a recapitalization, a change in control,
a reorganization, a merger and a spin-off, stockholder approval is required (i) to reduce the exercise price or base price of outstanding
stock options or SARs, (ii) to cancel outstanding stock options or SARs in exchange for the same type of grant with a lower exercise
price or base price, and (iii) to cancel outstanding stock options or SARs that have an exercise price or base price above the current
price of a share of our common stock, in exchange for cash or other securities, each as applicable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Establishment
of Sub-Plans&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
Board may, from time to time, establish one or more sub-plans under the 2020 EIP to satisfy applicable blue sky, securities or tax laws
of various jurisdictions. Our Board may establish such sub-plans by adopting supplements to the 2020 EIP setting forth limitations on
the committee&#x2019;s discretion and such additional terms and conditions not otherwise inconsistent with the 2020 EIP as our Board deems
necessary or desirable. All such supplements will be deemed part of the 2020 EIP, but each supplement will only apply to participants
within the affected jurisdiction, and we will not be required to provide copies of any supplement to such unaffected participants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Clawback&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subject
to applicable law, the committee may provide in any grant instrument that if a participant breaches any restrictive covenant agreement
between the participant and us, or otherwise engages in activities that constitute cause (as defined in the 2020 EIP) either while employed
by, or providing services to, us or within a specified period of time thereafter, all grants held by the participant will terminate,
and we may rescind any exercise of an option or stock appreciation right and the vesting of any other grant and delivery of shares upon
such exercise or vesting, as applicable on such terms as the committee will determine, including the right to require that in the event
of any rescission:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
    participant must return the shares received upon the exercise of any option or stock appreciation right or the vesting and payment
    of any other grants; or &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if
    the participant no longer owns the shares, the participant must pay to us the amount of any gain realized or payment received as
    a result of any sale or other disposition of the shares (if the participant transferred the shares by gift or without consideration,
    then the fair market value of the shares on the date of the breach of the restrictive covenant agreement or activity constituting
    cause), net of the price originally paid by the participant for the shares. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
committee may also provide for clawbacks pursuant to a clawback policy, which our Board may in the future adopt and amend from time to
time. Payment by the participant will be made in such manner and on such terms and conditions as may be required by the committee. We
will be entitled to set off against the amount of any such payment any amounts that we otherwise owe to the participant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Certain
United States Federal Income Tax Aspects&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following is a summary of certain U.S. federal income tax consequences of awards under the 2020 EIP. It does not purport to be a complete
description of all applicable rules, and those rules (including those summarized here) are subject to change.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Options&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
optionee generally will not recognize taxable income upon the grant of a non-statutory option. Rather, at the time of exercise of the
option, the optionee will recognize ordinary income for income tax purposes in an amount equal to the excess, if any, of the fair market
value of the shares purchased over the exercise price. We generally will be entitled to a tax deduction at such time and in the same
amount, if any, that the optionee recognizes as ordinary income. The optionee&#x2019;s tax basis in any shares received upon exercise
of an option will be the fair market value of the shares on the date of exercise, and if the shares are later sold or exchanged, then
the difference between the amount received upon such sale or exchange and the fair market value of such shares on the date of exercise
will generally be taxable as long-term or short-term capital gain or loss (if the shares are a capital asset of the optionee) depending
upon the length of time such shares were held by the optionee.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Incentive
stock options are eligible for favorable U.S. federal income tax treatment if certain requirements are satisfied. An incentive stock
option must have an option price that is not less than the fair market value of the stock at the time the option is granted and must
be exercisable within ten years from the date of grant. An employee granted an incentive stock option generally does not realize compensation
income for U.S. federal income tax purposes upon the grant of the option. At the time of exercise of an incentive stock option, no compensation
income is realized by the optionee other than tax preference income for purposes of the federal alternative minimum tax on individual
income. If the shares acquired on exercise of an incentive stock option are held for at least two years after grant of the option and
one year after exercise, the excess of the amount realized on the sale over the exercise price will be taxed as capital gain. If the
shares acquired on exercise of an incentive stock option are disposed of within less than two years after grant or one year of exercise,
the optionee will realize taxable compensation income equal to the lesser of (i) the excess of the fair market value of the shares on
the date of exercise over the option price or (ii) the excess of the amount realized on the sale over the option price. Any additional
amount realized will be taxed as capital gain.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Stock
Awards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
participant generally will not be taxed upon the grant of stock awards subject to restrictions, but rather will recognize ordinary income
in an amount equal to the fair market value of the shares at the time the shares are no longer subject to a &#x201c;substantial risk of
forfeiture&#x201d; (within the meaning of the Code). We generally will be entitled to a deduction at the time when, and in the amount
that, the participant recognizes ordinary income on account of the lapse of the restrictions. A participant&#x2019;s tax basis in the
shares will equal their fair market value at the time the restrictions lapse, and the participant&#x2019;s holding period for capital
gains purposes will begin at that time. Any cash dividends paid on the restricted stock before the restrictions lapse will be taxable
to the participant as additional compensation (and not as dividend income). Under Section 83(b) of the Code, a participant may elect
to recognize ordinary income at the time the shares of stock are awarded in an amount equal to their fair market value at that time,
notwithstanding the fact that such shares of stock are subject to restrictions and a substantial risk of forfeiture. If such an election
is made, no additional taxable income will be recognized by such participant at the time the restrictions lapse, the participant will
have a tax basis in the shares equal to their fair market value on the date of their award, and the participant&#x2019;s holding period
for capital gains purposes will begin at that time. We generally will be entitled to a tax deduction at the time when, and to the extent
that, ordinary income is recognized by such participant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Stock
Units&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
general, the grant of stock units will not result in income for the participant or in a tax deduction for us. Upon the settlement of
such an award in cash or shares, the participant will recognize ordinary income equal to the aggregate value of the payment received,
and we generally will be entitled to a tax deduction at the same time and in the same amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Stock
Appreciation Rights&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
participant who is granted a SAR generally will not recognize ordinary income upon receipt of the SAR. Rather, at the time of exercise
of such SAR, the participant will recognize ordinary income for U.S. federal income tax purposes in an amount equal to the value of any
cash received and the fair market value on the date of exercise of any shares received. We generally will be entitled to a tax deduction
at such time and in the same amount, if any, that the participant recognizes as ordinary income. The participant&#x2019;s tax basis in
any shares received upon exercise of a SAR will be the fair market value of the shares on the date of exercise, and if the shares are
later sold or exchanged, then the difference between the amount received upon such sale or exchange and the fair market value of such
shares on the date of exercise will generally be taxable as long-term or short- term capital gain or loss (if the shares are a capital
asset of the participant) depending upon the length of time such shares were held by the participant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Other
Awards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;With
respect to other stock-based awards granted under the 2020 EIP, generally when the participant receives payment with respect to an award,
the amount of cash and/or the fair market value of any shares or other property received will be ordinary income to the participant,
and we generally will be entitled to a tax deduction at the same time and in the same amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Impact
of Section 409A&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Section
409A of the Code applies to deferred compensation, which is generally defined as compensation earned currently, the payment of which
is deferred to a later taxable year. Awards under the 2020 EIP are intended to be exempt from the requirements of Section 409A or to
satisfy its requirements. An award that is subject to Section 409A and fails to satisfy its requirements will subject the holder of the
award to immediate taxation, interest and an additional 20% tax on the vested amount underlying the award.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
162(m) of the Code&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prior
to 2018, Section 162(m) of the Code imposed a $1 million limit on the amount a public company may deduct for compensation paid to a company&#x2019;s
chief executive officer or any of the company&#x2019;s three other most highly compensated executive officers (other than the chief financial
officer) who are employed as of the end of the year. This limitation did not apply to compensation that meets the tax code requirements
for &#x201c;qualifying performance-based&#x201d; compensation (i.e., compensation paid only if the individual&#x2019;s performance meets
pre- established objective goals based on performance criteria approved by stockholders, including stock options).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
performance-based compensation exemption and the exemption of the chief financial officer from Section 162(m)&#x2019;s deduction limit
have been repealed, among other changes, effective for taxable years beginning after December 31, 2017, such that awards paid to our
covered executive officers (including our chief executive officer) in excess of $1 million will not be deductible in future years, unless
it qualifies for transition relief applicable to certain arrangements that were in effect as of November 2, 2017 and are not materially
modified thereafter.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
in prior years, while deductibility of executive compensation for federal income tax purposes is among the factors the committee considers
when structuring our executive compensation arrangements, it is not the sole or primary factor considered. We retain the flexibility
to authorize compensation that may not be deductible if we believe it is in the best interests of the company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Existing
Plan Benefits&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Future
benefits under the 2020 EIP generally are granted at the discretion of the committee and are therefore not currently determinable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Because
future grants of awards under the 2020 EIP are subject to the discretion of the Board or Compensation Committee, the amount and terms
of future awards to particular participants or groups of participants are not determinable at this time. No awards have been previously
granted that are contingent on the approval of this amendment to the 2020 EIP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Vote
Required for Approval&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
proposal to amend the 2020 EIP will be approved upon the affirmative vote of a majority of the outstanding shares of common stock present
through virtual attendance or by proxy at the Meeting and entitled to vote on the proposal. Stockholders may vote &#x201c;FOR&#x201d; or
&#x201c;AGAINST,&#x201d; or &#x201c;ABSTAIN&#x201d; from voting. Abstentions will have the effect of a vote &#x201c;AGAINST&#x201d; this proposal.
Broker non-votes, if any, will be disregarded and will have no effect on the outcome of the vote for this Proposal 2.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Board
Recommendation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;The
Board recommends that the stockholders vote &#x201c;FOR&#x201d; the approval of the amendment to the Kopin Corporation 2020 Equity Incentive
Plan to increase the number of shares available by 5,000,000.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
existence of financial and personal interests of one or more of Kopin Corporation directors may result in a conflict of interest on the
part of such director(s) between what he, she or they may believe is in the best interests of Kopin Corporation and its stockholders
and what he, she or they may believe is best for himself, herself or themselves in determining to recommend that stockholders vote for
the proposals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PROPOSAL
3&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;APPROVAL
OF THE AMENDMENT TO THE COMPANY&#x2019;S AMENDED AND RESTATED&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED COMMON&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARES FROM 200,000,000 TO 275,000,000&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
Board has approved the amendment to our Certificate of Incorporation, subject to stockholder approval, to increase the number of
authorized shares of common stock from 200,000,000 shares to 275,000,000 shares (the &#x201c;Share Increase Amendment&#x201d;) and
recommends unanimously that our stockholders approve the Share Increase Amendment. The proposed amendment is reflected in the
proposed amendment to the Certificate of Incorporation attached to this proxy statement as Appendix B. As of May 1, 2025,
there were 162,797,922 shares of common stock issued and outstanding and the Company had warrants and options outstanding to
acquire 10,591,366 shares of its common stock, leaving a total of 26,610,712 authorized shares of common stock available for
future issuance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
additional 75,000,000 shares of common stock will be part of the existing class of common stock, and, if and when issued, would have
the same rights and privileges as the shares of common stock presently issued and outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s Certificate of Incorporation was amended on June 11, 2024 to increase the number of authorized shares of common stock
to 200,000,000.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Board believes that it is desirable and in the best interests of the Company and its shareholders to have a sufficient number of additional
shares of common stock available for issuance from time to time, as the occasion may arise, for future financing and acquisition transactions,
to permit stock dividends or stock splits at some future date, and for other proper corporate purposes. Therefore, the Board has approved,
and unanimously recommends that the stockholders of the Company approve the Share Increase Amendment. The proposed form of the Articles
of Amendment to the Company&#x2019;s Certificate of Incorporation amending Article &#x201c;FOURTH&#x201d; of such Certificate of Incorporation
is set forth in Appendix A to this proxy statement. The Articles of Amendment will have no effect on the number of authorized shares
of preferred stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Certain
Risks Associated with the Share Increase Amendment&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
market price of our common stock will also be based on our performance and other factors, some of which are unrelated to the number of
shares outstanding. These factors include the status of the market for our common stock, our reported results of operations in future
periods, and general economic, market and industry conditions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Principal
Effects on Outstanding Common Stock&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Holders
of common stock are entitled to one vote per share on all matters submitted to a vote of stockholders. Upon a liquidation, dissolution
or windup of the Company, holders of common stock would be entitled to share ratably in any assets for distribution to stockholders after
payment of all of the Company&#x2019;s obligations, subject to the rights to receive preferential distributions of the holders of any
preferred stock then outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
additional shares of common stock would have rights identical to our common stock currently outstanding. Approval of the Share Increase
Amendment and any issuance of common stock would not affect the rights of the holders of our common stock currently outstanding, except
to the extent that future issuances of common stock would reduce each existing stockholder&#x2019;s proportionate ownership. If the proposed
Share Increase Amendment is approved and the Board decides to issue such shares of common stock, such issuance of common stock would
increase the outstanding number of shares of common stock, thereby causing dilution in earnings per share and voting interests of the
outstanding common stock. As of May 1, 2025, 162,797,922 shares of our common stock were issued and outstanding and we
had warrants and options outstanding to acquire 10,591,366 shares of our common stock. We had no other shares of our common stock subject
to outstanding stock options or other convertible securities, thereby leaving 26,610,712 shares of common stock unassigned and
authorized for potential issuance of the current 200,000,000 shares of common stock authorized. If the Share Increase Amendment is approved,
there will be 101,610,712 shares of common stock unassigned and authorized for potential issuance. If approved, the Share Increase
Amendment will not change the number of shares of preferred stock authorized for issuance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additionally,
the issuance of additional shares of common stock could have the effect of making it more difficult for a third party to acquire, or
discouraging a third party from attempting to acquire, control of the Company. While the issuance of additional shares of common stock
may be deemed to have potential anti-takeover effects, including by delaying or preventing a change in control of the Company through
subsequent issuances of these shares and the other reasons set forth above, which among other things, could include issuances in one
or more transactions that would make a change in control of the Company more difficult, and therefore, less likely, this proposal to
increase the authorized common stock is not prompted by any specific effort of which we are aware to accumulate shares of our common
stock or obtain control of the Company. A takeover may be beneficial to independent stockholders because, among other reasons, a potential
suitor may offer such stockholders a premium for their shares of common stock as compared to the then-existing market price. Although
the issuance of additional shares of common stock could, under certain circumstances, have an anti-takeover effect, this proposal to
adopt the Share Increase Amendment is not in response to any attempt to accumulate common stock or obtain control of the Company that
we are aware of, nor is it part of a plan by management to recommend a series of similar amendments to the Board or stockholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Interests
of Certain Persons in the Proposal&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
directors and executive officers have no substantial interests, directly or indirectly, in the matters set forth in this Proposal 3,
except to the extent of their ownership in shares of our common stock and securities convertible or exercisable for common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Vote
Required for Approval&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
approval of the Shares Increase Amendment requires the affirmative vote of a majority of the Company&#x2019;s outstanding stock entitled
to vote thereon.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Board
Recommendation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;The
Board recommends that the stockholders vote &#x201c;FOR&#x201d; the proposal to approve an amendment to the Company&#x2019;s Certificate
of Incorporation to increase the number of authorized shares of common stock to 275,000,000.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PROPOSAL
4&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;RATIFICATION
OF APPOINTMENT OF ACCOUNTANTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 2, 2024, the Audit Committee appointed BDO USA, P.C. (&#x201c;BDO&#x201d;) as our independent registered public accounting firm
for the fiscal year ending December 27, 2025. The Audit Committee is seeking ratification of this selection by our stockholders at the Annual Meeting.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RSM
US LLP (RSM), served as the Company&#x2019;s independent registered public accounting firm of the Company from November 22,
2019 until December 2, 2024. On December 2, 2024, the Board approved the engagement of BDO as our independent registered public
accounting firm, effective upon the execution of a satisfactory engagement letter with BDO and dismissed our prior independent registered
public accounting firm, RSM, effective immediately prior to the engagement of BDO. RSM&#x2019;s audit reports on our consolidated financial
statements for the fiscal years ended December 30, 2023 and December 31, 2022 did not contain any adverse opinion or disclaimer of opinion
and were not qualified or modified as to uncertainty, audit scope, or accounting principles.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
representative of BDO is expected to be present at the Meeting and will be afforded an opportunity to make a statement, if such
representative desires to do so, and will be available to respond to appropriate questions. &lt;/span&gt;Furthermore, a representative of
RSM is expected to be present at the Meeting and will be afforded an opportunity to make a statement, if such representative desires
to do so, and will be available to respond to appropriate questions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;RSM&#x2019;s audit reports
on our consolidated financial statements for the fiscal years ended December 30, 2023 and December 31, 2022 did not contain any adverse
opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principles. During
the fiscal years ended December 30, 2023 and December 31, 2022, and the subsequent interim period through the date of our engagement
of BDO on December 2, 2024, neither the Company, nor anyone acting on our behalf, consulted with BDO regarding any of the matters described
in Items 304(a)(2)(i) and (ii) of Regulation S-K.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;During the two most recent
fiscal years ended December 30, 2023 and December 31, 2022, and the subsequent interim period through their dismissal on December 2,
2024: (i) there were no disagreements within the meaning of Item 304(a)(1)(iv) of Regulation S-K between us and RSM on any matter of
accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved
to RSM&#x2019;s satisfaction, would have caused RSM to make reference to the subject matter of the disagreements in connection with its
reports on our consolidated financial statements for such years, and (ii) no reportable events within the meaning of Item 304(a)(1)(v)
of Regulation S-K.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Vote
Required for Approval&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 40pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
affirmative vote of the holders of a majority of the shares of our common stock represented in person or by proxy at the Meeting and
entitled to vote is required to ratify the appointment of BDO as our independent registered public accounting firm for the current
fiscal year ending December 27, 2025. Although stockholder ratification is not required by our bylaws or otherwise, the Board believes
it is advisable to provide stockholders an opportunity to ratify this selection and is submitting the selection of BDO as our independent
registered public accounting firm to our stockholders for ratification as a matter of good corporate practice.  In the event the appointment of BDO should not be approved by the stockholders, the Board will consider making
another appointment to be effective at the earliest possible time but has no obligation to do so. Any broker non-votes and abstentions
from voting received will have no effect on the outcome of this Proposal 4.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Board
Recommendation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;The
Board recommends that the stockholders vote &#x201c;FOR&#x201d; the proposal to ratify the appointment of BDO USA, P.C. as our independent
registered public accounting firm for the fiscal year ending December 27, 2025.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Proxies
solicited by the Board will be voted &#x201c;FOR&#x201d; this Proposal 4.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PRINCIPAL
ACCOUNTANT FEES AND SERVICES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
discussed above, BDO has served as the Company&#x2019;s independent registered public accounting firm since December 2, 2024. Previously,
RSM served as the Company&#x2019;s independent registered public accounting firm from November 22, 2019 to December 2, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Audit
Fees&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
aggregate fees for the fiscal years ended December 28, 2024 and December 30, 2023 billed by the Company&#x2019;s independent registered
public accounting firm, BDO USA, P.C. for fiscal year 2024 and RSM US LLP for fiscal year 2023 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Fee Category&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;% of Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;% of Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: left"&gt;Audit Fees&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,038,950&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;620,124&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;99.9&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Audit-Related Fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;152,250&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Tax Fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,453&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;All Other Fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total Fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,049,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;780,827&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Audit
Fees&lt;/i&gt;&#x2014;consists of fees for the audit of our financial statements and attestation services relating to the report on our internal
controls in accordance with Section 404 of the Sarbanes-Oxley Act of 2002, review of the interim condensed consolidated financial statements
included in quarterly reports, assistance with review of documents filed with the SEC, and services that are normally provided by the
Company&#x2019;s independent registered public accounting firm in connection with statutory and regulatory filings or engagements, and
attestation services, except those not required by statute or regulation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Audit-Related
Fees&lt;/i&gt;&#x2014;consists of fees for assurance and related services that are reasonably related to the performance of the audit or review
of our consolidated financial statements and are not reported under &#x201c;Audit Fees.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Tax
Fees&lt;/i&gt;&#x2014;consists of fees for tax compliance and planning services. Tax compliance includes fees for professional services related
to international tax compliance and preparation. Tax planning consists primarily of fees related to a transfer pricing study and preparation
of our subsidiary tax returns.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;All
Other Fees&lt;/i&gt;&#x2014;consists of fees for all other permissible services other than those reported above.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Policy
on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of Independent Registered Public Accounting Firm&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Audit Committee pre-approves all audit and non-audit services provided by the Company&#x2019;s independent registered public accounting
firm prior to the engagement with respect to such services. The Chairman of the Audit Committee has been delegated the authority by the
Audit Committee to pre-approve the engagement of the independent accountants when the entire committee is unable to do so. The Audit
Committee approved 100% of the services listed under the preceding captions &#x201c;Audit Fees,&#x201d; &#x201c;Audit-Related Fees,&#x201d;
&#x201c;Tax Fees&#x201d; and &#x201c;All Other Fees.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PROPOSAL
5&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;ADVISORY
NON-BINDING VOTE ON COMPENSATION OF NAMED EXECUTIVE OFFICERS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with Section 951 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, as well as the provisions of Section 14A
of the Exchange Act, we are providing our stockholders the opportunity to vote on a non-binding, advisory resolution to approve the compensation
of our named executive officers, which is described in the section titled &#x201c;Compensation Discussion and Analysis&#x201d; in this
Proxy Statement. Accordingly, the following resolution will be submitted for a stockholder vote at the 2025 Annual Meeting:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x201c;RESOLVED,
that the stockholders of Kopin Corporation (the &#x201c;Company&#x201d;) approve, on an advisory basis, the overall compensation of the
Company&#x2019;s named executive officers, as described in the Compensation Discussion and Analysis section set forth in the Proxy Statement
for this Annual Meeting.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
described in the section titled &#x201c;Compensation Discussion and Analysis,&#x201d; our executive compensation program is designed to
provide a competitive level of compensation necessary to attract, motivate and retain talented and experienced executives and to motivate
them to achieve short-term and long-term corporate goals that enhance stockholder value. In order to align executive pay with our financial
performance and the creation of sustainable stockholder value, a significant portion of compensation paid to our named executive officers
is allocated to performance-based, short- and long-term incentive programs to make executive pay dependent on our performance (or &#x201c;at-risk&#x201d;).
In addition, as an executive officer&#x2019;s responsibility and ability to affect our financial results increases, the portion of his
or her total compensation deemed &#x201c;at-risk&#x201d; increases. Stockholders are urged to read the &#x201c;Compensation Discussion and
Analysis&#x201d; section of this Proxy Statement, which more thoroughly discusses how our compensation policies and procedures implement
our compensation philosophy. The Compensation Committee and the Board believe that these policies and procedures are effective in implementing
our compensation philosophy and in achieving its goals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
provide our stockholders the opportunity every year to vote on a non-binding, advisory basis to approve the compensation of our named
executive officers. The Company expects that the next advisory vote on executive compensation will be at the 2026 Annual Meeting of Stockholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;This
vote is merely advisory and will not be binding upon the Company or the Board. However, the Board values constructive dialogue on executive
compensation and other important governance topics with our stockholders and encourages all stockholders to vote their shares on this
matter.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Vote
Required for Approval&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Proposal
5 will be approved upon the affirmative vote of a majority of shares present in person or represented by proxy at the Meeting and entitled
to vote on each such proposal. Abstentions will be counted for Proposal 5 and will have the same effect as a vote against the proposal.
Broker non-votes, if any, will be disregarded and will have no effect on the outcome of the vote of this Proposal 5.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Board
Recommendation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;The
Board recommends that the stockholders vote to approve, on an advisory basis, the overall compensation of the Company&#x2019;s named executive
officers by voting &#x201c;FOR&#x201d; this resolution.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;COST
AND METHOD OF SOLICITATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
will pay the cost of soliciting proxies. Proxies may be solicited on behalf of the Company by directors, officers or employees of the
Company in person or by telephone, facsimile or other electronic means. As required by the SEC, we also will reimburse brokerage firms
and other custodians, nominees and fiduciaries for their expenses incurred in sending proxies and proxy materials to beneficial owners
of our common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GENERAL&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
are not aware of any other matter other than the foregoing to be brought before the Meeting. However, the enclosed proxy gives discretionary
authority to the named proxies in the event any additional matters should be presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
will provide free of charge to any stockholder from whom a proxy is solicited pursuant to this proxy statement, upon written request
from such stockholder, our Annual Reports on Form 10-K for the fiscal years 2024 and 2023 as filed with the SEC. Our 2024 Annual Report
on Form 10-K is enclosed. Only one copy of the Annual Report and this proxy statement and notice of annual meeting is being delivered
to multiple stockholders sharing one address, unless we have received contrary instructions. Upon written or oral request, we will deliver
promptly a separate copy to a stockholder at a shared address to which a copy was delivered. If you received more than one copy of the
proxy statement and wish to reduce the number of reports you receive, we will discontinue the mailing of reports on the accounts you
select. Requests for the foregoing should be directed to Kopin Corporation, 125 North Drive, Westborough MA 01581, Attention: Chief Financial
Officer, 508-870-5959.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;MISCELLANEOUS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Your
vote is important. Whether or not you plan to attend the Annual Meeting, we hope you will vote in advance so that your vote will be counted
if you later decide not to attend the Annual Meeting.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;You
may obtain a copy of our Annual Report on Form 10-K (without exhibits) filed with the SEC for the year ended December 28, 2024, without
charge upon written request to: Kopin Corporation, 125 North Drive, Westborough MA 01581, Attention: Chief Financial Officer, 508-870-5959.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of the date of this proxy statement, we know of no matter not specifically referred to above as to which any action is expected to be
taken at the Annual Meeting. The persons named as proxies will vote the proxies, insofar as they are not otherwise instructed, regarding
such other matters and the transaction of such other business as may be properly brought before the Annual Meeting, as they determine
to be in the best interest of the Company and our stockholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 50%"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Michael
    Murray&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chairman&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Appendix
A&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;KOPIN
CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2020
EQUITY INCENTIVE PLAN&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
as of the Effective Date (as defined below), the Kopin Corporation 2020 Incentive Equity Plan (as in effect from time to time, the &#x201c;Plan&#x201d;)
is hereby established.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
purpose of the Plan is to provide employees of Kopin Corporation, a Delaware corporation (together with its successors, the &#x201c;Company&#x201d;),
and its subsidiaries, certain consultants and advisors who perform services for the Company or its subsidiaries, and non-employee members
of the Board of Directors of the Company, with the opportunity to receive grants of incentive stock options, nonqualified stock options,
stock appreciation rights, stock awards, stock units, and other stock-based awards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company believes that the Plan will encourage the participants to contribute materially to the growth of the Company, thereby benefitting
the Company&#x2019;s stockholders, and will align the economic interests of the participants with those of the stockholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Plan is a successor to the Kopin Corporation 2010 Equity Incentive Plan, as amended and restated (the &#x201c;Prior Plan&#x201d;). No additional
grants shall be made under the Prior Plan after the Effective Date. Outstanding grants under the Prior Plan shall continue in effect
according to their terms, consistent with the applicable terms of the Prior Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
1. Definitions&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following terms shall have the meanings set forth below for purposes of the Plan:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &#x201c;&lt;span style="text-decoration: underline"&gt;Board&#x201d; &lt;/span&gt;shall
mean the Board of Directors of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &#x201c;&lt;span style="text-decoration: underline"&gt;Cause&lt;/span&gt;&#x201d;
shall have the meaning given to that term in any written employment agreement, offer letter or severance agreement between the Employer
and the Participant, or if no such agreement exists or if such term is not defined therein, and unless otherwise defined in the Grant
Instrument, Cause shall mean a finding by the Committee that the Participant (i) has breached his or her employment or service contract
with the Employer, (ii) has engaged in disloyalty to the Employer, including, without limitation, fraud, embezzlement, theft, commission
of a felony or proven dishonesty, (iii) has disclosed trade secrets or confidential information of the Employer to persons not entitled
to receive such information, (iv) has breached any written non-competition, non-solicitation, invention assignment or confidentiality
agreement between the Participant and the Employer or (v) has engaged in such other behavior detrimental to the interests of the Employer
as the Committee determines.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c) &#x201c;&lt;span style="text-decoration: underline"&gt;CEO&#x201d;
&lt;/span&gt;shall mean the Chief Executive Officer of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d) Unless
otherwise set forth in a Grant Instrument, a &#x201c;&lt;span style="text-decoration: underline"&gt;Change of Control&lt;/span&gt;&#x201d; shall be deemed to have occurred if:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i) Any
&#x201c;person&#x201d; (as such term is used in sections 13(d) and 14(d) of the Exchange Act) becomes a &#x201c;beneficial owner&#x201d;
(as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing more than 50% of
the voting power of the then outstanding securities of the Company; provided that a Change of Control shall not be deemed to occur as
a result of a transaction in which the Company becomes a direct or indirect subsidiary of another Person and in which the stockholders
of the Company, immediately prior to the transaction, will beneficially own, immediately after the transaction, shares of such other
Person representing more than 50% of the voting power of the then outstanding securities of such other Person.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii) The
consummation of (A) a merger or consolidation of the Company with another Person where, immediately after the merger or consolidation,
the stockholders of the Company, immediately prior to the merger or consolidation, will not beneficially own, in substantially the same
proportion as ownership immediately prior to the merger or consolidation, shares entitling such stockholders to more than 50% of all
votes to which all stockholders of the surviving Person would be entitled in the election of directors, or where the members of the Board,
immediately prior to the merger or consolidation, will not, immediately after the merger or consolidation, constitute a majority of the
board of directors of the surviving Person or (B) a sale or other disposition of all or substantially all of the assets of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iii) A
change in the composition of the Board over a period of 12 consecutive months or less such that a majority of the Board members ceases,
by reason of one or more contested elections, or threatened election contests, for Board membership, to be comprised of individuals who
either (A) have been Board members continuously since the beginning of such period or (B) have been elected or nominated for election
as Board members during such period by at least a majority of the Board members described in clause (A) who were still in office at the
time the Board approved such election or nomination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iv) The
consummation of a complete dissolution or liquidation of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Committee may modify the definition of Change of Control for a particular Grant as the Committee deems appropriate to comply with section
409A of the Code or otherwise. Notwithstanding the foregoing, if a Grant constitutes deferred compensation subject to section 409A of
the Code and the Grant provides for payment upon a Change of Control, then, for purposes of such payment provisions, no Change of Control
shall be deemed to have occurred upon an event described in items (i) &#x2013; (iv) above unless the event would also constitute a change
in ownership or effective control of, or a change in the ownership of a substantial portion of the assets of, the Company under section
409A of the Code.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(e) &#x201c;&lt;span style="text-decoration: underline"&gt;Code&lt;/span&gt;&#x201d;
shall mean the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(f) &#x201c;&lt;span style="text-decoration: underline"&gt;Committee&lt;/span&gt;&#x201d;
shall mean the Compensation Committee of the Board or another committee appointed by the Board to administer the Plan. The Committee
shall consist of directors who are &#x201c;non-employee directors&#x201d; as defined under Rule 16b-3 promulgated under the Exchange Act
and &#x201c;independent directors,&#x201d; as determined in accordance with the independence standards established by the stock exchange
on which the Company Stock is at the time primarily traded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(g) &#x201c;&lt;span style="text-decoration: underline"&gt;Company
Stock&lt;/span&gt;&#x201d; shall mean common stock, par value $0.01 per share, of the Company, and such other securities as may be substituted
for Company Stock pursuant to Section 4(c).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(h) &#x201c;&lt;span style="text-decoration: underline"&gt;Disability&lt;/span&gt;&#x201d;
or &#x201c;&lt;span style="text-decoration: underline"&gt;Disabled&lt;/span&gt;&#x201d; shall mean, unless otherwise set forth in the Grant Instrument, a Participant&#x2019;s becoming disabled
within the meaning of the Employer&#x2019;s long-term disability plan applicable to the Participant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i) &#x201c;&lt;span style="text-decoration: underline"&gt;Dividend
Equivalent&lt;/span&gt;&#x201d; shall mean an amount determined by multiplying the number of shares of Company Stock subject to a Stock Unit or
Other Stock-Based Award by the per-share cash dividend paid by the Company on its outstanding Company Stock, or the per-share Fair Market
Value of any dividend paid on its outstanding Company Stock in consideration other than cash. If interest is credited on accumulated
divided equivalents, the term &#x201c;Dividend Equivalent&#x201d; shall include the accrued interest.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(j) &#x201c;&lt;span style="text-decoration: underline"&gt;Effective
Date&lt;/span&gt;&#x201d; shall mean the date of the Annual Meeting of Stockholders to be held on May 20, 2020 or such other date upon which the
Company&#x2019;s stockholders approve the Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(k) &#x201c;&lt;span style="text-decoration: underline"&gt;Employee&lt;/span&gt;&#x201d;
shall mean an employee of the Employer (including an officer or director who is also an employee), but excluding any person who is classified
by the Employer as a &#x201c;contractor&#x201d; or &#x201c;consultant,&#x201d; no matter how characterized by the Internal Revenue Service,
other governmental agency or a court. Any change of characterization of an individual by the Internal Revenue Service or any court or
government agency shall have no effect upon the classification of an individual as an Employee for purposes of this Plan, unless the
Committee determines otherwise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(l) &#x201c;&lt;span style="text-decoration: underline"&gt;Employed
by, or providing service to, the Employer&lt;/span&gt;&#x201d; shall mean employment or service as an Employee, Key Advisor or member of the Board
(so that, for purposes of exercising Options and SARs and satisfying conditions with respect to Stock Awards, Stock Units, and Other
Stock-Based Awards, a Participant shall not be considered to have terminated employment or service until the Participant ceases to be
an Employee, Key Advisor and member of the Board), unless the Committee determines otherwise. If a Participant&#x2019;s relationship is
with a subsidiary of the Company and that entity ceases to be a subsidiary of the Company, the Participant will be deemed to cease employment
or service when the entity ceases to be a subsidiary of the Company, unless the Participant transfers employment or service to an Employer.
If a Participant has military, sick leave or other bona fide leave, the Participant will not be deemed to cease employment or service
solely as a result of such leave; provided that such leave does not exceed the longer of 90 days or the period during which the absent
Participant&#x2019;s reemployment rights, if any, are guaranteed by statute or contract. To the extent consistent with applicable law,
the Committee may provide that Grants continue to vest for all or a portion of the period of such leave, or that vesting shall be tolled
during such leave and only recommence upon the Participant&#x2019;s return from such leave.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(m) &#x201c;&lt;span style="text-decoration: underline"&gt;Employer&lt;/span&gt;&#x201d;
shall mean the Company and its subsidiaries.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(n) &#x201c;&lt;span style="text-decoration: underline"&gt;Exchange
Act&#x201d;&lt;/span&gt; shall mean the Securities Exchange Act of 1934, as amended.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(o) &#x201c;&lt;span style="text-decoration: underline"&gt;Exercise
Price&lt;/span&gt;&#x201d; shall mean the per share price at which shares of Company Stock may be purchased under an Option, as designated by the
Committee.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(p) &#x201c;&lt;span style="text-decoration: underline"&gt;Fair
Market Value&#x201d;&lt;/span&gt; shall mean:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i) If
the Company Stock is publicly traded, the Fair Market Value per share shall be determined as follows: (A) if the principal trading market
for the Company Stock is a national securities exchange, the closing sales price during regular trading hours on the relevant date or,
if there were no trades on that date, the latest preceding date upon which a sale was reported, or (B) if the Company Stock is not principally
traded on any such exchange, the last reported sale price of a share of Company Stock during regular trading hours on the relevant date,
as reported by the OTC Bulletin Board.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii) If
the Company Stock is not publicly traded or, if publicly traded, is not subject to reported transactions as set forth above, the Fair
Market Value per share shall be determined by the Committee through any reasonable valuation method authorized under the Code.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(q) &#x201c;&lt;span style="text-decoration: underline"&gt;GAAP&lt;/span&gt;&#x201d;
shall mean United States generally accepted accounting principles.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(r) &#x201c;&lt;span style="text-decoration: underline"&gt;Grant&lt;/span&gt;&#x201d;
shall mean an Option, SAR, Stock Award, Stock Unit or Other Stock-Based Award granted under the Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(s) &#x201c;&lt;span style="text-decoration: underline"&gt;Grant
Instrument&lt;/span&gt;&#x201d; shall mean the written agreement that sets forth the terms and conditions of a Grant, including all amendments
thereto.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(t) &#x201c;&lt;span style="text-decoration: underline"&gt;Incentive
Stock Option&lt;/span&gt;&#x201d; shall mean an Option that is intended to meet the requirements of an incentive stock option under section 422
of the Code.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(u) &#x201c;&lt;span style="text-decoration: underline"&gt;Key
Advisor&#x201d;&lt;/span&gt; shall mean a consultant or advisor of the Employer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(v) &#x201c;&lt;span style="text-decoration: underline"&gt;Non-Employee
Director&lt;/span&gt;&#x201d; shall mean a member of the Board who is not an Employee.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(w) &#x201c;&lt;span style="text-decoration: underline"&gt;Nonqualified
Stock Option&lt;/span&gt;&#x201d; shall mean an Option that is not intended to be taxed as an incentive stock option under section 422 of the Code.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(x) &#x201c;&lt;span style="text-decoration: underline"&gt;Option&#x201d;
&lt;/span&gt;shall mean an option to purchase shares of Company Stock, as described in Section 6.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(y) &#x201c;&lt;span style="text-decoration: underline"&gt;Other
Stock-Based Award&lt;/span&gt;&#x201d; shall mean any Grant based on, measured by or payable in Company Stock (other than an Option, Stock Unit,
Stock Award, or SAR), as described in Section 10.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(z) &#x201c;&lt;span style="text-decoration: underline"&gt;Participant&lt;/span&gt;&#x201d;
shall mean an Employee, Key Advisor or Non-Employee Director designated by the Committee to participate in the Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(aa) &#x201c;&lt;span style="text-decoration: underline"&gt;Performance
Goals&lt;/span&gt;&#x201d; shall mean the business criteria selected by the Company to measure the level of performance of the Company or an
affiliate during a performance period, which may include, but are not limited to, one or more of the following criteria: cash flow;
free cash flow; earnings (including gross margin, earnings before interest and taxes, earnings before taxes, earnings before
interest, taxes, depreciation, amortization and charges for stock-based compensation, earnings before interest, taxes, depreciation
and amortization, adjusted earnings before interest, taxes, depreciation and amortization and net earnings); earnings per share;
growth in earnings or earnings per share; book value growth; stock price; return on equity or average stockholder equity; total
stockholder return or growth in total stockholder return either directly or in relation to a comparative group; return on capital;
return on assets or net assets; &lt;/span&gt;revenue, growth in revenue or return on sales; sales; expense reduction or expense control;
expense to revenue ratio; income, net income or adjusted net income; operating income, net operating income, adjusted operating
income or net operating income after tax; operating profit or net operating profit; operating margin; gross profit margin; return on
operating revenue or return on operating profit; regulatory filings; regulatory approvals, litigation and regulatory resolution
goals; other operational, regulatory or departmental objectives; budget comparisons; growth in stockholder value relative to
established indexes, or another peer group or peer group index; development and implementation of strategic plans and/or
organizational restructuring goals; development and implementation of risk and crisis management programs; improvement in workforce
diversity; compliance requirements and compliance relief; safety goals; productivity goals; workforce management and succession
planning goals; economic value added (including typical adjustments consistently applied from generally accepted accounting
principles required to determine economic value added performance measures); measures of customer satisfaction, employee
satisfaction or staff development; development or marketing collaborations, formations of joint ventures or partnerships or the
completion of other similar transactions intended to enhance the Company&#x2019;s revenue or profitability or enhance its customer
base; merger and acquisitions; and other similar criteria as determined by the Committee. Performance goals applicable to a Grant
shall be determined by the Committee, and may be established on an absolute or relative basis and may be established on a
corporate-wide basis or with respect to one or more business units, divisions, subsidiaries or business segments. Relative
performance may be measured against a group of peer companies, a financial market index or other objective and quantifiable
indices.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(bb) &#x201c;&lt;span style="text-decoration: underline"&gt;Person&lt;/span&gt;&#x201d;
shall mean any natural person, corporation, limited liability company, partnership, trust, joint stock company, business trust, unincorporated
association, joint venture, governmental authority or other legal entity of any nature whatsoever.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(cc) &#x201c;&lt;span style="text-decoration: underline"&gt;Restriction
Period&#x201d;&lt;/span&gt; shall have the meaning given that term in Section 7(a).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(dd) &#x201c;&lt;span style="text-decoration: underline"&gt;SAR&#x201d;
&lt;/span&gt;shall mean a stock appreciation right, as described in Section 9.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ee) &#x201c;&lt;span style="text-decoration: underline"&gt;Stock
Award&#x201d;&lt;/span&gt; shall mean an award of Company Stock, as described in Section 7.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ff) &#x201c;&lt;span style="text-decoration: underline"&gt;Stock
Unit&lt;/span&gt;&#x201d; shall mean an award of a phantom unit representing a share of Company Stock, as described in Section 8.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(gg) &#x201c;&lt;span style="text-decoration: underline"&gt;Substitute
Awards&#x201d;&lt;/span&gt; shall have the meaning given that term in Section 4(c).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
2. Administration&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;Committee&lt;/span&gt;.
The Plan shall be administered and interpreted by the Committee; provided, however, that any Grants to members of the Board must be authorized
by a majority of the Board. The Committee may delegate authority to one or more subcommittees, as it deems appropriate. Subject to compliance
with applicable law and the applicable stock exchange rules, the Board, in its discretion, may perform any action of the Committee hereunder.
To the extent that the Board, a subcommittee or the CEO, as described below administers the Plan, references in the Plan to the &#x201c;&lt;span style="text-decoration: underline"&gt;Committee&lt;/span&gt;&#x201d;
shall be deemed to refer to the Board or such subcommittee or the CEO.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;Delegation
to CEO&lt;/span&gt;. Subject to compliance with applicable law and applicable stock exchange requirements, the Committee may delegate all or part
of its authority and power to the CEO, as it deems appropriate, with respect to Grants to Employees or Key Advisors who are not executive
officers under section 16 of the Exchange Act.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c) &lt;span style="text-decoration: underline"&gt;Committee
Authority&lt;/span&gt;. The Committee shall have the sole authority to (i) determine the individuals to whom Grants shall be made under the Plan,
(ii) determine the type, size, terms and conditions of the Grants to be made to each such individual, (iii) determine the time when the
Grants will be made and the duration of any applicable exercise or restriction period, including the criteria for exercisability and
the acceleration of exercisability, (v) amend the terms of any previously issued Grant, subject to the provisions of Section 17 below,
(vi) determine and adopt terms, guidelines, and provisions, not inconsistent with the Plan and applicable law, that apply to individuals
residing outside of the United States who receive Grants under the Plan, and (vii) deal with any other matters arising under the Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d) &lt;span style="text-decoration: underline"&gt;Committee
Determinations&lt;/span&gt;. The Committee shall have full power and express discretionary authority to administer and interpret the Plan, to
make factual determinations and to adopt or amend such rules, regulations, agreements and instruments for implementing the Plan and for
the conduct of its business as it deems necessary or advisable, in its sole discretion. The Committee&#x2019;s interpretations of the
Plan and all determinations made by the Committee pursuant to the powers vested in it hereunder shall be conclusive and binding on all
persons having any interest in the Plan or in any awards granted hereunder. All powers of the Committee shall be executed in its sole
discretion, in the best interest of the Company, not as a fiduciary, and in keeping with the objectives of the Plan and need not be uniform
as to similarly situated individuals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(e) &lt;span style="text-decoration: underline"&gt;Indemnification&lt;/span&gt;.
No member of the Committee or the Board, and no employee of the Company shall be liable for any act or failure to act with respect to
the Plan, except in circumstances involving his or her bad faith or willful misconduct, or for any act or failure to act hereunder by
any other member of the Committee or employee or by any agent to whom duties in connection with the administration of this Plan have
been delegated. The Company shall indemnify members of the Committee and the Board and any agent of the Committee or the Board who is
an employee of the Company or a subsidiary against any and all liabilities or expenses to which they may be subjected by reason of any
act or failure to act with respect to their duties on behalf of the Plan, except in circumstances involving such person&#x2019;s bad faith
or willful misconduct.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
3. Grants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Grants
under the Plan may consist of Options as described in Section 6, Stock Awards as described in Section 7, Stock Units as described in
Section 8, SARs as described in Section 9, and Other Stock-Based Awards as described in Section 10. All Grants shall be subject to the
terms and conditions set forth herein and to such other terms and conditions consistent with this Plan as the Committee deems appropriate
and as are specified in writing by the Committee to the individual in the Grant Instrument. All Grants shall be made conditional upon
the Participant&#x2019;s acknowledgement, in writing or by acceptance of the Grant, that all decisions and determinations of the Committee
shall be final and binding on the Participant, his or her beneficiaries and any other person having or claiming an interest under such
Grant. Grants under a particular Section of the Plan need not be uniform as among the Participants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
4. Shares Subject to the Plan&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;Shares
Authorized&lt;/span&gt;. Subject to adjustment as described below in Sections 4(b) and 4(e) below, the aggregate number of shares of Company Stock
that may be issued or transferred under the Plan shall be 14,000,000 shares of Company Stock. In addition, shares of the Company Stock
underlying any outstanding award granted under the Prior Plan that, following the Effective Date, expires, or is terminated, surrendered
or forfeited for any reason without issuance of such shares shall be available for the award of new Grants under this Plan. Subject to
adjustment as described below in Sections 4(b) and 4(e) below, the aggregate number of shares of Company Stock that may be issued or
transferred under the Plan pursuant to Incentive Stock Options shall not exceed 10,000,000 shares of Company Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;Source
of Shares&lt;/span&gt;; Share Counting. Shares issued or transferred under the Plan may be authorized but unissued shares of Company Stock or
reacquired shares of Company Stock, including shares purchased by the Company on the open market for purposes of the Plan. If and to
the extent Options or SARs granted under the Plan, expire or are canceled, forfeited, exchanged or surrendered without having been exercised,
or if any Stock Awards, Stock Units or Other Stock-Based Awards are forfeited, terminated or otherwise not paid in full, the shares subject
to such Grants shall again be available for purposes of the Plan. If shares of Company Stock otherwise issuable under the Plan are surrendered
in payment of the Exercise Price of an Option, then the number of shares of Company Stock available for issuance under the Plan shall
be reduced only by the net number of shares actually issued by the Company upon such exercise and not by the gross number of shares as
to which such Option is exercised. Upon the exercise of any SAR under the Plan, the number of shares of Company Stock available for issuance
under the Plan shall be reduced by only by the net number of shares actually issued by the Company upon such exercise. If shares of Company
Stock otherwise issuable under the Plan are withheld by the Company in satisfaction of the withholding taxes incurred in connection with
the issuance, vesting or exercise of any Grant or the issuance of Company Stock thereunder, then the number of shares of Company Stock
available for issuance under the Plan shall be reduced by the net number of shares issued, vested or exercised under such Grant, calculated
in each instance after payment of such share withholding. To the extent any Grants are paid in cash, and not in shares of Company Stock,
any shares previously subject to such Grants shall again be available for issuance or transfer under the Plan. For the avoidance of doubt,
if shares are repurchased by the Company on the open market with the proceeds of the Exercise Price of Options, such shares may not again
be made available for issuance under the Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c) &lt;span style="text-decoration: underline"&gt;Substitute
Awards&lt;/span&gt;. Shares issued or transferred under Grants made pursuant to an assumption, substitution or exchange for previously granted
awards of a company acquired by the Company in a transaction (&#x201c;Substitute Awards&#x201d;) shall not reduce the number of shares
of Company Stock available under the Plan and available shares under a stockholder approved plan of an acquired company (as appropriately
adjusted to reflect the transaction) may be used for Grants under the Plan and shall not reduce the Plan&#x2019;s share reserve (subject
to applicable stock exchange listing and Code requirements).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d) &lt;span style="text-decoration: underline"&gt;Individual
Limits for Non-Employee Directors&lt;/span&gt;. Subject to adjustment as described below in Section 4(e), the maximum aggregate grant date value
of shares of Company Stock subject to Grants granted to any Non-Employee Director during any calendar year, taken together with any cash
fees earned by such Non- Employee Director for services rendered during the calendar year, shall not exceed $250,000 in total value.
For purposes of this limit, the value of such Grants shall be calculated based on the grant date fair value of such Grants for financial
reporting purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(e) &lt;span style="text-decoration: underline"&gt;Adjustments&lt;/span&gt;.
If there is any change in the number or kind of shares of Company Stock outstanding by reason of (i) a stock dividend, spinoff, recapitalization,
stock split, or combination or exchange of shares, (ii) a merger, reorganization or consolidation, (iii) a reclassification or change
in par value, or (iv) any other extraordinary or unusual event affecting the outstanding Company Stock as a class without the Company&#x2019;s
receipt of consideration, or if the value of outstanding shares of Company Stock is substantially reduced as a result of a spinoff or
the Company&#x2019;s payment of an extraordinary dividend or distribution, the maximum number and kind of shares of Company Stock available
for issuance under the Plan, the maximum amount of Grants which a Non-Employee Director may receive in any year, the number and kind
of shares covered by outstanding Grants, the number and kind of shares issued and to be issued under the Plan, and the price per share
or the applicable market value of such Grants shall be equitably adjusted by the Committee to reflect any increase or decrease in the
number of, or change in the kind or value of, the issued shares of Company Stock to preclude, to the extent practicable, the enlargement
or dilution of rights and benefits under the Plan and such outstanding Grants; provided, however, that any fractional shares resulting
from such adjustment shall be eliminated. In addition, in the event of a Change of Control, the provisions of Section 12 of the Plan
shall apply. Any adjustments to outstanding Grants shall be consistent with section 409A or 424 of the Code, to the extent applicable.
The adjustments of Grants under this Section 4(e) shall include adjustment of shares, Exercise Price of Stock Options, base amount of
SARs, Performance Goals or other terms and conditions, as the Committee deems appropriate. The Committee shall have the sole discretion
and authority to determine what appropriate adjustments shall be made and any adjustments determined by the Committee shall be final,
binding and conclusive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
5. Eligibility for Participation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;Eligible
Persons&lt;/span&gt;. All Employees and Non-Employee Directors shall be eligible to participate in the Plan. Key Advisors shall be eligible to
participate in the Plan if the Key Advisors render bona fide services to the Employer, the services are not in connection with the offer
and sale of securities in a capital-raising transaction and the Key Advisors do not directly or indirectly promote or maintain a market
for the Company&#x2019;s securities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;Selection
of Participants&lt;/span&gt;. The Committee shall select the Employees, Non-Employee Directors and Key Advisors to receive Grants and shall determine
the number of shares of Company Stock subject to a particular Grant in such manner as the Committee determines.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
6. Options&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Committee may grant Options to an Employee, Non-Employee Director or Key Advisor upon such terms as the Committee deems appropriate.
The following provisions are applicable to Options:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;Number
of Shares&lt;/span&gt;. The Committee shall determine the number of shares of Company Stock that will be subject to each Grant of Options to Employees,
Non-Employee Directors and Key Advisors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;Type
of Option and Exercise Price.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i) The
Committee may grant Incentive Stock Options or Nonqualified Stock Options or any combination of the two, all in accordance with the terms
and conditions set forth herein. Incentive Stock Options may be granted only to employees of the Company or its parent or subsidiary
corporations, as defined in section 424 of the Code. Nonqualified Stock Options may be granted to Employees, Non-Employee Directors and
Key Advisors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii) The
Exercise Price of Company Stock subject to an Option shall be determined by the Committee and shall be equal to or greater than the Fair
Market Value of a share of Company Stock on the date the Option is granted. However, an Incentive Stock Option may not be granted to
an Employee who, at the time of grant, owns stock possessing more than 10% of the total combined voting power of all classes of stock
of the Company, or any parent or subsidiary corporation of the Company, as defined in section 424 of the Code, unless the Exercise Price
per share is not less than 110% of the Fair Market Value of a share of Company Stock on the date of grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c) &lt;span style="text-decoration: underline"&gt;Option
Term&lt;/span&gt;. The Committee shall determine the term of each Option. The term of any Option shall not exceed ten years from the date of grant.
However, an Incentive Stock Option that is granted to an Employee who, at the time of grant, owns stock possessing more than 10% of the
total combined voting power of all classes of stock of the Company, or any parent or subsidiary corporation of the Company, as defined
in section 424 of the Code, may not have a term that exceeds five years from the date of grant. Notwithstanding the foregoing, in the
event that on the last business day of the term of an Option (other than an Incentive Stock Option), the exercise of the Option is prohibited
by applicable law, including a prohibition on purchases or sales of Company Stock under the Company&#x2019;s insider trading policy, the
term of the Option shall be extended for a period of 30 days following the end of the legal prohibition, unless the Committee determines
otherwise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d) &lt;span style="text-decoration: underline"&gt;Exercisability
of Options&lt;/span&gt;. Options shall become exercisable in accordance with such terms and conditions, consistent with the Plan, as may be determined
by the Committee and specified in the Grant Instrument. The Committee may accelerate the exercisability of any or all outstanding Options
at any time for any reason.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(e) &lt;span style="text-decoration: underline"&gt;Grants
to Non-Exempt Employees&lt;/span&gt;. Notwithstanding the foregoing, Options granted to persons who are non-exempt employees under the Fair Labor
Standards Act of 1938, as amended, may not be exercisable for at least six months after the date of grant (except that such Options may
become exercisable, as determined by the Committee, upon the Participant&#x2019;s death, Disability or retirement, or upon a Change of
Control or other circumstances permitted by applicable regulations).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(f) &lt;span style="text-decoration: underline"&gt;Termination
of Employment or Service&lt;/span&gt;. Except as provided in the Grant Instrument, an Option may only be exercised while the Participant is employed
by, or providing services to, the Employer. The Committee shall determine in the Grant Instrument under what circumstances and during
what time periods a Participant may exercise an Option after termination of employment or service.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(g) &lt;span style="text-decoration: underline"&gt;Exercise
of Options&lt;/span&gt;. A Participant may exercise an Option that has become exercisable, in whole or in part, by delivering a notice of exercise
to the Company. The Participant shall pay the Exercise Price for an Option as specified by the Committee (i) in cash, (ii) unless the
Committee determines otherwise, by delivering shares of Company Stock owned by the Participant and having a Fair Market Value on the
date of exercise at least equal to the Exercise Price or by attestation (on a form prescribed by the Committee) to ownership of shares
of Company Stock having a Fair Market Value on the date of exercise at least equal to the Exercise Price, (iii) by payment through a
broker in accordance with procedures permitted by Regulation T of the Federal Reserve Board, (iv) if permitted by the Committee, by withholding
shares of Company Stock subject to the exercisable Option, which have a Fair Market Value on the date of exercise equal to the Exercise
Price, or (v) by such other method as the Committee may approve. Shares of Company Stock used to exercise an Option shall have been held
by the Participant for the requisite period of time necessary to avoid adverse accounting consequences to the Company with respect to
the Option. Payment for the shares to be issued or transferred pursuant to the Option, and any required withholding taxes, must be received
by the Company by the time specified by the Committee depending on the type of payment being made, but in all cases prior to the issuance
or transfer of such shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(h) &lt;span style="text-decoration: underline"&gt;Limits
on Incentive Stock Options&lt;/span&gt;. Each Incentive Stock Option shall provide that, if the aggregate Fair Market Value of the Company Stock
on the date of the grant with respect to which Incentive Stock Options are exercisable for the first time by a Participant during any
calendar year, under the Plan or any other stock option plan of the Company or a parent or subsidiary, exceeds $100,000, then the Option,
as to the excess, shall be treated as a Nonqualified Stock Option.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
7. Stock Awards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Committee may issue or transfer shares of Company Stock to an Employee, Non-Employee Director or Key Advisor under a Stock Award, upon
such terms as the Committee deems appropriate. The following provisions are applicable to Stock Awards:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;General
Requirements&lt;/span&gt;. Shares of Company Stock issued or transferred pursuant to Stock Awards may be issued or transferred for consideration
or for no consideration, and subject to restrictions or no restrictions, as determined by the Committee. The Committee may, but shall
not be required to, establish conditions under which restrictions on Stock Awards shall lapse over a period of time or according to such
other criteria as the Committee deems appropriate, including, without limitation, restrictions based on the achievement of specific Performance
Goals. The period of time during which the Stock Awards will remain subject to restrictions will be designated in the Grant Instrument
as the &#x201c;&lt;span style="text-decoration: underline"&gt;Restriction Period.&#x201d;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;Number
of Shares&lt;/span&gt;. The Committee shall determine the number of shares of Company Stock to be issued or transferred pursuant to a Stock Award
and the restrictions applicable to such shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c) &lt;span style="text-decoration: underline"&gt;Requirement
of Employment or Service&lt;/span&gt;. If the Participant ceases to be employed by, or provide service to, the Employer during a period designated
in the Grant Instrument as the Restriction Period, or if other specified conditions are not met, the Stock Award shall terminate as to
all shares covered by the Grant as to which the restrictions have not lapsed, and those shares of Company Stock must be immediately returned
to the Company. The Committee may, however, provide for complete or partial exceptions to this requirement as it deems appropriate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d) &lt;span style="text-decoration: underline"&gt;Restrictions
on Transfer and Legend on Stock Certificate&lt;/span&gt;. During the Restriction Period, a Participant may not sell, assign, transfer, pledge
or otherwise dispose of the shares of a Stock Award except under Section 15 below. Unless otherwise determined by the Committee, the
Company will retain possession of certificates for shares of Stock Awards until all restrictions on such shares have lapsed. Each certificate
for a Stock Award, unless held by the Company, shall contain a legend giving appropriate notice of the restrictions in the Grant. The
Participant shall be entitled to have the legend removed from the stock certificate covering the shares subject to restrictions when
all restrictions on such shares have lapsed. The Committee may determine that the Company will not issue certificates for Stock Awards
until all restrictions on such shares have lapsed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(e) &lt;span style="text-decoration: underline"&gt;Right
to Vote and to Receive Dividends&lt;/span&gt;. Unless the Committee determines otherwise, during the Restriction Period, the Participant shall
have the right to vote shares of Stock Awards and to receive any dividends or other distributions paid on such shares, subject to any
restrictions deemed appropriate by the Committee, including, without limitation, the achievement of specific Performance Goals. Dividends
with respect to Stock Awards that vest based on performance shall vest if and to the extent that the underlying Stock Award vests, as
determined by the Committee.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(f) &lt;span style="text-decoration: underline"&gt;Lapse
of Restrictions&lt;/span&gt;. All restrictions imposed on Stock Awards shall lapse upon the expiration of the applicable Restriction Period and
the satisfaction of all conditions, if any, imposed by the Committee. The Committee may determine, as to any or all Stock Awards, that
the restrictions shall lapse without regard to any Restriction Period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
8. Stock Units&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Committee may grant Stock Units, each of which shall represent one hypothetical share of Company Stock, to an Employee, Non-Employee
Director or Key Advisor upon such terms and conditions as the Committee deems appropriate. The following provisions are applicable to
Stock Units:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;Crediting
of Units&lt;/span&gt;. Each Stock Unit shall represent the right of the Participant to receive a share of Company Stock or an amount of cash based
on the value of a share of Company Stock, if and when specified conditions are met. All Stock Units shall be credited to bookkeeping
accounts established on the Company&#x2019;s records for purposes of the Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;Terms
of Stock Units&lt;/span&gt;. The Committee may grant Stock Units that vest and are payable if specified Performance Goals or other conditions
are met, or under other circumstances. Stock Units may be paid at the end of a specified performance period or other period, or payment
may be deferred to a date authorized by the Committee. The Committee may accelerate vesting or payment, as to any or all Stock Units
at any time for any reason, provided such acceleration complies with section 409A of the Code. The Committee shall determine the number
of Stock Units to be granted and the requirements applicable to such Stock Units.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c) &lt;span style="text-decoration: underline"&gt;Requirement
of Employment or Service&lt;/span&gt;. If the Participant ceases to be employed by, or provide service to, the Employer prior to the vesting of
Stock Units, or if other conditions established by the Committee are not met, the Participant&#x2019;s Stock Units shall be forfeited.
The Committee may, however, provide for complete or partial exceptions to this requirement as it deems appropriate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d) &lt;span style="text-decoration: underline"&gt;Payment
With Respect to Stock Units&lt;/span&gt;. Payments with respect to Stock Units shall be made in cash, Company Stock or any combination of the
foregoing, as the Committee shall determine.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
9. Stock Appreciation Rights&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Committee may grant SARs to an Employee, Non-Employee Director or Key Advisor separately or in tandem with any Option. The following
provisions are applicable to SARs:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;General
Requirements&lt;/span&gt;. The Committee may grant SARs to an Employee, Non-Employee Director or Key Advisor separately or in tandem with any
Option (for all or a portion of the applicable Option). Tandem SARs may be granted either at the time the Option is granted or at any
time thereafter while the Option remains outstanding; provided, however, that, in the case of an Incentive Stock Option, SARs may be
granted only at the time of the grant of the Incentive Stock Option. The Committee shall establish the base amount of the SAR at the
time the SAR is granted. The base amount of each SAR shall be equal to or greater than the Fair Market Value of a share of Company Stock
as of the date of grant of the SAR. The term of any SAR shall not exceed ten years from the date of grant. Notwithstanding the foregoing,
in the event that on the last business day of the term of a SAR, the exercise of the SAR is prohibited by applicable law, including a
prohibition on purchases or sales of Company Stock under the Company&#x2019;s insider trading policy, the term shall be extended for a
period of 30 days following the end of the legal prohibition, unless the Committee determines otherwise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;Tandem
SARs&lt;/span&gt;. In the case of tandem SARs, the number of SARs granted to a Participant that shall be exercisable during a specified period
shall not exceed the number of shares of Company Stock that the Participant may purchase upon the exercise of the related Option during
such period. Upon the exercise of an Option, the SARs relating to the Company Stock covered by such Option shall terminate. Upon the
exercise of SARs, the related Option shall terminate to the extent of an equal number of shares of Company Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c) &lt;span style="text-decoration: underline"&gt;Exercisability&lt;/span&gt;.
A SAR shall be exercisable during the period specified by the Committee in the Grant Instrument and shall be subject to such vesting
and other restrictions as may be specified in the Grant Instrument. The Committee may accelerate the exercisability of any or all outstanding
SARs at any time for any reason. SARs may only be exercised while the Participant is employed by, or providing service to, the Employer
or during the applicable period after termination of employment or service as specified by the Committee. A tandem SAR shall be exercisable
only during the period when the Option to which it is related is also exercisable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d) &lt;span style="text-decoration: underline"&gt;Grants
to Non-Exempt Employees&lt;/span&gt;. Notwithstanding the foregoing, SARs granted to persons who are non-exempt employees under the Fair Labor
Standards Act of 1938, as amended, may not be exercisable for at least six months after the date of grant (except that such SARs may
become exercisable, as determined by the Committee, upon the Participant&#x2019;s death, Disability or retirement, or upon a Change of
Control or other circumstances permitted by applicable regulations).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(e) &lt;span style="text-decoration: underline"&gt;Value
of SARs&lt;/span&gt;. When a Participant exercises SARs, the Participant shall receive in settlement of such SARs an amount equal to the value
of the stock appreciation for the number of SARs exercised. The stock appreciation for a SAR is the amount by which the Fair Market Value
of the underlying Company Stock on the date of exercise of the SAR exceeds the base amount of the SAR as described in subsection (a).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(f) &lt;span style="text-decoration: underline"&gt;Form
of Payment&lt;/span&gt;. The appreciation in a SAR shall be paid in shares of Company Stock, cash or any combination of the foregoing, as the
Committee shall determine. For purposes of calculating the number of shares of Company Stock to be received, shares of Company Stock
shall be valued at their Fair Market Value on the date of exercise of the SAR.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
10. Other Stock-Based Awards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Committee may grant Other Stock-Based Awards, which are awards (other than those described in Sections 6, 7, 8 and 9 of the Plan) that
are based on or measured by Company Stock, to any Employee, Non- Employee Director or Key Advisor, on such terms and conditions as the
Committee shall determine. Other Stock-Based Awards may be awarded subject to the achievement of Performance Goals or other criteria
or other conditions and may be payable in cash, Company Stock or any combination of the foregoing, as the Committee shall determine.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
11. Dividend Equivalents&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Committee may grant Dividend Equivalents in connection with Stock Units or Other Stock-Based Awards. Dividend Equivalents may be paid
currently or accrued as contingent cash obligations and may be payable in cash or shares of Company Stock, and upon such terms and conditions
as the Committee shall determine. Dividend Equivalents with respect to Stock Units or Other Stock-Based Awards that vest based on performance
shall vest and be paid only if and to the extent the underlying Stock Units or Other Stock-Based Awards vest and are paid, as determined
by the Committee.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
12. Consequences of a Change of Control&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;Assumption
of Outstanding Grants&lt;/span&gt;. Upon a Change of Control where the Company is not the surviving corporation (or survives only as a subsidiary
of another corporation), unless the Committee determines otherwise, all outstanding Grants that are not exercised or paid at the time
of the Change of Control shall be assumed by, or replaced with grants (with respect to cash, securities, or a combination thereof) that
have comparable terms by, the surviving corporation (or a parent or subsidiary of the surviving corporation). After a Change of Control,
references to the &#x201c;Company&#x201d; as they relate to employment matters shall include the successor employer in the transaction,
subject to applicable law.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;Vesting
Upon Certain Terminations of Employment&lt;/span&gt;. Unless the Grant Instrument provides otherwise, if a Participant&#x2019;s employment is terminated
by the Employer without Cause upon or within 12 months following a Change of Control, the Participant&#x2019;s outstanding Grants shall
become fully vested as of the date of such termination; provided that if the vesting of any such Grants is based, in whole or in part,
on performance, the applicable Grant Instrument shall specify how the portion of the Grant that becomes vested pursuant to this Section
12(b) shall be calculated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c) &lt;span style="text-decoration: underline"&gt;Other
Alternatives&lt;/span&gt;. In the event of a Change of Control, if any outstanding Grants are not assumed by, or replaced with grants that have
comparable terms by, the surviving corporation (or a parent or subsidiary of the surviving corporation), the Committee may (but is not
obligated to) make adjustments to the terms and conditions of outstanding Grants, including, without limitation, taking any of the following
actions (or combination thereof) with respect to any or all outstanding Grants, without the consent of any Participant: (i) the Committee
may determine that outstanding Stock Options and SARs shall automatically accelerate and become fully exercisable and the restrictions
and conditions on outstanding Stock Awards, Stock Units and Dividend Equivalents shall immediately lapse; (ii) the Committee may determine
that Participants shall receive a payment in settlement of outstanding Stock Units or Dividend Equivalents, in such amount and form as
may be determined by the Committee; (iii) the Committee may require that Participants surrender their outstanding Stock Options and SARs
in exchange for a payment by the Company, in cash or Company Stock as determined by the Committee, in an amount equal to the amount,
if any, by which the then Fair Market Value of the shares of Company Stock subject to the Participant&#x2019;s unexercised Stock Options
and SARs exceeds the Stock Option Exercise Price or SAR base amount, and (iv) after giving Participants an opportunity to exercise all
of their outstanding Stock Options and SARs, the Committee may terminate any or all unexercised Stock Options and SARs at such time as
the Committee deems appropriate. Such surrender, termination or payment shall take place as of the date of the Change of Control or such
other date as the Committee may specify. Without limiting the foregoing, if the per share Fair Market Value of the Company Stock does
not exceed the per share Stock Option Exercise Price or SAR base amount, as applicable, the Company shall not be required to make any
payment to the Participant upon surrender of the Stock Option or SAR.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
13. Deferrals&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Committee may permit or require a Participant to defer receipt of the payment of cash or the delivery of shares that would otherwise
be due to such Participant in connection with any Grant. If any such deferral election is permitted or required, the Committee shall
establish rules and procedures for such deferrals and may provide for interest or other earnings to be paid on such deferrals. The rules
and procedures for any such deferrals shall be consistent with applicable requirements of section 409A of the Code.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
14. Withholding of Taxes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;Required
Withholding&lt;/span&gt;. All Grants under the Plan shall be subject to applicable United States federal (including FICA), state and local, foreign
country or other tax withholding requirements. The Employer may require that the Participant or other person receiving Grants or exercising
Grants pay to the Employer an amount sufficient to satisfy such tax withholding requirements with respect to such Grants, or the Employer
may deduct from other wages and compensation paid by the Employer the amount of any withholding taxes due with respect to such Grants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;Share
Withholding&lt;/span&gt;. The Committee may permit or require the Employer&#x2019;s tax withholding obligation with respect to Grants paid in Company
Stock to be satisfied by having shares withheld up to an amount that does not exceed the Participant&#x2019;s applicable withholding tax
rate for United States federal (including FICA), state and local, foreign country or other tax liabilities. The Committee may, in its
discretion, and subject to such rules as the Committee may adopt, allow Participants to elect to have such share withholding applied
to all or a portion of the tax withholding obligation arising in connection with any particular Grant. Unless the Committee determines
otherwise, share withholding for taxes shall not exceed the Participant&#x2019;s minimum applicable tax withholding amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
15. Transferability of Grants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;Nontransferability
of Grants&lt;/span&gt;. Except as described in subsection (b) below, only the Participant may exercise rights under a Grant during the Participant&#x2019;s
lifetime. A Participant may not transfer those rights except (i) by will or by the laws of descent and distribution or (ii) with respect
to Grants other than Incentive Stock Options, pursuant to a domestic relations order. When a Participant dies, the personal representative
or other person entitled to succeed to the rights of the Participant may exercise such rights. Any such successor must furnish proof
satisfactory to the Company of his or her right to receive the Grant under the Participant&#x2019;s will or under the applicable laws
of descent and distribution.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;Transfer
of Nonqualified Stock Options and Stock Awards&lt;/span&gt;. Notwithstanding the foregoing, the Committee may provide, in a Grant Instrument or
at such other time after the grant of an award, that a Participant may transfer Nonqualified Stock Options or Stock Awards to family
members, or one or more trusts or other entities for the benefit of or owned by family members, consistent with the applicable securities
laws, according to such terms as the Committee may determine; provided that the Participant receives no consideration for the transfer
of an Option or Stock Award and the transferred Option or Stock Award shall continue to be subject to the same terms and conditions as
were applicable to the Option or Stock Award immediately before the transfer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
16. Requirements for Issuance or Transfer of Shares&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;No
Company Stock shall be issued or transferred in connection with any Grant hereunder unless and until all legal requirements applicable
to the issuance or transfer of such Company Stock have been complied with to the satisfaction of the Committee. The Committee shall have
the right to condition any Grant on the Participant&#x2019;s undertaking in writing to comply with such restrictions on his or her subsequent
disposition of the shares of Company Stock as the Committee shall deem necessary or advisable, and certificates representing such shares
may be legended to reflect any such restrictions. Certificates representing shares of Company Stock issued or transferred under the Plan
may be subject to such stop-transfer orders and other restrictions as the Committee deems appropriate to comply with applicable laws,
regulations and interpretations, including any requirement that a legend be placed thereon.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
17. Amendment and Termination of the Plan&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;Amendment&lt;/span&gt;.
The Board may amend or terminate the Plan at any time; provided, however, that the Board shall not amend the Plan without stockholder
approval if such approval is required in order to comply with the Code or other applicable law, or to comply with applicable stock exchange
requirements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;No
Repricing of Options or SARs&lt;/span&gt;. Except in connection with a corporate transaction involving the Company (including, without limitation,
any stock dividend, distribution (whether in the form of cash, Company Stock, other securities or property), stock split, extraordinary
cash dividend, recapitalization, change in control, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase
or exchange of shares of Company Stock or other securities, or similar transactions), the Company may not, without obtaining stockholder
approval, (i) amend the terms of outstanding Stock Options or SARs to reduce the Exercise Price of such outstanding Stock Options or
base price of such SARs, (ii) cancel outstanding Stock Options or SARs in exchange for Stock Options or SARs with an Exercise Price or
base price, as applicable, that is less than the Exercise Price or base price of the original Stock Options or SARs or (iii) cancel outstanding
Stock Options or SARs with an Exercise Price or base price, as applicable, above the current stock price in exchange for cash or other
securities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c) &lt;span style="text-decoration: underline"&gt;Termination
of Plan&lt;/span&gt;. The Plan shall terminate on the day immediately preceding the tenth anniversary of its Effective Date, unless the Plan is
terminated earlier by the Board or is extended by the Board with the approval of the stockholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d) &lt;span style="text-decoration: underline"&gt;Termination
and Amendment of Outstanding Grants&lt;/span&gt;. A termination or amendment of the Plan that occurs after a Grant is made shall not materially
impair the rights of a Participant with respect to such Grant unless the Participant consents or unless the Committee acts under Section
18(f) below. The termination of the Plan shall not impair the power and authority of the Committee with respect to an outstanding Grant.
Whether or not the Plan has terminated, an outstanding Grant may be terminated or amended under Section 18(f) below or may be amended
by agreement of the Company and the Participant consistent with the Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Section
18. Miscellaneous&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a) &lt;span style="text-decoration: underline"&gt;Grants
in Connection with Corporate Transactions and Otherwise&lt;/span&gt;. Nothing contained in the Plan shall be construed to (i) limit the right
of the Committee to make Grants under the Plan in connection with the acquisition, by purchase, lease, merger, consolidation or otherwise,
of the business or assets of any corporation, firm or association, including Grants to employees thereof who become Employees, or (ii)
limit the right of the Company to grant stock options or make other awards outside of the Plan. The Committee may make a Grant to an
employee of another corporation who becomes an Employee by reason of a corporate merger, consolidation, acquisition of stock or property,
reorganization or liquidation involving the Company, in substitution for a stock option or stock awards grant made by such corporation.
Notwithstanding anything in the Plan to the contrary, the Committee may establish such terms and conditions of the new Grants as it deems
appropriate, including setting the Exercise Price of Options or the base price of SARs at a price necessary to retain for the Participant
the same economic value as the prior options or rights.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b) &lt;span style="text-decoration: underline"&gt;Governing
Document. The Plan shall be the controlling document&lt;/span&gt;. No other statements, representations, explanatory materials or examples, oral
or written, may amend the Plan in any manner. The Plan shall be binding upon and enforceable against the Company and its successors and
assigns.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c) &lt;span style="text-decoration: underline"&gt;Funding
of the Plan&lt;/span&gt;. The Plan shall be unfunded. The Company shall not be required to establish any special or separate fund or to make any
other segregation of assets to assure the payment of any Grants under the Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d) &lt;span style="text-decoration: underline"&gt;Rights
of Participants&lt;/span&gt;. Nothing in the Plan shall entitle any Employee, Non-Employee Director, Key Advisor or other person to any claim
or right to receive a Grant under the Plan. Neither the Plan nor any action taken hereunder shall be construed as giving any individual
any rights to be retained by or in the employ of the Employer or any other employment rights.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(e) &lt;span style="text-decoration: underline"&gt;No
Fractional Shares&lt;/span&gt;. No fractional shares of Company Stock shall be issued or delivered pursuant to the Plan or any Grant. Except as
otherwise provided under the Plan, the Committee shall determine whether cash, other awards or other property shall be issued or paid
in lieu of such fractional shares or whether such fractional shares or any rights thereto shall be forfeited or otherwise eliminated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(f) &lt;span style="text-decoration: underline"&gt;Compliance
with Law.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i) The
Plan, the exercise of Options and SARs and the obligations of the Company to issue or transfer shares of Company Stock under Grants shall
be subject to all applicable laws and regulations, and to approvals by any governmental or regulatory agency as may be required. With
respect to persons subject to section 16 of the Exchange Act, it is the intent of the Company that the Plan and all transactions under
the Plan comply with all applicable provisions of Rule 16b-3 or its successors under the Exchange Act. In addition, it is the intent
of the Company that Incentive Stock Options comply with the applicable provisions of section 422 of the Code, and that, to the extent
applicable, Grants comply with the requirements of section 409A of the Code. To the extent that any legal requirement of section 16 of
the Exchange Act or section 422 or 409A of the Code as set forth in the Plan ceases to be required under section 16 of the Exchange Act
or section 422 or 409A of the Code, that Plan provision shall cease to apply. The Committee may revoke any Grant if it is contrary to
law or modify a Grant to bring it into compliance with any valid and mandatory government regulation. The Committee may also adopt rules
regarding the withholding of taxes on payments to Participants. The Committee may, in its sole discretion, agree to limit its authority
under this Section.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii) The
Plan is intended to comply with the requirements of section 409A of the Code, to the extent applicable. Each Grant shall be construed
and administered such that the Grant either (A) qualifies for an exemption from the requirements of section 409A of the Code or (B) satisfies
the requirements of section 409A of the Code. If a Grant is subject to section 409A of the Code, (I) distributions shall only be made
in a manner and upon an event permitted under section 409A of the Code, (II) payments to be made upon a termination of employment or
service shall only be made upon a &#x201c;separation from service&#x201d; under section 409A of the Code, (III) unless the Grant specifies
otherwise, each installment payment shall be treated as a separate payment for purposes of section 409A of the Code, and (IV) in no event
shall a Participant, directly or indirectly, designate the calendar year in which a distribution is made except in accordance with section
409A of the Code.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iii) Any
Grant that is subject to section 409A of the Code and that is to be distributed to a Key Employee (as defined below) upon separation
from service shall be administered so that any distribution with respect to such Grant shall be postponed for six months following the
date of the Participant&#x2019;s separation from service, if required by section 409A of the Code. If a distribution is delayed pursuant
to section 409A of the Code, the distribution shall be paid within 15 days after the end of the six-month period. If the Participant
dies during such six-month period, any postponed amounts shall be paid within 90 days of the Participant&#x2019;s death. The determination
of Key Employees, including the number and identity of persons considered Key Employees and the identification date, shall be made by
the Committee or its delegate each year in accordance with section 416(i) of the Code and the &#x201c;specified employee&#x201d; requirements
of section 409A of the Code.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iv) Notwithstanding
anything in the Plan or any Grant agreement to the contrary, each Participant shall be solely responsible for the tax consequences
of Grants under the Plan, and in no event shall the Company or any subsidiary or affiliate of the Company have any responsibility or
liability if a Grant does not meet any applicable requirements of section 409A of the Code. Although the Company intends to
administer the Plan to prevent taxation under section 409A of the Code, the Company does not represent or warrant that the Plan or
any Grant complies with any provision of federal, state, local or other tax law.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(g) &lt;span style="text-decoration: underline"&gt;Grants
in Foreign Countries; Establishment of Subplans&lt;/span&gt;. The Committee has the authority to award Grants to Participants who are foreign
nationals or employed outside the United States on any different terms and conditions than those specified in the Plan that the Committee,
in its discretion, believes to be necessary or desirable to accommodate differences in applicable law, tax policy, or custom, while furthering
the purposes of the Plan. The Board may from time to time establish one or more sub-plans under the Plan for purposes of satisfying applicable
blue sky, securities or tax laws of various jurisdictions. The Board shall establish such sub-plans by adopting supplements to the Plan
setting forth (i) such limitations on the Committee&#x2019;s discretion under the Plan as the Board deems necessary or desirable and (ii)
such additional terms and conditions not otherwise inconsistent with the Plan as the Board shall deem necessary or desirable. All supplements
adopted by the Board shall be deemed to be part of the Plan, but each supplement shall apply only to Participants within the affected
jurisdiction and the Employer shall not be required to provide copies of any supplement to Participants in any jurisdiction that is not
affected. Notwithstanding the foregoing, the Committee may not approve any sub-plan inconsistent with the terms or share limits in the
Plan or which would otherwise cause the Plan to cease to satisfy any conditions under Rule 16b-3 under the 1934 Act.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(h) &lt;span style="text-decoration: underline"&gt;Clawback
Rights&lt;/span&gt;. Subject to the requirements of applicable law, the Committee may provide in any Grant Instrument that, if a Participant breaches
any restrictive covenant agreement between the Participant and the Employer (which may be set forth in any Grant Instrument) or otherwise
engages in activities that constitute Cause either while employed by, or providing service to, the Employer or within a specified period
of time thereafter, all Grants held by the Participant shall terminate, and the Company may rescind any exercise of an Option or SAR
and the vesting of any other Grant and delivery of shares upon such exercise or vesting (including pursuant to dividends and Dividend
Equivalents), as applicable on such terms as the Committee shall determine, including the right to require that in the event of any such
rescission, (i) the Participant shall return to the Company the shares received upon the exercise of any Option or SAR and/or the vesting
and payment of any other Grant (including pursuant to dividends and Dividend Equivalents) or, (ii) if the Participant no longer owns
the shares, the Participant shall pay to the Company the amount of any gain realized or payment received as a result of any sale or other
disposition of the shares (or, in the event the Participant transfers the shares by gift or otherwise without consideration, the Fair
Market Value of the shares on the date of the breach of the restrictive covenant agreement (including a Participant&#x2019;s Grant Instrument
containing restrictive covenants) or activity constituting Cause), net of the price originally paid by the Participant for the shares.
Payment by the Participant shall be made in such manner and on such terms and conditions as may be required by the Committee. The Employer
shall be entitled to set off against the amount of any such payment any amounts otherwise owed to the Participant by the Employer. In
addition, all Grants under the Plan shall be subject to any applicable clawback or recoupment policies, share trading policies and other
policies that may be implemented by the Board from time to time.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i) &lt;span style="text-decoration: underline"&gt;Governing
Law; Jurisdiction&lt;/span&gt;. The validity, construction, interpretation and effect of the Plan and Grant Instrument issued under the Plan shall
be governed and construed by and determined in accordance with the laws of the Commonwealth of Massachusetts, without giving effect to
the conflict of laws provisions thereof. Any action arising out of, or relating to, any of the provisions of the Plan and Grants made
hereunder shall be brought only in the United States District Court for the District of Massachusetts, or if such court does not have
jurisdiction or will not accept jurisdiction, in any court of general jurisdiction in Massachusetts, and the jurisdiction of such court
in any such proceeding shall be exclusive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Appendix
B&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;CERTIFICATE
OF AMENDMENT&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;OF&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;CERTIFICATE
OF INCORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;OF&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;KOPIN
CORPORATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to Section 242 of the&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;General
Corporation Law of the State of Delaware&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;KOPIN
CORPORATION (the &#x201c;Corporation&#x201d;), a corporation organized and existing under and by virtue of the General Corporation
Law of the State of Delaware,&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;DOES
HEREBY CERTIFY:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FIRST:
That at a meeting of the Board of Directors of the Corporation resolutions were duly adopted setting forth a proposed
amendment to the Certificate of Incorporation, as amended to date (the &#x201c;Charter Amendment&#x201d;) and declaring said Charter
Amendment to be advisable and directing the stockholders of the Corporation to consider said Charter Amendment and to indicate their
approval and adoption thereof. The resolution setting forth the amendment is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RESOLVED,
That the first sentence of Article Fourth of the Restated Certificate of Incorporation of the Corporation be and it hereby is amended
to read as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x201c;FOURTH:
The total number of shares of stock which the Corporation shall have authority to issue is two hundred and seventy-five
million and three thousand (275,003,000) shares, of which three thousand (3,000) shares, par value of $.01 each, are to be of
a class designated Preferred Stock, and two hundred and seventy five million (275,000,000) shares, par value of $.01 each,
are to be of a class designated Common Stock.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SECOND:
That thereafter, pursuant to resolution of its Board of Directors, an annual meeting of the stockholders of said corporation was duly
called and held, upon notice in accordance with Sections 211 and 222 of the General Corporation Law of the State of Delaware at
which meeting the necessary number of shares as required by statute were voted in favor of the amendment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;THIRD:
That the aforesaid Charter Amendment was duly adopted in accordance with the applicable provisions of Section 242 of the General
Corporation Law of the State of Delaware.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FOURTH:
That this Certificate of Amendment to the Certificate of Incorporation shall become effective upon the filing of the Certificate of Amendment
with the Delaware Secretary of State, which will occur as soon as reasonably practicable after approval.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;IN
WITNESS WHEREOF, said Kopin Corporation has caused this Certificate of Amendment to the Certificate of Incorporation to be executed,
acknowledged and filed by its Chief Financial Officer this [&#x25cf;] day of June 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;KOPIN
    CORPORATION &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;By:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;/s/
    Richard A. Sneider&lt;/i&gt; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 5%"&gt;Name:&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 45%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Richard
    A. Sneider &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Title:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chief
    Financial Officer&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;img alt="" src="proxy_001.jpg" style="width: 800px"/&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;img alt="" src="proxy_002.jpg" style="width: 800px"/&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;








</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#xdx2ixbrl0016"
          xlink:label="xdx2ixbrl0016"
          xlink:type="locator"/>
        <link:footnote id="Footnote000046" xlink:label="Footnote000046" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Dr
    Fan was our PEO for part of fiscal year 2022 and was replaced by Mr. Murray for part of fiscal year 2022. Mr. Murray was PEO for
    fiscal years 2023 and 2024. The Non-PEO NEOs for the presented consists of Mr. Sneider and Mr. Baker in 2024 and 2023.The Non-PEO NEOs consisted of Messrs. Sneider and Baker and Drs. Tsaur and Choi in 2022.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0016"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0017"
          xlink:label="xdx2ixbrl0017"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0017"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000018"
          xlink:label="Fact000018"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000018"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000019"
          xlink:label="Fact000019"
          xlink:type="locator"/>
        <link:footnote id="Footnote000047" xlink:label="Footnote000047" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Compensation
    Actually Paid reflects the exclusions and inclusions of certain amounts for the PEO and the Non-PEO NEOs as set forth below. Equity
    values are calculated in accordance with FASB ASC Topic 718. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000019"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000019"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000020"
          xlink:label="Fact000020"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000020"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000021"
          xlink:label="Fact000021"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000021"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000021"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0024"
          xlink:label="xdx2ixbrl0024"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0024"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0025"
          xlink:label="xdx2ixbrl0025"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0025"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000026"
          xlink:label="Fact000026"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000026"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000027"
          xlink:label="Fact000027"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000027"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000027"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000028"
          xlink:label="Fact000028"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000028"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000029"
          xlink:label="Fact000029"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000029"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000029"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000032"
          xlink:label="Fact000032"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000032"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000033"
          xlink:label="Fact000033"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000033"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000034"
          xlink:label="Fact000034"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000034"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000035"
          xlink:label="Fact000035"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000035"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000035"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000036"
          xlink:label="Fact000036"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000036"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000037"
          xlink:label="Fact000037"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000037"
          xlink:to="Footnote000047"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000037"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000051"
          xlink:label="Fact000051"
          xlink:type="locator"/>
        <link:footnote id="Footnote000062" xlink:label="Footnote000062" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents
    the total of the grant date fair value of equity award reported in the &#x201c;Stock Awards&#x201d; column in the Summary Compensation
    Table for the applicable year. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000051"
          xlink:to="Footnote000062"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000055"
          xlink:label="Fact000055"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000055"
          xlink:to="Footnote000062"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000059"
          xlink:label="Fact000059"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000059"
          xlink:to="Footnote000062"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000052"
          xlink:label="Fact000052"
          xlink:type="locator"/>
        <link:footnote id="Footnote000063" xlink:label="Footnote000063" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The
    equity award adjustments include the addition (or subtraction, as applicable) of the following: (i) the year-end fair value of any
    equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change
    as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that
    are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in same applicable
    year, the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the applicable year, the amount
    equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for awards granted in prior
    years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount
    equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on
    stock awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or
    included in any other component of total compensation for the applicable year. The valuation assumptions used to calculate fair value
    did not materially differ from those disclosed at the time of grant. The amounts deducted or added in calculating the equity award
    adjustments are as follows: </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000052"
          xlink:to="Footnote000063"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000056"
          xlink:label="Fact000056"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000056"
          xlink:to="Footnote000063"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000060"
          xlink:label="Fact000060"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000060"
          xlink:to="Footnote000063"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0086"
          xlink:label="xdx2ixbrl0086"
          xlink:type="locator"/>
        <link:footnote id="Footnote000089" xlink:label="Footnote000089" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the total of the grant date fair value of the equity
    awards reported in the &#x201c;Stock Awards&#x201d; column in the Summary Compensation Table for the applicable year. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0086"
          xlink:to="Footnote000089"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000087"
          xlink:label="Fact000087"
          xlink:type="locator"/>
        <link:footnote id="Footnote000090" xlink:label="Footnote000090" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The
    equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i)&#160;the
    year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year;
    (ii)&#160;the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any
    awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii)&#160;for awards that
    are granted and vest in same applicable year, the fair value as of the vesting date; (iv)&#160;for awards granted in prior years
    that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in
    fair value; (v)&#160;for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during
    the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi)&#160;the dollar
    value of any dividends or other earnings paid on stock awards in the applicable year prior to the vesting date that are not otherwise
    reflected in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation
    assumptions used to calculate fair value did not materially differ from those disclosed at the time of grant. The amounts deducted
    or added in calculating the equity award adjustments are as follows: </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000087"
          xlink:to="Footnote000090"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000100"
          xlink:label="Fact000100"
          xlink:type="locator"/>
        <link:footnote id="Footnote000112" xlink:label="Footnote000112" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents
    the total of the average grant date fair value of the equity awards reported in the &#x201c;Stock Awards&#x201d; column in the Summary
    Compensation Table for the applicable year for all Non- PEO NEOs. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000100"
          xlink:to="Footnote000112"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000104"
          xlink:label="Fact000104"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000104"
          xlink:to="Footnote000112"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000108"
          xlink:label="Fact000108"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000108"
          xlink:to="Footnote000112"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000102"
          xlink:label="Fact000102"
          xlink:type="locator"/>
        <link:footnote id="Footnote000113" xlink:label="Footnote000113" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The
    equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i) the
    year- end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year;
    (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards
    granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted
    and vest in same applicable year, the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the
    applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v)
    for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year,
    a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends
    or other earnings paid on stock awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair
    value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions used
    to calculate fair value did not materially differ from those disclosed at the time of grant. The amounts deducted or added in calculating
    the equity award adjustments are as follows: </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000102"
          xlink:to="Footnote000113"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000103"
          xlink:label="Fact000103"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000103"
          xlink:to="Footnote000113"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000106"
          xlink:label="Fact000106"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000106"
          xlink:to="Footnote000113"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000107"
          xlink:label="Fact000107"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000107"
          xlink:to="Footnote000113"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000110"
          xlink:label="Fact000110"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000110"
          xlink:to="Footnote000113"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000111"
          xlink:label="Fact000111"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000111"
          xlink:to="Footnote000113"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Kopin
Corporation<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000771266<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="6">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 26, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 28, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 30, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88B_eecd--PvpTableTextBlock_zRpWZcajCUtc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Year</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_484_eecd--PeoTotalCompAmt_hecd--IndividualAxis__custom--JohnCCFanMember_z4wRl1hxl8k" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Table
                                            Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>for
                                            former PEO&#8211;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>John
                                            C.C. Fan</b></span><b><sup id="xdx_F55_zb6YVkpu2qb6">(1)</sup></b></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_48B_eecd--PeoActuallyPaidCompAmt_hecd--IndividualAxis__custom--JohnCCFanMember_zEMRIXLELuL2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Actually
                                            Paid</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>to
                                            former PEO&#8211;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>John
                                            C.C. Fan<sup id="xdx_F5C_zdfgBLSvTxbf">(1)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_484_eecd--PeoTotalCompAmt_hecd--IndividualAxis__custom--MMurrayMember_zHEfdEXFgGi7" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Table
                                            Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>for
                                            PEO&#8211;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>M.
                                            Murray<sup id="xdx_F52_zcnsdqsc2nXl">(1)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_48A_eecd--PeoActuallyPaidCompAmt_hecd--IndividualAxis__custom--MMurrayMember_zGkS5cGILmJ8" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Actually
                                            Paid</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>to
                                            PEO&#8211;</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>M
                                            Murray<sup id="xdx_F58_zWsJJ7DYPXa1">(1)(2)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_48D_eecd--NonPeoNeoAvgTotalCompAmt_z3hVIJxlJDS9" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Table
                                            Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>for
                                            Non-PEO</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEOs<sup id="xdx_F59_zuglffXQwHhj">(1)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_484_eecd--NonPeoNeoAvgCompActuallyPaidAmt_z85v9RHtquGc" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Actually
                                            Paid</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>to
                                            Non-PEO</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEOs<span><sup id="xdx_F5C_zhRjq8b5ahai">(1)(2)</sup></span></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_488_eecd--TotalShareholderRtnAmt_pp2d_zpgChxSN4eH1" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Initial
                                            Fixed</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$100</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Based
                                            On</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Return</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_486_eus-gaap--NetIncomeLoss_iN_di_zSb71LOH3WSd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Net
    Loss</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_412_20231231__20241228_zU2eKW0ZmDpe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0016">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0017">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">2,390,838</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">2,491,558</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">516,011</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="-sec-ix-redline: true">427,512</span></p></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">33.25</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(43,877,896</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_41B_20230101__20231230_zv7f82SojZ84" style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0024">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0025">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">1,042,357</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,651,367</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">602,068</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">684,290</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">49.63</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(19,748,219</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_418_20211226__20221231_zQcEgrBxxTEc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">609,776</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right">(<span style="font-family: Times New Roman, Times, Serif">254,406</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">1,263,936</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,223,936</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">378,934</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right">(<span style="font-family: Times New Roman, Times, Serif">89,244</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="-sec-ix-redline: true">30.32</span></p></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(19,326,265</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table><span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_890_eecd--NamedExecutiveOfficersFnTextBlock_dU_zwyp40JLOSEd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_902_eecd--PeoName_c20211226__20220626_zFGJOJxTSiwi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Fan</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">was
    our PEO for part of fiscal year 2022 and was replaced by <span id="xdx_909_eecd--PeoName_c20220627__20221231_zlOvYzLZSms7">Mr.
    Murray</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for part of fiscal year 2022. <span id="xdx_909_eecd--PeoName_c20231231__20241228_zQEeWYVKwSTf"><span id="xdx_904_eecd--PeoName_c20230101__20231230_zlBst7p3SJPj">Mr.
    Murray</span></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">was PEO for fiscal years 2023 and
    2024. The Non-PEO NEOs for the presented consists of Mr. Sneider and Mr. Baker in 2024 and 2023. The Non-PEO NEOs consisted of
    Messrs. Sneider and Baker and Drs. Tsaur and Choi in 2022.</span></td></tr>
</table>

<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_899_eecd--AdjToPeoCompFnTextBlock_dU_zHHuMAof0Bv3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Year</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_481_eecd--PeoTotalCompAmt_hecd--IndividualAxis__custom--MMurrayMember_zQ6j8WTmiJ7" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reported
                                            Summary</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Table
                                            Total for PEO</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Michael
                                            Murray)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_483_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zPrH3YDavYH5" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reported</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards<sup id="xdx_F57_zpgb0GiYdrZa">(a)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_485_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember_zA4V4Yyp6cpa" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
                                            Award</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjustments<sup id="xdx_F52_zZFn3M0v2AJc">(b)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_48A_eecd--PeoActuallyPaidCompAmt_hecd--IndividualAxis__custom--MMurrayMember_zlr9QbnM7hrf" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Actually
                                            Paid to</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PEO</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Michael
                                            Murray) </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_412_20231231__20241228_zFafbaCTnjD8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">2,390,838</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="-sec-ix-redline: true">(<span style="font-family: Times New Roman, Times, Serif">1,007,880</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,108,600</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">2,491,558</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_41B_20230101__20231230_zl2U9EmvEgE1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">1,042,357</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="-sec-ix-redline: true">(<span style="font-family: Times New Roman, Times, Serif">431,999</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,041,010</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,651,367</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_41E_20220627__20221231_zn8FSskPbaGh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">2022</p>
</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><p style="margin: 0"><span style="-sec-ix-redline: true">1,263,936</span></p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1,032,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><p style="margin: 0">992,000</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><p style="margin: 0">1,223,936</p></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F05_z6RhFUPa3wU2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F11_zdEDv0kMaXK6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the total of the grant date fair value of equity award reported in the &#8220;Stock Awards&#8221; column in the Summary Compensation
    Table for the applicable year. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F02_zr7ZhfIJyHSk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1F_z2XxxZFMjVnj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    equity award adjustments include the addition (or subtraction, as applicable) of the following: (i) the year-end fair value of any
    equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change
    as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that
    are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in same applicable
    year, the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the applicable year, the amount
    equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for awards granted in prior
    years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount
    equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on
    stock awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or
    included in any other component of total compensation for the applicable year. The valuation assumptions used to calculate fair value
    did not materially differ from those disclosed at the time of grant. The amounts deducted or added in calculating the equity award
    adjustments are as follows: </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Year</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_487_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember__ecd--AdjToCompAxis__custom--YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember_z0s5a8OoOWcc" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            End Fair</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            of Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Award
                                            Granted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>during
                                            Year</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>that
                                            Remains</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unvested
                                            </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_487_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_zzwtBVdwR6r4" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            over</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            Change</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in
                                            Fair Value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unvested</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_48E_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember__ecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_z94ceg9Pzne2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            as</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vesting</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Granted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vested</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in
                                            the Year</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_486_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember_zy7jwfIfeXWh" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change
                                            in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
                                            Value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
                                            Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Granted
                                            in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prior
                                            Years</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>that
                                            Vested</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in
                                            the Year</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_485_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember__ecd--AdjToCompAxis__custom--FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember_zmLfWJHSgSb3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
                                            Value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>at
                                            the End</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
                                            the</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prior
                                            Year</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
                                            Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>that
                                            Failed</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>to
                                            Meet</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vesting</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Conditions</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in
                                            the Year</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_486_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember__ecd--AdjToCompAxis__custom--ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember_zlX1Xo6lhJA9" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends
                                            or</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Earnings</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid
                                            on Stock</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards
                                            not</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Otherwise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reflected
                                            in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
                                            Value or</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_48A_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--MMurrayMember_zOQ0Po365Q7l" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Award</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjustments
                                            </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_412_20231231__20241228_zUYYsPHu85J5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,668,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right">(<span style="font-family: Times New Roman, Times, Serif">328,533</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0066">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(220,392</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,475</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0069">&#8212;</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,108,600</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_41B_20230101__20231230_zDNnbRYbENa3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">428,190</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">505,600</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">56,020</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">51,200</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0075">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0076">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,041,010</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_41E_20220627__20221231_zadP0vScuEd4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">992,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0079">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0080">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0081">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0082">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0083">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">992,000</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">For Dr. Fan:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Year</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_488_eecd--PeoTotalCompAmt_hecd--IndividualAxis__custom--DrFanMember_zgANI7iBLIrg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported<br/> Summary<br/>
    Compensation<br/> Table Total for<br/> Former PEO<br/> (John C.C. Fan)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_484_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_zT2KELBmfOJ1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported<br/>
    Value of<br/> Equity<br/>
    Awards<span id="xdx_F54_z1gHOC6GC5Qk">(a)</span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48D_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember_zw0mnUjJEqXa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Equity
    Award<br/> Adjustments<span id="xdx_F51_ziLhoKWKNyrh">(b)</span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48B_eecd--PeoActuallyPaidCompAmt_hecd--IndividualAxis__custom--DrFanMember_znoiyykjJRm5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Compensation<br/> Actually<br/> Paid
    to<br/> Former PEO<br/> (John<br/> C.C.Fan)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_418_20211226__20221231_zxDdt3m37cm5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 24%; text-align: justify">2022</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">609,776</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0086">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">(864,182</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">(254,406</td><td style="width: 1%; text-align: left">)</td></tr>
  </table>



<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="width: 0.5in">&#160;</td>
    <td style="vertical-align: top; width: 0.25in"><span id="xdx_F00_zLaKcgg2L1cj" style="font-size: 10pt">(a)</span></td>
    <td style="vertical-align: top"><span id="xdx_F14_z55aOHeFNCU4" style="font-size: 10pt">Represents the total of the grant date fair value of the equity
    awards reported in the &#8220;Stock Awards&#8221; column in the Summary Compensation Table for the applicable year. </span></td></tr>

<tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
<tr>
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 0.25in"><span id="xdx_F0E_zAqV709ELNFf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="text-align: justify; vertical-align: top"><span id="xdx_F11_zp2CHklhu3I9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i)&#160;the
    year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year;
    (ii)&#160;the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any
    awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii)&#160;for awards that
    are granted and vest in same applicable year, the fair value as of the vesting date; (iv)&#160;for awards granted in prior years
    that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in
    fair value; (v)&#160;for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during
    the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi)&#160;the dollar
    value of any dividends or other earnings paid on stock awards in the applicable year prior to the vesting date that are not otherwise
    reflected in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation
    assumptions used to calculate fair value did not materially differ from those disclosed at the time of grant. The amounts deducted
    or added in calculating the equity award adjustments are as follows: </span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Year</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48D_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember__ecd--AdjToCompAxis__custom--YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember_zcgB7BD4mRBk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Granted<br/> during Year<br/> that<br/>
    Remains<br/> Unvested<br/> Year&#160;End&#160;Fair<br/> Value of<br/> Equity Award</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_483_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_z1LX1UmN5x3c" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year over<br/> Year Change<br/>
    in Fair Value<br/> of<br/> Outstanding<br/> and<br/> Unvested<br/> Equity<br/> Awards</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48B_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember__ecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_zQeDQ9Awfg75" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value<br/> as of<br/> Vesting<br/>
    Date of<br/> Equity<br/> Awards<br/> Granted<br/> and Vested<br/> in the&#160;Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48A_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember__ecd--AdjToCompAxis__custom--ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember_zlEngPYUEjDe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Change in<br/> Fair Value<br/> of
    Equity<br/> Awards<br/> Granted&#160;in<br/> Prior Years<br/> that Vested<br/> in the Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48E_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember__ecd--AdjToCompAxis__custom--FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember_z8sv8QaEEYgk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value<br/> at the End<br/> of
    the Prior<br/> Year of<br/> Equity<br/> Awards<br/> that Failed<br/> to Meet<br/> Vesting<br/> Conditions<br/> in the Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48E_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember__ecd--AdjToCompAxis__custom--ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember_zPWjbhLW4Z1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value of<br/> Dividends or<br/> other<br/>
    Earnings <br/> Paid on Stock<br/> Awards not<br/> Otherwise<br/> Reflected in<br/> Fair Value or<br/> Total<br/> Compensation</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48C_eecd--AdjToCompAmt_hecd--IndividualAxis__custom--DrFanMember_z6Nz2eP0ZuH6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total<br/> Equity<br/> Award<br/> Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_418_20211226__20221231_zw30x4IiQsZ5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%; text-align: justify; text-indent: -12pt; padding-left: 12pt">2022</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0091">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">(94,860</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0093">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">(493,723</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><span style="-sec-ix-redline: true">(275,599</span></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0096">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">(864,182</td><td style="width: 1%; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 516,011<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 602,068<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 378,934<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 427,512<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">684,290<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">89,244<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_894_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zFN0DfyZZ3Pf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Year</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_481_eecd--NonPeoNeoAvgTotalCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember_zYnhtNet5cM2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reported</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Table
                                            Total for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-PEO</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEOs<sup id="xdx_F5E_zBntIm0ubbpk">(a)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_482_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_z75OrM2woAp" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reported</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            of Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_480_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember_zSNIylIFC0i1" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average
                                            Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Award</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjustments<sup id="xdx_F5B_zw90ROD8V3ll">(b)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_486_eecd--NonPeoNeoAvgCompActuallyPaidAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember_ztvw3FN3EqX" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average
                                            Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Actually</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid
                                            to Non-PEO</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEOs<sup id="xdx_F54_zvOxqNQbwXr4">(b)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_412_20231231__20241228_zuFT2YBeL5F7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 24%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">516,011</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(159,873</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">71,375</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 15%; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">427,512</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_41B_20230101__20231230_ziQGj7MPTKw1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">602,068</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="-sec-ix-redline: true">(<span style="font-family: Times New Roman, Times, Serif">255,140</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">337,362</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">684,290</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_418_20211226__20221231_zT2TvIYh3Wxc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td style="padding-bottom: 1pt; text-align: right">378,934</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td style="padding-bottom: 1pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0109">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td style="padding-bottom: 1pt; text-align: right">(468,178</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td style="padding-bottom: 1pt; text-align: right">(89,244</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span id="xdx_F0C_zoJmxMA2MSY4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F11_zQpwRaImKLk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the total of the average grant date fair value of the equity awards reported in the &#8220;Stock Awards&#8221; column in the Summary
    Compensation Table for the applicable year for all Non- PEO NEOs. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F0F_zYv5J8d1759c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F17_zwFGwrDqsNQ1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i) the
    year- end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year;
    (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards
    granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted
    and vest in same applicable year, the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the
    applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v)
    for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year,
    a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends
    or other earnings paid on stock awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair
    value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions used
    to calculate fair value did not materially differ from those disclosed at the time of grant. The amounts deducted or added in calculating
    the equity award adjustments are as follows: </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Year</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_488_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember_z1q7H81SMZ67" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            End</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
                                            Value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
                                            Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Award</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Granted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>during</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            that</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remains</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unvested</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_48F_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember_zBu658BZKngg" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            over</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change
                                            in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
                                            Value of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unvested
                                            Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_480_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember_zQcyI5rHd7yj" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair</b></span> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            as</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vesting</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Granted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vested</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in
                                            the</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_484_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember_ziEayOBWkpe5" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            over</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change
                                            in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
                                            Value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
                                            Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Granted
                                            in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prior</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Years
                                            that</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vested
                                            in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>the
                                            Year </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_489_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember_zxraYp4bQMZd" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average
                                            Fair</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            at the</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>End
                                            of the</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prior
                                            Year of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards
                                            that</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Failed
                                            to</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Meet
                                            Vesting</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Conditions
                                            in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>the
                                            Year </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_483_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember_zvb4YGl5cLy7" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average
                                            Value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
                                            Dividends or</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>other
                                            Earnings</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid
                                            on Stock</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards
                                            not</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Otherwise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reflected
                                            in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
                                            Value or</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
                                            </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_48E_eecd--AdjToCompAmt_hecd--IndividualAxis__ecd--NonPeoNeoMember_zzLZlLyzyM15" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Award</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjustments
                                            </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_412_20231231__20241228_zWYCWtAprAP3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">164,090</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="-sec-ix-redline: true">(<span style="font-family: Times New Roman, Times, Serif">27,840</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0116">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-redline: true">(57,187</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,688</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0119">&#8212;</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">71,375</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_41B_20230101__20231230_zfXUfxQAXgjh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">260,026</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,130</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">45,538</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,920</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(15,252</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0126">&#8212;</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">337,362</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_418_20211226__20221231_zQNDfM9nSzu4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0128">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(276,055</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0130">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(94,670</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(97,453</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0133">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(468,178</td><td style="text-align: left">)</td></tr>
</table>

<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_899_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zsBe2f9AfGW2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="formdef14a_001.jpg" style="height: 591px; width: 800px"/></p>

<p id="xdx_89D_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zdQLge7iPOxb" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="formdef14a_002.jpg" style="height: 520px; width: 750px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
Compensation Plan Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information as of December 28, 2024 about shares of our common stock issuable upon exercise of outstanding
options, warrants and rights and available for issuance under our existing equity compensation plans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Plan Category</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of securities to</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>be
                                            issued upon exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
                                            outstanding options,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>warrants
                                            and rights</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>exercise
                                            price of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>outstanding
                                            options,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>warrants
                                            and rights</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>remaining
                                            available</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>for
                                            future issuance</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>under
                                            equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>compensation
                                            plans</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(excluding
                                            securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>reflected
                                            in column (a)) </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(a)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(b)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(c)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity compensation
    plans approved by security holders<sup>(1)</sup></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,833,611</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.19</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,913,621</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;<sup>(2)</sup></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Equity compensation plans not approved by security holders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">&#8212;</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">&#8212;</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">&#8212;</p></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">4,833,611</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><p style="margin: 0">1.19</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0; text-indent: 0.25in">4,913,621</p></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of shares available under the 2020 Equity Incentive Plan.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 28, 2024, there were 4,913,621 shares available for grant under the 2020 Equity Incentive Plan.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Compensation Commencing in Fiscal Year 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2023, the Compensation Committee engaged Aon to perform a peer review of our Board of Director compensation. Commencing in 2024
our Board-approved compensation for non-employee directors is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
    retainer: $40,000 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Annual
    stock grant: 64,500 shares of restricted stock which vest on the anniversary of the grant Committee membership fees paid annually:</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    Committee Chairperson: $15,000 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Non-employee Chairperson of the Board: $30,000</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominating
    Committee Chairperson: $10,000 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
    Committee Chairperson: $10,000 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    Committee member: $8,000 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominating
    Committee member: $4,375 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
    Committee member: $5,000 </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the adoption of the Board Compensation plan commencing in 2024 the following adjustments were made:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Annual retainer was decreased from $45,000 to $40,000 </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
    annual stock grant was increased to 64,500 shares of restricted stock from 10,000 shares Committee membership fees paid annually:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Non-employee Chairperson of the Board: $30,000</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    Committee Chairperson compensation was increased $5,000</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
    Committee Chairperson compensation increased $6,250 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    Committee member compensation increased $3,000 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominating
    Committee member compensation increased $1,875 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Compensation Committee
    member compensation decreased $1,250</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Meeting
    fees were eliminated</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
non-employee director was also entitled to receive an initial restricted stock award for 64,500 shares of our common stock on the date
of his or her initial election to the Board. We also pay expenses for attendance at meetings of the Board and committees thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information regarding the compensation earned by or awards to each non-employee director who served
on our Board of Directors in the 2024 fiscal year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Murray, who was an employee of Kopin during 2024, was not compensated for his service as director and his compensation is fully reflected
in the Summary Compensation Table above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Compensation Table for 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fees</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Earned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>or
                                            Paid</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in
                                            Cash</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)<sup>(1)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)<sup>(2)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incentive</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)<sup>(3)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change
                                            in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pension
                                            Value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nonqualified</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deferred</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Earnings<sup>(3)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All
                                            Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)<sup>(3)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)
                                            </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jill J. Avery<sup>(4)</sup></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">61,188</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,310</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">111,498</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chi Chia Hsieh<sup>(5)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">54,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,310</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">104,310</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Nieuwsma <sup>(6)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">55,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,310</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">105,310</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Margaret Seif<sup>(7)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,188</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,310</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">85,828</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul Walsh, Jr.<sup>(8)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,333</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">54,573</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">81,907</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    Board member received his or her annual restricted stock grant of 64,500 shares which vests on the anniversary of the grant if the
    person is still a member of our Board of Directors on such anniversary with the exception of Mr. Walsh. The amounts in the column
    were determined by multiplying the number of shares of restricted common stock granted by the closing price of our common stock as
    listed on the Nasdaq on the day of grant. The 2024 grant occurred on June 6, 2024, and the closing price of our stock was $0.78.
    Mr. Walsh joined the Board of Directors on September 9, 2024 and he was granted 64,500 shares of restricted stock. Our stock price
    on September 9, 2024 was $0.85. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
    were no stock options issued in 2024. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    non-equity incentive compensation, pension, non-qualified deferred compensation or other compensation payments were made as compensation
    for director services in fiscal year 2024 or are contemplated under our current compensation plan. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Avery&#8217;s annual cash fees were comprised of the annual retainer of $40,000, $7,188 for serving on the Nominating Committee,
    and $8,000 for serving on the Audit Committee. In addition, prior to the implementation of the current Board member compensation
    plan members were paid meeting fees. Ms. Avery was paid $2,000 for attending meetings of the Board and $4,000 for attending meetings
    of the Audit Committee under the prior Board member compensation plan. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Hsieh&#8217;s annual cash fees were comprised of the annual retainer of $40,000 and $10.000 for serving as the Compensation Committee
    Chairperson. In addition, prior to the implementation of the current Board member compensation plan members were paid meeting fees.
    Dr. Hsieh was paid $2,000 for attending meetings of the Board and $2,000 for attending meetings of the Compensation Committee under
    the prior Board member compensation plan.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Nieuwsma&#8217;s annual cash fees were comprised of the annual retainer of $40,000, $8,000 for serving on the Audit Committee and
    $5.000 for serving as the Compensation Committee. In addition, prior to the implementation of the current Board member compensation
    plan members were paid meeting fees. Mr. Nieuwsma was paid $2,000 for attending meetings of the Board. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Sief&#8217;s annual cash fees were comprised of the annual retainer of $40,000, $7,188 for serving as Chairperson of the Nominating
    Committee and $5.000 for serving on the Compensation Committee. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Walsch, Jr.&#8217;s annual cash fees were comprised of a prorated annual retainer of $12,333, and $15,000 for serving as the Audit
    Committee Chairperson. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    Director, excluding Michael Murray, has 64,500 of unvested restricted shares.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Committee Report</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee of the Board currently consists of Paul Walsch, Jr., Jill J. Avery and David Nieuwsma, each of whom the Board
has determined is independent under applicable SEC and Nasdaq Rules. The Board also has determined that Mr. Walsh is an &#8220;audit
committee financial expert&#8221; under applicable SEC rules and regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Audit Committee is to assist the Board in its general oversight of the Company&#8217;s financial reporting, internal controls
and audit functions. The Audit Committee charter, which is available at the Company&#8217;s website at <i>www.kopin.com</i>, under the
heading &#8220;Investors: Corporate Governance,&#8221; describes in greater detail the full responsibilities of the Audit Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
is responsible for the preparation, presentation and integrity of the Company&#8217;s financial statements; accounting and financial
reporting principles; establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)); establishing
and maintaining internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f)); evaluating the effectiveness of
disclosure controls and procedures; evaluating the effectiveness of internal control over financial reporting; and evaluating any change
in internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, internal control
over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BDO
USA, P.C.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> (&#8220;BDO&#8221;), the Company&#8217;s
independent registered public accounting firm, has been engaged to perform an independent audit of the consolidated financial statements
and to express an opinion on the conformity of those financial statements with accounting principles generally accepted in the United
States of America and also to express an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting.
The Audit Committee has reviewed and discussed the consolidated financial statements with management and BDO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the course of the 2024 fiscal year, management completed the documentation, testing and evaluation of the Company&#8217;s system of internal
control over financial reporting in response to the requirements set forth in Section 404 of the Sarbanes-Oxley Act of 2002 and related
rules and regulations. The Audit Committee was kept apprised of the progress of the evaluation and provided oversight and advice to management
during this process. In connection with this oversight, the Audit Committee also received periodic updates provided by management and
Stowe &amp; Degon LLC, an independent registered public accounting firm that the Company uses for internal controls review, at regularly
scheduled Audit Committee meetings. At the conclusion of the process, management provided the Audit Committee with, and the Audit Committee
reviewed, a report on the effectiveness of the Company&#8217;s internal control over financial reporting. The Audit Committee also received
a report of results from Stowe &amp; Degon LLC. The Audit Committee also reviewed the report of management contained in the Company&#8217;s
Annual Reports on Form 10-K for the fiscal year ended December 28, 2024, filed with the SEC, as well as BDO&#8217;s Reports of Independent
Registered Public Accounting Firm included in the Company&#8217;s Annual Report on Form 10-K related to its audit of the consolidated
financial statements and financial statement schedule, for the fiscal year ended December 28, 2024. In conjunction, the Audit Committee
continues to oversee the Company&#8217;s efforts related to its internal control over financial reporting and management&#8217;s preparations
for the evaluation in fiscal year 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee has discussed with BDO the matters that are required to be discussed by applicable standards of the Public Company Accounting
Oversight Board (&#8220;PCAOB&#8221;), including Statement on Auditing Standards No. 61, &#8220;<i>Communication with Audit Committees</i>,&#8221;
as amended, and as adopted by the PCAOB, as well as Rule 2-07 of Regulation S-X of the SEC &#8220;<i>Communication with Audit Committees</i>.&#8221;
BDO has also provided to the Committee its letter required by PCAOB Ethics and Independence Rule 3526, &#8220;<i>Communications with
Audit Committees Concerning Independence</i>,&#8221; and the Committee discussed with RSM the firm&#8217;s independence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on its review and the discussion noted above, the Audit Committee recommended to the Board that the Company&#8217;s Consolidated Financial
Statements for the fiscal year 2024 be included in the Company&#8217;s Annual Report on Form 10-K for the 2024 fiscal year for filing
with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUDIT
    COMMITTEE</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Walsh, Jr., Chairperson </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jill
    J. Avery </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Nieuwsma</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
2</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>APPROVAL
OF AN AMENDMENT TO THE COMPANY&#8217;S 2020 EQUITY INCENTIVE PLAN</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Equity Incentive Plan Amendment Proposal&#8212;</b> The Board has authorized, subject to stockholder approval, an amendment to our 2020
Equity Incentive Plan (the &#8220;2020 EIP&#8221;) to increase the number of shares available under the 2020 EIP by 5,000,000 shares
(the &#8220;Plan Amendment&#8221;). Currently, the 2020 EIP authorizes the issuance of up to 14,000,000 shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the 2020 EIP is to encourage ownership of the Company&#8217;s common stock by key employees and to provide additional incentive
for such employees to promote the success of the Company&#8217;s business. The Board believes that the 2020 EIP:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aligns
    the long-term interests of key employees and stockholders by creating a direct link between key employee compensation and stockholder
    return; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enables
    key employees to develop and maintain a meaningful stock ownership in the Company; and </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provides
    incentives for key employees to contribute to the success of the Company. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan Amendment is being submitted to stockholders for approval. A copy of the 2020 EIP as it is proposed to be amended is attached to
this Proxy Statement as Appendix A. The Board believes it is in the best interests of the Company and its stockholders to approve the
Plan Amendment to increase the number of shares available under the 2020 EIP by 5,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
total of 19,000,000 shares of Kopin common stock will be reserved for issuance under the amended 2020 EIP. As of April 30, 2025,
the closing price on Nasdaq per share of common stock was $1.28. Our Board approved the Plan Amendment on March 20, 2025, subject to
approval by Kopin&#8217;s stockholders. The Plan Amendment will be effective upon approval by Kopin&#8217;s stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">The following table
includes information regarding all of our outstanding equity awards and shares available for future awards under the Plan as of May
1, 2025:</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Total number of shares underlying outstanding stock options</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">591,366</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Weighted average exercise price of outstanding stock options</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.76</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Weighted average remaining life of outstanding stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.75</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total shares of common stock outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">162,797,922</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total shares underlying outstanding and unvested restricted stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,492,501</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Shares available for future awards under the 2020 Equity Incentive plan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,343,521</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reasons
for the Amendment to the 2020 EIP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
incentive compensation programs play a pivotal role in Kopin&#8217;s efforts to attract and retain key personnel essential to Kopin&#8217;s
long-term growth and financial success. We are asking our stockholders to approve the Plan Amendment to assist Kopin in attracting and
retaining qualified personnel. If our stockholders do not approve the Plan Amendment, we will be limited in our ability to continue to
issue awards in numbers sufficient to attract and motivate the highly skilled employees we need to recruit and retain, due to low share
reserves remaining in our 2020 EIP and the dilution to our share reserve and outstanding equity awards from the increase in our stock
outstanding from recent financing activities, and our employees&#8217; motivation and incentives will be negatively affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering
a broad-based equity compensation program is vital to attracting and retaining highly skilled people in the highly competitive technology
industry. We use equity awards to increase incentives on the part of employees, non-employee directors and consultants who provide significant
services to the Company. We believe that providing an equity stake in the future success of our business encourages our employees to
be highly motivated to achieve our long-term business goals and to increase stockholder value. Their innovation and productivity are
critical to our success. Accordingly, approving the Plan Amendment is in the best interest of our stockholders because equity awards
help us to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">attract,
    motivate and retain talented employees and directors; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">align
    employee and stockholder interests; and </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">link
    employee compensation with Kopin&#8217;s performance. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
strongly believe that approval of the Plan Amendment will enable us to achieve our goals in attracting and retaining our most valuable
asset: our employees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
the appropriate share reserve to grant competitive equity-based incentives, we would be forced to consider cash replacement alternatives
to provide a market-competitive total compensation package necessary to attract, retain and motivate the employee talent critical to
our future successes. These cash replacement alternatives could, among other things, reduce the cash available for investment in growth
and development and cause a loss of motivation by employees to achieve superior performance over a longer period of time. Equity- based
incentives, by contrast, directly align a portion of the compensation of our employees with the economic interests of our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
that reason, Kopin has structured the 2020 EIP to provide flexibility in designing equity incentive programs with a broad array of equity
incentives, such as stock options, stock appreciation rights, stock awards and restricted stock units and implement competitive incentive
compensation programs for its employees and non-employee Board members. The 2020 EIP will continue to be the only plan under which new
equity awards may be granted to our employees and other service providers. If this Proposal 2 is not approved, then we would be at a
disadvantage against our competitors for recruiting, retaining and motivating individuals critical to our success and could be forced
to increase cash compensation, thereby reducing resources available to meet our business needs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of May 1, 2025, 11,668,479 shares of common stock, net of 4,373,315 of forfeitures, had been issued pursuant to awards under the
2020 EIP. All awards outstanding under the 2020 EIP on the date of the Plan Amendment will continue to be governed solely by the terms
of the documents evidencing such awards, and no provision of the Plan Amendment will be deemed to affect or otherwise modify the rights
or obligations of the holders of such transferred awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with our stock-based compensation programs, we are committed to using equity incentive awards prudently and within reasonable
limits. We anticipate that the share reserve under the amended 2020 EIP, will enable us to fund our equity compensation program for approximately
two years. While we believe this is a reasonable estimate of how long the share reserve would last, the actual period for which the proposed
share reserve will fund our equity compensation program may be shorter or longer than expected, depending on changes in our granting
practices, stock price and headcount growth.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
Description of the Kopin Corporation 2020 Equity Incentive Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of the principal provisions of the 2020 EIP. This summary is qualified in its entirety by reference to the full
text of the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Types
of Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2020 EIP provides for the issuance of stock options (including non-statutory stock options and incentive stock option), stock appreciation
rights (referred to as &#8220;SARs&#8221;), restricted stock, restricted stock units (&#8220;RSUs&#8221;), stock bonuses and other stock-based
awards to officers, employees, non-employee directors, independent contractors and consultants of Kopin Corporation or its affiliates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purpose
and Types of Grants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the 2020 EIP is to attract and retain employees, non-employee directors and consultants, and advisors. The 2020 EIP provides
for the issuance of incentive stock options, non-qualified stock options, stock awards, stock units, stock appreciation rights and other
stock-based awards. The 2020 EIP is intended to provide an incentive to participants to contribute to our economic success by aligning
the economic interests of participants with those of our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Administration</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2020 EIP is administered by the Compensation Committee of our Board, and the Compensation Committee will determine all of the terms and
conditions applicable to grants under the 2020 EIP. Our Compensation Committee determines who receives grants under the 2020 EIP and
the number of shares of common stock that will be subject to grants, except that grants to members of our Board must be authorized by
a majority of our Board. Our Compensation Committee may delegate authority under the 2020 EIP to one or more subcommittees as it deems
appropriate. Subject to compliance with applicable law and stock exchange requirements, the Compensation Committee (or our Board or a
subcommittee, as applicable) may delegate all or part of its authority to our Chief Executive Officer, as it deems appropriate, with
respect to grants to employees or key advisors who are not executive officers under Section 16 of the Exchange Act. Our Compensation
Committee, our Board, any subcommittee or the Chief Executive Officer, as applicable, that has authority with respect to a specific grant
will be referred to as &#8220;the committee&#8221; in this description of the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shares
Subject to the Plan</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to adjustment, our 2020 EIP currently authorizes the issuance or transfer of up to 14,000,000 shares of our common stock. In addition,
shares of common stock underlying any outstanding award granted under the Prior Plan that, following the effective date of the 2020 EIP,
expires, or is terminated, surrendered or forfeited for any reason without issuance of such shares shall be available for new grants
under the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any options or SARs expire or are canceled, forfeited, exchanged or surrendered without having been exercised, or if any stock awards,
stock units or other stock-based awards are forfeited, terminated or otherwise not paid in full, the shares of our common stock subject
to such awards will again be available for purposes of the 2020 EIP. If shares of our common stock are surrendered in payment of the
exercise price of an option, the number of shares of common stock available for issuance under the 2020 EIP will be reduced only by the
net number of shares actually issued by us upon such exercise and not by the gross number of shares as to which such option is exercised.
Upon the exercise of any SAR under the 2020 EIP, the number of shares of our common stock available for issuance will be reduced only
by the net number of shares actually issued by us upon such exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
shares of our common stock are withheld by us in satisfaction of the withholding taxes incurred in connection with the issuance, vesting
or exercise of any grant or the issuance of our common stock under the 2020 EIP, the number of shares of common stock available for issuance
will be reduced by the net number of shares issued, vested or exercised under such grant, calculated in each instance after payment of
such share withholding. If any awards are paid in cash, and not in shares of our common stock, any shares of our common stock subject
to such awards will also be available for future awards. If we repurchase shares of our common stock on the open market with the proceeds
from the exercise price we receive from options, the repurchased shares will not be available for issuance under the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Individual
Limits for Non-Employee Directors</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
maximum aggregate grant date value of shares of common stock granted to any non-employee director in any one calendar year, taken together
with any cash fees earned by such non-employee director for services rendered during the calendar year, shall not exceed $250,000 in
total value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Adjustments</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with stock splits, stock dividends, recapitalizations and certain other events affecting our common stock, the committee will
make adjustments as it deems appropriate in: the maximum number of shares of common stock reserved for issuance as grants; the maximum
amount of awards that may be granted to any individual non-employee director in any year; the number and kind of shares covered by outstanding
grants; the number and kind of shares that may be issued under the 2020 EIP; the price per share or market value of any outstanding grants;
the exercise price of options; the base amount of stock appreciation rights; and the performance goals or other terms and conditions
as the committee deems appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Eligibility
and Vesting</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of our employees are eligible to receive grants under the 2020 EIP. In addition, our non-employee directors and key advisors who perform
services for us may receive grants under the 2020 EIP. The committee determines the vesting and exercisability terms of awards granted
under the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Options</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our 2020 EIP, the committee determines the exercise price of the options granted and may grant options to purchase shares of our common
stock in such amounts as it determines. The committee may grant options that are intended to qualify as incentive stock options under
Section 422 of the Code, or non-qualified stock options, which are not intended to so qualify. Incentive stock options may only be granted
to our employees. Anyone eligible to participate in the 2020 EIP may receive a grant of non-qualified stock options. The exercise price
of a stock option granted under the 2020 EIP cannot be less than the fair market value of a share of our common stock on the date the
option is granted. If an incentive stock option is granted to a 10% stockholder of the total combined voting power of all classes of
our stock, the exercise price cannot be less than 110% of the fair market value of a share of our common stock on the date the option
is granted. The aggregate number of shares of common stock that may be issued or transferred under the 2020 EIP pursuant to incentive
stock options under Section 422 of the Code may not exceed 10% of the number of shares of common stock outstanding on the effective date
of the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price for any option is generally payable in cash. In certain circumstances as permitted by the committee, the exercise price
may be paid: by the surrender of shares of our common stock with an aggregate fair market value, on the date the option is exercised,
equal to the exercise price; by payment through a broker in accordance with procedures established by the Federal Reserve Board; by withholding
shares of common stock subject to the exercisable option that have a fair market value on the date of exercise equal to the aggregate
exercise price; or by such other method as the committee approves.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term of an option cannot exceed ten years from the date of grant, except that if an incentive stock option is granted to a 10% stockholder
of the total combined voting power of all class of our stock, the term cannot exceed five years from the date of grant. In the event
that on the last day of the term of a non-qualified stock option, the exercise is prohibited by applicable law, including a prohibition
on purchases or sales of our common stock under our insider trading policy, the term of the non-qualified option will be extended for
a period of 30 days following the end of the legal prohibition, unless the committee determines otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as provided in the grant instrument, an option may only be exercised while a participant is employed by or providing service to us. The
committee will determine in the grant instrument under what circumstances and during what time periods a participant may exercise an
option after termination of employment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2020 EIP, the committee may grant stock awards. A stock award is an award of our common stock that may be subject to restrictions
as the committee determines. The restrictions, if any, may lapse over a specified period of employment or based on the satisfaction of
pre-established criteria, in installments or otherwise, as the committee may determine, including, but not limited to, restrictions based
on the achievement of performance goals. Except to the extent restricted under the grant instrument relating to the stock award, a participant
will have all of the rights of a stockholder as to those shares, including the right to vote and the right to receive dividends or distributions
on the shares. Dividends with respect to stock awards that vest based on performance shall vest if and to the extent that the underlying
stock award vests, as determined by the committee. All unvested stock awards are forfeited if the participant&#8217;s employment or service
is terminated for any reason, unless the committee determines otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Units</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2020 EIP, the committee may grant stock units to anyone eligible to participate in the 2020 EIP. Stock units represent hypothetical
shares of our common stock. Stock units become payable on terms and conditions determined by the committee, including specified performance
goals, and will be payable in cash, shares of common stock, or a combination thereof, as determined by the committee. All unvested stock
units are forfeited if the participant&#8217;s employment or service is terminated for any reason, unless the committee determines otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Appreciation Rights</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2020 EIP, the committee may grant SARs, which may be granted separately or in tandem with any option. SARs granted in tandem with
a non-qualified stock option may be granted either at the time the non- qualified stock option is granted or any time thereafter while
the option remains outstanding. SARs granted in tandem with an incentive stock option may be granted only at the time the grant of the
incentive stock option is made. The committee will establish the base amount of the SAR at the time the SAR is granted, which will be
equal to or greater than the fair market value of a share of our common stock as of the date of grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a SAR is granted in tandem with an option, the number of SARs that are exercisable during a specified period will not exceed the number
of shares of our common stock that the participant may purchase upon exercising the related option during such period. Upon exercising
the related option, the related SARs will terminate, and upon the exercise of a SAR, the related option will terminate to the extent
of an equal number of shares of our common stock. Generally, SARs may only be exercised while the participant is employed by, or providing
services to, us. When a participant exercises a SAR, the participant will receive the excess of the fair market value of the underlying
common stock over the base amount of the SAR. The appreciation of a SAR will be paid in shares of our common stock, cash or both.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term of a SAR cannot exceed ten years from the date of grant. In the event that on the last day of the term of a SAR, the exercise is
prohibited by applicable law, including a prohibition on purchases or sales of our common stock under our insider trading policy, the
term of the SAR will be extended for a period of 30 days following the end of the legal prohibition, unless the committee determines
otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Stock-Based Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2020 EIP, the committee may grant other types of awards that are based on, or measured by, our common stock, and granted to anyone
eligible to participate in the 2020 EIP. The committee will determine the terms and conditions of such awards. Other stock-based awards
may be payable in cash, shares of our common stock or a combination of the two, as determined by the committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividend
Equivalents</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2020 EIP, the committee may grant dividend equivalents in connection with grants of stock units or other stock-based awards made
under the 2020 EIP. Dividend equivalents entitle the participant to receive amounts equal to ordinary dividends that are paid on the
shares underlying a grant while the grant is outstanding. The committee will determine whether dividend equivalents will be paid currently
or accrued as contingent cash obligations. Dividend equivalents may be paid in cash or shares of our common stock. The committee will
determine the terms and conditions of the dividend equivalent grants, including whether the grants are payable upon the achievement of
specific performance goals. Dividend equivalents with respect to stock units or other stock-based awards that vest based on performance
shall vest and be paid only if and to the extent that the underlying stock units or other stock-based awards vest and are paid as determined
by the committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Prohibition
on Repricing</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the 2020 EIP, the committee may not (i) amend the terms of any outstanding stock options or SARs to reduce the exercise
price or base price, as applicable, (ii) cancel outstanding stock options or SARs in exchange for stock options or SARs with an exercise
price or base price, as applicable, that is less than the exercise price or base price of the original stock options or SARs or (iii)
cancel outstanding stock options or SARs with an exercise price or base price, as applicable, above the current stock price in exchange
for cash or other securities, except in connection with a corporate transaction involving the Company, without in each such instance
obtaining the approval of our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change
of Control</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we experience a change of control where we are not the surviving corporation (or survive only as a subsidiary of another corporation),
unless the committee determines otherwise, all outstanding grants that are not exercised or paid at the time of the change of control
will be assumed by, or replaced with grants (with respect to cash, securities or a combination thereof) that have comparable terms by,
the surviving corporation (or a parent or subsidiary of the surviving corporation).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise set forth in a grant instrument, if a participant is terminated without cause upon or within 12 months of a change of control,
all outstanding time-based awards shall become fully vested.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
there is a change of control and all outstanding grants are not assumed by, or replaced with grants that have comparable terms by the
surviving corporation, the committee may (but is not obligated to) make adjustments to the terms and conditions of outstanding grants,
including, without limitation, taking any of the following actions (or combination thereof) without the consent of any participant:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determine
    that outstanding options and SARs will accelerate and become fully exercisable and the restrictions and conditions on outstanding
    stock awards, stock units and dividend equivalents immediately lapse; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pay
    participants, in an amount and form determined by the committee, in settlement of outstanding stock units or dividend equivalents;
    </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">require
    that participants surrender their outstanding stock options and SARs in exchange for a payment by us, in cash or shares of our common
    stock, equal to the difference between the exercise price and the fair market value of the underlying shares of our common stock;
    provided, however, if the per share </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fair
    market value of our common stock does not exceed the per share stock option exercise price or stock appreciation right base amount,
    as applicable, we will not be required to make any payment to the participant upon surrender of the stock option or stock appreciation
    right; or </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">after
    giving participants an opportunity to exercise all of their outstanding stock options and SARs, terminate any unexercised stock options
    and SARs on the date determined by the committee. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general terms, a change of control under the 2020 EIP occurs if:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    person, entity or affiliated group, with certain exceptions, acquires more than 50% of our then- outstanding voting securities; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    merge into another entity unless the holders of our voting shares immediately prior to the merger have at least 50% of the combined
    voting power of the securities in the merged entity or its parent; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    merge into another entity and the members of our Board prior to the merger would not constitute a majority of the board of the merged
    entity or its parent; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    sell or dispose of all or substantially all of our assets; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    consummate a complete liquidation or dissolution; or </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    majority of the members of our Board is replaced during any 12-month period by directors whose appointment or election is not endorsed
    by a majority of the incumbent directors. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Deferrals</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
committee may permit or require participants to defer receipt of the payment of cash or the delivery of shares of common stock that would
otherwise be due to the participant in connection with a grant under the 2020 EIP. The committee will establish the rules and procedures
applicable to any such deferrals, consistent with the requirements of Section 409A of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Withholding</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
grants under the 2020 EIP are subject to applicable U.S. federal (including FICA), state and local, foreign or other tax withholding
requirements. We may require participants or other persons receiving grants or exercising grants to pay an amount sufficient to satisfy
such tax withholding requirements with respect to such grants, or we may deduct from other wages and compensation paid by us the amount
of any withholding taxes due with respect to such grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
committee may permit or require that our tax withholding obligation with respect to grants paid in our common stock be paid by having
shares withheld up to an amount that does not exceed the participant&#8217;s minimum applicable withholding tax rate for United States
federal (including FICA), state and local tax liabilities, or as otherwise determined by the committee. In addition, the committee may,
in its discretion, and subject to such rules as the committee may adopt, allow participants to elect to have such share withholding applied
to all or a portion of the tax withholding obligation arising in connection with any particular grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transferability</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as permitted by the committee with respect to non-qualified stock options, only a participant may exercise rights under a grant during
the participant&#8217;s lifetime. Upon death, the personal representative or other person entitled to succeed to the rights of the participant
may exercise such rights. A participant cannot transfer those rights except by will or by the laws of descent and distribution or, with
respect to grants other than incentive stock options, pursuant to a domestic relations order. The committee may provide in a grant instrument
that a participant may transfer non-qualified stock options and stock award to family members, or one or more trusts or other entities
for the benefit of or owned by family members, consistent with applicable securities laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Amendment;
Termination</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board may amend or terminate our 2020 EIP at any time, except that our stockholders must approve an amendment if such approval is required
in order to comply with the Code, applicable laws or applicable stock exchange requirements. Unless terminated sooner by our Board or
extended with stockholder approval, the 2020 EIP will terminate on the day immediately preceding the tenth anniversary of the effective
date of the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stockholder
Approval</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
in connection with certain corporate transactions, including stock dividends, stock splits, a recapitalization, a change in control,
a reorganization, a merger and a spin-off, stockholder approval is required (i) to reduce the exercise price or base price of outstanding
stock options or SARs, (ii) to cancel outstanding stock options or SARs in exchange for the same type of grant with a lower exercise
price or base price, and (iii) to cancel outstanding stock options or SARs that have an exercise price or base price above the current
price of a share of our common stock, in exchange for cash or other securities, each as applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Establishment
of Sub-Plans</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board may, from time to time, establish one or more sub-plans under the 2020 EIP to satisfy applicable blue sky, securities or tax laws
of various jurisdictions. Our Board may establish such sub-plans by adopting supplements to the 2020 EIP setting forth limitations on
the committee&#8217;s discretion and such additional terms and conditions not otherwise inconsistent with the 2020 EIP as our Board deems
necessary or desirable. All such supplements will be deemed part of the 2020 EIP, but each supplement will only apply to participants
within the affected jurisdiction, and we will not be required to provide copies of any supplement to such unaffected participants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Clawback</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to applicable law, the committee may provide in any grant instrument that if a participant breaches any restrictive covenant agreement
between the participant and us, or otherwise engages in activities that constitute cause (as defined in the 2020 EIP) either while employed
by, or providing services to, us or within a specified period of time thereafter, all grants held by the participant will terminate,
and we may rescind any exercise of an option or stock appreciation right and the vesting of any other grant and delivery of shares upon
such exercise or vesting, as applicable on such terms as the committee will determine, including the right to require that in the event
of any rescission:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    participant must return the shares received upon the exercise of any option or stock appreciation right or the vesting and payment
    of any other grants; or </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    the participant no longer owns the shares, the participant must pay to us the amount of any gain realized or payment received as
    a result of any sale or other disposition of the shares (if the participant transferred the shares by gift or without consideration,
    then the fair market value of the shares on the date of the breach of the restrictive covenant agreement or activity constituting
    cause), net of the price originally paid by the participant for the shares. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
committee may also provide for clawbacks pursuant to a clawback policy, which our Board may in the future adopt and amend from time to
time. Payment by the participant will be made in such manner and on such terms and conditions as may be required by the committee. We
will be entitled to set off against the amount of any such payment any amounts that we otherwise owe to the participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain
United States Federal Income Tax Aspects</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of certain U.S. federal income tax consequences of awards under the 2020 EIP. It does not purport to be a complete
description of all applicable rules, and those rules (including those summarized here) are subject to change.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Options</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
optionee generally will not recognize taxable income upon the grant of a non-statutory option. Rather, at the time of exercise of the
option, the optionee will recognize ordinary income for income tax purposes in an amount equal to the excess, if any, of the fair market
value of the shares purchased over the exercise price. We generally will be entitled to a tax deduction at such time and in the same
amount, if any, that the optionee recognizes as ordinary income. The optionee&#8217;s tax basis in any shares received upon exercise
of an option will be the fair market value of the shares on the date of exercise, and if the shares are later sold or exchanged, then
the difference between the amount received upon such sale or exchange and the fair market value of such shares on the date of exercise
will generally be taxable as long-term or short-term capital gain or loss (if the shares are a capital asset of the optionee) depending
upon the length of time such shares were held by the optionee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incentive
stock options are eligible for favorable U.S. federal income tax treatment if certain requirements are satisfied. An incentive stock
option must have an option price that is not less than the fair market value of the stock at the time the option is granted and must
be exercisable within ten years from the date of grant. An employee granted an incentive stock option generally does not realize compensation
income for U.S. federal income tax purposes upon the grant of the option. At the time of exercise of an incentive stock option, no compensation
income is realized by the optionee other than tax preference income for purposes of the federal alternative minimum tax on individual
income. If the shares acquired on exercise of an incentive stock option are held for at least two years after grant of the option and
one year after exercise, the excess of the amount realized on the sale over the exercise price will be taxed as capital gain. If the
shares acquired on exercise of an incentive stock option are disposed of within less than two years after grant or one year of exercise,
the optionee will realize taxable compensation income equal to the lesser of (i) the excess of the fair market value of the shares on
the date of exercise over the option price or (ii) the excess of the amount realized on the sale over the option price. Any additional
amount realized will be taxed as capital gain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
participant generally will not be taxed upon the grant of stock awards subject to restrictions, but rather will recognize ordinary income
in an amount equal to the fair market value of the shares at the time the shares are no longer subject to a &#8220;substantial risk of
forfeiture&#8221; (within the meaning of the Code). We generally will be entitled to a deduction at the time when, and in the amount
that, the participant recognizes ordinary income on account of the lapse of the restrictions. A participant&#8217;s tax basis in the
shares will equal their fair market value at the time the restrictions lapse, and the participant&#8217;s holding period for capital
gains purposes will begin at that time. Any cash dividends paid on the restricted stock before the restrictions lapse will be taxable
to the participant as additional compensation (and not as dividend income). Under Section 83(b) of the Code, a participant may elect
to recognize ordinary income at the time the shares of stock are awarded in an amount equal to their fair market value at that time,
notwithstanding the fact that such shares of stock are subject to restrictions and a substantial risk of forfeiture. If such an election
is made, no additional taxable income will be recognized by such participant at the time the restrictions lapse, the participant will
have a tax basis in the shares equal to their fair market value on the date of their award, and the participant&#8217;s holding period
for capital gains purposes will begin at that time. We generally will be entitled to a tax deduction at the time when, and to the extent
that, ordinary income is recognized by such participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Units</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, the grant of stock units will not result in income for the participant or in a tax deduction for us. Upon the settlement of
such an award in cash or shares, the participant will recognize ordinary income equal to the aggregate value of the payment received,
and we generally will be entitled to a tax deduction at the same time and in the same amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Appreciation Rights</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
participant who is granted a SAR generally will not recognize ordinary income upon receipt of the SAR. Rather, at the time of exercise
of such SAR, the participant will recognize ordinary income for U.S. federal income tax purposes in an amount equal to the value of any
cash received and the fair market value on the date of exercise of any shares received. We generally will be entitled to a tax deduction
at such time and in the same amount, if any, that the participant recognizes as ordinary income. The participant&#8217;s tax basis in
any shares received upon exercise of a SAR will be the fair market value of the shares on the date of exercise, and if the shares are
later sold or exchanged, then the difference between the amount received upon such sale or exchange and the fair market value of such
shares on the date of exercise will generally be taxable as long-term or short- term capital gain or loss (if the shares are a capital
asset of the participant) depending upon the length of time such shares were held by the participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to other stock-based awards granted under the 2020 EIP, generally when the participant receives payment with respect to an award,
the amount of cash and/or the fair market value of any shares or other property received will be ordinary income to the participant,
and we generally will be entitled to a tax deduction at the same time and in the same amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Impact
of Section 409A</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
409A of the Code applies to deferred compensation, which is generally defined as compensation earned currently, the payment of which
is deferred to a later taxable year. Awards under the 2020 EIP are intended to be exempt from the requirements of Section 409A or to
satisfy its requirements. An award that is subject to Section 409A and fails to satisfy its requirements will subject the holder of the
award to immediate taxation, interest and an additional 20% tax on the vested amount underlying the award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
162(m) of the Code</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to 2018, Section 162(m) of the Code imposed a $1 million limit on the amount a public company may deduct for compensation paid to a company&#8217;s
chief executive officer or any of the company&#8217;s three other most highly compensated executive officers (other than the chief financial
officer) who are employed as of the end of the year. This limitation did not apply to compensation that meets the tax code requirements
for &#8220;qualifying performance-based&#8221; compensation (i.e., compensation paid only if the individual&#8217;s performance meets
pre- established objective goals based on performance criteria approved by stockholders, including stock options).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
performance-based compensation exemption and the exemption of the chief financial officer from Section 162(m)&#8217;s deduction limit
have been repealed, among other changes, effective for taxable years beginning after December 31, 2017, such that awards paid to our
covered executive officers (including our chief executive officer) in excess of $1 million will not be deductible in future years, unless
it qualifies for transition relief applicable to certain arrangements that were in effect as of November 2, 2017 and are not materially
modified thereafter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
in prior years, while deductibility of executive compensation for federal income tax purposes is among the factors the committee considers
when structuring our executive compensation arrangements, it is not the sole or primary factor considered. We retain the flexibility
to authorize compensation that may not be deductible if we believe it is in the best interests of the company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Existing
Plan Benefits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
benefits under the 2020 EIP generally are granted at the discretion of the committee and are therefore not currently determinable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
future grants of awards under the 2020 EIP are subject to the discretion of the Board or Compensation Committee, the amount and terms
of future awards to particular participants or groups of participants are not determinable at this time. No awards have been previously
granted that are contingent on the approval of this amendment to the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
proposal to amend the 2020 EIP will be approved upon the affirmative vote of a majority of the outstanding shares of common stock present
through virtual attendance or by proxy at the Meeting and entitled to vote on the proposal. Stockholders may vote &#8220;FOR&#8221; or
&#8220;AGAINST,&#8221; or &#8220;ABSTAIN&#8221; from voting. Abstentions will have the effect of a vote &#8220;AGAINST&#8221; this proposal.
Broker non-votes, if any, will be disregarded and will have no effect on the outcome of the vote for this Proposal 2.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Recommendation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Board recommends that the stockholders vote &#8220;FOR&#8221; the approval of the amendment to the Kopin Corporation 2020 Equity Incentive
Plan to increase the number of shares available by 5,000,000.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
existence of financial and personal interests of one or more of Kopin Corporation directors may result in a conflict of interest on the
part of such director(s) between what he, she or they may believe is in the best interests of Kopin Corporation and its stockholders
and what he, she or they may believe is best for himself, herself or themselves in determining to recommend that stockholders vote for
the proposals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
3</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>APPROVAL
OF THE AMENDMENT TO THE COMPANY&#8217;S AMENDED AND RESTATED</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED COMMON</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARES FROM 200,000,000 TO 275,000,000</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board has approved the amendment to our Certificate of Incorporation, subject to stockholder approval, to increase the number of
authorized shares of common stock from 200,000,000 shares to 275,000,000 shares (the &#8220;Share Increase Amendment&#8221;) and
recommends unanimously that our stockholders approve the Share Increase Amendment. The proposed amendment is reflected in the
proposed amendment to the Certificate of Incorporation attached to this proxy statement as Appendix B. As of May 1, 2025,
there were 162,797,922 shares of common stock issued and outstanding and the Company had warrants and options outstanding to
acquire 10,591,366 shares of its common stock, leaving a total of 26,610,712 authorized shares of common stock available for
future issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
additional 75,000,000 shares of common stock will be part of the existing class of common stock, and, if and when issued, would have
the same rights and privileges as the shares of common stock presently issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s Certificate of Incorporation was amended on June 11, 2024 to increase the number of authorized shares of common stock
to 200,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that it is desirable and in the best interests of the Company and its shareholders to have a sufficient number of additional
shares of common stock available for issuance from time to time, as the occasion may arise, for future financing and acquisition transactions,
to permit stock dividends or stock splits at some future date, and for other proper corporate purposes. Therefore, the Board has approved,
and unanimously recommends that the stockholders of the Company approve the Share Increase Amendment. The proposed form of the Articles
of Amendment to the Company&#8217;s Certificate of Incorporation amending Article &#8220;FOURTH&#8221; of such Certificate of Incorporation
is set forth in Appendix A to this proxy statement. The Articles of Amendment will have no effect on the number of authorized shares
of preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain
Risks Associated with the Share Increase Amendment</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market price of our common stock will also be based on our performance and other factors, some of which are unrelated to the number of
shares outstanding. These factors include the status of the market for our common stock, our reported results of operations in future
periods, and general economic, market and industry conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal
Effects on Outstanding Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of common stock are entitled to one vote per share on all matters submitted to a vote of stockholders. Upon a liquidation, dissolution
or windup of the Company, holders of common stock would be entitled to share ratably in any assets for distribution to stockholders after
payment of all of the Company&#8217;s obligations, subject to the rights to receive preferential distributions of the holders of any
preferred stock then outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
additional shares of common stock would have rights identical to our common stock currently outstanding. Approval of the Share Increase
Amendment and any issuance of common stock would not affect the rights of the holders of our common stock currently outstanding, except
to the extent that future issuances of common stock would reduce each existing stockholder&#8217;s proportionate ownership. If the proposed
Share Increase Amendment is approved and the Board decides to issue such shares of common stock, such issuance of common stock would
increase the outstanding number of shares of common stock, thereby causing dilution in earnings per share and voting interests of the
outstanding common stock. As of May 1, 2025, 162,797,922 shares of our common stock were issued and outstanding and we
had warrants and options outstanding to acquire 10,591,366 shares of our common stock. We had no other shares of our common stock subject
to outstanding stock options or other convertible securities, thereby leaving 26,610,712 shares of common stock unassigned and
authorized for potential issuance of the current 200,000,000 shares of common stock authorized. If the Share Increase Amendment is approved,
there will be 101,610,712 shares of common stock unassigned and authorized for potential issuance. If approved, the Share Increase
Amendment will not change the number of shares of preferred stock authorized for issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the issuance of additional shares of common stock could have the effect of making it more difficult for a third party to acquire, or
discouraging a third party from attempting to acquire, control of the Company. While the issuance of additional shares of common stock
may be deemed to have potential anti-takeover effects, including by delaying or preventing a change in control of the Company through
subsequent issuances of these shares and the other reasons set forth above, which among other things, could include issuances in one
or more transactions that would make a change in control of the Company more difficult, and therefore, less likely, this proposal to
increase the authorized common stock is not prompted by any specific effort of which we are aware to accumulate shares of our common
stock or obtain control of the Company. A takeover may be beneficial to independent stockholders because, among other reasons, a potential
suitor may offer such stockholders a premium for their shares of common stock as compared to the then-existing market price. Although
the issuance of additional shares of common stock could, under certain circumstances, have an anti-takeover effect, this proposal to
adopt the Share Increase Amendment is not in response to any attempt to accumulate common stock or obtain control of the Company that
we are aware of, nor is it part of a plan by management to recommend a series of similar amendments to the Board or stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Interests
of Certain Persons in the Proposal</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
directors and executive officers have no substantial interests, directly or indirectly, in the matters set forth in this Proposal 3,
except to the extent of their ownership in shares of our common stock and securities convertible or exercisable for common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of the Shares Increase Amendment requires the affirmative vote of a majority of the Company&#8217;s outstanding stock entitled
to vote thereon.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Recommendation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Board recommends that the stockholders vote &#8220;FOR&#8221; the proposal to approve an amendment to the Company&#8217;s Certificate
of Incorporation to increase the number of authorized shares of common stock to 275,000,000.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
4</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RATIFICATION
OF APPOINTMENT OF ACCOUNTANTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 2, 2024, the Audit Committee appointed BDO USA, P.C. (&#8220;BDO&#8221;) as our independent registered public accounting firm
for the fiscal year ending December 27, 2025. The Audit Committee is seeking ratification of this selection by our stockholders at the Annual Meeting.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSM
US LLP (RSM), served as the Company&#8217;s independent registered public accounting firm of the Company from November 22,
2019 until December 2, 2024. On December 2, 2024, the Board approved the engagement of BDO as our independent registered public
accounting firm, effective upon the execution of a satisfactory engagement letter with BDO and dismissed our prior independent registered
public accounting firm, RSM, effective immediately prior to the engagement of BDO. RSM&#8217;s audit reports on our consolidated financial
statements for the fiscal years ended December 30, 2023 and December 31, 2022 did not contain any adverse opinion or disclaimer of opinion
and were not qualified or modified as to uncertainty, audit scope, or accounting principles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
representative of BDO is expected to be present at the Meeting and will be afforded an opportunity to make a statement, if such
representative desires to do so, and will be available to respond to appropriate questions. </span>Furthermore, a representative of
RSM is expected to be present at the Meeting and will be afforded an opportunity to make a statement, if such representative desires
to do so, and will be available to respond to appropriate questions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">RSM&#8217;s audit reports
on our consolidated financial statements for the fiscal years ended December 30, 2023 and December 31, 2022 did not contain any adverse
opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principles. During
the fiscal years ended December 30, 2023 and December 31, 2022, and the subsequent interim period through the date of our engagement
of BDO on December 2, 2024, neither the Company, nor anyone acting on our behalf, consulted with BDO regarding any of the matters described
in Items 304(a)(2)(i) and (ii) of Regulation S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">During the two most recent
fiscal years ended December 30, 2023 and December 31, 2022, and the subsequent interim period through their dismissal on December 2,
2024: (i) there were no disagreements within the meaning of Item 304(a)(1)(iv) of Regulation S-K between us and RSM on any matter of
accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved
to RSM&#8217;s satisfaction, would have caused RSM to make reference to the subject matter of the disagreements in connection with its
reports on our consolidated financial statements for such years, and (ii) no reportable events within the meaning of Item 304(a)(1)(v)
of Regulation S-K.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 40pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
affirmative vote of the holders of a majority of the shares of our common stock represented in person or by proxy at the Meeting and
entitled to vote is required to ratify the appointment of BDO as our independent registered public accounting firm for the current
fiscal year ending December 27, 2025. Although stockholder ratification is not required by our bylaws or otherwise, the Board believes
it is advisable to provide stockholders an opportunity to ratify this selection and is submitting the selection of BDO as our independent
registered public accounting firm to our stockholders for ratification as a matter of good corporate practice.  In the event the appointment of BDO should not be approved by the stockholders, the Board will consider making
another appointment to be effective at the earliest possible time but has no obligation to do so. Any broker non-votes and abstentions
from voting received will have no effect on the outcome of this Proposal 4.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Recommendation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Board recommends that the stockholders vote &#8220;FOR&#8221; the proposal to ratify the appointment of BDO USA, P.C. as our independent
registered public accounting firm for the fiscal year ending December 27, 2025.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proxies
solicited by the Board will be voted &#8220;FOR&#8221; this Proposal 4.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRINCIPAL
ACCOUNTANT FEES AND SERVICES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed above, BDO has served as the Company&#8217;s independent registered public accounting firm since December 2, 2024. Previously,
RSM served as the Company&#8217;s independent registered public accounting firm from November 22, 2019 to December 2, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><b></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Fees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate fees for the fiscal years ended December 28, 2024 and December 30, 2023 billed by the Company&#8217;s independent registered
public accounting firm, BDO USA, P.C. for fiscal year 2024 and RSM US LLP for fiscal year 2023 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Fee Category</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left">Audit Fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,038,950</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">620,124</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">99.9</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Audit-Related Fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">152,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax Fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,453</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.9</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">All Other Fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total Fees</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,049,450</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">780,827</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Audit
Fees</i>&#8212;consists of fees for the audit of our financial statements and attestation services relating to the report on our internal
controls in accordance with Section 404 of the Sarbanes-Oxley Act of 2002, review of the interim condensed consolidated financial statements
included in quarterly reports, assistance with review of documents filed with the SEC, and services that are normally provided by the
Company&#8217;s independent registered public accounting firm in connection with statutory and regulatory filings or engagements, and
attestation services, except those not required by statute or regulation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Audit-Related
Fees</i>&#8212;consists of fees for assurance and related services that are reasonably related to the performance of the audit or review
of our consolidated financial statements and are not reported under &#8220;Audit Fees.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Tax
Fees</i>&#8212;consists of fees for tax compliance and planning services. Tax compliance includes fees for professional services related
to international tax compliance and preparation. Tax planning consists primarily of fees related to a transfer pricing study and preparation
of our subsidiary tax returns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>All
Other Fees</i>&#8212;consists of fees for all other permissible services other than those reported above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Policy
on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of Independent Registered Public Accounting Firm</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee pre-approves all audit and non-audit services provided by the Company&#8217;s independent registered public accounting
firm prior to the engagement with respect to such services. The Chairman of the Audit Committee has been delegated the authority by the
Audit Committee to pre-approve the engagement of the independent accountants when the entire committee is unable to do so. The Audit
Committee approved 100% of the services listed under the preceding captions &#8220;Audit Fees,&#8221; &#8220;Audit-Related Fees,&#8221;
&#8220;Tax Fees&#8221; and &#8220;All Other Fees.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
5</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ADVISORY
NON-BINDING VOTE ON COMPENSATION OF NAMED EXECUTIVE OFFICERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with Section 951 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, as well as the provisions of Section 14A
of the Exchange Act, we are providing our stockholders the opportunity to vote on a non-binding, advisory resolution to approve the compensation
of our named executive officers, which is described in the section titled &#8220;Compensation Discussion and Analysis&#8221; in this
Proxy Statement. Accordingly, the following resolution will be submitted for a stockholder vote at the 2025 Annual Meeting:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;RESOLVED,
that the stockholders of Kopin Corporation (the &#8220;Company&#8221;) approve, on an advisory basis, the overall compensation of the
Company&#8217;s named executive officers, as described in the Compensation Discussion and Analysis section set forth in the Proxy Statement
for this Annual Meeting.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in the section titled &#8220;Compensation Discussion and Analysis,&#8221; our executive compensation program is designed to
provide a competitive level of compensation necessary to attract, motivate and retain talented and experienced executives and to motivate
them to achieve short-term and long-term corporate goals that enhance stockholder value. In order to align executive pay with our financial
performance and the creation of sustainable stockholder value, a significant portion of compensation paid to our named executive officers
is allocated to performance-based, short- and long-term incentive programs to make executive pay dependent on our performance (or &#8220;at-risk&#8221;).
In addition, as an executive officer&#8217;s responsibility and ability to affect our financial results increases, the portion of his
or her total compensation deemed &#8220;at-risk&#8221; increases. Stockholders are urged to read the &#8220;Compensation Discussion and
Analysis&#8221; section of this Proxy Statement, which more thoroughly discusses how our compensation policies and procedures implement
our compensation philosophy. The Compensation Committee and the Board believe that these policies and procedures are effective in implementing
our compensation philosophy and in achieving its goals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
provide our stockholders the opportunity every year to vote on a non-binding, advisory basis to approve the compensation of our named
executive officers. The Company expects that the next advisory vote on executive compensation will be at the 2026 Annual Meeting of Stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>This
vote is merely advisory and will not be binding upon the Company or the Board. However, the Board values constructive dialogue on executive
compensation and other important governance topics with our stockholders and encourages all stockholders to vote their shares on this
matter.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
5 will be approved upon the affirmative vote of a majority of shares present in person or represented by proxy at the Meeting and entitled
to vote on each such proposal. Abstentions will be counted for Proposal 5 and will have the same effect as a vote against the proposal.
Broker non-votes, if any, will be disregarded and will have no effect on the outcome of the vote of this Proposal 5.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Recommendation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Board recommends that the stockholders vote to approve, on an advisory basis, the overall compensation of the Company&#8217;s named executive
officers by voting &#8220;FOR&#8221; this resolution.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COST
AND METHOD OF SOLICITATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will pay the cost of soliciting proxies. Proxies may be solicited on behalf of the Company by directors, officers or employees of the
Company in person or by telephone, facsimile or other electronic means. As required by the SEC, we also will reimburse brokerage firms
and other custodians, nominees and fiduciaries for their expenses incurred in sending proxies and proxy materials to beneficial owners
of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GENERAL</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not aware of any other matter other than the foregoing to be brought before the Meeting. However, the enclosed proxy gives discretionary
authority to the named proxies in the event any additional matters should be presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will provide free of charge to any stockholder from whom a proxy is solicited pursuant to this proxy statement, upon written request
from such stockholder, our Annual Reports on Form 10-K for the fiscal years 2024 and 2023 as filed with the SEC. Our 2024 Annual Report
on Form 10-K is enclosed. Only one copy of the Annual Report and this proxy statement and notice of annual meeting is being delivered
to multiple stockholders sharing one address, unless we have received contrary instructions. Upon written or oral request, we will deliver
promptly a separate copy to a stockholder at a shared address to which a copy was delivered. If you received more than one copy of the
proxy statement and wish to reduce the number of reports you receive, we will discontinue the mailing of reports on the accounts you
select. Requests for the foregoing should be directed to Kopin Corporation, 125 North Drive, Westborough MA 01581, Attention: Chief Financial
Officer, 508-870-5959.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MISCELLANEOUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
vote is important. Whether or not you plan to attend the Annual Meeting, we hope you will vote in advance so that your vote will be counted
if you later decide not to attend the Annual Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>You
may obtain a copy of our Annual Report on Form 10-K (without exhibits) filed with the SEC for the year ended December 28, 2024, without
charge upon written request to: Kopin Corporation, 125 North Drive, Westborough MA 01581, Attention: Chief Financial Officer, 508-870-5959.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this proxy statement, we know of no matter not specifically referred to above as to which any action is expected to be
taken at the Annual Meeting. The persons named as proxies will vote the proxies, insofar as they are not otherwise instructed, regarding
such other matters and the transaction of such other business as may be properly brought before the Annual Meeting, as they determine
to be in the best interest of the Company and our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 50%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Murray</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Appendix
A</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>KOPIN
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020
EQUITY INCENTIVE PLAN</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
as of the Effective Date (as defined below), the Kopin Corporation 2020 Incentive Equity Plan (as in effect from time to time, the &#8220;Plan&#8221;)
is hereby established.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Plan is to provide employees of Kopin Corporation, a Delaware corporation (together with its successors, the &#8220;Company&#8221;),
and its subsidiaries, certain consultants and advisors who perform services for the Company or its subsidiaries, and non-employee members
of the Board of Directors of the Company, with the opportunity to receive grants of incentive stock options, nonqualified stock options,
stock appreciation rights, stock awards, stock units, and other stock-based awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company believes that the Plan will encourage the participants to contribute materially to the growth of the Company, thereby benefitting
the Company&#8217;s stockholders, and will align the economic interests of the participants with those of the stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan is a successor to the Kopin Corporation 2010 Equity Incentive Plan, as amended and restated (the &#8220;Prior Plan&#8221;). No additional
grants shall be made under the Prior Plan after the Effective Date. Outstanding grants under the Prior Plan shall continue in effect
according to their terms, consistent with the applicable terms of the Prior Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
1. Definitions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following terms shall have the meanings set forth below for purposes of the Plan:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) &#8220;<span style="text-decoration: underline">Board&#8221; </span>shall
mean the Board of Directors of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) &#8220;<span style="text-decoration: underline">Cause</span>&#8221;
shall have the meaning given to that term in any written employment agreement, offer letter or severance agreement between the Employer
and the Participant, or if no such agreement exists or if such term is not defined therein, and unless otherwise defined in the Grant
Instrument, Cause shall mean a finding by the Committee that the Participant (i) has breached his or her employment or service contract
with the Employer, (ii) has engaged in disloyalty to the Employer, including, without limitation, fraud, embezzlement, theft, commission
of a felony or proven dishonesty, (iii) has disclosed trade secrets or confidential information of the Employer to persons not entitled
to receive such information, (iv) has breached any written non-competition, non-solicitation, invention assignment or confidentiality
agreement between the Participant and the Employer or (v) has engaged in such other behavior detrimental to the interests of the Employer
as the Committee determines.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) &#8220;<span style="text-decoration: underline">CEO&#8221;
</span>shall mean the Chief Executive Officer of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Unless
otherwise set forth in a Grant Instrument, a &#8220;<span style="text-decoration: underline">Change of Control</span>&#8221; shall be deemed to have occurred if:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) Any
&#8220;person&#8221; (as such term is used in sections 13(d) and 14(d) of the Exchange Act) becomes a &#8220;beneficial owner&#8221;
(as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing more than 50% of
the voting power of the then outstanding securities of the Company; provided that a Change of Control shall not be deemed to occur as
a result of a transaction in which the Company becomes a direct or indirect subsidiary of another Person and in which the stockholders
of the Company, immediately prior to the transaction, will beneficially own, immediately after the transaction, shares of such other
Person representing more than 50% of the voting power of the then outstanding securities of such other Person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) The
consummation of (A) a merger or consolidation of the Company with another Person where, immediately after the merger or consolidation,
the stockholders of the Company, immediately prior to the merger or consolidation, will not beneficially own, in substantially the same
proportion as ownership immediately prior to the merger or consolidation, shares entitling such stockholders to more than 50% of all
votes to which all stockholders of the surviving Person would be entitled in the election of directors, or where the members of the Board,
immediately prior to the merger or consolidation, will not, immediately after the merger or consolidation, constitute a majority of the
board of directors of the surviving Person or (B) a sale or other disposition of all or substantially all of the assets of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) A
change in the composition of the Board over a period of 12 consecutive months or less such that a majority of the Board members ceases,
by reason of one or more contested elections, or threatened election contests, for Board membership, to be comprised of individuals who
either (A) have been Board members continuously since the beginning of such period or (B) have been elected or nominated for election
as Board members during such period by at least a majority of the Board members described in clause (A) who were still in office at the
time the Board approved such election or nomination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) The
consummation of a complete dissolution or liquidation of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may modify the definition of Change of Control for a particular Grant as the Committee deems appropriate to comply with section
409A of the Code or otherwise. Notwithstanding the foregoing, if a Grant constitutes deferred compensation subject to section 409A of
the Code and the Grant provides for payment upon a Change of Control, then, for purposes of such payment provisions, no Change of Control
shall be deemed to have occurred upon an event described in items (i) &#8211; (iv) above unless the event would also constitute a change
in ownership or effective control of, or a change in the ownership of a substantial portion of the assets of, the Company under section
409A of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) &#8220;<span style="text-decoration: underline">Code</span>&#8221;
shall mean the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) &#8220;<span style="text-decoration: underline">Committee</span>&#8221;
shall mean the Compensation Committee of the Board or another committee appointed by the Board to administer the Plan. The Committee
shall consist of directors who are &#8220;non-employee directors&#8221; as defined under Rule 16b-3 promulgated under the Exchange Act
and &#8220;independent directors,&#8221; as determined in accordance with the independence standards established by the stock exchange
on which the Company Stock is at the time primarily traded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) &#8220;<span style="text-decoration: underline">Company
Stock</span>&#8221; shall mean common stock, par value $0.01 per share, of the Company, and such other securities as may be substituted
for Company Stock pursuant to Section 4(c).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) &#8220;<span style="text-decoration: underline">Disability</span>&#8221;
or &#8220;<span style="text-decoration: underline">Disabled</span>&#8221; shall mean, unless otherwise set forth in the Grant Instrument, a Participant&#8217;s becoming disabled
within the meaning of the Employer&#8217;s long-term disability plan applicable to the Participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) &#8220;<span style="text-decoration: underline">Dividend
Equivalent</span>&#8221; shall mean an amount determined by multiplying the number of shares of Company Stock subject to a Stock Unit or
Other Stock-Based Award by the per-share cash dividend paid by the Company on its outstanding Company Stock, or the per-share Fair Market
Value of any dividend paid on its outstanding Company Stock in consideration other than cash. If interest is credited on accumulated
divided equivalents, the term &#8220;Dividend Equivalent&#8221; shall include the accrued interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) &#8220;<span style="text-decoration: underline">Effective
Date</span>&#8221; shall mean the date of the Annual Meeting of Stockholders to be held on May 20, 2020 or such other date upon which the
Company&#8217;s stockholders approve the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) &#8220;<span style="text-decoration: underline">Employee</span>&#8221;
shall mean an employee of the Employer (including an officer or director who is also an employee), but excluding any person who is classified
by the Employer as a &#8220;contractor&#8221; or &#8220;consultant,&#8221; no matter how characterized by the Internal Revenue Service,
other governmental agency or a court. Any change of characterization of an individual by the Internal Revenue Service or any court or
government agency shall have no effect upon the classification of an individual as an Employee for purposes of this Plan, unless the
Committee determines otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) &#8220;<span style="text-decoration: underline">Employed
by, or providing service to, the Employer</span>&#8221; shall mean employment or service as an Employee, Key Advisor or member of the Board
(so that, for purposes of exercising Options and SARs and satisfying conditions with respect to Stock Awards, Stock Units, and Other
Stock-Based Awards, a Participant shall not be considered to have terminated employment or service until the Participant ceases to be
an Employee, Key Advisor and member of the Board), unless the Committee determines otherwise. If a Participant&#8217;s relationship is
with a subsidiary of the Company and that entity ceases to be a subsidiary of the Company, the Participant will be deemed to cease employment
or service when the entity ceases to be a subsidiary of the Company, unless the Participant transfers employment or service to an Employer.
If a Participant has military, sick leave or other bona fide leave, the Participant will not be deemed to cease employment or service
solely as a result of such leave; provided that such leave does not exceed the longer of 90 days or the period during which the absent
Participant&#8217;s reemployment rights, if any, are guaranteed by statute or contract. To the extent consistent with applicable law,
the Committee may provide that Grants continue to vest for all or a portion of the period of such leave, or that vesting shall be tolled
during such leave and only recommence upon the Participant&#8217;s return from such leave.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) &#8220;<span style="text-decoration: underline">Employer</span>&#8221;
shall mean the Company and its subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) &#8220;<span style="text-decoration: underline">Exchange
Act&#8221;</span> shall mean the Securities Exchange Act of 1934, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) &#8220;<span style="text-decoration: underline">Exercise
Price</span>&#8221; shall mean the per share price at which shares of Company Stock may be purchased under an Option, as designated by the
Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p) &#8220;<span style="text-decoration: underline">Fair
Market Value&#8221;</span> shall mean:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) If
the Company Stock is publicly traded, the Fair Market Value per share shall be determined as follows: (A) if the principal trading market
for the Company Stock is a national securities exchange, the closing sales price during regular trading hours on the relevant date or,
if there were no trades on that date, the latest preceding date upon which a sale was reported, or (B) if the Company Stock is not principally
traded on any such exchange, the last reported sale price of a share of Company Stock during regular trading hours on the relevant date,
as reported by the OTC Bulletin Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) If
the Company Stock is not publicly traded or, if publicly traded, is not subject to reported transactions as set forth above, the Fair
Market Value per share shall be determined by the Committee through any reasonable valuation method authorized under the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q) &#8220;<span style="text-decoration: underline">GAAP</span>&#8221;
shall mean United States generally accepted accounting principles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r) &#8220;<span style="text-decoration: underline">Grant</span>&#8221;
shall mean an Option, SAR, Stock Award, Stock Unit or Other Stock-Based Award granted under the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s) &#8220;<span style="text-decoration: underline">Grant
Instrument</span>&#8221; shall mean the written agreement that sets forth the terms and conditions of a Grant, including all amendments
thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t) &#8220;<span style="text-decoration: underline">Incentive
Stock Option</span>&#8221; shall mean an Option that is intended to meet the requirements of an incentive stock option under section 422
of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u) &#8220;<span style="text-decoration: underline">Key
Advisor&#8221;</span> shall mean a consultant or advisor of the Employer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) &#8220;<span style="text-decoration: underline">Non-Employee
Director</span>&#8221; shall mean a member of the Board who is not an Employee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w) &#8220;<span style="text-decoration: underline">Nonqualified
Stock Option</span>&#8221; shall mean an Option that is not intended to be taxed as an incentive stock option under section 422 of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x) &#8220;<span style="text-decoration: underline">Option&#8221;
</span>shall mean an option to purchase shares of Company Stock, as described in Section 6.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y) &#8220;<span style="text-decoration: underline">Other
Stock-Based Award</span>&#8221; shall mean any Grant based on, measured by or payable in Company Stock (other than an Option, Stock Unit,
Stock Award, or SAR), as described in Section 10.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z) &#8220;<span style="text-decoration: underline">Participant</span>&#8221;
shall mean an Employee, Key Advisor or Non-Employee Director designated by the Committee to participate in the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa) &#8220;<span style="text-decoration: underline">Performance
Goals</span>&#8221; shall mean the business criteria selected by the Company to measure the level of performance of the Company or an
affiliate during a performance period, which may include, but are not limited to, one or more of the following criteria: cash flow;
free cash flow; earnings (including gross margin, earnings before interest and taxes, earnings before taxes, earnings before
interest, taxes, depreciation, amortization and charges for stock-based compensation, earnings before interest, taxes, depreciation
and amortization, adjusted earnings before interest, taxes, depreciation and amortization and net earnings); earnings per share;
growth in earnings or earnings per share; book value growth; stock price; return on equity or average stockholder equity; total
stockholder return or growth in total stockholder return either directly or in relation to a comparative group; return on capital;
return on assets or net assets; </span>revenue, growth in revenue or return on sales; sales; expense reduction or expense control;
expense to revenue ratio; income, net income or adjusted net income; operating income, net operating income, adjusted operating
income or net operating income after tax; operating profit or net operating profit; operating margin; gross profit margin; return on
operating revenue or return on operating profit; regulatory filings; regulatory approvals, litigation and regulatory resolution
goals; other operational, regulatory or departmental objectives; budget comparisons; growth in stockholder value relative to
established indexes, or another peer group or peer group index; development and implementation of strategic plans and/or
organizational restructuring goals; development and implementation of risk and crisis management programs; improvement in workforce
diversity; compliance requirements and compliance relief; safety goals; productivity goals; workforce management and succession
planning goals; economic value added (including typical adjustments consistently applied from generally accepted accounting
principles required to determine economic value added performance measures); measures of customer satisfaction, employee
satisfaction or staff development; development or marketing collaborations, formations of joint ventures or partnerships or the
completion of other similar transactions intended to enhance the Company&#8217;s revenue or profitability or enhance its customer
base; merger and acquisitions; and other similar criteria as determined by the Committee. Performance goals applicable to a Grant
shall be determined by the Committee, and may be established on an absolute or relative basis and may be established on a
corporate-wide basis or with respect to one or more business units, divisions, subsidiaries or business segments. Relative
performance may be measured against a group of peer companies, a financial market index or other objective and quantifiable
indices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb) &#8220;<span style="text-decoration: underline">Person</span>&#8221;
shall mean any natural person, corporation, limited liability company, partnership, trust, joint stock company, business trust, unincorporated
association, joint venture, governmental authority or other legal entity of any nature whatsoever.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc) &#8220;<span style="text-decoration: underline">Restriction
Period&#8221;</span> shall have the meaning given that term in Section 7(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd) &#8220;<span style="text-decoration: underline">SAR&#8221;
</span>shall mean a stock appreciation right, as described in Section 9.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee) &#8220;<span style="text-decoration: underline">Stock
Award&#8221;</span> shall mean an award of Company Stock, as described in Section 7.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff) &#8220;<span style="text-decoration: underline">Stock
Unit</span>&#8221; shall mean an award of a phantom unit representing a share of Company Stock, as described in Section 8.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg) &#8220;<span style="text-decoration: underline">Substitute
Awards&#8221;</span> shall have the meaning given that term in Section 4(c).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
2. Administration</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Committee</span>.
The Plan shall be administered and interpreted by the Committee; provided, however, that any Grants to members of the Board must be authorized
by a majority of the Board. The Committee may delegate authority to one or more subcommittees, as it deems appropriate. Subject to compliance
with applicable law and the applicable stock exchange rules, the Board, in its discretion, may perform any action of the Committee hereunder.
To the extent that the Board, a subcommittee or the CEO, as described below administers the Plan, references in the Plan to the &#8220;<span style="text-decoration: underline">Committee</span>&#8221;
shall be deemed to refer to the Board or such subcommittee or the CEO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Delegation
to CEO</span>. Subject to compliance with applicable law and applicable stock exchange requirements, the Committee may delegate all or part
of its authority and power to the CEO, as it deems appropriate, with respect to Grants to Employees or Key Advisors who are not executive
officers under section 16 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Committee
Authority</span>. The Committee shall have the sole authority to (i) determine the individuals to whom Grants shall be made under the Plan,
(ii) determine the type, size, terms and conditions of the Grants to be made to each such individual, (iii) determine the time when the
Grants will be made and the duration of any applicable exercise or restriction period, including the criteria for exercisability and
the acceleration of exercisability, (v) amend the terms of any previously issued Grant, subject to the provisions of Section 17 below,
(vi) determine and adopt terms, guidelines, and provisions, not inconsistent with the Plan and applicable law, that apply to individuals
residing outside of the United States who receive Grants under the Plan, and (vii) deal with any other matters arising under the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Committee
Determinations</span>. The Committee shall have full power and express discretionary authority to administer and interpret the Plan, to
make factual determinations and to adopt or amend such rules, regulations, agreements and instruments for implementing the Plan and for
the conduct of its business as it deems necessary or advisable, in its sole discretion. The Committee&#8217;s interpretations of the
Plan and all determinations made by the Committee pursuant to the powers vested in it hereunder shall be conclusive and binding on all
persons having any interest in the Plan or in any awards granted hereunder. All powers of the Committee shall be executed in its sole
discretion, in the best interest of the Company, not as a fiduciary, and in keeping with the objectives of the Plan and need not be uniform
as to similarly situated individuals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <span style="text-decoration: underline">Indemnification</span>.
No member of the Committee or the Board, and no employee of the Company shall be liable for any act or failure to act with respect to
the Plan, except in circumstances involving his or her bad faith or willful misconduct, or for any act or failure to act hereunder by
any other member of the Committee or employee or by any agent to whom duties in connection with the administration of this Plan have
been delegated. The Company shall indemnify members of the Committee and the Board and any agent of the Committee or the Board who is
an employee of the Company or a subsidiary against any and all liabilities or expenses to which they may be subjected by reason of any
act or failure to act with respect to their duties on behalf of the Plan, except in circumstances involving such person&#8217;s bad faith
or willful misconduct.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
3. Grants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grants
under the Plan may consist of Options as described in Section 6, Stock Awards as described in Section 7, Stock Units as described in
Section 8, SARs as described in Section 9, and Other Stock-Based Awards as described in Section 10. All Grants shall be subject to the
terms and conditions set forth herein and to such other terms and conditions consistent with this Plan as the Committee deems appropriate
and as are specified in writing by the Committee to the individual in the Grant Instrument. All Grants shall be made conditional upon
the Participant&#8217;s acknowledgement, in writing or by acceptance of the Grant, that all decisions and determinations of the Committee
shall be final and binding on the Participant, his or her beneficiaries and any other person having or claiming an interest under such
Grant. Grants under a particular Section of the Plan need not be uniform as among the Participants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
4. Shares Subject to the Plan</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Shares
Authorized</span>. Subject to adjustment as described below in Sections 4(b) and 4(e) below, the aggregate number of shares of Company Stock
that may be issued or transferred under the Plan shall be 14,000,000 shares of Company Stock. In addition, shares of the Company Stock
underlying any outstanding award granted under the Prior Plan that, following the Effective Date, expires, or is terminated, surrendered
or forfeited for any reason without issuance of such shares shall be available for the award of new Grants under this Plan. Subject to
adjustment as described below in Sections 4(b) and 4(e) below, the aggregate number of shares of Company Stock that may be issued or
transferred under the Plan pursuant to Incentive Stock Options shall not exceed 10,000,000 shares of Company Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Source
of Shares</span>; Share Counting. Shares issued or transferred under the Plan may be authorized but unissued shares of Company Stock or
reacquired shares of Company Stock, including shares purchased by the Company on the open market for purposes of the Plan. If and to
the extent Options or SARs granted under the Plan, expire or are canceled, forfeited, exchanged or surrendered without having been exercised,
or if any Stock Awards, Stock Units or Other Stock-Based Awards are forfeited, terminated or otherwise not paid in full, the shares subject
to such Grants shall again be available for purposes of the Plan. If shares of Company Stock otherwise issuable under the Plan are surrendered
in payment of the Exercise Price of an Option, then the number of shares of Company Stock available for issuance under the Plan shall
be reduced only by the net number of shares actually issued by the Company upon such exercise and not by the gross number of shares as
to which such Option is exercised. Upon the exercise of any SAR under the Plan, the number of shares of Company Stock available for issuance
under the Plan shall be reduced by only by the net number of shares actually issued by the Company upon such exercise. If shares of Company
Stock otherwise issuable under the Plan are withheld by the Company in satisfaction of the withholding taxes incurred in connection with
the issuance, vesting or exercise of any Grant or the issuance of Company Stock thereunder, then the number of shares of Company Stock
available for issuance under the Plan shall be reduced by the net number of shares issued, vested or exercised under such Grant, calculated
in each instance after payment of such share withholding. To the extent any Grants are paid in cash, and not in shares of Company Stock,
any shares previously subject to such Grants shall again be available for issuance or transfer under the Plan. For the avoidance of doubt,
if shares are repurchased by the Company on the open market with the proceeds of the Exercise Price of Options, such shares may not again
be made available for issuance under the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Substitute
Awards</span>. Shares issued or transferred under Grants made pursuant to an assumption, substitution or exchange for previously granted
awards of a company acquired by the Company in a transaction (&#8220;Substitute Awards&#8221;) shall not reduce the number of shares
of Company Stock available under the Plan and available shares under a stockholder approved plan of an acquired company (as appropriately
adjusted to reflect the transaction) may be used for Grants under the Plan and shall not reduce the Plan&#8217;s share reserve (subject
to applicable stock exchange listing and Code requirements).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Individual
Limits for Non-Employee Directors</span>. Subject to adjustment as described below in Section 4(e), the maximum aggregate grant date value
of shares of Company Stock subject to Grants granted to any Non-Employee Director during any calendar year, taken together with any cash
fees earned by such Non- Employee Director for services rendered during the calendar year, shall not exceed $250,000 in total value.
For purposes of this limit, the value of such Grants shall be calculated based on the grant date fair value of such Grants for financial
reporting purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <span style="text-decoration: underline">Adjustments</span>.
If there is any change in the number or kind of shares of Company Stock outstanding by reason of (i) a stock dividend, spinoff, recapitalization,
stock split, or combination or exchange of shares, (ii) a merger, reorganization or consolidation, (iii) a reclassification or change
in par value, or (iv) any other extraordinary or unusual event affecting the outstanding Company Stock as a class without the Company&#8217;s
receipt of consideration, or if the value of outstanding shares of Company Stock is substantially reduced as a result of a spinoff or
the Company&#8217;s payment of an extraordinary dividend or distribution, the maximum number and kind of shares of Company Stock available
for issuance under the Plan, the maximum amount of Grants which a Non-Employee Director may receive in any year, the number and kind
of shares covered by outstanding Grants, the number and kind of shares issued and to be issued under the Plan, and the price per share
or the applicable market value of such Grants shall be equitably adjusted by the Committee to reflect any increase or decrease in the
number of, or change in the kind or value of, the issued shares of Company Stock to preclude, to the extent practicable, the enlargement
or dilution of rights and benefits under the Plan and such outstanding Grants; provided, however, that any fractional shares resulting
from such adjustment shall be eliminated. In addition, in the event of a Change of Control, the provisions of Section 12 of the Plan
shall apply. Any adjustments to outstanding Grants shall be consistent with section 409A or 424 of the Code, to the extent applicable.
The adjustments of Grants under this Section 4(e) shall include adjustment of shares, Exercise Price of Stock Options, base amount of
SARs, Performance Goals or other terms and conditions, as the Committee deems appropriate. The Committee shall have the sole discretion
and authority to determine what appropriate adjustments shall be made and any adjustments determined by the Committee shall be final,
binding and conclusive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
5. Eligibility for Participation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Eligible
Persons</span>. All Employees and Non-Employee Directors shall be eligible to participate in the Plan. Key Advisors shall be eligible to
participate in the Plan if the Key Advisors render bona fide services to the Employer, the services are not in connection with the offer
and sale of securities in a capital-raising transaction and the Key Advisors do not directly or indirectly promote or maintain a market
for the Company&#8217;s securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Selection
of Participants</span>. The Committee shall select the Employees, Non-Employee Directors and Key Advisors to receive Grants and shall determine
the number of shares of Company Stock subject to a particular Grant in such manner as the Committee determines.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
6. Options</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may grant Options to an Employee, Non-Employee Director or Key Advisor upon such terms as the Committee deems appropriate.
The following provisions are applicable to Options:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Number
of Shares</span>. The Committee shall determine the number of shares of Company Stock that will be subject to each Grant of Options to Employees,
Non-Employee Directors and Key Advisors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Type
of Option and Exercise Price.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) The
Committee may grant Incentive Stock Options or Nonqualified Stock Options or any combination of the two, all in accordance with the terms
and conditions set forth herein. Incentive Stock Options may be granted only to employees of the Company or its parent or subsidiary
corporations, as defined in section 424 of the Code. Nonqualified Stock Options may be granted to Employees, Non-Employee Directors and
Key Advisors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) The
Exercise Price of Company Stock subject to an Option shall be determined by the Committee and shall be equal to or greater than the Fair
Market Value of a share of Company Stock on the date the Option is granted. However, an Incentive Stock Option may not be granted to
an Employee who, at the time of grant, owns stock possessing more than 10% of the total combined voting power of all classes of stock
of the Company, or any parent or subsidiary corporation of the Company, as defined in section 424 of the Code, unless the Exercise Price
per share is not less than 110% of the Fair Market Value of a share of Company Stock on the date of grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Option
Term</span>. The Committee shall determine the term of each Option. The term of any Option shall not exceed ten years from the date of grant.
However, an Incentive Stock Option that is granted to an Employee who, at the time of grant, owns stock possessing more than 10% of the
total combined voting power of all classes of stock of the Company, or any parent or subsidiary corporation of the Company, as defined
in section 424 of the Code, may not have a term that exceeds five years from the date of grant. Notwithstanding the foregoing, in the
event that on the last business day of the term of an Option (other than an Incentive Stock Option), the exercise of the Option is prohibited
by applicable law, including a prohibition on purchases or sales of Company Stock under the Company&#8217;s insider trading policy, the
term of the Option shall be extended for a period of 30 days following the end of the legal prohibition, unless the Committee determines
otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Exercisability
of Options</span>. Options shall become exercisable in accordance with such terms and conditions, consistent with the Plan, as may be determined
by the Committee and specified in the Grant Instrument. The Committee may accelerate the exercisability of any or all outstanding Options
at any time for any reason.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <span style="text-decoration: underline">Grants
to Non-Exempt Employees</span>. Notwithstanding the foregoing, Options granted to persons who are non-exempt employees under the Fair Labor
Standards Act of 1938, as amended, may not be exercisable for at least six months after the date of grant (except that such Options may
become exercisable, as determined by the Committee, upon the Participant&#8217;s death, Disability or retirement, or upon a Change of
Control or other circumstances permitted by applicable regulations).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <span style="text-decoration: underline">Termination
of Employment or Service</span>. Except as provided in the Grant Instrument, an Option may only be exercised while the Participant is employed
by, or providing services to, the Employer. The Committee shall determine in the Grant Instrument under what circumstances and during
what time periods a Participant may exercise an Option after termination of employment or service.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <span style="text-decoration: underline">Exercise
of Options</span>. A Participant may exercise an Option that has become exercisable, in whole or in part, by delivering a notice of exercise
to the Company. The Participant shall pay the Exercise Price for an Option as specified by the Committee (i) in cash, (ii) unless the
Committee determines otherwise, by delivering shares of Company Stock owned by the Participant and having a Fair Market Value on the
date of exercise at least equal to the Exercise Price or by attestation (on a form prescribed by the Committee) to ownership of shares
of Company Stock having a Fair Market Value on the date of exercise at least equal to the Exercise Price, (iii) by payment through a
broker in accordance with procedures permitted by Regulation T of the Federal Reserve Board, (iv) if permitted by the Committee, by withholding
shares of Company Stock subject to the exercisable Option, which have a Fair Market Value on the date of exercise equal to the Exercise
Price, or (v) by such other method as the Committee may approve. Shares of Company Stock used to exercise an Option shall have been held
by the Participant for the requisite period of time necessary to avoid adverse accounting consequences to the Company with respect to
the Option. Payment for the shares to be issued or transferred pursuant to the Option, and any required withholding taxes, must be received
by the Company by the time specified by the Committee depending on the type of payment being made, but in all cases prior to the issuance
or transfer of such shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <span style="text-decoration: underline">Limits
on Incentive Stock Options</span>. Each Incentive Stock Option shall provide that, if the aggregate Fair Market Value of the Company Stock
on the date of the grant with respect to which Incentive Stock Options are exercisable for the first time by a Participant during any
calendar year, under the Plan or any other stock option plan of the Company or a parent or subsidiary, exceeds $100,000, then the Option,
as to the excess, shall be treated as a Nonqualified Stock Option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
7. Stock Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may issue or transfer shares of Company Stock to an Employee, Non-Employee Director or Key Advisor under a Stock Award, upon
such terms as the Committee deems appropriate. The following provisions are applicable to Stock Awards:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">General
Requirements</span>. Shares of Company Stock issued or transferred pursuant to Stock Awards may be issued or transferred for consideration
or for no consideration, and subject to restrictions or no restrictions, as determined by the Committee. The Committee may, but shall
not be required to, establish conditions under which restrictions on Stock Awards shall lapse over a period of time or according to such
other criteria as the Committee deems appropriate, including, without limitation, restrictions based on the achievement of specific Performance
Goals. The period of time during which the Stock Awards will remain subject to restrictions will be designated in the Grant Instrument
as the &#8220;<span style="text-decoration: underline">Restriction Period.&#8221;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Number
of Shares</span>. The Committee shall determine the number of shares of Company Stock to be issued or transferred pursuant to a Stock Award
and the restrictions applicable to such shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Requirement
of Employment or Service</span>. If the Participant ceases to be employed by, or provide service to, the Employer during a period designated
in the Grant Instrument as the Restriction Period, or if other specified conditions are not met, the Stock Award shall terminate as to
all shares covered by the Grant as to which the restrictions have not lapsed, and those shares of Company Stock must be immediately returned
to the Company. The Committee may, however, provide for complete or partial exceptions to this requirement as it deems appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Restrictions
on Transfer and Legend on Stock Certificate</span>. During the Restriction Period, a Participant may not sell, assign, transfer, pledge
or otherwise dispose of the shares of a Stock Award except under Section 15 below. Unless otherwise determined by the Committee, the
Company will retain possession of certificates for shares of Stock Awards until all restrictions on such shares have lapsed. Each certificate
for a Stock Award, unless held by the Company, shall contain a legend giving appropriate notice of the restrictions in the Grant. The
Participant shall be entitled to have the legend removed from the stock certificate covering the shares subject to restrictions when
all restrictions on such shares have lapsed. The Committee may determine that the Company will not issue certificates for Stock Awards
until all restrictions on such shares have lapsed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <span style="text-decoration: underline">Right
to Vote and to Receive Dividends</span>. Unless the Committee determines otherwise, during the Restriction Period, the Participant shall
have the right to vote shares of Stock Awards and to receive any dividends or other distributions paid on such shares, subject to any
restrictions deemed appropriate by the Committee, including, without limitation, the achievement of specific Performance Goals. Dividends
with respect to Stock Awards that vest based on performance shall vest if and to the extent that the underlying Stock Award vests, as
determined by the Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <span style="text-decoration: underline">Lapse
of Restrictions</span>. All restrictions imposed on Stock Awards shall lapse upon the expiration of the applicable Restriction Period and
the satisfaction of all conditions, if any, imposed by the Committee. The Committee may determine, as to any or all Stock Awards, that
the restrictions shall lapse without regard to any Restriction Period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
8. Stock Units</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may grant Stock Units, each of which shall represent one hypothetical share of Company Stock, to an Employee, Non-Employee
Director or Key Advisor upon such terms and conditions as the Committee deems appropriate. The following provisions are applicable to
Stock Units:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Crediting
of Units</span>. Each Stock Unit shall represent the right of the Participant to receive a share of Company Stock or an amount of cash based
on the value of a share of Company Stock, if and when specified conditions are met. All Stock Units shall be credited to bookkeeping
accounts established on the Company&#8217;s records for purposes of the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Terms
of Stock Units</span>. The Committee may grant Stock Units that vest and are payable if specified Performance Goals or other conditions
are met, or under other circumstances. Stock Units may be paid at the end of a specified performance period or other period, or payment
may be deferred to a date authorized by the Committee. The Committee may accelerate vesting or payment, as to any or all Stock Units
at any time for any reason, provided such acceleration complies with section 409A of the Code. The Committee shall determine the number
of Stock Units to be granted and the requirements applicable to such Stock Units.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Requirement
of Employment or Service</span>. If the Participant ceases to be employed by, or provide service to, the Employer prior to the vesting of
Stock Units, or if other conditions established by the Committee are not met, the Participant&#8217;s Stock Units shall be forfeited.
The Committee may, however, provide for complete or partial exceptions to this requirement as it deems appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Payment
With Respect to Stock Units</span>. Payments with respect to Stock Units shall be made in cash, Company Stock or any combination of the
foregoing, as the Committee shall determine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
9. Stock Appreciation Rights</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may grant SARs to an Employee, Non-Employee Director or Key Advisor separately or in tandem with any Option. The following
provisions are applicable to SARs:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">General
Requirements</span>. The Committee may grant SARs to an Employee, Non-Employee Director or Key Advisor separately or in tandem with any
Option (for all or a portion of the applicable Option). Tandem SARs may be granted either at the time the Option is granted or at any
time thereafter while the Option remains outstanding; provided, however, that, in the case of an Incentive Stock Option, SARs may be
granted only at the time of the grant of the Incentive Stock Option. The Committee shall establish the base amount of the SAR at the
time the SAR is granted. The base amount of each SAR shall be equal to or greater than the Fair Market Value of a share of Company Stock
as of the date of grant of the SAR. The term of any SAR shall not exceed ten years from the date of grant. Notwithstanding the foregoing,
in the event that on the last business day of the term of a SAR, the exercise of the SAR is prohibited by applicable law, including a
prohibition on purchases or sales of Company Stock under the Company&#8217;s insider trading policy, the term shall be extended for a
period of 30 days following the end of the legal prohibition, unless the Committee determines otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Tandem
SARs</span>. In the case of tandem SARs, the number of SARs granted to a Participant that shall be exercisable during a specified period
shall not exceed the number of shares of Company Stock that the Participant may purchase upon the exercise of the related Option during
such period. Upon the exercise of an Option, the SARs relating to the Company Stock covered by such Option shall terminate. Upon the
exercise of SARs, the related Option shall terminate to the extent of an equal number of shares of Company Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Exercisability</span>.
A SAR shall be exercisable during the period specified by the Committee in the Grant Instrument and shall be subject to such vesting
and other restrictions as may be specified in the Grant Instrument. The Committee may accelerate the exercisability of any or all outstanding
SARs at any time for any reason. SARs may only be exercised while the Participant is employed by, or providing service to, the Employer
or during the applicable period after termination of employment or service as specified by the Committee. A tandem SAR shall be exercisable
only during the period when the Option to which it is related is also exercisable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Grants
to Non-Exempt Employees</span>. Notwithstanding the foregoing, SARs granted to persons who are non-exempt employees under the Fair Labor
Standards Act of 1938, as amended, may not be exercisable for at least six months after the date of grant (except that such SARs may
become exercisable, as determined by the Committee, upon the Participant&#8217;s death, Disability or retirement, or upon a Change of
Control or other circumstances permitted by applicable regulations).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <span style="text-decoration: underline">Value
of SARs</span>. When a Participant exercises SARs, the Participant shall receive in settlement of such SARs an amount equal to the value
of the stock appreciation for the number of SARs exercised. The stock appreciation for a SAR is the amount by which the Fair Market Value
of the underlying Company Stock on the date of exercise of the SAR exceeds the base amount of the SAR as described in subsection (a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <span style="text-decoration: underline">Form
of Payment</span>. The appreciation in a SAR shall be paid in shares of Company Stock, cash or any combination of the foregoing, as the
Committee shall determine. For purposes of calculating the number of shares of Company Stock to be received, shares of Company Stock
shall be valued at their Fair Market Value on the date of exercise of the SAR.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
10. Other Stock-Based Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may grant Other Stock-Based Awards, which are awards (other than those described in Sections 6, 7, 8 and 9 of the Plan) that
are based on or measured by Company Stock, to any Employee, Non- Employee Director or Key Advisor, on such terms and conditions as the
Committee shall determine. Other Stock-Based Awards may be awarded subject to the achievement of Performance Goals or other criteria
or other conditions and may be payable in cash, Company Stock or any combination of the foregoing, as the Committee shall determine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
11. Dividend Equivalents</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may grant Dividend Equivalents in connection with Stock Units or Other Stock-Based Awards. Dividend Equivalents may be paid
currently or accrued as contingent cash obligations and may be payable in cash or shares of Company Stock, and upon such terms and conditions
as the Committee shall determine. Dividend Equivalents with respect to Stock Units or Other Stock-Based Awards that vest based on performance
shall vest and be paid only if and to the extent the underlying Stock Units or Other Stock-Based Awards vest and are paid, as determined
by the Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
12. Consequences of a Change of Control</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Assumption
of Outstanding Grants</span>. Upon a Change of Control where the Company is not the surviving corporation (or survives only as a subsidiary
of another corporation), unless the Committee determines otherwise, all outstanding Grants that are not exercised or paid at the time
of the Change of Control shall be assumed by, or replaced with grants (with respect to cash, securities, or a combination thereof) that
have comparable terms by, the surviving corporation (or a parent or subsidiary of the surviving corporation). After a Change of Control,
references to the &#8220;Company&#8221; as they relate to employment matters shall include the successor employer in the transaction,
subject to applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Vesting
Upon Certain Terminations of Employment</span>. Unless the Grant Instrument provides otherwise, if a Participant&#8217;s employment is terminated
by the Employer without Cause upon or within 12 months following a Change of Control, the Participant&#8217;s outstanding Grants shall
become fully vested as of the date of such termination; provided that if the vesting of any such Grants is based, in whole or in part,
on performance, the applicable Grant Instrument shall specify how the portion of the Grant that becomes vested pursuant to this Section
12(b) shall be calculated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Other
Alternatives</span>. In the event of a Change of Control, if any outstanding Grants are not assumed by, or replaced with grants that have
comparable terms by, the surviving corporation (or a parent or subsidiary of the surviving corporation), the Committee may (but is not
obligated to) make adjustments to the terms and conditions of outstanding Grants, including, without limitation, taking any of the following
actions (or combination thereof) with respect to any or all outstanding Grants, without the consent of any Participant: (i) the Committee
may determine that outstanding Stock Options and SARs shall automatically accelerate and become fully exercisable and the restrictions
and conditions on outstanding Stock Awards, Stock Units and Dividend Equivalents shall immediately lapse; (ii) the Committee may determine
that Participants shall receive a payment in settlement of outstanding Stock Units or Dividend Equivalents, in such amount and form as
may be determined by the Committee; (iii) the Committee may require that Participants surrender their outstanding Stock Options and SARs
in exchange for a payment by the Company, in cash or Company Stock as determined by the Committee, in an amount equal to the amount,
if any, by which the then Fair Market Value of the shares of Company Stock subject to the Participant&#8217;s unexercised Stock Options
and SARs exceeds the Stock Option Exercise Price or SAR base amount, and (iv) after giving Participants an opportunity to exercise all
of their outstanding Stock Options and SARs, the Committee may terminate any or all unexercised Stock Options and SARs at such time as
the Committee deems appropriate. Such surrender, termination or payment shall take place as of the date of the Change of Control or such
other date as the Committee may specify. Without limiting the foregoing, if the per share Fair Market Value of the Company Stock does
not exceed the per share Stock Option Exercise Price or SAR base amount, as applicable, the Company shall not be required to make any
payment to the Participant upon surrender of the Stock Option or SAR.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
13. Deferrals</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may permit or require a Participant to defer receipt of the payment of cash or the delivery of shares that would otherwise
be due to such Participant in connection with any Grant. If any such deferral election is permitted or required, the Committee shall
establish rules and procedures for such deferrals and may provide for interest or other earnings to be paid on such deferrals. The rules
and procedures for any such deferrals shall be consistent with applicable requirements of section 409A of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
14. Withholding of Taxes</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Required
Withholding</span>. All Grants under the Plan shall be subject to applicable United States federal (including FICA), state and local, foreign
country or other tax withholding requirements. The Employer may require that the Participant or other person receiving Grants or exercising
Grants pay to the Employer an amount sufficient to satisfy such tax withholding requirements with respect to such Grants, or the Employer
may deduct from other wages and compensation paid by the Employer the amount of any withholding taxes due with respect to such Grants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Share
Withholding</span>. The Committee may permit or require the Employer&#8217;s tax withholding obligation with respect to Grants paid in Company
Stock to be satisfied by having shares withheld up to an amount that does not exceed the Participant&#8217;s applicable withholding tax
rate for United States federal (including FICA), state and local, foreign country or other tax liabilities. The Committee may, in its
discretion, and subject to such rules as the Committee may adopt, allow Participants to elect to have such share withholding applied
to all or a portion of the tax withholding obligation arising in connection with any particular Grant. Unless the Committee determines
otherwise, share withholding for taxes shall not exceed the Participant&#8217;s minimum applicable tax withholding amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
15. Transferability of Grants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Nontransferability
of Grants</span>. Except as described in subsection (b) below, only the Participant may exercise rights under a Grant during the Participant&#8217;s
lifetime. A Participant may not transfer those rights except (i) by will or by the laws of descent and distribution or (ii) with respect
to Grants other than Incentive Stock Options, pursuant to a domestic relations order. When a Participant dies, the personal representative
or other person entitled to succeed to the rights of the Participant may exercise such rights. Any such successor must furnish proof
satisfactory to the Company of his or her right to receive the Grant under the Participant&#8217;s will or under the applicable laws
of descent and distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Transfer
of Nonqualified Stock Options and Stock Awards</span>. Notwithstanding the foregoing, the Committee may provide, in a Grant Instrument or
at such other time after the grant of an award, that a Participant may transfer Nonqualified Stock Options or Stock Awards to family
members, or one or more trusts or other entities for the benefit of or owned by family members, consistent with the applicable securities
laws, according to such terms as the Committee may determine; provided that the Participant receives no consideration for the transfer
of an Option or Stock Award and the transferred Option or Stock Award shall continue to be subject to the same terms and conditions as
were applicable to the Option or Stock Award immediately before the transfer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
16. Requirements for Issuance or Transfer of Shares</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
Company Stock shall be issued or transferred in connection with any Grant hereunder unless and until all legal requirements applicable
to the issuance or transfer of such Company Stock have been complied with to the satisfaction of the Committee. The Committee shall have
the right to condition any Grant on the Participant&#8217;s undertaking in writing to comply with such restrictions on his or her subsequent
disposition of the shares of Company Stock as the Committee shall deem necessary or advisable, and certificates representing such shares
may be legended to reflect any such restrictions. Certificates representing shares of Company Stock issued or transferred under the Plan
may be subject to such stop-transfer orders and other restrictions as the Committee deems appropriate to comply with applicable laws,
regulations and interpretations, including any requirement that a legend be placed thereon.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
17. Amendment and Termination of the Plan</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Amendment</span>.
The Board may amend or terminate the Plan at any time; provided, however, that the Board shall not amend the Plan without stockholder
approval if such approval is required in order to comply with the Code or other applicable law, or to comply with applicable stock exchange
requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">No
Repricing of Options or SARs</span>. Except in connection with a corporate transaction involving the Company (including, without limitation,
any stock dividend, distribution (whether in the form of cash, Company Stock, other securities or property), stock split, extraordinary
cash dividend, recapitalization, change in control, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase
or exchange of shares of Company Stock or other securities, or similar transactions), the Company may not, without obtaining stockholder
approval, (i) amend the terms of outstanding Stock Options or SARs to reduce the Exercise Price of such outstanding Stock Options or
base price of such SARs, (ii) cancel outstanding Stock Options or SARs in exchange for Stock Options or SARs with an Exercise Price or
base price, as applicable, that is less than the Exercise Price or base price of the original Stock Options or SARs or (iii) cancel outstanding
Stock Options or SARs with an Exercise Price or base price, as applicable, above the current stock price in exchange for cash or other
securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Termination
of Plan</span>. The Plan shall terminate on the day immediately preceding the tenth anniversary of its Effective Date, unless the Plan is
terminated earlier by the Board or is extended by the Board with the approval of the stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Termination
and Amendment of Outstanding Grants</span>. A termination or amendment of the Plan that occurs after a Grant is made shall not materially
impair the rights of a Participant with respect to such Grant unless the Participant consents or unless the Committee acts under Section
18(f) below. The termination of the Plan shall not impair the power and authority of the Committee with respect to an outstanding Grant.
Whether or not the Plan has terminated, an outstanding Grant may be terminated or amended under Section 18(f) below or may be amended
by agreement of the Company and the Participant consistent with the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
18. Miscellaneous</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Grants
in Connection with Corporate Transactions and Otherwise</span>. Nothing contained in the Plan shall be construed to (i) limit the right
of the Committee to make Grants under the Plan in connection with the acquisition, by purchase, lease, merger, consolidation or otherwise,
of the business or assets of any corporation, firm or association, including Grants to employees thereof who become Employees, or (ii)
limit the right of the Company to grant stock options or make other awards outside of the Plan. The Committee may make a Grant to an
employee of another corporation who becomes an Employee by reason of a corporate merger, consolidation, acquisition of stock or property,
reorganization or liquidation involving the Company, in substitution for a stock option or stock awards grant made by such corporation.
Notwithstanding anything in the Plan to the contrary, the Committee may establish such terms and conditions of the new Grants as it deems
appropriate, including setting the Exercise Price of Options or the base price of SARs at a price necessary to retain for the Participant
the same economic value as the prior options or rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Governing
Document. The Plan shall be the controlling document</span>. No other statements, representations, explanatory materials or examples, oral
or written, may amend the Plan in any manner. The Plan shall be binding upon and enforceable against the Company and its successors and
assigns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Funding
of the Plan</span>. The Plan shall be unfunded. The Company shall not be required to establish any special or separate fund or to make any
other segregation of assets to assure the payment of any Grants under the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Rights
of Participants</span>. Nothing in the Plan shall entitle any Employee, Non-Employee Director, Key Advisor or other person to any claim
or right to receive a Grant under the Plan. Neither the Plan nor any action taken hereunder shall be construed as giving any individual
any rights to be retained by or in the employ of the Employer or any other employment rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <span style="text-decoration: underline">No
Fractional Shares</span>. No fractional shares of Company Stock shall be issued or delivered pursuant to the Plan or any Grant. Except as
otherwise provided under the Plan, the Committee shall determine whether cash, other awards or other property shall be issued or paid
in lieu of such fractional shares or whether such fractional shares or any rights thereto shall be forfeited or otherwise eliminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <span style="text-decoration: underline">Compliance
with Law.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) The
Plan, the exercise of Options and SARs and the obligations of the Company to issue or transfer shares of Company Stock under Grants shall
be subject to all applicable laws and regulations, and to approvals by any governmental or regulatory agency as may be required. With
respect to persons subject to section 16 of the Exchange Act, it is the intent of the Company that the Plan and all transactions under
the Plan comply with all applicable provisions of Rule 16b-3 or its successors under the Exchange Act. In addition, it is the intent
of the Company that Incentive Stock Options comply with the applicable provisions of section 422 of the Code, and that, to the extent
applicable, Grants comply with the requirements of section 409A of the Code. To the extent that any legal requirement of section 16 of
the Exchange Act or section 422 or 409A of the Code as set forth in the Plan ceases to be required under section 16 of the Exchange Act
or section 422 or 409A of the Code, that Plan provision shall cease to apply. The Committee may revoke any Grant if it is contrary to
law or modify a Grant to bring it into compliance with any valid and mandatory government regulation. The Committee may also adopt rules
regarding the withholding of taxes on payments to Participants. The Committee may, in its sole discretion, agree to limit its authority
under this Section.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) The
Plan is intended to comply with the requirements of section 409A of the Code, to the extent applicable. Each Grant shall be construed
and administered such that the Grant either (A) qualifies for an exemption from the requirements of section 409A of the Code or (B) satisfies
the requirements of section 409A of the Code. If a Grant is subject to section 409A of the Code, (I) distributions shall only be made
in a manner and upon an event permitted under section 409A of the Code, (II) payments to be made upon a termination of employment or
service shall only be made upon a &#8220;separation from service&#8221; under section 409A of the Code, (III) unless the Grant specifies
otherwise, each installment payment shall be treated as a separate payment for purposes of section 409A of the Code, and (IV) in no event
shall a Participant, directly or indirectly, designate the calendar year in which a distribution is made except in accordance with section
409A of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) Any
Grant that is subject to section 409A of the Code and that is to be distributed to a Key Employee (as defined below) upon separation
from service shall be administered so that any distribution with respect to such Grant shall be postponed for six months following the
date of the Participant&#8217;s separation from service, if required by section 409A of the Code. If a distribution is delayed pursuant
to section 409A of the Code, the distribution shall be paid within 15 days after the end of the six-month period. If the Participant
dies during such six-month period, any postponed amounts shall be paid within 90 days of the Participant&#8217;s death. The determination
of Key Employees, including the number and identity of persons considered Key Employees and the identification date, shall be made by
the Committee or its delegate each year in accordance with section 416(i) of the Code and the &#8220;specified employee&#8221; requirements
of section 409A of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) Notwithstanding
anything in the Plan or any Grant agreement to the contrary, each Participant shall be solely responsible for the tax consequences
of Grants under the Plan, and in no event shall the Company or any subsidiary or affiliate of the Company have any responsibility or
liability if a Grant does not meet any applicable requirements of section 409A of the Code. Although the Company intends to
administer the Plan to prevent taxation under section 409A of the Code, the Company does not represent or warrant that the Plan or
any Grant complies with any provision of federal, state, local or other tax law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <span style="text-decoration: underline">Grants
in Foreign Countries; Establishment of Subplans</span>. The Committee has the authority to award Grants to Participants who are foreign
nationals or employed outside the United States on any different terms and conditions than those specified in the Plan that the Committee,
in its discretion, believes to be necessary or desirable to accommodate differences in applicable law, tax policy, or custom, while furthering
the purposes of the Plan. The Board may from time to time establish one or more sub-plans under the Plan for purposes of satisfying applicable
blue sky, securities or tax laws of various jurisdictions. The Board shall establish such sub-plans by adopting supplements to the Plan
setting forth (i) such limitations on the Committee&#8217;s discretion under the Plan as the Board deems necessary or desirable and (ii)
such additional terms and conditions not otherwise inconsistent with the Plan as the Board shall deem necessary or desirable. All supplements
adopted by the Board shall be deemed to be part of the Plan, but each supplement shall apply only to Participants within the affected
jurisdiction and the Employer shall not be required to provide copies of any supplement to Participants in any jurisdiction that is not
affected. Notwithstanding the foregoing, the Committee may not approve any sub-plan inconsistent with the terms or share limits in the
Plan or which would otherwise cause the Plan to cease to satisfy any conditions under Rule 16b-3 under the 1934 Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <span style="text-decoration: underline">Clawback
Rights</span>. Subject to the requirements of applicable law, the Committee may provide in any Grant Instrument that, if a Participant breaches
any restrictive covenant agreement between the Participant and the Employer (which may be set forth in any Grant Instrument) or otherwise
engages in activities that constitute Cause either while employed by, or providing service to, the Employer or within a specified period
of time thereafter, all Grants held by the Participant shall terminate, and the Company may rescind any exercise of an Option or SAR
and the vesting of any other Grant and delivery of shares upon such exercise or vesting (including pursuant to dividends and Dividend
Equivalents), as applicable on such terms as the Committee shall determine, including the right to require that in the event of any such
rescission, (i) the Participant shall return to the Company the shares received upon the exercise of any Option or SAR and/or the vesting
and payment of any other Grant (including pursuant to dividends and Dividend Equivalents) or, (ii) if the Participant no longer owns
the shares, the Participant shall pay to the Company the amount of any gain realized or payment received as a result of any sale or other
disposition of the shares (or, in the event the Participant transfers the shares by gift or otherwise without consideration, the Fair
Market Value of the shares on the date of the breach of the restrictive covenant agreement (including a Participant&#8217;s Grant Instrument
containing restrictive covenants) or activity constituting Cause), net of the price originally paid by the Participant for the shares.
Payment by the Participant shall be made in such manner and on such terms and conditions as may be required by the Committee. The Employer
shall be entitled to set off against the amount of any such payment any amounts otherwise owed to the Participant by the Employer. In
addition, all Grants under the Plan shall be subject to any applicable clawback or recoupment policies, share trading policies and other
policies that may be implemented by the Board from time to time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <span style="text-decoration: underline">Governing
Law; Jurisdiction</span>. The validity, construction, interpretation and effect of the Plan and Grant Instrument issued under the Plan shall
be governed and construed by and determined in accordance with the laws of the Commonwealth of Massachusetts, without giving effect to
the conflict of laws provisions thereof. Any action arising out of, or relating to, any of the provisions of the Plan and Grants made
hereunder shall be brought only in the United States District Court for the District of Massachusetts, or if such court does not have
jurisdiction or will not accept jurisdiction, in any court of general jurisdiction in Massachusetts, and the jurisdiction of such court
in any such proceeding shall be exclusive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Appendix
B</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTIFICATE
OF AMENDMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OF</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTIFICATE
OF INCORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OF</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>KOPIN
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 242 of the</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
Corporation Law of the State of Delaware</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KOPIN
CORPORATION (the &#8220;Corporation&#8221;), a corporation organized and existing under and by virtue of the General Corporation
Law of the State of Delaware,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DOES
HEREBY CERTIFY:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FIRST:
That at a meeting of the Board of Directors of the Corporation resolutions were duly adopted setting forth a proposed
amendment to the Certificate of Incorporation, as amended to date (the &#8220;Charter Amendment&#8221;) and declaring said Charter
Amendment to be advisable and directing the stockholders of the Corporation to consider said Charter Amendment and to indicate their
approval and adoption thereof. The resolution setting forth the amendment is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RESOLVED,
That the first sentence of Article Fourth of the Restated Certificate of Incorporation of the Corporation be and it hereby is amended
to read as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;FOURTH:
The total number of shares of stock which the Corporation shall have authority to issue is two hundred and seventy-five
million and three thousand (275,003,000) shares, of which three thousand (3,000) shares, par value of $.01 each, are to be of
a class designated Preferred Stock, and two hundred and seventy five million (275,000,000) shares, par value of $.01 each,
are to be of a class designated Common Stock.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECOND:
That thereafter, pursuant to resolution of its Board of Directors, an annual meeting of the stockholders of said corporation was duly
called and held, upon notice in accordance with Sections 211 and 222 of the General Corporation Law of the State of Delaware at
which meeting the necessary number of shares as required by statute were voted in favor of the amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIRD:
That the aforesaid Charter Amendment was duly adopted in accordance with the applicable provisions of Section 242 of the General
Corporation Law of the State of Delaware.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOURTH:
That this Certificate of Amendment to the Certificate of Incorporation shall become effective upon the filing of the Certificate of Amendment
with the Delaware Secretary of State, which will occur as soon as reasonably practicable after approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, said Kopin Corporation has caused this Certificate of Amendment to the Certificate of Incorporation to be executed,
acknowledged and filed by its Chief Financial Officer this [&#9679;] day of June 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KOPIN
    CORPORATION </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Richard A. Sneider</i> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 5%">Name:</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
    A. Sneider </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="proxy_001.jpg" style="width: 800px"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="proxy_002.jpg" style="width: 800px"/>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>








<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_89D_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zdQLge7iPOxb" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="formdef14a_002.jpg" style="height: 520px; width: 750px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
Compensation Plan Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information as of December 28, 2024 about shares of our common stock issuable upon exercise of outstanding
options, warrants and rights and available for issuance under our existing equity compensation plans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Plan Category</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of securities to</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>be
                                            issued upon exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
                                            outstanding options,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>warrants
                                            and rights</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>exercise
                                            price of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>outstanding
                                            options,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>warrants
                                            and rights</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>remaining
                                            available</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>for
                                            future issuance</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>under
                                            equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>compensation
                                            plans</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(excluding
                                            securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>reflected
                                            in column (a)) </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(a)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(b)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(c)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity compensation
    plans approved by security holders<sup>(1)</sup></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,833,611</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.19</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,913,621</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;<sup>(2)</sup></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Equity compensation plans not approved by security holders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">&#8212;</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">&#8212;</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">&#8212;</p></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">4,833,611</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><p style="margin: 0">1.19</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0; text-indent: 0.25in">4,913,621</p></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of shares available under the 2020 Equity Incentive Plan.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 28, 2024, there were 4,913,621 shares available for grant under the 2020 Equity Incentive Plan.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Compensation Commencing in Fiscal Year 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2023, the Compensation Committee engaged Aon to perform a peer review of our Board of Director compensation. Commencing in 2024
our Board-approved compensation for non-employee directors is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
    retainer: $40,000 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Annual
    stock grant: 64,500 shares of restricted stock which vest on the anniversary of the grant Committee membership fees paid annually:</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    Committee Chairperson: $15,000 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Non-employee Chairperson of the Board: $30,000</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominating
    Committee Chairperson: $10,000 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
    Committee Chairperson: $10,000 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    Committee member: $8,000 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominating
    Committee member: $4,375 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
    Committee member: $5,000 </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the adoption of the Board Compensation plan commencing in 2024 the following adjustments were made:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Annual retainer was decreased from $45,000 to $40,000 </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
    annual stock grant was increased to 64,500 shares of restricted stock from 10,000 shares Committee membership fees paid annually:</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Non-employee Chairperson of the Board: $30,000</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    Committee Chairperson compensation was increased $5,000</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
    Committee Chairperson compensation increased $6,250 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    Committee member compensation increased $3,000 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominating
    Committee member compensation increased $1,875 </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Compensation Committee
    member compensation decreased $1,250</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Meeting
    fees were eliminated</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
non-employee director was also entitled to receive an initial restricted stock award for 64,500 shares of our common stock on the date
of his or her initial election to the Board. We also pay expenses for attendance at meetings of the Board and committees thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information regarding the compensation earned by or awards to each non-employee director who served
on our Board of Directors in the 2024 fiscal year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Murray, who was an employee of Kopin during 2024, was not compensated for his service as director and his compensation is fully reflected
in the Summary Compensation Table above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Compensation Table for 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Name</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fees</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Earned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>or
                                            Paid</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in
                                            Cash</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)<sup>(1)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)<sup>(2)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incentive</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)<sup>(3)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change
                                            in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pension
                                            Value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nonqualified</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deferred</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Earnings<sup>(3)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All
                                            Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)<sup>(3)</sup></b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)
                                            </b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jill J. Avery<sup>(4)</sup></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">61,188</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,310</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">111,498</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chi Chia Hsieh<sup>(5)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">54,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,310</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">104,310</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Nieuwsma <sup>(6)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">55,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,310</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">105,310</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Margaret Seif<sup>(7)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,188</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,310</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">85,828</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul Walsh, Jr.<sup>(8)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,333</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">54,573</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">81,907</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    Board member received his or her annual restricted stock grant of 64,500 shares which vests on the anniversary of the grant if the
    person is still a member of our Board of Directors on such anniversary with the exception of Mr. Walsh. The amounts in the column
    were determined by multiplying the number of shares of restricted common stock granted by the closing price of our common stock as
    listed on the Nasdaq on the day of grant. The 2024 grant occurred on June 6, 2024, and the closing price of our stock was $0.78.
    Mr. Walsh joined the Board of Directors on September 9, 2024 and he was granted 64,500 shares of restricted stock. Our stock price
    on September 9, 2024 was $0.85. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
    were no stock options issued in 2024. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    non-equity incentive compensation, pension, non-qualified deferred compensation or other compensation payments were made as compensation
    for director services in fiscal year 2024 or are contemplated under our current compensation plan. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Avery&#8217;s annual cash fees were comprised of the annual retainer of $40,000, $7,188 for serving on the Nominating Committee,
    and $8,000 for serving on the Audit Committee. In addition, prior to the implementation of the current Board member compensation
    plan members were paid meeting fees. Ms. Avery was paid $2,000 for attending meetings of the Board and $4,000 for attending meetings
    of the Audit Committee under the prior Board member compensation plan. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Hsieh&#8217;s annual cash fees were comprised of the annual retainer of $40,000 and $10.000 for serving as the Compensation Committee
    Chairperson. In addition, prior to the implementation of the current Board member compensation plan members were paid meeting fees.
    Dr. Hsieh was paid $2,000 for attending meetings of the Board and $2,000 for attending meetings of the Compensation Committee under
    the prior Board member compensation plan.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Nieuwsma&#8217;s annual cash fees were comprised of the annual retainer of $40,000, $8,000 for serving on the Audit Committee and
    $5.000 for serving as the Compensation Committee. In addition, prior to the implementation of the current Board member compensation
    plan members were paid meeting fees. Mr. Nieuwsma was paid $2,000 for attending meetings of the Board. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Sief&#8217;s annual cash fees were comprised of the annual retainer of $40,000, $7,188 for serving as Chairperson of the Nominating
    Committee and $5.000 for serving on the Compensation Committee. </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Walsch, Jr.&#8217;s annual cash fees were comprised of a prorated annual retainer of $12,333, and $15,000 for serving as the Audit
    Committee Chairperson. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    Director, excluding Michael Murray, has 64,500 of unvested restricted shares.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Committee Report</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee of the Board currently consists of Paul Walsch, Jr., Jill J. Avery and David Nieuwsma, each of whom the Board
has determined is independent under applicable SEC and Nasdaq Rules. The Board also has determined that Mr. Walsh is an &#8220;audit
committee financial expert&#8221; under applicable SEC rules and regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Audit Committee is to assist the Board in its general oversight of the Company&#8217;s financial reporting, internal controls
and audit functions. The Audit Committee charter, which is available at the Company&#8217;s website at <i>www.kopin.com</i>, under the
heading &#8220;Investors: Corporate Governance,&#8221; describes in greater detail the full responsibilities of the Audit Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
is responsible for the preparation, presentation and integrity of the Company&#8217;s financial statements; accounting and financial
reporting principles; establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)); establishing
and maintaining internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f)); evaluating the effectiveness of
disclosure controls and procedures; evaluating the effectiveness of internal control over financial reporting; and evaluating any change
in internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, internal control
over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BDO
USA, P.C.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> (&#8220;BDO&#8221;), the Company&#8217;s
independent registered public accounting firm, has been engaged to perform an independent audit of the consolidated financial statements
and to express an opinion on the conformity of those financial statements with accounting principles generally accepted in the United
States of America and also to express an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting.
The Audit Committee has reviewed and discussed the consolidated financial statements with management and BDO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the course of the 2024 fiscal year, management completed the documentation, testing and evaluation of the Company&#8217;s system of internal
control over financial reporting in response to the requirements set forth in Section 404 of the Sarbanes-Oxley Act of 2002 and related
rules and regulations. The Audit Committee was kept apprised of the progress of the evaluation and provided oversight and advice to management
during this process. In connection with this oversight, the Audit Committee also received periodic updates provided by management and
Stowe &amp; Degon LLC, an independent registered public accounting firm that the Company uses for internal controls review, at regularly
scheduled Audit Committee meetings. At the conclusion of the process, management provided the Audit Committee with, and the Audit Committee
reviewed, a report on the effectiveness of the Company&#8217;s internal control over financial reporting. The Audit Committee also received
a report of results from Stowe &amp; Degon LLC. The Audit Committee also reviewed the report of management contained in the Company&#8217;s
Annual Reports on Form 10-K for the fiscal year ended December 28, 2024, filed with the SEC, as well as BDO&#8217;s Reports of Independent
Registered Public Accounting Firm included in the Company&#8217;s Annual Report on Form 10-K related to its audit of the consolidated
financial statements and financial statement schedule, for the fiscal year ended December 28, 2024. In conjunction, the Audit Committee
continues to oversee the Company&#8217;s efforts related to its internal control over financial reporting and management&#8217;s preparations
for the evaluation in fiscal year 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee has discussed with BDO the matters that are required to be discussed by applicable standards of the Public Company Accounting
Oversight Board (&#8220;PCAOB&#8221;), including Statement on Auditing Standards No. 61, &#8220;<i>Communication with Audit Committees</i>,&#8221;
as amended, and as adopted by the PCAOB, as well as Rule 2-07 of Regulation S-X of the SEC &#8220;<i>Communication with Audit Committees</i>.&#8221;
BDO has also provided to the Committee its letter required by PCAOB Ethics and Independence Rule 3526, &#8220;<i>Communications with
Audit Committees Concerning Independence</i>,&#8221; and the Committee discussed with RSM the firm&#8217;s independence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on its review and the discussion noted above, the Audit Committee recommended to the Board that the Company&#8217;s Consolidated Financial
Statements for the fiscal year 2024 be included in the Company&#8217;s Annual Report on Form 10-K for the 2024 fiscal year for filing
with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUDIT
    COMMITTEE</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Walsh, Jr., Chairperson </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jill
    J. Avery </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Nieuwsma</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
2</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>APPROVAL
OF AN AMENDMENT TO THE COMPANY&#8217;S 2020 EQUITY INCENTIVE PLAN</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Equity Incentive Plan Amendment Proposal&#8212;</b> The Board has authorized, subject to stockholder approval, an amendment to our 2020
Equity Incentive Plan (the &#8220;2020 EIP&#8221;) to increase the number of shares available under the 2020 EIP by 5,000,000 shares
(the &#8220;Plan Amendment&#8221;). Currently, the 2020 EIP authorizes the issuance of up to 14,000,000 shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the 2020 EIP is to encourage ownership of the Company&#8217;s common stock by key employees and to provide additional incentive
for such employees to promote the success of the Company&#8217;s business. The Board believes that the 2020 EIP:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aligns
    the long-term interests of key employees and stockholders by creating a direct link between key employee compensation and stockholder
    return; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enables
    key employees to develop and maintain a meaningful stock ownership in the Company; and </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provides
    incentives for key employees to contribute to the success of the Company. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan Amendment is being submitted to stockholders for approval. A copy of the 2020 EIP as it is proposed to be amended is attached to
this Proxy Statement as Appendix A. The Board believes it is in the best interests of the Company and its stockholders to approve the
Plan Amendment to increase the number of shares available under the 2020 EIP by 5,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
total of 19,000,000 shares of Kopin common stock will be reserved for issuance under the amended 2020 EIP. As of April 30, 2025,
the closing price on Nasdaq per share of common stock was $1.28. Our Board approved the Plan Amendment on March 20, 2025, subject to
approval by Kopin&#8217;s stockholders. The Plan Amendment will be effective upon approval by Kopin&#8217;s stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">The following table
includes information regarding all of our outstanding equity awards and shares available for future awards under the Plan as of May
1, 2025:</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Total number of shares underlying outstanding stock options</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">591,366</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Weighted average exercise price of outstanding stock options</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.76</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Weighted average remaining life of outstanding stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.75</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total shares of common stock outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">162,797,922</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total shares underlying outstanding and unvested restricted stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,492,501</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Shares available for future awards under the 2020 Equity Incentive plan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,343,521</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reasons
for the Amendment to the 2020 EIP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
incentive compensation programs play a pivotal role in Kopin&#8217;s efforts to attract and retain key personnel essential to Kopin&#8217;s
long-term growth and financial success. We are asking our stockholders to approve the Plan Amendment to assist Kopin in attracting and
retaining qualified personnel. If our stockholders do not approve the Plan Amendment, we will be limited in our ability to continue to
issue awards in numbers sufficient to attract and motivate the highly skilled employees we need to recruit and retain, due to low share
reserves remaining in our 2020 EIP and the dilution to our share reserve and outstanding equity awards from the increase in our stock
outstanding from recent financing activities, and our employees&#8217; motivation and incentives will be negatively affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering
a broad-based equity compensation program is vital to attracting and retaining highly skilled people in the highly competitive technology
industry. We use equity awards to increase incentives on the part of employees, non-employee directors and consultants who provide significant
services to the Company. We believe that providing an equity stake in the future success of our business encourages our employees to
be highly motivated to achieve our long-term business goals and to increase stockholder value. Their innovation and productivity are
critical to our success. Accordingly, approving the Plan Amendment is in the best interest of our stockholders because equity awards
help us to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">attract,
    motivate and retain talented employees and directors; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">align
    employee and stockholder interests; and </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">link
    employee compensation with Kopin&#8217;s performance. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
strongly believe that approval of the Plan Amendment will enable us to achieve our goals in attracting and retaining our most valuable
asset: our employees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
the appropriate share reserve to grant competitive equity-based incentives, we would be forced to consider cash replacement alternatives
to provide a market-competitive total compensation package necessary to attract, retain and motivate the employee talent critical to
our future successes. These cash replacement alternatives could, among other things, reduce the cash available for investment in growth
and development and cause a loss of motivation by employees to achieve superior performance over a longer period of time. Equity- based
incentives, by contrast, directly align a portion of the compensation of our employees with the economic interests of our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
that reason, Kopin has structured the 2020 EIP to provide flexibility in designing equity incentive programs with a broad array of equity
incentives, such as stock options, stock appreciation rights, stock awards and restricted stock units and implement competitive incentive
compensation programs for its employees and non-employee Board members. The 2020 EIP will continue to be the only plan under which new
equity awards may be granted to our employees and other service providers. If this Proposal 2 is not approved, then we would be at a
disadvantage against our competitors for recruiting, retaining and motivating individuals critical to our success and could be forced
to increase cash compensation, thereby reducing resources available to meet our business needs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of May 1, 2025, 11,668,479 shares of common stock, net of 4,373,315 of forfeitures, had been issued pursuant to awards under the
2020 EIP. All awards outstanding under the 2020 EIP on the date of the Plan Amendment will continue to be governed solely by the terms
of the documents evidencing such awards, and no provision of the Plan Amendment will be deemed to affect or otherwise modify the rights
or obligations of the holders of such transferred awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with our stock-based compensation programs, we are committed to using equity incentive awards prudently and within reasonable
limits. We anticipate that the share reserve under the amended 2020 EIP, will enable us to fund our equity compensation program for approximately
two years. While we believe this is a reasonable estimate of how long the share reserve would last, the actual period for which the proposed
share reserve will fund our equity compensation program may be shorter or longer than expected, depending on changes in our granting
practices, stock price and headcount growth.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
Description of the Kopin Corporation 2020 Equity Incentive Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of the principal provisions of the 2020 EIP. This summary is qualified in its entirety by reference to the full
text of the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Types
of Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2020 EIP provides for the issuance of stock options (including non-statutory stock options and incentive stock option), stock appreciation
rights (referred to as &#8220;SARs&#8221;), restricted stock, restricted stock units (&#8220;RSUs&#8221;), stock bonuses and other stock-based
awards to officers, employees, non-employee directors, independent contractors and consultants of Kopin Corporation or its affiliates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purpose
and Types of Grants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the 2020 EIP is to attract and retain employees, non-employee directors and consultants, and advisors. The 2020 EIP provides
for the issuance of incentive stock options, non-qualified stock options, stock awards, stock units, stock appreciation rights and other
stock-based awards. The 2020 EIP is intended to provide an incentive to participants to contribute to our economic success by aligning
the economic interests of participants with those of our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Administration</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2020 EIP is administered by the Compensation Committee of our Board, and the Compensation Committee will determine all of the terms and
conditions applicable to grants under the 2020 EIP. Our Compensation Committee determines who receives grants under the 2020 EIP and
the number of shares of common stock that will be subject to grants, except that grants to members of our Board must be authorized by
a majority of our Board. Our Compensation Committee may delegate authority under the 2020 EIP to one or more subcommittees as it deems
appropriate. Subject to compliance with applicable law and stock exchange requirements, the Compensation Committee (or our Board or a
subcommittee, as applicable) may delegate all or part of its authority to our Chief Executive Officer, as it deems appropriate, with
respect to grants to employees or key advisors who are not executive officers under Section 16 of the Exchange Act. Our Compensation
Committee, our Board, any subcommittee or the Chief Executive Officer, as applicable, that has authority with respect to a specific grant
will be referred to as &#8220;the committee&#8221; in this description of the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shares
Subject to the Plan</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to adjustment, our 2020 EIP currently authorizes the issuance or transfer of up to 14,000,000 shares of our common stock. In addition,
shares of common stock underlying any outstanding award granted under the Prior Plan that, following the effective date of the 2020 EIP,
expires, or is terminated, surrendered or forfeited for any reason without issuance of such shares shall be available for new grants
under the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any options or SARs expire or are canceled, forfeited, exchanged or surrendered without having been exercised, or if any stock awards,
stock units or other stock-based awards are forfeited, terminated or otherwise not paid in full, the shares of our common stock subject
to such awards will again be available for purposes of the 2020 EIP. If shares of our common stock are surrendered in payment of the
exercise price of an option, the number of shares of common stock available for issuance under the 2020 EIP will be reduced only by the
net number of shares actually issued by us upon such exercise and not by the gross number of shares as to which such option is exercised.
Upon the exercise of any SAR under the 2020 EIP, the number of shares of our common stock available for issuance will be reduced only
by the net number of shares actually issued by us upon such exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
shares of our common stock are withheld by us in satisfaction of the withholding taxes incurred in connection with the issuance, vesting
or exercise of any grant or the issuance of our common stock under the 2020 EIP, the number of shares of common stock available for issuance
will be reduced by the net number of shares issued, vested or exercised under such grant, calculated in each instance after payment of
such share withholding. If any awards are paid in cash, and not in shares of our common stock, any shares of our common stock subject
to such awards will also be available for future awards. If we repurchase shares of our common stock on the open market with the proceeds
from the exercise price we receive from options, the repurchased shares will not be available for issuance under the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Individual
Limits for Non-Employee Directors</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
maximum aggregate grant date value of shares of common stock granted to any non-employee director in any one calendar year, taken together
with any cash fees earned by such non-employee director for services rendered during the calendar year, shall not exceed $250,000 in
total value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Adjustments</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with stock splits, stock dividends, recapitalizations and certain other events affecting our common stock, the committee will
make adjustments as it deems appropriate in: the maximum number of shares of common stock reserved for issuance as grants; the maximum
amount of awards that may be granted to any individual non-employee director in any year; the number and kind of shares covered by outstanding
grants; the number and kind of shares that may be issued under the 2020 EIP; the price per share or market value of any outstanding grants;
the exercise price of options; the base amount of stock appreciation rights; and the performance goals or other terms and conditions
as the committee deems appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Eligibility
and Vesting</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of our employees are eligible to receive grants under the 2020 EIP. In addition, our non-employee directors and key advisors who perform
services for us may receive grants under the 2020 EIP. The committee determines the vesting and exercisability terms of awards granted
under the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Options</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our 2020 EIP, the committee determines the exercise price of the options granted and may grant options to purchase shares of our common
stock in such amounts as it determines. The committee may grant options that are intended to qualify as incentive stock options under
Section 422 of the Code, or non-qualified stock options, which are not intended to so qualify. Incentive stock options may only be granted
to our employees. Anyone eligible to participate in the 2020 EIP may receive a grant of non-qualified stock options. The exercise price
of a stock option granted under the 2020 EIP cannot be less than the fair market value of a share of our common stock on the date the
option is granted. If an incentive stock option is granted to a 10% stockholder of the total combined voting power of all classes of
our stock, the exercise price cannot be less than 110% of the fair market value of a share of our common stock on the date the option
is granted. The aggregate number of shares of common stock that may be issued or transferred under the 2020 EIP pursuant to incentive
stock options under Section 422 of the Code may not exceed 10% of the number of shares of common stock outstanding on the effective date
of the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price for any option is generally payable in cash. In certain circumstances as permitted by the committee, the exercise price
may be paid: by the surrender of shares of our common stock with an aggregate fair market value, on the date the option is exercised,
equal to the exercise price; by payment through a broker in accordance with procedures established by the Federal Reserve Board; by withholding
shares of common stock subject to the exercisable option that have a fair market value on the date of exercise equal to the aggregate
exercise price; or by such other method as the committee approves.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term of an option cannot exceed ten years from the date of grant, except that if an incentive stock option is granted to a 10% stockholder
of the total combined voting power of all class of our stock, the term cannot exceed five years from the date of grant. In the event
that on the last day of the term of a non-qualified stock option, the exercise is prohibited by applicable law, including a prohibition
on purchases or sales of our common stock under our insider trading policy, the term of the non-qualified option will be extended for
a period of 30 days following the end of the legal prohibition, unless the committee determines otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as provided in the grant instrument, an option may only be exercised while a participant is employed by or providing service to us. The
committee will determine in the grant instrument under what circumstances and during what time periods a participant may exercise an
option after termination of employment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2020 EIP, the committee may grant stock awards. A stock award is an award of our common stock that may be subject to restrictions
as the committee determines. The restrictions, if any, may lapse over a specified period of employment or based on the satisfaction of
pre-established criteria, in installments or otherwise, as the committee may determine, including, but not limited to, restrictions based
on the achievement of performance goals. Except to the extent restricted under the grant instrument relating to the stock award, a participant
will have all of the rights of a stockholder as to those shares, including the right to vote and the right to receive dividends or distributions
on the shares. Dividends with respect to stock awards that vest based on performance shall vest if and to the extent that the underlying
stock award vests, as determined by the committee. All unvested stock awards are forfeited if the participant&#8217;s employment or service
is terminated for any reason, unless the committee determines otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Units</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2020 EIP, the committee may grant stock units to anyone eligible to participate in the 2020 EIP. Stock units represent hypothetical
shares of our common stock. Stock units become payable on terms and conditions determined by the committee, including specified performance
goals, and will be payable in cash, shares of common stock, or a combination thereof, as determined by the committee. All unvested stock
units are forfeited if the participant&#8217;s employment or service is terminated for any reason, unless the committee determines otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Appreciation Rights</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2020 EIP, the committee may grant SARs, which may be granted separately or in tandem with any option. SARs granted in tandem with
a non-qualified stock option may be granted either at the time the non- qualified stock option is granted or any time thereafter while
the option remains outstanding. SARs granted in tandem with an incentive stock option may be granted only at the time the grant of the
incentive stock option is made. The committee will establish the base amount of the SAR at the time the SAR is granted, which will be
equal to or greater than the fair market value of a share of our common stock as of the date of grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a SAR is granted in tandem with an option, the number of SARs that are exercisable during a specified period will not exceed the number
of shares of our common stock that the participant may purchase upon exercising the related option during such period. Upon exercising
the related option, the related SARs will terminate, and upon the exercise of a SAR, the related option will terminate to the extent
of an equal number of shares of our common stock. Generally, SARs may only be exercised while the participant is employed by, or providing
services to, us. When a participant exercises a SAR, the participant will receive the excess of the fair market value of the underlying
common stock over the base amount of the SAR. The appreciation of a SAR will be paid in shares of our common stock, cash or both.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term of a SAR cannot exceed ten years from the date of grant. In the event that on the last day of the term of a SAR, the exercise is
prohibited by applicable law, including a prohibition on purchases or sales of our common stock under our insider trading policy, the
term of the SAR will be extended for a period of 30 days following the end of the legal prohibition, unless the committee determines
otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Stock-Based Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2020 EIP, the committee may grant other types of awards that are based on, or measured by, our common stock, and granted to anyone
eligible to participate in the 2020 EIP. The committee will determine the terms and conditions of such awards. Other stock-based awards
may be payable in cash, shares of our common stock or a combination of the two, as determined by the committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividend
Equivalents</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2020 EIP, the committee may grant dividend equivalents in connection with grants of stock units or other stock-based awards made
under the 2020 EIP. Dividend equivalents entitle the participant to receive amounts equal to ordinary dividends that are paid on the
shares underlying a grant while the grant is outstanding. The committee will determine whether dividend equivalents will be paid currently
or accrued as contingent cash obligations. Dividend equivalents may be paid in cash or shares of our common stock. The committee will
determine the terms and conditions of the dividend equivalent grants, including whether the grants are payable upon the achievement of
specific performance goals. Dividend equivalents with respect to stock units or other stock-based awards that vest based on performance
shall vest and be paid only if and to the extent that the underlying stock units or other stock-based awards vest and are paid as determined
by the committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Prohibition
on Repricing</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the 2020 EIP, the committee may not (i) amend the terms of any outstanding stock options or SARs to reduce the exercise
price or base price, as applicable, (ii) cancel outstanding stock options or SARs in exchange for stock options or SARs with an exercise
price or base price, as applicable, that is less than the exercise price or base price of the original stock options or SARs or (iii)
cancel outstanding stock options or SARs with an exercise price or base price, as applicable, above the current stock price in exchange
for cash or other securities, except in connection with a corporate transaction involving the Company, without in each such instance
obtaining the approval of our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change
of Control</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we experience a change of control where we are not the surviving corporation (or survive only as a subsidiary of another corporation),
unless the committee determines otherwise, all outstanding grants that are not exercised or paid at the time of the change of control
will be assumed by, or replaced with grants (with respect to cash, securities or a combination thereof) that have comparable terms by,
the surviving corporation (or a parent or subsidiary of the surviving corporation).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise set forth in a grant instrument, if a participant is terminated without cause upon or within 12 months of a change of control,
all outstanding time-based awards shall become fully vested.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
there is a change of control and all outstanding grants are not assumed by, or replaced with grants that have comparable terms by the
surviving corporation, the committee may (but is not obligated to) make adjustments to the terms and conditions of outstanding grants,
including, without limitation, taking any of the following actions (or combination thereof) without the consent of any participant:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determine
    that outstanding options and SARs will accelerate and become fully exercisable and the restrictions and conditions on outstanding
    stock awards, stock units and dividend equivalents immediately lapse; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pay
    participants, in an amount and form determined by the committee, in settlement of outstanding stock units or dividend equivalents;
    </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">require
    that participants surrender their outstanding stock options and SARs in exchange for a payment by us, in cash or shares of our common
    stock, equal to the difference between the exercise price and the fair market value of the underlying shares of our common stock;
    provided, however, if the per share </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fair
    market value of our common stock does not exceed the per share stock option exercise price or stock appreciation right base amount,
    as applicable, we will not be required to make any payment to the participant upon surrender of the stock option or stock appreciation
    right; or </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">after
    giving participants an opportunity to exercise all of their outstanding stock options and SARs, terminate any unexercised stock options
    and SARs on the date determined by the committee. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general terms, a change of control under the 2020 EIP occurs if:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    person, entity or affiliated group, with certain exceptions, acquires more than 50% of our then- outstanding voting securities; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    merge into another entity unless the holders of our voting shares immediately prior to the merger have at least 50% of the combined
    voting power of the securities in the merged entity or its parent; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    merge into another entity and the members of our Board prior to the merger would not constitute a majority of the board of the merged
    entity or its parent; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    sell or dispose of all or substantially all of our assets; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    consummate a complete liquidation or dissolution; or </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    majority of the members of our Board is replaced during any 12-month period by directors whose appointment or election is not endorsed
    by a majority of the incumbent directors. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Deferrals</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
committee may permit or require participants to defer receipt of the payment of cash or the delivery of shares of common stock that would
otherwise be due to the participant in connection with a grant under the 2020 EIP. The committee will establish the rules and procedures
applicable to any such deferrals, consistent with the requirements of Section 409A of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Withholding</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
grants under the 2020 EIP are subject to applicable U.S. federal (including FICA), state and local, foreign or other tax withholding
requirements. We may require participants or other persons receiving grants or exercising grants to pay an amount sufficient to satisfy
such tax withholding requirements with respect to such grants, or we may deduct from other wages and compensation paid by us the amount
of any withholding taxes due with respect to such grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
committee may permit or require that our tax withholding obligation with respect to grants paid in our common stock be paid by having
shares withheld up to an amount that does not exceed the participant&#8217;s minimum applicable withholding tax rate for United States
federal (including FICA), state and local tax liabilities, or as otherwise determined by the committee. In addition, the committee may,
in its discretion, and subject to such rules as the committee may adopt, allow participants to elect to have such share withholding applied
to all or a portion of the tax withholding obligation arising in connection with any particular grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transferability</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as permitted by the committee with respect to non-qualified stock options, only a participant may exercise rights under a grant during
the participant&#8217;s lifetime. Upon death, the personal representative or other person entitled to succeed to the rights of the participant
may exercise such rights. A participant cannot transfer those rights except by will or by the laws of descent and distribution or, with
respect to grants other than incentive stock options, pursuant to a domestic relations order. The committee may provide in a grant instrument
that a participant may transfer non-qualified stock options and stock award to family members, or one or more trusts or other entities
for the benefit of or owned by family members, consistent with applicable securities laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Amendment;
Termination</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board may amend or terminate our 2020 EIP at any time, except that our stockholders must approve an amendment if such approval is required
in order to comply with the Code, applicable laws or applicable stock exchange requirements. Unless terminated sooner by our Board or
extended with stockholder approval, the 2020 EIP will terminate on the day immediately preceding the tenth anniversary of the effective
date of the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stockholder
Approval</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
in connection with certain corporate transactions, including stock dividends, stock splits, a recapitalization, a change in control,
a reorganization, a merger and a spin-off, stockholder approval is required (i) to reduce the exercise price or base price of outstanding
stock options or SARs, (ii) to cancel outstanding stock options or SARs in exchange for the same type of grant with a lower exercise
price or base price, and (iii) to cancel outstanding stock options or SARs that have an exercise price or base price above the current
price of a share of our common stock, in exchange for cash or other securities, each as applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Establishment
of Sub-Plans</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board may, from time to time, establish one or more sub-plans under the 2020 EIP to satisfy applicable blue sky, securities or tax laws
of various jurisdictions. Our Board may establish such sub-plans by adopting supplements to the 2020 EIP setting forth limitations on
the committee&#8217;s discretion and such additional terms and conditions not otherwise inconsistent with the 2020 EIP as our Board deems
necessary or desirable. All such supplements will be deemed part of the 2020 EIP, but each supplement will only apply to participants
within the affected jurisdiction, and we will not be required to provide copies of any supplement to such unaffected participants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Clawback</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to applicable law, the committee may provide in any grant instrument that if a participant breaches any restrictive covenant agreement
between the participant and us, or otherwise engages in activities that constitute cause (as defined in the 2020 EIP) either while employed
by, or providing services to, us or within a specified period of time thereafter, all grants held by the participant will terminate,
and we may rescind any exercise of an option or stock appreciation right and the vesting of any other grant and delivery of shares upon
such exercise or vesting, as applicable on such terms as the committee will determine, including the right to require that in the event
of any rescission:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    participant must return the shares received upon the exercise of any option or stock appreciation right or the vesting and payment
    of any other grants; or </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    the participant no longer owns the shares, the participant must pay to us the amount of any gain realized or payment received as
    a result of any sale or other disposition of the shares (if the participant transferred the shares by gift or without consideration,
    then the fair market value of the shares on the date of the breach of the restrictive covenant agreement or activity constituting
    cause), net of the price originally paid by the participant for the shares. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
committee may also provide for clawbacks pursuant to a clawback policy, which our Board may in the future adopt and amend from time to
time. Payment by the participant will be made in such manner and on such terms and conditions as may be required by the committee. We
will be entitled to set off against the amount of any such payment any amounts that we otherwise owe to the participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain
United States Federal Income Tax Aspects</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of certain U.S. federal income tax consequences of awards under the 2020 EIP. It does not purport to be a complete
description of all applicable rules, and those rules (including those summarized here) are subject to change.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Options</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
optionee generally will not recognize taxable income upon the grant of a non-statutory option. Rather, at the time of exercise of the
option, the optionee will recognize ordinary income for income tax purposes in an amount equal to the excess, if any, of the fair market
value of the shares purchased over the exercise price. We generally will be entitled to a tax deduction at such time and in the same
amount, if any, that the optionee recognizes as ordinary income. The optionee&#8217;s tax basis in any shares received upon exercise
of an option will be the fair market value of the shares on the date of exercise, and if the shares are later sold or exchanged, then
the difference between the amount received upon such sale or exchange and the fair market value of such shares on the date of exercise
will generally be taxable as long-term or short-term capital gain or loss (if the shares are a capital asset of the optionee) depending
upon the length of time such shares were held by the optionee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incentive
stock options are eligible for favorable U.S. federal income tax treatment if certain requirements are satisfied. An incentive stock
option must have an option price that is not less than the fair market value of the stock at the time the option is granted and must
be exercisable within ten years from the date of grant. An employee granted an incentive stock option generally does not realize compensation
income for U.S. federal income tax purposes upon the grant of the option. At the time of exercise of an incentive stock option, no compensation
income is realized by the optionee other than tax preference income for purposes of the federal alternative minimum tax on individual
income. If the shares acquired on exercise of an incentive stock option are held for at least two years after grant of the option and
one year after exercise, the excess of the amount realized on the sale over the exercise price will be taxed as capital gain. If the
shares acquired on exercise of an incentive stock option are disposed of within less than two years after grant or one year of exercise,
the optionee will realize taxable compensation income equal to the lesser of (i) the excess of the fair market value of the shares on
the date of exercise over the option price or (ii) the excess of the amount realized on the sale over the option price. Any additional
amount realized will be taxed as capital gain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
participant generally will not be taxed upon the grant of stock awards subject to restrictions, but rather will recognize ordinary income
in an amount equal to the fair market value of the shares at the time the shares are no longer subject to a &#8220;substantial risk of
forfeiture&#8221; (within the meaning of the Code). We generally will be entitled to a deduction at the time when, and in the amount
that, the participant recognizes ordinary income on account of the lapse of the restrictions. A participant&#8217;s tax basis in the
shares will equal their fair market value at the time the restrictions lapse, and the participant&#8217;s holding period for capital
gains purposes will begin at that time. Any cash dividends paid on the restricted stock before the restrictions lapse will be taxable
to the participant as additional compensation (and not as dividend income). Under Section 83(b) of the Code, a participant may elect
to recognize ordinary income at the time the shares of stock are awarded in an amount equal to their fair market value at that time,
notwithstanding the fact that such shares of stock are subject to restrictions and a substantial risk of forfeiture. If such an election
is made, no additional taxable income will be recognized by such participant at the time the restrictions lapse, the participant will
have a tax basis in the shares equal to their fair market value on the date of their award, and the participant&#8217;s holding period
for capital gains purposes will begin at that time. We generally will be entitled to a tax deduction at the time when, and to the extent
that, ordinary income is recognized by such participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Units</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, the grant of stock units will not result in income for the participant or in a tax deduction for us. Upon the settlement of
such an award in cash or shares, the participant will recognize ordinary income equal to the aggregate value of the payment received,
and we generally will be entitled to a tax deduction at the same time and in the same amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Appreciation Rights</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
participant who is granted a SAR generally will not recognize ordinary income upon receipt of the SAR. Rather, at the time of exercise
of such SAR, the participant will recognize ordinary income for U.S. federal income tax purposes in an amount equal to the value of any
cash received and the fair market value on the date of exercise of any shares received. We generally will be entitled to a tax deduction
at such time and in the same amount, if any, that the participant recognizes as ordinary income. The participant&#8217;s tax basis in
any shares received upon exercise of a SAR will be the fair market value of the shares on the date of exercise, and if the shares are
later sold or exchanged, then the difference between the amount received upon such sale or exchange and the fair market value of such
shares on the date of exercise will generally be taxable as long-term or short- term capital gain or loss (if the shares are a capital
asset of the participant) depending upon the length of time such shares were held by the participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to other stock-based awards granted under the 2020 EIP, generally when the participant receives payment with respect to an award,
the amount of cash and/or the fair market value of any shares or other property received will be ordinary income to the participant,
and we generally will be entitled to a tax deduction at the same time and in the same amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Impact
of Section 409A</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
409A of the Code applies to deferred compensation, which is generally defined as compensation earned currently, the payment of which
is deferred to a later taxable year. Awards under the 2020 EIP are intended to be exempt from the requirements of Section 409A or to
satisfy its requirements. An award that is subject to Section 409A and fails to satisfy its requirements will subject the holder of the
award to immediate taxation, interest and an additional 20% tax on the vested amount underlying the award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
162(m) of the Code</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to 2018, Section 162(m) of the Code imposed a $1 million limit on the amount a public company may deduct for compensation paid to a company&#8217;s
chief executive officer or any of the company&#8217;s three other most highly compensated executive officers (other than the chief financial
officer) who are employed as of the end of the year. This limitation did not apply to compensation that meets the tax code requirements
for &#8220;qualifying performance-based&#8221; compensation (i.e., compensation paid only if the individual&#8217;s performance meets
pre- established objective goals based on performance criteria approved by stockholders, including stock options).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
performance-based compensation exemption and the exemption of the chief financial officer from Section 162(m)&#8217;s deduction limit
have been repealed, among other changes, effective for taxable years beginning after December 31, 2017, such that awards paid to our
covered executive officers (including our chief executive officer) in excess of $1 million will not be deductible in future years, unless
it qualifies for transition relief applicable to certain arrangements that were in effect as of November 2, 2017 and are not materially
modified thereafter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
in prior years, while deductibility of executive compensation for federal income tax purposes is among the factors the committee considers
when structuring our executive compensation arrangements, it is not the sole or primary factor considered. We retain the flexibility
to authorize compensation that may not be deductible if we believe it is in the best interests of the company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Existing
Plan Benefits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
benefits under the 2020 EIP generally are granted at the discretion of the committee and are therefore not currently determinable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
future grants of awards under the 2020 EIP are subject to the discretion of the Board or Compensation Committee, the amount and terms
of future awards to particular participants or groups of participants are not determinable at this time. No awards have been previously
granted that are contingent on the approval of this amendment to the 2020 EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
proposal to amend the 2020 EIP will be approved upon the affirmative vote of a majority of the outstanding shares of common stock present
through virtual attendance or by proxy at the Meeting and entitled to vote on the proposal. Stockholders may vote &#8220;FOR&#8221; or
&#8220;AGAINST,&#8221; or &#8220;ABSTAIN&#8221; from voting. Abstentions will have the effect of a vote &#8220;AGAINST&#8221; this proposal.
Broker non-votes, if any, will be disregarded and will have no effect on the outcome of the vote for this Proposal 2.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Recommendation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Board recommends that the stockholders vote &#8220;FOR&#8221; the approval of the amendment to the Kopin Corporation 2020 Equity Incentive
Plan to increase the number of shares available by 5,000,000.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
existence of financial and personal interests of one or more of Kopin Corporation directors may result in a conflict of interest on the
part of such director(s) between what he, she or they may believe is in the best interests of Kopin Corporation and its stockholders
and what he, she or they may believe is best for himself, herself or themselves in determining to recommend that stockholders vote for
the proposals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
3</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>APPROVAL
OF THE AMENDMENT TO THE COMPANY&#8217;S AMENDED AND RESTATED</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED COMMON</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARES FROM 200,000,000 TO 275,000,000</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board has approved the amendment to our Certificate of Incorporation, subject to stockholder approval, to increase the number of
authorized shares of common stock from 200,000,000 shares to 275,000,000 shares (the &#8220;Share Increase Amendment&#8221;) and
recommends unanimously that our stockholders approve the Share Increase Amendment. The proposed amendment is reflected in the
proposed amendment to the Certificate of Incorporation attached to this proxy statement as Appendix B. As of May 1, 2025,
there were 162,797,922 shares of common stock issued and outstanding and the Company had warrants and options outstanding to
acquire 10,591,366 shares of its common stock, leaving a total of 26,610,712 authorized shares of common stock available for
future issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
additional 75,000,000 shares of common stock will be part of the existing class of common stock, and, if and when issued, would have
the same rights and privileges as the shares of common stock presently issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s Certificate of Incorporation was amended on June 11, 2024 to increase the number of authorized shares of common stock
to 200,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that it is desirable and in the best interests of the Company and its shareholders to have a sufficient number of additional
shares of common stock available for issuance from time to time, as the occasion may arise, for future financing and acquisition transactions,
to permit stock dividends or stock splits at some future date, and for other proper corporate purposes. Therefore, the Board has approved,
and unanimously recommends that the stockholders of the Company approve the Share Increase Amendment. The proposed form of the Articles
of Amendment to the Company&#8217;s Certificate of Incorporation amending Article &#8220;FOURTH&#8221; of such Certificate of Incorporation
is set forth in Appendix A to this proxy statement. The Articles of Amendment will have no effect on the number of authorized shares
of preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain
Risks Associated with the Share Increase Amendment</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market price of our common stock will also be based on our performance and other factors, some of which are unrelated to the number of
shares outstanding. These factors include the status of the market for our common stock, our reported results of operations in future
periods, and general economic, market and industry conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal
Effects on Outstanding Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of common stock are entitled to one vote per share on all matters submitted to a vote of stockholders. Upon a liquidation, dissolution
or windup of the Company, holders of common stock would be entitled to share ratably in any assets for distribution to stockholders after
payment of all of the Company&#8217;s obligations, subject to the rights to receive preferential distributions of the holders of any
preferred stock then outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
additional shares of common stock would have rights identical to our common stock currently outstanding. Approval of the Share Increase
Amendment and any issuance of common stock would not affect the rights of the holders of our common stock currently outstanding, except
to the extent that future issuances of common stock would reduce each existing stockholder&#8217;s proportionate ownership. If the proposed
Share Increase Amendment is approved and the Board decides to issue such shares of common stock, such issuance of common stock would
increase the outstanding number of shares of common stock, thereby causing dilution in earnings per share and voting interests of the
outstanding common stock. As of May 1, 2025, 162,797,922 shares of our common stock were issued and outstanding and we
had warrants and options outstanding to acquire 10,591,366 shares of our common stock. We had no other shares of our common stock subject
to outstanding stock options or other convertible securities, thereby leaving 26,610,712 shares of common stock unassigned and
authorized for potential issuance of the current 200,000,000 shares of common stock authorized. If the Share Increase Amendment is approved,
there will be 101,610,712 shares of common stock unassigned and authorized for potential issuance. If approved, the Share Increase
Amendment will not change the number of shares of preferred stock authorized for issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the issuance of additional shares of common stock could have the effect of making it more difficult for a third party to acquire, or
discouraging a third party from attempting to acquire, control of the Company. While the issuance of additional shares of common stock
may be deemed to have potential anti-takeover effects, including by delaying or preventing a change in control of the Company through
subsequent issuances of these shares and the other reasons set forth above, which among other things, could include issuances in one
or more transactions that would make a change in control of the Company more difficult, and therefore, less likely, this proposal to
increase the authorized common stock is not prompted by any specific effort of which we are aware to accumulate shares of our common
stock or obtain control of the Company. A takeover may be beneficial to independent stockholders because, among other reasons, a potential
suitor may offer such stockholders a premium for their shares of common stock as compared to the then-existing market price. Although
the issuance of additional shares of common stock could, under certain circumstances, have an anti-takeover effect, this proposal to
adopt the Share Increase Amendment is not in response to any attempt to accumulate common stock or obtain control of the Company that
we are aware of, nor is it part of a plan by management to recommend a series of similar amendments to the Board or stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Interests
of Certain Persons in the Proposal</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
directors and executive officers have no substantial interests, directly or indirectly, in the matters set forth in this Proposal 3,
except to the extent of their ownership in shares of our common stock and securities convertible or exercisable for common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of the Shares Increase Amendment requires the affirmative vote of a majority of the Company&#8217;s outstanding stock entitled
to vote thereon.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Recommendation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Board recommends that the stockholders vote &#8220;FOR&#8221; the proposal to approve an amendment to the Company&#8217;s Certificate
of Incorporation to increase the number of authorized shares of common stock to 275,000,000.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
4</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RATIFICATION
OF APPOINTMENT OF ACCOUNTANTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 2, 2024, the Audit Committee appointed BDO USA, P.C. (&#8220;BDO&#8221;) as our independent registered public accounting firm
for the fiscal year ending December 27, 2025. The Audit Committee is seeking ratification of this selection by our stockholders at the Annual Meeting.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSM
US LLP (RSM), served as the Company&#8217;s independent registered public accounting firm of the Company from November 22,
2019 until December 2, 2024. On December 2, 2024, the Board approved the engagement of BDO as our independent registered public
accounting firm, effective upon the execution of a satisfactory engagement letter with BDO and dismissed our prior independent registered
public accounting firm, RSM, effective immediately prior to the engagement of BDO. RSM&#8217;s audit reports on our consolidated financial
statements for the fiscal years ended December 30, 2023 and December 31, 2022 did not contain any adverse opinion or disclaimer of opinion
and were not qualified or modified as to uncertainty, audit scope, or accounting principles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
representative of BDO is expected to be present at the Meeting and will be afforded an opportunity to make a statement, if such
representative desires to do so, and will be available to respond to appropriate questions. </span>Furthermore, a representative of
RSM is expected to be present at the Meeting and will be afforded an opportunity to make a statement, if such representative desires
to do so, and will be available to respond to appropriate questions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">RSM&#8217;s audit reports
on our consolidated financial statements for the fiscal years ended December 30, 2023 and December 31, 2022 did not contain any adverse
opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principles. During
the fiscal years ended December 30, 2023 and December 31, 2022, and the subsequent interim period through the date of our engagement
of BDO on December 2, 2024, neither the Company, nor anyone acting on our behalf, consulted with BDO regarding any of the matters described
in Items 304(a)(2)(i) and (ii) of Regulation S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">During the two most recent
fiscal years ended December 30, 2023 and December 31, 2022, and the subsequent interim period through their dismissal on December 2,
2024: (i) there were no disagreements within the meaning of Item 304(a)(1)(iv) of Regulation S-K between us and RSM on any matter of
accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved
to RSM&#8217;s satisfaction, would have caused RSM to make reference to the subject matter of the disagreements in connection with its
reports on our consolidated financial statements for such years, and (ii) no reportable events within the meaning of Item 304(a)(1)(v)
of Regulation S-K.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 40pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
affirmative vote of the holders of a majority of the shares of our common stock represented in person or by proxy at the Meeting and
entitled to vote is required to ratify the appointment of BDO as our independent registered public accounting firm for the current
fiscal year ending December 27, 2025. Although stockholder ratification is not required by our bylaws or otherwise, the Board believes
it is advisable to provide stockholders an opportunity to ratify this selection and is submitting the selection of BDO as our independent
registered public accounting firm to our stockholders for ratification as a matter of good corporate practice.  In the event the appointment of BDO should not be approved by the stockholders, the Board will consider making
another appointment to be effective at the earliest possible time but has no obligation to do so. Any broker non-votes and abstentions
from voting received will have no effect on the outcome of this Proposal 4.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Recommendation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Board recommends that the stockholders vote &#8220;FOR&#8221; the proposal to ratify the appointment of BDO USA, P.C. as our independent
registered public accounting firm for the fiscal year ending December 27, 2025.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proxies
solicited by the Board will be voted &#8220;FOR&#8221; this Proposal 4.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRINCIPAL
ACCOUNTANT FEES AND SERVICES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed above, BDO has served as the Company&#8217;s independent registered public accounting firm since December 2, 2024. Previously,
RSM served as the Company&#8217;s independent registered public accounting firm from November 22, 2019 to December 2, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><b></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Fees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate fees for the fiscal years ended December 28, 2024 and December 30, 2023 billed by the Company&#8217;s independent registered
public accounting firm, BDO USA, P.C. for fiscal year 2024 and RSM US LLP for fiscal year 2023 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Fee Category</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left">Audit Fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,038,950</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">620,124</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">99.9</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Audit-Related Fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">152,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax Fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,453</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.9</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">All Other Fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total Fees</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,049,450</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">780,827</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Audit
Fees</i>&#8212;consists of fees for the audit of our financial statements and attestation services relating to the report on our internal
controls in accordance with Section 404 of the Sarbanes-Oxley Act of 2002, review of the interim condensed consolidated financial statements
included in quarterly reports, assistance with review of documents filed with the SEC, and services that are normally provided by the
Company&#8217;s independent registered public accounting firm in connection with statutory and regulatory filings or engagements, and
attestation services, except those not required by statute or regulation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Audit-Related
Fees</i>&#8212;consists of fees for assurance and related services that are reasonably related to the performance of the audit or review
of our consolidated financial statements and are not reported under &#8220;Audit Fees.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Tax
Fees</i>&#8212;consists of fees for tax compliance and planning services. Tax compliance includes fees for professional services related
to international tax compliance and preparation. Tax planning consists primarily of fees related to a transfer pricing study and preparation
of our subsidiary tax returns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>All
Other Fees</i>&#8212;consists of fees for all other permissible services other than those reported above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Policy
on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of Independent Registered Public Accounting Firm</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee pre-approves all audit and non-audit services provided by the Company&#8217;s independent registered public accounting
firm prior to the engagement with respect to such services. The Chairman of the Audit Committee has been delegated the authority by the
Audit Committee to pre-approve the engagement of the independent accountants when the entire committee is unable to do so. The Audit
Committee approved 100% of the services listed under the preceding captions &#8220;Audit Fees,&#8221; &#8220;Audit-Related Fees,&#8221;
&#8220;Tax Fees&#8221; and &#8220;All Other Fees.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL
5</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ADVISORY
NON-BINDING VOTE ON COMPENSATION OF NAMED EXECUTIVE OFFICERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with Section 951 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, as well as the provisions of Section 14A
of the Exchange Act, we are providing our stockholders the opportunity to vote on a non-binding, advisory resolution to approve the compensation
of our named executive officers, which is described in the section titled &#8220;Compensation Discussion and Analysis&#8221; in this
Proxy Statement. Accordingly, the following resolution will be submitted for a stockholder vote at the 2025 Annual Meeting:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;RESOLVED,
that the stockholders of Kopin Corporation (the &#8220;Company&#8221;) approve, on an advisory basis, the overall compensation of the
Company&#8217;s named executive officers, as described in the Compensation Discussion and Analysis section set forth in the Proxy Statement
for this Annual Meeting.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in the section titled &#8220;Compensation Discussion and Analysis,&#8221; our executive compensation program is designed to
provide a competitive level of compensation necessary to attract, motivate and retain talented and experienced executives and to motivate
them to achieve short-term and long-term corporate goals that enhance stockholder value. In order to align executive pay with our financial
performance and the creation of sustainable stockholder value, a significant portion of compensation paid to our named executive officers
is allocated to performance-based, short- and long-term incentive programs to make executive pay dependent on our performance (or &#8220;at-risk&#8221;).
In addition, as an executive officer&#8217;s responsibility and ability to affect our financial results increases, the portion of his
or her total compensation deemed &#8220;at-risk&#8221; increases. Stockholders are urged to read the &#8220;Compensation Discussion and
Analysis&#8221; section of this Proxy Statement, which more thoroughly discusses how our compensation policies and procedures implement
our compensation philosophy. The Compensation Committee and the Board believe that these policies and procedures are effective in implementing
our compensation philosophy and in achieving its goals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
provide our stockholders the opportunity every year to vote on a non-binding, advisory basis to approve the compensation of our named
executive officers. The Company expects that the next advisory vote on executive compensation will be at the 2026 Annual Meeting of Stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>This
vote is merely advisory and will not be binding upon the Company or the Board. However, the Board values constructive dialogue on executive
compensation and other important governance topics with our stockholders and encourages all stockholders to vote their shares on this
matter.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
Required for Approval</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposal
5 will be approved upon the affirmative vote of a majority of shares present in person or represented by proxy at the Meeting and entitled
to vote on each such proposal. Abstentions will be counted for Proposal 5 and will have the same effect as a vote against the proposal.
Broker non-votes, if any, will be disregarded and will have no effect on the outcome of the vote of this Proposal 5.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Recommendation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Board recommends that the stockholders vote to approve, on an advisory basis, the overall compensation of the Company&#8217;s named executive
officers by voting &#8220;FOR&#8221; this resolution.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COST
AND METHOD OF SOLICITATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will pay the cost of soliciting proxies. Proxies may be solicited on behalf of the Company by directors, officers or employees of the
Company in person or by telephone, facsimile or other electronic means. As required by the SEC, we also will reimburse brokerage firms
and other custodians, nominees and fiduciaries for their expenses incurred in sending proxies and proxy materials to beneficial owners
of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GENERAL</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not aware of any other matter other than the foregoing to be brought before the Meeting. However, the enclosed proxy gives discretionary
authority to the named proxies in the event any additional matters should be presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will provide free of charge to any stockholder from whom a proxy is solicited pursuant to this proxy statement, upon written request
from such stockholder, our Annual Reports on Form 10-K for the fiscal years 2024 and 2023 as filed with the SEC. Our 2024 Annual Report
on Form 10-K is enclosed. Only one copy of the Annual Report and this proxy statement and notice of annual meeting is being delivered
to multiple stockholders sharing one address, unless we have received contrary instructions. Upon written or oral request, we will deliver
promptly a separate copy to a stockholder at a shared address to which a copy was delivered. If you received more than one copy of the
proxy statement and wish to reduce the number of reports you receive, we will discontinue the mailing of reports on the accounts you
select. Requests for the foregoing should be directed to Kopin Corporation, 125 North Drive, Westborough MA 01581, Attention: Chief Financial
Officer, 508-870-5959.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MISCELLANEOUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
vote is important. Whether or not you plan to attend the Annual Meeting, we hope you will vote in advance so that your vote will be counted
if you later decide not to attend the Annual Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>You
may obtain a copy of our Annual Report on Form 10-K (without exhibits) filed with the SEC for the year ended December 28, 2024, without
charge upon written request to: Kopin Corporation, 125 North Drive, Westborough MA 01581, Attention: Chief Financial Officer, 508-870-5959.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this proxy statement, we know of no matter not specifically referred to above as to which any action is expected to be
taken at the Annual Meeting. The persons named as proxies will vote the proxies, insofar as they are not otherwise instructed, regarding
such other matters and the transaction of such other business as may be properly brought before the Annual Meeting, as they determine
to be in the best interest of the Company and our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 50%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Murray</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Appendix
A</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>KOPIN
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020
EQUITY INCENTIVE PLAN</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
as of the Effective Date (as defined below), the Kopin Corporation 2020 Incentive Equity Plan (as in effect from time to time, the &#8220;Plan&#8221;)
is hereby established.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Plan is to provide employees of Kopin Corporation, a Delaware corporation (together with its successors, the &#8220;Company&#8221;),
and its subsidiaries, certain consultants and advisors who perform services for the Company or its subsidiaries, and non-employee members
of the Board of Directors of the Company, with the opportunity to receive grants of incentive stock options, nonqualified stock options,
stock appreciation rights, stock awards, stock units, and other stock-based awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company believes that the Plan will encourage the participants to contribute materially to the growth of the Company, thereby benefitting
the Company&#8217;s stockholders, and will align the economic interests of the participants with those of the stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan is a successor to the Kopin Corporation 2010 Equity Incentive Plan, as amended and restated (the &#8220;Prior Plan&#8221;). No additional
grants shall be made under the Prior Plan after the Effective Date. Outstanding grants under the Prior Plan shall continue in effect
according to their terms, consistent with the applicable terms of the Prior Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
1. Definitions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following terms shall have the meanings set forth below for purposes of the Plan:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) &#8220;<span style="text-decoration: underline">Board&#8221; </span>shall
mean the Board of Directors of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) &#8220;<span style="text-decoration: underline">Cause</span>&#8221;
shall have the meaning given to that term in any written employment agreement, offer letter or severance agreement between the Employer
and the Participant, or if no such agreement exists or if such term is not defined therein, and unless otherwise defined in the Grant
Instrument, Cause shall mean a finding by the Committee that the Participant (i) has breached his or her employment or service contract
with the Employer, (ii) has engaged in disloyalty to the Employer, including, without limitation, fraud, embezzlement, theft, commission
of a felony or proven dishonesty, (iii) has disclosed trade secrets or confidential information of the Employer to persons not entitled
to receive such information, (iv) has breached any written non-competition, non-solicitation, invention assignment or confidentiality
agreement between the Participant and the Employer or (v) has engaged in such other behavior detrimental to the interests of the Employer
as the Committee determines.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) &#8220;<span style="text-decoration: underline">CEO&#8221;
</span>shall mean the Chief Executive Officer of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Unless
otherwise set forth in a Grant Instrument, a &#8220;<span style="text-decoration: underline">Change of Control</span>&#8221; shall be deemed to have occurred if:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) Any
&#8220;person&#8221; (as such term is used in sections 13(d) and 14(d) of the Exchange Act) becomes a &#8220;beneficial owner&#8221;
(as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing more than 50% of
the voting power of the then outstanding securities of the Company; provided that a Change of Control shall not be deemed to occur as
a result of a transaction in which the Company becomes a direct or indirect subsidiary of another Person and in which the stockholders
of the Company, immediately prior to the transaction, will beneficially own, immediately after the transaction, shares of such other
Person representing more than 50% of the voting power of the then outstanding securities of such other Person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) The
consummation of (A) a merger or consolidation of the Company with another Person where, immediately after the merger or consolidation,
the stockholders of the Company, immediately prior to the merger or consolidation, will not beneficially own, in substantially the same
proportion as ownership immediately prior to the merger or consolidation, shares entitling such stockholders to more than 50% of all
votes to which all stockholders of the surviving Person would be entitled in the election of directors, or where the members of the Board,
immediately prior to the merger or consolidation, will not, immediately after the merger or consolidation, constitute a majority of the
board of directors of the surviving Person or (B) a sale or other disposition of all or substantially all of the assets of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) A
change in the composition of the Board over a period of 12 consecutive months or less such that a majority of the Board members ceases,
by reason of one or more contested elections, or threatened election contests, for Board membership, to be comprised of individuals who
either (A) have been Board members continuously since the beginning of such period or (B) have been elected or nominated for election
as Board members during such period by at least a majority of the Board members described in clause (A) who were still in office at the
time the Board approved such election or nomination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) The
consummation of a complete dissolution or liquidation of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may modify the definition of Change of Control for a particular Grant as the Committee deems appropriate to comply with section
409A of the Code or otherwise. Notwithstanding the foregoing, if a Grant constitutes deferred compensation subject to section 409A of
the Code and the Grant provides for payment upon a Change of Control, then, for purposes of such payment provisions, no Change of Control
shall be deemed to have occurred upon an event described in items (i) &#8211; (iv) above unless the event would also constitute a change
in ownership or effective control of, or a change in the ownership of a substantial portion of the assets of, the Company under section
409A of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) &#8220;<span style="text-decoration: underline">Code</span>&#8221;
shall mean the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) &#8220;<span style="text-decoration: underline">Committee</span>&#8221;
shall mean the Compensation Committee of the Board or another committee appointed by the Board to administer the Plan. The Committee
shall consist of directors who are &#8220;non-employee directors&#8221; as defined under Rule 16b-3 promulgated under the Exchange Act
and &#8220;independent directors,&#8221; as determined in accordance with the independence standards established by the stock exchange
on which the Company Stock is at the time primarily traded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) &#8220;<span style="text-decoration: underline">Company
Stock</span>&#8221; shall mean common stock, par value $0.01 per share, of the Company, and such other securities as may be substituted
for Company Stock pursuant to Section 4(c).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) &#8220;<span style="text-decoration: underline">Disability</span>&#8221;
or &#8220;<span style="text-decoration: underline">Disabled</span>&#8221; shall mean, unless otherwise set forth in the Grant Instrument, a Participant&#8217;s becoming disabled
within the meaning of the Employer&#8217;s long-term disability plan applicable to the Participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) &#8220;<span style="text-decoration: underline">Dividend
Equivalent</span>&#8221; shall mean an amount determined by multiplying the number of shares of Company Stock subject to a Stock Unit or
Other Stock-Based Award by the per-share cash dividend paid by the Company on its outstanding Company Stock, or the per-share Fair Market
Value of any dividend paid on its outstanding Company Stock in consideration other than cash. If interest is credited on accumulated
divided equivalents, the term &#8220;Dividend Equivalent&#8221; shall include the accrued interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) &#8220;<span style="text-decoration: underline">Effective
Date</span>&#8221; shall mean the date of the Annual Meeting of Stockholders to be held on May 20, 2020 or such other date upon which the
Company&#8217;s stockholders approve the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) &#8220;<span style="text-decoration: underline">Employee</span>&#8221;
shall mean an employee of the Employer (including an officer or director who is also an employee), but excluding any person who is classified
by the Employer as a &#8220;contractor&#8221; or &#8220;consultant,&#8221; no matter how characterized by the Internal Revenue Service,
other governmental agency or a court. Any change of characterization of an individual by the Internal Revenue Service or any court or
government agency shall have no effect upon the classification of an individual as an Employee for purposes of this Plan, unless the
Committee determines otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) &#8220;<span style="text-decoration: underline">Employed
by, or providing service to, the Employer</span>&#8221; shall mean employment or service as an Employee, Key Advisor or member of the Board
(so that, for purposes of exercising Options and SARs and satisfying conditions with respect to Stock Awards, Stock Units, and Other
Stock-Based Awards, a Participant shall not be considered to have terminated employment or service until the Participant ceases to be
an Employee, Key Advisor and member of the Board), unless the Committee determines otherwise. If a Participant&#8217;s relationship is
with a subsidiary of the Company and that entity ceases to be a subsidiary of the Company, the Participant will be deemed to cease employment
or service when the entity ceases to be a subsidiary of the Company, unless the Participant transfers employment or service to an Employer.
If a Participant has military, sick leave or other bona fide leave, the Participant will not be deemed to cease employment or service
solely as a result of such leave; provided that such leave does not exceed the longer of 90 days or the period during which the absent
Participant&#8217;s reemployment rights, if any, are guaranteed by statute or contract. To the extent consistent with applicable law,
the Committee may provide that Grants continue to vest for all or a portion of the period of such leave, or that vesting shall be tolled
during such leave and only recommence upon the Participant&#8217;s return from such leave.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) &#8220;<span style="text-decoration: underline">Employer</span>&#8221;
shall mean the Company and its subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) &#8220;<span style="text-decoration: underline">Exchange
Act&#8221;</span> shall mean the Securities Exchange Act of 1934, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) &#8220;<span style="text-decoration: underline">Exercise
Price</span>&#8221; shall mean the per share price at which shares of Company Stock may be purchased under an Option, as designated by the
Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p) &#8220;<span style="text-decoration: underline">Fair
Market Value&#8221;</span> shall mean:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) If
the Company Stock is publicly traded, the Fair Market Value per share shall be determined as follows: (A) if the principal trading market
for the Company Stock is a national securities exchange, the closing sales price during regular trading hours on the relevant date or,
if there were no trades on that date, the latest preceding date upon which a sale was reported, or (B) if the Company Stock is not principally
traded on any such exchange, the last reported sale price of a share of Company Stock during regular trading hours on the relevant date,
as reported by the OTC Bulletin Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) If
the Company Stock is not publicly traded or, if publicly traded, is not subject to reported transactions as set forth above, the Fair
Market Value per share shall be determined by the Committee through any reasonable valuation method authorized under the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q) &#8220;<span style="text-decoration: underline">GAAP</span>&#8221;
shall mean United States generally accepted accounting principles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r) &#8220;<span style="text-decoration: underline">Grant</span>&#8221;
shall mean an Option, SAR, Stock Award, Stock Unit or Other Stock-Based Award granted under the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s) &#8220;<span style="text-decoration: underline">Grant
Instrument</span>&#8221; shall mean the written agreement that sets forth the terms and conditions of a Grant, including all amendments
thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t) &#8220;<span style="text-decoration: underline">Incentive
Stock Option</span>&#8221; shall mean an Option that is intended to meet the requirements of an incentive stock option under section 422
of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u) &#8220;<span style="text-decoration: underline">Key
Advisor&#8221;</span> shall mean a consultant or advisor of the Employer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) &#8220;<span style="text-decoration: underline">Non-Employee
Director</span>&#8221; shall mean a member of the Board who is not an Employee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w) &#8220;<span style="text-decoration: underline">Nonqualified
Stock Option</span>&#8221; shall mean an Option that is not intended to be taxed as an incentive stock option under section 422 of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x) &#8220;<span style="text-decoration: underline">Option&#8221;
</span>shall mean an option to purchase shares of Company Stock, as described in Section 6.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y) &#8220;<span style="text-decoration: underline">Other
Stock-Based Award</span>&#8221; shall mean any Grant based on, measured by or payable in Company Stock (other than an Option, Stock Unit,
Stock Award, or SAR), as described in Section 10.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z) &#8220;<span style="text-decoration: underline">Participant</span>&#8221;
shall mean an Employee, Key Advisor or Non-Employee Director designated by the Committee to participate in the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa) &#8220;<span style="text-decoration: underline">Performance
Goals</span>&#8221; shall mean the business criteria selected by the Company to measure the level of performance of the Company or an
affiliate during a performance period, which may include, but are not limited to, one or more of the following criteria: cash flow;
free cash flow; earnings (including gross margin, earnings before interest and taxes, earnings before taxes, earnings before
interest, taxes, depreciation, amortization and charges for stock-based compensation, earnings before interest, taxes, depreciation
and amortization, adjusted earnings before interest, taxes, depreciation and amortization and net earnings); earnings per share;
growth in earnings or earnings per share; book value growth; stock price; return on equity or average stockholder equity; total
stockholder return or growth in total stockholder return either directly or in relation to a comparative group; return on capital;
return on assets or net assets; </span>revenue, growth in revenue or return on sales; sales; expense reduction or expense control;
expense to revenue ratio; income, net income or adjusted net income; operating income, net operating income, adjusted operating
income or net operating income after tax; operating profit or net operating profit; operating margin; gross profit margin; return on
operating revenue or return on operating profit; regulatory filings; regulatory approvals, litigation and regulatory resolution
goals; other operational, regulatory or departmental objectives; budget comparisons; growth in stockholder value relative to
established indexes, or another peer group or peer group index; development and implementation of strategic plans and/or
organizational restructuring goals; development and implementation of risk and crisis management programs; improvement in workforce
diversity; compliance requirements and compliance relief; safety goals; productivity goals; workforce management and succession
planning goals; economic value added (including typical adjustments consistently applied from generally accepted accounting
principles required to determine economic value added performance measures); measures of customer satisfaction, employee
satisfaction or staff development; development or marketing collaborations, formations of joint ventures or partnerships or the
completion of other similar transactions intended to enhance the Company&#8217;s revenue or profitability or enhance its customer
base; merger and acquisitions; and other similar criteria as determined by the Committee. Performance goals applicable to a Grant
shall be determined by the Committee, and may be established on an absolute or relative basis and may be established on a
corporate-wide basis or with respect to one or more business units, divisions, subsidiaries or business segments. Relative
performance may be measured against a group of peer companies, a financial market index or other objective and quantifiable
indices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb) &#8220;<span style="text-decoration: underline">Person</span>&#8221;
shall mean any natural person, corporation, limited liability company, partnership, trust, joint stock company, business trust, unincorporated
association, joint venture, governmental authority or other legal entity of any nature whatsoever.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc) &#8220;<span style="text-decoration: underline">Restriction
Period&#8221;</span> shall have the meaning given that term in Section 7(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd) &#8220;<span style="text-decoration: underline">SAR&#8221;
</span>shall mean a stock appreciation right, as described in Section 9.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee) &#8220;<span style="text-decoration: underline">Stock
Award&#8221;</span> shall mean an award of Company Stock, as described in Section 7.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff) &#8220;<span style="text-decoration: underline">Stock
Unit</span>&#8221; shall mean an award of a phantom unit representing a share of Company Stock, as described in Section 8.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg) &#8220;<span style="text-decoration: underline">Substitute
Awards&#8221;</span> shall have the meaning given that term in Section 4(c).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
2. Administration</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Committee</span>.
The Plan shall be administered and interpreted by the Committee; provided, however, that any Grants to members of the Board must be authorized
by a majority of the Board. The Committee may delegate authority to one or more subcommittees, as it deems appropriate. Subject to compliance
with applicable law and the applicable stock exchange rules, the Board, in its discretion, may perform any action of the Committee hereunder.
To the extent that the Board, a subcommittee or the CEO, as described below administers the Plan, references in the Plan to the &#8220;<span style="text-decoration: underline">Committee</span>&#8221;
shall be deemed to refer to the Board or such subcommittee or the CEO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Delegation
to CEO</span>. Subject to compliance with applicable law and applicable stock exchange requirements, the Committee may delegate all or part
of its authority and power to the CEO, as it deems appropriate, with respect to Grants to Employees or Key Advisors who are not executive
officers under section 16 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Committee
Authority</span>. The Committee shall have the sole authority to (i) determine the individuals to whom Grants shall be made under the Plan,
(ii) determine the type, size, terms and conditions of the Grants to be made to each such individual, (iii) determine the time when the
Grants will be made and the duration of any applicable exercise or restriction period, including the criteria for exercisability and
the acceleration of exercisability, (v) amend the terms of any previously issued Grant, subject to the provisions of Section 17 below,
(vi) determine and adopt terms, guidelines, and provisions, not inconsistent with the Plan and applicable law, that apply to individuals
residing outside of the United States who receive Grants under the Plan, and (vii) deal with any other matters arising under the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Committee
Determinations</span>. The Committee shall have full power and express discretionary authority to administer and interpret the Plan, to
make factual determinations and to adopt or amend such rules, regulations, agreements and instruments for implementing the Plan and for
the conduct of its business as it deems necessary or advisable, in its sole discretion. The Committee&#8217;s interpretations of the
Plan and all determinations made by the Committee pursuant to the powers vested in it hereunder shall be conclusive and binding on all
persons having any interest in the Plan or in any awards granted hereunder. All powers of the Committee shall be executed in its sole
discretion, in the best interest of the Company, not as a fiduciary, and in keeping with the objectives of the Plan and need not be uniform
as to similarly situated individuals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <span style="text-decoration: underline">Indemnification</span>.
No member of the Committee or the Board, and no employee of the Company shall be liable for any act or failure to act with respect to
the Plan, except in circumstances involving his or her bad faith or willful misconduct, or for any act or failure to act hereunder by
any other member of the Committee or employee or by any agent to whom duties in connection with the administration of this Plan have
been delegated. The Company shall indemnify members of the Committee and the Board and any agent of the Committee or the Board who is
an employee of the Company or a subsidiary against any and all liabilities or expenses to which they may be subjected by reason of any
act or failure to act with respect to their duties on behalf of the Plan, except in circumstances involving such person&#8217;s bad faith
or willful misconduct.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
3. Grants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grants
under the Plan may consist of Options as described in Section 6, Stock Awards as described in Section 7, Stock Units as described in
Section 8, SARs as described in Section 9, and Other Stock-Based Awards as described in Section 10. All Grants shall be subject to the
terms and conditions set forth herein and to such other terms and conditions consistent with this Plan as the Committee deems appropriate
and as are specified in writing by the Committee to the individual in the Grant Instrument. All Grants shall be made conditional upon
the Participant&#8217;s acknowledgement, in writing or by acceptance of the Grant, that all decisions and determinations of the Committee
shall be final and binding on the Participant, his or her beneficiaries and any other person having or claiming an interest under such
Grant. Grants under a particular Section of the Plan need not be uniform as among the Participants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
4. Shares Subject to the Plan</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Shares
Authorized</span>. Subject to adjustment as described below in Sections 4(b) and 4(e) below, the aggregate number of shares of Company Stock
that may be issued or transferred under the Plan shall be 14,000,000 shares of Company Stock. In addition, shares of the Company Stock
underlying any outstanding award granted under the Prior Plan that, following the Effective Date, expires, or is terminated, surrendered
or forfeited for any reason without issuance of such shares shall be available for the award of new Grants under this Plan. Subject to
adjustment as described below in Sections 4(b) and 4(e) below, the aggregate number of shares of Company Stock that may be issued or
transferred under the Plan pursuant to Incentive Stock Options shall not exceed 10,000,000 shares of Company Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Source
of Shares</span>; Share Counting. Shares issued or transferred under the Plan may be authorized but unissued shares of Company Stock or
reacquired shares of Company Stock, including shares purchased by the Company on the open market for purposes of the Plan. If and to
the extent Options or SARs granted under the Plan, expire or are canceled, forfeited, exchanged or surrendered without having been exercised,
or if any Stock Awards, Stock Units or Other Stock-Based Awards are forfeited, terminated or otherwise not paid in full, the shares subject
to such Grants shall again be available for purposes of the Plan. If shares of Company Stock otherwise issuable under the Plan are surrendered
in payment of the Exercise Price of an Option, then the number of shares of Company Stock available for issuance under the Plan shall
be reduced only by the net number of shares actually issued by the Company upon such exercise and not by the gross number of shares as
to which such Option is exercised. Upon the exercise of any SAR under the Plan, the number of shares of Company Stock available for issuance
under the Plan shall be reduced by only by the net number of shares actually issued by the Company upon such exercise. If shares of Company
Stock otherwise issuable under the Plan are withheld by the Company in satisfaction of the withholding taxes incurred in connection with
the issuance, vesting or exercise of any Grant or the issuance of Company Stock thereunder, then the number of shares of Company Stock
available for issuance under the Plan shall be reduced by the net number of shares issued, vested or exercised under such Grant, calculated
in each instance after payment of such share withholding. To the extent any Grants are paid in cash, and not in shares of Company Stock,
any shares previously subject to such Grants shall again be available for issuance or transfer under the Plan. For the avoidance of doubt,
if shares are repurchased by the Company on the open market with the proceeds of the Exercise Price of Options, such shares may not again
be made available for issuance under the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Substitute
Awards</span>. Shares issued or transferred under Grants made pursuant to an assumption, substitution or exchange for previously granted
awards of a company acquired by the Company in a transaction (&#8220;Substitute Awards&#8221;) shall not reduce the number of shares
of Company Stock available under the Plan and available shares under a stockholder approved plan of an acquired company (as appropriately
adjusted to reflect the transaction) may be used for Grants under the Plan and shall not reduce the Plan&#8217;s share reserve (subject
to applicable stock exchange listing and Code requirements).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Individual
Limits for Non-Employee Directors</span>. Subject to adjustment as described below in Section 4(e), the maximum aggregate grant date value
of shares of Company Stock subject to Grants granted to any Non-Employee Director during any calendar year, taken together with any cash
fees earned by such Non- Employee Director for services rendered during the calendar year, shall not exceed $250,000 in total value.
For purposes of this limit, the value of such Grants shall be calculated based on the grant date fair value of such Grants for financial
reporting purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <span style="text-decoration: underline">Adjustments</span>.
If there is any change in the number or kind of shares of Company Stock outstanding by reason of (i) a stock dividend, spinoff, recapitalization,
stock split, or combination or exchange of shares, (ii) a merger, reorganization or consolidation, (iii) a reclassification or change
in par value, or (iv) any other extraordinary or unusual event affecting the outstanding Company Stock as a class without the Company&#8217;s
receipt of consideration, or if the value of outstanding shares of Company Stock is substantially reduced as a result of a spinoff or
the Company&#8217;s payment of an extraordinary dividend or distribution, the maximum number and kind of shares of Company Stock available
for issuance under the Plan, the maximum amount of Grants which a Non-Employee Director may receive in any year, the number and kind
of shares covered by outstanding Grants, the number and kind of shares issued and to be issued under the Plan, and the price per share
or the applicable market value of such Grants shall be equitably adjusted by the Committee to reflect any increase or decrease in the
number of, or change in the kind or value of, the issued shares of Company Stock to preclude, to the extent practicable, the enlargement
or dilution of rights and benefits under the Plan and such outstanding Grants; provided, however, that any fractional shares resulting
from such adjustment shall be eliminated. In addition, in the event of a Change of Control, the provisions of Section 12 of the Plan
shall apply. Any adjustments to outstanding Grants shall be consistent with section 409A or 424 of the Code, to the extent applicable.
The adjustments of Grants under this Section 4(e) shall include adjustment of shares, Exercise Price of Stock Options, base amount of
SARs, Performance Goals or other terms and conditions, as the Committee deems appropriate. The Committee shall have the sole discretion
and authority to determine what appropriate adjustments shall be made and any adjustments determined by the Committee shall be final,
binding and conclusive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
5. Eligibility for Participation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Eligible
Persons</span>. All Employees and Non-Employee Directors shall be eligible to participate in the Plan. Key Advisors shall be eligible to
participate in the Plan if the Key Advisors render bona fide services to the Employer, the services are not in connection with the offer
and sale of securities in a capital-raising transaction and the Key Advisors do not directly or indirectly promote or maintain a market
for the Company&#8217;s securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Selection
of Participants</span>. The Committee shall select the Employees, Non-Employee Directors and Key Advisors to receive Grants and shall determine
the number of shares of Company Stock subject to a particular Grant in such manner as the Committee determines.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
6. Options</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may grant Options to an Employee, Non-Employee Director or Key Advisor upon such terms as the Committee deems appropriate.
The following provisions are applicable to Options:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Number
of Shares</span>. The Committee shall determine the number of shares of Company Stock that will be subject to each Grant of Options to Employees,
Non-Employee Directors and Key Advisors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Type
of Option and Exercise Price.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) The
Committee may grant Incentive Stock Options or Nonqualified Stock Options or any combination of the two, all in accordance with the terms
and conditions set forth herein. Incentive Stock Options may be granted only to employees of the Company or its parent or subsidiary
corporations, as defined in section 424 of the Code. Nonqualified Stock Options may be granted to Employees, Non-Employee Directors and
Key Advisors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) The
Exercise Price of Company Stock subject to an Option shall be determined by the Committee and shall be equal to or greater than the Fair
Market Value of a share of Company Stock on the date the Option is granted. However, an Incentive Stock Option may not be granted to
an Employee who, at the time of grant, owns stock possessing more than 10% of the total combined voting power of all classes of stock
of the Company, or any parent or subsidiary corporation of the Company, as defined in section 424 of the Code, unless the Exercise Price
per share is not less than 110% of the Fair Market Value of a share of Company Stock on the date of grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Option
Term</span>. The Committee shall determine the term of each Option. The term of any Option shall not exceed ten years from the date of grant.
However, an Incentive Stock Option that is granted to an Employee who, at the time of grant, owns stock possessing more than 10% of the
total combined voting power of all classes of stock of the Company, or any parent or subsidiary corporation of the Company, as defined
in section 424 of the Code, may not have a term that exceeds five years from the date of grant. Notwithstanding the foregoing, in the
event that on the last business day of the term of an Option (other than an Incentive Stock Option), the exercise of the Option is prohibited
by applicable law, including a prohibition on purchases or sales of Company Stock under the Company&#8217;s insider trading policy, the
term of the Option shall be extended for a period of 30 days following the end of the legal prohibition, unless the Committee determines
otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Exercisability
of Options</span>. Options shall become exercisable in accordance with such terms and conditions, consistent with the Plan, as may be determined
by the Committee and specified in the Grant Instrument. The Committee may accelerate the exercisability of any or all outstanding Options
at any time for any reason.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <span style="text-decoration: underline">Grants
to Non-Exempt Employees</span>. Notwithstanding the foregoing, Options granted to persons who are non-exempt employees under the Fair Labor
Standards Act of 1938, as amended, may not be exercisable for at least six months after the date of grant (except that such Options may
become exercisable, as determined by the Committee, upon the Participant&#8217;s death, Disability or retirement, or upon a Change of
Control or other circumstances permitted by applicable regulations).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <span style="text-decoration: underline">Termination
of Employment or Service</span>. Except as provided in the Grant Instrument, an Option may only be exercised while the Participant is employed
by, or providing services to, the Employer. The Committee shall determine in the Grant Instrument under what circumstances and during
what time periods a Participant may exercise an Option after termination of employment or service.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <span style="text-decoration: underline">Exercise
of Options</span>. A Participant may exercise an Option that has become exercisable, in whole or in part, by delivering a notice of exercise
to the Company. The Participant shall pay the Exercise Price for an Option as specified by the Committee (i) in cash, (ii) unless the
Committee determines otherwise, by delivering shares of Company Stock owned by the Participant and having a Fair Market Value on the
date of exercise at least equal to the Exercise Price or by attestation (on a form prescribed by the Committee) to ownership of shares
of Company Stock having a Fair Market Value on the date of exercise at least equal to the Exercise Price, (iii) by payment through a
broker in accordance with procedures permitted by Regulation T of the Federal Reserve Board, (iv) if permitted by the Committee, by withholding
shares of Company Stock subject to the exercisable Option, which have a Fair Market Value on the date of exercise equal to the Exercise
Price, or (v) by such other method as the Committee may approve. Shares of Company Stock used to exercise an Option shall have been held
by the Participant for the requisite period of time necessary to avoid adverse accounting consequences to the Company with respect to
the Option. Payment for the shares to be issued or transferred pursuant to the Option, and any required withholding taxes, must be received
by the Company by the time specified by the Committee depending on the type of payment being made, but in all cases prior to the issuance
or transfer of such shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <span style="text-decoration: underline">Limits
on Incentive Stock Options</span>. Each Incentive Stock Option shall provide that, if the aggregate Fair Market Value of the Company Stock
on the date of the grant with respect to which Incentive Stock Options are exercisable for the first time by a Participant during any
calendar year, under the Plan or any other stock option plan of the Company or a parent or subsidiary, exceeds $100,000, then the Option,
as to the excess, shall be treated as a Nonqualified Stock Option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
7. Stock Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may issue or transfer shares of Company Stock to an Employee, Non-Employee Director or Key Advisor under a Stock Award, upon
such terms as the Committee deems appropriate. The following provisions are applicable to Stock Awards:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">General
Requirements</span>. Shares of Company Stock issued or transferred pursuant to Stock Awards may be issued or transferred for consideration
or for no consideration, and subject to restrictions or no restrictions, as determined by the Committee. The Committee may, but shall
not be required to, establish conditions under which restrictions on Stock Awards shall lapse over a period of time or according to such
other criteria as the Committee deems appropriate, including, without limitation, restrictions based on the achievement of specific Performance
Goals. The period of time during which the Stock Awards will remain subject to restrictions will be designated in the Grant Instrument
as the &#8220;<span style="text-decoration: underline">Restriction Period.&#8221;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Number
of Shares</span>. The Committee shall determine the number of shares of Company Stock to be issued or transferred pursuant to a Stock Award
and the restrictions applicable to such shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Requirement
of Employment or Service</span>. If the Participant ceases to be employed by, or provide service to, the Employer during a period designated
in the Grant Instrument as the Restriction Period, or if other specified conditions are not met, the Stock Award shall terminate as to
all shares covered by the Grant as to which the restrictions have not lapsed, and those shares of Company Stock must be immediately returned
to the Company. The Committee may, however, provide for complete or partial exceptions to this requirement as it deems appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Restrictions
on Transfer and Legend on Stock Certificate</span>. During the Restriction Period, a Participant may not sell, assign, transfer, pledge
or otherwise dispose of the shares of a Stock Award except under Section 15 below. Unless otherwise determined by the Committee, the
Company will retain possession of certificates for shares of Stock Awards until all restrictions on such shares have lapsed. Each certificate
for a Stock Award, unless held by the Company, shall contain a legend giving appropriate notice of the restrictions in the Grant. The
Participant shall be entitled to have the legend removed from the stock certificate covering the shares subject to restrictions when
all restrictions on such shares have lapsed. The Committee may determine that the Company will not issue certificates for Stock Awards
until all restrictions on such shares have lapsed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <span style="text-decoration: underline">Right
to Vote and to Receive Dividends</span>. Unless the Committee determines otherwise, during the Restriction Period, the Participant shall
have the right to vote shares of Stock Awards and to receive any dividends or other distributions paid on such shares, subject to any
restrictions deemed appropriate by the Committee, including, without limitation, the achievement of specific Performance Goals. Dividends
with respect to Stock Awards that vest based on performance shall vest if and to the extent that the underlying Stock Award vests, as
determined by the Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <span style="text-decoration: underline">Lapse
of Restrictions</span>. All restrictions imposed on Stock Awards shall lapse upon the expiration of the applicable Restriction Period and
the satisfaction of all conditions, if any, imposed by the Committee. The Committee may determine, as to any or all Stock Awards, that
the restrictions shall lapse without regard to any Restriction Period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
8. Stock Units</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may grant Stock Units, each of which shall represent one hypothetical share of Company Stock, to an Employee, Non-Employee
Director or Key Advisor upon such terms and conditions as the Committee deems appropriate. The following provisions are applicable to
Stock Units:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Crediting
of Units</span>. Each Stock Unit shall represent the right of the Participant to receive a share of Company Stock or an amount of cash based
on the value of a share of Company Stock, if and when specified conditions are met. All Stock Units shall be credited to bookkeeping
accounts established on the Company&#8217;s records for purposes of the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Terms
of Stock Units</span>. The Committee may grant Stock Units that vest and are payable if specified Performance Goals or other conditions
are met, or under other circumstances. Stock Units may be paid at the end of a specified performance period or other period, or payment
may be deferred to a date authorized by the Committee. The Committee may accelerate vesting or payment, as to any or all Stock Units
at any time for any reason, provided such acceleration complies with section 409A of the Code. The Committee shall determine the number
of Stock Units to be granted and the requirements applicable to such Stock Units.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Requirement
of Employment or Service</span>. If the Participant ceases to be employed by, or provide service to, the Employer prior to the vesting of
Stock Units, or if other conditions established by the Committee are not met, the Participant&#8217;s Stock Units shall be forfeited.
The Committee may, however, provide for complete or partial exceptions to this requirement as it deems appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Payment
With Respect to Stock Units</span>. Payments with respect to Stock Units shall be made in cash, Company Stock or any combination of the
foregoing, as the Committee shall determine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
9. Stock Appreciation Rights</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may grant SARs to an Employee, Non-Employee Director or Key Advisor separately or in tandem with any Option. The following
provisions are applicable to SARs:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">General
Requirements</span>. The Committee may grant SARs to an Employee, Non-Employee Director or Key Advisor separately or in tandem with any
Option (for all or a portion of the applicable Option). Tandem SARs may be granted either at the time the Option is granted or at any
time thereafter while the Option remains outstanding; provided, however, that, in the case of an Incentive Stock Option, SARs may be
granted only at the time of the grant of the Incentive Stock Option. The Committee shall establish the base amount of the SAR at the
time the SAR is granted. The base amount of each SAR shall be equal to or greater than the Fair Market Value of a share of Company Stock
as of the date of grant of the SAR. The term of any SAR shall not exceed ten years from the date of grant. Notwithstanding the foregoing,
in the event that on the last business day of the term of a SAR, the exercise of the SAR is prohibited by applicable law, including a
prohibition on purchases or sales of Company Stock under the Company&#8217;s insider trading policy, the term shall be extended for a
period of 30 days following the end of the legal prohibition, unless the Committee determines otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Tandem
SARs</span>. In the case of tandem SARs, the number of SARs granted to a Participant that shall be exercisable during a specified period
shall not exceed the number of shares of Company Stock that the Participant may purchase upon the exercise of the related Option during
such period. Upon the exercise of an Option, the SARs relating to the Company Stock covered by such Option shall terminate. Upon the
exercise of SARs, the related Option shall terminate to the extent of an equal number of shares of Company Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Exercisability</span>.
A SAR shall be exercisable during the period specified by the Committee in the Grant Instrument and shall be subject to such vesting
and other restrictions as may be specified in the Grant Instrument. The Committee may accelerate the exercisability of any or all outstanding
SARs at any time for any reason. SARs may only be exercised while the Participant is employed by, or providing service to, the Employer
or during the applicable period after termination of employment or service as specified by the Committee. A tandem SAR shall be exercisable
only during the period when the Option to which it is related is also exercisable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Grants
to Non-Exempt Employees</span>. Notwithstanding the foregoing, SARs granted to persons who are non-exempt employees under the Fair Labor
Standards Act of 1938, as amended, may not be exercisable for at least six months after the date of grant (except that such SARs may
become exercisable, as determined by the Committee, upon the Participant&#8217;s death, Disability or retirement, or upon a Change of
Control or other circumstances permitted by applicable regulations).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <span style="text-decoration: underline">Value
of SARs</span>. When a Participant exercises SARs, the Participant shall receive in settlement of such SARs an amount equal to the value
of the stock appreciation for the number of SARs exercised. The stock appreciation for a SAR is the amount by which the Fair Market Value
of the underlying Company Stock on the date of exercise of the SAR exceeds the base amount of the SAR as described in subsection (a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <span style="text-decoration: underline">Form
of Payment</span>. The appreciation in a SAR shall be paid in shares of Company Stock, cash or any combination of the foregoing, as the
Committee shall determine. For purposes of calculating the number of shares of Company Stock to be received, shares of Company Stock
shall be valued at their Fair Market Value on the date of exercise of the SAR.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
10. Other Stock-Based Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may grant Other Stock-Based Awards, which are awards (other than those described in Sections 6, 7, 8 and 9 of the Plan) that
are based on or measured by Company Stock, to any Employee, Non- Employee Director or Key Advisor, on such terms and conditions as the
Committee shall determine. Other Stock-Based Awards may be awarded subject to the achievement of Performance Goals or other criteria
or other conditions and may be payable in cash, Company Stock or any combination of the foregoing, as the Committee shall determine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
11. Dividend Equivalents</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may grant Dividend Equivalents in connection with Stock Units or Other Stock-Based Awards. Dividend Equivalents may be paid
currently or accrued as contingent cash obligations and may be payable in cash or shares of Company Stock, and upon such terms and conditions
as the Committee shall determine. Dividend Equivalents with respect to Stock Units or Other Stock-Based Awards that vest based on performance
shall vest and be paid only if and to the extent the underlying Stock Units or Other Stock-Based Awards vest and are paid, as determined
by the Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
12. Consequences of a Change of Control</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Assumption
of Outstanding Grants</span>. Upon a Change of Control where the Company is not the surviving corporation (or survives only as a subsidiary
of another corporation), unless the Committee determines otherwise, all outstanding Grants that are not exercised or paid at the time
of the Change of Control shall be assumed by, or replaced with grants (with respect to cash, securities, or a combination thereof) that
have comparable terms by, the surviving corporation (or a parent or subsidiary of the surviving corporation). After a Change of Control,
references to the &#8220;Company&#8221; as they relate to employment matters shall include the successor employer in the transaction,
subject to applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Vesting
Upon Certain Terminations of Employment</span>. Unless the Grant Instrument provides otherwise, if a Participant&#8217;s employment is terminated
by the Employer without Cause upon or within 12 months following a Change of Control, the Participant&#8217;s outstanding Grants shall
become fully vested as of the date of such termination; provided that if the vesting of any such Grants is based, in whole or in part,
on performance, the applicable Grant Instrument shall specify how the portion of the Grant that becomes vested pursuant to this Section
12(b) shall be calculated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Other
Alternatives</span>. In the event of a Change of Control, if any outstanding Grants are not assumed by, or replaced with grants that have
comparable terms by, the surviving corporation (or a parent or subsidiary of the surviving corporation), the Committee may (but is not
obligated to) make adjustments to the terms and conditions of outstanding Grants, including, without limitation, taking any of the following
actions (or combination thereof) with respect to any or all outstanding Grants, without the consent of any Participant: (i) the Committee
may determine that outstanding Stock Options and SARs shall automatically accelerate and become fully exercisable and the restrictions
and conditions on outstanding Stock Awards, Stock Units and Dividend Equivalents shall immediately lapse; (ii) the Committee may determine
that Participants shall receive a payment in settlement of outstanding Stock Units or Dividend Equivalents, in such amount and form as
may be determined by the Committee; (iii) the Committee may require that Participants surrender their outstanding Stock Options and SARs
in exchange for a payment by the Company, in cash or Company Stock as determined by the Committee, in an amount equal to the amount,
if any, by which the then Fair Market Value of the shares of Company Stock subject to the Participant&#8217;s unexercised Stock Options
and SARs exceeds the Stock Option Exercise Price or SAR base amount, and (iv) after giving Participants an opportunity to exercise all
of their outstanding Stock Options and SARs, the Committee may terminate any or all unexercised Stock Options and SARs at such time as
the Committee deems appropriate. Such surrender, termination or payment shall take place as of the date of the Change of Control or such
other date as the Committee may specify. Without limiting the foregoing, if the per share Fair Market Value of the Company Stock does
not exceed the per share Stock Option Exercise Price or SAR base amount, as applicable, the Company shall not be required to make any
payment to the Participant upon surrender of the Stock Option or SAR.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
13. Deferrals</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may permit or require a Participant to defer receipt of the payment of cash or the delivery of shares that would otherwise
be due to such Participant in connection with any Grant. If any such deferral election is permitted or required, the Committee shall
establish rules and procedures for such deferrals and may provide for interest or other earnings to be paid on such deferrals. The rules
and procedures for any such deferrals shall be consistent with applicable requirements of section 409A of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
14. Withholding of Taxes</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Required
Withholding</span>. All Grants under the Plan shall be subject to applicable United States federal (including FICA), state and local, foreign
country or other tax withholding requirements. The Employer may require that the Participant or other person receiving Grants or exercising
Grants pay to the Employer an amount sufficient to satisfy such tax withholding requirements with respect to such Grants, or the Employer
may deduct from other wages and compensation paid by the Employer the amount of any withholding taxes due with respect to such Grants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Share
Withholding</span>. The Committee may permit or require the Employer&#8217;s tax withholding obligation with respect to Grants paid in Company
Stock to be satisfied by having shares withheld up to an amount that does not exceed the Participant&#8217;s applicable withholding tax
rate for United States federal (including FICA), state and local, foreign country or other tax liabilities. The Committee may, in its
discretion, and subject to such rules as the Committee may adopt, allow Participants to elect to have such share withholding applied
to all or a portion of the tax withholding obligation arising in connection with any particular Grant. Unless the Committee determines
otherwise, share withholding for taxes shall not exceed the Participant&#8217;s minimum applicable tax withholding amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
15. Transferability of Grants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Nontransferability
of Grants</span>. Except as described in subsection (b) below, only the Participant may exercise rights under a Grant during the Participant&#8217;s
lifetime. A Participant may not transfer those rights except (i) by will or by the laws of descent and distribution or (ii) with respect
to Grants other than Incentive Stock Options, pursuant to a domestic relations order. When a Participant dies, the personal representative
or other person entitled to succeed to the rights of the Participant may exercise such rights. Any such successor must furnish proof
satisfactory to the Company of his or her right to receive the Grant under the Participant&#8217;s will or under the applicable laws
of descent and distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Transfer
of Nonqualified Stock Options and Stock Awards</span>. Notwithstanding the foregoing, the Committee may provide, in a Grant Instrument or
at such other time after the grant of an award, that a Participant may transfer Nonqualified Stock Options or Stock Awards to family
members, or one or more trusts or other entities for the benefit of or owned by family members, consistent with the applicable securities
laws, according to such terms as the Committee may determine; provided that the Participant receives no consideration for the transfer
of an Option or Stock Award and the transferred Option or Stock Award shall continue to be subject to the same terms and conditions as
were applicable to the Option or Stock Award immediately before the transfer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
16. Requirements for Issuance or Transfer of Shares</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
Company Stock shall be issued or transferred in connection with any Grant hereunder unless and until all legal requirements applicable
to the issuance or transfer of such Company Stock have been complied with to the satisfaction of the Committee. The Committee shall have
the right to condition any Grant on the Participant&#8217;s undertaking in writing to comply with such restrictions on his or her subsequent
disposition of the shares of Company Stock as the Committee shall deem necessary or advisable, and certificates representing such shares
may be legended to reflect any such restrictions. Certificates representing shares of Company Stock issued or transferred under the Plan
may be subject to such stop-transfer orders and other restrictions as the Committee deems appropriate to comply with applicable laws,
regulations and interpretations, including any requirement that a legend be placed thereon.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
17. Amendment and Termination of the Plan</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Amendment</span>.
The Board may amend or terminate the Plan at any time; provided, however, that the Board shall not amend the Plan without stockholder
approval if such approval is required in order to comply with the Code or other applicable law, or to comply with applicable stock exchange
requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">No
Repricing of Options or SARs</span>. Except in connection with a corporate transaction involving the Company (including, without limitation,
any stock dividend, distribution (whether in the form of cash, Company Stock, other securities or property), stock split, extraordinary
cash dividend, recapitalization, change in control, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase
or exchange of shares of Company Stock or other securities, or similar transactions), the Company may not, without obtaining stockholder
approval, (i) amend the terms of outstanding Stock Options or SARs to reduce the Exercise Price of such outstanding Stock Options or
base price of such SARs, (ii) cancel outstanding Stock Options or SARs in exchange for Stock Options or SARs with an Exercise Price or
base price, as applicable, that is less than the Exercise Price or base price of the original Stock Options or SARs or (iii) cancel outstanding
Stock Options or SARs with an Exercise Price or base price, as applicable, above the current stock price in exchange for cash or other
securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Termination
of Plan</span>. The Plan shall terminate on the day immediately preceding the tenth anniversary of its Effective Date, unless the Plan is
terminated earlier by the Board or is extended by the Board with the approval of the stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Termination
and Amendment of Outstanding Grants</span>. A termination or amendment of the Plan that occurs after a Grant is made shall not materially
impair the rights of a Participant with respect to such Grant unless the Participant consents or unless the Committee acts under Section
18(f) below. The termination of the Plan shall not impair the power and authority of the Committee with respect to an outstanding Grant.
Whether or not the Plan has terminated, an outstanding Grant may be terminated or amended under Section 18(f) below or may be amended
by agreement of the Company and the Participant consistent with the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Section
18. Miscellaneous</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <span style="text-decoration: underline">Grants
in Connection with Corporate Transactions and Otherwise</span>. Nothing contained in the Plan shall be construed to (i) limit the right
of the Committee to make Grants under the Plan in connection with the acquisition, by purchase, lease, merger, consolidation or otherwise,
of the business or assets of any corporation, firm or association, including Grants to employees thereof who become Employees, or (ii)
limit the right of the Company to grant stock options or make other awards outside of the Plan. The Committee may make a Grant to an
employee of another corporation who becomes an Employee by reason of a corporate merger, consolidation, acquisition of stock or property,
reorganization or liquidation involving the Company, in substitution for a stock option or stock awards grant made by such corporation.
Notwithstanding anything in the Plan to the contrary, the Committee may establish such terms and conditions of the new Grants as it deems
appropriate, including setting the Exercise Price of Options or the base price of SARs at a price necessary to retain for the Participant
the same economic value as the prior options or rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <span style="text-decoration: underline">Governing
Document. The Plan shall be the controlling document</span>. No other statements, representations, explanatory materials or examples, oral
or written, may amend the Plan in any manner. The Plan shall be binding upon and enforceable against the Company and its successors and
assigns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <span style="text-decoration: underline">Funding
of the Plan</span>. The Plan shall be unfunded. The Company shall not be required to establish any special or separate fund or to make any
other segregation of assets to assure the payment of any Grants under the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <span style="text-decoration: underline">Rights
of Participants</span>. Nothing in the Plan shall entitle any Employee, Non-Employee Director, Key Advisor or other person to any claim
or right to receive a Grant under the Plan. Neither the Plan nor any action taken hereunder shall be construed as giving any individual
any rights to be retained by or in the employ of the Employer or any other employment rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <span style="text-decoration: underline">No
Fractional Shares</span>. No fractional shares of Company Stock shall be issued or delivered pursuant to the Plan or any Grant. Except as
otherwise provided under the Plan, the Committee shall determine whether cash, other awards or other property shall be issued or paid
in lieu of such fractional shares or whether such fractional shares or any rights thereto shall be forfeited or otherwise eliminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <span style="text-decoration: underline">Compliance
with Law.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) The
Plan, the exercise of Options and SARs and the obligations of the Company to issue or transfer shares of Company Stock under Grants shall
be subject to all applicable laws and regulations, and to approvals by any governmental or regulatory agency as may be required. With
respect to persons subject to section 16 of the Exchange Act, it is the intent of the Company that the Plan and all transactions under
the Plan comply with all applicable provisions of Rule 16b-3 or its successors under the Exchange Act. In addition, it is the intent
of the Company that Incentive Stock Options comply with the applicable provisions of section 422 of the Code, and that, to the extent
applicable, Grants comply with the requirements of section 409A of the Code. To the extent that any legal requirement of section 16 of
the Exchange Act or section 422 or 409A of the Code as set forth in the Plan ceases to be required under section 16 of the Exchange Act
or section 422 or 409A of the Code, that Plan provision shall cease to apply. The Committee may revoke any Grant if it is contrary to
law or modify a Grant to bring it into compliance with any valid and mandatory government regulation. The Committee may also adopt rules
regarding the withholding of taxes on payments to Participants. The Committee may, in its sole discretion, agree to limit its authority
under this Section.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) The
Plan is intended to comply with the requirements of section 409A of the Code, to the extent applicable. Each Grant shall be construed
and administered such that the Grant either (A) qualifies for an exemption from the requirements of section 409A of the Code or (B) satisfies
the requirements of section 409A of the Code. If a Grant is subject to section 409A of the Code, (I) distributions shall only be made
in a manner and upon an event permitted under section 409A of the Code, (II) payments to be made upon a termination of employment or
service shall only be made upon a &#8220;separation from service&#8221; under section 409A of the Code, (III) unless the Grant specifies
otherwise, each installment payment shall be treated as a separate payment for purposes of section 409A of the Code, and (IV) in no event
shall a Participant, directly or indirectly, designate the calendar year in which a distribution is made except in accordance with section
409A of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) Any
Grant that is subject to section 409A of the Code and that is to be distributed to a Key Employee (as defined below) upon separation
from service shall be administered so that any distribution with respect to such Grant shall be postponed for six months following the
date of the Participant&#8217;s separation from service, if required by section 409A of the Code. If a distribution is delayed pursuant
to section 409A of the Code, the distribution shall be paid within 15 days after the end of the six-month period. If the Participant
dies during such six-month period, any postponed amounts shall be paid within 90 days of the Participant&#8217;s death. The determination
of Key Employees, including the number and identity of persons considered Key Employees and the identification date, shall be made by
the Committee or its delegate each year in accordance with section 416(i) of the Code and the &#8220;specified employee&#8221; requirements
of section 409A of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) Notwithstanding
anything in the Plan or any Grant agreement to the contrary, each Participant shall be solely responsible for the tax consequences
of Grants under the Plan, and in no event shall the Company or any subsidiary or affiliate of the Company have any responsibility or
liability if a Grant does not meet any applicable requirements of section 409A of the Code. Although the Company intends to
administer the Plan to prevent taxation under section 409A of the Code, the Company does not represent or warrant that the Plan or
any Grant complies with any provision of federal, state, local or other tax law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <span style="text-decoration: underline">Grants
in Foreign Countries; Establishment of Subplans</span>. The Committee has the authority to award Grants to Participants who are foreign
nationals or employed outside the United States on any different terms and conditions than those specified in the Plan that the Committee,
in its discretion, believes to be necessary or desirable to accommodate differences in applicable law, tax policy, or custom, while furthering
the purposes of the Plan. The Board may from time to time establish one or more sub-plans under the Plan for purposes of satisfying applicable
blue sky, securities or tax laws of various jurisdictions. The Board shall establish such sub-plans by adopting supplements to the Plan
setting forth (i) such limitations on the Committee&#8217;s discretion under the Plan as the Board deems necessary or desirable and (ii)
such additional terms and conditions not otherwise inconsistent with the Plan as the Board shall deem necessary or desirable. All supplements
adopted by the Board shall be deemed to be part of the Plan, but each supplement shall apply only to Participants within the affected
jurisdiction and the Employer shall not be required to provide copies of any supplement to Participants in any jurisdiction that is not
affected. Notwithstanding the foregoing, the Committee may not approve any sub-plan inconsistent with the terms or share limits in the
Plan or which would otherwise cause the Plan to cease to satisfy any conditions under Rule 16b-3 under the 1934 Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <span style="text-decoration: underline">Clawback
Rights</span>. Subject to the requirements of applicable law, the Committee may provide in any Grant Instrument that, if a Participant breaches
any restrictive covenant agreement between the Participant and the Employer (which may be set forth in any Grant Instrument) or otherwise
engages in activities that constitute Cause either while employed by, or providing service to, the Employer or within a specified period
of time thereafter, all Grants held by the Participant shall terminate, and the Company may rescind any exercise of an Option or SAR
and the vesting of any other Grant and delivery of shares upon such exercise or vesting (including pursuant to dividends and Dividend
Equivalents), as applicable on such terms as the Committee shall determine, including the right to require that in the event of any such
rescission, (i) the Participant shall return to the Company the shares received upon the exercise of any Option or SAR and/or the vesting
and payment of any other Grant (including pursuant to dividends and Dividend Equivalents) or, (ii) if the Participant no longer owns
the shares, the Participant shall pay to the Company the amount of any gain realized or payment received as a result of any sale or other
disposition of the shares (or, in the event the Participant transfers the shares by gift or otherwise without consideration, the Fair
Market Value of the shares on the date of the breach of the restrictive covenant agreement (including a Participant&#8217;s Grant Instrument
containing restrictive covenants) or activity constituting Cause), net of the price originally paid by the Participant for the shares.
Payment by the Participant shall be made in such manner and on such terms and conditions as may be required by the Committee. The Employer
shall be entitled to set off against the amount of any such payment any amounts otherwise owed to the Participant by the Employer. In
addition, all Grants under the Plan shall be subject to any applicable clawback or recoupment policies, share trading policies and other
policies that may be implemented by the Board from time to time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <span style="text-decoration: underline">Governing
Law; Jurisdiction</span>. The validity, construction, interpretation and effect of the Plan and Grant Instrument issued under the Plan shall
be governed and construed by and determined in accordance with the laws of the Commonwealth of Massachusetts, without giving effect to
the conflict of laws provisions thereof. Any action arising out of, or relating to, any of the provisions of the Plan and Grants made
hereunder shall be brought only in the United States District Court for the District of Massachusetts, or if such court does not have
jurisdiction or will not accept jurisdiction, in any court of general jurisdiction in Massachusetts, and the jurisdiction of such court
in any such proceeding shall be exclusive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Appendix
B</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTIFICATE
OF AMENDMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OF</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTIFICATE
OF INCORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OF</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>KOPIN
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 242 of the</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
Corporation Law of the State of Delaware</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KOPIN
CORPORATION (the &#8220;Corporation&#8221;), a corporation organized and existing under and by virtue of the General Corporation
Law of the State of Delaware,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DOES
HEREBY CERTIFY:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FIRST:
That at a meeting of the Board of Directors of the Corporation resolutions were duly adopted setting forth a proposed
amendment to the Certificate of Incorporation, as amended to date (the &#8220;Charter Amendment&#8221;) and declaring said Charter
Amendment to be advisable and directing the stockholders of the Corporation to consider said Charter Amendment and to indicate their
approval and adoption thereof. The resolution setting forth the amendment is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RESOLVED,
That the first sentence of Article Fourth of the Restated Certificate of Incorporation of the Corporation be and it hereby is amended
to read as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;FOURTH:
The total number of shares of stock which the Corporation shall have authority to issue is two hundred and seventy-five
million and three thousand (275,003,000) shares, of which three thousand (3,000) shares, par value of $.01 each, are to be of
a class designated Preferred Stock, and two hundred and seventy five million (275,000,000) shares, par value of $.01 each,
are to be of a class designated Common Stock.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECOND:
That thereafter, pursuant to resolution of its Board of Directors, an annual meeting of the stockholders of said corporation was duly
called and held, upon notice in accordance with Sections 211 and 222 of the General Corporation Law of the State of Delaware at
which meeting the necessary number of shares as required by statute were voted in favor of the amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIRD:
That the aforesaid Charter Amendment was duly adopted in accordance with the applicable provisions of Section 242 of the General
Corporation Law of the State of Delaware.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOURTH:
That this Certificate of Amendment to the Certificate of Incorporation shall become effective upon the filing of the Certificate of Amendment
with the Delaware Secretary of State, which will occur as soon as reasonably practicable after approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, said Kopin Corporation has caused this Certificate of Amendment to the Certificate of Incorporation to be executed,
acknowledged and filed by its Chief Financial Officer this [&#9679;] day of June 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KOPIN
    CORPORATION </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Richard A. Sneider</i> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 5%">Name:</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
    A. Sneider </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="proxy_001.jpg" style="width: 800px"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="proxy_002.jpg" style="width: 800px"/>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>








<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33.25<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">49.63<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">30.32<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (43,877,896)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (19,748,219)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(19,326,265)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Mr.
    Murray<span></span>
</td>
<td class="text">Dr.
    Fan<span></span>
</td>
<td class="text">Mr.
    Murray<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">Mr.
    Murray<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=KOPN_JohnCCFanMember', window );">John C.C.Fan [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">609,776<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">254,406<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=KOPN_MMurrayMember', window );">M.Murray [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,263,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,390,838<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,042,357<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,263,936<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,223,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,491,558<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">1,651,367<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">1,223,936<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">992,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,108,600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,041,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=KOPN_MMurrayMember', window );">M.Murray [Member] | Reported Value of Equity Awards [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">(1,032,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,007,880<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">431,999<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=KOPN_MMurrayMember', window );">M.Murray [Member] | Year End Fair Value Of Equity Award Granted During Year That Remains Unvested [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">992,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,668,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">428,190<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=KOPN_MMurrayMember', window );">M.Murray [Member] | Year Over Year Change In Fair Value Of Outstanding And Unvested Equity Awards [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">328,533<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">505,600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=KOPN_MMurrayMember', window );">M.Murray [Member] | Fair Value As Of Vesting Date Of Equity Awards Granted And Vested In The Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">56,020<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=KOPN_MMurrayMember', window );">M.Murray [Member] | Change In Fair Value Of Equity Awards Granted In Prior Years That Vested In The Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(220,392)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">51,200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=KOPN_MMurrayMember', window );">M.Murray [Member] | Fair Value At The End Of The Prior Year Of Equity Awards That Failed To Meet Vesting Conditions In The Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,475)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=KOPN_MMurrayMember', window );">M.Murray [Member] | Value Of Dividends Or Other Earnings Paid On Stock Awards Not Other Wise Reflected In Fair Value Or Total Compensation [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=KOPN_DrFanMember', window );">Dr. Fan [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">609,776<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(254,406)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(864,182)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=KOPN_DrFanMember', window );">Dr. Fan [Member] | Reported Value of Equity Awards [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=KOPN_DrFanMember', window );">Dr. Fan [Member] | Year End Fair Value Of Equity Award Granted During Year That Remains Unvested [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=KOPN_DrFanMember', window );">Dr. Fan [Member] | Year Over Year Change In Fair Value Of Outstanding And Unvested Equity Awards [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(94,860)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=KOPN_DrFanMember', window );">Dr. Fan [Member] | Fair Value As Of Vesting Date Of Equity Awards Granted And Vested In The Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=KOPN_DrFanMember', window );">Dr. Fan [Member] | Change In Fair Value Of Equity Awards Granted In Prior Years That Vested In The Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(493,723)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=KOPN_DrFanMember', window );">Dr. Fan [Member] | Fair Value At The End Of The Prior Year Of Equity Awards That Failed To Meet Vesting Conditions In The Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(275,599)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=KOPN_DrFanMember', window );">Dr. Fan [Member] | Value Of Dividends Or Other Earnings Paid On Stock Awards Not Other Wise Reflected In Fair Value Or Total Compensation [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">516,011<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">602,068<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">378,934<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">427,512<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">684,290<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(89,244)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,375<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">337,362<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(468,178)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Reported Value of Equity Awards [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(159,873)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">255,140<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Year End Fair Value Of Equity Award Granted During Year That Remains Unvested [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164,090<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">260,026<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Year Over Year Average Change In Fair Value Of Outstanding And Unvested Equity Awards [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,840<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">37,130<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(276,055)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Average Fair Value As Of Vesting Date Of Equity Awards Granted And Vested In The Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">45,538<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Year Over Year Average Change In Fair Value Of Equity Awards Granted In Prior Years That Vested In The Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57,187)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,920<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(94,670)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Average Fair Value At The End Of The Prior Year Of Equity Awards That Failed To Meet Vesting Conditions In The Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,688)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(15,252)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(97,453)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Average Value Of Dividends Or Other Earnings Paid On Stock Awards Not Other Wise Reflected In Fair Value Or Total Compensation [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Dr
    Fan was our PEO for part of fiscal year 2022 and was replaced by Mr. Murray for part of fiscal year 2022. Mr. Murray was PEO for
    fiscal years 2023 and 2024. The Non-PEO NEOs for the presented consists of Mr. Sneider and Mr. Baker in 2024 and 2023.The Non-PEO NEOs consisted of Messrs. Sneider and Baker and Drs. Tsaur and Choi in 2022.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Compensation
    Actually Paid reflects the exclusions and inclusions of certain amounts for the PEO and the Non-PEO NEOs as set forth below. Equity
    values are calculated in accordance with FASB ASC Topic 718.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The
    equity award adjustments include the addition (or subtraction, as applicable) of the following: (i) the year-end fair value of any
    equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change
    as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that
    are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in same applicable
    year, the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the applicable year, the amount
    equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for awards granted in prior
    years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount
    equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on
    stock awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or
    included in any other component of total compensation for the applicable year. The valuation assumptions used to calculate fair value
    did not materially differ from those disclosed at the time of grant. The amounts deducted or added in calculating the equity award
    adjustments are as follows:</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Represents
    the total of the grant date fair value of equity award reported in the &#8220;Stock Awards&#8221; column in the Summary Compensation
    Table for the applicable year.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">The
    equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i)&#160;the
    year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year;
    (ii)&#160;the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any
    awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii)&#160;for awards that
    are granted and vest in same applicable year, the fair value as of the vesting date; (iv)&#160;for awards granted in prior years
    that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in
    fair value; (v)&#160;for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during
    the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi)&#160;the dollar
    value of any dividends or other earnings paid on stock awards in the applicable year prior to the vesting date that are not otherwise
    reflected in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation
    assumptions used to calculate fair value did not materially differ from those disclosed at the time of grant. The amounts deducted
    or added in calculating the equity award adjustments are as follows:</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">Represents the total of the grant date fair value of the equity
    awards reported in the &#8220;Stock Awards&#8221; column in the Summary Compensation Table for the applicable year.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">Represents
    the total of the average grant date fair value of the equity awards reported in the &#8220;Stock Awards&#8221; column in the Summary
    Compensation Table for the applicable year for all Non- PEO NEOs.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top">The
    equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i) the
    year- end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year;
    (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards
    granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted
    and vest in same applicable year, the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the
    applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v)
    for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year,
    a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends
    or other earnings paid on stock awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair
    value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions used
    to calculate fair value did not materially differ from those disclosed at the time of grant. The amounts deducted or added in calculating
    the equity award adjustments are as follows:</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=KOPN_JohnCCFanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=KOPN_JohnCCFanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=KOPN_MMurrayMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=KOPN_MMurrayMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=KOPN_ReportedValueOfEquityAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=KOPN_ReportedValueOfEquityAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=KOPN_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=KOPN_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=KOPN_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=KOPN_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=KOPN_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=KOPN_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=KOPN_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=KOPN_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=KOPN_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=KOPN_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=KOPN_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=KOPN_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=KOPN_DrFanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=KOPN_DrFanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=KOPN_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=KOPN_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=KOPN_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=KOPN_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=KOPN_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=KOPN_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=KOPN_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=KOPN_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=KOPN_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=KOPN_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>65</ContextCount>
  <ElementCount>19</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>16</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="formdef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kopin.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="formdef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="formdef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="formdef14a.htm">formdef14a.htm</File>
    <File>kopn-20241228.xsd</File>
    <File>kopn-20241228_def.xml</File>
    <File>kopn-20241228_lab.xml</File>
    <File>kopn-20241228_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>formdef14a_001.jpg</File>
    <File>formdef14a_002.jpg</File>
    <File>proxy_001.jpg</File>
    <File>proxy_002.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="109">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>29
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "formdef14a.htm": {
   "nsprefix": "KOPN",
   "nsuri": "http://kopin.com/20241228",
   "dts": {
    "inline": {
     "local": [
      "formdef14a.htm"
     ]
    },
    "schema": {
     "local": [
      "kopn-20241228.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "kopn-20241228_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "kopn-20241228_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "kopn-20241228_pre.xml"
     ]
    }
   },
   "keyStandard": 19,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 15,
   "hidden": {
    "total": 27,
    "http://xbrl.sec.gov/ecd/2024": 24,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 65,
   "entityCount": 1,
   "segmentCount": 16,
   "elementCount": 110,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2024": 109,
    "http://xbrl.sec.gov/dei/2024": 4,
    "http://fasb.org/us-gaap/2024": 3
   },
   "report": {
    "R1": {
     "role": "http://kopin.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2023-12-31to2024-12-28",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-12-31to2024-12-28",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "From2023-12-31to2024-12-28",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-12-31to2024-12-28",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "3",
     "firstAnchor": {
      "contextRef": "From2023-12-31to2024-12-28",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-12-31to2024-12-28",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r67",
      "r77",
      "r87",
      "r112"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r70",
      "r80",
      "r90",
      "r115"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r108",
      "r116",
      "r120",
      "r128"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "auth_ref": [
      "r126"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://kopin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://kopin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "KOPN_AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kopin.com/20241228",
     "localname": "AverageFairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Fair Value As Of Vesting Date Of Equity Awards Granted And Vested In The Year [Member]",
        "documentation": "Average Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "KOPN_AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kopin.com/20241228",
     "localname": "AverageFairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Fair Value At The End Of The Prior Year Of Equity Awards That Failed To Meet Vesting Conditions In The Year [Member]",
        "documentation": "Average Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "KOPN_AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kopin.com/20241228",
     "localname": "AverageValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Value Of Dividends Or Other Earnings Paid On Stock Awards Not Other Wise Reflected In Fair Value Or Total Compensation [Member]",
        "documentation": "Average Value of Dividends or Other Earnings Paid on Stock Awards Not Otherwise Reflected in Fair Value or Total Compensation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "KOPN_ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kopin.com/20241228",
     "localname": "ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Fair Value Of Equity Awards Granted In Prior Years That Vested In The Year [Member]",
        "documentation": "Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://kopin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://kopin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "KOPN_DrFanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kopin.com/20241228",
     "localname": "DrFanMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dr. Fan [Member]",
        "documentation": "Dr. Fan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://kopin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://kopin.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r67",
      "r77",
      "r87",
      "r112"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r64",
      "r74",
      "r84",
      "r109"
     ]
    },
    "KOPN_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kopin.com/20241228",
     "localname": "FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value As Of Vesting Date Of Equity Awards Granted And Vested In The Year [Member]",
        "documentation": "Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "KOPN_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kopin.com/20241228",
     "localname": "FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value At The End Of The Prior Year Of Equity Awards That Failed To Meet Vesting Conditions In The Year [Member]",
        "documentation": "Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r108",
      "r116",
      "r120",
      "r128"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r63",
      "r131"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r63",
      "r131"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r63",
      "r131"
     ]
    },
    "KOPN_JohnCCFanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kopin.com/20241228",
     "localname": "JohnCCFanMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "John C.C.Fan [Member]",
        "documentation": "John C.C.Fan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "KOPN_MMurrayMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kopin.com/20241228",
     "localname": "MMurrayMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "M.Murray [Member]",
        "documentation": "M.Murray [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net Income (Loss) Attributable to Parent",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r132"
     ]
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r69",
      "r79",
      "r89",
      "r114"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r72",
      "r82",
      "r92",
      "r117"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r72",
      "r82",
      "r92",
      "r117"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "auth_ref": [
      "r95"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "auth_ref": [
      "r64",
      "r74",
      "r84",
      "r109"
     ]
    },
    "KOPN_ReportedValueOfEquityAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kopin.com/20241228",
     "localname": "ReportedValueOfEquityAwardsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reported Value of Equity Awards [Member]",
        "documentation": "Reported Value of Equity Awards [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r65",
      "r75",
      "r85",
      "r110"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r66",
      "r76",
      "r86",
      "r111"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r83",
      "r93",
      "r118"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r68",
      "r78",
      "r88",
      "r113"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "KOPN_ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kopin.com/20241228",
     "localname": "ValueOfDividendsOrOtherEarningsPaidOnStockAwardsNotOtherWiseReflectedInFairValueOrTotalCompensationMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value Of Dividends Or Other Earnings Paid On Stock Awards Not Other Wise Reflected In Fair Value Or Total Compensation [Member]",
        "documentation": "Value of Dividends or other Earnings Paid on Stock Awards Not Otherwise Reflected in Fair Value or Total Compensation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "KOPN_YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kopin.com/20241228",
     "localname": "YearEndFairValueOfEquityAwardGrantedDuringYearThatRemainsUnvestedMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year End Fair Value Of Equity Award Granted During Year That Remains Unvested [Member]",
        "documentation": "Year End Fair Value of Equity Award Granted During Year that Remains Unvested [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "KOPN_YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kopin.com/20241228",
     "localname": "YearOverYearAverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year Over Year Average Change In Fair Value Of Equity Awards Granted In Prior Years That Vested In The Year [Member]",
        "documentation": "Year Over Year Average Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "KOPN_YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kopin.com/20241228",
     "localname": "YearOverYearAverageChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year Over Year Average Change In Fair Value Of Outstanding And Unvested Equity Awards [Member]",
        "documentation": "Year Over Year Average Change in Fair Value of Outstanding and Unvested Equity Awards [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "KOPN_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kopin.com/20241228",
     "localname": "YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year Over Year Change In Fair Value Of Outstanding And Unvested Equity Awards [Member]",
        "documentation": "Year Over Year Change in Fair Value of Outstanding and Unvested Equity Awards [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
